data_2kr5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kr5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 112.239 -0.344 . . . . 0.55000000000000004 112.239 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 m -119.38 158.24 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.55 -0.537 . . . . 1.1399999999999999 109.55 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 p -83.74 172.85 11.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.186 -0.301 . . . . 1.8899999999999999 110.186 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -70.23 -16.76 63.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.279 0.561 . . . . 2.3300000000000001 110.196 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -66.27 -47.69 72.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.367 -0.833 . . . . 1.9099999999999999 109.702 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -68.99 -27.56 65.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.884 -0.598 . . . . 2.1099999999999999 109.926 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -24.81 63.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.478 -0.783 . . . . 1.6000000000000001 110.688 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.26 -32.78 26.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.385 0.612 . . . . 0.88 110.246 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.08 -27.32 57.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 1.05 111.051 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.83 HG12 ' HZ1' ' A' ' 79' ' ' LYS . 2.8 p -70.65 -40.73 77.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.053 -0.521 . . . . 1.0700000000000001 111.674 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.4 mtp -61.49 -31.14 71.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 2.2400000000000002 111.309 -173.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -78.69 -27.76 45.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.589 -0.444 . . . . 3.6899999999999999 111.101 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.3 t -73.72 -37.63 49.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.525 -0.917 . . . . 1.0800000000000001 108.525 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 t -65.14 -44.08 95.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.413 -1.267 . . . . 1.04 110.433 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.5 p -56.01 -50.47 70.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.231 0.539 . . . . 1.8400000000000001 110.346 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -55.37 -53.92 50.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.968 -1.015 . . . . 2.2599999999999998 112.749 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -82.66 -16.43 48.28 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.62 0.6 . . . . 0.77000000000000002 112.62 -170.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 81.6 p -91.72 -36.48 13.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.093 0.473 . . . . 1.23 110.722 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.87 -0.01 56.36 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.844 -0.693 . . . . 0.54000000000000004 111.685 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.655 HD12 ' HG2' ' A' ' 40' ' ' MET . 3.1 mt -93.91 123.98 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 109.517 -0.549 . . . . 1.28 109.517 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.66 141.76 36.59 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.315 0.385 . . . . 1.26 111.101 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.14 -34.14 59.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.899 -0.591 . . . . 1.6000000000000001 111.227 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.35 -10.42 59.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 2.23 111.292 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -109.99 -3.85 16.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.971 0.415 . . . . 2.2400000000000002 110.231 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.9 tp -74.31 99.34 3.45 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.387 0.613 . . . . 1.6799999999999999 110.239 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 44.6 p -121.73 164.53 17.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.271 -0.877 . . . . 1.21 108.857 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.97 -9.88 34.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.801 0.334 . . . . 2.29 111.307 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.92 -19.6 60.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 2.29 110.487 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.51 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 18.3 m -71.5 143.08 50.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.038 0.446 . . . . 1.3300000000000001 109.835 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.64 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.9 t-20 -128.43 117.87 22.12 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.579 -0.526 . . . . 1.2 109.579 -176.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.647 ' HD1' HG13 ' A' ' 42' ' ' ILE . 48.1 m-85 -55.36 -39.7 70.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.889 0.376 . . . . 0.63 111.698 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.23 -29.25 60.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.875 0.369 . . . . 1.1499999999999999 111.212 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.64 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 34.6 t70 -74.81 -31.15 61.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.185 0.517 . . . . 0.82999999999999996 110.267 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.655 ' HG2' HD12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -81.04 -14.65 57.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.401 -0.818 . . . . 2.98 110.761 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.67 42.87 6.29 Favored Glycine 0 CA--C 1.511 -0.207 0 C-N-CA 120.378 -0.915 . . . . 0.54000000000000004 112.153 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.647 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.6 mm -75.54 107.28 6.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.988 0.423 . . . . 1.2 109.903 176.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -80.19 175.19 10.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.438 0.637 . . . . 1.9399999999999999 111.82 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 t -52.86 -42.86 65.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.557 -1.201 . . . . 1.1399999999999999 111.189 177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.36 -61.64 2.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.99 -0.55 . . . . 1.22 110.257 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 50' ' ' ILE . 29.0 t -61.18 -47.09 87.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.473 -0.33 . . . . 1.46 111.601 -175.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.488 ' HB3' HG22 ' A' ' 42' ' ' ILE . 51.0 p -62.38 -27.44 69.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.682 0.253 . . . . 1.1000000000000001 111.682 -176.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.9 ttt -80.36 -39.9 27.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.246 0.546 . . . . 2.8500000000000001 109.841 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.85 -42.21 95.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.315 -0.857 . . . . 1.1499999999999999 109.986 -177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 46' ' ' SER . 73.8 mt -56.75 -58.18 6.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.932 -0.576 . . . . 1.05 111.232 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -65.35 -23.73 70.26 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.607 -0.806 . . . . 0.35999999999999999 112.398 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.576 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -69.63 -45.71 67.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.803 -0.443 . . . . 1.6599999999999999 109.803 175.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -61.27 -31.99 71.81 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.428 -0.351 . . . . 1.48 110.533 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE2' HD23 ' A' ' 78' ' ' LEU . 13.1 m-30 -53.68 -40.58 66.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.892 -0.594 . . . . 0.33000000000000002 110.02 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.576 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 53.2 mtm180 -81.04 -37.76 28.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.068 -0.514 . . . . 3.3300000000000001 111.142 -175.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -87.86 -52.45 5.28 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.316 0.488 . . . . 2.2599999999999998 112.316 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -80.41 -42.24 23.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.807 -0.633 . . . . 2.6200000000000001 111.18 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.2 mp -96.08 -33.0 12.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.405 -0.361 . . . . 1.1200000000000001 111.685 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.23 35.07 9.05 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.516 -0.85 . . . . 0.45000000000000001 112.101 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 54' ' ' PHE . 82.2 mt -87.08 131.15 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.582 0.23 . . . . 1.23 110.939 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -89.33 47.11 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.639 -0.504 . . . . 2.27 109.639 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -59.16 4.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.188 -0.915 . . . . 2.1299999999999999 110.726 -174.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.48 ' O ' ' HD3' ' A' ' 55' ' ' ARG . . . 172.41 167.86 33.01 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.629 -0.588 . . . . 0.92000000000000004 111.629 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.89 -37.08 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.465 2.11 . . . . 1.2 113.38 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.14 45.34 2.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.308 0.575 . . . . 2.3599999999999999 110.438 -175.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -74.2 112.53 10.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.448 -0.797 . . . . 0.84999999999999998 109.876 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.1 p -118.3 129.04 55.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 1.71 111.173 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.488 HD11 HD13 ' A' ' 50' ' ' ILE . 75.3 mt -76.2 2.96 11.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 1.3700000000000001 111.672 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.69 -17.7 22.93 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.122 -0.49 . . . . 0.83999999999999997 110.15 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.2 mt -132.26 -37.39 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.093 0.473 . . . . 1.51 111.141 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.78 -2.8 46.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.684 0.754 . . . . 2.23 110.683 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 98.5 m -147.23 157.8 43.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.167 -0.924 . . . . 1.0 108.735 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.3 p -129.95 -73.41 0.56 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.163 -0.215 . . . . 1.29 111.276 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.2 p -90.25 -171.58 3.16 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.246 -0.284 . . . . 1.1399999999999999 110.625 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 1.8 t -79.47 -44.33 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.568 -0.53 . . . . 1.3700000000000001 109.568 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -59.15 -32.69 70.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.691 -0.686 . . . . 3.71 110.985 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -56.68 -37.16 70.48 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.35 -0.386 . . . . 1.1100000000000001 111.171 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.491 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -74.28 -43.2 57.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.536 0.684 . . . . 1.3100000000000001 109.398 178.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 1.019 ' HZ2' ' HA ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -53.92 -61.33 2.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.618 -1.174 . . . . 2.96 112.102 178.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.99 -37.83 77.76 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.107 0.254 . . . . 1.6599999999999999 111.596 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.559 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 3.7 t80 -52.69 -39.65 62.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.598 0.561 . . . . 1.2 111.067 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.662 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 7.9 mtt . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.564 -0.744 . . . . 1.1000000000000001 112.092 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.124 0 N-CA-C 111.809 -0.516 . . . . 0.55000000000000004 111.809 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.461 HG22 ' SD ' ' A' ' 82' ' ' MET . 5.9 m -97.93 158.37 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.963 -0.384 . . . . 1.1399999999999999 109.963 -175.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.4 t -83.86 -177.11 6.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.844 -0.428 . . . . 1.8899999999999999 109.844 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -71.83 -22.03 61.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.005 0.431 . . . . 2.3300000000000001 110.603 -174.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -73.96 -41.6 61.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.462 -0.495 . . . . 1.9099999999999999 110.076 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -66.71 -30.87 71.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.893 -0.78 . . . . 2.1099999999999999 108.893 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.1 tp -69.78 -26.19 64.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.975 -1.012 . . . . 1.6000000000000001 110.701 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.693 ' HA ' ' HE3' ' A' ' 17' ' ' MET . 0.4 OUTLIER -86.28 -27.07 24.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.414 0.626 . . . . 0.88 110.095 177.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.76 -35.36 57.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.687 -0.688 . . . . 1.05 110.802 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.71 ' HB ' ' HE2' ' A' ' 82' ' ' MET . 3.6 p -61.68 -45.42 98.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.989 -0.551 . . . . 1.0700000000000001 110.624 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.693 ' HE3' ' HA ' ' A' ' 14' ' ' ASP . 67.1 mtm -59.39 -39.0 81.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.796 -0.638 . . . . 2.2400000000000002 111.52 -174.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.442 ' HA ' ' HB2' ' A' ' 21' ' ' SER . 11.8 ptt180 -74.07 -29.38 61.85 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.087 -0.645 . . . . 3.6899999999999999 111.569 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.6 t -71.68 -33.01 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.087 0.946 . . . . 1.0800000000000001 108.56 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -70.66 -43.63 77.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.032 -1.44 . . . . 1.04 109.712 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.442 ' HB2' ' HA ' ' A' ' 18' ' ' ARG . 6.3 m -62.66 -21.87 66.03 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 122.748 0.419 . . . . 1.8400000000000001 111.828 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.09 -51.71 6.15 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.316 -0.402 . . . . 2.2599999999999998 111.365 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.484 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 15.2 mm-40 -90.49 -27.94 18.88 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.104 0.409 . . . . 0.77000000000000002 112.104 -172.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.426 ' HB3' HD11 ' A' ' 42' ' ' ILE . 17.5 m -86.4 -32.44 20.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.114 0.483 . . . . 1.23 110.544 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.41 -9.53 62.82 Favored Glycine 0 C--O 1.23 -0.111 0 C-N-CA 120.503 -0.856 . . . . 0.54000000000000004 112.682 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mt -79.37 104.77 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.623 -0.51 . . . . 1.28 109.623 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.59 ' HB1' ' HG2' ' A' ' 30' ' ' GLU . . . -43.67 145.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.857 0.723 . . . . 1.26 112.02 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.4 tp -56.47 -31.5 64.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.705 -0.679 . . . . 1.6000000000000001 111.002 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -80.39 -9.75 59.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.057 -0.519 . . . . 2.23 111.181 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.59 ' HG2' ' HB1' ' A' ' 27' ' ' ALA . 40.6 mm-40 -110.71 -13.9 14.11 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.192 -0.458 . . . . 2.2400000000000002 110.052 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.8 tp -69.6 98.14 1.12 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.639 -0.71 . . . . 1.6799999999999999 110.27 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.1 p -107.62 161.84 14.5 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.361 -0.836 . . . . 1.21 108.969 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.737 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 7.5 p-10 -75.54 -9.05 58.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.765 0.317 . . . . 2.29 111.064 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -91.02 -23.65 20.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.416 0.525 . . . . 2.29 112.416 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.7 m -71.3 148.44 47.12 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.423 0.63 . . . . 1.3300000000000001 110.011 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.731 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 4.4 t-20 -113.24 123.49 50.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.417 -0.81 . . . . 1.2 109.812 -170.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.777 ' HD1' HG13 ' A' ' 42' ' ' ILE . 32.3 m-85 -56.49 -53.1 61.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.964 0.412 . . . . 0.63 111.587 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.06 -27.91 66.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.179 -0.464 . . . . 1.1499999999999999 111.321 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.731 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 23.4 t70 -72.06 -32.65 67.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.397 0.617 . . . . 0.82999999999999996 110.251 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.83 ' HE2' ' HA ' ' A' ' 40' ' ' MET . 4.8 mmt -83.48 -13.99 53.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.252 -0.885 . . . . 2.98 111.178 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.82 36.07 6.2 Favored Glycine 0 N--CA 1.457 0.071 0 C-N-CA 120.063 -1.065 . . . . 0.54000000000000004 112.516 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.777 HG13 ' HD1' ' A' ' 37' ' ' PHE . 32.7 mm -73.19 108.07 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.201 0.524 . . . . 1.2 110.013 175.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.29 163.84 27.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.539 -0.755 . . . . 1.9399999999999999 111.351 -173.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.5 t -54.49 -37.3 65.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.293 -0.867 . . . . 1.1399999999999999 111.054 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.77 -61.54 2.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 1.22 110.203 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.575 ' O ' HG13 ' A' ' 50' ' ' ILE . 11.6 m -62.68 -42.89 99.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.433 -0.349 . . . . 1.46 111.69 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.553 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 57.6 p -63.86 -32.18 73.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.95 0.405 . . . . 1.1000000000000001 111.204 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.9 tpt -75.78 -39.85 56.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.326 0.584 . . . . 2.8500000000000001 109.734 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.9 t -60.25 -45.82 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.292 -0.867 . . . . 1.1499999999999999 109.97 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 46' ' ' SER . 78.8 mt -55.56 -54.31 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.932 -0.576 . . . . 1.05 111.355 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.35 -36.36 92.36 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.736 -0.745 . . . . 0.35999999999999999 112.419 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 m -61.36 -47.44 85.84 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 120.591 -0.443 . . . . 1.6599999999999999 110.108 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -61.48 -32.25 72.25 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.431 -0.349 . . . . 1.48 111.31 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.484 ' HD2' HD13 ' A' ' 62' ' ' LEU . 11.0 m-30 -53.09 -38.95 62.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.151 0.5 . . . . 0.33000000000000002 110.21 176.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -83.54 -29.77 27.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.482 -0.781 . . . . 3.3300000000000001 111.116 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -85.12 -62.17 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.268 0.556 . . . . 2.2599999999999998 111.044 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -44.31 52.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.116 -0.947 . . . . 2.6200000000000001 111.094 -173.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 mp -93.7 -32.18 14.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.378 -0.374 . . . . 1.1200000000000001 111.312 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.99 29.76 30.59 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.681 -0.771 . . . . 0.45000000000000001 112.354 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.8 mt -82.54 108.15 15.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.731 -0.47 . . . . 1.23 109.731 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -81.18 78.43 7.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.641 0.734 . . . . 2.27 109.353 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.484 HD13 ' HD2' ' A' ' 54' ' ' PHE . 27.1 mt -76.07 -71.97 0.35 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.326 -1.306 . . . . 2.1299999999999999 110.995 -176.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.98 169.45 38.91 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.415 -0.811 . . . . 0.92000000000000004 111.289 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.23 -15.46 11.46 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.672 2.248 . . . . 1.2 113.006 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -119.12 10.87 12.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.313 -0.403 . . . . 2.3599999999999999 111.19 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.433 ' CD2' HD11 ' A' ' 62' ' ' LEU . 73.2 t80 -71.93 112.85 8.37 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.948 0.404 . . . . 0.84999999999999998 110.488 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.7 m -131.13 121.24 24.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.692 -0.686 . . . . 1.71 109.628 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.535 HD21 HD11 ' A' ' 78' ' ' LEU . 2.5 mp -54.12 -32.12 54.19 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.24 0.459 . . . . 1.3700000000000001 112.24 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.553 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 1.8 t80 -65.99 -14.57 61.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.946 0.403 . . . . 0.83999999999999997 110.855 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.0 mt -124.0 -39.01 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.514 -0.312 . . . . 1.51 110.671 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -95.15 6.09 50.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 2.23 111.796 -172.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.487 ' SG ' ' HG ' ' A' ' 78' ' ' LEU . 80.1 m -148.96 100.71 3.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.554 0.693 . . . . 1.0 109.983 -175.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.8 p -90.02 -72.88 0.54 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.694 -0.685 . . . . 1.29 110.194 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 77.5 p -86.67 -177.67 6.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.415 -0.587 . . . . 1.1399999999999999 109.415 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.7 t -80.21 -40.68 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 120.361 -0.536 . . . . 1.3700000000000001 110.419 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.737 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 8.4 tpt180 -54.67 -32.22 58.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.926 -0.579 . . . . 3.71 110.533 173.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -59.42 -31.57 69.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 1.1100000000000001 111.739 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.535 HD11 HD21 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -81.7 -45.28 15.93 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.706 -0.85 . . . . 1.3100000000000001 108.706 -179.007 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -53.2 -61.56 2.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.945 -1.48 . . . . 2.96 110.832 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.17 -19.05 63.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.937 -1.029 . . . . 1.6599999999999999 111.019 -173.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 83.4 t80 -63.06 -42.66 99.75 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.278 0.561 . . . . 1.2 109.596 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.71 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 12.5 mtt . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.203 -0.908 . . . . 1.1000000000000001 111.385 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 111.557 -0.617 . . . . 0.55000000000000004 111.557 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 12' ' ' LYS . 2.7 m -114.39 157.49 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.929 -0.397 . . . . 1.1399999999999999 109.929 -176.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.1 t -91.4 175.12 7.04 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.845 -0.798 . . . . 1.8899999999999999 108.845 173.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -67.08 -23.27 65.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.977 0.417 . . . . 2.3300000000000001 110.08 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -47.51 84.46 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.469 -0.787 . . . . 1.9099999999999999 110.903 172.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.6 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -71.74 -25.23 61.97 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.554 -0.536 . . . . 2.1099999999999999 109.554 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.578 ' HA ' HG11 ' A' ' 16' ' ' VAL . 4.0 tp -72.22 -29.21 63.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.07 -0.514 . . . . 1.6000000000000001 110.421 173.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.39 -24.0 57.14 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.023 0.916 . . . . 0.88 109.301 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.35 -36.89 20.47 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.72 -1.127 . . . . 1.05 110.884 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.578 HG11 ' HA ' ' A' ' 13' ' ' LEU . 4.0 p -70.61 -44.11 77.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.873 -0.603 . . . . 1.0700000000000001 112.295 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.444 ' HB3' HD23 ' A' ' 31' ' ' LEU . 88.5 mtp -60.0 -32.56 70.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.847 0.314 . . . . 2.2400000000000002 111.847 -173.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.557 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 8.2 ptt180 -84.24 -18.25 37.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.37 0.507 . . . . 3.6899999999999999 112.37 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.29 -32.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.188 -1.042 . . . . 1.0800000000000001 108.188 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 t -66.71 -39.88 84.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.21 -1.359 . . . . 1.04 110.122 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.5 p -64.37 -49.3 72.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.217 0.532 . . . . 1.8400000000000001 110.71 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 7.2 mm-40 -60.94 -39.4 89.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.401 -0.818 . . . . 2.2599999999999998 112.24 -178.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -80.14 -31.94 38.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.951 0.352 . . . . 0.77000000000000002 111.951 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.455 ' HA ' HD12 ' A' ' 42' ' ' ILE . 72.7 p -82.4 -44.59 15.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.886 0.374 . . . . 1.23 111.558 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.91 6.7 37.06 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.654 -0.784 . . . . 0.54000000000000004 111.705 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.761 HD12 ' HG2' ' A' ' 40' ' ' MET . 3.5 mt -97.61 137.07 26.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.501 -0.555 . . . . 1.28 109.501 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.35 141.99 58.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.742 0.306 . . . . 1.26 110.415 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -55.98 -34.48 65.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 1.6000000000000001 111.28 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -71.47 -10.45 59.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 2.23 111.378 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -111.61 -4.22 14.83 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.497 -0.319 . . . . 2.2400000000000002 111.103 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' A' ' 17' ' ' MET . 30.0 tp -72.05 97.88 1.98 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.516 0.674 . . . . 1.6799999999999999 110.472 -173.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 34' ' ' ASP . 70.0 p -124.95 165.8 17.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.193 -0.912 . . . . 1.21 109.052 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.494 ' CB ' ' HB2' ' A' ' 76' ' ' ARG . 7.7 p-10 -70.83 -5.87 33.62 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.206 0.527 . . . . 2.29 110.484 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.422 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 24.5 t70 -70.56 -22.04 62.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.202 -0.908 . . . . 2.29 109.687 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.458 ' HB2' HG21 ' A' ' 75' ' ' VAL . 14.1 m -81.29 147.45 29.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.648 -0.706 . . . . 1.3300000000000001 109.901 176.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.674 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 3.7 t-20 -127.64 119.78 26.64 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.074 -0.713 . . . . 1.2 109.074 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.612 ' HD1' HG13 ' A' ' 42' ' ' ILE . 5.5 m-85 -51.52 -50.23 60.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.955 0.407 . . . . 0.63 110.925 -176.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.03 -31.42 71.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.004 -0.543 . . . . 1.1499999999999999 111.627 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.674 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 30.8 t70 -74.94 -29.2 60.88 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.152 0.501 . . . . 0.82999999999999996 110.322 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.761 ' HG2' HD12 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -82.65 -15.07 53.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.256 -0.884 . . . . 2.98 111.08 -178.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.59 20.99 9.54 Favored Glycine 0 N--CA 1.455 -0.088 0 C-N-CA 120.231 -0.985 . . . . 0.54000000000000004 112.787 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.612 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.3 mm -71.47 107.15 2.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.52 0.676 . . . . 1.2 110.72 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -88.55 170.45 10.86 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.092 -0.958 . . . . 1.9399999999999999 110.088 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.9 t -55.19 -37.71 67.42 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.301 0.24 . . . . 1.1399999999999999 111.016 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.49 -56.34 23.41 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.012 -0.366 . . . . 1.22 110.012 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.554 ' O ' HG13 ' A' ' 50' ' ' ILE . 19.8 m -68.25 -41.43 81.14 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.874 0.324 . . . . 1.46 111.874 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.622 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 36.2 p -66.22 -30.36 70.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.03 0.443 . . . . 1.1000000000000001 110.965 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -39.57 64.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.619 -0.882 . . . . 2.8500000000000001 108.619 178.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 39.6 t -64.39 -44.66 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.902 -0.59 . . . . 1.1499999999999999 110.261 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 46' ' ' SER . 65.6 mt -52.06 -59.78 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.596 -0.275 . . . . 1.05 110.772 176.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.51 -27.33 67.79 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.11 -0.567 . . . . 0.35999999999999999 111.9 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.434 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -67.68 -44.13 78.55 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 122.902 -0.176 . . . . 1.6599999999999999 111.1 176.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 27.7 mtp180 -65.97 -23.98 66.7 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.716 0.293 . . . . 1.48 110.473 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.575 ' CZ ' HG23 ' A' ' 16' ' ' VAL . 12.2 m-30 -58.3 -40.56 82.33 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.169 0.509 . . . . 0.33000000000000002 109.688 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.434 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 66.7 mtm180 -82.03 -25.08 34.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.438 -0.801 . . . . 3.3300000000000001 111.043 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -83.0 -59.13 2.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.787 -0.642 . . . . 2.2599999999999998 110.927 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.62 -48.53 7.01 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.516 -0.766 . . . . 2.6200000000000001 111.797 -174.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.71 -26.51 34.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.421 -0.354 . . . . 1.1200000000000001 111.666 -173.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.31 40.41 49.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.12 -0.562 . . . . 0.45000000000000001 112.419 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.44 HD13 ' HB3' ' A' ' 54' ' ' PHE . 78.5 mt -86.35 146.15 26.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.839 0.352 . . . . 1.23 110.966 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.21 94.82 6.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 2.27 110.849 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.479 HD11 ' O ' ' A' ' 63' ' ' GLY . 0.3 OUTLIER -121.53 -52.35 2.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.117 -0.492 . . . . 2.1299999999999999 110.914 176.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.479 ' O ' HD11 ' A' ' 62' ' ' LEU . . . 124.52 169.0 12.96 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.628 -0.796 . . . . 0.92000000000000004 111.988 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.41 -4.83 11.76 Favored 'Trans proline' 0 C--N 1.333 -0.258 0 C-N-CA 122.48 2.12 . . . . 1.2 113.041 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.26 -16.56 19.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.118 -0.492 . . . . 2.3599999999999999 111.023 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -69.77 112.8 6.47 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.102 0.477 . . . . 0.84999999999999998 110.25 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 p -128.23 132.54 48.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.052 -0.522 . . . . 1.71 111.281 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 83.0 mt -81.23 15.13 2.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 1.3700000000000001 111.357 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.419 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 6.7 t80 -111.37 -8.49 14.31 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.105 0.479 . . . . 0.83999999999999997 109.907 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.6 mt -131.57 -40.64 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-O 120.862 0.363 . . . . 1.51 111.488 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.12 5.53 42.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.228 0.537 . . . . 2.23 110.531 -170.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 96.5 m -158.77 129.24 6.0 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.2 p -109.42 -48.3 3.26 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.748 -0.381 . . . . 1.29 111.068 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.6 p -99.87 -171.2 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.306 0.574 . . . . 1.1399999999999999 111.128 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 35' ' ' SER . 2.2 t -81.75 -44.45 20.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.773 -0.649 . . . . 1.3700000000000001 110.718 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.504 ' HD3' ' HB2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -67.31 -24.5 65.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.585 . . . . 3.71 110.684 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.36 64.87 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.165 0.507 . . . . 1.1100000000000001 110.386 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.701 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.6 OUTLIER -77.43 -49.06 15.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.633 -0.712 . . . . 1.3100000000000001 109.339 177.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.504 ' HB2' ' HD3' ' A' ' 76' ' ' ARG . 30.5 mmtm -57.85 -45.43 86.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.828 -1.078 . . . . 2.96 110.902 -176.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.45 -29.89 70.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.563 -0.744 . . . . 1.6599999999999999 110.77 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -77.0 -36.45 56.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.075 -0.511 . . . . 1.2 111.09 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.701 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 44.4 mtp . . . . . 0 N--CA 1.465 0.305 0 CA-C-N 116.207 -0.452 . . . . 1.1000000000000001 110.914 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 110.875 -0.89 . . . . 0.55000000000000004 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -113.36 156.26 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.736 0.303 . . . . 1.1399999999999999 110.274 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.9 p -71.88 157.83 37.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.12 -0.491 . . . . 1.8899999999999999 110.382 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.64 -26.17 68.28 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.118 -1.067 . . . . 2.3300000000000001 108.118 175.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.44 -42.58 96.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.608 -1.178 . . . . 1.9099999999999999 110.56 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.739 ' HB2' ' HZ2' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -70.88 -27.77 64.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.146 -0.479 . . . . 2.1099999999999999 109.735 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' ' HG3' ' A' ' 17' ' ' MET . 0.1 OUTLIER -68.32 -27.99 66.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.842 -0.617 . . . . 1.6000000000000001 109.565 175.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -25.78 41.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.375 0.607 . . . . 0.88 110.156 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.88 -19.29 29.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.503 -0.771 . . . . 1.05 111.663 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.561 ' HB ' ' HE3' ' A' ' 82' ' ' MET . 3.3 p -82.16 -43.59 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.758 -0.377 . . . . 1.0700000000000001 111.777 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.548 ' HB3' HD23 ' A' ' 31' ' ' LEU . 57.3 mtm -61.56 -30.39 70.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.468 -0.333 . . . . 2.2400000000000002 111.508 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.18 -33.97 74.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.476 0.179 . . . . 3.6899999999999999 111.127 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.445 HG11 ' HB2' ' A' ' 53' ' ' ARG . 56.3 t -75.94 -37.13 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.694 0.759 . . . . 1.0800000000000001 109.113 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.03 -39.23 84.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.763 -1.108 . . . . 1.04 111.007 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -24.25 50.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.653 0.74 . . . . 1.8400000000000001 109.729 -173.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -78.8 -42.26 28.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.788 -1.097 . . . . 2.2599999999999998 111.101 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.525 ' HG3' HG12 ' A' ' 50' ' ' ILE . 62.0 mm-40 -74.69 -37.49 62.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.27 -0.423 . . . . 0.77000000000000002 111.351 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -71.51 -44.22 65.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.869 0.366 . . . . 1.23 110.516 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.99 5.13 35.64 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.819 -0.705 . . . . 0.54000000000000004 112.071 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.544 HD12 ' HG2' ' A' ' 40' ' ' MET . 2.3 mt -90.68 160.15 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.912 0.387 . . . . 1.28 110.107 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.37 140.23 42.89 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.766 -0.652 . . . . 1.26 110.269 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.2 tp -58.52 -35.52 72.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.952 -0.567 . . . . 1.6000000000000001 111.229 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -73.84 -14.57 61.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.186 0.517 . . . . 2.23 110.547 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -103.98 -6.3 21.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.762 -0.654 . . . . 2.2400000000000002 110.801 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 17' ' ' MET . 46.5 tp -72.04 99.21 2.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.934 -0.575 . . . . 1.6799999999999999 109.967 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.2 p -117.63 158.85 23.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.014 -0.539 . . . . 1.21 109.71 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.668 ' OD1' ' HB2' ' A' ' 76' ' ' ARG . 6.9 t70 -54.22 -23.72 15.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.226 0.61 . . . . 2.29 112.57 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.48 -19.41 64.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.883 -0.599 . . . . 2.29 111.408 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.531 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 14.8 m -71.95 151.47 43.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.342 0.591 . . . . 1.3300000000000001 110.84 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.76 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.6 t-20 -131.0 120.42 23.46 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.473 -0.566 . . . . 1.2 109.473 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.812 ' HD1' HG13 ' A' ' 42' ' ' ILE . 33.7 m-85 -51.36 -46.44 62.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.156 0.503 . . . . 0.63 111.219 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.39 -29.62 63.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.784 -0.644 . . . . 1.1499999999999999 111.571 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.76 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 21.5 t70 -74.72 -31.17 61.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.43 0.633 . . . . 0.82999999999999996 110.283 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.544 ' HG2' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -75.64 -23.12 56.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.602 -0.727 . . . . 2.98 110.453 178.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.32 27.93 7.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.325 -0.941 . . . . 0.54000000000000004 112.026 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.812 HG13 ' HD1' ' A' ' 37' ' ' PHE . 28.6 mm -68.21 107.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 1.2 109.833 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.35 171.44 15.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.521 -0.763 . . . . 1.9399999999999999 111.211 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.3 t -57.88 -32.69 67.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.721 -1.127 . . . . 1.1399999999999999 111.167 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.408 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.2 tm? -64.25 -57.48 9.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.721 -0.672 . . . . 1.22 110.088 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.549 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.6 m -63.93 -40.84 97.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.979 -0.555 . . . . 1.46 111.585 -173.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.6 p -62.38 -30.14 70.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.211 -0.45 . . . . 1.1000000000000001 111.447 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.7 ttt -79.15 -37.64 37.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.514 0.673 . . . . 2.8500000000000001 109.775 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 52' ' ' SER . 78.0 t -69.39 -40.68 80.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.765 -1.107 . . . . 1.1499999999999999 110.233 -175.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 46' ' ' SER . 73.2 mt -51.69 -54.11 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.881 0.372 . . . . 1.05 110.705 174.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -63.46 -26.22 69.38 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.974 -0.631 . . . . 0.35999999999999999 112.247 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 10.3 m -70.99 -42.33 69.79 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 120.659 0.266 . . . . 1.6599999999999999 110.715 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.445 ' HB2' HG11 ' A' ' 19' ' ' VAL . 10.0 mtp180 -64.95 -26.34 68.26 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.525 -0.307 . . . . 1.48 110.351 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.702 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 16.5 m-30 -56.31 -43.98 79.46 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.261 0.553 . . . . 0.33000000000000002 109.58 173.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 61.7 mtp180 -79.32 -27.97 42.11 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.227 -0.897 . . . . 3.3300000000000001 110.573 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -77.29 -62.82 1.53 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.82 -0.627 . . . . 2.2599999999999998 112.023 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -88.54 -44.13 10.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 2.6200000000000001 111.477 -169.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.56 -39.11 15.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.108 -0.497 . . . . 1.1200000000000001 111.591 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.99 23.34 15.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.503 -0.856 . . . . 0.45000000000000001 112.307 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.702 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 73.2 mt -80.81 113.18 18.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.726 -0.472 . . . . 1.23 109.726 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -97.87 87.39 3.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.45 0.643 . . . . 2.27 110.01 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.673 HD11 ' HD2' ' A' ' 54' ' ' PHE . 37.2 mt -87.88 -66.1 0.95 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.756 -1.111 . . . . 2.1299999999999999 110.304 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.15 167.62 20.08 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.724 -0.95 . . . . 0.92000000000000004 110.724 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -87.62 5.24 5.62 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 123.361 2.707 . . . . 1.2 112.96 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -107.19 -7.67 16.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.708 -0.678 . . . . 2.3599999999999999 111.692 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -85.38 120.87 27.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.774 0.321 . . . . 0.84999999999999998 111.428 -171.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -135.16 127.8 30.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 1.71 110.42 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.424 HD12 HD12 ' A' ' 50' ' ' ILE . 68.2 mt -66.12 -11.02 46.24 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.223 0.453 . . . . 1.3700000000000001 112.223 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -85.12 -11.33 55.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.125 0.488 . . . . 0.83999999999999997 109.944 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.5 mt -127.52 -39.81 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.344 -0.389 . . . . 1.51 110.906 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -95.73 8.26 43.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.529 -0.305 . . . . 2.23 111.146 -173.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 89.6 m -157.59 159.56 37.2 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -132.67 -78.28 0.49 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.303 -0.408 . . . . 1.29 110.615 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.8 p -83.65 -169.72 2.7 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.26 -0.275 . . . . 1.1399999999999999 110.596 177.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.6 OUTLIER -77.05 -41.84 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.568 -0.453 . . . . 1.3700000000000001 110.095 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.668 ' HB2' ' OD1' ' A' ' 33' ' ' ASP . 24.6 ttm180 -59.87 -33.43 71.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.428 -0.351 . . . . 3.71 111.324 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.69 -29.86 28.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.498 0.499 . . . . 1.1100000000000001 110.718 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.597 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.5 OUTLIER -85.39 -51.27 6.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.924 -0.58 . . . . 1.3100000000000001 109.753 175.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.414 ' HE3' HG11 ' A' ' 75' ' ' VAL . 10.5 mmtp -49.58 -59.25 3.94 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.069 -0.969 . . . . 2.96 111.298 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.45 -29.02 69.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.648 -1.16 . . . . 1.6599999999999999 110.899 -173.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.9 -37.12 75.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 1.2 111.138 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.597 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 22.3 mtp . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.077 -0.51 . . . . 1.1000000000000001 110.618 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.135 0 N-CA-C 111.945 -0.462 . . . . 0.55000000000000004 111.945 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.91 157.21 10.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.8 0.333 . . . . 1.1399999999999999 110.489 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.0 m -78.94 165.59 23.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.346 -0.388 . . . . 1.8899999999999999 110.159 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -61.37 -31.44 71.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.821 0.819 . . . . 2.3300000000000001 109.204 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.14 -45.94 83.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.381 -1.281 . . . . 1.9099999999999999 110.788 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -72.87 -21.85 60.86 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.339 -0.846 . . . . 2.1099999999999999 110.823 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 tp -73.22 -26.07 61.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.828 -0.623 . . . . 1.6000000000000001 110.273 172.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -25.59 36.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.698 0.761 . . . . 0.88 109.796 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.75 -32.77 23.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.048 -0.978 . . . . 1.05 111.356 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.7 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 2.9 p -67.28 -44.53 87.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 120.874 -0.33 . . . . 1.0700000000000001 111.785 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.6 mtp -60.43 -27.82 67.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.204 -0.453 . . . . 2.2400000000000002 111.931 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 24.4 ptt85 -79.85 -32.87 40.51 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.598 . . . . 3.6899999999999999 111.459 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.35 -37.86 78.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.72 -0.844 . . . . 1.0800000000000001 108.72 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.2 t -64.87 -39.16 84.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.793 -1.094 . . . . 1.04 109.977 174.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -69.16 -27.33 65.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.91 -0.586 . . . . 1.8400000000000001 111.344 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 43.9 mt-10 -85.98 -30.27 22.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.018 0.437 . . . . 2.2599999999999998 111.117 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.7 ' HG3' HG12 ' A' ' 50' ' ' ILE . 72.2 mm-40 -82.63 -45.49 14.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.859 -0.609 . . . . 0.77000000000000002 112.031 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.479 ' HA ' HD11 ' A' ' 42' ' ' ILE . 73.4 p -72.13 -45.38 60.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.85 0.357 . . . . 1.23 111.248 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.72 2.2 43.09 Favored Glycine 0 C--O 1.23 -0.095 0 N-CA-C 111.104 -0.798 . . . . 0.54000000000000004 111.104 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.736 HD12 ' HG3' ' A' ' 40' ' ' MET . 3.9 mt -93.7 104.98 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.297 -0.631 . . . . 1.28 109.297 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -42.21 143.75 0.56 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.841 0.713 . . . . 1.26 112.317 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.6 tp -54.44 -32.84 58.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.799 -0.637 . . . . 1.6000000000000001 111.281 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -78.0 -10.51 59.63 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.889 0.376 . . . . 2.23 111.013 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -109.3 -6.54 15.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.187 -0.672 . . . . 2.2400000000000002 109.187 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.543 HD12 HG11 ' A' ' 75' ' ' VAL . 41.3 tp -76.84 98.72 4.94 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.399 -0.819 . . . . 1.6799999999999999 110.221 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.3 p -121.93 163.63 18.97 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.967 -1.015 . . . . 1.21 108.476 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.05 -3.75 14.39 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.782 0.29 . . . . 2.29 111.782 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -70.91 -23.44 62.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.373 -0.376 . . . . 2.29 110.595 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.455 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 21.3 m -75.65 149.8 38.1 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.527 0.68 . . . . 1.3300000000000001 111.399 -174.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.741 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 16.8 t-20 -126.13 122.15 34.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.099 -0.955 . . . . 1.2 108.768 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.784 ' HD1' HG13 ' A' ' 42' ' ' ILE . 20.6 m-85 -55.34 -46.84 76.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.852 0.358 . . . . 0.63 111.18 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.31 -29.59 62.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.341 -0.391 . . . . 1.1499999999999999 111.573 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.741 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 30.7 t70 -71.17 -35.58 71.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.537 0.684 . . . . 0.82999999999999996 110.36 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.736 ' HG3' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -75.54 -24.53 56.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.35 -0.841 . . . . 2.98 109.663 -175.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.16 28.28 4.73 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.529 -0.843 . . . . 0.54000000000000004 112.429 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.784 HG13 ' HD1' ' A' ' 37' ' ' PHE . 33.2 mm -74.34 107.94 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 1.2 110.571 176.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.77 170.97 15.75 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.512 -0.551 . . . . 1.9399999999999999 109.512 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.3 p -55.33 -36.85 66.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.884 -0.598 . . . . 1.1399999999999999 110.388 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -52.23 -59.05 4.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.32 -0.854 . . . . 1.22 110.539 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.568 ' O ' HG13 ' A' ' 50' ' ' ILE . 32.8 t -66.75 -43.26 84.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.14 -0.224 . . . . 1.46 111.134 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 87.7 p -60.35 -29.97 69.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.376 . . . . 1.1000000000000001 111.254 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.8 tpp -75.81 -46.12 32.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.895 -0.593 . . . . 2.8500000000000001 109.806 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.554 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 49.8 t -59.54 -45.46 93.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.958 -1.019 . . . . 1.1499999999999999 110.616 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.7 HG12 ' HG3' ' A' ' 23' ' ' GLU . 55.8 mt -51.7 -52.8 19.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.904 0.383 . . . . 1.05 110.447 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -57.59 -37.24 81.94 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.712 -0.677 . . . . 0.35999999999999999 112.551 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -66.46 -45.91 78.18 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.983 -0.377 . . . . 1.6599999999999999 109.983 177.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 6.0 mtp180 -60.64 -27.07 67.51 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.567 -0.288 . . . . 1.48 111.061 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 12.5 m-30 -58.01 -41.07 82.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.205 0.526 . . . . 0.33000000000000002 110.135 173.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.73 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 61.3 mtp180 -84.0 -32.11 25.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.833 -0.621 . . . . 3.3300000000000001 111.205 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 52' ' ' SER . 20.0 mm-40 -82.9 -47.07 12.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.237 -0.438 . . . . 2.2599999999999998 111.158 -174.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.09 -42.58 11.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 2.6200000000000001 112.151 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.55 -32.76 12.1 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.695 0.257 . . . . 1.1200000000000001 111.695 -174.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.96 33.41 8.99 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.746 -0.74 . . . . 0.45000000000000001 112.574 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.73 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 87.7 mt -86.5 115.84 24.26 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 110.409 -0.219 . . . . 1.23 110.409 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -95.21 58.37 2.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.649 0.737 . . . . 2.27 109.589 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.86 -29.79 50.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.859 -1.064 . . . . 2.1299999999999999 111.449 -175.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.28 169.9 12.59 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.734 -0.746 . . . . 0.92000000000000004 112.394 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -89.36 -13.29 2.92 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.171 2.58 . . . . 1.2 112.671 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -82.81 -17.36 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.523 . . . . 2.3599999999999999 112.239 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -82.3 114.27 20.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.173 0.511 . . . . 0.84999999999999998 111.139 -173.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.9 m -128.93 125.3 37.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.911 -0.586 . . . . 1.71 109.94 176.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 68.2 mt -58.55 -40.0 81.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.327 -0.397 . . . . 1.3700000000000001 111.691 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -60.8 -8.1 2.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.193 -0.458 . . . . 0.83999999999999997 111.674 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.5 -40.19 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.939 -0.475 . . . . 1.51 111.47 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -109.77 -1.91 17.65 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.56 0.578 . . . . 2.23 112.56 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.8 m -142.38 97.83 3.19 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.488 -0.757 . . . . 1.0 110.281 -175.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.6 p -89.58 -30.27 18.3 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.638 -0.71 . . . . 1.29 111.034 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -114.46 -176.51 2.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.135 -0.484 . . . . 1.1399999999999999 110.468 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.543 HG11 HD12 ' A' ' 31' ' ' LEU . 1.5 t -81.61 -43.3 19.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.998 0.428 . . . . 1.3700000000000001 110.437 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.6 ' HA ' ' CG ' ' A' ' 79' ' ' LYS . 29.3 ttm180 -64.97 -28.41 69.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.106 -0.497 . . . . 3.71 111.002 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.5 -31.21 55.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 1.1100000000000001 110.749 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.518 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.8 OUTLIER -75.7 -47.89 24.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.304 -0.628 . . . . 1.3100000000000001 109.304 176.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.6 ' CG ' ' HA ' ' A' ' 76' ' ' ARG . 26.8 mmtp -46.97 -50.01 19.77 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.96 -1.018 . . . . 2.96 110.59 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -54.36 -55.33 29.66 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.301 -0.863 . . . . 1.6599999999999999 111.709 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -56.29 -37.62 70.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.479 -0.782 . . . . 1.2 112.245 -173.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.7 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 24.8 mtp . . . . . 0 C--N 1.324 -0.506 0 CA-C-O 120.871 0.367 . . . . 1.1000000000000001 111.439 -174.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 111.339 -0.704 . . . . 0.55000000000000004 111.339 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.464 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 3.9 m -112.21 158.96 12.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.159 -0.312 . . . . 1.1399999999999999 110.159 -177.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.1 p -87.11 -178.59 6.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.204 -0.453 . . . . 1.8899999999999999 110.5 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -68.43 -30.34 69.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.295 -0.631 . . . . 2.3300000000000001 109.295 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.4 -41.0 96.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.322 -0.854 . . . . 1.9099999999999999 110.408 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.464 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 58.1 mttt -74.3 -26.64 60.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.842 -0.617 . . . . 2.1099999999999999 111.002 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.23 -23.2 54.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.008 -0.542 . . . . 1.6000000000000001 110.057 173.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.3 -27.11 42.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.5 0.667 . . . . 0.88 109.694 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.54 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -83.9 -26.76 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.054 -0.975 . . . . 1.05 111.66 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.832 ' HB ' ' HE3' ' A' ' 82' ' ' MET . 2.7 p -71.83 -44.56 67.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 111.782 0.29 . . . . 1.0700000000000001 111.782 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.495 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 73.8 mtp -60.44 -34.37 73.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.486 -0.325 . . . . 2.2400000000000002 111.42 -175.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 12.3 ptt180 -69.64 -29.47 66.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.707 0.289 . . . . 3.6899999999999999 110.688 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.37 -39.33 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.01 -0.737 . . . . 1.0800000000000001 109.01 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.86 -49.05 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.838 -1.074 . . . . 1.04 110.06 176.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.492 ' OG ' HD23 ' A' ' 31' ' ' LEU . 25.7 m -54.96 -47.19 74.84 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 112.401 0.519 . . . . 1.8400000000000001 112.401 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -57.33 -46.43 83.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.055 0.391 . . . . 2.2599999999999998 112.055 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -79.75 -33.51 40.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.292 -0.413 . . . . 0.77000000000000002 111.882 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.422 ' HB3' HD12 ' A' ' 42' ' ' ILE . 76.7 p -80.72 -42.8 21.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 1.23 111.525 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.32 12.92 34.59 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.982 -0.628 . . . . 0.54000000000000004 111.978 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.764 HG12 ' HE1' ' A' ' 40' ' ' MET . 3.5 mt -102.88 125.89 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 122.802 -0.234 . . . . 1.28 110.544 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.42 ' HB1' ' HG2' ' A' ' 30' ' ' GLU . . . -56.3 145.11 27.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.394 -0.367 . . . . 1.26 110.788 175.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.76 -43.9 38.23 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.579 0.549 . . . . 1.6000000000000001 110.404 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -76.41 -10.66 59.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.963 -0.562 . . . . 2.23 111.286 -173.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' HG2' ' HB1' ' A' ' 27' ' ' ALA . 34.1 mm-40 -107.93 -10.59 15.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.987 -0.745 . . . . 2.2400000000000002 108.987 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.492 HD23 ' OG ' ' A' ' 21' ' ' SER . 17.8 tp -79.49 97.47 6.43 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.347 -0.842 . . . . 1.6799999999999999 109.18 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.2 p -116.73 162.38 17.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.322 -0.854 . . . . 1.21 108.855 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.836 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 45.5 m-20 -74.59 -3.54 31.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.782 0.325 . . . . 2.29 111.059 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.29 -20.22 44.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.705 -0.679 . . . . 2.29 110.528 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.422 ' HB2' HG23 ' A' ' 75' ' ' VAL . 43.6 m -70.88 157.32 38.34 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.749 0.785 . . . . 1.3300000000000001 111.275 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.644 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.1 t-20 -124.43 126.16 45.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.86 -1.064 . . . . 1.2 108.682 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.514 ' HD1' HG13 ' A' ' 42' ' ' ILE . 26.1 m-85 -57.08 -52.78 63.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.116 0.484 . . . . 0.63 111.308 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.07 -22.87 63.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.053 -0.521 . . . . 1.1499999999999999 111.254 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.644 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.6 t70 -83.54 -16.0 47.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.82999999999999996 110.538 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.764 ' HE1' HG12 ' A' ' 26' ' ' ILE . 65.9 mmm -101.46 1.49 38.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 2.98 111.706 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.53 26.22 23.56 Favored Glycine 0 C--O 1.23 -0.152 0 C-N-CA 119.79 -1.195 . . . . 0.54000000000000004 112.767 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.514 HG13 ' HD1' ' A' ' 37' ' ' PHE . 18.3 mm -72.01 107.7 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.195 0.521 . . . . 1.2 110.018 175.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.8 159.78 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.291 -0.868 . . . . 1.9399999999999999 110.194 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.459 ' HB2' ' CD2' ' A' ' 69' ' ' PHE . 1.4 t -55.07 -39.62 69.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.433 0.635 . . . . 1.1399999999999999 109.704 171.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -56.96 -53.09 61.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.315 -0.857 . . . . 1.22 109.827 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.569 ' O ' HG13 ' A' ' 50' ' ' ILE . 32.4 t -67.91 -42.76 80.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.758 -0.201 . . . . 1.46 111.52 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 33.0 p -60.73 -34.25 74.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.005 0.431 . . . . 1.1000000000000001 111.151 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 30.2 ttp -72.69 -36.7 67.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.738 -0.664 . . . . 2.8500000000000001 109.563 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 42.6 t -70.34 -41.2 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.325 -0.852 . . . . 1.1499999999999999 110.256 -177.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 46' ' ' SER . 59.0 mt -55.14 -55.63 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.742 0.306 . . . . 1.05 110.431 176.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.74 -28.96 72.5 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.11 -0.566 . . . . 0.35999999999999999 112.031 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.26 -42.66 75.28 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.717 0.294 . . . . 1.6599999999999999 110.689 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.746 ' HA ' ' HB3' ' A' ' 56' ' ' GLU . 28.9 mtp180 -69.01 -22.53 64.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 121.0 -0.28 . . . . 1.48 110.592 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.573 ' HE2' HD22 ' A' ' 78' ' ' LEU . 13.8 m-30 -57.46 -41.89 81.44 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.246 -0.649 . . . . 0.33000000000000002 109.246 172.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.657 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 35.8 mtp180 -81.19 -25.67 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.552 -0.749 . . . . 3.3300000000000001 110.665 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.746 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 29.9 tt0 -77.68 -62.77 1.56 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.754 -0.657 . . . . 2.2599999999999998 111.687 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -87.21 -41.56 13.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.969 -0.56 . . . . 2.6200000000000001 111.415 -172.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.99 -40.67 11.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.182 -0.463 . . . . 1.1200000000000001 111.33 -174.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.59 28.26 9.77 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.019 -0.61 . . . . 0.45000000000000001 112.047 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.657 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 51.2 mt -80.8 107.41 13.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.297 -0.26 . . . . 1.23 110.297 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.55 78.78 9.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.186 0.993 . . . . 2.27 110.196 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.473 HD13 ' HD2' ' A' ' 54' ' ' PHE . 13.8 mt -83.1 -72.98 0.43 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.422 -1.263 . . . . 2.1299999999999999 110.932 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.13 156.23 16.16 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.733 -0.947 . . . . 0.92000000000000004 110.733 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HG2' ' OE2' ' A' ' 65' ' ' GLU . 58.9 Cg_endo -78.37 -26.75 5.85 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.351 2.034 . . . . 1.2 113.613 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.422 ' OE2' ' HG2' ' A' ' 64' ' ' PRO . 37.4 mp0 -98.7 26.42 5.65 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 122.082 -0.386 . . . . 2.3599999999999999 111.178 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -92.12 112.54 24.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.46 -0.336 . . . . 0.84999999999999998 110.439 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.5 t -132.46 123.87 27.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.968 0.414 . . . . 1.71 110.199 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.468 HD11 HD12 ' A' ' 50' ' ' ILE . 70.2 mt -61.47 -16.45 47.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.089 -0.505 . . . . 1.3700000000000001 111.546 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.459 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 8.9 t80 -73.82 -15.05 61.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.186 -0.461 . . . . 0.83999999999999997 110.76 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.0 mt -130.04 -35.82 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.197 -0.456 . . . . 1.51 110.965 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -91.97 6.8 44.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.484 -0.325 . . . . 2.23 111.871 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.75 162.78 37.14 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -175.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.0 p -134.92 -72.65 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.306 -0.406 . . . . 1.29 111.209 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 71.8 p -84.88 -179.46 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.999 -0.371 . . . . 1.1399999999999999 109.999 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -79.68 -39.92 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 108.865 -0.791 . . . . 1.3700000000000001 108.865 -176.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.836 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 13.6 tpt180 -60.38 -30.23 69.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.476 -1.238 . . . . 3.71 111.188 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.03 -33.63 73.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.433 -0.348 . . . . 1.1100000000000001 110.491 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.643 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.0 OUTLIER -71.93 -51.18 23.37 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.81 -0.811 . . . . 1.3100000000000001 108.81 176.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.495 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 27.9 mmtp -48.09 -57.57 5.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.51 -1.223 . . . . 2.96 111.833 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -60.52 -37.27 80.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.572 -0.74 . . . . 1.6599999999999999 111.506 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -62.64 -38.24 89.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.941 -0.572 . . . . 1.2 111.125 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.832 ' HE3' ' HB ' ' A' ' 16' ' ' VAL . 30.0 mtp . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 1.1000000000000001 111.519 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 110.749 -0.941 . . . . 0.55000000000000004 110.749 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.99 158.93 9.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.817 0.341 . . . . 1.1399999999999999 110.562 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.3 t -85.79 179.2 7.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.783 -0.451 . . . . 1.8899999999999999 109.783 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.81 -20.71 65.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.535 0.683 . . . . 2.3300000000000001 109.643 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.9 -50.87 71.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.987 -1.006 . . . . 1.9099999999999999 110.689 175.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HG2' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -70.54 -23.85 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.054 -0.721 . . . . 2.1099999999999999 109.054 -177.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.448 ' O ' ' HG3' ' A' ' 17' ' ' MET . 2.2 tp -69.49 -27.14 64.94 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.724 -0.671 . . . . 1.6000000000000001 110.403 174.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.7 -28.57 33.4 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.591 0.71 . . . . 0.88 109.986 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.51 -31.76 37.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.23 -0.895 . . . . 1.05 111.013 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.803 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 4.5 p -69.61 -46.99 73.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.275 -0.421 . . . . 1.0700000000000001 111.617 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.692 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 65.8 mtm -61.9 -28.88 69.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.426 -0.352 . . . . 2.2400000000000002 111.725 -172.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -81.61 -22.44 37.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.37 -0.377 . . . . 3.6899999999999999 111.25 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.0 t -82.42 -35.22 12.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.758 -0.83 . . . . 1.0800000000000001 108.758 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.4 t -64.89 -36.21 77.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.574 -1.194 . . . . 1.04 110.09 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -59.7 -53.03 62.72 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.051 0.453 . . . . 1.8400000000000001 110.663 -176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -54.76 -55.61 28.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.165 -0.925 . . . . 2.2599999999999998 112.324 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -77.42 -22.84 50.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.341 0.497 . . . . 0.77000000000000002 112.341 -170.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.1 m -85.96 -31.41 22.11 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.553 -0.459 . . . . 1.23 110.006 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.13 -2.92 44.02 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.745 -0.741 . . . . 0.54000000000000004 112.844 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mt -101.48 153.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.833 0.349 . . . . 1.28 110.603 -175.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.523 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -66.77 145.34 55.62 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.855 -0.612 . . . . 1.26 110.646 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.2 tp -60.87 -36.39 79.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.996 0.427 . . . . 1.6000000000000001 110.422 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -72.58 -10.92 60.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 2.23 110.963 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.523 ' HG3' ' HB1' ' A' ' 27' ' ' ALA . 19.2 mt-10 -115.55 6.32 14.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.727 -0.669 . . . . 2.2400000000000002 110.793 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.452 HD12 HG13 ' A' ' 75' ' ' VAL . 44.6 tp -75.48 97.78 3.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.31 0.576 . . . . 1.6799999999999999 109.501 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 59.4 p -101.11 156.85 17.18 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.203 -0.908 . . . . 1.21 110.363 -175.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.654 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 16.5 p-10 -81.56 -4.61 56.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.279 0.562 . . . . 2.29 110.027 177.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.14 -22.85 60.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.891 -1.05 . . . . 2.29 110.841 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.453 ' HB2' HG22 ' A' ' 75' ' ' VAL . 39.8 m -77.43 155.4 31.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.957 0.884 . . . . 1.3300000000000001 111.568 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.923 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.4 t-20 -127.05 123.76 37.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.455 -1.313 . . . . 1.2 107.455 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.643 ' HD1' HG13 ' A' ' 42' ' ' ILE . 11.6 m-85 -56.8 -54.76 42.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.855 -0.338 . . . . 0.63 111.443 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.19 62.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.86 0.362 . . . . 1.1499999999999999 111.006 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.923 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 22.8 t70 -74.04 -29.12 61.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.495 . . . . 0.82999999999999996 110.815 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.1 mmt -83.04 -15.03 52.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.618 . . . . 2.98 111.228 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.11 14.86 15.66 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.158 -1.02 . . . . 0.54000000000000004 112.258 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.643 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.0 mm -67.59 106.8 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.947 -0.76 . . . . 1.2 108.947 174.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.91 177.52 8.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.473 -0.785 . . . . 1.9399999999999999 111.225 -177.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 t -58.59 -31.88 68.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.193 -0.912 . . . . 1.1399999999999999 109.766 175.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.43 -62.93 1.51 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.985 -1.007 . . . . 1.22 110.86 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.569 ' O ' HG13 ' A' ' 50' ' ' ILE . 15.2 m -68.64 -39.34 80.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.448 -0.342 . . . . 1.46 111.519 -173.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.474 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 47.0 p -65.6 -21.93 66.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.814 0.34 . . . . 1.1000000000000001 111.255 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.39 -43.73 20.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.101 -0.703 . . . . 2.8500000000000001 109.101 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.408 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.7 t -62.76 -48.02 90.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.048 -0.978 . . . . 1.1499999999999999 110.84 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 46' ' ' SER . 77.1 mt -51.32 -56.6 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.317 -0.401 . . . . 1.05 111.473 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -63.85 -30.65 78.31 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.611 -0.805 . . . . 0.35999999999999999 112.459 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -39.52 89.5 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.04 -0.264 . . . . 1.6599999999999999 110.451 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 25.6 mtp180 -65.19 -23.96 67.24 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.488 0.185 . . . . 1.48 110.882 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.624 ' HD2' HD11 ' A' ' 62' ' ' LEU . 11.8 m-30 -58.51 -38.69 78.23 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.482 0.658 . . . . 0.33000000000000002 109.501 175.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -79.07 -24.67 43.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.174 -0.921 . . . . 3.3300000000000001 110.95 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -78.56 -62.07 1.81 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.996 -0.547 . . . . 2.2599999999999998 111.412 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -87.82 -53.57 4.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.023 -0.535 . . . . 2.6200000000000001 111.639 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 mp -72.81 -27.59 62.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.963 -0.562 . . . . 1.1200000000000001 111.289 -171.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.65 31.1 57.02 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.623 -0.798 . . . . 0.45000000000000001 111.708 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 54' ' ' PHE . 81.8 mt -82.05 114.55 20.68 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 110.292 -0.262 . . . . 1.23 110.292 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -88.89 75.85 8.0 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.252 -0.647 . . . . 2.27 109.252 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.624 HD11 ' HD2' ' A' ' 54' ' ' PHE . 37.1 mt -82.4 -65.47 1.01 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.165 -0.925 . . . . 2.1299999999999999 109.998 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.24 165.71 23.0 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 114.647 -1.16 . . . . 0.92000000000000004 110.75 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.94 -8.3 10.09 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.02 2.48 . . . . 1.2 113.075 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -117.56 20.64 13.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.468 0.652 . . . . 2.3599999999999999 110.709 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.409 ' HE1' ' CE2' ' A' ' 81' ' ' PHE . 83.6 t80 -77.87 111.81 14.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.074 -0.512 . . . . 0.84999999999999998 109.916 -177.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.1 m -123.16 118.17 27.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.626 -0.715 . . . . 1.71 110.739 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 42.6 mt -63.26 -33.31 75.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 1.3700000000000001 110.489 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.468 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 37.1 t80 -59.6 -16.65 27.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.618 -0.719 . . . . 0.83999999999999997 111.151 -175.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.7 mt -121.76 -40.14 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 121.044 -0.262 . . . . 1.51 111.515 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.51 6.84 32.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.933 -0.707 . . . . 2.23 112.526 -173.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 82.1 m -150.2 86.65 1.43 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.251 0.548 . . . . 1.0 109.639 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.1 p -78.25 -59.01 2.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.591 -0.731 . . . . 1.29 110.927 -172.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 82.3 p -86.9 -178.92 6.42 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.852 -0.425 . . . . 1.1399999999999999 109.852 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 35' ' ' SER . 0.2 OUTLIER -81.59 -42.54 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.306 0.574 . . . . 1.3700000000000001 109.89 -179.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.654 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 4.9 tpp180 -60.13 -29.06 68.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.361 -0.836 . . . . 3.71 110.613 176.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -59.59 -35.72 74.85 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.532 -0.304 . . . . 1.1100000000000001 110.951 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.542 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -72.58 -45.3 59.82 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.192 -0.67 . . . . 1.3100000000000001 109.192 177.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.692 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.8 mmtp -51.19 -61.3 2.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.853 -1.067 . . . . 2.96 111.048 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.95 -24.42 65.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.766 -0.652 . . . . 1.6599999999999999 111.79 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 46.5 t80 -64.82 -37.15 86.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.009 0.433 . . . . 1.2 110.262 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.803 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 12.8 mtp . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.633 -0.712 . . . . 1.1000000000000001 111.463 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 N-CA-C 111.465 -0.654 . . . . 0.55000000000000004 111.465 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.552 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 4.0 m -110.57 160.49 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.741 0.305 . . . . 1.1399999999999999 110.699 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -82.61 174.39 11.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.405 -0.591 . . . . 1.8899999999999999 109.405 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -66.9 -35.71 80.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.409 0.623 . . . . 2.3300000000000001 109.74 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -56.93 -41.4 78.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.014 -0.994 . . . . 1.9099999999999999 111.202 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.552 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 47.5 mmtm -68.02 -24.72 65.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.697 -0.683 . . . . 2.1099999999999999 110.53 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.6 ' HG ' ' HE1' ' A' ' 17' ' ' MET . 24.9 tp -70.72 -26.76 63.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.136 -0.484 . . . . 1.6000000000000001 111.146 173.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.94 -30.79 50.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.659 0.742 . . . . 0.88 109.3 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.577 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -75.83 -33.44 60.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.071 -0.968 . . . . 1.05 110.405 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 13' ' ' LEU . 3.0 p -71.48 -45.46 68.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.318 -0.401 . . . . 1.0700000000000001 111.716 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.6 ' HE1' ' HG ' ' A' ' 13' ' ' LEU . 63.7 mtt -59.54 -33.95 72.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.69 -0.232 . . . . 2.2400000000000002 110.948 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 39.3 ptt180 -73.25 -30.35 63.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.046 -0.262 . . . . 3.6899999999999999 111.216 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -77.46 -34.17 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.739 -0.837 . . . . 1.0800000000000001 108.739 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 t -66.55 -40.96 87.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.681 -1.145 . . . . 1.04 109.304 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.8 t -61.76 -23.48 66.2 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.318 -0.401 . . . . 1.8400000000000001 111.021 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.51 -49.69 10.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.203 0.525 . . . . 2.2599999999999998 111.165 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -84.85 -31.39 23.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.439 -0.801 . . . . 0.77000000000000002 112.372 -169.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.4 p -79.12 -35.43 42.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 1.23 111.129 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.75 13.8 56.17 Favored Glycine 0 C--O 1.234 0.106 0 C-N-CA 120.404 -0.903 . . . . 0.54000000000000004 111.336 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mt -105.08 111.73 35.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.494 -0.558 . . . . 1.28 109.494 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.19 145.37 13.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 1.26 111.256 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.5 tp -52.96 -34.61 56.56 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.912 -0.585 . . . . 1.6000000000000001 110.919 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.43 -19.46 61.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.865 -0.607 . . . . 2.23 111.579 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.34 -1.38 21.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.927 -0.398 . . . . 2.2400000000000002 109.927 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -73.93 97.91 2.91 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.577 0.703 . . . . 1.6799999999999999 109.493 -177.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.2 p -106.59 151.22 25.33 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.272 -0.876 . . . . 1.21 109.097 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.827 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 27.1 m-20 -81.21 -3.19 51.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.84 0.352 . . . . 2.29 111.515 -174.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -93.62 -3.95 51.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.258 -0.428 . . . . 2.29 110.636 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.435 ' HB2' HG22 ' A' ' 75' ' ' VAL . 55.3 m -73.69 158.63 34.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.394 0.616 . . . . 1.3300000000000001 110.022 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.793 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.0 t-20 -125.82 124.95 42.07 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.538 -0.755 . . . . 1.2 109.465 -176.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.731 ' HD1' HG13 ' A' ' 42' ' ' ILE . 35.5 m-85 -55.65 -50.19 70.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.891 0.376 . . . . 0.63 111.181 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.07 70.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.015 0.436 . . . . 1.1499999999999999 111.221 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.793 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 32.8 t70 -72.68 -27.18 61.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.113 0.483 . . . . 0.82999999999999996 110.598 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.9 mmt -86.46 -12.28 49.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 2.98 111.423 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.44 23.17 9.73 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.317 -0.944 . . . . 0.54000000000000004 112.784 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.731 HG13 ' HD1' ' A' ' 37' ' ' PHE . 24.5 mm -72.39 106.91 2.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.267 0.556 . . . . 1.2 110.217 176.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -91.11 -178.66 5.23 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.648 -0.706 . . . . 1.9399999999999999 111.139 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.6 t -54.61 -49.03 71.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.278 -0.873 . . . . 1.1399999999999999 110.796 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.436 ' O ' HG21 ' A' ' 49' ' ' VAL . 3.3 tm? -50.32 -58.42 5.7 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.719 -0.673 . . . . 1.22 110.883 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.469 ' O ' HG13 ' A' ' 50' ' ' ILE . 22.6 t -66.78 -46.34 75.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.854 0.359 . . . . 1.46 111.442 -174.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.576 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 59.0 p -65.16 -30.66 71.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.427 -0.352 . . . . 1.1000000000000001 111.73 -176.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.565 ' HE3' ' HA ' ' A' ' 65' ' ' GLU . 12.6 tpt -74.73 -41.69 59.68 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.055 -0.72 . . . . 2.8500000000000001 109.055 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.47 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 31.8 t -57.48 -53.1 48.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.278 -0.874 . . . . 1.1499999999999999 110.503 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 46' ' ' SER . 68.9 mt -49.08 -53.9 6.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 O-C-N 123.131 0.27 . . . . 1.05 111.264 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.37 -34.99 83.15 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.81 -0.71 . . . . 0.35999999999999999 112.485 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -68.52 -41.92 79.25 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.91 -0.316 . . . . 1.6599999999999999 110.222 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 1.8 mtp180 -68.54 -20.57 64.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.67 -0.241 . . . . 1.48 110.711 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.59 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.7 m-30 -59.92 -39.83 86.78 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.646 0.736 . . . . 0.33000000000000002 109.658 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.672 ' HD2' ' O ' ' A' ' 60' ' ' LEU . 9.8 mmm180 -73.76 -28.64 61.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.887 -1.051 . . . . 3.3300000000000001 110.298 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -81.53 -64.09 1.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.078 -0.51 . . . . 2.2599999999999998 112.096 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -83.78 -34.62 24.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.977 -0.556 . . . . 2.6200000000000001 111.392 -169.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.3 mp -97.22 -39.71 9.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.051 -0.522 . . . . 1.1200000000000001 110.817 -175.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.38 36.2 8.97 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.534 -0.841 . . . . 0.45000000000000001 111.802 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.672 ' O ' ' HD2' ' A' ' 55' ' ' ARG . 93.4 mt -78.79 133.5 37.06 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.67 -0.122 . . . . 1.23 110.67 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.62 77.71 9.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.212 0.529 . . . . 2.27 110.732 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.59 HD11 ' HD2' ' A' ' 54' ' ' PHE . 55.1 mt -94.66 -60.54 1.68 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.609 0.719 . . . . 2.1299999999999999 109.694 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.41 176.75 24.53 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 109.916 -1.274 . . . . 0.92000000000000004 109.916 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.77 -23.03 7.23 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.994 1.796 . . . . 1.2 112.608 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.565 ' HA ' ' HE3' ' A' ' 48' ' ' MET . 42.0 tt0 -119.71 70.23 0.85 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.716 0.769 . . . . 2.3599999999999999 110.695 -175.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -109.92 111.46 22.89 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.282 -0.872 . . . . 0.84999999999999998 109.487 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.2 m -121.18 118.4 29.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.198 -0.455 . . . . 1.71 110.51 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 59.8 mt -64.58 -25.19 67.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.376 . . . . 1.3700000000000001 111.047 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.538 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.9 t80 -72.16 -4.4 28.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.841 -0.618 . . . . 0.83999999999999997 110.353 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.94 -42.59 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.28 -0.418 . . . . 1.51 110.947 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.46 8.87 33.66 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.365 0.505 . . . . 2.23 112.365 -169.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 89.2 m -152.5 159.23 43.34 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.044 -0.41 . . . . 1.0 110.089 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.9 p -134.25 -70.61 0.51 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.405 -0.362 . . . . 1.29 110.962 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 77.6 p -83.26 -177.65 6.82 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.242 -0.286 . . . . 1.1399999999999999 110.318 175.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.71 HG12 ' HZ1' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -83.25 -41.58 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.635 0 N-CA-C 108.637 -0.875 . . . . 1.3700000000000001 108.637 -176.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.827 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 7.7 tpt180 -59.26 -29.62 67.7 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 113.743 -1.572 . . . . 3.71 110.91 175.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.26 68.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.786 0.326 . . . . 1.1100000000000001 110.826 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.431 HD12 HD13 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -76.47 -43.07 41.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.972 0.892 . . . . 1.3100000000000001 109.151 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.71 ' HZ1' HG12 ' A' ' 75' ' ' VAL . 24.9 mmtm -60.01 -51.54 69.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.152 -1.386 . . . . 2.96 109.83 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.81 -29.75 70.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.714 -1.13 . . . . 1.6599999999999999 111.162 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -72.96 -39.13 66.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.864 -0.607 . . . . 1.2 110.767 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.595 -0.729 . . . . 1.1000000000000001 112.349 -174.588 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.708 0 N-CA-C 111.172 -0.771 . . . . 0.55000000000000004 111.172 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.702 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 2.7 m -114.26 156.28 15.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.855 0.359 . . . . 1.1399999999999999 110.344 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.6 t -95.41 -176.52 3.8 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.12 -0.491 . . . . 1.8899999999999999 109.728 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -62.65 -26.17 68.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.052 0.453 . . . . 2.3300000000000001 109.969 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.48 -55.17 37.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.736 -0.666 . . . . 1.9099999999999999 110.937 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.702 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 88.0 mttt -75.32 -19.8 59.43 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.31 -0.404 . . . . 2.1099999999999999 110.468 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.599 HD12 ' HD2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -73.76 -31.14 63.17 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.022 -0.535 . . . . 1.6000000000000001 110.183 172.457 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.16 -29.39 43.02 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.232 -0.918 . . . . 0.88 109.585 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.54 -25.7 41.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.936 -1.029 . . . . 1.05 111.021 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.633 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 3.7 p -77.68 -43.76 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.557 -0.292 . . . . 1.0700000000000001 111.32 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.546 ' HB3' HD22 ' A' ' 31' ' ' LEU . 66.9 mtm -63.35 -28.99 70.38 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.983 -0.287 . . . . 2.2400000000000002 111.006 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -74.45 -33.62 62.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.86 -0.336 . . . . 3.6899999999999999 110.62 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.12 -38.32 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.624 0.726 . . . . 1.0800000000000001 109.143 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.3 t -61.87 -42.1 93.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.614 -1.175 . . . . 1.04 110.982 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.0 m -71.55 -41.36 69.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.286 0.565 . . . . 1.8400000000000001 110.259 -171.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.06 -46.61 82.34 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.987 -1.006 . . . . 2.2599999999999998 111.663 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.44 -31.46 48.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.459 -0.337 . . . . 0.77000000000000002 111.502 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.432 ' HA ' HD13 ' A' ' 42' ' ' ILE . 53.1 m -77.85 -35.87 50.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.844 0.354 . . . . 1.23 111.175 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.72 0.72 36.79 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.793 -0.718 . . . . 0.54000000000000004 112.494 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.847 HD12 ' SD ' ' A' ' 40' ' ' MET . 5.7 mt -92.81 161.18 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.286 0.565 . . . . 1.28 110.6 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.412 ' N ' HG23 ' A' ' 26' ' ' ILE . . . -87.16 143.13 27.44 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.134 -0.939 . . . . 1.26 109.264 171.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.0 tp -56.18 -29.17 60.47 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.278 0.362 . . . . 1.6000000000000001 111.56 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -69.32 -15.21 63.28 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.34 -0.391 . . . . 2.23 111.944 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -114.07 3.71 15.38 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.121 -0.231 . . . . 2.2400000000000002 111.334 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.554 HD13 HG11 ' A' ' 75' ' ' VAL . 39.1 tp -78.73 99.09 6.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.332 0.587 . . . . 1.6799999999999999 110.335 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.1 p -120.06 163.28 17.89 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.007 -0.738 . . . . 1.21 109.007 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.8 p-10 -70.91 -3.0 16.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.158 0.429 . . . . 2.29 112.158 -177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.41 -22.97 61.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.983 0.42 . . . . 2.29 110.878 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.466 ' HB3' ' CG2' ' A' ' 75' ' ' VAL . 33.7 t -76.14 158.78 31.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.422 0.63 . . . . 1.3300000000000001 111.742 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.2 t-20 -127.16 119.42 26.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.363 -0.835 . . . . 1.2 109.277 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.768 ' HD1' HG13 ' A' ' 42' ' ' ILE . 38.5 m-85 -50.84 -49.6 58.49 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.123 0.487 . . . . 0.63 111.291 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.8 -32.77 74.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.798 -0.637 . . . . 1.1499999999999999 111.28 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 34.2 t70 -73.51 -26.99 61.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.157 0.503 . . . . 0.82999999999999996 110.541 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.847 ' SD ' HD12 ' A' ' 26' ' ' ILE . 65.3 mtm -79.7 -24.1 41.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.805 -0.634 . . . . 2.98 110.183 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.08 26.44 6.66 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.426 -0.892 . . . . 0.54000000000000004 112.584 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.768 HG13 ' HD1' ' A' ' 37' ' ' PHE . 26.9 mm -65.14 108.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.604 -0.517 . . . . 1.2 109.604 175.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -82.34 176.49 9.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.581 -0.736 . . . . 1.9399999999999999 110.435 -175.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.0 t -61.02 -40.25 92.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.805 -0.634 . . . . 1.1399999999999999 109.865 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.27 -56.71 17.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.522 -0.763 . . . . 1.22 110.002 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.504 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.5 m -59.78 -44.22 94.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.09 -0.504 . . . . 1.46 111.206 -177.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.561 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 50.2 m -58.72 -39.29 80.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.744 -0.662 . . . . 1.1000000000000001 111.606 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.4 tpt -72.66 -37.5 67.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.374 0.606 . . . . 2.8500000000000001 110.13 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.581 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.0 t -62.83 -53.84 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.14 -0.936 . . . . 1.1499999999999999 109.871 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 46' ' ' SER . 66.5 mt -49.97 -52.4 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.281 -0.418 . . . . 1.05 111.281 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.09 -36.97 93.15 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.871 -0.681 . . . . 0.35999999999999999 112.518 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t -63.66 -44.2 94.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.715 0.293 . . . . 1.6599999999999999 110.467 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 11.7 mtp180 -65.87 -27.05 67.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.394 -0.366 . . . . 1.48 110.65 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.461 ' HB3' HD12 ' A' ' 60' ' ' LEU . 13.4 m-30 -57.31 -40.66 78.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.36 0.6 . . . . 0.33000000000000002 110.032 175.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -78.62 -27.82 45.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.732 -0.667 . . . . 3.3300000000000001 111.002 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.74 -56.73 4.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.217 -0.447 . . . . 2.2599999999999998 111.474 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -88.14 -36.46 16.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.235 -0.439 . . . . 2.6200000000000001 112.005 -172.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.483 HD13 ' N ' ' A' ' 58' ' ' LEU . 8.3 mp -99.76 -25.08 14.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.892 0.33 . . . . 1.1200000000000001 111.892 -172.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.26 41.62 37.75 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.514 -0.85 . . . . 0.45000000000000001 111.699 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 54' ' ' PHE . 19.1 mt -83.65 136.73 34.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.986 0.365 . . . . 1.23 111.986 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -93.4 88.38 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 2.27 110.208 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.507 HD12 ' HE2' ' A' ' 81' ' ' PHE . 0.7 OUTLIER -112.89 -61.05 1.79 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.135 -0.484 . . . . 2.1299999999999999 109.92 178.55 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.58 170.72 12.45 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.811 -0.709 . . . . 0.92000000000000004 112.155 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.57 10.43 3.71 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.995 2.463 . . . . 1.2 111.937 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.21 9.97 12.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.161 -0.927 . . . . 2.3599999999999999 110.751 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -95.47 116.21 28.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.993 -0.548 . . . . 0.84999999999999998 110.678 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.0 m -136.81 122.45 19.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.024 -0.535 . . . . 1.71 110.255 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.407 HD12 HD12 ' A' ' 50' ' ' ILE . 57.2 mt -56.85 -41.82 78.6 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.953 -0.567 . . . . 1.3700000000000001 111.98 -176.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.561 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.4 t80 -55.67 -14.18 2.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.888 -0.596 . . . . 0.83999999999999997 112.223 -174.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.51 -40.7 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.095 -0.378 . . . . 1.51 111.112 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -106.05 7.84 32.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.059 0.392 . . . . 2.23 112.059 -169.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 92.3 m -148.91 136.63 20.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.342 0.591 . . . . 1.0 109.863 -176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.2 p -114.24 -76.15 0.58 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.038 -0.528 . . . . 1.29 111.071 -173.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 77.7 p -83.19 -172.8 4.34 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.12 -0.362 . . . . 1.1399999999999999 110.449 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.554 HG11 HD13 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -81.36 -40.87 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.03 -0.729 . . . . 1.3700000000000001 109.03 -175.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.595 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -66.98 -24.89 66.09 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.897 -1.047 . . . . 3.71 110.397 179.323 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.0 -34.41 71.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.444 -0.344 . . . . 1.1100000000000001 110.462 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.641 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -71.22 -48.05 53.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.745 -0.835 . . . . 1.3100000000000001 108.745 177.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.599 ' HD2' HD12 ' A' ' 13' ' ' LEU . 30.0 mmtm -54.04 -50.09 67.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.964 -1.471 . . . . 2.96 111.164 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.12 -44.99 92.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 1.6599999999999999 110.627 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.507 ' HE2' HD12 ' A' ' 62' ' ' LEU . 34.2 t80 -63.39 -30.07 71.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.043 -0.98 . . . . 1.2 111.162 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.641 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 32.8 mtp . . . . . 0 N--CA 1.462 0.175 0 CA-C-N 116.177 -0.465 . . . . 1.1000000000000001 110.707 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 111.744 -0.543 . . . . 0.55000000000000004 111.744 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.44 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 4.0 m -114.43 162.11 12.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.324 -0.25 . . . . 1.1399999999999999 110.324 -175.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 p -84.25 174.09 10.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.153 -0.314 . . . . 1.8899999999999999 110.153 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -73.38 -19.46 60.99 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.197 -0.668 . . . . 2.3300000000000001 109.197 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.59 -42.11 95.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.094 -0.957 . . . . 1.9099999999999999 109.398 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.44 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 43.8 mmtm -67.36 -36.26 81.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.364 -0.835 . . . . 2.1099999999999999 110.219 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -62.98 -29.44 70.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.941 -0.572 . . . . 1.6000000000000001 110.678 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.538 ' HA ' ' HE3' ' A' ' 17' ' ' MET . 1.0 OUTLIER -77.38 -28.6 52.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.598 0.713 . . . . 0.88 109.682 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.52 -34.24 31.34 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.098 -0.956 . . . . 1.05 111.124 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.692 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 5.7 p -68.55 -45.99 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.654 0.613 . . . . 1.0700000000000001 112.654 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.538 ' HE3' ' HA ' ' A' ' 14' ' ' ASP . 58.4 mtm -56.35 -34.95 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.943 0.349 . . . . 2.2400000000000002 111.943 -172.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -78.69 -22.97 45.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.34 -0.544 . . . . 3.6899999999999999 111.673 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.415 HG12 HG22 ' A' ' 50' ' ' ILE . 47.3 t -74.58 -34.88 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 122.05 0.929 . . . . 1.0800000000000001 108.551 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 t -69.11 -36.84 75.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.184 -1.371 . . . . 1.04 110.469 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.4 t -68.91 -22.62 64.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.787 0.327 . . . . 1.8400000000000001 110.765 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -86.23 -48.96 8.08 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.976 0.417 . . . . 2.2599999999999998 111.919 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -79.5 -9.92 59.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.475 . . . . 0.77000000000000002 112.1 -172.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -99.91 -42.8 6.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.989 0.423 . . . . 1.23 111.309 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.07 7.03 50.93 Favored Glycine 0 C--O 1.235 0.19 0 C-N-CA 120.711 -0.757 . . . . 0.54000000000000004 111.261 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.555 HD13 ' HG3' ' A' ' 40' ' ' MET . 4.9 mt -93.14 111.91 25.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.307 -0.627 . . . . 1.28 109.307 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.456 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -48.4 144.63 3.92 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.456 0.473 . . . . 1.26 111.229 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.2 tp -55.23 -29.3 57.72 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.141 -0.481 . . . . 1.6000000000000001 111.6 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -83.8 -10.25 58.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 2.23 111.039 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.456 ' HG3' ' HB1' ' A' ' 27' ' ' ALA . 33.2 mt-10 -105.57 -9.46 17.4 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.728 -0.842 . . . . 2.2400000000000002 108.728 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.577 HD11 HG11 ' A' ' 75' ' ' VAL . 36.7 tp -72.76 98.28 2.37 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.812 -1.085 . . . . 1.6799999999999999 109.649 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.6 p -115.79 158.89 22.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.147 -1.057 . . . . 1.21 108.147 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.887 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 17.4 p-10 -75.6 -2.41 29.1 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.931 -0.308 . . . . 2.29 110.821 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -88.22 -3.04 58.92 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.939 -0.573 . . . . 2.29 110.842 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.464 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 45.6 m -81.61 152.91 26.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.488 0.661 . . . . 1.3300000000000001 110.704 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 15.0 t-20 -122.0 122.96 40.53 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.49 -0.777 . . . . 1.2 109.141 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.658 ' HD1' HG13 ' A' ' 42' ' ' ILE . 23.7 m-85 -55.75 -53.58 54.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.988 0.423 . . . . 0.63 111.359 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.86 -27.79 67.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.054 -0.521 . . . . 1.1499999999999999 111.066 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.658 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 35.8 t70 -72.45 -29.2 63.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.82999999999999996 110.586 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.555 ' HG3' HD13 ' A' ' 26' ' ' ILE . 14.9 mmt -83.35 -19.9 35.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.896 -0.593 . . . . 2.98 111.318 -176.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.92 16.73 8.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.356 -0.926 . . . . 0.54000000000000004 112.441 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.658 HG13 ' HD1' ' A' ' 37' ' ' PHE . 23.4 mm -66.6 108.27 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.139 0.495 . . . . 1.2 110.323 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -81.34 167.49 19.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.667 -0.697 . . . . 1.9399999999999999 110.068 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.8 t -54.02 -35.14 61.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.447 -0.575 . . . . 1.1399999999999999 109.447 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.483 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.1 tm? -59.55 -62.56 1.78 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.562 -0.745 . . . . 1.22 110.022 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.539 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.2 m -59.86 -44.52 94.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.247 -0.433 . . . . 1.46 112.153 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.531 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 36.4 p -65.34 -30.36 71.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.021 0.438 . . . . 1.1000000000000001 111.125 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.4 tpt -75.06 -30.82 61.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.647 -0.706 . . . . 2.8500000000000001 109.621 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 45' ' ' LEU . 76.3 t -78.62 -36.78 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.148 -0.933 . . . . 1.1499999999999999 110.497 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 46' ' ' SER . 66.9 mt -56.44 -52.57 50.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.37 -0.233 . . . . 1.05 110.37 173.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.67 -26.25 68.29 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.774 -0.727 . . . . 0.35999999999999999 111.943 178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 4.1 m -69.62 -45.21 69.05 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 120.679 0.276 . . . . 1.6599999999999999 110.863 176.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -65.07 -27.0 68.48 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.624 0.249 . . . . 1.48 110.856 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.62 ' HD2' HD13 ' A' ' 62' ' ' LEU . 12.7 m-30 -54.86 -39.97 69.18 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.718 -0.475 . . . . 0.33000000000000002 109.718 174.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.685 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 12.2 mtp180 -81.64 -34.77 30.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.72 -0.673 . . . . 3.3300000000000001 111.534 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -86.05 -63.88 1.24 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.039 0.447 . . . . 2.2599999999999998 111.544 -173.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -71.14 -36.3 72.03 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.454 -0.794 . . . . 2.6200000000000001 111.499 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.75 -57.0 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 1.1200000000000001 111.055 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.85 27.61 3.19 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.823 -0.703 . . . . 0.45000000000000001 113.221 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.685 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 55.2 mt -84.1 112.19 20.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.78 0.29 . . . . 1.23 110.353 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -85.58 66.37 9.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 122.235 1.017 . . . . 2.27 110.163 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.62 HD13 ' HD2' ' A' ' 54' ' ' PHE . 19.4 mt -64.72 -67.45 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.507 -1.224 . . . . 2.1299999999999999 110.682 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.75 173.25 39.12 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 110.285 -1.126 . . . . 0.92000000000000004 110.285 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.8 -35.89 0.68 Allowed 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.372 2.048 . . . . 1.2 113.048 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -108.27 62.83 0.61 Allowed 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 121.078 0.466 . . . . 2.3599999999999999 110.766 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -109.66 111.66 23.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.698 -0.482 . . . . 0.84999999999999998 109.698 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.6 m -129.27 118.89 23.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.98 -0.555 . . . . 1.71 110.74 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 84.1 mt -64.64 -16.06 62.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.911 -0.586 . . . . 1.3700000000000001 111.092 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.531 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 46.0 t80 -82.5 -12.03 58.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.923 -0.581 . . . . 0.83999999999999997 110.948 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 71.8 mt -117.77 -41.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.773 -0.371 . . . . 1.51 111.624 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.26 15.23 16.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.454 0.645 . . . . 2.23 110.671 -173.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 76.8 m -146.72 156.63 43.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.7 p -135.93 -63.17 0.66 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.685 0.279 . . . . 1.29 110.776 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 44.3 p -93.04 179.08 5.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.195 -0.298 . . . . 1.1399999999999999 110.195 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.577 HG11 HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -75.83 -42.91 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 121.484 0.659 . . . . 1.3700000000000001 109.397 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.887 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 40.7 ttp180 -52.86 -37.96 60.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.501 -1.227 . . . . 3.71 111.728 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -55.83 -33.9 64.91 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.852 0.72 . . . . 1.1100000000000001 111.311 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.47 -47.96 30.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.203 0.525 . . . . 1.3100000000000001 110.144 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.579 ' HD3' ' HA ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -56.4 -60.97 2.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.263 -0.88 . . . . 2.96 110.235 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -54.62 -37.5 65.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.774 -1.103 . . . . 1.6599999999999999 111.609 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.526 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 38.2 t80 -62.07 -37.88 86.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 1.2 110.966 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.692 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 12.2 mtt . . . . . 0 C--O 1.235 0.307 0 CA-C-N 116.059 -0.519 . . . . 1.1000000000000001 112.017 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 111.829 -0.508 . . . . 0.55000000000000004 111.829 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 m -109.92 159.31 9.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.822 0.344 . . . . 1.1399999999999999 110.46 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 m -75.49 166.99 22.74 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.777 -0.453 . . . . 1.8899999999999999 109.777 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -69.41 -29.56 67.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.99 -0.744 . . . . 2.3300000000000001 108.99 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.44 -34.64 77.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.079 -0.964 . . . . 1.9099999999999999 110.242 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -63.69 -29.43 70.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 2.1099999999999999 110.31 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.41 ' O ' ' HG3' ' A' ' 17' ' ' MET . 18.2 tp -66.95 -23.97 66.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.831 -0.622 . . . . 1.6000000000000001 110.86 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.46 -31.57 26.49 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.585 0.707 . . . . 0.88 109.516 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -29.03 55.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.155 -0.93 . . . . 1.05 110.509 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.443 HG22 ' HE3' ' A' ' 82' ' ' MET . 3.3 p -73.65 -45.95 49.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.18 -0.464 . . . . 1.0700000000000001 111.036 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.879 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 75.6 mtp -61.13 -35.32 76.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 2.2400000000000002 111.226 -175.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 12.5 ptm180 -66.13 -37.64 86.2 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 120.459 -0.497 . . . . 3.6899999999999999 110.567 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.9 -41.03 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 109.039 -0.726 . . . . 1.0800000000000001 109.039 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -57.65 -47.23 86.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.841 -1.072 . . . . 1.04 110.129 175.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.2 m -68.08 -42.37 80.5 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.071 0.397 . . . . 1.8400000000000001 112.071 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 45.2 mt-10 -63.46 -27.76 69.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.252 -0.431 . . . . 2.2599999999999998 111.579 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -91.06 -38.79 12.57 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.967 0.358 . . . . 0.77000000000000002 111.967 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.6 p -72.95 -44.98 60.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.958 0.409 . . . . 1.23 111.57 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.98 38.26 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.68 -0.771 . . . . 0.54000000000000004 111.549 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mt -94.79 117.8 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.483 -0.562 . . . . 1.28 109.483 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.659 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -47.28 141.75 4.44 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.131 0.419 . . . . 1.26 112.131 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 tp -52.7 -38.64 60.99 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.509 -0.769 . . . . 1.6000000000000001 111.472 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.39 -9.22 58.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.761 -0.654 . . . . 2.23 111.253 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.659 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 15.6 mm-40 -110.81 -6.87 14.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.93 -0.577 . . . . 2.2400000000000002 109.983 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.413 HD23 ' HE2' ' A' ' 17' ' ' MET . 25.5 tp -75.06 98.56 3.67 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.201 0.524 . . . . 1.6799999999999999 110.284 -176.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.3 p -111.65 158.94 18.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.529 -0.759 . . . . 1.21 109.696 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.658 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.2 p-10 -76.26 -4.99 44.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.349 . . . . 2.29 111.463 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.08 -21.18 60.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.811 -0.632 . . . . 2.29 110.639 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.427 ' HB3' HG23 ' A' ' 75' ' ' VAL . 16.3 t -77.31 158.07 30.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.81 0.814 . . . . 1.3300000000000001 111.207 -173.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.639 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 20.7 t-20 -126.32 122.64 36.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.861 -1.063 . . . . 1.2 108.594 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.744 ' HD1' HG13 ' A' ' 42' ' ' ILE . 18.6 m-85 -55.17 -48.18 74.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.106 0.479 . . . . 0.63 111.408 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.4 68.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.103 -0.499 . . . . 1.1499999999999999 110.999 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 14.3 t70 -67.58 -34.51 77.18 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.161 0.505 . . . . 0.82999999999999996 110.203 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.2 mmt -81.0 -17.67 49.52 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.633 -0.712 . . . . 2.98 111.238 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.87 22.03 9.19 Favored Glycine 0 C--O 1.23 -0.099 0 C-N-CA 120.566 -0.826 . . . . 0.54000000000000004 112.773 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.744 HG13 ' HD1' ' A' ' 37' ' ' PHE . 26.9 mm -64.2 108.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.213 0.53 . . . . 1.2 110.192 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -76.1 161.64 28.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.35 -0.841 . . . . 1.9399999999999999 111.04 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.3 t -56.07 -41.52 75.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.938 -0.574 . . . . 1.1399999999999999 110.576 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.92 -53.18 60.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 1.22 109.788 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.554 ' O ' HG13 ' A' ' 50' ' ' ILE . 16.2 m -57.84 -44.87 86.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.419 -0.355 . . . . 1.46 110.903 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.512 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 50.2 m -58.38 -37.66 75.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.096 -0.502 . . . . 1.1000000000000001 111.234 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.2 tpt -74.71 -34.99 62.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.909 -0.587 . . . . 2.8500000000000001 109.93 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.504 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 44.1 t -68.3 -48.54 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.664 -0.698 . . . . 1.1499999999999999 109.587 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 46' ' ' SER . 73.1 mt -52.04 -54.89 11.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.72 0.295 . . . . 1.05 110.391 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.514 ' O ' ' HG3' ' A' ' 55' ' ' ARG . . . -60.41 -32.98 79.22 Favored Glycine 0 C--O 1.228 -0.245 0 CA-C-N 115.829 -0.623 . . . . 0.35999999999999999 112.578 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.468 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -72.94 -45.59 57.22 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.048 -0.261 . . . . 1.6599999999999999 110.549 177.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 6.1 mtp180 -63.39 -30.68 71.77 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.913 0.387 . . . . 1.48 110.188 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.504 ' CE2' HD21 ' A' ' 78' ' ' LEU . 9.1 m-30 -50.99 -48.52 61.24 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.857 -0.61 . . . . 0.33000000000000002 109.782 171.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 19.0 mtm105 -83.76 -40.51 18.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.637 -0.711 . . . . 3.3300000000000001 110.952 -170.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -88.21 -49.01 7.27 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.351 -0.386 . . . . 2.2599999999999998 111.874 -171.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -79.58 -52.05 8.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.85 0.357 . . . . 2.6200000000000001 111.349 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 mp -82.63 -58.31 2.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.194 -0.457 . . . . 1.1200000000000001 111.541 -175.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.65 24.22 1.58 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.091 -0.576 . . . . 0.45000000000000001 112.154 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.527 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 16.6 mt -104.19 92.72 4.48 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.757 -0.26 . . . . 1.23 110.516 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.453 ' HA ' ' HG2' ' A' ' 55' ' ' ARG . 18.4 t70 -101.36 80.04 2.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.581 0.705 . . . . 2.27 110.021 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.503 HD12 ' HE2' ' A' ' 81' ' ' PHE . 71.4 mt -71.17 -32.53 69.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.895 -1.048 . . . . 2.1299999999999999 109.43 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.06 160.98 21.8 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 114.642 -1.163 . . . . 0.92000000000000004 110.75 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -82.99 -12.58 9.55 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.89 2.393 . . . . 1.2 113.066 -175.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -130.67 31.36 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.812 0.815 . . . . 2.3599999999999999 110.717 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -95.01 120.24 34.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.84999999999999998 109.563 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 t -126.63 131.76 51.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.7 -0.4 . . . . 1.71 110.498 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 72' ' ' CYS . 48.1 mt -58.4 -41.38 84.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.808 -0.633 . . . . 1.3700000000000001 110.475 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.512 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 15.0 t80 -62.59 -12.4 22.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.731 -0.668 . . . . 0.83999999999999997 111.494 -175.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 63.7 mt -109.87 -42.34 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.874 -0.33 . . . . 1.51 111.126 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -130.71 22.11 5.04 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.64 0.978 . . . . 2.23 113.64 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 98.3 m -143.99 99.55 3.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.282 0.563 . . . . 1.0 109.81 174.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.5 p -90.81 -51.78 5.19 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.012 -0.54 . . . . 1.29 111.624 -170.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.4 p -96.82 -178.64 4.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.19 -0.3 . . . . 1.1399999999999999 110.19 176.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.543 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -81.09 -41.33 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 109.764 -0.458 . . . . 1.3700000000000001 109.764 -178.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.658 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 5.2 tpt180 -60.6 -28.22 68.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.671 -0.695 . . . . 3.71 110.483 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -58.32 -32.83 68.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.498 -0.319 . . . . 1.1100000000000001 110.69 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.504 HD21 ' CE2' ' A' ' 54' ' ' PHE . 0.7 OUTLIER -81.27 -48.66 11.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.546 0.689 . . . . 1.3100000000000001 109.431 176.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.879 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.9 mmtp -53.99 -57.84 9.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.695 -1.139 . . . . 2.96 110.928 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.476 ' HB2' ' HE ' ' A' ' 76' ' ' ARG . 5.7 t70 -72.33 -19.38 61.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.208 -0.905 . . . . 1.6599999999999999 111.1 -171.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.503 ' HE2' HD12 ' A' ' 62' ' ' LEU . 76.2 t80 -73.62 -44.12 57.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.215 0.531 . . . . 1.2 110.418 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.447 ' SD ' HD12 ' A' ' 60' ' ' LEU . 6.3 mtm . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.73 -0.668 . . . . 1.1000000000000001 112.123 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 111.324 -0.71 . . . . 0.55000000000000004 111.324 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.03 155.36 14.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.851 0.358 . . . . 1.1399999999999999 110.167 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 t -82.96 173.63 11.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.536 -0.542 . . . . 1.8899999999999999 109.536 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -65.52 -25.8 67.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.293 0.568 . . . . 2.3300000000000001 109.853 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -67.29 -46.45 73.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.395 -0.82 . . . . 1.9099999999999999 110.503 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -73.82 -20.32 60.49 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.724 -0.391 . . . . 2.1099999999999999 110.508 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 tp -74.18 -25.54 59.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 1.6000000000000001 110.33 172.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.37 -27.51 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.721 0.772 . . . . 0.88 110.311 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.456 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -79.54 -30.77 41.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.987 -1.006 . . . . 1.05 110.878 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.656 ' HB ' ' HE2' ' A' ' 82' ' ' MET . 2.3 p -68.33 -43.59 84.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.314 -0.403 . . . . 1.0700000000000001 111.459 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.812 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 30.7 mtt -56.85 -34.77 68.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.515 -0.311 . . . . 2.2400000000000002 111.132 -174.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.614 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 12.8 ptp180 -81.85 -27.08 33.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.475 -0.329 . . . . 3.6899999999999999 111.785 -176.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.9 t -71.35 -34.93 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 108.078 -1.082 . . . . 1.0800000000000001 108.078 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.1 t -66.88 -36.82 78.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 114.025 -1.443 . . . . 1.04 109.8 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' A' ' 18' ' ' ARG . 19.5 m -70.66 -26.12 63.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 116.231 -0.44 . . . . 1.8400000000000001 112.16 -177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.614 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 74.6 mt-10 -86.68 -37.73 17.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.865 0.364 . . . . 2.2599999999999998 111.177 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HG3' HG12 ' A' ' 50' ' ' ILE . 72.3 mm-40 -76.85 -37.91 54.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.968 -0.56 . . . . 0.77000000000000002 112.23 -176.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.463 ' CB ' HD13 ' A' ' 42' ' ' ILE . 66.4 p -80.3 -45.35 18.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.132 0.491 . . . . 1.23 110.816 -178.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.71 -4.38 26.07 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.688 -0.687 . . . . 0.54000000000000004 112.467 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.687 HD12 ' HG3' ' A' ' 40' ' ' MET . 8.6 mt -75.32 141.23 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.625 -0.43 . . . . 1.28 110.002 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.86 140.05 56.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.097 -0.501 . . . . 1.26 109.667 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.3 tp -55.09 -31.9 61.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 1.6000000000000001 111.763 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -77.95 -8.27 57.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.513 -0.312 . . . . 2.23 110.909 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -107.22 -5.44 17.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.934 0.397 . . . . 2.2400000000000002 110.132 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.438 HD22 ' HB3' ' A' ' 17' ' ' MET . 32.6 tp -75.89 97.51 3.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.429 0.633 . . . . 1.6799999999999999 109.921 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.0 p -116.82 165.56 13.17 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.76 -0.829 . . . . 1.21 108.76 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.9 p-10 -72.6 -3.7 26.33 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 111.49 0.181 . . . . 2.29 111.49 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -74.81 -22.69 58.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.992 0.425 . . . . 2.29 110.429 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.471 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 18.0 m -74.15 153.98 39.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.735 0.778 . . . . 1.3300000000000001 111.34 -174.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.905 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.5 t-20 -128.31 127.55 42.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.121 -0.945 . . . . 1.2 108.674 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.583 ' HD1' HG13 ' A' ' 42' ' ' ILE . 11.7 m-85 -56.48 -53.41 57.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.973 0.416 . . . . 0.63 111.649 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.49 -30.01 66.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.314 -0.403 . . . . 1.1499999999999999 111.189 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.905 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.5 t70 -69.66 -30.48 68.18 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.345 0.593 . . . . 0.82999999999999996 110.412 176.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.687 ' HG3' HD12 ' A' ' 26' ' ' ILE . 1.8 tmm? -74.18 -23.37 59.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.541 -0.754 . . . . 2.98 110.461 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.3 14.69 15.76 Favored Glycine 0 CA--C 1.511 -0.175 0 C-N-CA 120.354 -0.927 . . . . 0.54000000000000004 111.358 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.583 HG13 ' HD1' ' A' ' 37' ' ' PHE . 24.6 mm -76.24 113.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.584 -0.308 . . . . 1.2 110.337 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.53 -172.74 2.58 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.05 -0.722 . . . . 1.9399999999999999 109.05 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.8 t -68.24 -30.82 69.95 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 111.618 0.229 . . . . 1.1399999999999999 111.618 -174.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.69 -59.79 4.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.5 -0.318 . . . . 1.22 110.298 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.574 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.3 t -66.03 -40.95 91.48 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.029 -0.269 . . . . 1.46 110.496 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 49.0 m -56.78 -36.77 70.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.389 . . . . 1.1000000000000001 111.784 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -73.61 -43.77 58.77 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.655 -0.869 . . . . 2.8500000000000001 108.655 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.431 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 64.0 t -62.26 -43.17 97.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.837 -1.074 . . . . 1.1499999999999999 110.721 -176.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 46' ' ' SER . 72.3 mt -54.0 -52.86 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.871 0.367 . . . . 1.05 110.582 175.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -60.85 -31.87 77.46 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.076 -0.583 . . . . 0.35999999999999999 112.135 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.85 -46.39 82.06 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 122.441 0.296 . . . . 1.6599999999999999 110.802 176.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 12.4 mtp180 -65.28 -28.21 69.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.544 -0.298 . . . . 1.48 110.514 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.665 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.5 m-30 -57.66 -39.35 76.87 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.707 -0.479 . . . . 0.33000000000000002 109.707 173.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -80.17 -33.2 38.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.179 -0.464 . . . . 3.3300000000000001 110.437 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.21 -51.65 9.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.426 -0.352 . . . . 2.2599999999999998 111.024 -175.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.81 -48.74 7.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.959 -0.564 . . . . 2.6200000000000001 112.331 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -90.56 -13.29 34.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.54 -0.3 . . . . 1.1200000000000001 111.535 -173.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 33.14 68.7 Favored Glycine 0 C--O 1.229 -0.198 0 C-N-CA 121.008 -0.615 . . . . 0.45000000000000001 112.804 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.445 HD13 ' HB3' ' A' ' 54' ' ' PHE . 80.0 mt -90.64 116.65 28.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.505 0.153 . . . . 1.23 111.174 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.08 77.66 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.436 1.113 . . . . 2.27 109.706 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.665 HD11 ' HD2' ' A' ' 54' ' ' PHE . 25.2 mt -74.13 -27.01 60.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.652 -1.158 . . . . 2.1299999999999999 110.608 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.39 171.68 12.55 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 114.936 -1.029 . . . . 0.92000000000000004 110.799 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -87.04 -7.32 7.14 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.999 2.466 . . . . 1.2 112.388 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -134.49 45.44 2.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.63 0.729 . . . . 2.3599999999999999 110.291 -171.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -109.56 129.88 55.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.454 -0.794 . . . . 0.84999999999999998 110.8 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.2 t -140.69 131.09 25.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.329 -0.396 . . . . 1.71 110.013 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 50.6 mt -60.44 -37.84 82.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.917 0.389 . . . . 1.3700000000000001 110.458 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.44 ' H ' ' HB3' ' A' ' 47' ' ' SER . 40.5 t80 -60.05 -12.39 8.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.47 -0.786 . . . . 0.83999999999999997 111.641 -174.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.52 -38.94 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.565 -0.289 . . . . 1.51 111.417 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -114.72 10.97 16.72 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.395 0.517 . . . . 2.23 112.395 -171.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 82.9 m -150.22 100.13 2.87 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.181 0.515 . . . . 1.0 110.096 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.8 p -91.1 -54.13 4.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.26 -0.427 . . . . 1.29 111.638 -172.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.1 p -94.4 -177.28 4.2 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.084 -0.385 . . . . 1.1399999999999999 110.394 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.471 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -79.11 -43.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.457 0.646 . . . . 1.3700000000000001 109.845 -178.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.3 tpt180 -63.1 -25.65 68.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.246 -0.888 . . . . 3.71 110.637 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.43 -32.99 73.92 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 116.275 -0.421 . . . . 1.1100000000000001 110.559 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.638 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.8 OUTLIER -75.23 -50.42 16.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.87 -0.789 . . . . 1.3100000000000001 108.87 177.708 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.812 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.9 mmtp -50.32 -52.66 34.82 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.178 -0.919 . . . . 2.96 110.897 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -63.18 -39.65 95.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.482 -0.781 . . . . 1.6599999999999999 111.373 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.27 -35.12 79.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.792 -0.64 . . . . 1.2 111.667 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.656 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 28.7 mtp . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 120.882 0.373 . . . . 1.1000000000000001 110.708 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 110.843 -0.903 . . . . 0.55000000000000004 110.843 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.3 159.24 14.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.895 0.379 . . . . 1.1399999999999999 111.153 -173.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.2 m -87.31 175.22 8.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.973 -0.558 . . . . 1.8899999999999999 110.051 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -65.76 -33.24 75.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.978 0.418 . . . . 2.3300000000000001 110.885 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 1.7 mp0 -65.01 -36.27 83.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.586 0.708 . . . . 1.9099999999999999 109.783 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.402 ' HD2' HD22 ' A' ' 60' ' ' LEU . 39.9 mmtm -66.39 -33.92 76.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.04 -0.982 . . . . 2.1099999999999999 110.242 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.7 tp -67.46 -25.79 66.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.781 -0.645 . . . . 1.6000000000000001 110.697 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.69 -28.82 28.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.248 0.547 . . . . 0.88 110.252 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -80.14 -27.2 39.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.893 -0.594 . . . . 1.05 111.024 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.71 ' HB ' ' HE3' ' A' ' 82' ' ' MET . 2.7 p -72.62 -44.23 60.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.355 -0.384 . . . . 1.0700000000000001 111.661 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.1 mtp -63.69 -24.96 67.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.505 -0.316 . . . . 2.2400000000000002 111.389 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.617 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 16.1 ptt180 -76.86 -27.44 55.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 3.6899999999999999 110.757 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.1 t -82.4 -37.75 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.578 0.704 . . . . 1.0800000000000001 109.123 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.407 ' CG1' HD11 ' A' ' 31' ' ' LEU . 21.1 t -64.21 -32.03 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.913 -1.04 . . . . 1.04 109.296 174.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -61.87 -26.63 68.26 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.842 -0.617 . . . . 1.8400000000000001 111.449 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -87.33 -53.14 4.99 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.31 0.576 . . . . 2.2599999999999998 111.308 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -73.22 -30.53 63.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.318 -0.856 . . . . 0.77000000000000002 111.898 -171.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.47 ' HA ' HD13 ' A' ' 42' ' ' ILE . 24.5 m -92.22 -25.22 18.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.592 -0.276 . . . . 1.23 111.424 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.03 7.42 65.89 Favored Glycine 0 N--CA 1.461 0.356 0 C-N-CA 120.33 -0.938 . . . . 0.54000000000000004 113.007 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.587 HD13 ' SD ' ' A' ' 40' ' ' MET . 4.3 mt -98.51 131.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.728 -0.471 . . . . 1.28 109.728 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.07 146.28 47.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.119 -0.326 . . . . 1.26 110.119 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.5 tp -53.24 -33.55 53.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.581 0.352 . . . . 1.6000000000000001 111.183 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -83.25 -8.97 59.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.093 -0.503 . . . . 2.23 111.342 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -114.81 -6.15 12.65 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.22 -0.659 . . . . 2.2400000000000002 109.22 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.407 HD11 ' CG1' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -72.57 98.38 2.31 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.923 -1.035 . . . . 1.6799999999999999 109.048 179.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.8 p -103.17 153.49 20.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.642 -0.708 . . . . 1.21 109.723 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.931 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 20.7 m-20 -75.0 -9.95 59.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.918 0.39 . . . . 2.29 111.858 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -95.37 -11.58 27.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.869 -0.605 . . . . 2.29 111.891 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 t -78.41 156.05 29.65 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.556 0.693 . . . . 1.3300000000000001 109.946 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.56 ' HB3' ' CB ' ' A' ' 39' ' ' ASP . 18.3 t-20 -115.51 127.03 55.0 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.15 -0.932 . . . . 1.2 110.231 -168.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.758 ' HD1' HG13 ' A' ' 42' ' ' ILE . 18.0 m-85 -56.56 -51.8 67.22 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.891 0.377 . . . . 0.63 111.193 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.43 -31.16 71.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.239 -0.437 . . . . 1.1499999999999999 111.128 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.56 ' CB ' ' HB3' ' A' ' 36' ' ' ASN . 25.1 t70 -67.23 -31.76 72.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.076 0.465 . . . . 0.82999999999999996 110.499 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.587 ' SD ' HD13 ' A' ' 26' ' ' ILE . 68.2 mtp -89.52 -9.35 50.29 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.198 -0.456 . . . . 2.98 111.153 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.22 26.8 9.83 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.195 -1.003 . . . . 0.54000000000000004 112.975 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.758 HG13 ' HD1' ' A' ' 37' ' ' PHE . 30.2 mm -71.87 107.27 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.249 -0.278 . . . . 1.2 110.249 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -78.52 176.71 9.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.42 0.629 . . . . 1.9399999999999999 110.572 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.7 p -59.83 -41.66 91.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.011 -0.995 . . . . 1.1399999999999999 111.097 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -58.98 -58.71 7.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.611 -0.722 . . . . 1.22 110.4 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.651 ' O ' HG13 ' A' ' 50' ' ' ILE . 5.0 m -60.53 -46.01 91.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.402 -0.363 . . . . 1.46 111.39 -177.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.879 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 41.3 p -65.54 -31.49 72.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.345 -0.389 . . . . 1.1000000000000001 111.393 -177.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -40.47 66.77 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.845 -0.798 . . . . 2.8500000000000001 108.845 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.544 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 24.1 t -59.5 -44.83 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 115.221 -0.899 . . . . 1.1499999999999999 110.053 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 46' ' ' SER . 39.4 mt -52.82 -56.93 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 1.05 111.043 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.72 -29.62 74.41 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.021 -0.609 . . . . 0.35999999999999999 112.55 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -44.19 77.57 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.155 -0.313 . . . . 1.6599999999999999 110.155 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 16.4 mtp180 -62.94 -26.34 68.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.567 -0.288 . . . . 1.48 110.611 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.682 ' HD2' HD11 ' A' ' 62' ' ' LEU . 14.5 m-30 -56.77 -41.4 77.55 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.167 0.508 . . . . 0.33000000000000002 109.925 173.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 23.3 mtm180 -79.43 -25.78 41.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.513 -0.767 . . . . 3.3300000000000001 110.299 -177.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -74.27 -62.91 1.35 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.611 -0.722 . . . . 2.2599999999999998 111.82 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.84 -41.71 11.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.966 0.413 . . . . 2.6200000000000001 111.733 -173.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.77 -23.63 21.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.301 -0.409 . . . . 1.1200000000000001 111.572 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.89 27.55 60.35 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.145 -0.55 . . . . 0.45000000000000001 112.732 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.676 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 58.1 mt -87.03 95.72 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.767 -0.255 . . . . 1.23 110.591 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -86.83 78.2 9.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.6 0.714 . . . . 2.27 109.215 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.682 HD11 ' HD2' ' A' ' 54' ' ' PHE . 14.6 mt -71.05 -57.01 4.95 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.371 -1.286 . . . . 2.1299999999999999 110.305 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.38 150.44 9.38 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.753 -1.112 . . . . 0.92000000000000004 110.807 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.49 -9.84 20.23 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.234 1.956 . . . . 1.2 112.902 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -120.15 22.84 11.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.995 -0.548 . . . . 2.3599999999999999 110.733 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -80.34 124.43 28.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.282 -0.417 . . . . 0.84999999999999998 111.148 -177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.4 t -139.47 125.19 19.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.641 -0.503 . . . . 1.71 109.641 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.879 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 88.5 mt -60.37 -23.7 64.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.541 0.21 . . . . 1.3700000000000001 111.382 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.495 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 17.5 t80 -71.88 -14.06 61.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.246 0.546 . . . . 0.83999999999999997 110.445 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.2 mt -122.89 -39.75 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 1.51 110.868 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -95.02 8.46 42.84 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.74 0.274 . . . . 2.23 111.74 -172.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.31 167.23 30.31 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.9 p -138.49 -68.07 0.46 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 1.29 110.568 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 81.4 p -84.55 -175.43 5.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.747 -0.464 . . . . 1.1399999999999999 109.747 174.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.0 t -83.77 -38.75 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.879 0.847 . . . . 1.3700000000000001 109.929 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.931 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 35.6 ttm180 -61.88 -30.01 70.58 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.713 -1.131 . . . . 3.71 111.252 175.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.46 -31.44 65.95 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.988 0.423 . . . . 1.1100000000000001 110.513 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.761 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.1 tt -70.5 -48.32 56.26 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.574 -0.899 . . . . 1.3100000000000001 108.574 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.534 ' CG ' ' HA ' ' A' ' 76' ' ' ARG . 20.8 mmtm -50.76 -55.06 18.48 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.984 -1.007 . . . . 2.96 110.572 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -51.44 -49.43 61.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.276 -0.875 . . . . 1.6599999999999999 111.69 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -61.7 -36.49 81.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.743 -0.662 . . . . 1.2 111.8 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.761 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 44.1 mtp . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.367 -0.379 . . . . 1.1000000000000001 111.765 -173.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.513 0 N-CA-C 110.956 -0.857 . . . . 0.55000000000000004 110.956 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.655 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 4.1 m -103.98 156.74 5.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.707 0.289 . . . . 1.1399999999999999 110.628 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.3 m -85.39 173.93 9.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.639 -0.504 . . . . 1.8899999999999999 109.639 175.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -61.75 -36.08 79.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.774 0.797 . . . . 2.3300000000000001 109.013 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -59.17 -42.1 89.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.716 -1.129 . . . . 1.9099999999999999 111.211 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.655 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 41.4 mmtm -67.73 -31.65 71.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 2.1099999999999999 110.052 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.421 ' O ' ' HG3' ' A' ' 17' ' ' MET . 34.7 tp -68.11 -26.22 65.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.645 . . . . 1.6000000000000001 110.324 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.69 -29.96 36.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.103 0.478 . . . . 0.88 110.288 178.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.17 -27.22 39.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.619 . . . . 1.05 111.051 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.691 ' HB ' ' HE3' ' A' ' 82' ' ' MET . 4.0 p -75.71 -48.76 28.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.805 0.336 . . . . 1.0700000000000001 111.721 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 73.3 mtm -59.57 -30.32 68.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.176 -0.465 . . . . 2.2400000000000002 111.514 -174.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 6.5 ptm180 -70.38 -37.88 74.63 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.106 -0.638 . . . . 3.6899999999999999 110.635 176.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.475 HG12 HG22 ' A' ' 50' ' ' ILE . 29.2 t -64.5 -42.77 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.554 0.693 . . . . 1.0800000000000001 109.3 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.09 -42.03 93.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.983 -1.008 . . . . 1.04 110.807 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -23.48 61.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.828 0.347 . . . . 1.8400000000000001 110.174 -174.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 43.9 mt-10 -79.01 -43.27 24.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.158 -0.474 . . . . 2.2599999999999998 111.6 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -86.27 -8.31 57.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.329 -0.396 . . . . 0.77000000000000002 111.273 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.4 p -97.57 -41.25 8.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.052 0.453 . . . . 1.23 110.407 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.76 41.85 3.25 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.863 -0.684 . . . . 0.54000000000000004 111.603 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 27' ' ' ALA . 5.2 mt -127.16 165.87 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.808 -0.442 . . . . 1.28 109.808 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.467 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -83.96 142.02 30.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.643 -0.708 . . . . 1.26 110.257 172.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.0 tp -61.14 -33.26 73.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.043 -0.526 . . . . 1.6000000000000001 111.092 -177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.63 -11.98 60.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.179 0.514 . . . . 2.23 111.067 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 17.8 mm-40 -105.79 -5.04 20.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.796 -0.638 . . . . 2.2400000000000002 110.107 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.6 tp -84.85 96.55 9.35 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.107 -0.497 . . . . 1.6799999999999999 110.352 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 p -115.0 169.63 8.94 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.833 -0.803 . . . . 1.21 108.833 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.645 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 4.8 p-10 -75.66 -3.29 33.71 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.931 -0.308 . . . . 2.29 111.548 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.12 -20.22 60.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.14 -0.482 . . . . 2.29 110.406 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.493 ' HB2' HG21 ' A' ' 75' ' ' VAL . 16.3 m -79.74 157.69 27.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.606 0.717 . . . . 1.3300000000000001 111.541 -175.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.75 119.42 25.73 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.229 -1.026 . . . . 1.2 108.229 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.402 ' CZ ' HG13 ' A' ' 75' ' ' VAL . 16.8 m-85 -57.72 -39.26 76.86 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.45 -0.5 . . . . 0.63 111.642 -173.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.76 -26.91 67.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.984 0.421 . . . . 1.1499999999999999 110.472 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -68.89 -29.73 68.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.82999999999999996 110.296 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -83.59 -8.4 59.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.754 -0.657 . . . . 2.98 110.283 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.77 32.5 36.75 Favored Glycine 0 C--N 1.322 -0.225 0 C-N-CA 120.443 -0.884 . . . . 0.54000000000000004 112.002 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.497 ' CG2' ' HB3' ' A' ' 47' ' ' SER . 2.7 mt -67.76 108.46 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.018 0.437 . . . . 1.2 110.225 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -78.45 165.96 23.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.816 -0.629 . . . . 1.9399999999999999 110.48 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.0 t -51.54 -43.33 62.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 1.1399999999999999 110.861 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.14 -55.91 28.8 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.142 -0.481 . . . . 1.22 110.376 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.3 m -61.41 -44.14 97.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 1.46 111.525 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.845 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 63.7 p -68.09 -31.61 71.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.735 0.302 . . . . 1.1000000000000001 111.222 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.2 tpt -70.76 -36.45 73.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.449 0.642 . . . . 2.8500000000000001 109.805 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.31 -36.39 76.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.064 -0.971 . . . . 1.1499999999999999 110.22 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' A' ' 47' ' ' SER . 67.5 mt -59.83 -52.01 66.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.762 -0.653 . . . . 1.05 110.753 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -64.04 -28.69 73.19 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.144 -0.551 . . . . 0.35999999999999999 112.197 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -49.63 76.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.767 0.318 . . . . 1.6599999999999999 110.512 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -64.6 -28.43 69.62 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.417 -0.356 . . . . 1.48 111.07 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.591 ' CE1' HG22 ' A' ' 16' ' ' VAL . 14.6 m-30 -53.9 -44.22 70.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.613 -0.514 . . . . 0.33000000000000002 109.613 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -84.86 -35.36 22.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 3.3300000000000001 111.451 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -85.79 -56.16 3.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.036 0.446 . . . . 2.2599999999999998 111.299 -174.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.28 -52.71 11.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.971 -0.559 . . . . 2.6200000000000001 111.387 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 mp -88.25 -32.13 18.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.516 . . . . 1.1200000000000001 111.849 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.9 33.91 16.91 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.524 -0.846 . . . . 0.45000000000000001 112.115 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.15 152.0 21.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.789 -0.448 . . . . 1.23 109.789 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.72 110.97 21.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.942 0.401 . . . . 2.27 110.325 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -123.8 5.56 8.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 2.1299999999999999 109.501 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.56 164.22 39.47 Favored Glycine 0 CA--C 1.509 -0.323 0 CA-C-N 115.474 -0.785 . . . . 0.92000000000000004 111.456 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -87.74 -2.07 7.39 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.23 2.62 . . . . 1.2 112.078 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -106.48 12.92 29.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.387 -0.824 . . . . 2.3599999999999999 111.036 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -93.63 111.82 23.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.055 0.455 . . . . 0.84999999999999998 110.462 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.3 m -134.5 128.18 32.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.72 -0.673 . . . . 1.71 109.5 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.845 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 42.3 mt -66.58 -45.02 80.65 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.799 0.296 . . . . 1.3700000000000001 111.799 -173.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.96 -4.67 4.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.432 . . . . 0.83999999999999997 110.772 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -116.08 -40.35 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 O-C-N 122.223 -0.298 . . . . 1.51 111.555 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -126.07 8.41 7.34 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.122 0.416 . . . . 2.23 112.122 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 75.9 m -147.52 88.76 1.72 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.623 -0.673 . . . . 1.0 110.412 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 p -81.73 -31.76 31.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.904 -0.589 . . . . 1.29 111.812 -173.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.9 p -110.95 176.73 4.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.668 0.27 . . . . 1.1399999999999999 110.501 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' A' ' 35' ' ' SER . 0.2 OUTLIER -80.77 -44.72 21.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.965 -0.383 . . . . 1.3700000000000001 109.965 -177.651 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.645 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.2 tpt180 -57.94 -32.51 67.87 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.132 -0.486 . . . . 3.71 110.551 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.59 -29.54 62.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.116 -0.493 . . . . 1.1100000000000001 111.062 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.662 ' O ' ' HG3' ' A' ' 82' ' ' MET . 3.7 tp -86.39 -55.1 4.05 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.16 -0.682 . . . . 1.3100000000000001 109.16 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -56.01 -60.35 3.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.287 -1.324 . . . . 2.96 111.656 -174.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.47 ' HB2' ' HE ' ' A' ' 76' ' ' ARG . 9.7 t70 -66.93 -26.28 66.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.465 -0.789 . . . . 1.6599999999999999 110.681 -171.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.73 -26.58 66.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.22 -0.9 . . . . 1.2 110.731 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.691 ' HE3' ' HB ' ' A' ' 16' ' ' VAL . 28.6 mtp . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.905 -0.589 . . . . 1.1000000000000001 110.532 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.524 0 N-CA-C 111.908 -0.477 . . . . 0.55000000000000004 111.908 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.42 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 3.2 m -118.71 157.84 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.917 0.389 . . . . 1.1399999999999999 110.172 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.4 p -83.4 172.89 12.02 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.042 -0.526 . . . . 1.8899999999999999 110.114 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -67.68 -16.79 64.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.079 0.466 . . . . 2.3300000000000001 110.349 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -67.18 -46.95 72.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.491 -0.777 . . . . 1.9099999999999999 109.615 173.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.492 ' HG2' HD22 ' A' ' 60' ' ' LEU . 2.4 mptp? -66.25 -34.4 77.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.774 -0.648 . . . . 2.1099999999999999 109.931 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.7 tp -67.79 -26.88 66.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 1.6000000000000001 111.192 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.1 -28.83 27.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.176 0.513 . . . . 0.88 109.948 177.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -81.67 -30.58 32.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 1.05 111.297 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.824 ' HB ' ' HE3' ' A' ' 82' ' ' MET . 4.2 p -65.04 -43.07 96.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.828 -0.349 . . . . 1.0700000000000001 111.177 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.521 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 45.1 mtt -63.61 -28.6 70.03 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.174 -0.466 . . . . 2.2400000000000002 110.768 -174.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.655 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 15.3 ptm180 -84.1 -19.48 34.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.896 -0.322 . . . . 3.6899999999999999 111.725 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.9 t -81.37 -27.97 10.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 122.017 0.913 . . . . 1.0800000000000001 108.629 172.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.1 t -76.1 -36.11 30.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.458 -1.247 . . . . 1.04 110.294 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.5 p -62.75 -51.48 66.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.039 0.447 . . . . 1.8400000000000001 110.496 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 9.0 mm-40 -57.35 -52.0 67.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.354 -0.839 . . . . 2.2599999999999998 111.484 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HG3' HG12 ' A' ' 50' ' ' ILE . 76.9 mm-40 -72.41 -46.37 55.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.962 -0.563 . . . . 0.77000000000000002 112.323 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.444 ' HA ' HD13 ' A' ' 42' ' ' ILE . 17.8 m -73.67 -38.38 64.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.827 0.346 . . . . 1.23 111.587 -176.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.15 -2.19 40.64 Favored Glycine 0 N--CA 1.454 -0.124 0 C-N-CA 120.191 -1.004 . . . . 0.54000000000000004 112.07 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.45 HD11 ' HG3' ' A' ' 40' ' ' MET . 8.0 mt -94.0 123.14 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.639 -0.504 . . . . 1.28 109.639 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.582 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -54.14 145.58 16.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.381 -0.372 . . . . 1.26 111.552 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 tp -55.02 -36.92 65.98 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.937 -0.574 . . . . 1.6000000000000001 110.646 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.31 -10.7 59.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.983 -0.553 . . . . 2.23 111.293 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.582 ' HG3' ' HB1' ' A' ' 27' ' ' ALA . 41.4 mt-10 -116.2 2.06 13.25 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.138 -0.483 . . . . 2.2400000000000002 110.043 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.479 HD21 ' HA ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -75.26 97.34 3.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.164 -0.68 . . . . 1.6799999999999999 109.164 -178.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.9 p -106.55 154.91 20.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.695 -0.684 . . . . 1.21 109.273 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 57.7 m-20 -76.75 -3.67 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.055 0.455 . . . . 2.29 110.951 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.53 -6.25 59.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.498 -0.774 . . . . 2.29 110.413 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.459 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 46.9 m -79.6 150.63 30.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.594 . . . . 1.3300000000000001 110.006 177.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.744 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.1 t-20 -125.88 123.25 38.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.253 -0.647 . . . . 1.2 109.253 -175.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.701 ' HD1' HG13 ' A' ' 42' ' ' ILE . 34.1 m-85 -56.37 -48.61 76.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.943 0.401 . . . . 0.63 111.194 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.2 -31.0 68.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.268 -0.424 . . . . 1.1499999999999999 111.181 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.744 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 32.9 t70 -70.99 -33.24 70.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.331 0.586 . . . . 0.82999999999999996 110.589 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.45 ' HG3' HD11 ' A' ' 26' ' ' ILE . 15.1 mmt -79.8 -20.27 46.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.407 -0.815 . . . . 2.98 111.37 -176.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.03 32.81 4.23 Favored Glycine 0 C--O 1.229 -0.17 0 C-N-CA 120.271 -0.966 . . . . 0.54000000000000004 112.5 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.701 HG13 ' HD1' ' A' ' 37' ' ' PHE . 28.5 mm -79.83 107.74 12.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.854 0.359 . . . . 1.2 110.608 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -77.4 174.24 11.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.636 -0.505 . . . . 1.9399999999999999 109.636 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.674 ' HB3' ' HD2' ' A' ' 69' ' ' PHE . 90.0 p -69.9 -20.77 63.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.443 -0.577 . . . . 1.1399999999999999 109.443 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.431 ' O ' HG22 ' A' ' 49' ' ' VAL . 3.4 tm? -54.55 -61.99 1.95 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.195 -0.668 . . . . 1.22 109.195 171.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.451 ' O ' HG13 ' A' ' 50' ' ' ILE . 6.3 m -64.7 -39.69 94.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.116 -0.493 . . . . 1.46 110.81 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.46 ' HB2' ' HA ' ' A' ' 44' ' ' SER . 48.8 m -58.93 -40.57 84.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.069 -0.514 . . . . 1.1000000000000001 111.672 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 45.1 tpp -72.35 -40.33 67.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.265 0.555 . . . . 2.8500000000000001 109.674 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.501 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 54.6 t -63.51 -50.33 78.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.214 -0.903 . . . . 1.1499999999999999 110.453 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 46' ' ' SER . 77.7 mt -54.05 -54.58 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.684 0.278 . . . . 1.05 110.92 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -58.25 -35.82 79.99 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.973 -0.632 . . . . 0.35999999999999999 112.018 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.459 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -63.47 -46.16 87.47 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.849 -0.206 . . . . 1.6599999999999999 110.527 174.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 7.1 mtp180 -64.11 -28.0 69.48 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.576 -0.284 . . . . 1.48 111.057 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.556 ' CE2' HD22 ' A' ' 78' ' ' LEU . 12.5 m-30 -56.63 -42.39 78.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.477 -0.564 . . . . 0.33000000000000002 109.477 173.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.459 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 65.1 mtm180 -80.16 -39.21 29.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 3.3300000000000001 110.635 -176.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.82 -48.61 7.7 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.057 0.392 . . . . 2.2599999999999998 112.057 -172.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.28 -46.91 14.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.261 -0.427 . . . . 2.6200000000000001 111.649 -177.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.1 mp -95.7 -23.25 17.08 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.84 0.681 . . . . 1.1200000000000001 112.84 -173.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.34 32.3 23.0 Favored Glycine 0 CA--C 1.517 0.174 0 C-N-CA 120.793 -0.718 . . . . 0.45000000000000001 112.664 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.492 HD22 ' HG2' ' A' ' 12' ' ' LYS . 85.4 mt -88.22 120.3 29.45 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.733 -0.275 . . . . 1.23 110.524 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -82.78 82.07 8.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.228 0.537 . . . . 2.27 109.749 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.555 HD12 ' HD2' ' A' ' 54' ' ' PHE . 97.7 mt -89.8 -94.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.692 -0.685 . . . . 2.1299999999999999 111.356 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 162.55 168.86 25.1 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.892 -0.883 . . . . 0.92000000000000004 110.892 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.538 ' HG2' ' OE2' ' A' ' 65' ' ' GLU . 73.6 Cg_endo -81.85 -10.24 11.75 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.683 2.255 . . . . 1.2 113.65 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.538 ' OE2' ' HG2' ' A' ' 64' ' ' PRO . 5.3 mp0 -88.77 -0.07 56.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.625 -0.262 . . . . 2.3599999999999999 111.47 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.75 122.05 40.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.836 0.35 . . . . 0.84999999999999998 111.441 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.3 t -141.26 124.44 16.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 1.71 110.008 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 mt -56.13 -28.97 59.99 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.977 0.362 . . . . 1.3700000000000001 111.977 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.674 ' HD2' ' HB3' ' A' ' 44' ' ' SER . 3.2 t80 -67.91 -16.7 64.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.588 . . . . 0.83999999999999997 110.939 -173.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.1 mt -126.32 -35.93 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.803 0.335 . . . . 1.51 110.997 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -90.48 6.28 44.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.43 -0.35 . . . . 2.23 111.689 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.4 m -154.89 155.91 35.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.1 p -131.06 -73.73 0.54 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.31 -0.405 . . . . 1.29 110.464 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 76.8 p -83.16 -170.87 3.25 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.965 -0.384 . . . . 1.1399999999999999 109.965 174.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.459 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.9 OUTLIER -83.08 -40.67 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.555 -0.906 . . . . 1.3700000000000001 108.555 -177.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.488 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 34.0 ttm180 -60.89 -31.5 70.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.402 -1.272 . . . . 3.71 111.238 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.18 -34.88 64.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.819 0.342 . . . . 1.1100000000000001 110.952 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.556 HD22 ' CE2' ' A' ' 54' ' ' PHE . 0.9 OUTLIER -74.8 -50.7 16.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.485 -0.561 . . . . 1.3100000000000001 109.485 177.315 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.521 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 26.1 mmtp -49.21 -53.81 19.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.236 -0.893 . . . . 2.96 110.438 176.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.51 -45.02 62.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.877 -1.056 . . . . 1.6599999999999999 111.867 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -64.12 -37.86 88.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.014 -0.539 . . . . 1.2 111.838 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.824 ' HE3' ' HB ' ' A' ' 16' ' ' VAL . 21.3 mtp . . . . . 0 C--N 1.326 -0.443 0 CA-C-O 121.058 0.456 . . . . 1.1000000000000001 111.285 -174.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 N-CA-C 111.497 -0.641 . . . . 0.55000000000000004 111.497 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.575 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 2.8 m -123.59 160.88 26.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.701 0.286 . . . . 1.1399999999999999 110.789 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.7 p -92.66 -176.89 4.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.123 -0.695 . . . . 1.8899999999999999 109.123 171.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -68.34 -23.35 64.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.312 0.577 . . . . 2.3300000000000001 109.646 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -58.51 -44.07 89.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.333 -0.849 . . . . 1.9099999999999999 110.602 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.575 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 17.5 mttp -74.29 -24.91 59.32 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.724 -0.671 . . . . 2.1099999999999999 111.032 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.8 tp -73.45 -30.0 62.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.131 -0.486 . . . . 1.6000000000000001 110.753 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.67 -29.23 45.52 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.238 0.542 . . . . 0.88 109.843 176.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.647 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -81.61 -30.36 32.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.919 -0.582 . . . . 1.05 111.375 -176.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.407 ' HB ' ' CE ' ' A' ' 82' ' ' MET . 5.5 p -68.47 -45.7 81.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.396 -0.522 . . . . 1.0700000000000001 111.285 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 73.6 mtp -61.05 -35.24 76.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.997 -0.547 . . . . 2.2400000000000002 111.285 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.647 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 2.7 ptm180 -64.37 -35.8 82.06 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.127 -0.323 . . . . 3.6899999999999999 110.127 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.3 t -76.5 -38.09 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.544 0.688 . . . . 1.0800000000000001 109.278 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.41 -45.3 93.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.882 -1.054 . . . . 1.04 110.473 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.8 m -60.9 -40.95 95.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.884 0.373 . . . . 1.8400000000000001 111.614 -176.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 53.1 mt-10 -58.02 -56.76 17.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.816 -0.629 . . . . 2.2599999999999998 111.976 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -76.08 -25.69 55.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.247 -0.433 . . . . 0.77000000000000002 111.946 -172.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.7 p -81.27 -44.09 18.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.003 0.43 . . . . 1.23 110.3 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.02 16.83 26.96 Favored Glycine 0 C--O 1.229 -0.183 0 C-N-CA 120.924 -0.655 . . . . 0.54000000000000004 111.619 -176.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.28 123.0 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.796 -0.446 . . . . 1.28 109.796 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.45 143.95 6.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.299 0.481 . . . . 1.26 112.299 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.5 tp -54.5 -37.04 64.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.444 -0.798 . . . . 1.6000000000000001 111.159 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.75 -9.86 58.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.85 -0.614 . . . . 2.23 111.256 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -110.8 -6.33 14.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.072 -0.513 . . . . 2.2400000000000002 110.927 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.3 tp -71.96 98.25 2.01 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.396 0.617 . . . . 1.6799999999999999 109.973 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.0 p -107.57 162.42 13.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.32 -0.854 . . . . 1.21 109.079 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 80.8 m-20 -76.33 -5.54 47.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.027 0.442 . . . . 2.29 110.782 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -81.51 -22.57 37.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.352 -0.84 . . . . 2.29 111.135 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -81.03 149.9 29.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.667 0.746 . . . . 1.3300000000000001 111.132 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.554 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 20.8 t-20 -113.7 131.15 56.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.133 -0.939 . . . . 1.2 109.638 -171.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.738 ' HD1' HG13 ' A' ' 42' ' ' ILE . 28.4 m-85 -57.95 -47.31 83.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 0.63 111.569 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.26 -31.26 67.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.507 -0.315 . . . . 1.1499999999999999 111.318 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.0 t70 -68.76 -31.81 71.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.09 0.472 . . . . 0.82999999999999996 110.268 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.0 mmt -82.12 -18.97 41.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.548 -0.751 . . . . 2.98 111.882 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.18 28.5 6.1 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 120.275 -0.964 . . . . 0.54000000000000004 112.441 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.738 HG13 ' HD1' ' A' ' 37' ' ' PHE . 32.9 mm -75.3 108.48 7.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.028 0.442 . . . . 1.2 110.188 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -83.73 178.76 7.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.846 -0.616 . . . . 1.9399999999999999 110.691 -177.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 t -64.51 -28.04 69.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.437 -0.801 . . . . 1.1399999999999999 110.006 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.69 -62.45 1.45 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.708 -0.678 . . . . 1.22 110.27 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.1 p -64.12 -40.57 96.49 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.448 0.536 . . . . 1.46 112.448 -175.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.1 p -64.0 -29.86 70.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.962 0.41 . . . . 1.1000000000000001 111.071 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 48.2 tpp -75.86 -36.43 59.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.669 0.747 . . . . 2.8500000000000001 109.831 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 56.9 t -71.7 -36.56 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 114.92 -1.036 . . . . 1.1499999999999999 109.466 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 46' ' ' SER . 88.0 mt -58.4 -50.11 79.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.223 -0.444 . . . . 1.05 110.431 174.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.97 -37.48 85.34 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.099 -0.572 . . . . 0.35999999999999999 112.352 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.584 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 1.5 t -63.29 -48.32 78.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.843 -0.343 . . . . 1.6599999999999999 110.343 176.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 43.5 mtp180 -60.69 -32.74 71.96 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.659 -0.246 . . . . 1.48 111.053 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.449 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 10.7 m-30 -53.67 -40.47 65.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.056 0.455 . . . . 0.33000000000000002 110.124 174.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.584 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 67.4 mtm180 -81.89 -35.89 28.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.883 -0.598 . . . . 3.3300000000000001 110.957 -175.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.31 -51.08 6.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.983 -0.553 . . . . 2.2599999999999998 111.593 -170.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -81.74 -49.88 9.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.013 -0.539 . . . . 2.6200000000000001 110.839 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 mp -85.93 -55.12 4.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.87 -0.605 . . . . 1.1200000000000001 111.177 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.06 30.18 2.37 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.918 -0.658 . . . . 0.45000000000000001 112.057 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 59.5 mt -92.0 132.66 36.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.109 -0.33 . . . . 1.23 110.109 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -101.25 92.25 4.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.843 0.83 . . . . 2.27 110.681 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -88.07 -73.04 0.5 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.427 -0.806 . . . . 2.1299999999999999 109.95 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.69 170.14 16.81 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.469 -0.652 . . . . 0.92000000000000004 111.469 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.6 8.41 4.64 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.017 2.478 . . . . 1.2 111.979 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.9 1.03 12.62 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.092 -0.958 . . . . 2.3599999999999999 110.122 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -89.37 118.91 29.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.947 -0.57 . . . . 0.84999999999999998 110.951 -175.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.9 t -137.83 123.17 19.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.126 -0.488 . . . . 1.71 110.211 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.01 -37.78 83.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.169 0.509 . . . . 1.3700000000000001 110.566 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -65.46 -7.06 12.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.542 -0.754 . . . . 0.83999999999999997 111.05 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.65 -39.08 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 120.827 -0.349 . . . . 1.51 111.618 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -121.35 7.39 10.16 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 120.33 -0.548 . . . . 2.23 112.447 -172.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 66.6 m -147.68 87.7 1.65 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.805 -0.559 . . . . 1.0 110.523 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.5 p -85.47 -33.26 21.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.057 -0.52 . . . . 1.29 112.242 -173.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p -107.19 172.2 6.96 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.189 -0.319 . . . . 1.1399999999999999 110.61 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.434 ' HA ' ' HE2' ' A' ' 37' ' ' PHE . 5.7 t -80.72 -40.05 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 120.678 0.275 . . . . 1.3700000000000001 111.108 -175.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 30.8 ttm180 -61.45 -30.43 70.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 3.71 110.875 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.94 -32.23 65.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.954 -0.566 . . . . 1.1100000000000001 111.14 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.65 -44.48 18.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 1.3100000000000001 109.213 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 25.2 mmtp -56.17 -62.11 1.94 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.599 -1.182 . . . . 2.96 111.368 -178.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.93 -23.35 66.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 1.6599999999999999 110.833 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -67.68 -41.57 83.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.56 0.695 . . . . 1.2 109.822 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.407 ' CE ' ' HB ' ' A' ' 16' ' ' VAL . 1.3 mtm . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 115.158 -0.928 . . . . 1.1000000000000001 112.292 -176.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.448 0 N-CA-C 111.346 -0.701 . . . . 0.55000000000000004 111.346 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -108.88 157.12 9.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.752 -0.379 . . . . 1.1399999999999999 110.807 -174.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -78.65 171.8 14.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.678 -0.49 . . . . 1.8899999999999999 109.678 173.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.428 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.9 OUTLIER -72.49 -17.29 61.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.333 0.587 . . . . 2.3300000000000001 110.258 -175.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -68.78 -44.76 72.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.404 -0.816 . . . . 1.9099999999999999 109.888 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -70.72 -22.87 62.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.783 -0.644 . . . . 2.1099999999999999 110.542 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' A' ' 17' ' ' MET . 2.7 tp -72.26 -27.51 62.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.759 -0.655 . . . . 1.6000000000000001 110.54 173.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.22 -30.98 34.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.423 0.63 . . . . 0.88 109.383 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.61 -34.25 53.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.074 -0.967 . . . . 1.05 110.861 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.74 ' HB ' ' HE2' ' A' ' 82' ' ' MET . 2.8 p -66.09 -43.19 92.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.159 -0.473 . . . . 1.0700000000000001 111.446 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.458 ' HB3' HD22 ' A' ' 31' ' ' LEU . 66.7 mtm -64.23 -30.71 71.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.394 -0.366 . . . . 2.2400000000000002 111.395 -175.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.671 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 9.1 ptm180 -83.6 -19.28 35.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.949 0.351 . . . . 3.6899999999999999 111.949 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.1 t -78.43 -32.86 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.827 0.823 . . . . 1.0800000000000001 108.892 171.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.25 -37.77 72.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.512 -1.222 . . . . 1.04 110.333 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.6 p -61.18 -49.79 75.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.523 0.678 . . . . 1.8400000000000001 109.779 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 3.9 mm-40 -59.73 -50.17 74.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.441 -1.254 . . . . 2.2599999999999998 112.316 -176.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -86.96 -9.05 56.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.208 0.447 . . . . 0.77000000000000002 112.208 -171.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.1 m -95.4 -26.03 16.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.034 0.445 . . . . 1.23 110.279 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.51 -7.23 65.85 Favored Glycine 0 C--N 1.329 0.14 0 C-N-CA 120.488 -0.863 . . . . 0.54000000000000004 112.652 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mt -91.33 154.43 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 122.568 -0.372 . . . . 1.28 110.014 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.442 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -69.56 142.29 53.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.993 -0.549 . . . . 1.26 110.111 178.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -57.9 -39.32 77.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 1.6000000000000001 109.899 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -67.76 -15.15 63.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.37 -0.832 . . . . 2.23 111.355 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.442 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 33.8 mt-10 -108.68 1.95 21.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.374 -0.376 . . . . 2.2400000000000002 110.205 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' A' ' 17' ' ' MET . 27.4 tp -74.68 107.3 6.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.423 -0.584 . . . . 1.6799999999999999 109.423 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.2 p -113.55 162.71 15.85 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.818 -0.808 . . . . 1.21 108.818 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.711 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.9 p-10 -79.84 -11.96 59.79 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.654 -0.418 . . . . 2.29 110.526 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -84.03 -20.42 32.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.742 -0.663 . . . . 2.29 110.998 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.6 p -66.53 147.41 53.32 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.424 0.631 . . . . 1.3300000000000001 110.766 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.699 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.5 t-20 -114.17 127.28 55.83 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.147 -0.933 . . . . 1.2 108.89 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.845 ' HD1' HG13 ' A' ' 42' ' ' ILE . 23.9 m-85 -56.58 -50.72 71.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.94 0.4 . . . . 0.63 111.399 -178.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.29 68.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.133 -0.485 . . . . 1.1499999999999999 111.111 -176.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.699 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 28.7 t70 -72.17 -28.82 63.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.926 -0.579 . . . . 0.82999999999999996 110.478 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.1 mmt -83.24 -22.57 33.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.684 -0.689 . . . . 2.98 111.264 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.32 23.7 6.53 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.673 -0.775 . . . . 0.54000000000000004 112.445 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.845 HG13 ' HD1' ' A' ' 37' ' ' PHE . 31.9 mm -70.97 108.22 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.223 0.535 . . . . 1.2 111.24 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.9 176.82 9.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.587 -0.733 . . . . 1.9399999999999999 111.495 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 p -61.1 -39.39 89.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.148 -0.933 . . . . 1.1399999999999999 110.989 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -52.55 -59.66 4.19 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.703 -0.68 . . . . 1.22 110.181 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.546 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.2 m -62.2 -42.83 99.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.087 -0.506 . . . . 1.46 110.739 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.499 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 67.3 m -57.49 -37.62 73.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.169 -0.468 . . . . 1.1000000000000001 111.687 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.6 ttt -74.3 -40.32 62.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.121 0.486 . . . . 2.8500000000000001 109.749 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.39 -42.37 96.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.225 -0.898 . . . . 1.1499999999999999 110.363 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 46' ' ' SER . 88.3 mt -58.48 -55.85 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.069 -0.514 . . . . 1.05 111.154 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -63.56 -26.72 69.99 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.769 -0.729 . . . . 0.35999999999999999 112.224 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -50.4 68.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.585 -0.524 . . . . 1.6599999999999999 109.585 176.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -64.27 -27.05 68.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.434 -0.348 . . . . 1.48 110.844 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 10.8 m-30 -55.11 -42.53 73.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.406 -0.59 . . . . 0.33000000000000002 109.406 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -84.32 -36.47 22.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.81 -0.632 . . . . 3.3300000000000001 111.253 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -85.6 -47.97 9.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.533 -0.303 . . . . 2.2599999999999998 111.764 -172.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -86.42 -50.36 6.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.364 -0.38 . . . . 2.6200000000000001 111.268 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.42 -43.35 14.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.557 -0.292 . . . . 1.1200000000000001 111.674 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.16 20.22 11.52 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.907 -0.663 . . . . 0.45000000000000001 112.327 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.8 mt -77.46 141.96 39.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.474 0.178 . . . . 1.23 110.881 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -106.57 84.98 2.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.085 0.469 . . . . 2.27 110.477 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.505 HD12 ' HE2' ' A' ' 81' ' ' PHE . 2.9 mm? -86.57 -29.84 22.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.567 0.699 . . . . 2.1299999999999999 109.448 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 126.46 171.48 13.13 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.25 -1.14 . . . . 0.92000000000000004 110.25 -173.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -85.96 -9.08 7.69 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.821 2.347 . . . . 1.2 113.127 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -125.7 23.6 7.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.055 0.455 . . . . 2.3599999999999999 111.546 -173.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -82.08 114.4 20.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.04 -0.527 . . . . 0.84999999999999998 109.796 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.0 m -132.12 117.82 18.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.64 -0.255 . . . . 1.71 110.421 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.73 -39.19 68.01 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 111.994 0.368 . . . . 1.3700000000000001 111.994 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.499 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 12.7 t80 -62.07 -11.28 13.07 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.331 -0.395 . . . . 0.83999999999999997 111.694 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.6 mt -124.11 -34.67 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.195 0.522 . . . . 1.51 110.92 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -99.28 -11.87 20.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.718 0.636 . . . . 2.23 112.718 -172.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 71.9 m -141.61 165.77 26.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.6 p -135.96 -66.35 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.941 -0.303 . . . . 1.29 111.009 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 69.1 p -87.57 178.37 6.8 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.226 -0.287 . . . . 1.1399999999999999 110.226 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.455 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 4.6 t -81.86 -35.97 13.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-O 121.078 0.466 . . . . 1.3700000000000001 111.11 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.711 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.7 tpp180 -60.95 -33.64 73.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.787 -0.642 . . . . 3.71 110.77 175.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.61 69.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.745 0.307 . . . . 1.1100000000000001 111.151 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.719 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.7 OUTLIER -69.08 -48.84 61.66 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.184 -0.672 . . . . 1.3100000000000001 109.184 175.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -52.68 -61.62 2.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.09 -0.959 . . . . 2.96 110.766 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.55 -39.0 64.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.478 -0.783 . . . . 1.6599999999999999 111.697 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.505 ' HE2' HD12 ' A' ' 62' ' ' LEU . 75.4 t80 -59.68 -44.85 93.46 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.849 -0.614 . . . . 1.2 110.657 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.74 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 30.1 mtp . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.53 . . . . 1.1000000000000001 111.292 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.188 0 N-CA-C 111.279 -0.728 . . . . 0.55000000000000004 111.279 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 m -100.61 156.96 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 122.56 -0.377 . . . . 1.1399999999999999 110.174 -174.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -87.56 -179.84 6.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.599 -0.519 . . . . 1.8899999999999999 109.599 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -68.54 -28.2 66.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.187 0.518 . . . . 2.3300000000000001 110.424 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -64.16 -47.07 81.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.732 -0.667 . . . . 1.9099999999999999 110.866 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -70.99 -19.26 62.55 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.791 -0.641 . . . . 2.1099999999999999 110.754 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 29.8 tp -73.44 -25.13 60.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.816 -0.629 . . . . 1.6000000000000001 110.804 171.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.35 -31.48 29.8 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.376 0.608 . . . . 0.88 110.038 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.51 -22.64 50.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.647 -0.706 . . . . 1.05 111.062 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.762 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 2.5 p -78.62 -41.38 24.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.831 0.348 . . . . 1.0700000000000001 111.143 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 80.7 mtp -59.26 -31.92 69.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 2.2400000000000002 111.471 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -72.72 -35.97 67.69 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 120.941 -0.303 . . . . 3.6899999999999999 111.188 178.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.2 t -70.47 -33.56 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.946 0.879 . . . . 1.0800000000000001 108.951 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.72 -36.75 66.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.469 -1.242 . . . . 1.04 109.605 174.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 t -64.91 -25.43 67.88 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.193 -0.458 . . . . 1.8400000000000001 110.507 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -82.75 -43.26 16.98 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.987 0.422 . . . . 2.2599999999999998 111.119 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HG3' HG12 ' A' ' 50' ' ' ILE . 49.4 mm-40 -86.69 -23.31 25.63 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.217 0.451 . . . . 0.77000000000000002 112.217 -174.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.414 ' HA ' HD13 ' A' ' 42' ' ' ILE . 33.0 m -93.42 -28.7 15.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.646 0.26 . . . . 1.23 111.417 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.47 3.16 78.53 Favored Glycine 0 N--CA 1.458 0.162 0 C-N-CA 120.177 -1.011 . . . . 0.54000000000000004 112.191 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.0 mt -95.61 112.06 27.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.407 -0.59 . . . . 1.28 109.407 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.05 143.81 2.13 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.538 0.524 . . . . 1.26 111.894 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -52.51 -34.04 47.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.792 -0.64 . . . . 1.6000000000000001 111.763 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -76.04 -10.56 59.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.253 -0.431 . . . . 2.23 111.048 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -114.38 -6.35 12.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 2.2400000000000002 110.919 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.5 tp -70.46 99.32 1.58 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.226 0.536 . . . . 1.6799999999999999 110.192 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.9 p -116.81 158.9 23.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.687 -0.688 . . . . 1.21 109.305 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.494 ' OD1' ' HB2' ' A' ' 76' ' ' ARG . 43.4 m-20 -67.38 -7.05 21.87 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.733 0.301 . . . . 2.29 111.427 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -73.36 -24.56 60.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 2.29 110.776 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.536 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 36.0 m -69.17 146.86 52.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.057 0.456 . . . . 1.3300000000000001 110.573 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.699 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.8 t-20 -129.25 123.38 31.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.186 -1.042 . . . . 1.2 108.186 -177.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.829 ' HD1' HG13 ' A' ' 42' ' ' ILE . 36.1 m-85 -56.29 -51.14 69.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.0 0.429 . . . . 0.63 111.614 -174.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.86 -29.17 64.1 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.535 -0.302 . . . . 1.1499999999999999 111.359 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.699 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 23.5 t70 -72.11 -35.56 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.431 0.634 . . . . 0.82999999999999996 110.201 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 45.8 mmm -76.15 -23.76 54.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.21 -0.904 . . . . 2.98 111.177 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.26 30.53 5.32 Favored Glycine 0 C--N 1.323 -0.171 0 C-N-CA 120.328 -0.939 . . . . 0.54000000000000004 112.408 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.829 HG13 ' HD1' ' A' ' 37' ' ' PHE . 29.6 mm -71.52 107.94 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.415 0.626 . . . . 1.2 109.66 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -81.25 165.28 21.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.066 -0.97 . . . . 1.9399999999999999 110.844 -173.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.3 t -52.17 -38.93 59.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.689 -0.687 . . . . 1.1399999999999999 111.283 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -57.1 -60.32 3.78 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.13 -0.486 . . . . 1.22 110.38 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.488 ' O ' HG13 ' A' ' 50' ' ' ILE . 12.8 p -65.77 -33.61 76.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.623 -0.262 . . . . 1.46 111.376 -175.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.485 ' HB3' ' H ' ' A' ' 69' ' ' PHE . 50.5 m -61.38 -35.16 76.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.617 -0.265 . . . . 1.1000000000000001 111.671 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.1 ttt -84.63 -16.84 40.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 2.8500000000000001 110.522 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.571 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 74.6 t -88.98 -38.96 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 109.836 -0.431 . . . . 1.1499999999999999 109.836 -177.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.545 HG12 ' HG3' ' A' ' 23' ' ' GLU . 54.3 mt -53.13 -53.46 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.763 0.316 . . . . 1.05 110.235 172.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.21 -25.3 66.33 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.978 -0.63 . . . . 0.35999999999999999 112.285 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.564 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 2.9 m -75.28 -45.82 37.43 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 122.829 -0.218 . . . . 1.6599999999999999 111.023 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.571 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 23.7 mtp180 -63.8 -25.66 68.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 1.48 110.765 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.528 ' HD2' HD11 ' A' ' 62' ' ' LEU . 14.1 m-30 -56.99 -40.89 77.42 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 121.184 0.516 . . . . 0.33000000000000002 109.896 172.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.564 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 71.5 mtm180 -80.48 -30.02 37.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.74 -0.664 . . . . 3.3300000000000001 110.757 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.35 -61.72 1.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.073 0.463 . . . . 2.2599999999999998 111.819 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.61 -35.45 18.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.684 -0.689 . . . . 2.6200000000000001 111.535 -168.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.55 -33.23 11.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.519 -0.309 . . . . 1.1200000000000001 111.651 -175.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.69 37.94 11.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.832 -0.699 . . . . 0.45000000000000001 112.179 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 54' ' ' PHE . 88.3 mt -80.56 126.61 31.46 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.779 -0.248 . . . . 1.23 110.772 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.24 76.89 4.74 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.845 0.355 . . . . 2.27 110.491 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.528 HD11 ' HD2' ' A' ' 54' ' ' PHE . 68.1 mt -97.77 -77.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.27 0.557 . . . . 2.1299999999999999 110.857 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.25 170.1 14.0 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.962 -0.855 . . . . 0.92000000000000004 110.962 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -81.81 -11.21 11.46 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.718 2.278 . . . . 1.2 112.633 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -91.12 6.59 44.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.754 -0.657 . . . . 2.3599999999999999 111.853 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -93.07 120.03 32.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.927 0.394 . . . . 0.84999999999999998 111.069 -176.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.1 m -139.89 121.39 15.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 1.71 110.217 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.501 HD12 HD11 ' A' ' 50' ' ' ILE . 52.1 mt -58.81 -31.04 68.08 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.208 -0.451 . . . . 1.3700000000000001 111.869 -177.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.485 ' H ' ' HB3' ' A' ' 47' ' ' SER . 1.6 t80 -56.54 -16.26 5.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.858 0.463 . . . . 0.83999999999999997 111.713 -175.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.9 mt -126.69 -35.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.824 0.345 . . . . 1.51 110.708 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.58 -10.36 49.03 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.575 0.954 . . . . 2.23 113.575 -172.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.429 ' HB2' HD21 ' A' ' 68' ' ' LEU . 75.9 m -150.95 120.21 6.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.248 0.547 . . . . 1.0 110.718 -175.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.3 p -100.34 -51.94 3.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.98 -0.555 . . . . 1.29 110.841 -174.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.1 p -98.19 -175.23 3.06 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.88 -0.328 . . . . 1.1399999999999999 110.176 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 1.3 t -79.07 -45.71 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.32 0.581 . . . . 1.3700000000000001 109.781 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.746 ' HA ' ' HG3' ' A' ' 79' ' ' LYS . 4.3 tpp180 -61.93 -25.77 67.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.418 -0.81 . . . . 3.71 110.996 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.07 -34.67 72.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.71 0.29 . . . . 1.1100000000000001 110.511 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.692 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.7 OUTLIER -72.09 -48.68 42.23 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.707 -0.849 . . . . 1.3100000000000001 108.707 176.549 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.746 ' HG3' ' HA ' ' A' ' 76' ' ' ARG . 16.2 mmtp -50.59 -56.17 12.97 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.071 -0.968 . . . . 2.96 110.38 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -57.44 -33.61 68.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.726 -1.125 . . . . 1.6599999999999999 111.423 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -72.17 -34.94 68.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.09 0.472 . . . . 1.2 110.93 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.762 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 38.6 mtp . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 1.1000000000000001 111.487 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.44 0 N-CA-C 111.283 -0.727 . . . . 0.55000000000000004 111.283 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.852 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 4.2 m -108.73 157.44 8.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.947 0.403 . . . . 1.1399999999999999 110.989 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -85.97 174.7 9.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.355 -0.609 . . . . 1.8899999999999999 109.355 174.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -21.98 65.29 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.499 -0.926 . . . . 2.3300000000000001 108.499 176.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.25 -53.02 61.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.863 -1.062 . . . . 1.9099999999999999 110.799 175.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.852 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 40.7 mmtm -71.16 -23.57 62.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.278 -0.419 . . . . 2.1099999999999999 110.247 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.1 tp -74.9 -26.68 59.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.906 -0.588 . . . . 1.6000000000000001 110.144 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -29.61 27.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.512 0.672 . . . . 0.88 109.751 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.692 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -82.86 -27.04 31.06 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.664 -0.698 . . . . 1.05 111.359 -175.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.79 ' HB ' ' HE2' ' A' ' 82' ' ' MET . 2.7 p -68.55 -44.22 83.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.64 -0.424 . . . . 1.0700000000000001 111.328 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.2 mtp -64.29 -30.6 71.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.317 -0.402 . . . . 2.2400000000000002 110.622 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.692 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 30.3 ptt180 -74.2 -27.01 60.6 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.009 -0.276 . . . . 3.6899999999999999 110.852 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.0 t -83.07 -33.47 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.76 0.791 . . . . 1.0800000000000001 108.923 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 t -68.01 -34.2 65.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.636 -1.166 . . . . 1.04 110.232 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 49.4 m -58.33 -52.7 64.49 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.029 0.442 . . . . 1.8400000000000001 110.637 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -54.04 -59.08 5.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.947 -1.024 . . . . 2.2599999999999998 112.438 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -79.64 -17.49 53.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.89 -0.595 . . . . 0.77000000000000002 112.566 -167.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -97.75 -35.46 10.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.879 0.371 . . . . 1.23 111.081 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.78 8.14 58.38 Favored Glycine 0 CA--C 1.516 0.111 0 C-N-CA 120.352 -0.928 . . . . 0.54000000000000004 111.472 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 21' ' ' SER . 8.1 mt -104.38 107.81 23.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.818 -0.438 . . . . 1.28 109.818 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.18 148.87 17.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 1.26 110.977 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 tp -49.75 -32.79 14.52 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.077 0.551 . . . . 1.6000000000000001 111.551 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -73.35 -21.92 60.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.344 -0.389 . . . . 2.23 111.527 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -108.95 -1.76 18.79 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.313 0.577 . . . . 2.2400000000000002 109.686 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -76.31 96.73 4.04 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.835 -0.802 . . . . 1.6799999999999999 108.835 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.7 p -104.56 156.2 18.17 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.454 -0.794 . . . . 1.21 108.934 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.572 ' HB2' ' HD3' ' A' ' 76' ' ' ARG . 7.9 p-10 -74.04 -13.03 60.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.026 0.441 . . . . 2.29 110.534 -176.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -89.04 -22.89 22.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.428 -0.806 . . . . 2.29 111.577 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 m -67.71 149.15 50.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.414 0.626 . . . . 1.3300000000000001 110.366 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.522 ' HB3' ' CB ' ' A' ' 39' ' ' ASP . 3.0 t-20 -109.76 125.23 52.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.531 -0.758 . . . . 1.2 110.592 -171.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.685 ' HD1' HG13 ' A' ' 42' ' ' ILE . 30.6 m-85 -55.01 -50.68 68.43 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.959 0.409 . . . . 0.63 110.893 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.36 -32.19 73.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.98 -0.555 . . . . 1.1499999999999999 111.591 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.522 ' CB ' ' HB3' ' A' ' 36' ' ' ASN . 16.0 t70 -71.31 -35.49 71.27 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.564 0.697 . . . . 0.82999999999999996 109.656 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 tpp -76.25 -20.46 57.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.895 -1.048 . . . . 2.98 110.849 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.0 25.24 6.55 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.411 -0.899 . . . . 0.54000000000000004 112.586 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.685 HG13 ' HD1' ' A' ' 37' ' ' PHE . 27.1 mm -67.61 107.68 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.356 0.598 . . . . 1.2 110.378 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -82.43 170.63 15.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.402 -0.817 . . . . 1.9399999999999999 110.51 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.6 p -56.85 -40.74 76.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.33 -0.395 . . . . 1.1399999999999999 110.179 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.27 -53.31 59.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.94 -0.573 . . . . 1.22 109.818 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.518 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.6 m -62.62 -42.37 99.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 1.46 110.849 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 49.1 m -60.04 -39.06 84.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 1.1000000000000001 110.985 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.7 ttp -67.62 -46.18 73.24 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.544 0.688 . . . . 2.8500000000000001 109.216 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.435 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.6 t -57.87 -55.24 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.417 -1.265 . . . . 1.1499999999999999 110.618 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 46' ' ' SER . 63.0 mt -50.94 -52.78 16.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.616 0.246 . . . . 1.05 111.251 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -58.76 -37.15 89.54 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.948 -0.644 . . . . 0.35999999999999999 112.098 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -44.47 79.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.592 0.234 . . . . 1.6599999999999999 110.728 177.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.442 ' HA ' ' HB2' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -67.99 -21.85 65.04 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.013 -0.275 . . . . 1.48 110.318 -177.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 11.7 m-30 -58.86 -43.4 90.82 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.44 -0.578 . . . . 0.33000000000000002 109.44 170.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -77.59 -28.51 51.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.464 -0.789 . . . . 3.3300000000000001 110.077 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 53' ' ' ARG . 53.8 mt-10 -71.52 -63.91 1.03 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.224 0.535 . . . . 2.2599999999999998 111.395 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -87.89 -35.72 17.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.494 -0.775 . . . . 2.6200000000000001 111.927 -169.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.511 HD11 ' N ' ' A' ' 58' ' ' LEU . 7.8 mp -98.69 -40.06 8.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.812 0.339 . . . . 1.1200000000000001 111.114 -173.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.16 31.37 7.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.859 -0.686 . . . . 0.45000000000000001 112.417 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.77 102.15 10.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.742 0.306 . . . . 1.23 110.521 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -91.84 69.9 5.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.063 0.459 . . . . 2.27 110.938 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.412 HD13 ' HE2' ' A' ' 81' ' ' PHE . 80.3 mt -88.13 -7.25 57.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.986 -0.552 . . . . 2.1299999999999999 110.53 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.12 173.99 21.21 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.562 -0.828 . . . . 0.92000000000000004 111.998 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.56 -8.9 6.01 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.971 2.447 . . . . 1.2 112.471 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -88.0 3.65 48.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.459 -0.791 . . . . 2.3599999999999999 110.584 -174.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -91.18 120.45 32.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.909 -0.587 . . . . 0.84999999999999998 110.479 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.4 m -140.18 122.42 15.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.956 -0.565 . . . . 1.71 110.035 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 72' ' ' CYS . 49.2 mt -56.04 -46.73 78.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.081 -0.508 . . . . 1.3700000000000001 111.341 -177.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.527 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.1 t80 -56.58 -12.18 1.66 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.727 -0.669 . . . . 0.83999999999999997 112.417 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.5 mt -115.22 -40.54 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.793 -0.363 . . . . 1.51 111.489 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -118.32 9.07 12.37 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.361 0.504 . . . . 2.23 112.361 -171.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 72.8 m -145.1 114.38 7.06 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.7 -0.625 . . . . 1.0 110.085 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.7 p -98.79 -74.21 0.59 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.85 -0.614 . . . . 1.29 110.99 -170.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -83.48 -173.56 4.78 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.981 -0.449 . . . . 1.1399999999999999 110.59 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 11.7 t -84.16 -38.28 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.756 0.788 . . . . 1.3700000000000001 109.206 -176.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.572 ' HD3' ' HB2' ' A' ' 33' ' ' ASP . 6.6 tpt180 -57.95 -33.79 69.21 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.252 -1.34 . . . . 3.71 110.443 175.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.89 83.08 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.592 -0.276 . . . . 1.1100000000000001 111.012 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.748 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.2 tt -69.92 -49.88 47.6 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.932 -0.766 . . . . 1.3100000000000001 108.932 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 3.1 mmpm? -53.32 -56.32 17.61 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.044 -0.98 . . . . 2.96 110.853 178.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -56.27 -35.31 67.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.188 -0.915 . . . . 1.6599999999999999 111.36 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.412 ' HE2' HD13 ' A' ' 62' ' ' LEU . 70.4 t80 -69.92 -35.82 74.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.108 0.48 . . . . 1.2 111.121 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.79 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 32.2 mtp . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.042 -0.526 . . . . 1.1000000000000001 110.97 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 111.518 -0.633 . . . . 0.55000000000000004 111.518 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.93 158.26 10.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.664 0.269 . . . . 1.1399999999999999 110.448 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.2 m -73.25 166.13 23.73 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.239 -0.437 . . . . 1.8899999999999999 110.324 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -59.82 -27.59 66.74 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.526 0.679 . . . . 2.3300000000000001 109.4 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -50.7 -53.4 31.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.966 -1.016 . . . . 1.9099999999999999 111.753 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -66.88 -30.35 70.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.205 -0.598 . . . . 2.1099999999999999 110.242 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.26 -22.9 61.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 1.6000000000000001 110.933 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.581 ' HA ' ' HE1' ' A' ' 17' ' ' MET . 2.0 m-20 -84.55 -30.3 25.19 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.131 0.491 . . . . 0.88 110.625 173.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.602 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -79.59 -34.13 41.03 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.209 -0.45 . . . . 1.05 110.867 -177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.864 ' HB ' ' HE2' ' A' ' 82' ' ' MET . 2.9 p -58.11 -36.38 56.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.066 0.46 . . . . 1.0700000000000001 110.937 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.581 ' HE1' ' HA ' ' A' ' 14' ' ' ASP . 63.9 mtm -69.39 -30.11 68.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.814 -0.63 . . . . 2.2400000000000002 110.945 -175.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 24.6 ptt180 -72.26 -30.79 65.19 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 120.34 -0.544 . . . . 3.6899999999999999 109.758 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.6 t -79.61 -38.33 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.654 0.74 . . . . 1.0800000000000001 109.175 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.9 t -62.21 -47.66 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.608 -1.178 . . . . 1.04 110.361 175.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -62.09 -38.88 90.54 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.684 0.253 . . . . 1.8400000000000001 111.684 -176.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 18.2 mm-40 -62.69 -46.72 86.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.508 -0.314 . . . . 2.2599999999999998 111.557 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -83.47 -26.18 30.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.366 0.506 . . . . 0.77000000000000002 112.366 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.8 p -84.61 -45.24 12.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 1.23 110.444 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.88 5.64 53.27 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.795 -0.717 . . . . 0.54000000000000004 112.004 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mt -93.36 132.85 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.718 -0.284 . . . . 1.28 110.275 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 144.68 53.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.293 -0.412 . . . . 1.26 110.979 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -36.51 68.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.909 -0.587 . . . . 1.6000000000000001 110.48 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -70.38 -14.0 62.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.984 -0.553 . . . . 2.23 110.912 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -107.17 -4.86 18.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.017 -0.538 . . . . 2.2400000000000002 110.655 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.1 tp -78.82 96.79 5.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.46 0.648 . . . . 1.6799999999999999 109.873 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.6 p -124.17 167.87 13.68 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.273 -1.01 . . . . 1.21 108.273 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.637 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 2.5 p30 -71.61 -3.22 20.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.853 -0.339 . . . . 2.29 111.409 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -75.68 -20.84 58.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.949 0.404 . . . . 2.29 110.214 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.5 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 19.4 m -73.33 148.58 43.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.116 0.484 . . . . 1.3300000000000001 110.214 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.744 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.1 t-20 -128.18 117.38 21.47 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.852 -0.795 . . . . 1.2 108.852 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.795 ' HD1' HG13 ' A' ' 42' ' ' ILE . 30.0 m-85 -52.67 -54.43 33.56 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.979 0.418 . . . . 0.63 111.524 -174.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.21 -25.94 64.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.869 -0.605 . . . . 1.1499999999999999 111.669 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.744 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 38.7 t70 -81.53 -20.51 39.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.321 0.581 . . . . 0.82999999999999996 111.116 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -85.61 -24.38 27.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.856 -0.611 . . . . 2.98 109.9 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.41 13.4 6.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.585 -0.817 . . . . 0.54000000000000004 112.67 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.795 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.0 mm -67.82 107.82 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.94 0.4 . . . . 1.2 110.082 176.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -78.74 179.6 7.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.912 -0.586 . . . . 1.9399999999999999 110.453 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.4 p -57.99 -36.22 72.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.528 -0.76 . . . . 1.1399999999999999 109.791 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.44 -60.46 3.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.801 -1.091 . . . . 1.22 110.029 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.524 ' O ' HG13 ' A' ' 50' ' ' ILE . 1.3 m -57.72 -47.33 82.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.524 . . . . 1.46 111.353 -177.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.886 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 50.9 p -65.94 -29.06 69.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.893 0.377 . . . . 1.1000000000000001 111.298 -176.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.5 tpt -76.31 -35.48 58.8 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.532 -0.544 . . . . 2.8500000000000001 109.532 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.545 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 37.6 t -65.12 -50.16 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.334 -0.848 . . . . 1.1499999999999999 109.533 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 46' ' ' SER . 60.2 mt -52.7 -53.26 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.256 -0.429 . . . . 1.05 111.061 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.12 -41.62 98.18 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.03 -0.605 . . . . 0.35999999999999999 112.407 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 t -59.62 -44.7 93.36 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.792 0.329 . . . . 1.6599999999999999 110.707 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 56.6 mtp180 -68.14 -20.57 64.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.395 -0.366 . . . . 1.48 111.691 -175.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.573 ' HD2' HD12 ' A' ' 62' ' ' LEU . 15.9 m-30 -59.86 -42.27 93.31 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.37 0.605 . . . . 0.33000000000000002 109.595 171.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 67.4 mtp180 -74.1 -25.98 60.1 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.184 -0.916 . . . . 3.3300000000000001 110.196 -177.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -77.82 -63.75 1.31 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.765 -0.652 . . . . 2.2599999999999998 111.577 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.69 -46.79 10.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.679 -0.692 . . . . 2.6200000000000001 111.964 -170.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.2 -26.43 25.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.233 -0.44 . . . . 1.1200000000000001 111.042 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.49 33.28 31.8 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.785 -0.721 . . . . 0.45000000000000001 112.365 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.604 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 60.2 mt -89.65 104.95 17.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.797 -0.446 . . . . 1.23 109.797 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -85.35 77.87 9.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.707 0.765 . . . . 2.27 109.826 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.573 HD12 ' HD2' ' A' ' 54' ' ' PHE . 30.5 mt -75.77 -73.44 0.26 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.675 -1.148 . . . . 2.1299999999999999 111.199 -176.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 163.2 154.98 7.9 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.46 -0.791 . . . . 0.92000000000000004 111.132 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.74 -6.49 14.34 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.392 2.062 . . . . 1.2 112.034 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -103.7 2.08 32.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.589 -0.732 . . . . 2.3599999999999999 109.948 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -92.48 123.08 35.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.044 -0.526 . . . . 0.84999999999999998 110.571 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.9 m -137.79 128.45 26.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.056 -0.52 . . . . 1.71 109.976 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.886 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 32.9 mt -56.56 -33.44 66.13 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 120.635 0.255 . . . . 1.3700000000000001 110.833 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.491 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 24.6 t80 -58.1 -17.48 18.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.045 -0.525 . . . . 0.83999999999999997 111.633 -174.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.8 mt -125.09 -38.69 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.597 -0.274 . . . . 1.51 111.009 176.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -96.41 4.36 52.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.665 0.617 . . . . 2.23 112.665 -170.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.3 m -155.45 93.94 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.426 0.631 . . . . 1.0 109.577 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.9 p -80.02 -68.61 0.66 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.473 -0.785 . . . . 1.29 109.707 -171.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 65.2 p -86.5 -170.52 3.12 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.673 -0.491 . . . . 1.1399999999999999 109.673 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.534 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.3 t -81.58 -38.13 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 108.87 -0.789 . . . . 1.3700000000000001 108.87 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.637 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 5.8 tpt180 -62.97 -30.11 71.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.52 -1.218 . . . . 3.71 110.44 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.19 -34.72 75.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.239 -0.437 . . . . 1.1100000000000001 110.986 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.536 HD21 ' CE2' ' A' ' 54' ' ' PHE . 1.1 tt -73.89 -47.28 39.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.438 0.637 . . . . 1.3100000000000001 109.349 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 31.3 mmtp -54.91 -46.81 74.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.82 -1.082 . . . . 2.96 110.959 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.59 -48.53 80.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.502 -0.772 . . . . 1.6599999999999999 111.577 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -55.53 -37.62 68.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.819 -0.628 . . . . 1.2 111.781 -175.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.864 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 18.7 mtt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 1.1000000000000001 111.799 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.834 -0.432 . . . . 9.3499999999999996 109.834 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 73.8 mtm 62.71 80.38 0.23 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.819 0.699 . . . . 9.0299999999999994 109.262 -174.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 72.15 123.05 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.2 -0.909 . . . . 5.71 110.216 -170.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 3' ' ' ALA . 63.6 tttp 68.53 126.16 0.03 OUTLIER 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.31 -0.859 . . . . 7.0 111.703 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.74 -131.31 6.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.82 -0.705 . . . . 2.2400000000000002 111.685 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.14 -75.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.88 0.371 . . . . 1.6499999999999999 110.148 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 83' ' ' LEU . . . 108.04 105.62 3.01 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.615 -0.802 . . . . 0.55000000000000004 112.239 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 m -119.38 158.24 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.55 -0.537 . . . . 1.1399999999999999 109.55 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 p -83.74 172.85 11.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.186 -0.301 . . . . 1.8899999999999999 110.186 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -70.23 -16.76 63.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.279 0.561 . . . . 2.3300000000000001 110.196 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -66.27 -47.69 72.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.367 -0.833 . . . . 1.9099999999999999 109.702 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -68.99 -27.56 65.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.884 -0.598 . . . . 2.1099999999999999 109.926 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -24.81 63.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.478 -0.783 . . . . 1.6000000000000001 110.688 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.26 -32.78 26.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.385 0.612 . . . . 0.88 110.246 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.08 -27.32 57.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 1.05 111.051 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.83 HG12 ' HZ1' ' A' ' 79' ' ' LYS . 2.8 p -70.65 -40.73 77.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.053 -0.521 . . . . 1.0700000000000001 111.674 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.4 mtp -61.49 -31.14 71.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 2.2400000000000002 111.309 -173.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -78.69 -27.76 45.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.589 -0.444 . . . . 3.6899999999999999 111.101 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.3 t -73.72 -37.63 49.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.525 -0.917 . . . . 1.0800000000000001 108.525 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 t -65.14 -44.08 95.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.413 -1.267 . . . . 1.04 110.433 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.5 p -56.01 -50.47 70.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.231 0.539 . . . . 1.8400000000000001 110.346 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -55.37 -53.92 50.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.968 -1.015 . . . . 2.2599999999999998 112.749 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -82.66 -16.43 48.28 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.62 0.6 . . . . 0.77000000000000002 112.62 -170.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 81.6 p -91.72 -36.48 13.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.093 0.473 . . . . 1.23 110.722 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.87 -0.01 56.36 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.844 -0.693 . . . . 0.54000000000000004 111.685 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.655 HD12 ' HG2' ' A' ' 40' ' ' MET . 3.1 mt -93.91 123.98 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 109.517 -0.549 . . . . 1.28 109.517 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.66 141.76 36.59 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.315 0.385 . . . . 1.26 111.101 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.14 -34.14 59.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.899 -0.591 . . . . 1.6000000000000001 111.227 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.35 -10.42 59.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 2.23 111.292 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -109.99 -3.85 16.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.971 0.415 . . . . 2.2400000000000002 110.231 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.9 tp -74.31 99.34 3.45 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.387 0.613 . . . . 1.6799999999999999 110.239 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 44.6 p -121.73 164.53 17.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.271 -0.877 . . . . 1.21 108.857 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.97 -9.88 34.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.801 0.334 . . . . 2.29 111.307 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.92 -19.6 60.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 2.29 110.487 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.51 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 18.3 m -71.5 143.08 50.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.038 0.446 . . . . 1.3300000000000001 109.835 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.64 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.9 t-20 -128.43 117.87 22.12 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.579 -0.526 . . . . 1.2 109.579 -176.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.647 ' HD1' HG13 ' A' ' 42' ' ' ILE . 48.1 m-85 -55.36 -39.7 70.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.889 0.376 . . . . 0.63 111.698 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.23 -29.25 60.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.875 0.369 . . . . 1.1499999999999999 111.212 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.64 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 34.6 t70 -74.81 -31.15 61.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.185 0.517 . . . . 0.82999999999999996 110.267 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.655 ' HG2' HD12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -81.04 -14.65 57.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.401 -0.818 . . . . 2.98 110.761 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.67 42.87 6.29 Favored Glycine 0 CA--C 1.511 -0.207 0 C-N-CA 120.378 -0.915 . . . . 0.54000000000000004 112.153 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.647 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.6 mm -75.54 107.28 6.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.988 0.423 . . . . 1.2 109.903 176.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -80.19 175.19 10.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.438 0.637 . . . . 1.9399999999999999 111.82 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 t -52.86 -42.86 65.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.557 -1.201 . . . . 1.1399999999999999 111.189 177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.36 -61.64 2.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.99 -0.55 . . . . 1.22 110.257 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 50' ' ' ILE . 29.0 t -61.18 -47.09 87.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.473 -0.33 . . . . 1.46 111.601 -175.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.488 ' HB3' HG22 ' A' ' 42' ' ' ILE . 51.0 p -62.38 -27.44 69.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.682 0.253 . . . . 1.1000000000000001 111.682 -176.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.632 ' SD ' ' H32' ' A' ' 90' ' ' PNS . 13.9 ttt -80.36 -39.9 27.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.246 0.546 . . . . 2.8500000000000001 109.841 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.85 -42.21 95.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.315 -0.857 . . . . 1.1499999999999999 109.986 -177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 46' ' ' SER . 73.8 mt -56.75 -58.18 6.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.932 -0.576 . . . . 1.05 111.232 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -65.35 -23.73 70.26 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.607 -0.806 . . . . 0.35999999999999999 112.398 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.576 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -69.63 -45.71 67.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.803 -0.443 . . . . 1.6599999999999999 109.803 175.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -61.27 -31.99 71.81 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.428 -0.351 . . . . 1.48 110.533 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE2' HD23 ' A' ' 78' ' ' LEU . 13.1 m-30 -53.68 -40.58 66.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.892 -0.594 . . . . 0.33000000000000002 110.02 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.576 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 53.2 mtm180 -81.04 -37.76 28.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.068 -0.514 . . . . 3.3300000000000001 111.142 -175.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -87.86 -52.45 5.28 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.316 0.488 . . . . 2.2599999999999998 112.316 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -80.41 -42.24 23.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.807 -0.633 . . . . 2.6200000000000001 111.18 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.2 mp -96.08 -33.0 12.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.405 -0.361 . . . . 1.1200000000000001 111.685 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.23 35.07 9.05 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.516 -0.85 . . . . 0.45000000000000001 112.101 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 54' ' ' PHE . 82.2 mt -87.08 131.15 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.582 0.23 . . . . 1.23 110.939 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -89.33 47.11 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.639 -0.504 . . . . 2.27 109.639 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -59.16 4.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.188 -0.915 . . . . 2.1299999999999999 110.726 -174.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.48 ' O ' ' HD3' ' A' ' 55' ' ' ARG . . . 172.41 167.86 33.01 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.629 -0.588 . . . . 0.92000000000000004 111.629 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.89 -37.08 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.465 2.11 . . . . 1.2 113.38 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.14 45.34 2.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.308 0.575 . . . . 2.3599999999999999 110.438 -175.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -74.2 112.53 10.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.448 -0.797 . . . . 0.84999999999999998 109.876 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.1 p -118.3 129.04 55.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 1.71 111.173 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.488 HD11 HD13 ' A' ' 50' ' ' ILE . 75.3 mt -76.2 2.96 11.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 1.3700000000000001 111.672 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.69 -17.7 22.93 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.122 -0.49 . . . . 0.83999999999999997 110.15 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.2 mt -132.26 -37.39 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.093 0.473 . . . . 1.51 111.141 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.78 -2.8 46.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.684 0.754 . . . . 2.23 110.683 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 98.5 m -147.23 157.8 43.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.167 -0.924 . . . . 1.0 108.735 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.3 p -129.95 -73.41 0.56 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.163 -0.215 . . . . 1.29 111.276 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.2 p -90.25 -171.58 3.16 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.246 -0.284 . . . . 1.1399999999999999 110.625 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 1.8 t -79.47 -44.33 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.568 -0.53 . . . . 1.3700000000000001 109.568 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -59.15 -32.69 70.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.691 -0.686 . . . . 3.71 110.985 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -56.68 -37.16 70.48 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.35 -0.386 . . . . 1.1100000000000001 111.171 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.491 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -74.28 -43.2 57.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.536 0.684 . . . . 1.3100000000000001 109.398 178.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 1.019 ' HZ2' ' HA ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -53.92 -61.33 2.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.618 -1.174 . . . . 2.96 112.102 178.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.99 -37.83 77.76 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.107 0.254 . . . . 1.6599999999999999 111.596 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.559 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 3.7 t80 -52.69 -39.65 62.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.598 0.561 . . . . 1.2 111.067 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.662 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 7.9 mtt -55.85 -38.46 70.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.564 -0.744 . . . . 1.1000000000000001 112.092 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.486 HD11 ' N ' ' A' ' 83' ' ' LEU . 4.2 mp -94.74 -42.43 8.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.036 0.446 . . . . 1.8500000000000001 110.289 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.25 41.11 7.6 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.938 -0.649 . . . . 2.4199999999999999 111.666 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 t -91.5 8.65 35.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.021 0.915 . . . . 4.4699999999999998 110.597 -173.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.27 -27.57 10.68 Favored Glycine 0 C--N 1.307 -1.057 0 CA-C-N 114.426 -1.261 . . . . 4.5899999999999999 111.074 172.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 t70 52.42 41.2 30.67 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.394 0.678 . . . . 6.6100000000000003 110.458 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.24 -20.13 57.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.725 -0.67 . . . . 8.4800000000000004 110.74 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.327 -1.263 . . . . 9.7300000000000004 111.629 178.584 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . 0.632 ' H32' ' SD ' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 110.605 -0.146 . . . . 9.3499999999999996 110.605 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 89.9 mtp 71.46 157.55 0.18 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.036 0.835 . . . . 9.0299999999999994 110.932 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.64 135.3 14.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.098 0.475 . . . . 5.71 111.61 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 58.8 tttp -152.13 23.54 0.65 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.102 0.953 . . . . 7.0 109.304 175.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.08 -146.28 14.65 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.353 -0.839 . . . . 2.2400000000000002 111.944 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.56 -78.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 110.051 -0.351 . . . . 1.6499999999999999 110.051 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.91 86.62 0.23 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.581 -0.819 . . . . 0.55000000000000004 111.809 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.461 HG22 ' SD ' ' A' ' 82' ' ' MET . 5.9 m -97.93 158.37 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.963 -0.384 . . . . 1.1399999999999999 109.963 -175.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.4 t -83.86 -177.11 6.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.844 -0.428 . . . . 1.8899999999999999 109.844 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -71.83 -22.03 61.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.005 0.431 . . . . 2.3300000000000001 110.603 -174.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -73.96 -41.6 61.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.462 -0.495 . . . . 1.9099999999999999 110.076 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -66.71 -30.87 71.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.893 -0.78 . . . . 2.1099999999999999 108.893 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.1 tp -69.78 -26.19 64.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.975 -1.012 . . . . 1.6000000000000001 110.701 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.693 ' HA ' ' HE3' ' A' ' 17' ' ' MET . 0.4 OUTLIER -86.28 -27.07 24.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.414 0.626 . . . . 0.88 110.095 177.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.76 -35.36 57.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.687 -0.688 . . . . 1.05 110.802 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.71 ' HB ' ' HE2' ' A' ' 82' ' ' MET . 3.6 p -61.68 -45.42 98.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.989 -0.551 . . . . 1.0700000000000001 110.624 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.693 ' HE3' ' HA ' ' A' ' 14' ' ' ASP . 67.1 mtm -59.39 -39.0 81.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.796 -0.638 . . . . 2.2400000000000002 111.52 -174.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.442 ' HA ' ' HB2' ' A' ' 21' ' ' SER . 11.8 ptt180 -74.07 -29.38 61.85 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.087 -0.645 . . . . 3.6899999999999999 111.569 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.6 t -71.68 -33.01 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.087 0.946 . . . . 1.0800000000000001 108.56 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -70.66 -43.63 77.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.032 -1.44 . . . . 1.04 109.712 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.442 ' HB2' ' HA ' ' A' ' 18' ' ' ARG . 6.3 m -62.66 -21.87 66.03 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 122.748 0.419 . . . . 1.8400000000000001 111.828 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.09 -51.71 6.15 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.316 -0.402 . . . . 2.2599999999999998 111.365 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.484 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 15.2 mm-40 -90.49 -27.94 18.88 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.104 0.409 . . . . 0.77000000000000002 112.104 -172.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.426 ' HB3' HD11 ' A' ' 42' ' ' ILE . 17.5 m -86.4 -32.44 20.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.114 0.483 . . . . 1.23 110.544 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.41 -9.53 62.82 Favored Glycine 0 C--O 1.23 -0.111 0 C-N-CA 120.503 -0.856 . . . . 0.54000000000000004 112.682 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mt -79.37 104.77 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.623 -0.51 . . . . 1.28 109.623 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.59 ' HB1' ' HG2' ' A' ' 30' ' ' GLU . . . -43.67 145.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.857 0.723 . . . . 1.26 112.02 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.4 tp -56.47 -31.5 64.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.705 -0.679 . . . . 1.6000000000000001 111.002 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -80.39 -9.75 59.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.057 -0.519 . . . . 2.23 111.181 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.59 ' HG2' ' HB1' ' A' ' 27' ' ' ALA . 40.6 mm-40 -110.71 -13.9 14.11 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.192 -0.458 . . . . 2.2400000000000002 110.052 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.8 tp -69.6 98.14 1.12 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.639 -0.71 . . . . 1.6799999999999999 110.27 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.1 p -107.62 161.84 14.5 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.361 -0.836 . . . . 1.21 108.969 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.737 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 7.5 p-10 -75.54 -9.05 58.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.765 0.317 . . . . 2.29 111.064 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -91.02 -23.65 20.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.416 0.525 . . . . 2.29 112.416 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.7 m -71.3 148.44 47.12 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.423 0.63 . . . . 1.3300000000000001 110.011 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.731 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 4.4 t-20 -113.24 123.49 50.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.417 -0.81 . . . . 1.2 109.812 -170.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.777 ' HD1' HG13 ' A' ' 42' ' ' ILE . 32.3 m-85 -56.49 -53.1 61.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.964 0.412 . . . . 0.63 111.587 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.06 -27.91 66.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.179 -0.464 . . . . 1.1499999999999999 111.321 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.731 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 23.4 t70 -72.06 -32.65 67.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.397 0.617 . . . . 0.82999999999999996 110.251 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.83 ' HE2' ' HA ' ' A' ' 40' ' ' MET . 4.8 mmt -83.48 -13.99 53.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.252 -0.885 . . . . 2.98 111.178 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.82 36.07 6.2 Favored Glycine 0 N--CA 1.457 0.071 0 C-N-CA 120.063 -1.065 . . . . 0.54000000000000004 112.516 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.777 HG13 ' HD1' ' A' ' 37' ' ' PHE . 32.7 mm -73.19 108.07 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.201 0.524 . . . . 1.2 110.013 175.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.29 163.84 27.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.539 -0.755 . . . . 1.9399999999999999 111.351 -173.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.5 t -54.49 -37.3 65.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.293 -0.867 . . . . 1.1399999999999999 111.054 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.77 -61.54 2.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 1.22 110.203 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.575 ' O ' HG13 ' A' ' 50' ' ' ILE . 11.6 m -62.68 -42.89 99.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.433 -0.349 . . . . 1.46 111.69 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.553 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 57.6 p -63.86 -32.18 73.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.95 0.405 . . . . 1.1000000000000001 111.204 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.9 tpt -75.78 -39.85 56.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.326 0.584 . . . . 2.8500000000000001 109.734 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.9 t -60.25 -45.82 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.292 -0.867 . . . . 1.1499999999999999 109.97 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 46' ' ' SER . 78.8 mt -55.56 -54.31 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.932 -0.576 . . . . 1.05 111.355 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.35 -36.36 92.36 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.736 -0.745 . . . . 0.35999999999999999 112.419 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 m -61.36 -47.44 85.84 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 120.591 -0.443 . . . . 1.6599999999999999 110.108 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -61.48 -32.25 72.25 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.431 -0.349 . . . . 1.48 111.31 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.484 ' HD2' HD13 ' A' ' 62' ' ' LEU . 11.0 m-30 -53.09 -38.95 62.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.151 0.5 . . . . 0.33000000000000002 110.21 176.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -83.54 -29.77 27.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.482 -0.781 . . . . 3.3300000000000001 111.116 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -85.12 -62.17 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.268 0.556 . . . . 2.2599999999999998 111.044 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -44.31 52.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.116 -0.947 . . . . 2.6200000000000001 111.094 -173.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 mp -93.7 -32.18 14.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.378 -0.374 . . . . 1.1200000000000001 111.312 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.99 29.76 30.59 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.681 -0.771 . . . . 0.45000000000000001 112.354 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.8 mt -82.54 108.15 15.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.731 -0.47 . . . . 1.23 109.731 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -81.18 78.43 7.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.641 0.734 . . . . 2.27 109.353 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.484 HD13 ' HD2' ' A' ' 54' ' ' PHE . 27.1 mt -76.07 -71.97 0.35 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.326 -1.306 . . . . 2.1299999999999999 110.995 -176.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.98 169.45 38.91 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.415 -0.811 . . . . 0.92000000000000004 111.289 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.23 -15.46 11.46 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.672 2.248 . . . . 1.2 113.006 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -119.12 10.87 12.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.313 -0.403 . . . . 2.3599999999999999 111.19 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.433 ' CD2' HD11 ' A' ' 62' ' ' LEU . 73.2 t80 -71.93 112.85 8.37 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.948 0.404 . . . . 0.84999999999999998 110.488 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.7 m -131.13 121.24 24.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.692 -0.686 . . . . 1.71 109.628 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.535 HD21 HD11 ' A' ' 78' ' ' LEU . 2.5 mp -54.12 -32.12 54.19 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.24 0.459 . . . . 1.3700000000000001 112.24 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.553 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 1.8 t80 -65.99 -14.57 61.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.946 0.403 . . . . 0.83999999999999997 110.855 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.0 mt -124.0 -39.01 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.514 -0.312 . . . . 1.51 110.671 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -95.15 6.09 50.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 2.23 111.796 -172.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.487 ' SG ' ' HG ' ' A' ' 78' ' ' LEU . 80.1 m -148.96 100.71 3.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.554 0.693 . . . . 1.0 109.983 -175.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.8 p -90.02 -72.88 0.54 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.694 -0.685 . . . . 1.29 110.194 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 77.5 p -86.67 -177.67 6.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.415 -0.587 . . . . 1.1399999999999999 109.415 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.7 t -80.21 -40.68 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 120.361 -0.536 . . . . 1.3700000000000001 110.419 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.737 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 8.4 tpt180 -54.67 -32.22 58.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.926 -0.579 . . . . 3.71 110.533 173.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -59.42 -31.57 69.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 1.1100000000000001 111.739 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.535 HD11 HD21 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -81.7 -45.28 15.93 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.706 -0.85 . . . . 1.3100000000000001 108.706 -179.007 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -53.2 -61.56 2.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.945 -1.48 . . . . 2.96 110.832 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.17 -19.05 63.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.937 -1.029 . . . . 1.6599999999999999 111.019 -173.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 83.4 t80 -63.06 -42.66 99.75 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.278 0.561 . . . . 1.2 109.596 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.71 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 12.5 mtt -55.76 -38.11 69.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.203 -0.908 . . . . 1.1000000000000001 111.385 175.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.5 mp -79.34 -46.35 17.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.353 . . . . 1.8500000000000001 111.243 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.03 81.33 0.35 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.875 -0.679 . . . . 2.4199999999999999 112.397 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.3 p -82.68 67.9 8.92 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.758 -0.221 . . . . 4.4699999999999998 111.291 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.66 91.2 0.09 OUTLIER Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.681 -0.771 . . . . 4.5899999999999999 112.768 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.05 -48.81 61.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.385 0.612 . . . . 6.6100000000000003 110.561 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.55 24.21 4.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.548 -0.751 . . . . 8.4800000000000004 111.218 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.551 -1.138 . . . . 9.7300000000000004 112.271 -179.852 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.739 -0.467 . . . . 9.3499999999999996 109.739 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -78.52 132.09 37.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.61 -0.268 . . . . 9.0299999999999994 110.61 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -147.74 132.04 17.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.817 -0.809 . . . . 5.71 108.817 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -142.65 132.09 23.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.217 -0.447 . . . . 7.0 110.127 -175.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.64 76.39 1.25 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.729 -0.748 . . . . 2.2400000000000002 111.652 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.68 -62.13 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.785 0.326 . . . . 1.6499999999999999 110.855 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.82 84.55 1.79 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.78 -0.724 . . . . 0.55000000000000004 111.557 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 12' ' ' LYS . 2.7 m -114.39 157.49 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.929 -0.397 . . . . 1.1399999999999999 109.929 -176.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.1 t -91.4 175.12 7.04 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.845 -0.798 . . . . 1.8899999999999999 108.845 173.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -67.08 -23.27 65.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.977 0.417 . . . . 2.3300000000000001 110.08 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -47.51 84.46 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.469 -0.787 . . . . 1.9099999999999999 110.903 172.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.6 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -71.74 -25.23 61.97 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.554 -0.536 . . . . 2.1099999999999999 109.554 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.578 ' HA ' HG11 ' A' ' 16' ' ' VAL . 4.0 tp -72.22 -29.21 63.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.07 -0.514 . . . . 1.6000000000000001 110.421 173.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.39 -24.0 57.14 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.023 0.916 . . . . 0.88 109.301 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.35 -36.89 20.47 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.72 -1.127 . . . . 1.05 110.884 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.578 HG11 ' HA ' ' A' ' 13' ' ' LEU . 4.0 p -70.61 -44.11 77.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.873 -0.603 . . . . 1.0700000000000001 112.295 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.444 ' HB3' HD23 ' A' ' 31' ' ' LEU . 88.5 mtp -60.0 -32.56 70.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.847 0.314 . . . . 2.2400000000000002 111.847 -173.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.557 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 8.2 ptt180 -84.24 -18.25 37.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.37 0.507 . . . . 3.6899999999999999 112.37 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.29 -32.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.188 -1.042 . . . . 1.0800000000000001 108.188 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 t -66.71 -39.88 84.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.21 -1.359 . . . . 1.04 110.122 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.5 p -64.37 -49.3 72.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.217 0.532 . . . . 1.8400000000000001 110.71 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 7.2 mm-40 -60.94 -39.4 89.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.401 -0.818 . . . . 2.2599999999999998 112.24 -178.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -80.14 -31.94 38.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.951 0.352 . . . . 0.77000000000000002 111.951 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.455 ' HA ' HD12 ' A' ' 42' ' ' ILE . 72.7 p -82.4 -44.59 15.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.886 0.374 . . . . 1.23 111.558 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.91 6.7 37.06 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.654 -0.784 . . . . 0.54000000000000004 111.705 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.761 HD12 ' HG2' ' A' ' 40' ' ' MET . 3.5 mt -97.61 137.07 26.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.501 -0.555 . . . . 1.28 109.501 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.35 141.99 58.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.742 0.306 . . . . 1.26 110.415 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -55.98 -34.48 65.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 1.6000000000000001 111.28 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -71.47 -10.45 59.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 2.23 111.378 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -111.61 -4.22 14.83 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.497 -0.319 . . . . 2.2400000000000002 111.103 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' A' ' 17' ' ' MET . 30.0 tp -72.05 97.88 1.98 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.516 0.674 . . . . 1.6799999999999999 110.472 -173.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 34' ' ' ASP . 70.0 p -124.95 165.8 17.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.193 -0.912 . . . . 1.21 109.052 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.494 ' CB ' ' HB2' ' A' ' 76' ' ' ARG . 7.7 p-10 -70.83 -5.87 33.62 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.206 0.527 . . . . 2.29 110.484 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.422 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 24.5 t70 -70.56 -22.04 62.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.202 -0.908 . . . . 2.29 109.687 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.458 ' HB2' HG21 ' A' ' 75' ' ' VAL . 14.1 m -81.29 147.45 29.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.648 -0.706 . . . . 1.3300000000000001 109.901 176.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.674 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 3.7 t-20 -127.64 119.78 26.64 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.074 -0.713 . . . . 1.2 109.074 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.612 ' HD1' HG13 ' A' ' 42' ' ' ILE . 5.5 m-85 -51.52 -50.23 60.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.955 0.407 . . . . 0.63 110.925 -176.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.03 -31.42 71.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.004 -0.543 . . . . 1.1499999999999999 111.627 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.674 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 30.8 t70 -74.94 -29.2 60.88 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.152 0.501 . . . . 0.82999999999999996 110.322 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.761 ' HG2' HD12 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -82.65 -15.07 53.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.256 -0.884 . . . . 2.98 111.08 -178.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.59 20.99 9.54 Favored Glycine 0 N--CA 1.455 -0.088 0 C-N-CA 120.231 -0.985 . . . . 0.54000000000000004 112.787 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.612 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.3 mm -71.47 107.15 2.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.52 0.676 . . . . 1.2 110.72 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -88.55 170.45 10.86 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.092 -0.958 . . . . 1.9399999999999999 110.088 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.9 t -55.19 -37.71 67.42 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.301 0.24 . . . . 1.1399999999999999 111.016 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.49 -56.34 23.41 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.012 -0.366 . . . . 1.22 110.012 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.554 ' O ' HG13 ' A' ' 50' ' ' ILE . 19.8 m -68.25 -41.43 81.14 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.874 0.324 . . . . 1.46 111.874 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.622 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 36.2 p -66.22 -30.36 70.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.03 0.443 . . . . 1.1000000000000001 110.965 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -39.57 64.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.619 -0.882 . . . . 2.8500000000000001 108.619 178.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 39.6 t -64.39 -44.66 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.902 -0.59 . . . . 1.1499999999999999 110.261 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 46' ' ' SER . 65.6 mt -52.06 -59.78 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.596 -0.275 . . . . 1.05 110.772 176.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.51 -27.33 67.79 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.11 -0.567 . . . . 0.35999999999999999 111.9 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.434 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -67.68 -44.13 78.55 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 122.902 -0.176 . . . . 1.6599999999999999 111.1 176.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 27.7 mtp180 -65.97 -23.98 66.7 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.716 0.293 . . . . 1.48 110.473 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.575 ' CZ ' HG23 ' A' ' 16' ' ' VAL . 12.2 m-30 -58.3 -40.56 82.33 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.169 0.509 . . . . 0.33000000000000002 109.688 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.434 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 66.7 mtm180 -82.03 -25.08 34.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.438 -0.801 . . . . 3.3300000000000001 111.043 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -83.0 -59.13 2.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.787 -0.642 . . . . 2.2599999999999998 110.927 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.62 -48.53 7.01 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.516 -0.766 . . . . 2.6200000000000001 111.797 -174.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.71 -26.51 34.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.421 -0.354 . . . . 1.1200000000000001 111.666 -173.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.31 40.41 49.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.12 -0.562 . . . . 0.45000000000000001 112.419 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.44 HD13 ' HB3' ' A' ' 54' ' ' PHE . 78.5 mt -86.35 146.15 26.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.839 0.352 . . . . 1.23 110.966 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.21 94.82 6.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 2.27 110.849 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.479 HD11 ' O ' ' A' ' 63' ' ' GLY . 0.3 OUTLIER -121.53 -52.35 2.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.117 -0.492 . . . . 2.1299999999999999 110.914 176.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.479 ' O ' HD11 ' A' ' 62' ' ' LEU . . . 124.52 169.0 12.96 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.628 -0.796 . . . . 0.92000000000000004 111.988 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.41 -4.83 11.76 Favored 'Trans proline' 0 C--N 1.333 -0.258 0 C-N-CA 122.48 2.12 . . . . 1.2 113.041 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.26 -16.56 19.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.118 -0.492 . . . . 2.3599999999999999 111.023 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -69.77 112.8 6.47 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.102 0.477 . . . . 0.84999999999999998 110.25 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 p -128.23 132.54 48.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.052 -0.522 . . . . 1.71 111.281 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 83.0 mt -81.23 15.13 2.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 1.3700000000000001 111.357 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.419 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 6.7 t80 -111.37 -8.49 14.31 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.105 0.479 . . . . 0.83999999999999997 109.907 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.6 mt -131.57 -40.64 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-O 120.862 0.363 . . . . 1.51 111.488 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.12 5.53 42.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.228 0.537 . . . . 2.23 110.531 -170.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 96.5 m -158.77 129.24 6.0 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.2 p -109.42 -48.3 3.26 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.748 -0.381 . . . . 1.29 111.068 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.6 p -99.87 -171.2 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.306 0.574 . . . . 1.1399999999999999 111.128 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 35' ' ' SER . 2.2 t -81.75 -44.45 20.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.773 -0.649 . . . . 1.3700000000000001 110.718 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.504 ' HD3' ' HB2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -67.31 -24.5 65.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.585 . . . . 3.71 110.684 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.36 64.87 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.165 0.507 . . . . 1.1100000000000001 110.386 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.701 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.6 OUTLIER -77.43 -49.06 15.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.633 -0.712 . . . . 1.3100000000000001 109.339 177.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.504 ' HB2' ' HD3' ' A' ' 76' ' ' ARG . 30.5 mmtm -57.85 -45.43 86.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.828 -1.078 . . . . 2.96 110.902 -176.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.45 -29.89 70.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.563 -0.744 . . . . 1.6599999999999999 110.77 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -77.0 -36.45 56.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.075 -0.511 . . . . 1.2 111.09 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.701 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 44.4 mtp -60.58 -52.99 62.81 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.207 -0.452 . . . . 1.1000000000000001 110.914 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.418 HD11 ' N ' ' A' ' 83' ' ' LEU . 5.9 mp -78.0 -40.7 38.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.949 0.404 . . . . 1.8500000000000001 110.47 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.86 141.28 6.18 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.922 -0.656 . . . . 2.4199999999999999 111.516 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.5 m -83.94 33.22 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.669 0.271 . . . . 4.4699999999999998 111.087 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.12 47.59 87.08 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.322 -1.111 . . . . 4.5899999999999999 110.322 -172.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -147.25 157.55 43.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.21 -0.495 . . . . 6.6100000000000003 110.216 -172.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 75.62 147.88 0.09 Allowed 'General case' 0 CA--C 1.52 -0.178 0 O-C-N 124.103 0.877 . . . . 8.4800000000000004 111.645 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.852 0 CA-C-O 118.648 -1.084 . . . . 9.7300000000000004 111.601 179.641 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.977 0.418 . . . . 9.3499999999999996 110.212 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -128.16 164.65 22.02 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.565 -0.532 . . . . 9.0299999999999994 109.565 175.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 74.26 132.99 0.05 OUTLIER 'General case' 0 C--O 1.235 0.306 0 O-C-N 124.414 1.071 . . . . 5.71 110.744 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -152.61 97.53 2.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.72 -0.673 . . . . 7.0 110.144 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 130.01 128.99 3.07 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.699 -0.682 . . . . 2.2400000000000002 111.474 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.61 -45.27 14.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.0 0.428 . . . . 1.6499999999999999 110.588 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.15 83.78 1.55 Allowed Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.875 -0.89 . . . . 0.55000000000000004 110.875 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -113.36 156.26 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.736 0.303 . . . . 1.1399999999999999 110.274 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.9 p -71.88 157.83 37.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.12 -0.491 . . . . 1.8899999999999999 110.382 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.64 -26.17 68.28 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.118 -1.067 . . . . 2.3300000000000001 108.118 175.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.44 -42.58 96.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.608 -1.178 . . . . 1.9099999999999999 110.56 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.739 ' HB2' ' HZ2' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -70.88 -27.77 64.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.146 -0.479 . . . . 2.1099999999999999 109.735 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' ' HG3' ' A' ' 17' ' ' MET . 0.1 OUTLIER -68.32 -27.99 66.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.842 -0.617 . . . . 1.6000000000000001 109.565 175.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -25.78 41.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.375 0.607 . . . . 0.88 110.156 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.88 -19.29 29.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.503 -0.771 . . . . 1.05 111.663 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.561 ' HB ' ' HE3' ' A' ' 82' ' ' MET . 3.3 p -82.16 -43.59 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.758 -0.377 . . . . 1.0700000000000001 111.777 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.548 ' HB3' HD23 ' A' ' 31' ' ' LEU . 57.3 mtm -61.56 -30.39 70.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.468 -0.333 . . . . 2.2400000000000002 111.508 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.18 -33.97 74.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.476 0.179 . . . . 3.6899999999999999 111.127 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.445 HG11 ' HB2' ' A' ' 53' ' ' ARG . 56.3 t -75.94 -37.13 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.694 0.759 . . . . 1.0800000000000001 109.113 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.03 -39.23 84.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.763 -1.108 . . . . 1.04 111.007 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -24.25 50.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.653 0.74 . . . . 1.8400000000000001 109.729 -173.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -78.8 -42.26 28.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.788 -1.097 . . . . 2.2599999999999998 111.101 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.525 ' HG3' HG12 ' A' ' 50' ' ' ILE . 62.0 mm-40 -74.69 -37.49 62.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.27 -0.423 . . . . 0.77000000000000002 111.351 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -71.51 -44.22 65.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.869 0.366 . . . . 1.23 110.516 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.99 5.13 35.64 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.819 -0.705 . . . . 0.54000000000000004 112.071 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.544 HD12 ' HG2' ' A' ' 40' ' ' MET . 2.3 mt -90.68 160.15 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.912 0.387 . . . . 1.28 110.107 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.37 140.23 42.89 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.766 -0.652 . . . . 1.26 110.269 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.2 tp -58.52 -35.52 72.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.952 -0.567 . . . . 1.6000000000000001 111.229 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -73.84 -14.57 61.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.186 0.517 . . . . 2.23 110.547 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -103.98 -6.3 21.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.762 -0.654 . . . . 2.2400000000000002 110.801 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 17' ' ' MET . 46.5 tp -72.04 99.21 2.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.934 -0.575 . . . . 1.6799999999999999 109.967 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.2 p -117.63 158.85 23.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.014 -0.539 . . . . 1.21 109.71 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.668 ' OD1' ' HB2' ' A' ' 76' ' ' ARG . 6.9 t70 -54.22 -23.72 15.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.226 0.61 . . . . 2.29 112.57 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.48 -19.41 64.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.883 -0.599 . . . . 2.29 111.408 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.531 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 14.8 m -71.95 151.47 43.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.342 0.591 . . . . 1.3300000000000001 110.84 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.76 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.6 t-20 -131.0 120.42 23.46 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.473 -0.566 . . . . 1.2 109.473 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.812 ' HD1' HG13 ' A' ' 42' ' ' ILE . 33.7 m-85 -51.36 -46.44 62.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.156 0.503 . . . . 0.63 111.219 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.39 -29.62 63.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.784 -0.644 . . . . 1.1499999999999999 111.571 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.76 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 21.5 t70 -74.72 -31.17 61.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.43 0.633 . . . . 0.82999999999999996 110.283 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.544 ' HG2' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -75.64 -23.12 56.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.602 -0.727 . . . . 2.98 110.453 178.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.32 27.93 7.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.325 -0.941 . . . . 0.54000000000000004 112.026 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.812 HG13 ' HD1' ' A' ' 37' ' ' PHE . 28.6 mm -68.21 107.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 1.2 109.833 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.35 171.44 15.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.521 -0.763 . . . . 1.9399999999999999 111.211 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.3 t -57.88 -32.69 67.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.721 -1.127 . . . . 1.1399999999999999 111.167 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.408 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.2 tm? -64.25 -57.48 9.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.721 -0.672 . . . . 1.22 110.088 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.549 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.6 m -63.93 -40.84 97.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.979 -0.555 . . . . 1.46 111.585 -173.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.6 p -62.38 -30.14 70.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.211 -0.45 . . . . 1.1000000000000001 111.447 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.7 ttt -79.15 -37.64 37.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.514 0.673 . . . . 2.8500000000000001 109.775 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 52' ' ' SER . 78.0 t -69.39 -40.68 80.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.765 -1.107 . . . . 1.1499999999999999 110.233 -175.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 46' ' ' SER . 73.2 mt -51.69 -54.11 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.881 0.372 . . . . 1.05 110.705 174.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -63.46 -26.22 69.38 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.974 -0.631 . . . . 0.35999999999999999 112.247 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 10.3 m -70.99 -42.33 69.79 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 120.659 0.266 . . . . 1.6599999999999999 110.715 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.445 ' HB2' HG11 ' A' ' 19' ' ' VAL . 10.0 mtp180 -64.95 -26.34 68.26 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.525 -0.307 . . . . 1.48 110.351 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.702 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 16.5 m-30 -56.31 -43.98 79.46 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.261 0.553 . . . . 0.33000000000000002 109.58 173.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 61.7 mtp180 -79.32 -27.97 42.11 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.227 -0.897 . . . . 3.3300000000000001 110.573 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -77.29 -62.82 1.53 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.82 -0.627 . . . . 2.2599999999999998 112.023 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -88.54 -44.13 10.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 2.6200000000000001 111.477 -169.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.56 -39.11 15.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.108 -0.497 . . . . 1.1200000000000001 111.591 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.99 23.34 15.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.503 -0.856 . . . . 0.45000000000000001 112.307 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.702 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 73.2 mt -80.81 113.18 18.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.726 -0.472 . . . . 1.23 109.726 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -97.87 87.39 3.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.45 0.643 . . . . 2.27 110.01 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.673 HD11 ' HD2' ' A' ' 54' ' ' PHE . 37.2 mt -87.88 -66.1 0.95 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.756 -1.111 . . . . 2.1299999999999999 110.304 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.15 167.62 20.08 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.724 -0.95 . . . . 0.92000000000000004 110.724 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -87.62 5.24 5.62 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 123.361 2.707 . . . . 1.2 112.96 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -107.19 -7.67 16.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.708 -0.678 . . . . 2.3599999999999999 111.692 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -85.38 120.87 27.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.774 0.321 . . . . 0.84999999999999998 111.428 -171.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -135.16 127.8 30.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 1.71 110.42 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.424 HD12 HD12 ' A' ' 50' ' ' ILE . 68.2 mt -66.12 -11.02 46.24 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.223 0.453 . . . . 1.3700000000000001 112.223 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -85.12 -11.33 55.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.125 0.488 . . . . 0.83999999999999997 109.944 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.5 mt -127.52 -39.81 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.344 -0.389 . . . . 1.51 110.906 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -95.73 8.26 43.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.529 -0.305 . . . . 2.23 111.146 -173.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 89.6 m -157.59 159.56 37.2 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -132.67 -78.28 0.49 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.303 -0.408 . . . . 1.29 110.615 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.8 p -83.65 -169.72 2.7 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.26 -0.275 . . . . 1.1399999999999999 110.596 177.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.6 OUTLIER -77.05 -41.84 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.568 -0.453 . . . . 1.3700000000000001 110.095 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.668 ' HB2' ' OD1' ' A' ' 33' ' ' ASP . 24.6 ttm180 -59.87 -33.43 71.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.428 -0.351 . . . . 3.71 111.324 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.69 -29.86 28.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.498 0.499 . . . . 1.1100000000000001 110.718 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.597 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.5 OUTLIER -85.39 -51.27 6.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.924 -0.58 . . . . 1.3100000000000001 109.753 175.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.414 ' HE3' HG11 ' A' ' 75' ' ' VAL . 10.5 mmtp -49.58 -59.25 3.94 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.069 -0.969 . . . . 2.96 111.298 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.45 -29.02 69.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.648 -1.16 . . . . 1.6599999999999999 110.899 -173.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.9 -37.12 75.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 1.2 111.138 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.597 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 22.3 mtp -57.72 -45.03 86.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.077 -0.51 . . . . 1.1000000000000001 110.618 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 83' ' ' LEU . 5.8 mp -80.59 -41.9 23.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.197 -0.456 . . . . 1.8500000000000001 110.411 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.28 -82.43 0.3 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.709 -0.556 . . . . 2.4199999999999999 111.709 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.1 t -173.9 31.43 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.637 -0.875 . . . . 4.4699999999999998 108.637 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 145.18 166.71 11.86 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.573 -1.011 . . . . 4.5899999999999999 110.573 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -140.51 125.0 17.83 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.472 0.136 . . . . 6.6100000000000003 110.81 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 53.47 82.5 0.08 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.901 0.751 . . . . 8.4800000000000004 112.705 173.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 118.44 -1.2 . . . . 9.7300000000000004 112.261 177.894 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . 0.426 H303 ' H33' ' A' ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 110.441 -0.207 . . . . 9.3499999999999996 110.441 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 59.0 tpp 63.78 76.06 0.37 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.787 0.679 . . . . 9.0299999999999994 111.275 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.47 134.18 17.76 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.69 -0.485 . . . . 5.71 109.69 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -138.86 90.5 2.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.284 0.564 . . . . 7.0 110.763 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.31 119.96 2.11 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.853 -0.612 . . . . 2.2400000000000002 111.615 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.67 -81.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.585 0.192 . . . . 1.6499999999999999 110.814 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.71 96.29 1.11 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.583 -0.818 . . . . 0.55000000000000004 111.945 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.91 157.21 10.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.8 0.333 . . . . 1.1399999999999999 110.489 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.0 m -78.94 165.59 23.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.346 -0.388 . . . . 1.8899999999999999 110.159 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -61.37 -31.44 71.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.821 0.819 . . . . 2.3300000000000001 109.204 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.14 -45.94 83.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.381 -1.281 . . . . 1.9099999999999999 110.788 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -72.87 -21.85 60.86 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.339 -0.846 . . . . 2.1099999999999999 110.823 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 tp -73.22 -26.07 61.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.828 -0.623 . . . . 1.6000000000000001 110.273 172.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -25.59 36.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.698 0.761 . . . . 0.88 109.796 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.75 -32.77 23.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.048 -0.978 . . . . 1.05 111.356 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.7 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 2.9 p -67.28 -44.53 87.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 120.874 -0.33 . . . . 1.0700000000000001 111.785 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.6 mtp -60.43 -27.82 67.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.204 -0.453 . . . . 2.2400000000000002 111.931 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 24.4 ptt85 -79.85 -32.87 40.51 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.598 . . . . 3.6899999999999999 111.459 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.35 -37.86 78.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.72 -0.844 . . . . 1.0800000000000001 108.72 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.2 t -64.87 -39.16 84.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.793 -1.094 . . . . 1.04 109.977 174.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -69.16 -27.33 65.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.91 -0.586 . . . . 1.8400000000000001 111.344 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 43.9 mt-10 -85.98 -30.27 22.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.018 0.437 . . . . 2.2599999999999998 111.117 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.7 ' HG3' HG12 ' A' ' 50' ' ' ILE . 72.2 mm-40 -82.63 -45.49 14.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.859 -0.609 . . . . 0.77000000000000002 112.031 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.479 ' HA ' HD11 ' A' ' 42' ' ' ILE . 73.4 p -72.13 -45.38 60.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.85 0.357 . . . . 1.23 111.248 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.72 2.2 43.09 Favored Glycine 0 C--O 1.23 -0.095 0 N-CA-C 111.104 -0.798 . . . . 0.54000000000000004 111.104 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.736 HD12 ' HG3' ' A' ' 40' ' ' MET . 3.9 mt -93.7 104.98 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.297 -0.631 . . . . 1.28 109.297 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -42.21 143.75 0.56 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.841 0.713 . . . . 1.26 112.317 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.6 tp -54.44 -32.84 58.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.799 -0.637 . . . . 1.6000000000000001 111.281 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -78.0 -10.51 59.63 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.889 0.376 . . . . 2.23 111.013 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -109.3 -6.54 15.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.187 -0.672 . . . . 2.2400000000000002 109.187 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.543 HD12 HG11 ' A' ' 75' ' ' VAL . 41.3 tp -76.84 98.72 4.94 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.399 -0.819 . . . . 1.6799999999999999 110.221 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.3 p -121.93 163.63 18.97 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.967 -1.015 . . . . 1.21 108.476 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.05 -3.75 14.39 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.782 0.29 . . . . 2.29 111.782 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -70.91 -23.44 62.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.373 -0.376 . . . . 2.29 110.595 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.455 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 21.3 m -75.65 149.8 38.1 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.527 0.68 . . . . 1.3300000000000001 111.399 -174.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.741 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 16.8 t-20 -126.13 122.15 34.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.099 -0.955 . . . . 1.2 108.768 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.784 ' HD1' HG13 ' A' ' 42' ' ' ILE . 20.6 m-85 -55.34 -46.84 76.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.852 0.358 . . . . 0.63 111.18 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.31 -29.59 62.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.341 -0.391 . . . . 1.1499999999999999 111.573 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.741 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 30.7 t70 -71.17 -35.58 71.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.537 0.684 . . . . 0.82999999999999996 110.36 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.736 ' HG3' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -75.54 -24.53 56.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.35 -0.841 . . . . 2.98 109.663 -175.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.16 28.28 4.73 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.529 -0.843 . . . . 0.54000000000000004 112.429 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.784 HG13 ' HD1' ' A' ' 37' ' ' PHE . 33.2 mm -74.34 107.94 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 1.2 110.571 176.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.77 170.97 15.75 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.512 -0.551 . . . . 1.9399999999999999 109.512 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.3 p -55.33 -36.85 66.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.884 -0.598 . . . . 1.1399999999999999 110.388 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -52.23 -59.05 4.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.32 -0.854 . . . . 1.22 110.539 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.568 ' O ' HG13 ' A' ' 50' ' ' ILE . 32.8 t -66.75 -43.26 84.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.14 -0.224 . . . . 1.46 111.134 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 87.7 p -60.35 -29.97 69.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.376 . . . . 1.1000000000000001 111.254 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.8 tpp -75.81 -46.12 32.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.895 -0.593 . . . . 2.8500000000000001 109.806 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.554 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 49.8 t -59.54 -45.46 93.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.958 -1.019 . . . . 1.1499999999999999 110.616 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.7 HG12 ' HG3' ' A' ' 23' ' ' GLU . 55.8 mt -51.7 -52.8 19.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.904 0.383 . . . . 1.05 110.447 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -57.59 -37.24 81.94 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.712 -0.677 . . . . 0.35999999999999999 112.551 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -66.46 -45.91 78.18 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.983 -0.377 . . . . 1.6599999999999999 109.983 177.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 6.0 mtp180 -60.64 -27.07 67.51 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.567 -0.288 . . . . 1.48 111.061 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 12.5 m-30 -58.01 -41.07 82.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.205 0.526 . . . . 0.33000000000000002 110.135 173.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.73 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 61.3 mtp180 -84.0 -32.11 25.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.833 -0.621 . . . . 3.3300000000000001 111.205 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 52' ' ' SER . 20.0 mm-40 -82.9 -47.07 12.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.237 -0.438 . . . . 2.2599999999999998 111.158 -174.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.09 -42.58 11.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 2.6200000000000001 112.151 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.55 -32.76 12.1 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.695 0.257 . . . . 1.1200000000000001 111.695 -174.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.96 33.41 8.99 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.746 -0.74 . . . . 0.45000000000000001 112.574 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.73 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 87.7 mt -86.5 115.84 24.26 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 110.409 -0.219 . . . . 1.23 110.409 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -95.21 58.37 2.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.649 0.737 . . . . 2.27 109.589 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.86 -29.79 50.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.859 -1.064 . . . . 2.1299999999999999 111.449 -175.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.28 169.9 12.59 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.734 -0.746 . . . . 0.92000000000000004 112.394 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -89.36 -13.29 2.92 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.171 2.58 . . . . 1.2 112.671 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -82.81 -17.36 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.523 . . . . 2.3599999999999999 112.239 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -82.3 114.27 20.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.173 0.511 . . . . 0.84999999999999998 111.139 -173.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.9 m -128.93 125.3 37.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.911 -0.586 . . . . 1.71 109.94 176.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 68.2 mt -58.55 -40.0 81.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.327 -0.397 . . . . 1.3700000000000001 111.691 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -60.8 -8.1 2.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.193 -0.458 . . . . 0.83999999999999997 111.674 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.5 -40.19 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.939 -0.475 . . . . 1.51 111.47 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -109.77 -1.91 17.65 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.56 0.578 . . . . 2.23 112.56 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.8 m -142.38 97.83 3.19 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.488 -0.757 . . . . 1.0 110.281 -175.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.6 p -89.58 -30.27 18.3 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.638 -0.71 . . . . 1.29 111.034 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -114.46 -176.51 2.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.135 -0.484 . . . . 1.1399999999999999 110.468 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.543 HG11 HD12 ' A' ' 31' ' ' LEU . 1.5 t -81.61 -43.3 19.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.998 0.428 . . . . 1.3700000000000001 110.437 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.6 ' HA ' ' CG ' ' A' ' 79' ' ' LYS . 29.3 ttm180 -64.97 -28.41 69.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.106 -0.497 . . . . 3.71 111.002 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.5 -31.21 55.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 1.1100000000000001 110.749 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.518 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.8 OUTLIER -75.7 -47.89 24.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.304 -0.628 . . . . 1.3100000000000001 109.304 176.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.6 ' CG ' ' HA ' ' A' ' 76' ' ' ARG . 26.8 mmtp -46.97 -50.01 19.77 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.96 -1.018 . . . . 2.96 110.59 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -54.36 -55.33 29.66 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.301 -0.863 . . . . 1.6599999999999999 111.709 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -56.29 -37.62 70.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.479 -0.782 . . . . 1.2 112.245 -173.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.7 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 24.8 mtp -60.17 -47.67 84.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.871 0.367 . . . . 1.1000000000000001 111.439 -174.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' A' ' 82' ' ' MET . 5.7 mp -82.94 -27.62 30.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.367 -0.379 . . . . 1.8500000000000001 110.816 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.54 -145.8 18.14 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.302 -0.952 . . . . 2.4199999999999999 112.432 175.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.2 m -93.99 34.72 1.21 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.09 0.471 . . . . 4.4699999999999998 110.347 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.67 23.66 59.74 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.002 -0.839 . . . . 4.5899999999999999 111.002 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -71.14 103.39 2.75 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.97 0.414 . . . . 6.6100000000000003 110.418 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -163.02 -32.88 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.823 -0.626 . . . . 8.4800000000000004 111.055 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.72 -1.044 . . . . 9.7300000000000004 112.191 -179.021 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.135 -0.321 . . . . 9.3499999999999996 110.135 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.4 ttm 65.54 91.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.901 0.751 . . . . 9.0299999999999994 111.6 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.03 136.78 24.3 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.055 0.455 . . . . 5.71 110.415 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -156.74 112.89 2.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.588 -0.733 . . . . 7.0 109.79 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.76 -102.83 2.82 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.695 -0.764 . . . . 2.2400000000000002 111.619 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -119.73 -74.55 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 110.054 -0.35 . . . . 1.6499999999999999 110.054 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.67 98.28 1.41 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.785 -0.721 . . . . 0.55000000000000004 111.339 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.464 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 3.9 m -112.21 158.96 12.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.159 -0.312 . . . . 1.1399999999999999 110.159 -177.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.1 p -87.11 -178.59 6.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.204 -0.453 . . . . 1.8899999999999999 110.5 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -68.43 -30.34 69.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.295 -0.631 . . . . 2.3300000000000001 109.295 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.4 -41.0 96.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.322 -0.854 . . . . 1.9099999999999999 110.408 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.464 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 58.1 mttt -74.3 -26.64 60.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.842 -0.617 . . . . 2.1099999999999999 111.002 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.23 -23.2 54.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.008 -0.542 . . . . 1.6000000000000001 110.057 173.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.3 -27.11 42.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.5 0.667 . . . . 0.88 109.694 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.54 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -83.9 -26.76 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.054 -0.975 . . . . 1.05 111.66 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.832 ' HB ' ' HE3' ' A' ' 82' ' ' MET . 2.7 p -71.83 -44.56 67.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 111.782 0.29 . . . . 1.0700000000000001 111.782 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.495 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 73.8 mtp -60.44 -34.37 73.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.486 -0.325 . . . . 2.2400000000000002 111.42 -175.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 12.3 ptt180 -69.64 -29.47 66.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.707 0.289 . . . . 3.6899999999999999 110.688 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.37 -39.33 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.01 -0.737 . . . . 1.0800000000000001 109.01 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.86 -49.05 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.838 -1.074 . . . . 1.04 110.06 176.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.492 ' OG ' HD23 ' A' ' 31' ' ' LEU . 25.7 m -54.96 -47.19 74.84 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 112.401 0.519 . . . . 1.8400000000000001 112.401 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -57.33 -46.43 83.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.055 0.391 . . . . 2.2599999999999998 112.055 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -79.75 -33.51 40.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.292 -0.413 . . . . 0.77000000000000002 111.882 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.422 ' HB3' HD12 ' A' ' 42' ' ' ILE . 76.7 p -80.72 -42.8 21.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 1.23 111.525 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.32 12.92 34.59 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.982 -0.628 . . . . 0.54000000000000004 111.978 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.764 HG12 ' HE1' ' A' ' 40' ' ' MET . 3.5 mt -102.88 125.89 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 122.802 -0.234 . . . . 1.28 110.544 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.42 ' HB1' ' HG2' ' A' ' 30' ' ' GLU . . . -56.3 145.11 27.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.394 -0.367 . . . . 1.26 110.788 175.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.76 -43.9 38.23 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.579 0.549 . . . . 1.6000000000000001 110.404 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -76.41 -10.66 59.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.963 -0.562 . . . . 2.23 111.286 -173.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' HG2' ' HB1' ' A' ' 27' ' ' ALA . 34.1 mm-40 -107.93 -10.59 15.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.987 -0.745 . . . . 2.2400000000000002 108.987 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.492 HD23 ' OG ' ' A' ' 21' ' ' SER . 17.8 tp -79.49 97.47 6.43 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.347 -0.842 . . . . 1.6799999999999999 109.18 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.2 p -116.73 162.38 17.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.322 -0.854 . . . . 1.21 108.855 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.836 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 45.5 m-20 -74.59 -3.54 31.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.782 0.325 . . . . 2.29 111.059 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.29 -20.22 44.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.705 -0.679 . . . . 2.29 110.528 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.422 ' HB2' HG23 ' A' ' 75' ' ' VAL . 43.6 m -70.88 157.32 38.34 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.749 0.785 . . . . 1.3300000000000001 111.275 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.644 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.1 t-20 -124.43 126.16 45.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.86 -1.064 . . . . 1.2 108.682 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.514 ' HD1' HG13 ' A' ' 42' ' ' ILE . 26.1 m-85 -57.08 -52.78 63.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.116 0.484 . . . . 0.63 111.308 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.07 -22.87 63.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.053 -0.521 . . . . 1.1499999999999999 111.254 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.644 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.6 t70 -83.54 -16.0 47.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.82999999999999996 110.538 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.764 ' HE1' HG12 ' A' ' 26' ' ' ILE . 65.9 mmm -101.46 1.49 38.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 2.98 111.706 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.53 26.22 23.56 Favored Glycine 0 C--O 1.23 -0.152 0 C-N-CA 119.79 -1.195 . . . . 0.54000000000000004 112.767 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.514 HG13 ' HD1' ' A' ' 37' ' ' PHE . 18.3 mm -72.01 107.7 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.195 0.521 . . . . 1.2 110.018 175.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.8 159.78 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.291 -0.868 . . . . 1.9399999999999999 110.194 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.459 ' HB2' ' CD2' ' A' ' 69' ' ' PHE . 1.4 t -55.07 -39.62 69.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.433 0.635 . . . . 1.1399999999999999 109.704 171.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -56.96 -53.09 61.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.315 -0.857 . . . . 1.22 109.827 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.569 ' O ' HG13 ' A' ' 50' ' ' ILE . 32.4 t -67.91 -42.76 80.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.758 -0.201 . . . . 1.46 111.52 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 33.0 p -60.73 -34.25 74.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.005 0.431 . . . . 1.1000000000000001 111.151 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.562 ' SD ' H313 ' A' ' 90' ' ' PNS . 30.2 ttp -72.69 -36.7 67.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.738 -0.664 . . . . 2.8500000000000001 109.563 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 42.6 t -70.34 -41.2 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.325 -0.852 . . . . 1.1499999999999999 110.256 -177.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 46' ' ' SER . 59.0 mt -55.14 -55.63 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.742 0.306 . . . . 1.05 110.431 176.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.74 -28.96 72.5 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.11 -0.566 . . . . 0.35999999999999999 112.031 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.26 -42.66 75.28 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.717 0.294 . . . . 1.6599999999999999 110.689 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.746 ' HA ' ' HB3' ' A' ' 56' ' ' GLU . 28.9 mtp180 -69.01 -22.53 64.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 121.0 -0.28 . . . . 1.48 110.592 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.573 ' HE2' HD22 ' A' ' 78' ' ' LEU . 13.8 m-30 -57.46 -41.89 81.44 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.246 -0.649 . . . . 0.33000000000000002 109.246 172.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.657 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 35.8 mtp180 -81.19 -25.67 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.552 -0.749 . . . . 3.3300000000000001 110.665 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.746 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 29.9 tt0 -77.68 -62.77 1.56 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.754 -0.657 . . . . 2.2599999999999998 111.687 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -87.21 -41.56 13.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.969 -0.56 . . . . 2.6200000000000001 111.415 -172.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.99 -40.67 11.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.182 -0.463 . . . . 1.1200000000000001 111.33 -174.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.59 28.26 9.77 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.019 -0.61 . . . . 0.45000000000000001 112.047 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.657 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 51.2 mt -80.8 107.41 13.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.297 -0.26 . . . . 1.23 110.297 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.55 78.78 9.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.186 0.993 . . . . 2.27 110.196 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.473 HD13 ' HD2' ' A' ' 54' ' ' PHE . 13.8 mt -83.1 -72.98 0.43 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.422 -1.263 . . . . 2.1299999999999999 110.932 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.13 156.23 16.16 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.733 -0.947 . . . . 0.92000000000000004 110.733 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HG2' ' OE2' ' A' ' 65' ' ' GLU . 58.9 Cg_endo -78.37 -26.75 5.85 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.351 2.034 . . . . 1.2 113.613 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.422 ' OE2' ' HG2' ' A' ' 64' ' ' PRO . 37.4 mp0 -98.7 26.42 5.65 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 122.082 -0.386 . . . . 2.3599999999999999 111.178 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -92.12 112.54 24.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.46 -0.336 . . . . 0.84999999999999998 110.439 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.5 t -132.46 123.87 27.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.968 0.414 . . . . 1.71 110.199 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.468 HD11 HD12 ' A' ' 50' ' ' ILE . 70.2 mt -61.47 -16.45 47.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.089 -0.505 . . . . 1.3700000000000001 111.546 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.459 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 8.9 t80 -73.82 -15.05 61.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.186 -0.461 . . . . 0.83999999999999997 110.76 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.0 mt -130.04 -35.82 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.197 -0.456 . . . . 1.51 110.965 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -91.97 6.8 44.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.484 -0.325 . . . . 2.23 111.871 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.75 162.78 37.14 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -175.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.0 p -134.92 -72.65 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.306 -0.406 . . . . 1.29 111.209 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 71.8 p -84.88 -179.46 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.999 -0.371 . . . . 1.1399999999999999 109.999 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -79.68 -39.92 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 108.865 -0.791 . . . . 1.3700000000000001 108.865 -176.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.836 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 13.6 tpt180 -60.38 -30.23 69.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.476 -1.238 . . . . 3.71 111.188 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.03 -33.63 73.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.433 -0.348 . . . . 1.1100000000000001 110.491 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.643 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.0 OUTLIER -71.93 -51.18 23.37 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.81 -0.811 . . . . 1.3100000000000001 108.81 176.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.495 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 27.9 mmtp -48.09 -57.57 5.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.51 -1.223 . . . . 2.96 111.833 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -60.52 -37.27 80.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.572 -0.74 . . . . 1.6599999999999999 111.506 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -62.64 -38.24 89.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.941 -0.572 . . . . 1.2 111.125 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.832 ' HE3' ' HB ' ' A' ' 16' ' ' VAL . 30.0 mtp -59.98 -51.45 69.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 1.1000000000000001 111.519 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.1 mp -75.75 -42.3 50.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.578 0.228 . . . . 1.8500000000000001 110.762 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.55 125.23 3.05 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.559 -0.829 . . . . 2.4199999999999999 112.337 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.2 m -76.87 41.36 0.27 Allowed 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 122.532 0.333 . . . . 4.4699999999999998 111.47 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.62 -59.58 4.05 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.096 -0.573 . . . . 4.5899999999999999 111.797 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -157.9 116.31 3.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.689 0.281 . . . . 6.6100000000000003 110.364 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.64 -66.98 0.45 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.043 -0.526 . . . . 8.4800000000000004 110.342 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.864 0 CA-C-O 118.512 -1.16 . . . . 9.7300000000000004 111.783 -178.943 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . 0.562 H313 ' SD ' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 111.435 0.161 . . . . 9.3499999999999996 111.435 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 92.3 mtp 58.77 73.51 0.48 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.672 0.389 . . . . 9.0299999999999994 111.039 -176.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.01 130.41 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.942 0.776 . . . . 5.71 111.861 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -137.76 118.49 14.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.488 -0.778 . . . . 7.0 110.448 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 84' ' ' GLY . . . -107.62 -173.14 22.18 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.556 -0.747 . . . . 2.2400000000000002 111.637 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.8 t -81.18 -79.78 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.785 0.326 . . . . 1.6499999999999999 110.431 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.43 94.25 1.82 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.749 -0.941 . . . . 0.55000000000000004 110.749 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.99 158.93 9.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.817 0.341 . . . . 1.1399999999999999 110.562 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.3 t -85.79 179.2 7.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.783 -0.451 . . . . 1.8899999999999999 109.783 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.81 -20.71 65.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.535 0.683 . . . . 2.3300000000000001 109.643 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.9 -50.87 71.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.987 -1.006 . . . . 1.9099999999999999 110.689 175.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HG2' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -70.54 -23.85 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.054 -0.721 . . . . 2.1099999999999999 109.054 -177.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.448 ' O ' ' HG3' ' A' ' 17' ' ' MET . 2.2 tp -69.49 -27.14 64.94 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.724 -0.671 . . . . 1.6000000000000001 110.403 174.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.7 -28.57 33.4 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.591 0.71 . . . . 0.88 109.986 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.51 -31.76 37.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.23 -0.895 . . . . 1.05 111.013 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.803 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 4.5 p -69.61 -46.99 73.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.275 -0.421 . . . . 1.0700000000000001 111.617 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.692 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 65.8 mtm -61.9 -28.88 69.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.426 -0.352 . . . . 2.2400000000000002 111.725 -172.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -81.61 -22.44 37.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.37 -0.377 . . . . 3.6899999999999999 111.25 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.0 t -82.42 -35.22 12.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.758 -0.83 . . . . 1.0800000000000001 108.758 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.4 t -64.89 -36.21 77.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.574 -1.194 . . . . 1.04 110.09 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -59.7 -53.03 62.72 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.051 0.453 . . . . 1.8400000000000001 110.663 -176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -54.76 -55.61 28.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.165 -0.925 . . . . 2.2599999999999998 112.324 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -77.42 -22.84 50.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.341 0.497 . . . . 0.77000000000000002 112.341 -170.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.1 m -85.96 -31.41 22.11 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.553 -0.459 . . . . 1.23 110.006 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.13 -2.92 44.02 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.745 -0.741 . . . . 0.54000000000000004 112.844 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mt -101.48 153.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.833 0.349 . . . . 1.28 110.603 -175.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.523 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -66.77 145.34 55.62 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.855 -0.612 . . . . 1.26 110.646 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.2 tp -60.87 -36.39 79.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.996 0.427 . . . . 1.6000000000000001 110.422 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -72.58 -10.92 60.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 2.23 110.963 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.523 ' HG3' ' HB1' ' A' ' 27' ' ' ALA . 19.2 mt-10 -115.55 6.32 14.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.727 -0.669 . . . . 2.2400000000000002 110.793 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.452 HD12 HG13 ' A' ' 75' ' ' VAL . 44.6 tp -75.48 97.78 3.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.31 0.576 . . . . 1.6799999999999999 109.501 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 59.4 p -101.11 156.85 17.18 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.203 -0.908 . . . . 1.21 110.363 -175.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.654 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 16.5 p-10 -81.56 -4.61 56.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.279 0.562 . . . . 2.29 110.027 177.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.14 -22.85 60.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.891 -1.05 . . . . 2.29 110.841 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.453 ' HB2' HG22 ' A' ' 75' ' ' VAL . 39.8 m -77.43 155.4 31.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.957 0.884 . . . . 1.3300000000000001 111.568 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.923 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.4 t-20 -127.05 123.76 37.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.455 -1.313 . . . . 1.2 107.455 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.643 ' HD1' HG13 ' A' ' 42' ' ' ILE . 11.6 m-85 -56.8 -54.76 42.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.855 -0.338 . . . . 0.63 111.443 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.19 62.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.86 0.362 . . . . 1.1499999999999999 111.006 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.923 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 22.8 t70 -74.04 -29.12 61.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.495 . . . . 0.82999999999999996 110.815 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.1 mmt -83.04 -15.03 52.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.618 . . . . 2.98 111.228 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.11 14.86 15.66 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.158 -1.02 . . . . 0.54000000000000004 112.258 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.643 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.0 mm -67.59 106.8 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.947 -0.76 . . . . 1.2 108.947 174.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.91 177.52 8.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.473 -0.785 . . . . 1.9399999999999999 111.225 -177.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 t -58.59 -31.88 68.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.193 -0.912 . . . . 1.1399999999999999 109.766 175.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.413 ' HA ' H282 ' A' ' 90' ' ' PNS . 3.0 tm? -60.43 -62.93 1.51 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.985 -1.007 . . . . 1.22 110.86 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.569 ' O ' HG13 ' A' ' 50' ' ' ILE . 15.2 m -68.64 -39.34 80.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.448 -0.342 . . . . 1.46 111.519 -173.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.474 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 47.0 p -65.6 -21.93 66.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.814 0.34 . . . . 1.1000000000000001 111.255 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.39 -43.73 20.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.101 -0.703 . . . . 2.8500000000000001 109.101 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.408 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.7 t -62.76 -48.02 90.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.048 -0.978 . . . . 1.1499999999999999 110.84 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 46' ' ' SER . 77.1 mt -51.32 -56.6 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.317 -0.401 . . . . 1.05 111.473 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -63.85 -30.65 78.31 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.611 -0.805 . . . . 0.35999999999999999 112.459 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -39.52 89.5 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.04 -0.264 . . . . 1.6599999999999999 110.451 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 25.6 mtp180 -65.19 -23.96 67.24 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.488 0.185 . . . . 1.48 110.882 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.624 ' HD2' HD11 ' A' ' 62' ' ' LEU . 11.8 m-30 -58.51 -38.69 78.23 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.482 0.658 . . . . 0.33000000000000002 109.501 175.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -79.07 -24.67 43.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.174 -0.921 . . . . 3.3300000000000001 110.95 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -78.56 -62.07 1.81 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.996 -0.547 . . . . 2.2599999999999998 111.412 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -87.82 -53.57 4.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.023 -0.535 . . . . 2.6200000000000001 111.639 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 mp -72.81 -27.59 62.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.963 -0.562 . . . . 1.1200000000000001 111.289 -171.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.65 31.1 57.02 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.623 -0.798 . . . . 0.45000000000000001 111.708 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 54' ' ' PHE . 81.8 mt -82.05 114.55 20.68 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 110.292 -0.262 . . . . 1.23 110.292 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -88.89 75.85 8.0 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.252 -0.647 . . . . 2.27 109.252 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.624 HD11 ' HD2' ' A' ' 54' ' ' PHE . 37.1 mt -82.4 -65.47 1.01 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.165 -0.925 . . . . 2.1299999999999999 109.998 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.24 165.71 23.0 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 114.647 -1.16 . . . . 0.92000000000000004 110.75 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.94 -8.3 10.09 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.02 2.48 . . . . 1.2 113.075 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -117.56 20.64 13.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.468 0.652 . . . . 2.3599999999999999 110.709 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.409 ' HE1' ' CE2' ' A' ' 81' ' ' PHE . 83.6 t80 -77.87 111.81 14.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.074 -0.512 . . . . 0.84999999999999998 109.916 -177.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.1 m -123.16 118.17 27.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.626 -0.715 . . . . 1.71 110.739 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 42.6 mt -63.26 -33.31 75.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 1.3700000000000001 110.489 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.468 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 37.1 t80 -59.6 -16.65 27.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.618 -0.719 . . . . 0.83999999999999997 111.151 -175.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.7 mt -121.76 -40.14 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 121.044 -0.262 . . . . 1.51 111.515 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.51 6.84 32.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.933 -0.707 . . . . 2.23 112.526 -173.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 82.1 m -150.2 86.65 1.43 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.251 0.548 . . . . 1.0 109.639 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.1 p -78.25 -59.01 2.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.591 -0.731 . . . . 1.29 110.927 -172.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 82.3 p -86.9 -178.92 6.42 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.852 -0.425 . . . . 1.1399999999999999 109.852 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 35' ' ' SER . 0.2 OUTLIER -81.59 -42.54 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.306 0.574 . . . . 1.3700000000000001 109.89 -179.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.654 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 4.9 tpp180 -60.13 -29.06 68.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.361 -0.836 . . . . 3.71 110.613 176.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -59.59 -35.72 74.85 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.532 -0.304 . . . . 1.1100000000000001 110.951 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.542 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -72.58 -45.3 59.82 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.192 -0.67 . . . . 1.3100000000000001 109.192 177.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.692 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.8 mmtp -51.19 -61.3 2.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.853 -1.067 . . . . 2.96 111.048 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.95 -24.42 65.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.766 -0.652 . . . . 1.6599999999999999 111.79 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 46.5 t80 -64.82 -37.15 86.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.009 0.433 . . . . 1.2 110.262 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.803 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 12.8 mtp -62.2 -42.86 99.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.633 -0.712 . . . . 1.1000000000000001 111.463 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.434 HD13 ' N ' ' A' ' 83' ' ' LEU . 6.7 mp -74.84 -17.33 60.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 1.8500000000000001 110.849 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.412 ' O ' ' HA3' ' A' ' 5' ' ' GLY . . . -66.82 95.16 0.26 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.742 -0.742 . . . . 2.4199999999999999 111.964 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.9 t -103.83 11.58 35.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.982 0.896 . . . . 4.4699999999999998 109.982 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 159.48 147.13 4.78 Favored Glycine 0 C--N 1.311 -0.825 0 CA-C-N 114.485 -1.234 . . . . 4.5899999999999999 111.663 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -152.83 -82.96 0.08 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.305 -0.628 . . . . 6.6100000000000003 109.305 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 69.73 142.12 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.703 0.763 . . . . 8.4800000000000004 112.248 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.908 0 CA-C-O 118.119 -1.378 . . . . 9.7300000000000004 111.46 177.352 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . 0.624 H312 ' O26' ' A' ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.636 0.255 . . . . 9.3499999999999996 110.815 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.0 mmm -94.39 147.3 23.37 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.623 -0.51 . . . . 9.0299999999999994 109.623 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.05 -14.24 36.83 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.042 0.449 . . . . 5.71 111.441 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.4 tttt 69.25 115.31 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.643 -1.162 . . . . 7.0 111.372 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.08 173.85 22.75 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.883 -0.887 . . . . 2.2400000000000002 110.883 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.4 t -76.3 -71.27 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.91 0.386 . . . . 1.6499999999999999 110.263 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.16 83.93 1.49 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.54 -0.838 . . . . 0.55000000000000004 111.465 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.552 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 4.0 m -110.57 160.49 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.741 0.305 . . . . 1.1399999999999999 110.699 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -82.61 174.39 11.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.405 -0.591 . . . . 1.8899999999999999 109.405 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -66.9 -35.71 80.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.409 0.623 . . . . 2.3300000000000001 109.74 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -56.93 -41.4 78.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.014 -0.994 . . . . 1.9099999999999999 111.202 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.552 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 47.5 mmtm -68.02 -24.72 65.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.697 -0.683 . . . . 2.1099999999999999 110.53 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.847 HD13 HD12 ' A' ' 83' ' ' LEU . 24.9 tp -70.72 -26.76 63.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.136 -0.484 . . . . 1.6000000000000001 111.146 173.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.94 -30.79 50.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.659 0.742 . . . . 0.88 109.3 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.577 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -75.83 -33.44 60.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.071 -0.968 . . . . 1.05 110.405 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 13' ' ' LEU . 3.0 p -71.48 -45.46 68.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.318 -0.401 . . . . 1.0700000000000001 111.716 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.6 ' HE1' ' HG ' ' A' ' 13' ' ' LEU . 63.7 mtt -59.54 -33.95 72.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.69 -0.232 . . . . 2.2400000000000002 110.948 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 39.3 ptt180 -73.25 -30.35 63.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.046 -0.262 . . . . 3.6899999999999999 111.216 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -77.46 -34.17 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.739 -0.837 . . . . 1.0800000000000001 108.739 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 t -66.55 -40.96 87.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.681 -1.145 . . . . 1.04 109.304 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.8 t -61.76 -23.48 66.2 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.318 -0.401 . . . . 1.8400000000000001 111.021 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.51 -49.69 10.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.203 0.525 . . . . 2.2599999999999998 111.165 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -84.85 -31.39 23.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.439 -0.801 . . . . 0.77000000000000002 112.372 -169.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.4 p -79.12 -35.43 42.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 1.23 111.129 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.75 13.8 56.17 Favored Glycine 0 C--O 1.234 0.106 0 C-N-CA 120.404 -0.903 . . . . 0.54000000000000004 111.336 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mt -105.08 111.73 35.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.494 -0.558 . . . . 1.28 109.494 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.19 145.37 13.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 1.26 111.256 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.5 tp -52.96 -34.61 56.56 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.912 -0.585 . . . . 1.6000000000000001 110.919 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.43 -19.46 61.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.865 -0.607 . . . . 2.23 111.579 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.34 -1.38 21.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.927 -0.398 . . . . 2.2400000000000002 109.927 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -73.93 97.91 2.91 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.577 0.703 . . . . 1.6799999999999999 109.493 -177.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.2 p -106.59 151.22 25.33 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.272 -0.876 . . . . 1.21 109.097 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.827 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 27.1 m-20 -81.21 -3.19 51.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.84 0.352 . . . . 2.29 111.515 -174.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -93.62 -3.95 51.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.258 -0.428 . . . . 2.29 110.636 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.435 ' HB2' HG22 ' A' ' 75' ' ' VAL . 55.3 m -73.69 158.63 34.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.394 0.616 . . . . 1.3300000000000001 110.022 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.793 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.0 t-20 -125.82 124.95 42.07 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.538 -0.755 . . . . 1.2 109.465 -176.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.731 ' HD1' HG13 ' A' ' 42' ' ' ILE . 35.5 m-85 -55.65 -50.19 70.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.891 0.376 . . . . 0.63 111.181 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.07 70.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.015 0.436 . . . . 1.1499999999999999 111.221 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.793 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 32.8 t70 -72.68 -27.18 61.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.113 0.483 . . . . 0.82999999999999996 110.598 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.9 mmt -86.46 -12.28 49.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 2.98 111.423 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.44 23.17 9.73 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.317 -0.944 . . . . 0.54000000000000004 112.784 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.731 HG13 ' HD1' ' A' ' 37' ' ' PHE . 24.5 mm -72.39 106.91 2.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.267 0.556 . . . . 1.2 110.217 176.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -91.11 -178.66 5.23 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.648 -0.706 . . . . 1.9399999999999999 111.139 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.6 t -54.61 -49.03 71.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.278 -0.873 . . . . 1.1399999999999999 110.796 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.52 HD23 H302 ' A' ' 90' ' ' PNS . 3.3 tm? -50.32 -58.42 5.7 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.719 -0.673 . . . . 1.22 110.883 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.469 ' O ' HG13 ' A' ' 50' ' ' ILE . 22.6 t -66.78 -46.34 75.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.854 0.359 . . . . 1.46 111.442 -174.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.576 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 59.0 p -65.16 -30.66 71.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.427 -0.352 . . . . 1.1000000000000001 111.73 -176.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.565 ' HE3' ' HA ' ' A' ' 65' ' ' GLU . 12.6 tpt -74.73 -41.69 59.68 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.055 -0.72 . . . . 2.8500000000000001 109.055 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.47 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 31.8 t -57.48 -53.1 48.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.278 -0.874 . . . . 1.1499999999999999 110.503 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 46' ' ' SER . 68.9 mt -49.08 -53.9 6.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 O-C-N 123.131 0.27 . . . . 1.05 111.264 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.37 -34.99 83.15 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.81 -0.71 . . . . 0.35999999999999999 112.485 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -68.52 -41.92 79.25 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.91 -0.316 . . . . 1.6599999999999999 110.222 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 1.8 mtp180 -68.54 -20.57 64.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.67 -0.241 . . . . 1.48 110.711 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.59 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.7 m-30 -59.92 -39.83 86.78 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.646 0.736 . . . . 0.33000000000000002 109.658 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.672 ' HD2' ' O ' ' A' ' 60' ' ' LEU . 9.8 mmm180 -73.76 -28.64 61.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.887 -1.051 . . . . 3.3300000000000001 110.298 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -81.53 -64.09 1.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.078 -0.51 . . . . 2.2599999999999998 112.096 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -83.78 -34.62 24.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.977 -0.556 . . . . 2.6200000000000001 111.392 -169.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.3 mp -97.22 -39.71 9.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.051 -0.522 . . . . 1.1200000000000001 110.817 -175.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.38 36.2 8.97 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.534 -0.841 . . . . 0.45000000000000001 111.802 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.672 ' O ' ' HD2' ' A' ' 55' ' ' ARG . 93.4 mt -78.79 133.5 37.06 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.67 -0.122 . . . . 1.23 110.67 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.62 77.71 9.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.212 0.529 . . . . 2.27 110.732 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.59 HD11 ' HD2' ' A' ' 54' ' ' PHE . 55.1 mt -94.66 -60.54 1.68 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.609 0.719 . . . . 2.1299999999999999 109.694 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.41 176.75 24.53 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 109.916 -1.274 . . . . 0.92000000000000004 109.916 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.77 -23.03 7.23 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.994 1.796 . . . . 1.2 112.608 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.565 ' HA ' ' HE3' ' A' ' 48' ' ' MET . 42.0 tt0 -119.71 70.23 0.85 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.716 0.769 . . . . 2.3599999999999999 110.695 -175.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -109.92 111.46 22.89 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.282 -0.872 . . . . 0.84999999999999998 109.487 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.2 m -121.18 118.4 29.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.198 -0.455 . . . . 1.71 110.51 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 59.8 mt -64.58 -25.19 67.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.376 . . . . 1.3700000000000001 111.047 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.538 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.9 t80 -72.16 -4.4 28.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.841 -0.618 . . . . 0.83999999999999997 110.353 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.94 -42.59 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.28 -0.418 . . . . 1.51 110.947 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.46 8.87 33.66 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.365 0.505 . . . . 2.23 112.365 -169.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 89.2 m -152.5 159.23 43.34 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.044 -0.41 . . . . 1.0 110.089 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.9 p -134.25 -70.61 0.51 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.405 -0.362 . . . . 1.29 110.962 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 77.6 p -83.26 -177.65 6.82 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.242 -0.286 . . . . 1.1399999999999999 110.318 175.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.71 HG12 ' HZ1' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -83.25 -41.58 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.635 0 N-CA-C 108.637 -0.875 . . . . 1.3700000000000001 108.637 -176.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.827 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 7.7 tpt180 -59.26 -29.62 67.7 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 113.743 -1.572 . . . . 3.71 110.91 175.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.26 68.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.786 0.326 . . . . 1.1100000000000001 110.826 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.431 HD12 HD13 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -76.47 -43.07 41.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.972 0.892 . . . . 1.3100000000000001 109.151 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.71 ' HZ1' HG12 ' A' ' 75' ' ' VAL . 24.9 mmtm -60.01 -51.54 69.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.152 -1.386 . . . . 2.96 109.83 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.81 -29.75 70.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.714 -1.13 . . . . 1.6599999999999999 111.162 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -72.96 -39.13 66.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.864 -0.607 . . . . 1.2 110.767 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.2 mtm -81.75 -42.61 19.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.595 -0.729 . . . . 1.1000000000000001 112.349 -174.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.847 HD12 HD13 ' A' ' 13' ' ' LEU . 6.7 mp -83.67 -46.35 12.41 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.981 -0.45 . . . . 1.8500000000000001 111.13 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.61 145.12 13.14 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.941 -0.647 . . . . 2.4199999999999999 112.248 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.5 m -108.71 32.61 4.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.12 0.486 . . . . 4.4699999999999998 110.547 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.77 73.31 0.39 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.725 -0.671 . . . . 4.5899999999999999 112.008 -177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -91.33 24.18 3.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.052 0.453 . . . . 6.6100000000000003 110.037 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.27 12.84 25.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.698 -0.683 . . . . 8.4800000000000004 111.5 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.392 -1.227 . . . . 9.7300000000000004 111.356 177.904 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . 0.52 H302 HD23 ' A' ' 45' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.626 0.251 . . . . 9.3499999999999996 110.767 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 15.4 tpt -120.59 132.93 55.39 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.133 -0.321 . . . . 9.0299999999999994 110.133 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -140.6 136.5 32.83 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.365 0.602 . . . . 5.71 111.016 -177.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.43 ' HG2' ' N ' ' A' ' 5' ' ' GLY . 81.6 tttt -148.48 164.14 35.06 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.2 -0.909 . . . . 7.0 108.773 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.668 ' HA3' ' HA2' ' A' ' 84' ' ' GLY . . . -111.44 -157.88 14.64 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.663 -0.78 . . . . 2.2400000000000002 111.386 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.59 -65.9 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.087 0.47 . . . . 1.6499999999999999 109.798 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 83' ' ' LEU . . . 103.25 92.52 2.23 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.172 -0.771 . . . . 0.55000000000000004 111.172 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.702 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 2.7 m -114.26 156.28 15.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.855 0.359 . . . . 1.1399999999999999 110.344 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.6 t -95.41 -176.52 3.8 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.12 -0.491 . . . . 1.8899999999999999 109.728 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -62.65 -26.17 68.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.052 0.453 . . . . 2.3300000000000001 109.969 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.48 -55.17 37.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.736 -0.666 . . . . 1.9099999999999999 110.937 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.702 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 88.0 mttt -75.32 -19.8 59.43 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.31 -0.404 . . . . 2.1099999999999999 110.468 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.599 HD12 ' HD2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -73.76 -31.14 63.17 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.022 -0.535 . . . . 1.6000000000000001 110.183 172.457 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.16 -29.39 43.02 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.232 -0.918 . . . . 0.88 109.585 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.54 -25.7 41.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.936 -1.029 . . . . 1.05 111.021 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.633 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 3.7 p -77.68 -43.76 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.557 -0.292 . . . . 1.0700000000000001 111.32 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.546 ' HB3' HD22 ' A' ' 31' ' ' LEU . 66.9 mtm -63.35 -28.99 70.38 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.983 -0.287 . . . . 2.2400000000000002 111.006 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -74.45 -33.62 62.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.86 -0.336 . . . . 3.6899999999999999 110.62 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.12 -38.32 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.624 0.726 . . . . 1.0800000000000001 109.143 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.3 t -61.87 -42.1 93.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.614 -1.175 . . . . 1.04 110.982 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.0 m -71.55 -41.36 69.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.286 0.565 . . . . 1.8400000000000001 110.259 -171.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.06 -46.61 82.34 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.987 -1.006 . . . . 2.2599999999999998 111.663 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.44 -31.46 48.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.459 -0.337 . . . . 0.77000000000000002 111.502 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.432 ' HA ' HD13 ' A' ' 42' ' ' ILE . 53.1 m -77.85 -35.87 50.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.844 0.354 . . . . 1.23 111.175 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.72 0.72 36.79 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.793 -0.718 . . . . 0.54000000000000004 112.494 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.847 HD12 ' SD ' ' A' ' 40' ' ' MET . 5.7 mt -92.81 161.18 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.286 0.565 . . . . 1.28 110.6 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.412 ' N ' HG23 ' A' ' 26' ' ' ILE . . . -87.16 143.13 27.44 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.134 -0.939 . . . . 1.26 109.264 171.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.0 tp -56.18 -29.17 60.47 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.278 0.362 . . . . 1.6000000000000001 111.56 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -69.32 -15.21 63.28 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.34 -0.391 . . . . 2.23 111.944 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -114.07 3.71 15.38 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.121 -0.231 . . . . 2.2400000000000002 111.334 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.554 HD13 HG11 ' A' ' 75' ' ' VAL . 39.1 tp -78.73 99.09 6.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.332 0.587 . . . . 1.6799999999999999 110.335 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.1 p -120.06 163.28 17.89 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.007 -0.738 . . . . 1.21 109.007 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.8 p-10 -70.91 -3.0 16.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.158 0.429 . . . . 2.29 112.158 -177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.41 -22.97 61.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.983 0.42 . . . . 2.29 110.878 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.466 ' HB3' ' CG2' ' A' ' 75' ' ' VAL . 33.7 t -76.14 158.78 31.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.422 0.63 . . . . 1.3300000000000001 111.742 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.2 t-20 -127.16 119.42 26.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.363 -0.835 . . . . 1.2 109.277 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.768 ' HD1' HG13 ' A' ' 42' ' ' ILE . 38.5 m-85 -50.84 -49.6 58.49 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.123 0.487 . . . . 0.63 111.291 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.8 -32.77 74.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.798 -0.637 . . . . 1.1499999999999999 111.28 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 34.2 t70 -73.51 -26.99 61.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.157 0.503 . . . . 0.82999999999999996 110.541 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.847 ' SD ' HD12 ' A' ' 26' ' ' ILE . 65.3 mtm -79.7 -24.1 41.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.805 -0.634 . . . . 2.98 110.183 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.08 26.44 6.66 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.426 -0.892 . . . . 0.54000000000000004 112.584 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.768 HG13 ' HD1' ' A' ' 37' ' ' PHE . 26.9 mm -65.14 108.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.604 -0.517 . . . . 1.2 109.604 175.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -82.34 176.49 9.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.581 -0.736 . . . . 1.9399999999999999 110.435 -175.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.0 t -61.02 -40.25 92.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.805 -0.634 . . . . 1.1399999999999999 109.865 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.27 -56.71 17.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.522 -0.763 . . . . 1.22 110.002 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.504 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.5 m -59.78 -44.22 94.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.09 -0.504 . . . . 1.46 111.206 -177.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.561 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 50.2 m -58.72 -39.29 80.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.744 -0.662 . . . . 1.1000000000000001 111.606 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.641 ' HG2' H312 ' A' ' 90' ' ' PNS . 12.4 tpt -72.66 -37.5 67.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.374 0.606 . . . . 2.8500000000000001 110.13 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.581 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.0 t -62.83 -53.84 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.14 -0.936 . . . . 1.1499999999999999 109.871 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 46' ' ' SER . 66.5 mt -49.97 -52.4 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.281 -0.418 . . . . 1.05 111.281 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.09 -36.97 93.15 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.871 -0.681 . . . . 0.35999999999999999 112.518 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t -63.66 -44.2 94.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.715 0.293 . . . . 1.6599999999999999 110.467 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 11.7 mtp180 -65.87 -27.05 67.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.394 -0.366 . . . . 1.48 110.65 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.461 ' HB3' HD12 ' A' ' 60' ' ' LEU . 13.4 m-30 -57.31 -40.66 78.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.36 0.6 . . . . 0.33000000000000002 110.032 175.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -78.62 -27.82 45.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.732 -0.667 . . . . 3.3300000000000001 111.002 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.74 -56.73 4.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.217 -0.447 . . . . 2.2599999999999998 111.474 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -88.14 -36.46 16.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.235 -0.439 . . . . 2.6200000000000001 112.005 -172.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.483 HD13 ' N ' ' A' ' 58' ' ' LEU . 8.3 mp -99.76 -25.08 14.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.892 0.33 . . . . 1.1200000000000001 111.892 -172.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.26 41.62 37.75 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.514 -0.85 . . . . 0.45000000000000001 111.699 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 54' ' ' PHE . 19.1 mt -83.65 136.73 34.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.986 0.365 . . . . 1.23 111.986 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -93.4 88.38 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 2.27 110.208 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.507 HD12 ' HE2' ' A' ' 81' ' ' PHE . 0.7 OUTLIER -112.89 -61.05 1.79 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.135 -0.484 . . . . 2.1299999999999999 109.92 178.55 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.58 170.72 12.45 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.811 -0.709 . . . . 0.92000000000000004 112.155 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.57 10.43 3.71 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.995 2.463 . . . . 1.2 111.937 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.21 9.97 12.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.161 -0.927 . . . . 2.3599999999999999 110.751 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -95.47 116.21 28.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.993 -0.548 . . . . 0.84999999999999998 110.678 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.0 m -136.81 122.45 19.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.024 -0.535 . . . . 1.71 110.255 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.407 HD12 HD12 ' A' ' 50' ' ' ILE . 57.2 mt -56.85 -41.82 78.6 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.953 -0.567 . . . . 1.3700000000000001 111.98 -176.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.561 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.4 t80 -55.67 -14.18 2.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.888 -0.596 . . . . 0.83999999999999997 112.223 -174.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.51 -40.7 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.095 -0.378 . . . . 1.51 111.112 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -106.05 7.84 32.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.059 0.392 . . . . 2.23 112.059 -169.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 92.3 m -148.91 136.63 20.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.342 0.591 . . . . 1.0 109.863 -176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.2 p -114.24 -76.15 0.58 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.038 -0.528 . . . . 1.29 111.071 -173.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 77.7 p -83.19 -172.8 4.34 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.12 -0.362 . . . . 1.1399999999999999 110.449 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.554 HG11 HD13 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -81.36 -40.87 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.03 -0.729 . . . . 1.3700000000000001 109.03 -175.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.595 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -66.98 -24.89 66.09 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.897 -1.047 . . . . 3.71 110.397 179.323 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.0 -34.41 71.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.444 -0.344 . . . . 1.1100000000000001 110.462 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.641 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -71.22 -48.05 53.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.745 -0.835 . . . . 1.3100000000000001 108.745 177.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.599 ' HD2' HD12 ' A' ' 13' ' ' LEU . 30.0 mmtm -54.04 -50.09 67.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.964 -1.471 . . . . 2.96 111.164 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.12 -44.99 92.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 1.6599999999999999 110.627 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 84' ' ' GLY . 34.2 t80 -63.39 -30.07 71.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.043 -0.98 . . . . 1.2 111.162 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.641 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 32.8 mtp -61.0 -42.61 98.77 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.177 -0.465 . . . . 1.1000000000000001 110.707 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.513 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 6.2 mp -81.81 -44.55 16.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.737 0.303 . . . . 1.8500000000000001 110.875 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.668 ' HA2' ' HA3' ' A' ' 5' ' ' GLY . . . -148.5 148.81 20.61 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.076 -1.059 . . . . 2.4199999999999999 112.79 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -78.8 45.34 0.6 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.319 0.581 . . . . 4.4699999999999998 110.198 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.64 24.12 24.32 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.467 -1.053 . . . . 4.5899999999999999 110.467 -172.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -83.53 73.43 10.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.447 0.641 . . . . 6.6100000000000003 110.16 -175.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.06 123.82 7.95 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.36 -0.836 . . . . 8.4800000000000004 109.957 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 118.473 -1.182 . . . . 9.7300000000000004 111.406 178.358 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . 0.641 H312 ' HG2' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.751 0.31 . . . . 9.3499999999999996 110.952 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 12.2 tpt -115.29 141.23 48.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.206 -0.294 . . . . 9.0299999999999994 110.206 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.02 138.7 11.74 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.05 -0.352 . . . . 5.71 110.05 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt 67.25 91.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.939 0.775 . . . . 7.0 111.372 177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.56 150.91 5.52 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.663 -0.78 . . . . 2.2400000000000002 112.468 177.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.5 t -115.95 -75.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 110.16 -0.311 . . . . 1.6499999999999999 110.16 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.35 98.91 2.49 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.6 -0.809 . . . . 0.55000000000000004 111.744 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.44 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 4.0 m -114.43 162.11 12.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.324 -0.25 . . . . 1.1399999999999999 110.324 -175.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 p -84.25 174.09 10.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.153 -0.314 . . . . 1.8899999999999999 110.153 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -73.38 -19.46 60.99 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.197 -0.668 . . . . 2.3300000000000001 109.197 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.59 -42.11 95.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.094 -0.957 . . . . 1.9099999999999999 109.398 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.44 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 43.8 mmtm -67.36 -36.26 81.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.364 -0.835 . . . . 2.1099999999999999 110.219 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -62.98 -29.44 70.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.941 -0.572 . . . . 1.6000000000000001 110.678 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.538 ' HA ' ' HE3' ' A' ' 17' ' ' MET . 1.0 OUTLIER -77.38 -28.6 52.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.598 0.713 . . . . 0.88 109.682 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.52 -34.24 31.34 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.098 -0.956 . . . . 1.05 111.124 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.692 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 5.7 p -68.55 -45.99 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.654 0.613 . . . . 1.0700000000000001 112.654 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.538 ' HE3' ' HA ' ' A' ' 14' ' ' ASP . 58.4 mtm -56.35 -34.95 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.943 0.349 . . . . 2.2400000000000002 111.943 -172.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -78.69 -22.97 45.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.34 -0.544 . . . . 3.6899999999999999 111.673 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.415 HG12 HG22 ' A' ' 50' ' ' ILE . 47.3 t -74.58 -34.88 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 122.05 0.929 . . . . 1.0800000000000001 108.551 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 t -69.11 -36.84 75.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.184 -1.371 . . . . 1.04 110.469 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.4 t -68.91 -22.62 64.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.787 0.327 . . . . 1.8400000000000001 110.765 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -86.23 -48.96 8.08 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.976 0.417 . . . . 2.2599999999999998 111.919 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -79.5 -9.92 59.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.475 . . . . 0.77000000000000002 112.1 -172.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -99.91 -42.8 6.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.989 0.423 . . . . 1.23 111.309 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.07 7.03 50.93 Favored Glycine 0 C--O 1.235 0.19 0 C-N-CA 120.711 -0.757 . . . . 0.54000000000000004 111.261 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.555 HD13 ' HG3' ' A' ' 40' ' ' MET . 4.9 mt -93.14 111.91 25.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.307 -0.627 . . . . 1.28 109.307 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.456 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -48.4 144.63 3.92 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.456 0.473 . . . . 1.26 111.229 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.2 tp -55.23 -29.3 57.72 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.141 -0.481 . . . . 1.6000000000000001 111.6 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -83.8 -10.25 58.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 2.23 111.039 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.456 ' HG3' ' HB1' ' A' ' 27' ' ' ALA . 33.2 mt-10 -105.57 -9.46 17.4 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.728 -0.842 . . . . 2.2400000000000002 108.728 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.577 HD11 HG11 ' A' ' 75' ' ' VAL . 36.7 tp -72.76 98.28 2.37 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.812 -1.085 . . . . 1.6799999999999999 109.649 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.6 p -115.79 158.89 22.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.147 -1.057 . . . . 1.21 108.147 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.887 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 17.4 p-10 -75.6 -2.41 29.1 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.931 -0.308 . . . . 2.29 110.821 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -88.22 -3.04 58.92 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.939 -0.573 . . . . 2.29 110.842 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.464 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 45.6 m -81.61 152.91 26.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.488 0.661 . . . . 1.3300000000000001 110.704 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 15.0 t-20 -122.0 122.96 40.53 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.49 -0.777 . . . . 1.2 109.141 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.658 ' HD1' HG13 ' A' ' 42' ' ' ILE . 23.7 m-85 -55.75 -53.58 54.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.988 0.423 . . . . 0.63 111.359 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.86 -27.79 67.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.054 -0.521 . . . . 1.1499999999999999 111.066 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.658 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 35.8 t70 -72.45 -29.2 63.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.82999999999999996 110.586 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.555 ' HG3' HD13 ' A' ' 26' ' ' ILE . 14.9 mmt -83.35 -19.9 35.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.896 -0.593 . . . . 2.98 111.318 -176.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.92 16.73 8.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.356 -0.926 . . . . 0.54000000000000004 112.441 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.658 HG13 ' HD1' ' A' ' 37' ' ' PHE . 23.4 mm -66.6 108.27 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.139 0.495 . . . . 1.2 110.323 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -81.34 167.49 19.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.667 -0.697 . . . . 1.9399999999999999 110.068 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.8 t -54.02 -35.14 61.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.447 -0.575 . . . . 1.1399999999999999 109.447 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.483 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.1 tm? -59.55 -62.56 1.78 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.562 -0.745 . . . . 1.22 110.022 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.539 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.2 m -59.86 -44.52 94.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.247 -0.433 . . . . 1.46 112.153 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.531 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 36.4 p -65.34 -30.36 71.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.021 0.438 . . . . 1.1000000000000001 111.125 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.4 tpt -75.06 -30.82 61.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.647 -0.706 . . . . 2.8500000000000001 109.621 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 45' ' ' LEU . 76.3 t -78.62 -36.78 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.148 -0.933 . . . . 1.1499999999999999 110.497 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 46' ' ' SER . 66.9 mt -56.44 -52.57 50.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.37 -0.233 . . . . 1.05 110.37 173.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.67 -26.25 68.29 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.774 -0.727 . . . . 0.35999999999999999 111.943 178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 4.1 m -69.62 -45.21 69.05 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 120.679 0.276 . . . . 1.6599999999999999 110.863 176.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -65.07 -27.0 68.48 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.624 0.249 . . . . 1.48 110.856 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.62 ' HD2' HD13 ' A' ' 62' ' ' LEU . 12.7 m-30 -54.86 -39.97 69.18 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.718 -0.475 . . . . 0.33000000000000002 109.718 174.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.685 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 12.2 mtp180 -81.64 -34.77 30.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.72 -0.673 . . . . 3.3300000000000001 111.534 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -86.05 -63.88 1.24 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.039 0.447 . . . . 2.2599999999999998 111.544 -173.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -71.14 -36.3 72.03 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.454 -0.794 . . . . 2.6200000000000001 111.499 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.75 -57.0 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 1.1200000000000001 111.055 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.85 27.61 3.19 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.823 -0.703 . . . . 0.45000000000000001 113.221 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.685 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 55.2 mt -84.1 112.19 20.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.78 0.29 . . . . 1.23 110.353 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -85.58 66.37 9.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 122.235 1.017 . . . . 2.27 110.163 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.62 HD13 ' HD2' ' A' ' 54' ' ' PHE . 19.4 mt -64.72 -67.45 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.507 -1.224 . . . . 2.1299999999999999 110.682 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.75 173.25 39.12 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 110.285 -1.126 . . . . 0.92000000000000004 110.285 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.8 -35.89 0.68 Allowed 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.372 2.048 . . . . 1.2 113.048 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -108.27 62.83 0.61 Allowed 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 121.078 0.466 . . . . 2.3599999999999999 110.766 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -109.66 111.66 23.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.698 -0.482 . . . . 0.84999999999999998 109.698 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.6 m -129.27 118.89 23.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.98 -0.555 . . . . 1.71 110.74 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 84.1 mt -64.64 -16.06 62.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.911 -0.586 . . . . 1.3700000000000001 111.092 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.531 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 46.0 t80 -82.5 -12.03 58.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.923 -0.581 . . . . 0.83999999999999997 110.948 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 71.8 mt -117.77 -41.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.773 -0.371 . . . . 1.51 111.624 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.26 15.23 16.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.454 0.645 . . . . 2.23 110.671 -173.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 76.8 m -146.72 156.63 43.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.7 p -135.93 -63.17 0.66 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.685 0.279 . . . . 1.29 110.776 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 44.3 p -93.04 179.08 5.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.195 -0.298 . . . . 1.1399999999999999 110.195 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.577 HG11 HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -75.83 -42.91 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 121.484 0.659 . . . . 1.3700000000000001 109.397 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.887 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 40.7 ttp180 -52.86 -37.96 60.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.501 -1.227 . . . . 3.71 111.728 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -55.83 -33.9 64.91 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.852 0.72 . . . . 1.1100000000000001 111.311 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.47 -47.96 30.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.203 0.525 . . . . 1.3100000000000001 110.144 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.579 ' HD3' ' HA ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -56.4 -60.97 2.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.263 -0.88 . . . . 2.96 110.235 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -54.62 -37.5 65.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.774 -1.103 . . . . 1.6599999999999999 111.609 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.54 ' HA ' ' HB2' ' A' ' 85' ' ' SER . 38.2 t80 -62.07 -37.88 86.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 1.2 110.966 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.692 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 12.2 mtt -54.7 -49.87 69.67 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.059 -0.519 . . . . 1.1000000000000001 112.017 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.416 HD13 ' N ' ' A' ' 83' ' ' LEU . 5.7 mp -80.81 -31.32 35.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 1.8500000000000001 111.147 -174.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.52 86.53 0.11 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.995 -1.098 . . . . 2.4199999999999999 112.627 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.54 ' HB2' ' HA ' ' A' ' 81' ' ' PHE . 1.8 t -78.9 65.7 4.17 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.922 0.391 . . . . 4.4699999999999998 110.739 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.15 -116.65 1.64 Allowed Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.458 -0.657 . . . . 4.5899999999999999 111.458 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -78.91 147.8 32.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.599 -0.519 . . . . 6.6100000000000003 109.599 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.82 -170.49 2.95 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.654 -0.498 . . . . 8.4800000000000004 109.654 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.545 -1.142 . . . . 9.7300000000000004 111.304 -177.085 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.857 0.36 . . . . 9.3499999999999996 110.406 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.1 ttt -124.21 118.85 27.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.183 -0.673 . . . . 9.0299999999999994 109.183 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.16 136.9 40.4 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.089 0.471 . . . . 5.71 110.093 -176.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -136.28 80.28 1.81 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.311 -0.859 . . . . 7.0 109.824 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.98 74.13 0.18 Allowed Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.816 -0.629 . . . . 2.2400000000000002 111.731 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.6 t -81.52 -74.04 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.943 0.401 . . . . 1.6499999999999999 110.506 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.77 114.46 1.51 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.307 -0.949 . . . . 0.55000000000000004 111.829 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 m -109.92 159.31 9.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.822 0.344 . . . . 1.1399999999999999 110.46 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 m -75.49 166.99 22.74 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.777 -0.453 . . . . 1.8899999999999999 109.777 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -69.41 -29.56 67.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.99 -0.744 . . . . 2.3300000000000001 108.99 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.44 -34.64 77.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.079 -0.964 . . . . 1.9099999999999999 110.242 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -63.69 -29.43 70.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 2.1099999999999999 110.31 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 83' ' ' LEU . 18.2 tp -66.95 -23.97 66.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.831 -0.622 . . . . 1.6000000000000001 110.86 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.46 -31.57 26.49 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.585 0.707 . . . . 0.88 109.516 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -29.03 55.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.155 -0.93 . . . . 1.05 110.509 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.443 HG22 ' HE3' ' A' ' 82' ' ' MET . 3.3 p -73.65 -45.95 49.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.18 -0.464 . . . . 1.0700000000000001 111.036 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.879 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 75.6 mtp -61.13 -35.32 76.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 2.2400000000000002 111.226 -175.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 12.5 ptm180 -66.13 -37.64 86.2 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 120.459 -0.497 . . . . 3.6899999999999999 110.567 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.9 -41.03 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 109.039 -0.726 . . . . 1.0800000000000001 109.039 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -57.65 -47.23 86.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.841 -1.072 . . . . 1.04 110.129 175.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.2 m -68.08 -42.37 80.5 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.071 0.397 . . . . 1.8400000000000001 112.071 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 45.2 mt-10 -63.46 -27.76 69.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.252 -0.431 . . . . 2.2599999999999998 111.579 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -91.06 -38.79 12.57 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.967 0.358 . . . . 0.77000000000000002 111.967 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.6 p -72.95 -44.98 60.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.958 0.409 . . . . 1.23 111.57 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.98 38.26 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.68 -0.771 . . . . 0.54000000000000004 111.549 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mt -94.79 117.8 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.483 -0.562 . . . . 1.28 109.483 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.659 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -47.28 141.75 4.44 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.131 0.419 . . . . 1.26 112.131 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 tp -52.7 -38.64 60.99 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.509 -0.769 . . . . 1.6000000000000001 111.472 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.39 -9.22 58.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.761 -0.654 . . . . 2.23 111.253 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.659 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 15.6 mm-40 -110.81 -6.87 14.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.93 -0.577 . . . . 2.2400000000000002 109.983 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.413 HD23 ' HE2' ' A' ' 17' ' ' MET . 25.5 tp -75.06 98.56 3.67 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.201 0.524 . . . . 1.6799999999999999 110.284 -176.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.3 p -111.65 158.94 18.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.529 -0.759 . . . . 1.21 109.696 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.658 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.2 p-10 -76.26 -4.99 44.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.349 . . . . 2.29 111.463 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.08 -21.18 60.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.811 -0.632 . . . . 2.29 110.639 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.427 ' HB3' HG23 ' A' ' 75' ' ' VAL . 16.3 t -77.31 158.07 30.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.81 0.814 . . . . 1.3300000000000001 111.207 -173.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.639 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 20.7 t-20 -126.32 122.64 36.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.861 -1.063 . . . . 1.2 108.594 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.744 ' HD1' HG13 ' A' ' 42' ' ' ILE . 18.6 m-85 -55.17 -48.18 74.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.106 0.479 . . . . 0.63 111.408 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.4 68.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.103 -0.499 . . . . 1.1499999999999999 110.999 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 14.3 t70 -67.58 -34.51 77.18 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.161 0.505 . . . . 0.82999999999999996 110.203 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.2 mmt -81.0 -17.67 49.52 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.633 -0.712 . . . . 2.98 111.238 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.87 22.03 9.19 Favored Glycine 0 C--O 1.23 -0.099 0 C-N-CA 120.566 -0.826 . . . . 0.54000000000000004 112.773 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.744 HG13 ' HD1' ' A' ' 37' ' ' PHE . 26.9 mm -64.2 108.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.213 0.53 . . . . 1.2 110.192 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -76.1 161.64 28.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.35 -0.841 . . . . 1.9399999999999999 111.04 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.3 t -56.07 -41.52 75.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.938 -0.574 . . . . 1.1399999999999999 110.576 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.92 -53.18 60.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 1.22 109.788 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.554 ' O ' HG13 ' A' ' 50' ' ' ILE . 16.2 m -57.84 -44.87 86.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.419 -0.355 . . . . 1.46 110.903 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.512 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 50.2 m -58.38 -37.66 75.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.096 -0.502 . . . . 1.1000000000000001 111.234 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.522 ' HG2' ' H32' ' A' ' 90' ' ' PNS . 12.2 tpt -74.71 -34.99 62.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.909 -0.587 . . . . 2.8500000000000001 109.93 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.504 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 44.1 t -68.3 -48.54 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.664 -0.698 . . . . 1.1499999999999999 109.587 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 46' ' ' SER . 73.1 mt -52.04 -54.89 11.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.72 0.295 . . . . 1.05 110.391 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.514 ' O ' ' HG3' ' A' ' 55' ' ' ARG . . . -60.41 -32.98 79.22 Favored Glycine 0 C--O 1.228 -0.245 0 CA-C-N 115.829 -0.623 . . . . 0.35999999999999999 112.578 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.468 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -72.94 -45.59 57.22 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.048 -0.261 . . . . 1.6599999999999999 110.549 177.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 6.1 mtp180 -63.39 -30.68 71.77 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.913 0.387 . . . . 1.48 110.188 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.504 ' CE2' HD21 ' A' ' 78' ' ' LEU . 9.1 m-30 -50.99 -48.52 61.24 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.857 -0.61 . . . . 0.33000000000000002 109.782 171.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 19.0 mtm105 -83.76 -40.51 18.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.637 -0.711 . . . . 3.3300000000000001 110.952 -170.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -88.21 -49.01 7.27 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.351 -0.386 . . . . 2.2599999999999998 111.874 -171.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -79.58 -52.05 8.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.85 0.357 . . . . 2.6200000000000001 111.349 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 mp -82.63 -58.31 2.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.194 -0.457 . . . . 1.1200000000000001 111.541 -175.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.65 24.22 1.58 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.091 -0.576 . . . . 0.45000000000000001 112.154 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.527 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 16.6 mt -104.19 92.72 4.48 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.757 -0.26 . . . . 1.23 110.516 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.453 ' HA ' ' HG2' ' A' ' 55' ' ' ARG . 18.4 t70 -101.36 80.04 2.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.581 0.705 . . . . 2.27 110.021 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.503 HD12 ' HE2' ' A' ' 81' ' ' PHE . 71.4 mt -71.17 -32.53 69.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.895 -1.048 . . . . 2.1299999999999999 109.43 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.06 160.98 21.8 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 114.642 -1.163 . . . . 0.92000000000000004 110.75 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -82.99 -12.58 9.55 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.89 2.393 . . . . 1.2 113.066 -175.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -130.67 31.36 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.812 0.815 . . . . 2.3599999999999999 110.717 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -95.01 120.24 34.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.84999999999999998 109.563 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 t -126.63 131.76 51.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.7 -0.4 . . . . 1.71 110.498 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 72' ' ' CYS . 48.1 mt -58.4 -41.38 84.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.808 -0.633 . . . . 1.3700000000000001 110.475 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.512 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 15.0 t80 -62.59 -12.4 22.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.731 -0.668 . . . . 0.83999999999999997 111.494 -175.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 63.7 mt -109.87 -42.34 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.874 -0.33 . . . . 1.51 111.126 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -130.71 22.11 5.04 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.64 0.978 . . . . 2.23 113.64 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 98.3 m -143.99 99.55 3.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.282 0.563 . . . . 1.0 109.81 174.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.5 p -90.81 -51.78 5.19 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.012 -0.54 . . . . 1.29 111.624 -170.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.4 p -96.82 -178.64 4.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.19 -0.3 . . . . 1.1399999999999999 110.19 176.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.543 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -81.09 -41.33 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 109.764 -0.458 . . . . 1.3700000000000001 109.764 -178.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.658 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 5.2 tpt180 -60.6 -28.22 68.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.671 -0.695 . . . . 3.71 110.483 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -58.32 -32.83 68.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.498 -0.319 . . . . 1.1100000000000001 110.69 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.504 HD21 ' CE2' ' A' ' 54' ' ' PHE . 0.7 OUTLIER -81.27 -48.66 11.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.546 0.689 . . . . 1.3100000000000001 109.431 176.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.879 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.9 mmtp -53.99 -57.84 9.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.695 -1.139 . . . . 2.96 110.928 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.476 ' HB2' ' HE ' ' A' ' 76' ' ' ARG . 5.7 t70 -72.33 -19.38 61.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.208 -0.905 . . . . 1.6599999999999999 111.1 -171.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.503 ' HE2' HD12 ' A' ' 62' ' ' LEU . 76.2 t80 -73.62 -44.12 57.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.215 0.531 . . . . 1.2 110.418 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.447 ' SD ' HD12 ' A' ' 60' ' ' LEU . 6.3 mtm -70.9 -32.66 69.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.73 -0.668 . . . . 1.1000000000000001 112.123 -176.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 13' ' ' LEU . 7.5 mp -80.07 -44.69 19.61 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.772 -0.371 . . . . 1.8500000000000001 110.856 172.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -109.09 73.89 0.2 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.968 -0.634 . . . . 2.4199999999999999 112.369 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.1 m -87.56 35.91 0.73 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.871 0.367 . . . . 4.4699999999999998 111.14 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.79 -31.05 7.21 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.75 -0.738 . . . . 4.5899999999999999 112.102 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -106.3 -165.76 1.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.197 -0.668 . . . . 6.6100000000000003 109.197 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.56 -34.39 0.63 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.737 0.273 . . . . 8.4800000000000004 111.737 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.415 -1.214 . . . . 9.7300000000000004 112.212 -177.305 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . 0.522 ' H32' ' HG2' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 120.765 0.317 . . . . 9.3499999999999996 110.901 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 14.0 tpt -131.12 126.99 37.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.213 -0.662 . . . . 9.0299999999999994 109.213 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.16 -19.28 51.35 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.103 0.478 . . . . 5.71 111.878 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.0 tttp -137.33 104.18 5.3 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.991 -0.549 . . . . 7.0 110.502 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.2 125.1 1.52 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.981 -0.628 . . . . 2.2400000000000002 111.593 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.18 -84.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.477 0.18 . . . . 1.6499999999999999 110.534 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.4 93.76 1.63 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.571 -0.823 . . . . 0.55000000000000004 111.324 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.03 155.36 14.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.851 0.358 . . . . 1.1399999999999999 110.167 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 t -82.96 173.63 11.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.536 -0.542 . . . . 1.8899999999999999 109.536 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -65.52 -25.8 67.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.293 0.568 . . . . 2.3300000000000001 109.853 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -67.29 -46.45 73.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.395 -0.82 . . . . 1.9099999999999999 110.503 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -73.82 -20.32 60.49 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.724 -0.391 . . . . 2.1099999999999999 110.508 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 tp -74.18 -25.54 59.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 1.6000000000000001 110.33 172.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.37 -27.51 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.721 0.772 . . . . 0.88 110.311 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.456 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -79.54 -30.77 41.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.987 -1.006 . . . . 1.05 110.878 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.656 ' HB ' ' HE2' ' A' ' 82' ' ' MET . 2.3 p -68.33 -43.59 84.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.314 -0.403 . . . . 1.0700000000000001 111.459 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.812 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 30.7 mtt -56.85 -34.77 68.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.515 -0.311 . . . . 2.2400000000000002 111.132 -174.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.614 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 12.8 ptp180 -81.85 -27.08 33.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.475 -0.329 . . . . 3.6899999999999999 111.785 -176.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.9 t -71.35 -34.93 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 108.078 -1.082 . . . . 1.0800000000000001 108.078 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.1 t -66.88 -36.82 78.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 114.025 -1.443 . . . . 1.04 109.8 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' A' ' 18' ' ' ARG . 19.5 m -70.66 -26.12 63.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 116.231 -0.44 . . . . 1.8400000000000001 112.16 -177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.614 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 74.6 mt-10 -86.68 -37.73 17.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.865 0.364 . . . . 2.2599999999999998 111.177 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HG3' HG12 ' A' ' 50' ' ' ILE . 72.3 mm-40 -76.85 -37.91 54.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.968 -0.56 . . . . 0.77000000000000002 112.23 -176.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.463 ' CB ' HD13 ' A' ' 42' ' ' ILE . 66.4 p -80.3 -45.35 18.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.132 0.491 . . . . 1.23 110.816 -178.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.71 -4.38 26.07 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.688 -0.687 . . . . 0.54000000000000004 112.467 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.687 HD12 ' HG3' ' A' ' 40' ' ' MET . 8.6 mt -75.32 141.23 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.625 -0.43 . . . . 1.28 110.002 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.86 140.05 56.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.097 -0.501 . . . . 1.26 109.667 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.3 tp -55.09 -31.9 61.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 1.6000000000000001 111.763 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -77.95 -8.27 57.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.513 -0.312 . . . . 2.23 110.909 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -107.22 -5.44 17.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.934 0.397 . . . . 2.2400000000000002 110.132 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.438 HD22 ' HB3' ' A' ' 17' ' ' MET . 32.6 tp -75.89 97.51 3.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.429 0.633 . . . . 1.6799999999999999 109.921 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.0 p -116.82 165.56 13.17 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.76 -0.829 . . . . 1.21 108.76 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.9 p-10 -72.6 -3.7 26.33 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 111.49 0.181 . . . . 2.29 111.49 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -74.81 -22.69 58.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.992 0.425 . . . . 2.29 110.429 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.471 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 18.0 m -74.15 153.98 39.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.735 0.778 . . . . 1.3300000000000001 111.34 -174.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.905 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.5 t-20 -128.31 127.55 42.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.121 -0.945 . . . . 1.2 108.674 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.583 ' HD1' HG13 ' A' ' 42' ' ' ILE . 11.7 m-85 -56.48 -53.41 57.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.973 0.416 . . . . 0.63 111.649 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.49 -30.01 66.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.314 -0.403 . . . . 1.1499999999999999 111.189 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.905 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.5 t70 -69.66 -30.48 68.18 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.345 0.593 . . . . 0.82999999999999996 110.412 176.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.687 ' HG3' HD12 ' A' ' 26' ' ' ILE . 1.8 tmm? -74.18 -23.37 59.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.541 -0.754 . . . . 2.98 110.461 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.3 14.69 15.76 Favored Glycine 0 CA--C 1.511 -0.175 0 C-N-CA 120.354 -0.927 . . . . 0.54000000000000004 111.358 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.583 HG13 ' HD1' ' A' ' 37' ' ' PHE . 24.6 mm -76.24 113.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.584 -0.308 . . . . 1.2 110.337 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.53 -172.74 2.58 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.05 -0.722 . . . . 1.9399999999999999 109.05 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.8 t -68.24 -30.82 69.95 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 111.618 0.229 . . . . 1.1399999999999999 111.618 -174.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.69 -59.79 4.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.5 -0.318 . . . . 1.22 110.298 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.574 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.3 t -66.03 -40.95 91.48 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.029 -0.269 . . . . 1.46 110.496 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 49.0 m -56.78 -36.77 70.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.389 . . . . 1.1000000000000001 111.784 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -73.61 -43.77 58.77 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.655 -0.869 . . . . 2.8500000000000001 108.655 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.431 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 64.0 t -62.26 -43.17 97.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.837 -1.074 . . . . 1.1499999999999999 110.721 -176.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 46' ' ' SER . 72.3 mt -54.0 -52.86 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.871 0.367 . . . . 1.05 110.582 175.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -60.85 -31.87 77.46 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.076 -0.583 . . . . 0.35999999999999999 112.135 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.85 -46.39 82.06 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 122.441 0.296 . . . . 1.6599999999999999 110.802 176.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 12.4 mtp180 -65.28 -28.21 69.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.544 -0.298 . . . . 1.48 110.514 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.665 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.5 m-30 -57.66 -39.35 76.87 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.707 -0.479 . . . . 0.33000000000000002 109.707 173.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -80.17 -33.2 38.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.179 -0.464 . . . . 3.3300000000000001 110.437 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.21 -51.65 9.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.426 -0.352 . . . . 2.2599999999999998 111.024 -175.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.81 -48.74 7.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.959 -0.564 . . . . 2.6200000000000001 112.331 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -90.56 -13.29 34.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.54 -0.3 . . . . 1.1200000000000001 111.535 -173.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 33.14 68.7 Favored Glycine 0 C--O 1.229 -0.198 0 C-N-CA 121.008 -0.615 . . . . 0.45000000000000001 112.804 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.445 HD13 ' HB3' ' A' ' 54' ' ' PHE . 80.0 mt -90.64 116.65 28.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.505 0.153 . . . . 1.23 111.174 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.08 77.66 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.436 1.113 . . . . 2.27 109.706 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.665 HD11 ' HD2' ' A' ' 54' ' ' PHE . 25.2 mt -74.13 -27.01 60.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.652 -1.158 . . . . 2.1299999999999999 110.608 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.39 171.68 12.55 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 114.936 -1.029 . . . . 0.92000000000000004 110.799 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -87.04 -7.32 7.14 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.999 2.466 . . . . 1.2 112.388 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -134.49 45.44 2.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.63 0.729 . . . . 2.3599999999999999 110.291 -171.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -109.56 129.88 55.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.454 -0.794 . . . . 0.84999999999999998 110.8 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.2 t -140.69 131.09 25.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.329 -0.396 . . . . 1.71 110.013 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 50.6 mt -60.44 -37.84 82.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.917 0.389 . . . . 1.3700000000000001 110.458 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.44 ' H ' ' HB3' ' A' ' 47' ' ' SER . 40.5 t80 -60.05 -12.39 8.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.47 -0.786 . . . . 0.83999999999999997 111.641 -174.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.52 -38.94 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.565 -0.289 . . . . 1.51 111.417 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -114.72 10.97 16.72 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.395 0.517 . . . . 2.23 112.395 -171.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 82.9 m -150.22 100.13 2.87 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.181 0.515 . . . . 1.0 110.096 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.8 p -91.1 -54.13 4.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.26 -0.427 . . . . 1.29 111.638 -172.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.1 p -94.4 -177.28 4.2 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.084 -0.385 . . . . 1.1399999999999999 110.394 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.471 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -79.11 -43.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.457 0.646 . . . . 1.3700000000000001 109.845 -178.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.3 tpt180 -63.1 -25.65 68.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.246 -0.888 . . . . 3.71 110.637 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.43 -32.99 73.92 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 116.275 -0.421 . . . . 1.1100000000000001 110.559 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.638 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.8 OUTLIER -75.23 -50.42 16.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.87 -0.789 . . . . 1.3100000000000001 108.87 177.708 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.812 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.9 mmtp -50.32 -52.66 34.82 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.178 -0.919 . . . . 2.96 110.897 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -63.18 -39.65 95.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.482 -0.781 . . . . 1.6599999999999999 111.373 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.27 -35.12 79.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.792 -0.64 . . . . 1.2 111.667 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.656 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 28.7 mtp -62.25 -39.02 91.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.882 0.373 . . . . 1.1000000000000001 110.708 -177.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.428 HD11 ' N ' ' A' ' 83' ' ' LEU . 6.1 mp -80.89 -34.81 33.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.326 0.584 . . . . 1.8500000000000001 109.892 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.85 -77.83 0.9 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.699 -0.763 . . . . 2.4199999999999999 112.982 173.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.7 m -151.05 77.31 1.26 Allowed 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.743 -0.269 . . . . 4.4699999999999998 110.841 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.24 -152.25 7.02 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.987 -1.101 . . . . 4.5899999999999999 112.053 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.87 -34.56 75.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.852 0.358 . . . . 6.6100000000000003 110.099 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 72.78 3.66 4.75 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.01 -0.995 . . . . 8.4800000000000004 112.04 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.772 0 CA-C-O 118.738 -1.034 . . . . 9.7300000000000004 111.751 177.885 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.908 -0.404 . . . . 9.3499999999999996 109.908 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -142.48 150.79 40.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.627 0.251 . . . . 9.0299999999999994 110.869 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -135.52 132.47 37.32 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.327 0.584 . . . . 5.71 109.751 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -150.93 144.91 25.26 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.171 -0.922 . . . . 7.0 109.305 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.54 -96.39 0.59 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.844 -0.693 . . . . 2.2400000000000002 111.89 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -109.71 -125.82 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.57 -0.53 . . . . 1.6499999999999999 109.57 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 83' ' ' LEU . . . 124.96 106.48 1.63 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.843 -0.903 . . . . 0.55000000000000004 110.843 -174.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.3 159.24 14.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.895 0.379 . . . . 1.1399999999999999 111.153 -173.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.2 m -87.31 175.22 8.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.973 -0.558 . . . . 1.8899999999999999 110.051 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -65.76 -33.24 75.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.978 0.418 . . . . 2.3300000000000001 110.885 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 1.7 mp0 -65.01 -36.27 83.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.586 0.708 . . . . 1.9099999999999999 109.783 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.402 ' HD2' HD22 ' A' ' 60' ' ' LEU . 39.9 mmtm -66.39 -33.92 76.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.04 -0.982 . . . . 2.1099999999999999 110.242 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.7 tp -67.46 -25.79 66.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.781 -0.645 . . . . 1.6000000000000001 110.697 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.69 -28.82 28.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.248 0.547 . . . . 0.88 110.252 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -80.14 -27.2 39.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.893 -0.594 . . . . 1.05 111.024 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.71 ' HB ' ' HE3' ' A' ' 82' ' ' MET . 2.7 p -72.62 -44.23 60.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.355 -0.384 . . . . 1.0700000000000001 111.661 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.1 mtp -63.69 -24.96 67.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.505 -0.316 . . . . 2.2400000000000002 111.389 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.617 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 16.1 ptt180 -76.86 -27.44 55.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 3.6899999999999999 110.757 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.1 t -82.4 -37.75 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.578 0.704 . . . . 1.0800000000000001 109.123 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.407 ' CG1' HD11 ' A' ' 31' ' ' LEU . 21.1 t -64.21 -32.03 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.913 -1.04 . . . . 1.04 109.296 174.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -61.87 -26.63 68.26 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.842 -0.617 . . . . 1.8400000000000001 111.449 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -87.33 -53.14 4.99 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.31 0.576 . . . . 2.2599999999999998 111.308 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -73.22 -30.53 63.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.318 -0.856 . . . . 0.77000000000000002 111.898 -171.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.47 ' HA ' HD13 ' A' ' 42' ' ' ILE . 24.5 m -92.22 -25.22 18.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.592 -0.276 . . . . 1.23 111.424 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.03 7.42 65.89 Favored Glycine 0 N--CA 1.461 0.356 0 C-N-CA 120.33 -0.938 . . . . 0.54000000000000004 113.007 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.587 HD13 ' SD ' ' A' ' 40' ' ' MET . 4.3 mt -98.51 131.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.728 -0.471 . . . . 1.28 109.728 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.07 146.28 47.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.119 -0.326 . . . . 1.26 110.119 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.5 tp -53.24 -33.55 53.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.581 0.352 . . . . 1.6000000000000001 111.183 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -83.25 -8.97 59.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.093 -0.503 . . . . 2.23 111.342 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -114.81 -6.15 12.65 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.22 -0.659 . . . . 2.2400000000000002 109.22 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.407 HD11 ' CG1' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -72.57 98.38 2.31 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.923 -1.035 . . . . 1.6799999999999999 109.048 179.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.8 p -103.17 153.49 20.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.642 -0.708 . . . . 1.21 109.723 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.931 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 20.7 m-20 -75.0 -9.95 59.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.918 0.39 . . . . 2.29 111.858 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -95.37 -11.58 27.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.869 -0.605 . . . . 2.29 111.891 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 t -78.41 156.05 29.65 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.556 0.693 . . . . 1.3300000000000001 109.946 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.56 ' HB3' ' CB ' ' A' ' 39' ' ' ASP . 18.3 t-20 -115.51 127.03 55.0 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.15 -0.932 . . . . 1.2 110.231 -168.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.758 ' HD1' HG13 ' A' ' 42' ' ' ILE . 18.0 m-85 -56.56 -51.8 67.22 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.891 0.377 . . . . 0.63 111.193 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.43 -31.16 71.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.239 -0.437 . . . . 1.1499999999999999 111.128 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.56 ' CB ' ' HB3' ' A' ' 36' ' ' ASN . 25.1 t70 -67.23 -31.76 72.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.076 0.465 . . . . 0.82999999999999996 110.499 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.587 ' SD ' HD13 ' A' ' 26' ' ' ILE . 68.2 mtp -89.52 -9.35 50.29 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.198 -0.456 . . . . 2.98 111.153 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.22 26.8 9.83 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.195 -1.003 . . . . 0.54000000000000004 112.975 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.758 HG13 ' HD1' ' A' ' 37' ' ' PHE . 30.2 mm -71.87 107.27 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.249 -0.278 . . . . 1.2 110.249 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -78.52 176.71 9.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.42 0.629 . . . . 1.9399999999999999 110.572 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.7 p -59.83 -41.66 91.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.011 -0.995 . . . . 1.1399999999999999 111.097 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -58.98 -58.71 7.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.611 -0.722 . . . . 1.22 110.4 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.651 ' O ' HG13 ' A' ' 50' ' ' ILE . 5.0 m -60.53 -46.01 91.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.402 -0.363 . . . . 1.46 111.39 -177.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.879 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 41.3 p -65.54 -31.49 72.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.345 -0.389 . . . . 1.1000000000000001 111.393 -177.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -40.47 66.77 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.845 -0.798 . . . . 2.8500000000000001 108.845 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.544 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 24.1 t -59.5 -44.83 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 115.221 -0.899 . . . . 1.1499999999999999 110.053 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 46' ' ' SER . 39.4 mt -52.82 -56.93 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 1.05 111.043 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.72 -29.62 74.41 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.021 -0.609 . . . . 0.35999999999999999 112.55 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -44.19 77.57 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.155 -0.313 . . . . 1.6599999999999999 110.155 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 16.4 mtp180 -62.94 -26.34 68.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.567 -0.288 . . . . 1.48 110.611 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.682 ' HD2' HD11 ' A' ' 62' ' ' LEU . 14.5 m-30 -56.77 -41.4 77.55 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.167 0.508 . . . . 0.33000000000000002 109.925 173.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 23.3 mtm180 -79.43 -25.78 41.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.513 -0.767 . . . . 3.3300000000000001 110.299 -177.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -74.27 -62.91 1.35 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.611 -0.722 . . . . 2.2599999999999998 111.82 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.84 -41.71 11.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.966 0.413 . . . . 2.6200000000000001 111.733 -173.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.77 -23.63 21.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.301 -0.409 . . . . 1.1200000000000001 111.572 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.89 27.55 60.35 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.145 -0.55 . . . . 0.45000000000000001 112.732 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.676 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 58.1 mt -87.03 95.72 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.767 -0.255 . . . . 1.23 110.591 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -86.83 78.2 9.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.6 0.714 . . . . 2.27 109.215 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.682 HD11 ' HD2' ' A' ' 54' ' ' PHE . 14.6 mt -71.05 -57.01 4.95 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.371 -1.286 . . . . 2.1299999999999999 110.305 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.38 150.44 9.38 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.753 -1.112 . . . . 0.92000000000000004 110.807 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.49 -9.84 20.23 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.234 1.956 . . . . 1.2 112.902 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -120.15 22.84 11.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.995 -0.548 . . . . 2.3599999999999999 110.733 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -80.34 124.43 28.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.282 -0.417 . . . . 0.84999999999999998 111.148 -177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.4 t -139.47 125.19 19.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.641 -0.503 . . . . 1.71 109.641 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.879 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 88.5 mt -60.37 -23.7 64.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.541 0.21 . . . . 1.3700000000000001 111.382 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.495 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 17.5 t80 -71.88 -14.06 61.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.246 0.546 . . . . 0.83999999999999997 110.445 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.2 mt -122.89 -39.75 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 1.51 110.868 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -95.02 8.46 42.84 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.74 0.274 . . . . 2.23 111.74 -172.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.31 167.23 30.31 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.9 p -138.49 -68.07 0.46 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 1.29 110.568 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 81.4 p -84.55 -175.43 5.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.747 -0.464 . . . . 1.1399999999999999 109.747 174.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.0 t -83.77 -38.75 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.879 0.847 . . . . 1.3700000000000001 109.929 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.931 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 35.6 ttm180 -61.88 -30.01 70.58 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.713 -1.131 . . . . 3.71 111.252 175.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.46 -31.44 65.95 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.988 0.423 . . . . 1.1100000000000001 110.513 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.761 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.1 tt -70.5 -48.32 56.26 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.574 -0.899 . . . . 1.3100000000000001 108.574 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.534 ' CG ' ' HA ' ' A' ' 76' ' ' ARG . 20.8 mmtm -50.76 -55.06 18.48 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.984 -1.007 . . . . 2.96 110.572 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -51.44 -49.43 61.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.276 -0.875 . . . . 1.6599999999999999 111.69 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -61.7 -36.49 81.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.743 -0.662 . . . . 1.2 111.8 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.761 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 44.1 mtp -64.16 -45.82 86.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.367 -0.379 . . . . 1.1000000000000001 111.765 -173.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.63 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 5.3 mp -87.9 -38.78 15.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.764 0.316 . . . . 1.8500000000000001 110.806 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.68 128.67 2.53 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.769 -0.729 . . . . 2.4199999999999999 112.032 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.7 m -75.74 44.9 0.31 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.049 0.539 . . . . 4.4699999999999998 111.595 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.85 32.43 4.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.145 -0.55 . . . . 4.5899999999999999 112.489 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -109.11 106.24 16.07 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.592 -0.522 . . . . 6.6100000000000003 109.592 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 73.32 148.47 0.09 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.731 0.777 . . . . 8.4800000000000004 111.396 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.928 0 CA-C-O 118.401 -1.222 . . . . 9.7300000000000004 111.313 176.793 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . 0.44 H313 ' O35' ' A' ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.143 -0.317 . . . . 9.3499999999999996 110.143 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.2 ptm -106.0 150.31 25.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.758 -0.46 . . . . 9.0299999999999994 109.758 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.18 134.42 16.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.635 0.255 . . . . 5.71 110.702 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt 68.85 160.65 0.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 O-C-N 124.19 0.932 . . . . 7.0 110.88 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.97 -146.44 4.33 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.187 -0.765 . . . . 2.2400000000000002 111.187 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.0 t -86.11 -66.61 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.897 0.38 . . . . 1.6499999999999999 110.208 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.0 103.91 1.45 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.956 -0.857 . . . . 0.55000000000000004 110.956 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.655 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 4.1 m -103.98 156.74 5.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.707 0.289 . . . . 1.1399999999999999 110.628 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.3 m -85.39 173.93 9.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.639 -0.504 . . . . 1.8899999999999999 109.639 175.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -61.75 -36.08 79.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.774 0.797 . . . . 2.3300000000000001 109.013 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -59.17 -42.1 89.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.716 -1.129 . . . . 1.9099999999999999 111.211 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.655 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 41.4 mmtm -67.73 -31.65 71.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 2.1099999999999999 110.052 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.421 ' O ' ' HG3' ' A' ' 17' ' ' MET . 34.7 tp -68.11 -26.22 65.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.645 . . . . 1.6000000000000001 110.324 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.69 -29.96 36.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.103 0.478 . . . . 0.88 110.288 178.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.17 -27.22 39.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.619 . . . . 1.05 111.051 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.691 ' HB ' ' HE3' ' A' ' 82' ' ' MET . 4.0 p -75.71 -48.76 28.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.805 0.336 . . . . 1.0700000000000001 111.721 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 73.3 mtm -59.57 -30.32 68.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.176 -0.465 . . . . 2.2400000000000002 111.514 -174.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 6.5 ptm180 -70.38 -37.88 74.63 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.106 -0.638 . . . . 3.6899999999999999 110.635 176.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.475 HG12 HG22 ' A' ' 50' ' ' ILE . 29.2 t -64.5 -42.77 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.554 0.693 . . . . 1.0800000000000001 109.3 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.09 -42.03 93.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.983 -1.008 . . . . 1.04 110.807 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -23.48 61.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.828 0.347 . . . . 1.8400000000000001 110.174 -174.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 43.9 mt-10 -79.01 -43.27 24.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.158 -0.474 . . . . 2.2599999999999998 111.6 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -86.27 -8.31 57.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.329 -0.396 . . . . 0.77000000000000002 111.273 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.4 p -97.57 -41.25 8.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.052 0.453 . . . . 1.23 110.407 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.76 41.85 3.25 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.863 -0.684 . . . . 0.54000000000000004 111.603 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 27' ' ' ALA . 5.2 mt -127.16 165.87 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.808 -0.442 . . . . 1.28 109.808 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.467 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -83.96 142.02 30.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.643 -0.708 . . . . 1.26 110.257 172.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.0 tp -61.14 -33.26 73.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.043 -0.526 . . . . 1.6000000000000001 111.092 -177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.63 -11.98 60.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.179 0.514 . . . . 2.23 111.067 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 17.8 mm-40 -105.79 -5.04 20.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.796 -0.638 . . . . 2.2400000000000002 110.107 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.6 tp -84.85 96.55 9.35 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.107 -0.497 . . . . 1.6799999999999999 110.352 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 p -115.0 169.63 8.94 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.833 -0.803 . . . . 1.21 108.833 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.645 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 4.8 p-10 -75.66 -3.29 33.71 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.931 -0.308 . . . . 2.29 111.548 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.12 -20.22 60.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.14 -0.482 . . . . 2.29 110.406 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.493 ' HB2' HG21 ' A' ' 75' ' ' VAL . 16.3 m -79.74 157.69 27.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.606 0.717 . . . . 1.3300000000000001 111.541 -175.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.75 119.42 25.73 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.229 -1.026 . . . . 1.2 108.229 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.402 ' CZ ' HG13 ' A' ' 75' ' ' VAL . 16.8 m-85 -57.72 -39.26 76.86 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.45 -0.5 . . . . 0.63 111.642 -173.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.76 -26.91 67.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.984 0.421 . . . . 1.1499999999999999 110.472 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -68.89 -29.73 68.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.82999999999999996 110.296 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -83.59 -8.4 59.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.754 -0.657 . . . . 2.98 110.283 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.77 32.5 36.75 Favored Glycine 0 C--N 1.322 -0.225 0 C-N-CA 120.443 -0.884 . . . . 0.54000000000000004 112.002 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.497 ' CG2' ' HB3' ' A' ' 47' ' ' SER . 2.7 mt -67.76 108.46 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.018 0.437 . . . . 1.2 110.225 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -78.45 165.96 23.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.816 -0.629 . . . . 1.9399999999999999 110.48 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.0 t -51.54 -43.33 62.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 1.1399999999999999 110.861 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.14 -55.91 28.8 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.142 -0.481 . . . . 1.22 110.376 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.3 m -61.41 -44.14 97.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 1.46 111.525 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.845 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 63.7 p -68.09 -31.61 71.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.735 0.302 . . . . 1.1000000000000001 111.222 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.592 ' HG2' H311 ' A' ' 90' ' ' PNS . 13.2 tpt -70.76 -36.45 73.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.449 0.642 . . . . 2.8500000000000001 109.805 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.31 -36.39 76.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.064 -0.971 . . . . 1.1499999999999999 110.22 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' A' ' 47' ' ' SER . 67.5 mt -59.83 -52.01 66.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.762 -0.653 . . . . 1.05 110.753 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -64.04 -28.69 73.19 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.144 -0.551 . . . . 0.35999999999999999 112.197 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -49.63 76.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.767 0.318 . . . . 1.6599999999999999 110.512 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -64.6 -28.43 69.62 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.417 -0.356 . . . . 1.48 111.07 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.591 ' CE1' HG22 ' A' ' 16' ' ' VAL . 14.6 m-30 -53.9 -44.22 70.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.613 -0.514 . . . . 0.33000000000000002 109.613 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -84.86 -35.36 22.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 3.3300000000000001 111.451 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -85.79 -56.16 3.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.036 0.446 . . . . 2.2599999999999998 111.299 -174.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.28 -52.71 11.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.971 -0.559 . . . . 2.6200000000000001 111.387 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 mp -88.25 -32.13 18.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.516 . . . . 1.1200000000000001 111.849 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.9 33.91 16.91 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.524 -0.846 . . . . 0.45000000000000001 112.115 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.15 152.0 21.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.789 -0.448 . . . . 1.23 109.789 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.72 110.97 21.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.942 0.401 . . . . 2.27 110.325 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -123.8 5.56 8.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 2.1299999999999999 109.501 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.56 164.22 39.47 Favored Glycine 0 CA--C 1.509 -0.323 0 CA-C-N 115.474 -0.785 . . . . 0.92000000000000004 111.456 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -87.74 -2.07 7.39 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.23 2.62 . . . . 1.2 112.078 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -106.48 12.92 29.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.387 -0.824 . . . . 2.3599999999999999 111.036 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -93.63 111.82 23.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.055 0.455 . . . . 0.84999999999999998 110.462 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.3 m -134.5 128.18 32.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.72 -0.673 . . . . 1.71 109.5 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.845 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 42.3 mt -66.58 -45.02 80.65 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.799 0.296 . . . . 1.3700000000000001 111.799 -173.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.96 -4.67 4.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.432 . . . . 0.83999999999999997 110.772 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -116.08 -40.35 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 O-C-N 122.223 -0.298 . . . . 1.51 111.555 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -126.07 8.41 7.34 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.122 0.416 . . . . 2.23 112.122 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 75.9 m -147.52 88.76 1.72 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.623 -0.673 . . . . 1.0 110.412 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 p -81.73 -31.76 31.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.904 -0.589 . . . . 1.29 111.812 -173.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.9 p -110.95 176.73 4.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.668 0.27 . . . . 1.1399999999999999 110.501 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' A' ' 35' ' ' SER . 0.2 OUTLIER -80.77 -44.72 21.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.965 -0.383 . . . . 1.3700000000000001 109.965 -177.651 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.645 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.2 tpt180 -57.94 -32.51 67.87 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.132 -0.486 . . . . 3.71 110.551 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.59 -29.54 62.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.116 -0.493 . . . . 1.1100000000000001 111.062 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.662 ' O ' ' HG3' ' A' ' 82' ' ' MET . 3.7 tp -86.39 -55.1 4.05 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.16 -0.682 . . . . 1.3100000000000001 109.16 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -56.01 -60.35 3.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.287 -1.324 . . . . 2.96 111.656 -174.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.47 ' HB2' ' HE ' ' A' ' 76' ' ' ARG . 9.7 t70 -66.93 -26.28 66.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.465 -0.789 . . . . 1.6599999999999999 110.681 -171.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.73 -26.58 66.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.22 -0.9 . . . . 1.2 110.731 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.691 ' HE3' ' HB ' ' A' ' 16' ' ' VAL . 28.6 mtp -78.3 -36.72 46.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.905 -0.589 . . . . 1.1000000000000001 110.532 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.439 HD11 ' N ' ' A' ' 83' ' ' LEU . 6.2 mp -79.28 -44.77 21.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.024 -0.535 . . . . 1.8500000000000001 110.155 177.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.42 91.68 0.18 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.393 -0.908 . . . . 2.4199999999999999 113.201 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.9 m -79.62 45.59 0.7 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.244 0.545 . . . . 4.4699999999999998 111.068 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.83 51.55 0.22 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.072 -0.811 . . . . 4.5899999999999999 111.072 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -76.92 -42.16 40.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.735 0.302 . . . . 6.6100000000000003 111.068 -176.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.66 -39.95 15.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.268 0.556 . . . . 8.4800000000000004 110.081 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.283 -1.287 . . . . 9.7300000000000004 111.14 177.339 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . 0.592 H311 ' HG2' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.715 0.293 . . . . 9.3499999999999996 110.303 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -80.18 107.2 12.79 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.88 -0.415 . . . . 9.0299999999999994 109.88 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -121.54 122.24 39.26 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.347 -0.612 . . . . 5.71 109.347 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -143.29 118.38 10.09 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.363 -0.835 . . . . 7.0 110.697 -171.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.73 161.2 26.89 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.398 -0.819 . . . . 2.2400000000000002 111.55 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 82' ' ' MET . 59.1 t -73.83 -64.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.916 0.358 . . . . 1.6499999999999999 110.275 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.65 91.64 2.1 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.665 -0.779 . . . . 0.55000000000000004 111.908 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.42 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 3.2 m -118.71 157.84 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.917 0.389 . . . . 1.1399999999999999 110.172 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.4 p -83.4 172.89 12.02 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.042 -0.526 . . . . 1.8899999999999999 110.114 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -67.68 -16.79 64.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.079 0.466 . . . . 2.3300000000000001 110.349 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -67.18 -46.95 72.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.491 -0.777 . . . . 1.9099999999999999 109.615 173.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.492 ' HG2' HD22 ' A' ' 60' ' ' LEU . 2.4 mptp? -66.25 -34.4 77.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.774 -0.648 . . . . 2.1099999999999999 109.931 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.7 tp -67.79 -26.88 66.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 1.6000000000000001 111.192 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.1 -28.83 27.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.176 0.513 . . . . 0.88 109.948 177.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -81.67 -30.58 32.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 1.05 111.297 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.824 ' HB ' ' HE3' ' A' ' 82' ' ' MET . 4.2 p -65.04 -43.07 96.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.828 -0.349 . . . . 1.0700000000000001 111.177 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.521 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 45.1 mtt -63.61 -28.6 70.03 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.174 -0.466 . . . . 2.2400000000000002 110.768 -174.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.655 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 15.3 ptm180 -84.1 -19.48 34.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.896 -0.322 . . . . 3.6899999999999999 111.725 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.9 t -81.37 -27.97 10.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 122.017 0.913 . . . . 1.0800000000000001 108.629 172.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.1 t -76.1 -36.11 30.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.458 -1.247 . . . . 1.04 110.294 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.5 p -62.75 -51.48 66.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.039 0.447 . . . . 1.8400000000000001 110.496 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 9.0 mm-40 -57.35 -52.0 67.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.354 -0.839 . . . . 2.2599999999999998 111.484 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HG3' HG12 ' A' ' 50' ' ' ILE . 76.9 mm-40 -72.41 -46.37 55.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.962 -0.563 . . . . 0.77000000000000002 112.323 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.444 ' HA ' HD13 ' A' ' 42' ' ' ILE . 17.8 m -73.67 -38.38 64.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.827 0.346 . . . . 1.23 111.587 -176.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.15 -2.19 40.64 Favored Glycine 0 N--CA 1.454 -0.124 0 C-N-CA 120.191 -1.004 . . . . 0.54000000000000004 112.07 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.45 HD11 ' HG3' ' A' ' 40' ' ' MET . 8.0 mt -94.0 123.14 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.639 -0.504 . . . . 1.28 109.639 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.582 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -54.14 145.58 16.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.381 -0.372 . . . . 1.26 111.552 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 tp -55.02 -36.92 65.98 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.937 -0.574 . . . . 1.6000000000000001 110.646 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.31 -10.7 59.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.983 -0.553 . . . . 2.23 111.293 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.582 ' HG3' ' HB1' ' A' ' 27' ' ' ALA . 41.4 mt-10 -116.2 2.06 13.25 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.138 -0.483 . . . . 2.2400000000000002 110.043 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.479 HD21 ' HA ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -75.26 97.34 3.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.164 -0.68 . . . . 1.6799999999999999 109.164 -178.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.9 p -106.55 154.91 20.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.695 -0.684 . . . . 1.21 109.273 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 57.7 m-20 -76.75 -3.67 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.055 0.455 . . . . 2.29 110.951 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.53 -6.25 59.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.498 -0.774 . . . . 2.29 110.413 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.459 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 46.9 m -79.6 150.63 30.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.594 . . . . 1.3300000000000001 110.006 177.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.744 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.1 t-20 -125.88 123.25 38.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.253 -0.647 . . . . 1.2 109.253 -175.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.701 ' HD1' HG13 ' A' ' 42' ' ' ILE . 34.1 m-85 -56.37 -48.61 76.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.943 0.401 . . . . 0.63 111.194 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.2 -31.0 68.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.268 -0.424 . . . . 1.1499999999999999 111.181 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.744 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 32.9 t70 -70.99 -33.24 70.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.331 0.586 . . . . 0.82999999999999996 110.589 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.45 ' HG3' HD11 ' A' ' 26' ' ' ILE . 15.1 mmt -79.8 -20.27 46.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.407 -0.815 . . . . 2.98 111.37 -176.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.03 32.81 4.23 Favored Glycine 0 C--O 1.229 -0.17 0 C-N-CA 120.271 -0.966 . . . . 0.54000000000000004 112.5 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.701 HG13 ' HD1' ' A' ' 37' ' ' PHE . 28.5 mm -79.83 107.74 12.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.854 0.359 . . . . 1.2 110.608 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -77.4 174.24 11.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.636 -0.505 . . . . 1.9399999999999999 109.636 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.674 ' HB3' ' HD2' ' A' ' 69' ' ' PHE . 90.0 p -69.9 -20.77 63.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.443 -0.577 . . . . 1.1399999999999999 109.443 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.441 ' HA ' H303 ' A' ' 90' ' ' PNS . 3.4 tm? -54.55 -61.99 1.95 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.195 -0.668 . . . . 1.22 109.195 171.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.451 ' O ' HG13 ' A' ' 50' ' ' ILE . 6.3 m -64.7 -39.69 94.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.116 -0.493 . . . . 1.46 110.81 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.46 ' HB2' ' HA ' ' A' ' 44' ' ' SER . 48.8 m -58.93 -40.57 84.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.069 -0.514 . . . . 1.1000000000000001 111.672 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 45.1 tpp -72.35 -40.33 67.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.265 0.555 . . . . 2.8500000000000001 109.674 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.501 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 54.6 t -63.51 -50.33 78.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.214 -0.903 . . . . 1.1499999999999999 110.453 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 46' ' ' SER . 77.7 mt -54.05 -54.58 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.684 0.278 . . . . 1.05 110.92 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -58.25 -35.82 79.99 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.973 -0.632 . . . . 0.35999999999999999 112.018 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.459 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -63.47 -46.16 87.47 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.849 -0.206 . . . . 1.6599999999999999 110.527 174.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 7.1 mtp180 -64.11 -28.0 69.48 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.576 -0.284 . . . . 1.48 111.057 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.556 ' CE2' HD22 ' A' ' 78' ' ' LEU . 12.5 m-30 -56.63 -42.39 78.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.477 -0.564 . . . . 0.33000000000000002 109.477 173.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.459 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 65.1 mtm180 -80.16 -39.21 29.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 3.3300000000000001 110.635 -176.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.82 -48.61 7.7 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.057 0.392 . . . . 2.2599999999999998 112.057 -172.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.28 -46.91 14.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.261 -0.427 . . . . 2.6200000000000001 111.649 -177.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.1 mp -95.7 -23.25 17.08 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.84 0.681 . . . . 1.1200000000000001 112.84 -173.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.34 32.3 23.0 Favored Glycine 0 CA--C 1.517 0.174 0 C-N-CA 120.793 -0.718 . . . . 0.45000000000000001 112.664 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.492 HD22 ' HG2' ' A' ' 12' ' ' LYS . 85.4 mt -88.22 120.3 29.45 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.733 -0.275 . . . . 1.23 110.524 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -82.78 82.07 8.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.228 0.537 . . . . 2.27 109.749 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.555 HD12 ' HD2' ' A' ' 54' ' ' PHE . 97.7 mt -89.8 -94.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.692 -0.685 . . . . 2.1299999999999999 111.356 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 162.55 168.86 25.1 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.892 -0.883 . . . . 0.92000000000000004 110.892 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.538 ' HG2' ' OE2' ' A' ' 65' ' ' GLU . 73.6 Cg_endo -81.85 -10.24 11.75 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.683 2.255 . . . . 1.2 113.65 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.538 ' OE2' ' HG2' ' A' ' 64' ' ' PRO . 5.3 mp0 -88.77 -0.07 56.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.625 -0.262 . . . . 2.3599999999999999 111.47 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.75 122.05 40.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.836 0.35 . . . . 0.84999999999999998 111.441 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.3 t -141.26 124.44 16.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 1.71 110.008 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 mt -56.13 -28.97 59.99 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.977 0.362 . . . . 1.3700000000000001 111.977 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.674 ' HD2' ' HB3' ' A' ' 44' ' ' SER . 3.2 t80 -67.91 -16.7 64.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.588 . . . . 0.83999999999999997 110.939 -173.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.1 mt -126.32 -35.93 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.803 0.335 . . . . 1.51 110.997 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -90.48 6.28 44.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.43 -0.35 . . . . 2.23 111.689 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.4 m -154.89 155.91 35.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.1 p -131.06 -73.73 0.54 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.31 -0.405 . . . . 1.29 110.464 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 76.8 p -83.16 -170.87 3.25 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.965 -0.384 . . . . 1.1399999999999999 109.965 174.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.459 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.9 OUTLIER -83.08 -40.67 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.555 -0.906 . . . . 1.3700000000000001 108.555 -177.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.488 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 34.0 ttm180 -60.89 -31.5 70.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.402 -1.272 . . . . 3.71 111.238 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.18 -34.88 64.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.819 0.342 . . . . 1.1100000000000001 110.952 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.556 HD22 ' CE2' ' A' ' 54' ' ' PHE . 0.9 OUTLIER -74.8 -50.7 16.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.485 -0.561 . . . . 1.3100000000000001 109.485 177.315 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.521 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 26.1 mmtp -49.21 -53.81 19.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.236 -0.893 . . . . 2.96 110.438 176.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.51 -45.02 62.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.877 -1.056 . . . . 1.6599999999999999 111.867 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -64.12 -37.86 88.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.014 -0.539 . . . . 1.2 111.838 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.824 ' HE3' ' HB ' ' A' ' 16' ' ' VAL . 21.3 mtp -57.21 -49.72 75.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.058 0.456 . . . . 1.1000000000000001 111.285 -174.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.453 HD11 ' HB2' ' A' ' 82' ' ' MET . 5.2 mp -85.01 -31.37 23.51 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.493 -0.558 . . . . 1.8500000000000001 109.493 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.4 -143.62 39.33 Favored Glycine 0 CA--C 1.511 -0.207 0 C-N-CA 120.98 -0.629 . . . . 2.4199999999999999 112.124 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.0 m -105.4 36.5 2.48 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.336 0.589 . . . . 4.4699999999999998 109.987 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.77 31.13 7.53 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.759 -0.655 . . . . 4.5899999999999999 113.113 -175.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.71 -63.49 1.22 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.325 0.583 . . . . 6.6100000000000003 110.553 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.82 80.93 1.67 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.391 -0.822 . . . . 8.4800000000000004 109.643 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.651 -1.083 . . . . 9.7300000000000004 111.499 -177.364 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . 0.441 H303 ' HA ' ' A' ' 45' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 121.039 0.447 . . . . 9.3499999999999996 110.11 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -98.84 138.4 36.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.064 -0.717 . . . . 9.0299999999999994 109.064 173.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.38 131.57 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.578 0.704 . . . . 5.71 111.679 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -148.21 78.36 1.43 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.517 -0.765 . . . . 7.0 108.978 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.72 129.65 3.05 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.973 -0.851 . . . . 2.2400000000000002 110.973 -170.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.9 t -73.74 -61.59 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.928 0.394 . . . . 1.6499999999999999 110.896 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.41 76.58 0.95 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.497 -0.641 . . . . 0.55000000000000004 111.497 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.575 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 2.8 m -123.59 160.88 26.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.701 0.286 . . . . 1.1399999999999999 110.789 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.7 p -92.66 -176.89 4.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.123 -0.695 . . . . 1.8899999999999999 109.123 171.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -68.34 -23.35 64.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.312 0.577 . . . . 2.3300000000000001 109.646 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -58.51 -44.07 89.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.333 -0.849 . . . . 1.9099999999999999 110.602 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.575 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 17.5 mttp -74.29 -24.91 59.32 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.724 -0.671 . . . . 2.1099999999999999 111.032 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.826 HD12 HD13 ' A' ' 83' ' ' LEU . 19.8 tp -73.45 -30.0 62.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.131 -0.486 . . . . 1.6000000000000001 110.753 175.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.67 -29.23 45.52 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.238 0.542 . . . . 0.88 109.843 176.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.647 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -81.61 -30.36 32.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.919 -0.582 . . . . 1.05 111.375 -176.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.407 ' HB ' ' CE ' ' A' ' 82' ' ' MET . 5.5 p -68.47 -45.7 81.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.396 -0.522 . . . . 1.0700000000000001 111.285 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 73.6 mtp -61.05 -35.24 76.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.997 -0.547 . . . . 2.2400000000000002 111.285 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.647 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 2.7 ptm180 -64.37 -35.8 82.06 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.127 -0.323 . . . . 3.6899999999999999 110.127 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.3 t -76.5 -38.09 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.544 0.688 . . . . 1.0800000000000001 109.278 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.41 -45.3 93.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.882 -1.054 . . . . 1.04 110.473 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.8 m -60.9 -40.95 95.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.884 0.373 . . . . 1.8400000000000001 111.614 -176.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 53.1 mt-10 -58.02 -56.76 17.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.816 -0.629 . . . . 2.2599999999999998 111.976 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -76.08 -25.69 55.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.247 -0.433 . . . . 0.77000000000000002 111.946 -172.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.7 p -81.27 -44.09 18.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.003 0.43 . . . . 1.23 110.3 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.02 16.83 26.96 Favored Glycine 0 C--O 1.229 -0.183 0 C-N-CA 120.924 -0.655 . . . . 0.54000000000000004 111.619 -176.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.28 123.0 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.796 -0.446 . . . . 1.28 109.796 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.45 143.95 6.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.299 0.481 . . . . 1.26 112.299 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.5 tp -54.5 -37.04 64.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.444 -0.798 . . . . 1.6000000000000001 111.159 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.75 -9.86 58.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.85 -0.614 . . . . 2.23 111.256 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -110.8 -6.33 14.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.072 -0.513 . . . . 2.2400000000000002 110.927 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.3 tp -71.96 98.25 2.01 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.396 0.617 . . . . 1.6799999999999999 109.973 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.0 p -107.57 162.42 13.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.32 -0.854 . . . . 1.21 109.079 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 80.8 m-20 -76.33 -5.54 47.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.027 0.442 . . . . 2.29 110.782 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -81.51 -22.57 37.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.352 -0.84 . . . . 2.29 111.135 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -81.03 149.9 29.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.667 0.746 . . . . 1.3300000000000001 111.132 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.554 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 20.8 t-20 -113.7 131.15 56.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.133 -0.939 . . . . 1.2 109.638 -171.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.738 ' HD1' HG13 ' A' ' 42' ' ' ILE . 28.4 m-85 -57.95 -47.31 83.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 0.63 111.569 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.26 -31.26 67.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.507 -0.315 . . . . 1.1499999999999999 111.318 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.0 t70 -68.76 -31.81 71.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.09 0.472 . . . . 0.82999999999999996 110.268 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.0 mmt -82.12 -18.97 41.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.548 -0.751 . . . . 2.98 111.882 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.18 28.5 6.1 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 120.275 -0.964 . . . . 0.54000000000000004 112.441 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.738 HG13 ' HD1' ' A' ' 37' ' ' PHE . 32.9 mm -75.3 108.48 7.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.028 0.442 . . . . 1.2 110.188 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -83.73 178.76 7.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.846 -0.616 . . . . 1.9399999999999999 110.691 -177.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 t -64.51 -28.04 69.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.437 -0.801 . . . . 1.1399999999999999 110.006 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.69 -62.45 1.45 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.708 -0.678 . . . . 1.22 110.27 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.1 p -64.12 -40.57 96.49 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.448 0.536 . . . . 1.46 112.448 -175.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.1 p -64.0 -29.86 70.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.962 0.41 . . . . 1.1000000000000001 111.071 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.708 ' HG2' ' H32' ' A' ' 90' ' ' PNS . 48.2 tpp -75.86 -36.43 59.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.669 0.747 . . . . 2.8500000000000001 109.831 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 56.9 t -71.7 -36.56 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 114.92 -1.036 . . . . 1.1499999999999999 109.466 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 46' ' ' SER . 88.0 mt -58.4 -50.11 79.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.223 -0.444 . . . . 1.05 110.431 174.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.97 -37.48 85.34 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.099 -0.572 . . . . 0.35999999999999999 112.352 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.584 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 1.5 t -63.29 -48.32 78.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.843 -0.343 . . . . 1.6599999999999999 110.343 176.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 43.5 mtp180 -60.69 -32.74 71.96 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.659 -0.246 . . . . 1.48 111.053 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.449 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 10.7 m-30 -53.67 -40.47 65.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.056 0.455 . . . . 0.33000000000000002 110.124 174.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.584 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 67.4 mtm180 -81.89 -35.89 28.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.883 -0.598 . . . . 3.3300000000000001 110.957 -175.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.31 -51.08 6.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.983 -0.553 . . . . 2.2599999999999998 111.593 -170.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -81.74 -49.88 9.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.013 -0.539 . . . . 2.6200000000000001 110.839 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 mp -85.93 -55.12 4.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.87 -0.605 . . . . 1.1200000000000001 111.177 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.06 30.18 2.37 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.918 -0.658 . . . . 0.45000000000000001 112.057 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 59.5 mt -92.0 132.66 36.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.109 -0.33 . . . . 1.23 110.109 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -101.25 92.25 4.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.843 0.83 . . . . 2.27 110.681 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -88.07 -73.04 0.5 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.427 -0.806 . . . . 2.1299999999999999 109.95 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.69 170.14 16.81 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.469 -0.652 . . . . 0.92000000000000004 111.469 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.6 8.41 4.64 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.017 2.478 . . . . 1.2 111.979 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.9 1.03 12.62 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.092 -0.958 . . . . 2.3599999999999999 110.122 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -89.37 118.91 29.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.947 -0.57 . . . . 0.84999999999999998 110.951 -175.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.9 t -137.83 123.17 19.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.126 -0.488 . . . . 1.71 110.211 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.01 -37.78 83.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.169 0.509 . . . . 1.3700000000000001 110.566 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -65.46 -7.06 12.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.542 -0.754 . . . . 0.83999999999999997 111.05 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.65 -39.08 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 120.827 -0.349 . . . . 1.51 111.618 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -121.35 7.39 10.16 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 120.33 -0.548 . . . . 2.23 112.447 -172.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 66.6 m -147.68 87.7 1.65 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.805 -0.559 . . . . 1.0 110.523 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.5 p -85.47 -33.26 21.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.057 -0.52 . . . . 1.29 112.242 -173.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p -107.19 172.2 6.96 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.189 -0.319 . . . . 1.1399999999999999 110.61 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.434 ' HA ' ' HE2' ' A' ' 37' ' ' PHE . 5.7 t -80.72 -40.05 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 120.678 0.275 . . . . 1.3700000000000001 111.108 -175.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 30.8 ttm180 -61.45 -30.43 70.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 3.71 110.875 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.94 -32.23 65.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.954 -0.566 . . . . 1.1100000000000001 111.14 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.65 -44.48 18.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 1.3100000000000001 109.213 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 25.2 mmtp -56.17 -62.11 1.94 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.599 -1.182 . . . . 2.96 111.368 -178.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.93 -23.35 66.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 1.6599999999999999 110.833 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -67.68 -41.57 83.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.56 0.695 . . . . 1.2 109.822 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.407 ' CE ' ' HB ' ' A' ' 16' ' ' VAL . 1.3 mtm -78.46 -43.11 27.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.158 -0.928 . . . . 1.1000000000000001 112.292 -176.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.826 HD13 HD12 ' A' ' 13' ' ' LEU . 7.8 mp -74.94 -45.26 43.6 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.838 -0.345 . . . . 1.8500000000000001 111.546 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.32 133.32 7.4 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.226 -0.988 . . . . 2.4199999999999999 112.429 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.95 46.18 0.56 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.497 0.319 . . . . 4.4699999999999998 111.519 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.09 -29.78 44.83 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.966 -0.635 . . . . 4.5899999999999999 113.224 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 67.24 -74.47 0.07 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.983 0.513 . . . . 6.6100000000000003 111.221 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 61.84 92.19 0.06 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.358 0.663 . . . . 8.4800000000000004 111.657 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.908 -0.94 . . . . 9.7300000000000004 111.64 178.365 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . 0.708 ' H32' ' HG2' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.801 0.334 . . . . 9.3499999999999996 110.513 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.545 ' C ' ' H ' ' A' ' 4' ' ' LYS . 25.3 ptp -95.46 145.26 25.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.053 -0.721 . . . . 9.0299999999999994 109.053 175.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 72.44 -18.4 0.34 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.271 0.629 . . . . 5.71 111.748 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.545 ' H ' ' C ' ' A' ' 2' ' ' MET . 58.3 tptt -120.81 89.93 3.22 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.245 -1.02 . . . . 7.0 108.245 176.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.78 -169.05 20.84 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.769 -0.932 . . . . 2.2400000000000002 110.769 -171.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.5 t -80.9 -83.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.955 0.378 . . . . 1.6499999999999999 110.938 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.8 95.85 1.43 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.469 -0.872 . . . . 0.55000000000000004 111.346 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -108.88 157.12 9.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.752 -0.379 . . . . 1.1399999999999999 110.807 -174.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -78.65 171.8 14.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.678 -0.49 . . . . 1.8899999999999999 109.678 173.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.428 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.9 OUTLIER -72.49 -17.29 61.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.333 0.587 . . . . 2.3300000000000001 110.258 -175.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -68.78 -44.76 72.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.404 -0.816 . . . . 1.9099999999999999 109.888 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -70.72 -22.87 62.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.783 -0.644 . . . . 2.1099999999999999 110.542 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' A' ' 17' ' ' MET . 2.7 tp -72.26 -27.51 62.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.759 -0.655 . . . . 1.6000000000000001 110.54 173.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.22 -30.98 34.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.423 0.63 . . . . 0.88 109.383 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.61 -34.25 53.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.074 -0.967 . . . . 1.05 110.861 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.74 ' HB ' ' HE2' ' A' ' 82' ' ' MET . 2.8 p -66.09 -43.19 92.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.159 -0.473 . . . . 1.0700000000000001 111.446 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.458 ' HB3' HD22 ' A' ' 31' ' ' LEU . 66.7 mtm -64.23 -30.71 71.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.394 -0.366 . . . . 2.2400000000000002 111.395 -175.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.671 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 9.1 ptm180 -83.6 -19.28 35.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.949 0.351 . . . . 3.6899999999999999 111.949 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.1 t -78.43 -32.86 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.827 0.823 . . . . 1.0800000000000001 108.892 171.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.25 -37.77 72.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.512 -1.222 . . . . 1.04 110.333 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.6 p -61.18 -49.79 75.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.523 0.678 . . . . 1.8400000000000001 109.779 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 3.9 mm-40 -59.73 -50.17 74.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.441 -1.254 . . . . 2.2599999999999998 112.316 -176.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -86.96 -9.05 56.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.208 0.447 . . . . 0.77000000000000002 112.208 -171.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.1 m -95.4 -26.03 16.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.034 0.445 . . . . 1.23 110.279 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.51 -7.23 65.85 Favored Glycine 0 C--N 1.329 0.14 0 C-N-CA 120.488 -0.863 . . . . 0.54000000000000004 112.652 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mt -91.33 154.43 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 122.568 -0.372 . . . . 1.28 110.014 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.442 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -69.56 142.29 53.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.993 -0.549 . . . . 1.26 110.111 178.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -57.9 -39.32 77.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 1.6000000000000001 109.899 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -67.76 -15.15 63.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.37 -0.832 . . . . 2.23 111.355 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.442 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 33.8 mt-10 -108.68 1.95 21.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.374 -0.376 . . . . 2.2400000000000002 110.205 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' A' ' 17' ' ' MET . 27.4 tp -74.68 107.3 6.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.423 -0.584 . . . . 1.6799999999999999 109.423 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.2 p -113.55 162.71 15.85 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.818 -0.808 . . . . 1.21 108.818 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.711 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.9 p-10 -79.84 -11.96 59.79 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.654 -0.418 . . . . 2.29 110.526 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -84.03 -20.42 32.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.742 -0.663 . . . . 2.29 110.998 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.6 p -66.53 147.41 53.32 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.424 0.631 . . . . 1.3300000000000001 110.766 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.699 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.5 t-20 -114.17 127.28 55.83 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.147 -0.933 . . . . 1.2 108.89 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.845 ' HD1' HG13 ' A' ' 42' ' ' ILE . 23.9 m-85 -56.58 -50.72 71.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.94 0.4 . . . . 0.63 111.399 -178.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.29 68.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.133 -0.485 . . . . 1.1499999999999999 111.111 -176.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.699 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 28.7 t70 -72.17 -28.82 63.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.926 -0.579 . . . . 0.82999999999999996 110.478 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.1 mmt -83.24 -22.57 33.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.684 -0.689 . . . . 2.98 111.264 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.32 23.7 6.53 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.673 -0.775 . . . . 0.54000000000000004 112.445 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.845 HG13 ' HD1' ' A' ' 37' ' ' PHE . 31.9 mm -70.97 108.22 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.223 0.535 . . . . 1.2 111.24 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.9 176.82 9.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.587 -0.733 . . . . 1.9399999999999999 111.495 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 p -61.1 -39.39 89.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.148 -0.933 . . . . 1.1399999999999999 110.989 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.602 ' HA ' H301 ' A' ' 90' ' ' PNS . 3.2 tm? -52.55 -59.66 4.19 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.703 -0.68 . . . . 1.22 110.181 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.546 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.2 m -62.2 -42.83 99.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.087 -0.506 . . . . 1.46 110.739 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.499 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 67.3 m -57.49 -37.62 73.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.169 -0.468 . . . . 1.1000000000000001 111.687 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.646 ' SD ' H302 ' A' ' 90' ' ' PNS . 12.6 ttt -74.3 -40.32 62.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.121 0.486 . . . . 2.8500000000000001 109.749 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.39 -42.37 96.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.225 -0.898 . . . . 1.1499999999999999 110.363 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 46' ' ' SER . 88.3 mt -58.48 -55.85 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.069 -0.514 . . . . 1.05 111.154 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -63.56 -26.72 69.99 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.769 -0.729 . . . . 0.35999999999999999 112.224 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -50.4 68.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.585 -0.524 . . . . 1.6599999999999999 109.585 176.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -64.27 -27.05 68.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.434 -0.348 . . . . 1.48 110.844 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 10.8 m-30 -55.11 -42.53 73.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.406 -0.59 . . . . 0.33000000000000002 109.406 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -84.32 -36.47 22.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.81 -0.632 . . . . 3.3300000000000001 111.253 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -85.6 -47.97 9.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.533 -0.303 . . . . 2.2599999999999998 111.764 -172.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -86.42 -50.36 6.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.364 -0.38 . . . . 2.6200000000000001 111.268 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.42 -43.35 14.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.557 -0.292 . . . . 1.1200000000000001 111.674 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.16 20.22 11.52 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.907 -0.663 . . . . 0.45000000000000001 112.327 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.8 mt -77.46 141.96 39.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.474 0.178 . . . . 1.23 110.881 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -106.57 84.98 2.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.085 0.469 . . . . 2.27 110.477 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.505 HD12 ' HE2' ' A' ' 81' ' ' PHE . 2.9 mm? -86.57 -29.84 22.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.567 0.699 . . . . 2.1299999999999999 109.448 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 126.46 171.48 13.13 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.25 -1.14 . . . . 0.92000000000000004 110.25 -173.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -85.96 -9.08 7.69 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.821 2.347 . . . . 1.2 113.127 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -125.7 23.6 7.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.055 0.455 . . . . 2.3599999999999999 111.546 -173.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -82.08 114.4 20.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.04 -0.527 . . . . 0.84999999999999998 109.796 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.0 m -132.12 117.82 18.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.64 -0.255 . . . . 1.71 110.421 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.73 -39.19 68.01 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 111.994 0.368 . . . . 1.3700000000000001 111.994 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.499 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 12.7 t80 -62.07 -11.28 13.07 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.331 -0.395 . . . . 0.83999999999999997 111.694 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.6 mt -124.11 -34.67 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.195 0.522 . . . . 1.51 110.92 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -99.28 -11.87 20.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.718 0.636 . . . . 2.23 112.718 -172.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 71.9 m -141.61 165.77 26.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.6 p -135.96 -66.35 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.941 -0.303 . . . . 1.29 111.009 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 69.1 p -87.57 178.37 6.8 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.226 -0.287 . . . . 1.1399999999999999 110.226 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.455 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 4.6 t -81.86 -35.97 13.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-O 121.078 0.466 . . . . 1.3700000000000001 111.11 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.711 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.7 tpp180 -60.95 -33.64 73.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.787 -0.642 . . . . 3.71 110.77 175.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.61 69.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.745 0.307 . . . . 1.1100000000000001 111.151 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.719 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.7 OUTLIER -69.08 -48.84 61.66 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.184 -0.672 . . . . 1.3100000000000001 109.184 175.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -52.68 -61.62 2.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.09 -0.959 . . . . 2.96 110.766 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.55 -39.0 64.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.478 -0.783 . . . . 1.6599999999999999 111.697 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.505 ' HE2' HD12 ' A' ' 62' ' ' LEU . 75.4 t80 -59.68 -44.85 93.46 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.849 -0.614 . . . . 1.2 110.657 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.74 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 30.1 mtp -62.18 -44.45 96.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.53 . . . . 1.1000000000000001 111.292 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.0 mp -66.17 -15.09 62.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.534 -0.303 . . . . 1.8500000000000001 111.641 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 86' ' ' GLY . . . 127.89 25.72 1.09 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.113 -1.041 . . . . 2.4199999999999999 114.293 171.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.2 m -82.99 31.65 0.43 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.05 0.925 . . . . 4.4699999999999998 110.645 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 84' ' ' GLY . . . -104.62 22.87 32.89 Favored Glycine 0 C--O 1.223 -0.553 0 N-CA-C 110.38 -1.088 . . . . 4.5899999999999999 110.38 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.93 -18.38 65.18 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.243 0.617 . . . . 6.6100000000000003 111.638 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.0 -5.27 59.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.783 -0.644 . . . . 8.4800000000000004 112.06 -176.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.668 -1.073 . . . . 9.7300000000000004 112.348 -178.881 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . 0.646 H302 ' SD ' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 120.715 0.293 . . . . 9.3499999999999996 110.406 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 55.6 tpp -144.33 150.42 37.79 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.143 -0.317 . . . . 9.0299999999999994 110.143 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.83 142.27 13.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.809 -0.811 . . . . 5.71 108.809 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.715 ' HG3' ' H ' ' A' ' 5' ' ' GLY . 9.1 tppt? 73.22 -170.2 0.13 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.793 0.683 . . . . 7.0 109.77 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.715 ' H ' ' HG3' ' A' ' 4' ' ' LYS . . . -166.73 -141.85 3.27 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.818 -0.706 . . . . 2.2400000000000002 111.931 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.4 t -95.94 -78.08 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.736 0.303 . . . . 1.6499999999999999 110.839 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.99 88.49 1.21 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.744 -0.741 . . . . 0.55000000000000004 111.279 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 m -100.61 156.96 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 122.56 -0.377 . . . . 1.1399999999999999 110.174 -174.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -87.56 -179.84 6.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.599 -0.519 . . . . 1.8899999999999999 109.599 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -68.54 -28.2 66.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.187 0.518 . . . . 2.3300000000000001 110.424 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -64.16 -47.07 81.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.732 -0.667 . . . . 1.9099999999999999 110.866 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -70.99 -19.26 62.55 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.791 -0.641 . . . . 2.1099999999999999 110.754 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.506 HD11 HD13 ' A' ' 83' ' ' LEU . 29.8 tp -73.44 -25.13 60.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.816 -0.629 . . . . 1.6000000000000001 110.804 171.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.35 -31.48 29.8 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.376 0.608 . . . . 0.88 110.038 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.51 -22.64 50.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.647 -0.706 . . . . 1.05 111.062 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.762 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 2.5 p -78.62 -41.38 24.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.831 0.348 . . . . 1.0700000000000001 111.143 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 80.7 mtp -59.26 -31.92 69.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 2.2400000000000002 111.471 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -72.72 -35.97 67.69 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 120.941 -0.303 . . . . 3.6899999999999999 111.188 178.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.2 t -70.47 -33.56 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.946 0.879 . . . . 1.0800000000000001 108.951 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.72 -36.75 66.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.469 -1.242 . . . . 1.04 109.605 174.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 t -64.91 -25.43 67.88 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.193 -0.458 . . . . 1.8400000000000001 110.507 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -82.75 -43.26 16.98 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.987 0.422 . . . . 2.2599999999999998 111.119 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HG3' HG12 ' A' ' 50' ' ' ILE . 49.4 mm-40 -86.69 -23.31 25.63 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.217 0.451 . . . . 0.77000000000000002 112.217 -174.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.414 ' HA ' HD13 ' A' ' 42' ' ' ILE . 33.0 m -93.42 -28.7 15.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.646 0.26 . . . . 1.23 111.417 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.47 3.16 78.53 Favored Glycine 0 N--CA 1.458 0.162 0 C-N-CA 120.177 -1.011 . . . . 0.54000000000000004 112.191 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.0 mt -95.61 112.06 27.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.407 -0.59 . . . . 1.28 109.407 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.05 143.81 2.13 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.538 0.524 . . . . 1.26 111.894 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -52.51 -34.04 47.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.792 -0.64 . . . . 1.6000000000000001 111.763 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -76.04 -10.56 59.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.253 -0.431 . . . . 2.23 111.048 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -114.38 -6.35 12.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 2.2400000000000002 110.919 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.5 tp -70.46 99.32 1.58 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.226 0.536 . . . . 1.6799999999999999 110.192 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.9 p -116.81 158.9 23.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.687 -0.688 . . . . 1.21 109.305 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.494 ' OD1' ' HB2' ' A' ' 76' ' ' ARG . 43.4 m-20 -67.38 -7.05 21.87 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.733 0.301 . . . . 2.29 111.427 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -73.36 -24.56 60.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 2.29 110.776 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.536 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 36.0 m -69.17 146.86 52.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.057 0.456 . . . . 1.3300000000000001 110.573 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.699 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.8 t-20 -129.25 123.38 31.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.186 -1.042 . . . . 1.2 108.186 -177.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.829 ' HD1' HG13 ' A' ' 42' ' ' ILE . 36.1 m-85 -56.29 -51.14 69.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.0 0.429 . . . . 0.63 111.614 -174.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.86 -29.17 64.1 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.535 -0.302 . . . . 1.1499999999999999 111.359 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.699 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 23.5 t70 -72.11 -35.56 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.431 0.634 . . . . 0.82999999999999996 110.201 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 45.8 mmm -76.15 -23.76 54.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.21 -0.904 . . . . 2.98 111.177 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.26 30.53 5.32 Favored Glycine 0 C--N 1.323 -0.171 0 C-N-CA 120.328 -0.939 . . . . 0.54000000000000004 112.408 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.829 HG13 ' HD1' ' A' ' 37' ' ' PHE . 29.6 mm -71.52 107.94 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.415 0.626 . . . . 1.2 109.66 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -81.25 165.28 21.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.066 -0.97 . . . . 1.9399999999999999 110.844 -173.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.3 t -52.17 -38.93 59.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.689 -0.687 . . . . 1.1399999999999999 111.283 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -57.1 -60.32 3.78 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.13 -0.486 . . . . 1.22 110.38 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.488 ' O ' HG13 ' A' ' 50' ' ' ILE . 12.8 p -65.77 -33.61 76.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.623 -0.262 . . . . 1.46 111.376 -175.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.485 ' HB3' ' H ' ' A' ' 69' ' ' PHE . 50.5 m -61.38 -35.16 76.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.617 -0.265 . . . . 1.1000000000000001 111.671 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.794 ' SD ' ' H32' ' A' ' 90' ' ' PNS . 21.1 ttt -84.63 -16.84 40.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 2.8500000000000001 110.522 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.571 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 74.6 t -88.98 -38.96 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 109.836 -0.431 . . . . 1.1499999999999999 109.836 -177.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.545 HG12 ' HG3' ' A' ' 23' ' ' GLU . 54.3 mt -53.13 -53.46 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.763 0.316 . . . . 1.05 110.235 172.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.21 -25.3 66.33 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.978 -0.63 . . . . 0.35999999999999999 112.285 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.564 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 2.9 m -75.28 -45.82 37.43 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 122.829 -0.218 . . . . 1.6599999999999999 111.023 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.571 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 23.7 mtp180 -63.8 -25.66 68.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 1.48 110.765 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.528 ' HD2' HD11 ' A' ' 62' ' ' LEU . 14.1 m-30 -56.99 -40.89 77.42 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 121.184 0.516 . . . . 0.33000000000000002 109.896 172.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.564 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 71.5 mtm180 -80.48 -30.02 37.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.74 -0.664 . . . . 3.3300000000000001 110.757 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.35 -61.72 1.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.073 0.463 . . . . 2.2599999999999998 111.819 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.61 -35.45 18.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.684 -0.689 . . . . 2.6200000000000001 111.535 -168.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.55 -33.23 11.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.519 -0.309 . . . . 1.1200000000000001 111.651 -175.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.69 37.94 11.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.832 -0.699 . . . . 0.45000000000000001 112.179 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 54' ' ' PHE . 88.3 mt -80.56 126.61 31.46 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.779 -0.248 . . . . 1.23 110.772 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.24 76.89 4.74 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.845 0.355 . . . . 2.27 110.491 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.528 HD11 ' HD2' ' A' ' 54' ' ' PHE . 68.1 mt -97.77 -77.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.27 0.557 . . . . 2.1299999999999999 110.857 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.25 170.1 14.0 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.962 -0.855 . . . . 0.92000000000000004 110.962 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -81.81 -11.21 11.46 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.718 2.278 . . . . 1.2 112.633 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -91.12 6.59 44.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.754 -0.657 . . . . 2.3599999999999999 111.853 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -93.07 120.03 32.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.927 0.394 . . . . 0.84999999999999998 111.069 -176.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.1 m -139.89 121.39 15.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 1.71 110.217 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.501 HD12 HD11 ' A' ' 50' ' ' ILE . 52.1 mt -58.81 -31.04 68.08 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.208 -0.451 . . . . 1.3700000000000001 111.869 -177.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.485 ' H ' ' HB3' ' A' ' 47' ' ' SER . 1.6 t80 -56.54 -16.26 5.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.858 0.463 . . . . 0.83999999999999997 111.713 -175.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.9 mt -126.69 -35.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.824 0.345 . . . . 1.51 110.708 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.58 -10.36 49.03 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.575 0.954 . . . . 2.23 113.575 -172.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.429 ' HB2' HD21 ' A' ' 68' ' ' LEU . 75.9 m -150.95 120.21 6.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.248 0.547 . . . . 1.0 110.718 -175.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.3 p -100.34 -51.94 3.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.98 -0.555 . . . . 1.29 110.841 -174.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.1 p -98.19 -175.23 3.06 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.88 -0.328 . . . . 1.1399999999999999 110.176 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 1.3 t -79.07 -45.71 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.32 0.581 . . . . 1.3700000000000001 109.781 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.746 ' HA ' ' HG3' ' A' ' 79' ' ' LYS . 4.3 tpp180 -61.93 -25.77 67.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.418 -0.81 . . . . 3.71 110.996 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.07 -34.67 72.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.71 0.29 . . . . 1.1100000000000001 110.511 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.692 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.7 OUTLIER -72.09 -48.68 42.23 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.707 -0.849 . . . . 1.3100000000000001 108.707 176.549 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.746 ' HG3' ' HA ' ' A' ' 76' ' ' ARG . 16.2 mmtp -50.59 -56.17 12.97 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.071 -0.968 . . . . 2.96 110.38 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -57.44 -33.61 68.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.726 -1.125 . . . . 1.6599999999999999 111.423 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -72.17 -34.94 68.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.09 0.472 . . . . 1.2 110.93 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.762 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 38.6 mtp -73.01 -52.9 12.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 1.1000000000000001 111.487 -176.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.506 HD13 HD11 ' A' ' 13' ' ' LEU . 6.9 mp -71.36 -33.97 70.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.552 -0.294 . . . . 1.8500000000000001 110.906 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 127.14 119.05 2.22 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.452 -0.88 . . . . 2.4199999999999999 112.399 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.1 t -83.66 36.86 0.56 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.409 0.623 . . . . 4.4699999999999998 110.303 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.5 15.03 32.56 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.905 -0.664 . . . . 4.5899999999999999 112.603 -175.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.99 124.87 34.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.103 -0.332 . . . . 6.6100000000000003 110.103 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.12 -79.78 0.36 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.267 -0.424 . . . . 8.4800000000000004 111.999 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.42 -1.211 . . . . 9.7300000000000004 111.801 -175.429 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . 0.794 ' H32' ' SD ' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.815 0.34 . . . . 9.3499999999999996 110.214 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.1 mmt -104.21 82.71 1.98 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.485 -0.561 . . . . 9.0299999999999994 109.485 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.98 142.05 2.79 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.403 -0.362 . . . . 5.71 110.302 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -149.58 129.1 13.06 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.772 -0.455 . . . . 7.0 109.772 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.707 ' HA2' ' HB2' ' A' ' 85' ' ' SER . . . -74.55 126.64 9.25 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.825 -0.702 . . . . 2.2400000000000002 112.184 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.19 -75.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 110.098 -0.334 . . . . 1.6499999999999999 110.098 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.36 108.48 1.19 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.549 -0.834 . . . . 0.55000000000000004 111.283 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.852 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 4.2 m -108.73 157.44 8.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.947 0.403 . . . . 1.1399999999999999 110.989 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -85.97 174.7 9.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.355 -0.609 . . . . 1.8899999999999999 109.355 174.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -21.98 65.29 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.499 -0.926 . . . . 2.3300000000000001 108.499 176.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.25 -53.02 61.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.863 -1.062 . . . . 1.9099999999999999 110.799 175.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.852 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 40.7 mmtm -71.16 -23.57 62.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.278 -0.419 . . . . 2.1099999999999999 110.247 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.1 tp -74.9 -26.68 59.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.906 -0.588 . . . . 1.6000000000000001 110.144 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -29.61 27.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.512 0.672 . . . . 0.88 109.751 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.692 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -82.86 -27.04 31.06 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.664 -0.698 . . . . 1.05 111.359 -175.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.79 ' HB ' ' HE2' ' A' ' 82' ' ' MET . 2.7 p -68.55 -44.22 83.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.64 -0.424 . . . . 1.0700000000000001 111.328 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.2 mtp -64.29 -30.6 71.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.317 -0.402 . . . . 2.2400000000000002 110.622 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.692 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 30.3 ptt180 -74.2 -27.01 60.6 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.009 -0.276 . . . . 3.6899999999999999 110.852 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.0 t -83.07 -33.47 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.76 0.791 . . . . 1.0800000000000001 108.923 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 t -68.01 -34.2 65.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.636 -1.166 . . . . 1.04 110.232 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 49.4 m -58.33 -52.7 64.49 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.029 0.442 . . . . 1.8400000000000001 110.637 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -54.04 -59.08 5.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.947 -1.024 . . . . 2.2599999999999998 112.438 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -79.64 -17.49 53.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.89 -0.595 . . . . 0.77000000000000002 112.566 -167.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -97.75 -35.46 10.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.879 0.371 . . . . 1.23 111.081 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.78 8.14 58.38 Favored Glycine 0 CA--C 1.516 0.111 0 C-N-CA 120.352 -0.928 . . . . 0.54000000000000004 111.472 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 21' ' ' SER . 8.1 mt -104.38 107.81 23.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.818 -0.438 . . . . 1.28 109.818 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.18 148.87 17.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 1.26 110.977 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 tp -49.75 -32.79 14.52 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.077 0.551 . . . . 1.6000000000000001 111.551 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -73.35 -21.92 60.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.344 -0.389 . . . . 2.23 111.527 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -108.95 -1.76 18.79 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.313 0.577 . . . . 2.2400000000000002 109.686 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -76.31 96.73 4.04 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.835 -0.802 . . . . 1.6799999999999999 108.835 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.7 p -104.56 156.2 18.17 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.454 -0.794 . . . . 1.21 108.934 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.572 ' HB2' ' HD3' ' A' ' 76' ' ' ARG . 7.9 p-10 -74.04 -13.03 60.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.026 0.441 . . . . 2.29 110.534 -176.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -89.04 -22.89 22.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.428 -0.806 . . . . 2.29 111.577 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 m -67.71 149.15 50.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.414 0.626 . . . . 1.3300000000000001 110.366 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.522 ' HB3' ' CB ' ' A' ' 39' ' ' ASP . 3.0 t-20 -109.76 125.23 52.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.531 -0.758 . . . . 1.2 110.592 -171.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.685 ' HD1' HG13 ' A' ' 42' ' ' ILE . 30.6 m-85 -55.01 -50.68 68.43 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.959 0.409 . . . . 0.63 110.893 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.36 -32.19 73.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.98 -0.555 . . . . 1.1499999999999999 111.591 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.522 ' CB ' ' HB3' ' A' ' 36' ' ' ASN . 16.0 t70 -71.31 -35.49 71.27 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.564 0.697 . . . . 0.82999999999999996 109.656 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 tpp -76.25 -20.46 57.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.895 -1.048 . . . . 2.98 110.849 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.0 25.24 6.55 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.411 -0.899 . . . . 0.54000000000000004 112.586 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.685 HG13 ' HD1' ' A' ' 37' ' ' PHE . 27.1 mm -67.61 107.68 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.356 0.598 . . . . 1.2 110.378 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -82.43 170.63 15.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.402 -0.817 . . . . 1.9399999999999999 110.51 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.6 p -56.85 -40.74 76.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.33 -0.395 . . . . 1.1399999999999999 110.179 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.27 -53.31 59.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.94 -0.573 . . . . 1.22 109.818 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.518 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.6 m -62.62 -42.37 99.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 1.46 110.849 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 49.1 m -60.04 -39.06 84.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 1.1000000000000001 110.985 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.424 ' HG3' H372 ' A' ' 90' ' ' PNS . 25.7 ttp -67.62 -46.18 73.24 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.544 0.688 . . . . 2.8500000000000001 109.216 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.435 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.6 t -57.87 -55.24 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.417 -1.265 . . . . 1.1499999999999999 110.618 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 46' ' ' SER . 63.0 mt -50.94 -52.78 16.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.616 0.246 . . . . 1.05 111.251 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -58.76 -37.15 89.54 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.948 -0.644 . . . . 0.35999999999999999 112.098 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -44.47 79.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.592 0.234 . . . . 1.6599999999999999 110.728 177.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.442 ' HA ' ' HB2' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -67.99 -21.85 65.04 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.013 -0.275 . . . . 1.48 110.318 -177.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 11.7 m-30 -58.86 -43.4 90.82 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.44 -0.578 . . . . 0.33000000000000002 109.44 170.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -77.59 -28.51 51.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.464 -0.789 . . . . 3.3300000000000001 110.077 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 53' ' ' ARG . 53.8 mt-10 -71.52 -63.91 1.03 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.224 0.535 . . . . 2.2599999999999998 111.395 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -87.89 -35.72 17.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.494 -0.775 . . . . 2.6200000000000001 111.927 -169.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.511 HD11 ' N ' ' A' ' 58' ' ' LEU . 7.8 mp -98.69 -40.06 8.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.812 0.339 . . . . 1.1200000000000001 111.114 -173.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.16 31.37 7.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.859 -0.686 . . . . 0.45000000000000001 112.417 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.77 102.15 10.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.742 0.306 . . . . 1.23 110.521 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -91.84 69.9 5.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.063 0.459 . . . . 2.27 110.938 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.412 HD13 ' HE2' ' A' ' 81' ' ' PHE . 80.3 mt -88.13 -7.25 57.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.986 -0.552 . . . . 2.1299999999999999 110.53 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.12 173.99 21.21 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.562 -0.828 . . . . 0.92000000000000004 111.998 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.56 -8.9 6.01 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.971 2.447 . . . . 1.2 112.471 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -88.0 3.65 48.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.459 -0.791 . . . . 2.3599999999999999 110.584 -174.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -91.18 120.45 32.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.909 -0.587 . . . . 0.84999999999999998 110.479 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.4 m -140.18 122.42 15.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.956 -0.565 . . . . 1.71 110.035 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 72' ' ' CYS . 49.2 mt -56.04 -46.73 78.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.081 -0.508 . . . . 1.3700000000000001 111.341 -177.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.527 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.1 t80 -56.58 -12.18 1.66 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.727 -0.669 . . . . 0.83999999999999997 112.417 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.5 mt -115.22 -40.54 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.793 -0.363 . . . . 1.51 111.489 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -118.32 9.07 12.37 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.361 0.504 . . . . 2.23 112.361 -171.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 72.8 m -145.1 114.38 7.06 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.7 -0.625 . . . . 1.0 110.085 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.7 p -98.79 -74.21 0.59 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.85 -0.614 . . . . 1.29 110.99 -170.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -83.48 -173.56 4.78 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.981 -0.449 . . . . 1.1399999999999999 110.59 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 11.7 t -84.16 -38.28 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.756 0.788 . . . . 1.3700000000000001 109.206 -176.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.572 ' HD3' ' HB2' ' A' ' 33' ' ' ASP . 6.6 tpt180 -57.95 -33.79 69.21 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.252 -1.34 . . . . 3.71 110.443 175.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.89 83.08 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.592 -0.276 . . . . 1.1100000000000001 111.012 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.748 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.2 tt -69.92 -49.88 47.6 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.932 -0.766 . . . . 1.3100000000000001 108.932 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 3.1 mmpm? -53.32 -56.32 17.61 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.044 -0.98 . . . . 2.96 110.853 178.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -56.27 -35.31 67.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.188 -0.915 . . . . 1.6599999999999999 111.36 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.412 ' HE2' HD13 ' A' ' 62' ' ' LEU . 70.4 t80 -69.92 -35.82 74.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.108 0.48 . . . . 1.2 111.121 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.79 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 32.2 mtp -64.17 -44.17 92.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.042 -0.526 . . . . 1.1000000000000001 110.97 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.442 HD13 ' N ' ' A' ' 83' ' ' LEU . 5.5 mp -83.46 -40.67 18.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.412 . . . . 1.8500000000000001 110.63 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.19 81.37 0.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.575 -0.61 . . . . 2.4199999999999999 111.575 177.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.707 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 12.2 m -79.43 40.37 0.43 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.924 0.393 . . . . 4.4699999999999998 112.043 -174.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.36 76.02 1.22 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.976 -0.631 . . . . 4.5899999999999999 111.707 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.2 27.01 0.96 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.383 0.273 . . . . 6.6100000000000003 110.442 -176.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 61.56 81.68 0.19 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.726 0.641 . . . . 8.4800000000000004 110.098 -174.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.07 -1.406 . . . . 9.7300000000000004 111.434 -177.311 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . 0.424 H372 ' HG3' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.796 0.332 . . . . 9.3499999999999996 111.005 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -117.82 145.67 44.39 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.737 -0.468 . . . . 9.0299999999999994 109.737 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.41 -13.85 61.97 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.708 0.766 . . . . 5.71 110.584 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -141.77 123.3 15.01 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.589 -1.187 . . . . 7.0 109.192 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.25 -157.58 33.16 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.688 -0.767 . . . . 2.2400000000000002 112.349 -176.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.46 -71.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.69 -0.485 . . . . 1.6499999999999999 109.69 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 83' ' ' LEU . . . 83.68 90.44 0.73 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.381 -0.914 . . . . 0.55000000000000004 111.518 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.93 158.26 10.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.664 0.269 . . . . 1.1399999999999999 110.448 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.2 m -73.25 166.13 23.73 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.239 -0.437 . . . . 1.8899999999999999 110.324 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -59.82 -27.59 66.74 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.526 0.679 . . . . 2.3300000000000001 109.4 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -50.7 -53.4 31.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.966 -1.016 . . . . 1.9099999999999999 111.753 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -66.88 -30.35 70.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.205 -0.598 . . . . 2.1099999999999999 110.242 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.26 -22.9 61.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 1.6000000000000001 110.933 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.581 ' HA ' ' HE1' ' A' ' 17' ' ' MET . 2.0 m-20 -84.55 -30.3 25.19 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.131 0.491 . . . . 0.88 110.625 173.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.602 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -79.59 -34.13 41.03 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.209 -0.45 . . . . 1.05 110.867 -177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.864 ' HB ' ' HE2' ' A' ' 82' ' ' MET . 2.9 p -58.11 -36.38 56.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.066 0.46 . . . . 1.0700000000000001 110.937 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.581 ' HE1' ' HA ' ' A' ' 14' ' ' ASP . 63.9 mtm -69.39 -30.11 68.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.814 -0.63 . . . . 2.2400000000000002 110.945 -175.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 24.6 ptt180 -72.26 -30.79 65.19 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 120.34 -0.544 . . . . 3.6899999999999999 109.758 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.6 t -79.61 -38.33 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.654 0.74 . . . . 1.0800000000000001 109.175 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.9 t -62.21 -47.66 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.608 -1.178 . . . . 1.04 110.361 175.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -62.09 -38.88 90.54 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.684 0.253 . . . . 1.8400000000000001 111.684 -176.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 18.2 mm-40 -62.69 -46.72 86.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.508 -0.314 . . . . 2.2599999999999998 111.557 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -83.47 -26.18 30.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.366 0.506 . . . . 0.77000000000000002 112.366 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.8 p -84.61 -45.24 12.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 1.23 110.444 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.88 5.64 53.27 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.795 -0.717 . . . . 0.54000000000000004 112.004 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mt -93.36 132.85 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.718 -0.284 . . . . 1.28 110.275 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 144.68 53.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.293 -0.412 . . . . 1.26 110.979 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -36.51 68.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.909 -0.587 . . . . 1.6000000000000001 110.48 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -70.38 -14.0 62.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.984 -0.553 . . . . 2.23 110.912 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -107.17 -4.86 18.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.017 -0.538 . . . . 2.2400000000000002 110.655 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.1 tp -78.82 96.79 5.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.46 0.648 . . . . 1.6799999999999999 109.873 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.6 p -124.17 167.87 13.68 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.273 -1.01 . . . . 1.21 108.273 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.637 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 2.5 p30 -71.61 -3.22 20.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.853 -0.339 . . . . 2.29 111.409 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -75.68 -20.84 58.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.949 0.404 . . . . 2.29 110.214 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.5 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 19.4 m -73.33 148.58 43.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.116 0.484 . . . . 1.3300000000000001 110.214 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.744 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.1 t-20 -128.18 117.38 21.47 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.852 -0.795 . . . . 1.2 108.852 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.795 ' HD1' HG13 ' A' ' 42' ' ' ILE . 30.0 m-85 -52.67 -54.43 33.56 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.979 0.418 . . . . 0.63 111.524 -174.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.21 -25.94 64.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.869 -0.605 . . . . 1.1499999999999999 111.669 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.744 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 38.7 t70 -81.53 -20.51 39.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.321 0.581 . . . . 0.82999999999999996 111.116 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -85.61 -24.38 27.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.856 -0.611 . . . . 2.98 109.9 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.41 13.4 6.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.585 -0.817 . . . . 0.54000000000000004 112.67 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.795 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.0 mm -67.82 107.82 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.94 0.4 . . . . 1.2 110.082 176.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -78.74 179.6 7.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.912 -0.586 . . . . 1.9399999999999999 110.453 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.4 p -57.99 -36.22 72.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.528 -0.76 . . . . 1.1399999999999999 109.791 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.44 -60.46 3.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.801 -1.091 . . . . 1.22 110.029 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.524 ' O ' HG13 ' A' ' 50' ' ' ILE . 1.3 m -57.72 -47.33 82.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.524 . . . . 1.46 111.353 -177.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.886 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 50.9 p -65.94 -29.06 69.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.893 0.377 . . . . 1.1000000000000001 111.298 -176.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.5 tpt -76.31 -35.48 58.8 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.532 -0.544 . . . . 2.8500000000000001 109.532 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.545 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 37.6 t -65.12 -50.16 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.334 -0.848 . . . . 1.1499999999999999 109.533 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 46' ' ' SER . 60.2 mt -52.7 -53.26 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.256 -0.429 . . . . 1.05 111.061 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.12 -41.62 98.18 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.03 -0.605 . . . . 0.35999999999999999 112.407 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 t -59.62 -44.7 93.36 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.792 0.329 . . . . 1.6599999999999999 110.707 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 56.6 mtp180 -68.14 -20.57 64.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.395 -0.366 . . . . 1.48 111.691 -175.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.573 ' HD2' HD12 ' A' ' 62' ' ' LEU . 15.9 m-30 -59.86 -42.27 93.31 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.37 0.605 . . . . 0.33000000000000002 109.595 171.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 67.4 mtp180 -74.1 -25.98 60.1 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.184 -0.916 . . . . 3.3300000000000001 110.196 -177.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -77.82 -63.75 1.31 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.765 -0.652 . . . . 2.2599999999999998 111.577 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.69 -46.79 10.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.679 -0.692 . . . . 2.6200000000000001 111.964 -170.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.2 -26.43 25.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.233 -0.44 . . . . 1.1200000000000001 111.042 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.49 33.28 31.8 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.785 -0.721 . . . . 0.45000000000000001 112.365 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.604 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 60.2 mt -89.65 104.95 17.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.797 -0.446 . . . . 1.23 109.797 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -85.35 77.87 9.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.707 0.765 . . . . 2.27 109.826 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.573 HD12 ' HD2' ' A' ' 54' ' ' PHE . 30.5 mt -75.77 -73.44 0.26 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.675 -1.148 . . . . 2.1299999999999999 111.199 -176.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 163.2 154.98 7.9 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.46 -0.791 . . . . 0.92000000000000004 111.132 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.74 -6.49 14.34 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.392 2.062 . . . . 1.2 112.034 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -103.7 2.08 32.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.589 -0.732 . . . . 2.3599999999999999 109.948 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -92.48 123.08 35.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.044 -0.526 . . . . 0.84999999999999998 110.571 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.9 m -137.79 128.45 26.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.056 -0.52 . . . . 1.71 109.976 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.886 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 32.9 mt -56.56 -33.44 66.13 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 120.635 0.255 . . . . 1.3700000000000001 110.833 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.491 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 24.6 t80 -58.1 -17.48 18.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.045 -0.525 . . . . 0.83999999999999997 111.633 -174.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.8 mt -125.09 -38.69 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.597 -0.274 . . . . 1.51 111.009 176.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -96.41 4.36 52.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.665 0.617 . . . . 2.23 112.665 -170.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.3 m -155.45 93.94 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.426 0.631 . . . . 1.0 109.577 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.9 p -80.02 -68.61 0.66 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.473 -0.785 . . . . 1.29 109.707 -171.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 65.2 p -86.5 -170.52 3.12 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.673 -0.491 . . . . 1.1399999999999999 109.673 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.534 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.3 t -81.58 -38.13 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 108.87 -0.789 . . . . 1.3700000000000001 108.87 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.637 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 5.8 tpt180 -62.97 -30.11 71.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.52 -1.218 . . . . 3.71 110.44 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.19 -34.72 75.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.239 -0.437 . . . . 1.1100000000000001 110.986 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.536 HD21 ' CE2' ' A' ' 54' ' ' PHE . 1.1 tt -73.89 -47.28 39.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.438 0.637 . . . . 1.3100000000000001 109.349 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 31.3 mmtp -54.91 -46.81 74.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.82 -1.082 . . . . 2.96 110.959 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.59 -48.53 80.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.502 -0.772 . . . . 1.6599999999999999 111.577 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -55.53 -37.62 68.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.819 -0.628 . . . . 1.2 111.781 -175.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.864 ' HE2' ' HB ' ' A' ' 16' ' ' VAL . 18.7 mtt -54.44 -53.39 54.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 1.1000000000000001 111.799 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.474 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 5.6 mp -79.52 -37.76 35.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.284 -0.417 . . . . 1.8500000000000001 109.962 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 86' ' ' GLY . . . 107.23 146.63 13.11 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.646 -0.707 . . . . 2.4199999999999999 111.404 -177.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.2 m -78.06 33.8 0.19 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.025 0.441 . . . . 4.4699999999999998 111.451 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 84' ' ' GLY . . . -92.74 48.83 2.54 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.026 -0.607 . . . . 4.5899999999999999 111.867 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.06 106.71 5.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.116 0.484 . . . . 6.6100000000000003 110.589 -178.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.18 -53.7 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.533 -0.758 . . . . 8.4800000000000004 110.037 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.901 -0.944 . . . . 9.7300000000000004 111.786 179.178 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PNS . . . . . 0.471 H311 ' O35' ' A' ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 112.239 -0.344 . . . . 0.53000000000000003 112.239 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 m -119.38 158.24 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.55 -0.537 . . . . 0.39000000000000001 109.55 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 p -83.74 172.85 11.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.186 -0.301 . . . . 1.5600000000000001 110.186 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -70.23 -16.76 63.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.279 0.561 . . . . 2.02 110.196 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -66.27 -47.69 72.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.367 -0.833 . . . . 1.9099999999999999 109.702 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -68.99 -27.56 65.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.884 -0.598 . . . . 1.5800000000000001 109.926 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -24.81 63.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.478 -0.783 . . . . 0.98999999999999999 110.688 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.26 -32.78 26.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.385 0.612 . . . . 0.88 110.246 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.08 -27.32 57.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.29999999999999999 111.051 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.626 HG11 ' HZ1' ' A' ' 79' ' ' LYS . 2.8 p -70.65 -40.73 77.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.053 -0.521 . . . . 0.23000000000000001 111.674 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.4 mtp -61.49 -31.14 71.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 1.6299999999999999 111.309 -173.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -78.69 -27.76 45.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.589 -0.444 . . . . 3.1699999999999999 111.101 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.527 HG13 ' HD3' ' A' ' 53' ' ' ARG . 42.3 t -73.72 -37.63 49.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.525 -0.917 . . . . 0.23000000000000001 108.525 176.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 t -65.14 -44.08 95.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.413 -1.267 . . . . 0.33000000000000002 110.433 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.5 p -56.01 -50.47 70.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.231 0.539 . . . . 1.3799999999999999 110.346 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -55.37 -53.92 50.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.968 -1.015 . . . . 2.2599999999999998 112.749 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -82.66 -16.43 48.28 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.62 0.6 . . . . 0.77000000000000002 112.62 -170.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 81.6 p -91.72 -36.48 13.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.093 0.473 . . . . 1.23 110.722 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.87 -0.01 56.36 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.844 -0.693 . . . . 0.54000000000000004 111.685 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.61 HD11 ' HG2' ' A' ' 40' ' ' MET . 3.1 mt -93.91 123.98 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 109.517 -0.549 . . . . 0.80000000000000004 109.517 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.66 141.76 36.59 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.315 0.385 . . . . 0.56999999999999995 111.101 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.14 -34.14 59.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.899 -0.591 . . . . 0.96999999999999997 111.227 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.35 -10.42 59.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 2.23 111.292 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -109.99 -3.85 16.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.971 0.415 . . . . 2.2400000000000002 110.231 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.9 tp -74.31 99.34 3.45 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.387 0.613 . . . . 1.1000000000000001 110.239 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.405 ' O ' HG21 ' A' ' 75' ' ' VAL . 44.6 p -121.73 164.53 17.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.271 -0.877 . . . . 0.59999999999999998 108.857 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.97 -9.88 34.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.801 0.334 . . . . 2.29 111.307 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.92 -19.6 60.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 2.29 110.487 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.521 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 18.3 m -71.5 143.08 50.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.038 0.446 . . . . 1.0600000000000001 109.835 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.663 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.9 t-20 -128.43 117.87 22.12 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.579 -0.526 . . . . 0.80000000000000004 109.579 -176.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.644 ' HD1' HG13 ' A' ' 42' ' ' ILE . 48.1 m-85 -55.36 -39.7 70.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.889 0.376 . . . . 0.46999999999999997 111.698 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.23 -29.25 60.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.875 0.369 . . . . 0.46000000000000002 111.212 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.663 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 34.6 t70 -74.81 -31.15 61.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.185 0.517 . . . . 0.82999999999999996 110.267 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.61 ' HG2' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -81.04 -14.65 57.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.401 -0.818 . . . . 2.48 110.761 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.67 42.87 6.29 Favored Glycine 0 CA--C 1.511 -0.207 0 C-N-CA 120.378 -0.915 . . . . 0.44 112.153 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.644 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.6 mm -75.54 107.28 6.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.988 0.423 . . . . 0.52000000000000002 109.903 176.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -80.19 175.19 10.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.438 0.637 . . . . 1.9399999999999999 111.82 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 t -52.86 -42.86 65.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.557 -1.201 . . . . 1.03 111.189 177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.36 -61.64 2.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.99 -0.55 . . . . 0.58999999999999997 110.257 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.511 ' O ' HG13 ' A' ' 50' ' ' ILE . 29.0 t -61.18 -47.09 87.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.473 -0.33 . . . . 1.22 111.601 -175.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.469 ' HB3' HG22 ' A' ' 42' ' ' ILE . 51.0 p -62.38 -27.44 69.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.682 0.253 . . . . 0.81000000000000005 111.682 -176.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.9 ttt -80.36 -39.9 27.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.246 0.546 . . . . 2.25 109.841 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.85 -42.21 95.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.315 -0.857 . . . . 0.35999999999999999 109.986 -177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 46' ' ' SER . 73.8 mt -56.75 -58.18 6.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.932 -0.576 . . . . 0.26000000000000001 111.232 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -65.35 -23.73 70.26 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.607 -0.806 . . . . 0.28999999999999998 112.398 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.617 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -69.63 -45.71 67.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.803 -0.443 . . . . 0.92000000000000004 109.803 175.277 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.527 ' HD3' HG13 ' A' ' 19' ' ' VAL . 41.1 mtp180 -61.27 -31.99 71.81 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.428 -0.351 . . . . 1.23 110.533 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.474 ' CE2' HD21 ' A' ' 78' ' ' LEU . 13.1 m-30 -53.68 -40.58 66.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.892 -0.594 . . . . 0.28000000000000003 110.02 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.617 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 53.2 mtm180 -81.04 -37.76 28.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.068 -0.514 . . . . 2.8100000000000001 111.142 -175.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -87.86 -52.45 5.28 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.316 0.488 . . . . 2.2599999999999998 112.316 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -80.41 -42.24 23.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.807 -0.633 . . . . 2.6200000000000001 111.18 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.2 mp -96.08 -33.0 12.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.405 -0.361 . . . . 0.67000000000000004 111.685 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.23 35.07 9.05 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.516 -0.85 . . . . 0.45000000000000001 112.101 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.2 mt -87.08 131.15 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.582 0.23 . . . . 0.63 110.939 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -89.33 47.11 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.639 -0.504 . . . . 2.27 109.639 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -59.16 4.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.188 -0.915 . . . . 1.6399999999999999 110.726 -174.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' ' HD3' ' A' ' 55' ' ' ARG . . . 172.41 167.86 33.01 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.629 -0.588 . . . . 0.75 111.629 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.89 -37.08 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.465 2.11 . . . . 1.1299999999999999 113.38 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.14 45.34 2.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.308 0.575 . . . . 2.3599999999999999 110.438 -175.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -74.2 112.53 10.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.448 -0.797 . . . . 0.72999999999999998 109.876 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.1 p -118.3 129.04 55.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 1.3899999999999999 111.173 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.482 HD12 HD12 ' A' ' 50' ' ' ILE . 75.3 mt -76.2 2.96 11.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 0.72999999999999998 111.672 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.69 -17.7 22.93 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.122 -0.49 . . . . 0.58999999999999997 110.15 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.2 mt -132.26 -37.39 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.093 0.473 . . . . 0.89000000000000001 111.141 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.78 -2.8 46.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.684 0.754 . . . . 2.23 110.683 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.436 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 98.5 m -147.23 157.8 43.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.167 -0.924 . . . . 1.0 108.735 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.3 p -129.95 -73.41 0.56 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.163 -0.215 . . . . 0.67000000000000004 111.276 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.2 p -90.25 -171.58 3.16 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.246 -0.284 . . . . 0.38 110.625 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.521 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 1.8 t -79.47 -44.33 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.568 -0.53 . . . . 0.68000000000000005 109.568 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -59.15 -32.69 70.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.691 -0.686 . . . . 3.23 110.985 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -56.68 -37.16 70.48 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.35 -0.386 . . . . 0.28999999999999998 111.171 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.509 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -74.28 -43.2 57.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.536 0.684 . . . . 0.64000000000000001 109.398 178.529 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.716 ' HA ' ' NZ ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -53.92 -61.33 2.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.618 -1.174 . . . . 2.3999999999999999 112.102 178.091 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.99 -37.83 77.76 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.107 0.254 . . . . 1.6599999999999999 111.596 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 3.7 t80 -52.69 -39.65 62.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.598 0.561 . . . . 0.98999999999999999 111.067 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.509 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 7.9 mtt . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.564 -0.744 . . . . 1.1000000000000001 112.092 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.124 0 N-CA-C 111.809 -0.516 . . . . 0.53000000000000003 111.809 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG21 ' SD ' ' A' ' 82' ' ' MET . 5.9 m -97.93 158.37 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.963 -0.384 . . . . 0.39000000000000001 109.963 -175.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.4 t -83.86 -177.11 6.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.844 -0.428 . . . . 1.5600000000000001 109.844 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -71.83 -22.03 61.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.005 0.431 . . . . 2.02 110.603 -174.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -73.96 -41.6 61.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.462 -0.495 . . . . 1.9099999999999999 110.076 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -66.71 -30.87 71.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.893 -0.78 . . . . 1.5800000000000001 108.893 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.1 tp -69.78 -26.19 64.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.975 -1.012 . . . . 0.98999999999999999 110.701 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.28 -27.07 24.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.414 0.626 . . . . 0.88 110.095 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.76 -35.36 57.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.687 -0.688 . . . . 0.29999999999999999 110.802 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.519 HG21 HD22 ' A' ' 78' ' ' LEU . 3.6 p -61.68 -45.42 98.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.989 -0.551 . . . . 0.23000000000000001 110.624 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.1 mtm -59.39 -39.0 81.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.796 -0.638 . . . . 1.6299999999999999 111.52 -174.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HA ' ' HB2' ' A' ' 21' ' ' SER . 11.8 ptt180 -74.07 -29.38 61.85 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.087 -0.645 . . . . 3.1699999999999999 111.569 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.6 t -71.68 -33.01 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.087 0.946 . . . . 0.23000000000000001 108.56 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -70.66 -43.63 77.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.032 -1.44 . . . . 0.33000000000000002 109.712 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' A' ' 18' ' ' ARG . 6.3 m -62.66 -21.87 66.03 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 122.748 0.419 . . . . 1.3799999999999999 111.828 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.09 -51.71 6.15 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.316 -0.402 . . . . 2.2599999999999998 111.365 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 15.2 mm-40 -90.49 -27.94 18.88 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.104 0.409 . . . . 0.77000000000000002 112.104 -172.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.441 ' HB3' HD11 ' A' ' 42' ' ' ILE . 17.5 m -86.4 -32.44 20.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.114 0.483 . . . . 1.23 110.544 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.41 -9.53 62.82 Favored Glycine 0 C--O 1.23 -0.111 0 C-N-CA 120.503 -0.856 . . . . 0.54000000000000004 112.682 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mt -79.37 104.77 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.623 -0.51 . . . . 0.80000000000000004 109.623 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.567 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -43.67 145.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.857 0.723 . . . . 0.56999999999999995 112.02 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.4 tp -56.47 -31.5 64.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.705 -0.679 . . . . 0.96999999999999997 111.002 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -80.39 -9.75 59.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.057 -0.519 . . . . 2.23 111.181 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.567 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 40.6 mm-40 -110.71 -13.9 14.11 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.192 -0.458 . . . . 2.2400000000000002 110.052 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.8 tp -69.6 98.14 1.12 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.639 -0.71 . . . . 1.1000000000000001 110.27 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.1 p -107.62 161.84 14.5 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.361 -0.836 . . . . 0.59999999999999998 108.969 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.741 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 7.5 p-10 -75.54 -9.05 58.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.765 0.317 . . . . 2.29 111.064 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -91.02 -23.65 20.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.416 0.525 . . . . 2.29 112.416 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.7 m -71.3 148.44 47.12 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.423 0.63 . . . . 1.0600000000000001 110.011 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.764 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 4.4 t-20 -113.24 123.49 50.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.417 -0.81 . . . . 0.80000000000000004 109.812 -170.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.787 ' HD1' HG13 ' A' ' 42' ' ' ILE . 32.3 m-85 -56.49 -53.1 61.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.964 0.412 . . . . 0.46999999999999997 111.587 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.06 -27.91 66.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.179 -0.464 . . . . 0.46000000000000002 111.321 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.764 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 23.4 t70 -72.06 -32.65 67.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.397 0.617 . . . . 0.82999999999999996 110.251 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.575 ' CE ' ' HA ' ' A' ' 40' ' ' MET . 4.8 mmt -83.48 -13.99 53.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.252 -0.885 . . . . 2.48 111.178 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.82 36.07 6.2 Favored Glycine 0 N--CA 1.457 0.071 0 C-N-CA 120.063 -1.065 . . . . 0.44 112.516 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.787 HG13 ' HD1' ' A' ' 37' ' ' PHE . 32.7 mm -73.19 108.07 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.201 0.524 . . . . 0.52000000000000002 110.013 175.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.29 163.84 27.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.539 -0.755 . . . . 1.9399999999999999 111.351 -173.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.5 t -54.49 -37.3 65.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.293 -0.867 . . . . 1.03 111.054 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.77 -61.54 2.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.58999999999999997 110.203 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.574 ' O ' HG13 ' A' ' 50' ' ' ILE . 11.6 m -62.68 -42.89 99.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.433 -0.349 . . . . 1.22 111.69 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.564 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 57.6 p -63.86 -32.18 73.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.95 0.405 . . . . 0.81000000000000005 111.204 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.9 tpt -75.78 -39.85 56.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.326 0.584 . . . . 2.25 109.734 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.9 t -60.25 -45.82 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.292 -0.867 . . . . 0.35999999999999999 109.97 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 46' ' ' SER . 78.8 mt -55.56 -54.31 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.932 -0.576 . . . . 0.26000000000000001 111.355 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.35 -36.36 92.36 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.736 -0.745 . . . . 0.28999999999999998 112.419 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 m -61.36 -47.44 85.84 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 120.591 -0.443 . . . . 0.92000000000000004 110.108 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -61.48 -32.25 72.25 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.431 -0.349 . . . . 1.23 111.31 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.502 ' HD2' HD11 ' A' ' 62' ' ' LEU . 11.0 m-30 -53.09 -38.95 62.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.151 0.5 . . . . 0.28000000000000003 110.21 176.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -83.54 -29.77 27.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.482 -0.781 . . . . 2.8100000000000001 111.116 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -85.12 -62.17 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.268 0.556 . . . . 2.2599999999999998 111.044 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -44.31 52.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.116 -0.947 . . . . 2.6200000000000001 111.094 -173.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 mp -93.7 -32.18 14.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.378 -0.374 . . . . 0.67000000000000004 111.312 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.99 29.76 30.59 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.681 -0.771 . . . . 0.45000000000000001 112.354 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.8 mt -82.54 108.15 15.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.731 -0.47 . . . . 0.63 109.731 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -81.18 78.43 7.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.641 0.734 . . . . 2.27 109.353 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.502 HD11 ' HD2' ' A' ' 54' ' ' PHE . 27.1 mt -76.07 -71.97 0.35 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.326 -1.306 . . . . 1.6399999999999999 110.995 -176.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.98 169.45 38.91 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.415 -0.811 . . . . 0.75 111.289 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.23 -15.46 11.46 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.672 2.248 . . . . 1.1299999999999999 113.006 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -119.12 10.87 12.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.313 -0.403 . . . . 2.3599999999999999 111.19 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.451 ' CD2' HD13 ' A' ' 62' ' ' LEU . 73.2 t80 -71.93 112.85 8.37 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.948 0.404 . . . . 0.72999999999999998 110.488 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.7 m -131.13 121.24 24.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.692 -0.686 . . . . 1.3899999999999999 109.628 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.647 HD21 HD11 ' A' ' 78' ' ' LEU . 2.5 mp -54.12 -32.12 54.19 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.24 0.459 . . . . 0.72999999999999998 112.24 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.564 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 1.8 t80 -65.99 -14.57 61.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.946 0.403 . . . . 0.58999999999999997 110.855 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.0 mt -124.0 -39.01 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.514 -0.312 . . . . 0.89000000000000001 110.671 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -95.15 6.09 50.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 2.23 111.796 -172.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.493 ' SG ' ' HG ' ' A' ' 78' ' ' LEU . 80.1 m -148.96 100.71 3.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.554 0.693 . . . . 1.0 109.983 -175.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.8 p -90.02 -72.88 0.54 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.694 -0.685 . . . . 0.67000000000000004 110.194 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 77.5 p -86.67 -177.67 6.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.415 -0.587 . . . . 0.38 109.415 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.7 t -80.21 -40.68 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 120.361 -0.536 . . . . 0.68000000000000005 110.419 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.741 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 8.4 tpt180 -54.67 -32.22 58.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.926 -0.579 . . . . 3.23 110.533 173.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -59.42 -31.57 69.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.28999999999999998 111.739 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.647 HD11 HD21 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -81.7 -45.28 15.93 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.706 -0.85 . . . . 0.64000000000000001 108.706 -179.007 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -53.2 -61.56 2.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.945 -1.48 . . . . 2.3999999999999999 110.832 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.17 -19.05 63.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.937 -1.029 . . . . 1.6599999999999999 111.019 -173.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 83.4 t80 -63.06 -42.66 99.75 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.278 0.561 . . . . 0.98999999999999999 109.596 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.46 ' SD ' HG21 ' A' ' 8' ' ' VAL . 12.5 mtt . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.203 -0.908 . . . . 1.1000000000000001 111.385 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 111.557 -0.617 . . . . 0.53000000000000003 111.557 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 12' ' ' LYS . 2.7 m -114.39 157.49 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.929 -0.397 . . . . 0.39000000000000001 109.929 -176.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.1 t -91.4 175.12 7.04 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.845 -0.798 . . . . 1.5600000000000001 108.845 173.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -67.08 -23.27 65.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.977 0.417 . . . . 2.02 110.08 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -47.51 84.46 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.469 -0.787 . . . . 1.9099999999999999 110.903 172.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.615 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -71.74 -25.23 61.97 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.554 -0.536 . . . . 1.5800000000000001 109.554 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.579 ' HA ' HG12 ' A' ' 16' ' ' VAL . 4.0 tp -72.22 -29.21 63.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.07 -0.514 . . . . 0.98999999999999999 110.421 173.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.39 -24.0 57.14 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.023 0.916 . . . . 0.88 109.301 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.35 -36.89 20.47 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.72 -1.127 . . . . 0.29999999999999999 110.884 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.581 HG23 ' CZ ' ' A' ' 54' ' ' PHE . 4.0 p -70.61 -44.11 77.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.873 -0.603 . . . . 0.23000000000000001 112.295 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.451 ' HB3' HD23 ' A' ' 31' ' ' LEU . 88.5 mtp -60.0 -32.56 70.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.847 0.314 . . . . 1.6299999999999999 111.847 -173.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.57 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 8.2 ptt180 -84.24 -18.25 37.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.37 0.507 . . . . 3.1699999999999999 112.37 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.29 -32.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.188 -1.042 . . . . 0.23000000000000001 108.188 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 t -66.71 -39.88 84.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.21 -1.359 . . . . 0.33000000000000002 110.122 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.5 p -64.37 -49.3 72.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.217 0.532 . . . . 1.3799999999999999 110.71 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 7.2 mm-40 -60.94 -39.4 89.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.401 -0.818 . . . . 2.2599999999999998 112.24 -178.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -80.14 -31.94 38.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.951 0.352 . . . . 0.77000000000000002 111.951 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.436 ' HA ' HD11 ' A' ' 42' ' ' ILE . 72.7 p -82.4 -44.59 15.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.886 0.374 . . . . 1.23 111.558 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.91 6.7 37.06 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.654 -0.784 . . . . 0.54000000000000004 111.705 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.697 HD11 ' HG2' ' A' ' 40' ' ' MET . 3.5 mt -97.61 137.07 26.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.501 -0.555 . . . . 0.80000000000000004 109.501 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.35 141.99 58.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.742 0.306 . . . . 0.56999999999999995 110.415 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -55.98 -34.48 65.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.96999999999999997 111.28 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -71.47 -10.45 59.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 2.23 111.378 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -111.61 -4.22 14.83 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.497 -0.319 . . . . 2.2400000000000002 111.103 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 17' ' ' MET . 30.0 tp -72.05 97.88 1.98 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.516 0.674 . . . . 1.1000000000000001 110.472 -173.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 34' ' ' ASP . 70.0 p -124.95 165.8 17.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.193 -0.912 . . . . 0.59999999999999998 109.052 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.496 ' CB ' ' HB2' ' A' ' 76' ' ' ARG . 7.7 p-10 -70.83 -5.87 33.62 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.206 0.527 . . . . 2.29 110.484 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.435 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 24.5 t70 -70.56 -22.04 62.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.202 -0.908 . . . . 2.29 109.687 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.467 ' HB2' HG21 ' A' ' 75' ' ' VAL . 14.1 m -81.29 147.45 29.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.648 -0.706 . . . . 1.0600000000000001 109.901 176.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.7 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 3.7 t-20 -127.64 119.78 26.64 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.074 -0.713 . . . . 0.80000000000000004 109.074 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.621 ' HD1' HG13 ' A' ' 42' ' ' ILE . 5.5 m-85 -51.52 -50.23 60.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.955 0.407 . . . . 0.46999999999999997 110.925 -176.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.03 -31.42 71.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.004 -0.543 . . . . 0.46000000000000002 111.627 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.7 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 30.8 t70 -74.94 -29.2 60.88 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.152 0.501 . . . . 0.82999999999999996 110.322 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.697 ' HG2' HD11 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -82.65 -15.07 53.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.256 -0.884 . . . . 2.48 111.08 -178.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.59 20.99 9.54 Favored Glycine 0 N--CA 1.455 -0.088 0 C-N-CA 120.231 -0.985 . . . . 0.44 112.787 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.621 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.3 mm -71.47 107.15 2.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.52 0.676 . . . . 0.52000000000000002 110.72 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -88.55 170.45 10.86 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.092 -0.958 . . . . 1.9399999999999999 110.088 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.9 t -55.19 -37.71 67.42 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.301 0.24 . . . . 1.03 111.016 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.407 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.4 tm? -58.49 -56.34 23.41 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.012 -0.366 . . . . 0.58999999999999997 110.012 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.56 ' O ' HG13 ' A' ' 50' ' ' ILE . 19.8 m -68.25 -41.43 81.14 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.874 0.324 . . . . 1.22 111.874 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.648 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 36.2 p -66.22 -30.36 70.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.03 0.443 . . . . 0.81000000000000005 110.965 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -39.57 64.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.619 -0.882 . . . . 2.25 108.619 178.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 39.6 t -64.39 -44.66 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.902 -0.59 . . . . 0.35999999999999999 110.261 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 46' ' ' SER . 65.6 mt -52.06 -59.78 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.596 -0.275 . . . . 0.26000000000000001 110.772 176.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.51 -27.33 67.79 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.11 -0.567 . . . . 0.28999999999999998 111.9 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.496 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -67.68 -44.13 78.55 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 122.902 -0.176 . . . . 0.92000000000000004 111.1 176.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 27.7 mtp180 -65.97 -23.98 66.7 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.716 0.293 . . . . 1.23 110.473 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.581 ' CZ ' HG23 ' A' ' 16' ' ' VAL . 12.2 m-30 -58.3 -40.56 82.33 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.169 0.509 . . . . 0.28000000000000003 109.688 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 66.7 mtm180 -82.03 -25.08 34.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.438 -0.801 . . . . 2.8100000000000001 111.043 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -83.0 -59.13 2.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.787 -0.642 . . . . 2.2599999999999998 110.927 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.62 -48.53 7.01 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.516 -0.766 . . . . 2.6200000000000001 111.797 -174.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.401 HD23 ' HD2' ' A' ' 12' ' ' LYS . 10.9 mp -81.71 -26.51 34.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.421 -0.354 . . . . 0.67000000000000004 111.666 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.31 40.41 49.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.12 -0.562 . . . . 0.45000000000000001 112.419 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.453 HD21 ' HG2' ' A' ' 12' ' ' LYS . 78.5 mt -86.35 146.15 26.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.839 0.352 . . . . 0.63 110.966 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.21 94.82 6.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 2.27 110.849 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 63' ' ' GLY . 0.3 OUTLIER -121.53 -52.35 2.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.117 -0.492 . . . . 1.6399999999999999 110.914 176.71 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' HD12 ' A' ' 62' ' ' LEU . . . 124.52 169.0 12.96 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.628 -0.796 . . . . 0.75 111.988 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.41 -4.83 11.76 Favored 'Trans proline' 0 C--N 1.333 -0.258 0 C-N-CA 122.48 2.12 . . . . 1.1299999999999999 113.041 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.26 -16.56 19.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.118 -0.492 . . . . 2.3599999999999999 111.023 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -69.77 112.8 6.47 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.102 0.477 . . . . 0.72999999999999998 110.25 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 p -128.23 132.54 48.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.052 -0.522 . . . . 1.3899999999999999 111.281 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 83.0 mt -81.23 15.13 2.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.72999999999999998 111.357 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.444 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 6.7 t80 -111.37 -8.49 14.31 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.105 0.479 . . . . 0.58999999999999997 109.907 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.6 mt -131.57 -40.64 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-O 120.862 0.363 . . . . 0.89000000000000001 111.488 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.12 5.53 42.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.228 0.537 . . . . 2.23 110.531 -170.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 96.5 m -158.77 129.24 6.0 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.2 p -109.42 -48.3 3.26 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.748 -0.381 . . . . 0.67000000000000004 111.068 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.6 p -99.87 -171.2 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.306 0.574 . . . . 0.38 111.128 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.467 HG21 ' HB2' ' A' ' 35' ' ' SER . 2.2 t -81.75 -44.45 20.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.773 -0.649 . . . . 0.68000000000000005 110.718 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HD3' ' HB2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -67.31 -24.5 65.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.585 . . . . 3.23 110.684 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.36 64.87 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.165 0.507 . . . . 0.28999999999999998 110.386 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.715 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.6 OUTLIER -77.43 -49.06 15.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.633 -0.712 . . . . 0.64000000000000001 109.339 177.065 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.507 ' HB2' ' HD3' ' A' ' 76' ' ' ARG . 30.5 mmtm -57.85 -45.43 86.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.828 -1.078 . . . . 2.3999999999999999 110.902 -176.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.45 -29.89 70.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.563 -0.744 . . . . 1.6599999999999999 110.77 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -77.0 -36.45 56.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.075 -0.511 . . . . 0.98999999999999999 111.09 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.715 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 44.4 mtp . . . . . 0 N--CA 1.465 0.305 0 CA-C-N 116.207 -0.452 . . . . 1.1000000000000001 110.914 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 110.875 -0.89 . . . . 0.53000000000000003 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -113.36 156.26 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.736 0.303 . . . . 0.39000000000000001 110.274 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.9 p -71.88 157.83 37.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.12 -0.491 . . . . 1.5600000000000001 110.382 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.64 -26.17 68.28 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.118 -1.067 . . . . 2.02 108.118 175.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.44 -42.58 96.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.608 -1.178 . . . . 1.9099999999999999 110.56 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -27.77 64.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.146 -0.479 . . . . 1.5800000000000001 109.735 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.432 ' O ' ' HG3' ' A' ' 17' ' ' MET . 0.1 OUTLIER -68.32 -27.99 66.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.842 -0.617 . . . . 0.98999999999999999 109.565 175.173 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -25.78 41.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.375 0.607 . . . . 0.88 110.156 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.88 -19.29 29.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.503 -0.771 . . . . 0.29999999999999999 111.663 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.536 HG23 ' CE1' ' A' ' 54' ' ' PHE . 3.3 p -82.16 -43.59 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.758 -0.377 . . . . 0.23000000000000001 111.777 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.563 ' HB3' HD23 ' A' ' 31' ' ' LEU . 57.3 mtm -61.56 -30.39 70.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.468 -0.333 . . . . 1.6299999999999999 111.508 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.18 -33.97 74.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.476 0.179 . . . . 3.1699999999999999 111.127 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 53' ' ' ARG . 56.3 t -75.94 -37.13 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.694 0.759 . . . . 0.23000000000000001 109.113 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.03 -39.23 84.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.763 -1.108 . . . . 0.33000000000000002 111.007 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -24.25 50.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.653 0.74 . . . . 1.3799999999999999 109.729 -173.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -78.8 -42.26 28.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.788 -1.097 . . . . 2.2599999999999998 111.101 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.55 ' HG3' HG12 ' A' ' 50' ' ' ILE . 62.0 mm-40 -74.69 -37.49 62.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.27 -0.423 . . . . 0.77000000000000002 111.351 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -71.51 -44.22 65.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.869 0.366 . . . . 1.23 110.516 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.99 5.13 35.64 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.819 -0.705 . . . . 0.54000000000000004 112.071 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.568 HD11 ' HG2' ' A' ' 40' ' ' MET . 2.3 mt -90.68 160.15 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.912 0.387 . . . . 0.80000000000000004 110.107 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.37 140.23 42.89 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.766 -0.652 . . . . 0.56999999999999995 110.269 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.2 tp -58.52 -35.52 72.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.952 -0.567 . . . . 0.96999999999999997 111.229 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -73.84 -14.57 61.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.186 0.517 . . . . 2.23 110.547 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -103.98 -6.3 21.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.762 -0.654 . . . . 2.2400000000000002 110.801 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 17' ' ' MET . 46.5 tp -72.04 99.21 2.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.934 -0.575 . . . . 1.1000000000000001 109.967 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.489 ' O ' HG21 ' A' ' 75' ' ' VAL . 80.2 p -117.63 158.85 23.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.014 -0.539 . . . . 0.59999999999999998 109.71 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.692 ' OD1' ' HB2' ' A' ' 76' ' ' ARG . 6.9 t70 -54.22 -23.72 15.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.226 0.61 . . . . 2.29 112.57 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.48 -19.41 64.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.883 -0.599 . . . . 2.29 111.408 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.534 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 14.8 m -71.95 151.47 43.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.342 0.591 . . . . 1.0600000000000001 110.84 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.774 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.6 t-20 -131.0 120.42 23.46 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.473 -0.566 . . . . 0.80000000000000004 109.473 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.822 ' HD1' HG13 ' A' ' 42' ' ' ILE . 33.7 m-85 -51.36 -46.44 62.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.156 0.503 . . . . 0.46999999999999997 111.219 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.39 -29.62 63.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.784 -0.644 . . . . 0.46000000000000002 111.571 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.774 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 21.5 t70 -74.72 -31.17 61.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.43 0.633 . . . . 0.82999999999999996 110.283 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.568 ' HG2' HD11 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -75.64 -23.12 56.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.602 -0.727 . . . . 2.48 110.453 178.752 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.32 27.93 7.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.325 -0.941 . . . . 0.44 112.026 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.822 HG13 ' HD1' ' A' ' 37' ' ' PHE . 28.6 mm -68.21 107.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 0.52000000000000002 109.833 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.35 171.44 15.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.521 -0.763 . . . . 1.9399999999999999 111.211 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.3 t -57.88 -32.69 67.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.721 -1.127 . . . . 1.03 111.167 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.2 tm? -64.25 -57.48 9.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.721 -0.672 . . . . 0.58999999999999997 110.088 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.552 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.6 m -63.93 -40.84 97.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.979 -0.555 . . . . 1.22 111.585 -173.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.6 p -62.38 -30.14 70.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.211 -0.45 . . . . 0.81000000000000005 111.447 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.7 ttt -79.15 -37.64 37.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.514 0.673 . . . . 2.25 109.775 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 52' ' ' SER . 78.0 t -69.39 -40.68 80.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.765 -1.107 . . . . 0.35999999999999999 110.233 -175.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 46' ' ' SER . 73.2 mt -51.69 -54.11 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.881 0.372 . . . . 0.26000000000000001 110.705 174.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -63.46 -26.22 69.38 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.974 -0.631 . . . . 0.28999999999999998 112.247 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 10.3 m -70.99 -42.33 69.79 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 120.659 0.266 . . . . 0.92000000000000004 110.715 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.473 ' HB2' HG11 ' A' ' 19' ' ' VAL . 10.0 mtp180 -64.95 -26.34 68.26 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.525 -0.307 . . . . 1.23 110.351 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.734 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 16.5 m-30 -56.31 -43.98 79.46 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.261 0.553 . . . . 0.28000000000000003 109.58 173.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 61.7 mtp180 -79.32 -27.97 42.11 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.227 -0.897 . . . . 2.8100000000000001 110.573 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -77.29 -62.82 1.53 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.82 -0.627 . . . . 2.2599999999999998 112.023 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -88.54 -44.13 10.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 2.6200000000000001 111.477 -169.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.56 -39.11 15.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.108 -0.497 . . . . 0.67000000000000004 111.591 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.99 23.34 15.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.503 -0.856 . . . . 0.45000000000000001 112.307 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.734 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 73.2 mt -80.81 113.18 18.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.726 -0.472 . . . . 0.63 109.726 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -97.87 87.39 3.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.45 0.643 . . . . 2.27 110.01 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.644 HD11 ' HD2' ' A' ' 54' ' ' PHE . 37.2 mt -87.88 -66.1 0.95 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.756 -1.111 . . . . 1.6399999999999999 110.304 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.15 167.62 20.08 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.724 -0.95 . . . . 0.75 110.724 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -87.62 5.24 5.62 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 123.361 2.707 . . . . 1.1299999999999999 112.96 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -107.19 -7.67 16.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.708 -0.678 . . . . 2.3599999999999999 111.692 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -85.38 120.87 27.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.774 0.321 . . . . 0.72999999999999998 111.428 -171.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -135.16 127.8 30.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 1.3899999999999999 110.42 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 50' ' ' ILE . 68.2 mt -66.12 -11.02 46.24 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.223 0.453 . . . . 0.72999999999999998 112.223 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -85.12 -11.33 55.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.125 0.488 . . . . 0.58999999999999997 109.944 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.5 mt -127.52 -39.81 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.344 -0.389 . . . . 0.89000000000000001 110.906 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -95.73 8.26 43.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.529 -0.305 . . . . 2.23 111.146 -173.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 89.6 m -157.59 159.56 37.2 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -132.67 -78.28 0.49 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.303 -0.408 . . . . 0.67000000000000004 110.615 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 80.8 p -83.65 -169.72 2.7 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.26 -0.275 . . . . 0.38 110.596 177.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.6 OUTLIER -77.05 -41.84 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.568 -0.453 . . . . 0.68000000000000005 110.095 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.692 ' HB2' ' OD1' ' A' ' 33' ' ' ASP . 24.6 ttm180 -59.87 -33.43 71.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.428 -0.351 . . . . 3.23 111.324 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.69 -29.86 28.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.498 0.499 . . . . 0.28999999999999998 110.718 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.611 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.5 OUTLIER -85.39 -51.27 6.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.924 -0.58 . . . . 0.64000000000000001 109.753 175.235 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HD3' HD11 ' A' ' 13' ' ' LEU . 10.5 mmtp -49.58 -59.25 3.94 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.069 -0.969 . . . . 2.3999999999999999 111.298 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.45 -29.02 69.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.648 -1.16 . . . . 1.6599999999999999 110.899 -173.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.9 -37.12 75.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.98999999999999999 111.138 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.611 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 22.3 mtp . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.077 -0.51 . . . . 1.1000000000000001 110.618 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.135 0 N-CA-C 111.945 -0.462 . . . . 0.53000000000000003 111.945 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.91 157.21 10.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.8 0.333 . . . . 0.39000000000000001 110.489 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.0 m -78.94 165.59 23.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.346 -0.388 . . . . 1.5600000000000001 110.159 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -61.37 -31.44 71.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.821 0.819 . . . . 2.02 109.204 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.14 -45.94 83.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.381 -1.281 . . . . 1.9099999999999999 110.788 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -72.87 -21.85 60.86 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.339 -0.846 . . . . 1.5800000000000001 110.823 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 tp -73.22 -26.07 61.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.828 -0.623 . . . . 0.98999999999999999 110.273 172.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -25.59 36.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.698 0.761 . . . . 0.88 109.796 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.75 -32.77 23.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.048 -0.978 . . . . 0.29999999999999999 111.356 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.512 HG11 ' SD ' ' A' ' 82' ' ' MET . 2.9 p -67.28 -44.53 87.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 120.874 -0.33 . . . . 0.23000000000000001 111.785 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.6 mtp -60.43 -27.82 67.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.204 -0.453 . . . . 1.6299999999999999 111.931 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 24.4 ptt85 -79.85 -32.87 40.51 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.598 . . . . 3.1699999999999999 111.459 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.35 -37.86 78.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.72 -0.844 . . . . 0.23000000000000001 108.72 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.2 t -64.87 -39.16 84.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.793 -1.094 . . . . 0.33000000000000002 109.977 174.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -69.16 -27.33 65.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.91 -0.586 . . . . 1.3799999999999999 111.344 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 43.9 mt-10 -85.98 -30.27 22.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.018 0.437 . . . . 2.2599999999999998 111.117 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.727 ' HG3' HG12 ' A' ' 50' ' ' ILE . 72.2 mm-40 -82.63 -45.49 14.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.859 -0.609 . . . . 0.77000000000000002 112.031 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.507 ' HA ' HD11 ' A' ' 42' ' ' ILE . 73.4 p -72.13 -45.38 60.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.85 0.357 . . . . 1.23 111.248 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.72 2.2 43.09 Favored Glycine 0 C--O 1.23 -0.095 0 N-CA-C 111.104 -0.798 . . . . 0.54000000000000004 111.104 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.755 HD11 ' HG3' ' A' ' 40' ' ' MET . 3.9 mt -93.7 104.98 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.297 -0.631 . . . . 0.80000000000000004 109.297 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -42.21 143.75 0.56 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.841 0.713 . . . . 0.56999999999999995 112.317 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.6 tp -54.44 -32.84 58.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.799 -0.637 . . . . 0.96999999999999997 111.281 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -78.0 -10.51 59.63 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.889 0.376 . . . . 2.23 111.013 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -109.3 -6.54 15.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.187 -0.672 . . . . 2.2400000000000002 109.187 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.519 HD11 HG11 ' A' ' 75' ' ' VAL . 41.3 tp -76.84 98.72 4.94 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.399 -0.819 . . . . 1.1000000000000001 110.221 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.3 p -121.93 163.63 18.97 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.967 -1.015 . . . . 0.59999999999999998 108.476 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.05 -3.75 14.39 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.782 0.29 . . . . 2.29 111.782 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -70.91 -23.44 62.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.373 -0.376 . . . . 2.29 110.595 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.463 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 21.3 m -75.65 149.8 38.1 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.527 0.68 . . . . 1.0600000000000001 111.399 -174.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.773 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 16.8 t-20 -126.13 122.15 34.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.099 -0.955 . . . . 0.80000000000000004 108.768 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.797 ' HD1' HG13 ' A' ' 42' ' ' ILE . 20.6 m-85 -55.34 -46.84 76.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.852 0.358 . . . . 0.46999999999999997 111.18 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.31 -29.59 62.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.341 -0.391 . . . . 0.46000000000000002 111.573 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.773 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 30.7 t70 -71.17 -35.58 71.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.537 0.684 . . . . 0.82999999999999996 110.36 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.755 ' HG3' HD11 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -75.54 -24.53 56.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.35 -0.841 . . . . 2.48 109.663 -175.663 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.16 28.28 4.73 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.529 -0.843 . . . . 0.44 112.429 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.797 HG13 ' HD1' ' A' ' 37' ' ' PHE . 33.2 mm -74.34 107.94 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 0.52000000000000002 110.571 176.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.77 170.97 15.75 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.512 -0.551 . . . . 1.9399999999999999 109.512 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.3 p -55.33 -36.85 66.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.884 -0.598 . . . . 1.03 110.388 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -52.23 -59.05 4.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.32 -0.854 . . . . 0.58999999999999997 110.539 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.574 ' O ' HG13 ' A' ' 50' ' ' ILE . 32.8 t -66.75 -43.26 84.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.14 -0.224 . . . . 1.22 111.134 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.538 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 87.7 p -60.35 -29.97 69.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.376 . . . . 0.81000000000000005 111.254 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.8 tpp -75.81 -46.12 32.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.895 -0.593 . . . . 2.25 109.806 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.558 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 49.8 t -59.54 -45.46 93.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.958 -1.019 . . . . 0.35999999999999999 110.616 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.727 HG12 ' HG3' ' A' ' 23' ' ' GLU . 55.8 mt -51.7 -52.8 19.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.904 0.383 . . . . 0.26000000000000001 110.447 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -57.59 -37.24 81.94 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.712 -0.677 . . . . 0.28999999999999998 112.551 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -66.46 -45.91 78.18 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.983 -0.377 . . . . 0.92000000000000004 109.983 177.523 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 6.0 mtp180 -60.64 -27.07 67.51 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.567 -0.288 . . . . 1.23 111.061 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 12.5 m-30 -58.01 -41.07 82.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.205 0.526 . . . . 0.28000000000000003 110.135 173.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.735 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 61.3 mtp180 -84.0 -32.11 25.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.833 -0.621 . . . . 2.8100000000000001 111.205 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 52' ' ' SER . 20.0 mm-40 -82.9 -47.07 12.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.237 -0.438 . . . . 2.2599999999999998 111.158 -174.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.09 -42.58 11.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 2.6200000000000001 112.151 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.55 -32.76 12.1 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.695 0.257 . . . . 0.67000000000000004 111.695 -174.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.96 33.41 8.99 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.746 -0.74 . . . . 0.45000000000000001 112.574 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.735 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 87.7 mt -86.5 115.84 24.26 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 110.409 -0.219 . . . . 0.63 110.409 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -95.21 58.37 2.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.649 0.737 . . . . 2.27 109.589 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.86 -29.79 50.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.859 -1.064 . . . . 1.6399999999999999 111.449 -175.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.28 169.9 12.59 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.734 -0.746 . . . . 0.75 112.394 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -89.36 -13.29 2.92 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.171 2.58 . . . . 1.1299999999999999 112.671 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -82.81 -17.36 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.523 . . . . 2.3599999999999999 112.239 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -82.3 114.27 20.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.173 0.511 . . . . 0.72999999999999998 111.139 -173.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.9 m -128.93 125.3 37.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.911 -0.586 . . . . 1.3899999999999999 109.94 176.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 68.2 mt -58.55 -40.0 81.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.327 -0.397 . . . . 0.72999999999999998 111.691 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -60.8 -8.1 2.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.193 -0.458 . . . . 0.58999999999999997 111.674 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.5 -40.19 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.939 -0.475 . . . . 0.89000000000000001 111.47 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -109.77 -1.91 17.65 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.56 0.578 . . . . 2.23 112.56 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.8 m -142.38 97.83 3.19 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.488 -0.757 . . . . 1.0 110.281 -175.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.6 p -89.58 -30.27 18.3 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.638 -0.71 . . . . 0.67000000000000004 111.034 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -114.46 -176.51 2.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.135 -0.484 . . . . 0.38 110.468 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.519 HG11 HD11 ' A' ' 31' ' ' LEU . 1.5 t -81.61 -43.3 19.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.998 0.428 . . . . 0.68000000000000005 110.437 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.61 ' HA ' ' CG ' ' A' ' 79' ' ' LYS . 29.3 ttm180 -64.97 -28.41 69.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.106 -0.497 . . . . 3.23 111.002 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.5 -31.21 55.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 0.28999999999999998 110.749 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.8 OUTLIER -75.7 -47.89 24.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.304 -0.628 . . . . 0.64000000000000001 109.304 176.77 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.61 ' CG ' ' HA ' ' A' ' 76' ' ' ARG . 26.8 mmtp -46.97 -50.01 19.77 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.96 -1.018 . . . . 2.3999999999999999 110.59 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -54.36 -55.33 29.66 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.301 -0.863 . . . . 1.6599999999999999 111.709 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -56.29 -37.62 70.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.479 -0.782 . . . . 0.98999999999999999 112.245 -173.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 24.8 mtp . . . . . 0 C--N 1.324 -0.506 0 CA-C-O 120.871 0.367 . . . . 1.1000000000000001 111.439 -174.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 111.339 -0.704 . . . . 0.53000000000000003 111.339 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 3.9 m -112.21 158.96 12.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.159 -0.312 . . . . 0.39000000000000001 110.159 -177.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.1 p -87.11 -178.59 6.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.204 -0.453 . . . . 1.5600000000000001 110.5 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -68.43 -30.34 69.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.295 -0.631 . . . . 2.02 109.295 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.4 -41.0 96.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.322 -0.854 . . . . 1.9099999999999999 110.408 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.469 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 58.1 mttt -74.3 -26.64 60.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.842 -0.617 . . . . 1.5800000000000001 111.002 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.23 -23.2 54.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.008 -0.542 . . . . 0.98999999999999999 110.057 173.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.3 -27.11 42.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.5 0.667 . . . . 0.88 109.694 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -83.9 -26.76 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.054 -0.975 . . . . 0.29999999999999999 111.66 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 p -71.83 -44.56 67.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 111.782 0.29 . . . . 0.23000000000000001 111.782 -178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.524 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 73.8 mtp -60.44 -34.37 73.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.486 -0.325 . . . . 1.6299999999999999 111.42 -175.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 12.3 ptt180 -69.64 -29.47 66.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.707 0.289 . . . . 3.1699999999999999 110.688 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.37 -39.33 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.01 -0.737 . . . . 0.23000000000000001 109.01 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.86 -49.05 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.838 -1.074 . . . . 0.33000000000000002 110.06 176.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.499 ' OG ' HD22 ' A' ' 31' ' ' LEU . 25.7 m -54.96 -47.19 74.84 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 112.401 0.519 . . . . 1.3799999999999999 112.401 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -57.33 -46.43 83.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.055 0.391 . . . . 2.2599999999999998 112.055 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HB3' ' OG ' ' A' ' 46' ' ' SER . 75.4 mm-40 -79.75 -33.51 40.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.292 -0.413 . . . . 0.77000000000000002 111.882 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.451 ' HB3' HD11 ' A' ' 42' ' ' ILE . 76.7 p -80.72 -42.8 21.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 1.23 111.525 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.32 12.92 34.59 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.982 -0.628 . . . . 0.54000000000000004 111.978 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mt -102.88 125.89 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 122.802 -0.234 . . . . 0.80000000000000004 110.544 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.45 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -56.3 145.11 27.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.394 -0.367 . . . . 0.56999999999999995 110.788 175.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.76 -43.9 38.23 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.579 0.549 . . . . 0.96999999999999997 110.404 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -76.41 -10.66 59.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.963 -0.562 . . . . 2.23 111.286 -173.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.45 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 34.1 mm-40 -107.93 -10.59 15.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.987 -0.745 . . . . 2.2400000000000002 108.987 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.499 HD22 ' OG ' ' A' ' 21' ' ' SER . 17.8 tp -79.49 97.47 6.43 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.347 -0.842 . . . . 1.1000000000000001 109.18 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.2 p -116.73 162.38 17.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.322 -0.854 . . . . 0.59999999999999998 108.855 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.834 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 45.5 m-20 -74.59 -3.54 31.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.782 0.325 . . . . 2.29 111.059 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.29 -20.22 44.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.705 -0.679 . . . . 2.29 110.528 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB2' HG21 ' A' ' 75' ' ' VAL . 43.6 m -70.88 157.32 38.34 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.749 0.785 . . . . 1.0600000000000001 111.275 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.673 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.1 t-20 -124.43 126.16 45.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.86 -1.064 . . . . 0.80000000000000004 108.682 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.516 ' HD1' HG13 ' A' ' 42' ' ' ILE . 26.1 m-85 -57.08 -52.78 63.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.116 0.484 . . . . 0.46999999999999997 111.308 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.07 -22.87 63.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.053 -0.521 . . . . 0.46000000000000002 111.254 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.6 t70 -83.54 -16.0 47.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.82999999999999996 110.538 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 65.9 mmm -101.46 1.49 38.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 2.48 111.706 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.53 26.22 23.56 Favored Glycine 0 C--O 1.23 -0.152 0 C-N-CA 119.79 -1.195 . . . . 0.44 112.767 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.516 HG13 ' HD1' ' A' ' 37' ' ' PHE . 18.3 mm -72.01 107.7 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.195 0.521 . . . . 0.52000000000000002 110.018 175.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.8 159.78 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.291 -0.868 . . . . 1.9399999999999999 110.194 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 69' ' ' PHE . 1.4 t -55.07 -39.62 69.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.433 0.635 . . . . 1.03 109.704 171.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.0 tm? -56.96 -53.09 61.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.315 -0.857 . . . . 0.58999999999999997 109.827 175.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.575 ' O ' HG13 ' A' ' 50' ' ' ILE . 32.4 t -67.91 -42.76 80.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.758 -0.201 . . . . 1.22 111.52 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 33.0 p -60.73 -34.25 74.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.005 0.431 . . . . 0.81000000000000005 111.151 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 30.2 ttp -72.69 -36.7 67.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.738 -0.664 . . . . 2.25 109.563 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 45' ' ' LEU . 42.6 t -70.34 -41.2 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.325 -0.852 . . . . 0.35999999999999999 110.256 -177.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 46' ' ' SER . 59.0 mt -55.14 -55.63 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.742 0.306 . . . . 0.26000000000000001 110.431 176.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.74 -28.96 72.5 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.11 -0.566 . . . . 0.28999999999999998 112.031 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.26 -42.66 75.28 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.717 0.294 . . . . 0.92000000000000004 110.689 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.76 ' HA ' ' HB3' ' A' ' 56' ' ' GLU . 28.9 mtp180 -69.01 -22.53 64.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 121.0 -0.28 . . . . 1.23 110.592 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.577 ' HE2' HD21 ' A' ' 78' ' ' LEU . 13.8 m-30 -57.46 -41.89 81.44 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.246 -0.649 . . . . 0.28000000000000003 109.246 172.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.67 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 35.8 mtp180 -81.19 -25.67 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.552 -0.749 . . . . 2.8100000000000001 110.665 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.76 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 29.9 tt0 -77.68 -62.77 1.56 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.754 -0.657 . . . . 2.2599999999999998 111.687 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -87.21 -41.56 13.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.969 -0.56 . . . . 2.6200000000000001 111.415 -172.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.99 -40.67 11.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.182 -0.463 . . . . 0.67000000000000004 111.33 -174.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.59 28.26 9.77 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.019 -0.61 . . . . 0.45000000000000001 112.047 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.67 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 51.2 mt -80.8 107.41 13.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.297 -0.26 . . . . 0.63 110.297 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.55 78.78 9.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.186 0.993 . . . . 2.27 110.196 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.495 HD11 ' HD2' ' A' ' 54' ' ' PHE . 13.8 mt -83.1 -72.98 0.43 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.422 -1.263 . . . . 1.6399999999999999 110.932 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.13 156.23 16.16 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.733 -0.947 . . . . 0.75 110.733 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.446 ' HG2' ' OE2' ' A' ' 65' ' ' GLU . 58.9 Cg_endo -78.37 -26.75 5.85 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.351 2.034 . . . . 1.1299999999999999 113.613 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.446 ' OE2' ' HG2' ' A' ' 64' ' ' PRO . 37.4 mp0 -98.7 26.42 5.65 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 122.082 -0.386 . . . . 2.3599999999999999 111.178 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -92.12 112.54 24.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.46 -0.336 . . . . 0.72999999999999998 110.439 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.5 t -132.46 123.87 27.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.968 0.414 . . . . 1.3899999999999999 110.199 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.507 HD12 HD12 ' A' ' 50' ' ' ILE . 70.2 mt -61.47 -16.45 47.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.089 -0.505 . . . . 0.72999999999999998 111.546 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.474 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 8.9 t80 -73.82 -15.05 61.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.186 -0.461 . . . . 0.58999999999999997 110.76 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.0 mt -130.04 -35.82 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.197 -0.456 . . . . 0.89000000000000001 110.965 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -91.97 6.8 44.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.484 -0.325 . . . . 2.23 111.871 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.75 162.78 37.14 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -175.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.0 p -134.92 -72.65 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.306 -0.406 . . . . 0.67000000000000004 111.209 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 71.8 p -84.88 -179.46 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.999 -0.371 . . . . 0.38 109.999 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -79.68 -39.92 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 108.865 -0.791 . . . . 0.68000000000000005 108.865 -176.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.834 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 13.6 tpt180 -60.38 -30.23 69.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.476 -1.238 . . . . 3.23 111.188 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.03 -33.63 73.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.433 -0.348 . . . . 0.28999999999999998 110.491 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.658 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.0 OUTLIER -71.93 -51.18 23.37 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.81 -0.811 . . . . 0.64000000000000001 108.81 176.569 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.524 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 27.9 mmtp -48.09 -57.57 5.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.51 -1.223 . . . . 2.3999999999999999 111.833 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -60.52 -37.27 80.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.572 -0.74 . . . . 1.6599999999999999 111.506 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -62.64 -38.24 89.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.941 -0.572 . . . . 0.98999999999999999 111.125 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.658 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 30.0 mtp . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 1.1000000000000001 111.519 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 110.749 -0.941 . . . . 0.53000000000000003 110.749 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.99 158.93 9.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.817 0.341 . . . . 0.39000000000000001 110.562 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.3 t -85.79 179.2 7.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.783 -0.451 . . . . 1.5600000000000001 109.783 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.81 -20.71 65.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.535 0.683 . . . . 2.02 109.643 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.9 -50.87 71.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.987 -1.006 . . . . 1.9099999999999999 110.689 175.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.489 ' HG2' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -70.54 -23.85 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.054 -0.721 . . . . 1.5800000000000001 109.054 -177.498 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.457 ' O ' ' HG3' ' A' ' 17' ' ' MET . 2.2 tp -69.49 -27.14 64.94 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.724 -0.671 . . . . 0.98999999999999999 110.403 174.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.7 -28.57 33.4 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.591 0.71 . . . . 0.88 109.986 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.51 -31.76 37.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.23 -0.895 . . . . 0.29999999999999999 111.013 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.553 HG23 ' CZ ' ' A' ' 54' ' ' PHE . 4.5 p -69.61 -46.99 73.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.275 -0.421 . . . . 0.23000000000000001 111.617 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.712 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 65.8 mtm -61.9 -28.88 69.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.426 -0.352 . . . . 1.6299999999999999 111.725 -172.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -81.61 -22.44 37.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.37 -0.377 . . . . 3.1699999999999999 111.25 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.0 t -82.42 -35.22 12.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.758 -0.83 . . . . 0.23000000000000001 108.758 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.4 t -64.89 -36.21 77.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.574 -1.194 . . . . 0.33000000000000002 110.09 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -59.7 -53.03 62.72 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.051 0.453 . . . . 1.3799999999999999 110.663 -176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -54.76 -55.61 28.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.165 -0.925 . . . . 2.2599999999999998 112.324 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -77.42 -22.84 50.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.341 0.497 . . . . 0.77000000000000002 112.341 -170.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.401 ' HA ' HD11 ' A' ' 42' ' ' ILE . 20.1 m -85.96 -31.41 22.11 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.553 -0.459 . . . . 1.23 110.006 175.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.13 -2.92 44.02 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.745 -0.741 . . . . 0.54000000000000004 112.844 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mt -101.48 153.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.833 0.349 . . . . 0.80000000000000004 110.603 -175.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.5 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -66.77 145.34 55.62 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.855 -0.612 . . . . 0.56999999999999995 110.646 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.2 tp -60.87 -36.39 79.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.996 0.427 . . . . 0.96999999999999997 110.422 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -72.58 -10.92 60.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 2.23 110.963 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.5 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 19.2 mt-10 -115.55 6.32 14.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.727 -0.669 . . . . 2.2400000000000002 110.793 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.429 HD11 HG11 ' A' ' 75' ' ' VAL . 44.6 tp -75.48 97.78 3.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.31 0.576 . . . . 1.1000000000000001 109.501 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.459 ' O ' HG21 ' A' ' 75' ' ' VAL . 59.4 p -101.11 156.85 17.18 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.203 -0.908 . . . . 0.59999999999999998 110.363 -175.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.694 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 16.5 p-10 -81.56 -4.61 56.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.279 0.562 . . . . 2.29 110.027 177.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.14 -22.85 60.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.891 -1.05 . . . . 2.29 110.841 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.438 ' HB2' HG21 ' A' ' 75' ' ' VAL . 39.8 m -77.43 155.4 31.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.957 0.884 . . . . 1.0600000000000001 111.568 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.931 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.4 t-20 -127.05 123.76 37.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.455 -1.313 . . . . 0.80000000000000004 107.455 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.649 ' HD1' HG13 ' A' ' 42' ' ' ILE . 11.6 m-85 -56.8 -54.76 42.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.855 -0.338 . . . . 0.46999999999999997 111.443 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.19 62.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.86 0.362 . . . . 0.46000000000000002 111.006 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.931 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 22.8 t70 -74.04 -29.12 61.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.495 . . . . 0.82999999999999996 110.815 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.1 mmt -83.04 -15.03 52.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.618 . . . . 2.48 111.228 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.11 14.86 15.66 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.158 -1.02 . . . . 0.44 112.258 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.649 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.0 mm -67.59 106.8 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.947 -0.76 . . . . 0.52000000000000002 108.947 174.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.91 177.52 8.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.473 -0.785 . . . . 1.9399999999999999 111.225 -177.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 t -58.59 -31.88 68.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.193 -0.912 . . . . 1.03 109.766 175.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.43 -62.93 1.51 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.985 -1.007 . . . . 0.58999999999999997 110.86 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.567 ' O ' HG13 ' A' ' 50' ' ' ILE . 15.2 m -68.64 -39.34 80.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.448 -0.342 . . . . 1.22 111.519 -173.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 47.0 p -65.6 -21.93 66.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.814 0.34 . . . . 0.81000000000000005 111.255 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.39 -43.73 20.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.101 -0.703 . . . . 2.25 109.101 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.7 t -62.76 -48.02 90.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.048 -0.978 . . . . 0.35999999999999999 110.84 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 46' ' ' SER . 77.1 mt -51.32 -56.6 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.317 -0.401 . . . . 0.26000000000000001 111.473 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.85 -30.65 78.31 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.611 -0.805 . . . . 0.28999999999999998 112.459 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -39.52 89.5 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.04 -0.264 . . . . 0.92000000000000004 110.451 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 25.6 mtp180 -65.19 -23.96 67.24 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.488 0.185 . . . . 1.23 110.882 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.628 ' HD2' HD11 ' A' ' 62' ' ' LEU . 11.8 m-30 -58.51 -38.69 78.23 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.482 0.658 . . . . 0.28000000000000003 109.501 175.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -79.07 -24.67 43.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.174 -0.921 . . . . 2.8100000000000001 110.95 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -78.56 -62.07 1.81 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.996 -0.547 . . . . 2.2599999999999998 111.412 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -87.82 -53.57 4.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.023 -0.535 . . . . 2.6200000000000001 111.639 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 mp -72.81 -27.59 62.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.963 -0.562 . . . . 0.67000000000000004 111.289 -171.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.65 31.1 57.02 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.623 -0.798 . . . . 0.45000000000000001 111.708 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 54' ' ' PHE . 81.8 mt -82.05 114.55 20.68 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 110.292 -0.262 . . . . 0.63 110.292 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -88.89 75.85 8.0 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.252 -0.647 . . . . 2.27 109.252 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.628 HD11 ' HD2' ' A' ' 54' ' ' PHE . 37.1 mt -82.4 -65.47 1.01 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.165 -0.925 . . . . 1.6399999999999999 109.998 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.24 165.71 23.0 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 114.647 -1.16 . . . . 0.75 110.75 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.94 -8.3 10.09 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.02 2.48 . . . . 1.1299999999999999 113.075 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -117.56 20.64 13.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.468 0.652 . . . . 2.3599999999999999 110.709 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.411 ' HE1' ' CE2' ' A' ' 81' ' ' PHE . 83.6 t80 -77.87 111.81 14.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.074 -0.512 . . . . 0.72999999999999998 109.916 -177.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.1 m -123.16 118.17 27.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.626 -0.715 . . . . 1.3899999999999999 110.739 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 42.6 mt -63.26 -33.31 75.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 0.72999999999999998 110.489 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.483 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 37.1 t80 -59.6 -16.65 27.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.618 -0.719 . . . . 0.58999999999999997 111.151 -175.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.7 mt -121.76 -40.14 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 121.044 -0.262 . . . . 0.89000000000000001 111.515 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.51 6.84 32.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.933 -0.707 . . . . 2.23 112.526 -173.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 82.1 m -150.2 86.65 1.43 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.251 0.548 . . . . 1.0 109.639 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.1 p -78.25 -59.01 2.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.591 -0.731 . . . . 0.67000000000000004 110.927 -172.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 82.3 p -86.9 -178.92 6.42 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.852 -0.425 . . . . 0.38 109.852 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -81.59 -42.54 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.306 0.574 . . . . 0.68000000000000005 109.89 -179.246 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.694 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 4.9 tpp180 -60.13 -29.06 68.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.361 -0.836 . . . . 3.23 110.613 176.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -59.59 -35.72 74.85 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.532 -0.304 . . . . 0.28999999999999998 110.951 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.554 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -72.58 -45.3 59.82 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.192 -0.67 . . . . 0.64000000000000001 109.192 177.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.712 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.8 mmtp -51.19 -61.3 2.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.853 -1.067 . . . . 2.3999999999999999 111.048 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.95 -24.42 65.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.766 -0.652 . . . . 1.6599999999999999 111.79 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 46.5 t80 -64.82 -37.15 86.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.009 0.433 . . . . 0.98999999999999999 110.262 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 12.8 mtp . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.633 -0.712 . . . . 1.1000000000000001 111.463 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 N-CA-C 111.465 -0.654 . . . . 0.53000000000000003 111.465 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 4.0 m -110.57 160.49 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.741 0.305 . . . . 0.39000000000000001 110.699 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -82.61 174.39 11.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.405 -0.591 . . . . 1.5600000000000001 109.405 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -66.9 -35.71 80.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.409 0.623 . . . . 2.02 109.74 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -56.93 -41.4 78.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.014 -0.994 . . . . 1.9099999999999999 111.202 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.587 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 47.5 mmtm -68.02 -24.72 65.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.697 -0.683 . . . . 1.5800000000000001 110.53 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 17' ' ' MET . 24.9 tp -70.72 -26.76 63.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.136 -0.484 . . . . 0.98999999999999999 111.146 173.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.94 -30.79 50.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.659 0.742 . . . . 0.88 109.3 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.596 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -75.83 -33.44 60.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.071 -0.968 . . . . 0.29999999999999999 110.405 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 13' ' ' LEU . 3.0 p -71.48 -45.46 68.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.318 -0.401 . . . . 0.23000000000000001 111.716 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 63.7 mtt -59.54 -33.95 72.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.69 -0.232 . . . . 1.6299999999999999 110.948 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 39.3 ptt180 -73.25 -30.35 63.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.046 -0.262 . . . . 3.1699999999999999 111.216 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -77.46 -34.17 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.739 -0.837 . . . . 0.23000000000000001 108.739 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 t -66.55 -40.96 87.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.681 -1.145 . . . . 0.33000000000000002 109.304 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.8 t -61.76 -23.48 66.2 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.318 -0.401 . . . . 1.3799999999999999 111.021 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.51 -49.69 10.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.203 0.525 . . . . 2.2599999999999998 111.165 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -84.85 -31.39 23.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.439 -0.801 . . . . 0.77000000000000002 112.372 -169.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.4 p -79.12 -35.43 42.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 1.23 111.129 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.75 13.8 56.17 Favored Glycine 0 C--O 1.234 0.106 0 C-N-CA 120.404 -0.903 . . . . 0.54000000000000004 111.336 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mt -105.08 111.73 35.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.494 -0.558 . . . . 0.80000000000000004 109.494 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.19 145.37 13.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 0.56999999999999995 111.256 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.5 tp -52.96 -34.61 56.56 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.912 -0.585 . . . . 0.96999999999999997 110.919 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.43 -19.46 61.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.865 -0.607 . . . . 2.23 111.579 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.34 -1.38 21.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.927 -0.398 . . . . 2.2400000000000002 109.927 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -73.93 97.91 2.91 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.577 0.703 . . . . 1.1000000000000001 109.493 -177.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.2 p -106.59 151.22 25.33 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.272 -0.876 . . . . 0.59999999999999998 109.097 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.831 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 27.1 m-20 -81.21 -3.19 51.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.84 0.352 . . . . 2.29 111.515 -174.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -93.62 -3.95 51.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.258 -0.428 . . . . 2.29 110.636 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.446 ' HB2' HG21 ' A' ' 75' ' ' VAL . 55.3 m -73.69 158.63 34.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.394 0.616 . . . . 1.0600000000000001 110.022 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.823 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.0 t-20 -125.82 124.95 42.07 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.538 -0.755 . . . . 0.80000000000000004 109.465 -176.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.732 ' HD1' HG13 ' A' ' 42' ' ' ILE . 35.5 m-85 -55.65 -50.19 70.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.891 0.376 . . . . 0.46999999999999997 111.181 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.07 70.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.015 0.436 . . . . 0.46000000000000002 111.221 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.823 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 32.8 t70 -72.68 -27.18 61.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.113 0.483 . . . . 0.82999999999999996 110.598 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.9 mmt -86.46 -12.28 49.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 2.48 111.423 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.44 23.17 9.73 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.317 -0.944 . . . . 0.44 112.784 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.732 HG13 ' HD1' ' A' ' 37' ' ' PHE . 24.5 mm -72.39 106.91 2.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.267 0.556 . . . . 0.52000000000000002 110.217 176.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -91.11 -178.66 5.23 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.648 -0.706 . . . . 1.9399999999999999 111.139 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.6 t -54.61 -49.03 71.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.278 -0.873 . . . . 1.03 110.796 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.3 tm? -50.32 -58.42 5.7 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.719 -0.673 . . . . 0.58999999999999997 110.883 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.467 ' O ' HG13 ' A' ' 50' ' ' ILE . 22.6 t -66.78 -46.34 75.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.854 0.359 . . . . 1.22 111.442 -174.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 59.0 p -65.16 -30.66 71.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.427 -0.352 . . . . 0.81000000000000005 111.73 -176.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.6 tpt -74.73 -41.69 59.68 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.055 -0.72 . . . . 2.25 109.055 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 31.8 t -57.48 -53.1 48.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.278 -0.874 . . . . 0.35999999999999999 110.503 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 46' ' ' SER . 68.9 mt -49.08 -53.9 6.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 O-C-N 123.131 0.27 . . . . 0.26000000000000001 111.264 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.37 -34.99 83.15 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.81 -0.71 . . . . 0.28999999999999998 112.485 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -68.52 -41.92 79.25 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.91 -0.316 . . . . 0.92000000000000004 110.222 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 1.8 mtp180 -68.54 -20.57 64.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.67 -0.241 . . . . 1.23 110.711 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.597 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.7 m-30 -59.92 -39.83 86.78 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.646 0.736 . . . . 0.28000000000000003 109.658 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.685 ' HD2' ' O ' ' A' ' 60' ' ' LEU . 9.8 mmm180 -73.76 -28.64 61.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.887 -1.051 . . . . 2.8100000000000001 110.298 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -81.53 -64.09 1.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.078 -0.51 . . . . 2.2599999999999998 112.096 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -83.78 -34.62 24.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.977 -0.556 . . . . 2.6200000000000001 111.392 -169.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.3 mp -97.22 -39.71 9.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.051 -0.522 . . . . 0.67000000000000004 110.817 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.38 36.2 8.97 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.534 -0.841 . . . . 0.45000000000000001 111.802 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.685 ' O ' ' HD2' ' A' ' 55' ' ' ARG . 93.4 mt -78.79 133.5 37.06 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.67 -0.122 . . . . 0.63 110.67 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.62 77.71 9.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.212 0.529 . . . . 2.27 110.732 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.597 HD11 ' HD2' ' A' ' 54' ' ' PHE . 55.1 mt -94.66 -60.54 1.68 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.609 0.719 . . . . 1.6399999999999999 109.694 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.41 176.75 24.53 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 109.916 -1.274 . . . . 0.75 109.916 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.77 -23.03 7.23 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.994 1.796 . . . . 1.1299999999999999 112.608 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -119.71 70.23 0.85 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.716 0.769 . . . . 2.3599999999999999 110.695 -175.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -109.92 111.46 22.89 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.282 -0.872 . . . . 0.72999999999999998 109.487 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.2 m -121.18 118.4 29.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.198 -0.455 . . . . 1.3899999999999999 110.51 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 59.8 mt -64.58 -25.19 67.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.376 . . . . 0.72999999999999998 111.047 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.562 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.9 t80 -72.16 -4.4 28.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.841 -0.618 . . . . 0.58999999999999997 110.353 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.94 -42.59 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.28 -0.418 . . . . 0.89000000000000001 110.947 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.46 8.87 33.66 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.365 0.505 . . . . 2.23 112.365 -169.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 89.2 m -152.5 159.23 43.34 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.044 -0.41 . . . . 1.0 110.089 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.9 p -134.25 -70.61 0.51 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.405 -0.362 . . . . 0.67000000000000004 110.962 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 77.6 p -83.26 -177.65 6.82 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.242 -0.286 . . . . 0.38 110.318 175.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.525 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -83.25 -41.58 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.635 0 N-CA-C 108.637 -0.875 . . . . 0.68000000000000005 108.637 -176.291 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.831 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 7.7 tpt180 -59.26 -29.62 67.7 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 113.743 -1.572 . . . . 3.23 110.91 175.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.26 68.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.786 0.326 . . . . 0.28999999999999998 110.826 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.47 -43.07 41.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.972 0.892 . . . . 0.64000000000000001 109.151 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.53 ' HG3' ' HA ' ' A' ' 76' ' ' ARG . 24.9 mmtm -60.01 -51.54 69.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.152 -1.386 . . . . 2.3999999999999999 109.83 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.81 -29.75 70.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.714 -1.13 . . . . 1.6599999999999999 111.162 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -72.96 -39.13 66.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.864 -0.607 . . . . 0.98999999999999999 110.767 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.595 -0.729 . . . . 1.1000000000000001 112.349 -174.588 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.708 0 N-CA-C 111.172 -0.771 . . . . 0.53000000000000003 111.172 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.713 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 2.7 m -114.26 156.28 15.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.855 0.359 . . . . 0.39000000000000001 110.344 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.6 t -95.41 -176.52 3.8 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.12 -0.491 . . . . 1.5600000000000001 109.728 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -62.65 -26.17 68.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.052 0.453 . . . . 2.02 109.969 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.48 -55.17 37.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.736 -0.666 . . . . 1.9099999999999999 110.937 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.713 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 88.0 mttt -75.32 -19.8 59.43 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.31 -0.404 . . . . 1.5800000000000001 110.468 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.601 HD11 ' HD2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -73.76 -31.14 63.17 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.022 -0.535 . . . . 0.98999999999999999 110.183 172.457 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.16 -29.39 43.02 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.232 -0.918 . . . . 0.88 109.585 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -79.54 -25.7 41.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.936 -1.029 . . . . 0.29999999999999999 111.021 -175.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.7 p -77.68 -43.76 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.557 -0.292 . . . . 0.23000000000000001 111.32 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.555 ' HB3' HD23 ' A' ' 31' ' ' LEU . 66.9 mtm -63.35 -28.99 70.38 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.983 -0.287 . . . . 1.6299999999999999 111.006 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 20.0 ptt180 -74.45 -33.62 62.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.86 -0.336 . . . . 3.1699999999999999 110.62 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.12 -38.32 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.624 0.726 . . . . 0.23000000000000001 109.143 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.3 t -61.87 -42.1 93.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.614 -1.175 . . . . 0.33000000000000002 110.982 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.0 m -71.55 -41.36 69.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.286 0.565 . . . . 1.3799999999999999 110.259 -171.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.06 -46.61 82.34 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.987 -1.006 . . . . 2.2599999999999998 111.663 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.44 -31.46 48.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.459 -0.337 . . . . 0.77000000000000002 111.502 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.414 ' HA ' HD11 ' A' ' 42' ' ' ILE . 53.1 m -77.85 -35.87 50.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.844 0.354 . . . . 1.23 111.175 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.72 0.72 36.79 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.793 -0.718 . . . . 0.54000000000000004 112.494 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.853 HD11 ' SD ' ' A' ' 40' ' ' MET . 5.7 mt -92.81 161.18 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.286 0.565 . . . . 0.80000000000000004 110.6 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -87.16 143.13 27.44 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.134 -0.939 . . . . 0.56999999999999995 109.264 171.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.0 tp -56.18 -29.17 60.47 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.278 0.362 . . . . 0.96999999999999997 111.56 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -69.32 -15.21 63.28 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.34 -0.391 . . . . 2.23 111.944 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -114.07 3.71 15.38 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.121 -0.231 . . . . 2.2400000000000002 111.334 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.555 HD23 ' HB3' ' A' ' 17' ' ' MET . 39.1 tp -78.73 99.09 6.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.332 0.587 . . . . 1.1000000000000001 110.335 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.1 p -120.06 163.28 17.89 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.007 -0.738 . . . . 0.59999999999999998 109.007 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.643 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.8 p-10 -70.91 -3.0 16.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.158 0.429 . . . . 2.29 112.158 -177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.41 -22.97 61.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.983 0.42 . . . . 2.29 110.878 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.472 ' HB3' ' CG2' ' A' ' 75' ' ' VAL . 33.7 t -76.14 158.78 31.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.422 0.63 . . . . 1.0600000000000001 111.742 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.2 t-20 -127.16 119.42 26.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.363 -0.835 . . . . 0.80000000000000004 109.277 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.775 ' HD1' HG13 ' A' ' 42' ' ' ILE . 38.5 m-85 -50.84 -49.6 58.49 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.123 0.487 . . . . 0.46999999999999997 111.291 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.8 -32.77 74.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.798 -0.637 . . . . 0.46000000000000002 111.28 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 34.2 t70 -73.51 -26.99 61.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.157 0.503 . . . . 0.82999999999999996 110.541 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.853 ' SD ' HD11 ' A' ' 26' ' ' ILE . 65.3 mtm -79.7 -24.1 41.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.805 -0.634 . . . . 2.48 110.183 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.08 26.44 6.66 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.426 -0.892 . . . . 0.44 112.584 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.775 HG13 ' HD1' ' A' ' 37' ' ' PHE . 26.9 mm -65.14 108.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.604 -0.517 . . . . 0.52000000000000002 109.604 175.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -82.34 176.49 9.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.581 -0.736 . . . . 1.9399999999999999 110.435 -175.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.0 t -61.02 -40.25 92.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.805 -0.634 . . . . 1.03 109.865 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.27 -56.71 17.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.522 -0.763 . . . . 0.58999999999999997 110.002 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.5 m -59.78 -44.22 94.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.09 -0.504 . . . . 1.22 111.206 -177.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.577 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 50.2 m -58.72 -39.29 80.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.744 -0.662 . . . . 0.81000000000000005 111.606 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.4 tpt -72.66 -37.5 67.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.374 0.606 . . . . 2.25 110.13 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.606 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.0 t -62.83 -53.84 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.14 -0.936 . . . . 0.35999999999999999 109.871 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 46' ' ' SER . 66.5 mt -49.97 -52.4 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.281 -0.418 . . . . 0.26000000000000001 111.281 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.09 -36.97 93.15 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.871 -0.681 . . . . 0.28999999999999998 112.518 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t -63.66 -44.2 94.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.715 0.293 . . . . 0.92000000000000004 110.467 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 11.7 mtp180 -65.87 -27.05 67.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.394 -0.366 . . . . 1.23 110.65 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.454 ' HB3' HD12 ' A' ' 60' ' ' LEU . 13.4 m-30 -57.31 -40.66 78.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.36 0.6 . . . . 0.28000000000000003 110.032 175.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 47.5 mtp180 -78.62 -27.82 45.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.732 -0.667 . . . . 2.8100000000000001 111.002 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.74 -56.73 4.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.217 -0.447 . . . . 2.2599999999999998 111.474 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -88.14 -36.46 16.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.235 -0.439 . . . . 2.6200000000000001 112.005 -172.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.3 mp -99.76 -25.08 14.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.892 0.33 . . . . 0.67000000000000004 111.892 -172.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.26 41.62 37.75 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.514 -0.85 . . . . 0.45000000000000001 111.699 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 54' ' ' PHE . 19.1 mt -83.65 136.73 34.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.986 0.365 . . . . 0.63 111.986 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -93.4 88.38 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 2.27 110.208 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.495 HD11 ' HE2' ' A' ' 81' ' ' PHE . 0.7 OUTLIER -112.89 -61.05 1.79 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.135 -0.484 . . . . 1.6399999999999999 109.92 178.55 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.58 170.72 12.45 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.811 -0.709 . . . . 0.75 112.155 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.57 10.43 3.71 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.995 2.463 . . . . 1.1299999999999999 111.937 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.21 9.97 12.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.161 -0.927 . . . . 2.3599999999999999 110.751 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -95.47 116.21 28.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.993 -0.548 . . . . 0.72999999999999998 110.678 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.0 m -136.81 122.45 19.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.024 -0.535 . . . . 1.3899999999999999 110.255 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.412 HD12 HD12 ' A' ' 50' ' ' ILE . 57.2 mt -56.85 -41.82 78.6 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.953 -0.567 . . . . 0.72999999999999998 111.98 -176.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.577 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.4 t80 -55.67 -14.18 2.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.888 -0.596 . . . . 0.58999999999999997 112.223 -174.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.51 -40.7 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.095 -0.378 . . . . 0.89000000000000001 111.112 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -106.05 7.84 32.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.059 0.392 . . . . 2.23 112.059 -169.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 92.3 m -148.91 136.63 20.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.342 0.591 . . . . 1.0 109.863 -176.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.2 p -114.24 -76.15 0.58 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.038 -0.528 . . . . 0.67000000000000004 111.071 -173.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 77.7 p -83.19 -172.8 4.34 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.12 -0.362 . . . . 0.38 110.449 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.524 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -81.36 -40.87 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.03 -0.729 . . . . 0.68000000000000005 109.03 -175.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.643 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -66.98 -24.89 66.09 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.897 -1.047 . . . . 3.23 110.397 179.323 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.0 -34.41 71.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.444 -0.344 . . . . 0.28999999999999998 110.462 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.66 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -71.22 -48.05 53.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.745 -0.835 . . . . 0.64000000000000001 108.745 177.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HD2' HD11 ' A' ' 13' ' ' LEU . 30.0 mmtm -54.04 -50.09 67.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.964 -1.471 . . . . 2.3999999999999999 111.164 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.12 -44.99 92.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 1.6599999999999999 110.627 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.495 ' HE2' HD11 ' A' ' 62' ' ' LEU . 34.2 t80 -63.39 -30.07 71.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.043 -0.98 . . . . 0.98999999999999999 111.162 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.66 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 32.8 mtp . . . . . 0 N--CA 1.462 0.175 0 CA-C-N 116.177 -0.465 . . . . 1.1000000000000001 110.707 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 111.744 -0.543 . . . . 0.53000000000000003 111.744 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.45 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 4.0 m -114.43 162.11 12.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.324 -0.25 . . . . 0.39000000000000001 110.324 -175.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 p -84.25 174.09 10.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.153 -0.314 . . . . 1.5600000000000001 110.153 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -73.38 -19.46 60.99 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.197 -0.668 . . . . 2.02 109.197 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.59 -42.11 95.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.094 -0.957 . . . . 1.9099999999999999 109.398 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.45 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 43.8 mmtm -67.36 -36.26 81.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.364 -0.835 . . . . 1.5800000000000001 110.219 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -62.98 -29.44 70.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.941 -0.572 . . . . 0.98999999999999999 110.678 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.38 -28.6 52.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.598 0.713 . . . . 0.88 109.682 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.52 -34.24 31.34 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.098 -0.956 . . . . 0.29999999999999999 111.124 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.508 HG23 ' CE1' ' A' ' 54' ' ' PHE . 5.7 p -68.55 -45.99 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.654 0.613 . . . . 0.23000000000000001 112.654 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 58.4 mtm -56.35 -34.95 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.943 0.349 . . . . 1.6299999999999999 111.943 -172.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -78.69 -22.97 45.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.34 -0.544 . . . . 3.1699999999999999 111.673 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.58 -34.88 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 122.05 0.929 . . . . 0.23000000000000001 108.551 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 t -69.11 -36.84 75.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.184 -1.371 . . . . 0.33000000000000002 110.469 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.4 t -68.91 -22.62 64.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.787 0.327 . . . . 1.3799999999999999 110.765 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -86.23 -48.96 8.08 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.976 0.417 . . . . 2.2599999999999998 111.919 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -79.5 -9.92 59.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.475 . . . . 0.77000000000000002 112.1 -172.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -99.91 -42.8 6.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.989 0.423 . . . . 1.23 111.309 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.07 7.03 50.93 Favored Glycine 0 C--O 1.235 0.19 0 C-N-CA 120.711 -0.757 . . . . 0.54000000000000004 111.261 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.564 HD11 ' HG3' ' A' ' 40' ' ' MET . 4.9 mt -93.14 111.91 25.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.307 -0.627 . . . . 0.80000000000000004 109.307 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -48.4 144.63 3.92 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.456 0.473 . . . . 0.56999999999999995 111.229 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.2 tp -55.23 -29.3 57.72 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.141 -0.481 . . . . 0.96999999999999997 111.6 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -83.8 -10.25 58.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 2.23 111.039 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.435 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 33.2 mt-10 -105.57 -9.46 17.4 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.728 -0.842 . . . . 2.2400000000000002 108.728 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.565 HD11 HG11 ' A' ' 75' ' ' VAL . 36.7 tp -72.76 98.28 2.37 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.812 -1.085 . . . . 1.1000000000000001 109.649 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.6 p -115.79 158.89 22.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.147 -1.057 . . . . 0.59999999999999998 108.147 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.886 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 17.4 p-10 -75.6 -2.41 29.1 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.931 -0.308 . . . . 2.29 110.821 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -88.22 -3.04 58.92 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.939 -0.573 . . . . 2.29 110.842 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.474 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 45.6 m -81.61 152.91 26.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.488 0.661 . . . . 1.0600000000000001 110.704 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.686 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 15.0 t-20 -122.0 122.96 40.53 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.49 -0.777 . . . . 0.80000000000000004 109.141 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.664 ' HD1' HG13 ' A' ' 42' ' ' ILE . 23.7 m-85 -55.75 -53.58 54.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.988 0.423 . . . . 0.46999999999999997 111.359 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.86 -27.79 67.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.054 -0.521 . . . . 0.46000000000000002 111.066 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.686 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 35.8 t70 -72.45 -29.2 63.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.82999999999999996 110.586 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.564 ' HG3' HD11 ' A' ' 26' ' ' ILE . 14.9 mmt -83.35 -19.9 35.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.896 -0.593 . . . . 2.48 111.318 -176.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.92 16.73 8.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.356 -0.926 . . . . 0.44 112.441 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.664 HG13 ' HD1' ' A' ' 37' ' ' PHE . 23.4 mm -66.6 108.27 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.139 0.495 . . . . 0.52000000000000002 110.323 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -81.34 167.49 19.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.667 -0.697 . . . . 1.9399999999999999 110.068 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.8 t -54.02 -35.14 61.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.447 -0.575 . . . . 1.03 109.447 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.1 tm? -59.55 -62.56 1.78 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.562 -0.745 . . . . 0.58999999999999997 110.022 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.543 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.2 m -59.86 -44.52 94.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.247 -0.433 . . . . 1.22 112.153 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.554 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 36.4 p -65.34 -30.36 71.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.021 0.438 . . . . 0.81000000000000005 111.125 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.4 tpt -75.06 -30.82 61.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.647 -0.706 . . . . 2.25 109.621 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 45' ' ' LEU . 76.3 t -78.62 -36.78 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.148 -0.933 . . . . 0.35999999999999999 110.497 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 46' ' ' SER . 66.9 mt -56.44 -52.57 50.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.37 -0.233 . . . . 0.26000000000000001 110.37 173.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.67 -26.25 68.29 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.774 -0.727 . . . . 0.28999999999999998 111.943 178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 4.1 m -69.62 -45.21 69.05 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 120.679 0.276 . . . . 0.92000000000000004 110.863 176.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -65.07 -27.0 68.48 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.624 0.249 . . . . 1.23 110.856 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.611 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.7 m-30 -54.86 -39.97 69.18 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.718 -0.475 . . . . 0.28000000000000003 109.718 174.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.691 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 12.2 mtp180 -81.64 -34.77 30.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.72 -0.673 . . . . 2.8100000000000001 111.534 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -86.05 -63.88 1.24 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.039 0.447 . . . . 2.2599999999999998 111.544 -173.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -71.14 -36.3 72.03 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.454 -0.794 . . . . 2.6200000000000001 111.499 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.75 -57.0 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.67000000000000004 111.055 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.85 27.61 3.19 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.823 -0.703 . . . . 0.45000000000000001 113.221 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.691 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 55.2 mt -84.1 112.19 20.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.78 0.29 . . . . 0.63 110.353 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -85.58 66.37 9.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 122.235 1.017 . . . . 2.27 110.163 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.611 HD11 ' HD2' ' A' ' 54' ' ' PHE . 19.4 mt -64.72 -67.45 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.507 -1.224 . . . . 1.6399999999999999 110.682 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.75 173.25 39.12 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 110.285 -1.126 . . . . 0.75 110.285 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.8 -35.89 0.68 Allowed 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.372 2.048 . . . . 1.1299999999999999 113.048 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -108.27 62.83 0.61 Allowed 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 121.078 0.466 . . . . 2.3599999999999999 110.766 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -109.66 111.66 23.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.698 -0.482 . . . . 0.72999999999999998 109.698 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.6 m -129.27 118.89 23.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.98 -0.555 . . . . 1.3899999999999999 110.74 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 84.1 mt -64.64 -16.06 62.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.911 -0.586 . . . . 0.72999999999999998 111.092 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.554 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 46.0 t80 -82.5 -12.03 58.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.923 -0.581 . . . . 0.58999999999999997 110.948 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 71.8 mt -117.77 -41.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.773 -0.371 . . . . 0.89000000000000001 111.624 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.26 15.23 16.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.454 0.645 . . . . 2.23 110.671 -173.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 76.8 m -146.72 156.63 43.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.7 p -135.93 -63.17 0.66 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.685 0.279 . . . . 0.67000000000000004 110.776 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 44.3 p -93.04 179.08 5.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.195 -0.298 . . . . 0.38 110.195 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.565 HG11 HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -75.83 -42.91 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 121.484 0.659 . . . . 0.68000000000000005 109.397 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.886 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 40.7 ttp180 -52.86 -37.96 60.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.501 -1.227 . . . . 3.23 111.728 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -55.83 -33.9 64.91 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.852 0.72 . . . . 0.28999999999999998 111.311 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.47 -47.96 30.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.203 0.525 . . . . 0.64000000000000001 110.144 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.592 ' CD ' ' HA ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -56.4 -60.97 2.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.263 -0.88 . . . . 2.3999999999999999 110.235 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -54.62 -37.5 65.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.774 -1.103 . . . . 1.6599999999999999 111.609 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 38.2 t80 -62.07 -37.88 86.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.98999999999999999 110.966 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.445 ' HB3' HG22 ' A' ' 8' ' ' VAL . 12.2 mtt . . . . . 0 C--O 1.235 0.307 0 CA-C-N 116.059 -0.519 . . . . 1.1000000000000001 112.017 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 111.829 -0.508 . . . . 0.53000000000000003 111.829 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 m -109.92 159.31 9.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.822 0.344 . . . . 0.39000000000000001 110.46 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 m -75.49 166.99 22.74 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.777 -0.453 . . . . 1.5600000000000001 109.777 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -69.41 -29.56 67.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.99 -0.744 . . . . 2.02 108.99 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.44 -34.64 77.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.079 -0.964 . . . . 1.9099999999999999 110.242 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -63.69 -29.43 70.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 1.5800000000000001 110.31 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.407 ' O ' ' HG3' ' A' ' 17' ' ' MET . 18.2 tp -66.95 -23.97 66.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.831 -0.622 . . . . 0.98999999999999999 110.86 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.46 -31.57 26.49 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.585 0.707 . . . . 0.88 109.516 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -29.03 55.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.155 -0.93 . . . . 0.29999999999999999 110.509 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.459 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 3.3 p -73.65 -45.95 49.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.18 -0.464 . . . . 0.23000000000000001 111.036 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.907 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 75.6 mtp -61.13 -35.32 76.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 1.6299999999999999 111.226 -175.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.499 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 12.5 ptm180 -66.13 -37.64 86.2 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 120.459 -0.497 . . . . 3.1699999999999999 110.567 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.9 -41.03 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 109.039 -0.726 . . . . 0.23000000000000001 109.039 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -57.65 -47.23 86.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.841 -1.072 . . . . 0.33000000000000002 110.129 175.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.402 ' HA ' ' HG ' ' A' ' 24' ' ' SER . 17.2 m -68.08 -42.37 80.5 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.071 0.397 . . . . 1.3799999999999999 112.071 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 45.2 mt-10 -63.46 -27.76 69.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.252 -0.431 . . . . 2.2599999999999998 111.579 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -91.06 -38.79 12.57 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.967 0.358 . . . . 0.77000000000000002 111.967 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.402 ' HG ' ' HA ' ' A' ' 21' ' ' SER . 65.6 p -72.95 -44.98 60.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.958 0.409 . . . . 1.23 111.57 -176.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.98 38.26 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.68 -0.771 . . . . 0.54000000000000004 111.549 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mt -94.79 117.8 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.483 -0.562 . . . . 0.80000000000000004 109.483 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.662 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -47.28 141.75 4.44 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.131 0.419 . . . . 0.56999999999999995 112.131 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 tp -52.7 -38.64 60.99 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.509 -0.769 . . . . 0.96999999999999997 111.472 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.39 -9.22 58.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.761 -0.654 . . . . 2.23 111.253 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.662 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 15.6 mm-40 -110.81 -6.87 14.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.93 -0.577 . . . . 2.2400000000000002 109.983 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.5 tp -75.06 98.56 3.67 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.201 0.524 . . . . 1.1000000000000001 110.284 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.3 p -111.65 158.94 18.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.529 -0.759 . . . . 0.59999999999999998 109.696 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.705 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.2 p-10 -76.26 -4.99 44.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.349 . . . . 2.29 111.463 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.08 -21.18 60.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.811 -0.632 . . . . 2.29 110.639 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.436 ' HB3' HG21 ' A' ' 75' ' ' VAL . 16.3 t -77.31 158.07 30.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.81 0.814 . . . . 1.0600000000000001 111.207 -173.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.661 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 20.7 t-20 -126.32 122.64 36.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.861 -1.063 . . . . 0.80000000000000004 108.594 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.749 ' HD1' HG13 ' A' ' 42' ' ' ILE . 18.6 m-85 -55.17 -48.18 74.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.106 0.479 . . . . 0.46999999999999997 111.408 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.4 68.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.103 -0.499 . . . . 0.46000000000000002 110.999 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.661 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 14.3 t70 -67.58 -34.51 77.18 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.161 0.505 . . . . 0.82999999999999996 110.203 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.2 mmt -81.0 -17.67 49.52 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.633 -0.712 . . . . 2.48 111.238 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.87 22.03 9.19 Favored Glycine 0 C--O 1.23 -0.099 0 C-N-CA 120.566 -0.826 . . . . 0.44 112.773 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.749 HG13 ' HD1' ' A' ' 37' ' ' PHE . 26.9 mm -64.2 108.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.213 0.53 . . . . 0.52000000000000002 110.192 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -76.1 161.64 28.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.35 -0.841 . . . . 1.9399999999999999 111.04 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.3 t -56.07 -41.52 75.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.938 -0.574 . . . . 1.03 110.576 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.92 -53.18 60.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 0.58999999999999997 109.788 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.554 ' O ' HG13 ' A' ' 50' ' ' ILE . 16.2 m -57.84 -44.87 86.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.419 -0.355 . . . . 1.22 110.903 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.524 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 50.2 m -58.38 -37.66 75.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.096 -0.502 . . . . 0.81000000000000005 111.234 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.2 tpt -74.71 -34.99 62.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.909 -0.587 . . . . 2.25 109.93 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 44.1 t -68.3 -48.54 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.664 -0.698 . . . . 0.35999999999999999 109.587 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 46' ' ' SER . 73.1 mt -52.04 -54.89 11.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.72 0.295 . . . . 0.26000000000000001 110.391 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.52 ' O ' ' HG3' ' A' ' 55' ' ' ARG . . . -60.41 -32.98 79.22 Favored Glycine 0 C--O 1.228 -0.245 0 CA-C-N 115.829 -0.623 . . . . 0.28999999999999998 112.578 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.509 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -72.94 -45.59 57.22 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.048 -0.261 . . . . 0.92000000000000004 110.549 177.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 6.1 mtp180 -63.39 -30.68 71.77 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.913 0.387 . . . . 1.23 110.188 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.516 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 9.1 m-30 -50.99 -48.52 61.24 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.857 -0.61 . . . . 0.28000000000000003 109.782 171.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 19.0 mtm105 -83.76 -40.51 18.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.637 -0.711 . . . . 2.8100000000000001 110.952 -170.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -88.21 -49.01 7.27 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.351 -0.386 . . . . 2.2599999999999998 111.874 -171.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -79.58 -52.05 8.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.85 0.357 . . . . 2.6200000000000001 111.349 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 mp -82.63 -58.31 2.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.194 -0.457 . . . . 0.67000000000000004 111.541 -175.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.65 24.22 1.58 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.091 -0.576 . . . . 0.45000000000000001 112.154 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.541 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 16.6 mt -104.19 92.72 4.48 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.757 -0.26 . . . . 0.63 110.516 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.451 ' HA ' ' HG2' ' A' ' 55' ' ' ARG . 18.4 t70 -101.36 80.04 2.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.581 0.705 . . . . 2.27 110.021 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.518 HD13 ' HE2' ' A' ' 81' ' ' PHE . 71.4 mt -71.17 -32.53 69.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.895 -1.048 . . . . 1.6399999999999999 109.43 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.06 160.98 21.8 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 114.642 -1.163 . . . . 0.75 110.75 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -82.99 -12.58 9.55 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.89 2.393 . . . . 1.1299999999999999 113.066 -175.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -130.67 31.36 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.812 0.815 . . . . 2.3599999999999999 110.717 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -95.01 120.24 34.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.72999999999999998 109.563 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 t -126.63 131.76 51.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.7 -0.4 . . . . 1.3899999999999999 110.498 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 72' ' ' CYS . 48.1 mt -58.4 -41.38 84.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.808 -0.633 . . . . 0.72999999999999998 110.475 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.524 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 15.0 t80 -62.59 -12.4 22.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.731 -0.668 . . . . 0.58999999999999997 111.494 -175.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 63.7 mt -109.87 -42.34 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.874 -0.33 . . . . 0.89000000000000001 111.126 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -130.71 22.11 5.04 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.64 0.978 . . . . 2.23 113.64 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 98.3 m -143.99 99.55 3.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.282 0.563 . . . . 1.0 109.81 174.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.5 p -90.81 -51.78 5.19 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.012 -0.54 . . . . 0.67000000000000004 111.624 -170.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.4 p -96.82 -178.64 4.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.19 -0.3 . . . . 0.38 110.19 176.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.568 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -81.09 -41.33 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 109.764 -0.458 . . . . 0.68000000000000005 109.764 -178.392 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.705 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 5.2 tpt180 -60.6 -28.22 68.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.671 -0.695 . . . . 3.23 110.483 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -58.32 -32.83 68.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.498 -0.319 . . . . 0.28999999999999998 110.69 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.505 HD21 ' CE2' ' A' ' 54' ' ' PHE . 0.7 OUTLIER -81.27 -48.66 11.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.546 0.689 . . . . 0.64000000000000001 109.431 176.823 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.907 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.9 mmtp -53.99 -57.84 9.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.695 -1.139 . . . . 2.3999999999999999 110.928 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.498 ' HB2' ' HE ' ' A' ' 76' ' ' ARG . 5.7 t70 -72.33 -19.38 61.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.208 -0.905 . . . . 1.6599999999999999 111.1 -171.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.518 ' HE2' HD13 ' A' ' 62' ' ' LEU . 76.2 t80 -73.62 -44.12 57.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.215 0.531 . . . . 0.98999999999999999 110.418 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.459 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 6.3 mtm . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.73 -0.668 . . . . 1.1000000000000001 112.123 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 111.324 -0.71 . . . . 0.53000000000000003 111.324 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.03 155.36 14.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.851 0.358 . . . . 0.39000000000000001 110.167 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 t -82.96 173.63 11.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.536 -0.542 . . . . 1.5600000000000001 109.536 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -65.52 -25.8 67.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.293 0.568 . . . . 2.02 109.853 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -67.29 -46.45 73.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.395 -0.82 . . . . 1.9099999999999999 110.503 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -73.82 -20.32 60.49 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.724 -0.391 . . . . 1.5800000000000001 110.508 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 17' ' ' MET . 1.8 tp -74.18 -25.54 59.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 0.98999999999999999 110.33 172.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.37 -27.51 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.721 0.772 . . . . 0.88 110.311 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -79.54 -30.77 41.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.987 -1.006 . . . . 0.29999999999999999 110.878 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.624 HG11 ' SD ' ' A' ' 82' ' ' MET . 2.3 p -68.33 -43.59 84.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.314 -0.403 . . . . 0.23000000000000001 111.459 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.808 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 30.7 mtt -56.85 -34.77 68.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.515 -0.311 . . . . 1.6299999999999999 111.132 -174.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.617 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 12.8 ptp180 -81.85 -27.08 33.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.475 -0.329 . . . . 3.1699999999999999 111.785 -176.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.9 t -71.35 -34.93 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 108.078 -1.082 . . . . 0.23000000000000001 108.078 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.1 t -66.88 -36.82 78.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 114.025 -1.443 . . . . 0.33000000000000002 109.8 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.483 ' HB2' ' HA ' ' A' ' 18' ' ' ARG . 19.5 m -70.66 -26.12 63.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 116.231 -0.44 . . . . 1.3799999999999999 112.16 -177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.617 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 74.6 mt-10 -86.68 -37.73 17.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.865 0.364 . . . . 2.2599999999999998 111.177 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HG3' HG12 ' A' ' 50' ' ' ILE . 72.3 mm-40 -76.85 -37.91 54.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.968 -0.56 . . . . 0.77000000000000002 112.23 -176.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.482 ' CB ' HD11 ' A' ' 42' ' ' ILE . 66.4 p -80.3 -45.35 18.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.132 0.491 . . . . 1.23 110.816 -178.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.71 -4.38 26.07 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.688 -0.687 . . . . 0.54000000000000004 112.467 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.685 HD11 ' HG3' ' A' ' 40' ' ' MET . 8.6 mt -75.32 141.23 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.625 -0.43 . . . . 0.80000000000000004 110.002 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.86 140.05 56.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.097 -0.501 . . . . 0.56999999999999995 109.667 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.3 tp -55.09 -31.9 61.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 0.96999999999999997 111.763 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -77.95 -8.27 57.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.513 -0.312 . . . . 2.23 110.909 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -107.22 -5.44 17.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.934 0.397 . . . . 2.2400000000000002 110.132 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 17' ' ' MET . 32.6 tp -75.89 97.51 3.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.429 0.633 . . . . 1.1000000000000001 109.921 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.409 ' O ' HG21 ' A' ' 75' ' ' VAL . 16.0 p -116.82 165.56 13.17 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.76 -0.829 . . . . 0.59999999999999998 108.76 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.482 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.9 p-10 -72.6 -3.7 26.33 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 111.49 0.181 . . . . 2.29 111.49 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -74.81 -22.69 58.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.992 0.425 . . . . 2.29 110.429 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.478 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 18.0 m -74.15 153.98 39.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.735 0.778 . . . . 1.0600000000000001 111.34 -174.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.91 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.5 t-20 -128.31 127.55 42.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.121 -0.945 . . . . 0.80000000000000004 108.674 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.596 ' HD1' HG13 ' A' ' 42' ' ' ILE . 11.7 m-85 -56.48 -53.41 57.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.973 0.416 . . . . 0.46999999999999997 111.649 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.49 -30.01 66.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.314 -0.403 . . . . 0.46000000000000002 111.189 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.91 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.5 t70 -69.66 -30.48 68.18 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.345 0.593 . . . . 0.82999999999999996 110.412 176.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.685 ' HG3' HD11 ' A' ' 26' ' ' ILE . 1.8 tmm? -74.18 -23.37 59.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.541 -0.754 . . . . 2.48 110.461 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.3 14.69 15.76 Favored Glycine 0 CA--C 1.511 -0.175 0 C-N-CA 120.354 -0.927 . . . . 0.44 111.358 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.596 HG13 ' HD1' ' A' ' 37' ' ' PHE . 24.6 mm -76.24 113.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.584 -0.308 . . . . 0.52000000000000002 110.337 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.53 -172.74 2.58 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.05 -0.722 . . . . 1.9399999999999999 109.05 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.8 t -68.24 -30.82 69.95 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 111.618 0.229 . . . . 1.03 111.618 -174.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.69 -59.79 4.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.5 -0.318 . . . . 0.58999999999999997 110.298 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.575 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.3 t -66.03 -40.95 91.48 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.029 -0.269 . . . . 1.22 110.496 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.46 ' HB3' ' H ' ' A' ' 69' ' ' PHE . 49.0 m -56.78 -36.77 70.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.389 . . . . 0.81000000000000005 111.784 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -73.61 -43.77 58.77 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.655 -0.869 . . . . 2.25 108.655 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.44 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 64.0 t -62.26 -43.17 97.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.837 -1.074 . . . . 0.35999999999999999 110.721 -176.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 46' ' ' SER . 72.3 mt -54.0 -52.86 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.871 0.367 . . . . 0.26000000000000001 110.582 175.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -60.85 -31.87 77.46 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.076 -0.583 . . . . 0.28999999999999998 112.135 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.85 -46.39 82.06 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 122.441 0.296 . . . . 0.92000000000000004 110.802 176.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 12.4 mtp180 -65.28 -28.21 69.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.544 -0.298 . . . . 1.23 110.514 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.67 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.5 m-30 -57.66 -39.35 76.87 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.707 -0.479 . . . . 0.28000000000000003 109.707 173.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -80.17 -33.2 38.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.179 -0.464 . . . . 2.8100000000000001 110.437 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.21 -51.65 9.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.426 -0.352 . . . . 2.2599999999999998 111.024 -175.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.81 -48.74 7.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.959 -0.564 . . . . 2.6200000000000001 112.331 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -90.56 -13.29 34.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.54 -0.3 . . . . 0.67000000000000004 111.535 -173.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 33.14 68.7 Favored Glycine 0 C--O 1.229 -0.198 0 C-N-CA 121.008 -0.615 . . . . 0.45000000000000001 112.804 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.441 HD12 ' HB3' ' A' ' 54' ' ' PHE . 80.0 mt -90.64 116.65 28.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.505 0.153 . . . . 0.63 111.174 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.08 77.66 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.436 1.113 . . . . 2.27 109.706 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.67 HD11 ' HD2' ' A' ' 54' ' ' PHE . 25.2 mt -74.13 -27.01 60.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.652 -1.158 . . . . 1.6399999999999999 110.608 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.39 171.68 12.55 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 114.936 -1.029 . . . . 0.75 110.799 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -87.04 -7.32 7.14 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.999 2.466 . . . . 1.1299999999999999 112.388 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -134.49 45.44 2.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.63 0.729 . . . . 2.3599999999999999 110.291 -171.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -109.56 129.88 55.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.454 -0.794 . . . . 0.72999999999999998 110.8 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.2 t -140.69 131.09 25.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.329 -0.396 . . . . 1.3899999999999999 110.013 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.444 HD12 HD12 ' A' ' 50' ' ' ILE . 50.6 mt -60.44 -37.84 82.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.917 0.389 . . . . 0.72999999999999998 110.458 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.46 ' H ' ' HB3' ' A' ' 47' ' ' SER . 40.5 t80 -60.05 -12.39 8.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.47 -0.786 . . . . 0.58999999999999997 111.641 -174.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.52 -38.94 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.565 -0.289 . . . . 0.89000000000000001 111.417 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -114.72 10.97 16.72 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.395 0.517 . . . . 2.23 112.395 -171.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 82.9 m -150.22 100.13 2.87 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.181 0.515 . . . . 1.0 110.096 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.8 p -91.1 -54.13 4.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.26 -0.427 . . . . 0.67000000000000004 111.638 -172.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 70.1 p -94.4 -177.28 4.2 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.084 -0.385 . . . . 0.38 110.394 176.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.478 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -79.11 -43.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.457 0.646 . . . . 0.68000000000000005 109.845 -178.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.482 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.3 tpt180 -63.1 -25.65 68.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.246 -0.888 . . . . 3.23 110.637 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.43 -32.99 73.92 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 116.275 -0.421 . . . . 0.28999999999999998 110.559 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.656 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.8 OUTLIER -75.23 -50.42 16.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.87 -0.789 . . . . 0.64000000000000001 108.87 177.708 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.808 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.9 mmtp -50.32 -52.66 34.82 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.178 -0.919 . . . . 2.3999999999999999 110.897 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -63.18 -39.65 95.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.482 -0.781 . . . . 1.6599999999999999 111.373 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.27 -35.12 79.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.792 -0.64 . . . . 0.98999999999999999 111.667 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.656 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 28.7 mtp . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 120.882 0.373 . . . . 1.1000000000000001 110.708 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 110.843 -0.903 . . . . 0.53000000000000003 110.843 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.407 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 3.0 m -114.3 159.24 14.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.895 0.379 . . . . 0.39000000000000001 111.153 -173.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.2 m -87.31 175.22 8.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.973 -0.558 . . . . 1.5600000000000001 110.051 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -65.76 -33.24 75.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.978 0.418 . . . . 2.02 110.885 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 1.7 mp0 -65.01 -36.27 83.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.586 0.708 . . . . 1.9099999999999999 109.783 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HD2' HD21 ' A' ' 60' ' ' LEU . 39.9 mmtm -66.39 -33.92 76.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.04 -0.982 . . . . 1.5800000000000001 110.242 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.7 tp -67.46 -25.79 66.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.781 -0.645 . . . . 0.98999999999999999 110.697 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.69 -28.82 28.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.248 0.547 . . . . 0.88 110.252 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.64 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -80.14 -27.2 39.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.893 -0.594 . . . . 0.29999999999999999 111.024 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.457 HG23 ' CZ ' ' A' ' 54' ' ' PHE . 2.7 p -72.62 -44.23 60.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.355 -0.384 . . . . 0.23000000000000001 111.661 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.1 mtp -63.69 -24.96 67.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.505 -0.316 . . . . 1.6299999999999999 111.389 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 16.1 ptt180 -76.86 -27.44 55.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 3.1699999999999999 110.757 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.1 t -82.4 -37.75 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.578 0.704 . . . . 0.23000000000000001 109.123 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.402 ' CG1' HD11 ' A' ' 31' ' ' LEU . 21.1 t -64.21 -32.03 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.913 -1.04 . . . . 0.33000000000000002 109.296 174.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -61.87 -26.63 68.26 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.842 -0.617 . . . . 1.3799999999999999 111.449 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -87.33 -53.14 4.99 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.31 0.576 . . . . 2.2599999999999998 111.308 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -73.22 -30.53 63.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.318 -0.856 . . . . 0.77000000000000002 111.898 -171.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.476 ' HA ' HD11 ' A' ' 42' ' ' ILE . 24.5 m -92.22 -25.22 18.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.592 -0.276 . . . . 1.23 111.424 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.03 7.42 65.89 Favored Glycine 0 N--CA 1.461 0.356 0 C-N-CA 120.33 -0.938 . . . . 0.54000000000000004 113.007 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.601 HD11 ' SD ' ' A' ' 40' ' ' MET . 4.3 mt -98.51 131.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.728 -0.471 . . . . 0.80000000000000004 109.728 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.07 146.28 47.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.119 -0.326 . . . . 0.56999999999999995 110.119 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.5 tp -53.24 -33.55 53.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.581 0.352 . . . . 0.96999999999999997 111.183 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -83.25 -8.97 59.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.093 -0.503 . . . . 2.23 111.342 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -114.81 -6.15 12.65 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.22 -0.659 . . . . 2.2400000000000002 109.22 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.57 98.38 2.31 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.923 -1.035 . . . . 1.1000000000000001 109.048 179.223 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.8 p -103.17 153.49 20.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.642 -0.708 . . . . 0.59999999999999998 109.723 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.934 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 20.7 m-20 -75.0 -9.95 59.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.918 0.39 . . . . 2.29 111.858 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -95.37 -11.58 27.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.869 -0.605 . . . . 2.29 111.891 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 t -78.41 156.05 29.65 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.556 0.693 . . . . 1.0600000000000001 109.946 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.566 ' HB3' ' CB ' ' A' ' 39' ' ' ASP . 18.3 t-20 -115.51 127.03 55.0 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.15 -0.932 . . . . 0.80000000000000004 110.231 -168.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.776 ' HD1' HG13 ' A' ' 42' ' ' ILE . 18.0 m-85 -56.56 -51.8 67.22 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.891 0.377 . . . . 0.46999999999999997 111.193 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.43 -31.16 71.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.239 -0.437 . . . . 0.46000000000000002 111.128 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.566 ' CB ' ' HB3' ' A' ' 36' ' ' ASN . 25.1 t70 -67.23 -31.76 72.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.076 0.465 . . . . 0.82999999999999996 110.499 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.601 ' SD ' HD11 ' A' ' 26' ' ' ILE . 68.2 mtp -89.52 -9.35 50.29 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.198 -0.456 . . . . 2.48 111.153 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.22 26.8 9.83 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.195 -1.003 . . . . 0.44 112.975 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.776 HG13 ' HD1' ' A' ' 37' ' ' PHE . 30.2 mm -71.87 107.27 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.249 -0.278 . . . . 0.52000000000000002 110.249 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -78.52 176.71 9.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.42 0.629 . . . . 1.9399999999999999 110.572 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.7 p -59.83 -41.66 91.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.011 -0.995 . . . . 1.03 111.097 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -58.98 -58.71 7.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.611 -0.722 . . . . 0.58999999999999997 110.4 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.657 ' O ' HG13 ' A' ' 50' ' ' ILE . 5.0 m -60.53 -46.01 91.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.402 -0.363 . . . . 1.22 111.39 -177.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.908 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 41.3 p -65.54 -31.49 72.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.345 -0.389 . . . . 0.81000000000000005 111.393 -177.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -40.47 66.77 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.845 -0.798 . . . . 2.25 108.845 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.556 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 24.1 t -59.5 -44.83 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 115.221 -0.899 . . . . 0.35999999999999999 110.053 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 46' ' ' SER . 39.4 mt -52.82 -56.93 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.26000000000000001 111.043 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.72 -29.62 74.41 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.021 -0.609 . . . . 0.28999999999999998 112.55 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -44.19 77.57 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.155 -0.313 . . . . 0.92000000000000004 110.155 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.556 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 16.4 mtp180 -62.94 -26.34 68.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.567 -0.288 . . . . 1.23 110.611 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.684 ' HD2' HD11 ' A' ' 62' ' ' LEU . 14.5 m-30 -56.77 -41.4 77.55 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.167 0.508 . . . . 0.28000000000000003 109.925 173.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 23.3 mtm180 -79.43 -25.78 41.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.513 -0.767 . . . . 2.8100000000000001 110.299 -177.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -74.27 -62.91 1.35 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.611 -0.722 . . . . 2.2599999999999998 111.82 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.84 -41.71 11.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.966 0.413 . . . . 2.6200000000000001 111.733 -173.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.77 -23.63 21.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.301 -0.409 . . . . 0.67000000000000004 111.572 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.89 27.55 60.35 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.145 -0.55 . . . . 0.45000000000000001 112.732 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.68 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 58.1 mt -87.03 95.72 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.767 -0.255 . . . . 0.63 110.591 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -86.83 78.2 9.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.6 0.714 . . . . 2.27 109.215 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.684 HD11 ' HD2' ' A' ' 54' ' ' PHE . 14.6 mt -71.05 -57.01 4.95 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.371 -1.286 . . . . 1.6399999999999999 110.305 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.38 150.44 9.38 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.753 -1.112 . . . . 0.75 110.807 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.49 -9.84 20.23 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.234 1.956 . . . . 1.1299999999999999 112.902 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -120.15 22.84 11.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.995 -0.548 . . . . 2.3599999999999999 110.733 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -80.34 124.43 28.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.282 -0.417 . . . . 0.72999999999999998 111.148 -177.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.4 t -139.47 125.19 19.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.641 -0.503 . . . . 1.3899999999999999 109.641 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.908 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 88.5 mt -60.37 -23.7 64.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.541 0.21 . . . . 0.72999999999999998 111.382 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.52 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 17.5 t80 -71.88 -14.06 61.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.246 0.546 . . . . 0.58999999999999997 110.445 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.2 mt -122.89 -39.75 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.89000000000000001 110.868 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -95.02 8.46 42.84 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.74 0.274 . . . . 2.23 111.74 -172.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.31 167.23 30.31 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.9 p -138.49 -68.07 0.46 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 0.67000000000000004 110.568 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 81.4 p -84.55 -175.43 5.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.747 -0.464 . . . . 0.38 109.747 174.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.0 t -83.77 -38.75 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.879 0.847 . . . . 0.68000000000000005 109.929 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.934 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 35.6 ttm180 -61.88 -30.01 70.58 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.713 -1.131 . . . . 3.23 111.252 175.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.46 -31.44 65.95 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.988 0.423 . . . . 0.28999999999999998 110.513 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.776 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.1 tt -70.5 -48.32 56.26 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.574 -0.899 . . . . 0.64000000000000001 108.574 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.552 ' CG ' ' HA ' ' A' ' 76' ' ' ARG . 20.8 mmtm -50.76 -55.06 18.48 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.984 -1.007 . . . . 2.3999999999999999 110.572 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -51.44 -49.43 61.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.276 -0.875 . . . . 1.6599999999999999 111.69 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -61.7 -36.49 81.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.743 -0.662 . . . . 0.98999999999999999 111.8 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.776 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 44.1 mtp . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.367 -0.379 . . . . 1.1000000000000001 111.765 -173.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.513 0 N-CA-C 110.956 -0.857 . . . . 0.53000000000000003 110.956 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.661 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 4.1 m -103.98 156.74 5.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.707 0.289 . . . . 0.39000000000000001 110.628 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.3 m -85.39 173.93 9.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.639 -0.504 . . . . 1.5600000000000001 109.639 175.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -61.75 -36.08 79.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.774 0.797 . . . . 2.02 109.013 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -59.17 -42.1 89.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.716 -1.129 . . . . 1.9099999999999999 111.211 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.661 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 41.4 mmtm -67.73 -31.65 71.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 1.5800000000000001 110.052 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.421 ' O ' ' HG3' ' A' ' 17' ' ' MET . 34.7 tp -68.11 -26.22 65.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.645 . . . . 0.98999999999999999 110.324 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.69 -29.96 36.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.103 0.478 . . . . 0.88 110.288 178.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.17 -27.22 39.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.619 . . . . 0.29999999999999999 111.051 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.6 HG23 ' CE1' ' A' ' 54' ' ' PHE . 4.0 p -75.71 -48.76 28.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.805 0.336 . . . . 0.23000000000000001 111.721 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 73.3 mtm -59.57 -30.32 68.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.176 -0.465 . . . . 1.6299999999999999 111.514 -174.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 6.5 ptm180 -70.38 -37.88 74.63 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.106 -0.638 . . . . 3.1699999999999999 110.635 176.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.456 HG12 HG23 ' A' ' 50' ' ' ILE . 29.2 t -64.5 -42.77 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.554 0.693 . . . . 0.23000000000000001 109.3 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.09 -42.03 93.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.983 -1.008 . . . . 0.33000000000000002 110.807 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -23.48 61.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.828 0.347 . . . . 1.3799999999999999 110.174 -174.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 43.9 mt-10 -79.01 -43.27 24.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.158 -0.474 . . . . 2.2599999999999998 111.6 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -86.27 -8.31 57.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.329 -0.396 . . . . 0.77000000000000002 111.273 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.4 p -97.57 -41.25 8.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.052 0.453 . . . . 1.23 110.407 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.76 41.85 3.25 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.863 -0.684 . . . . 0.54000000000000004 111.603 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 27' ' ' ALA . 5.2 mt -127.16 165.87 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.808 -0.442 . . . . 0.80000000000000004 109.808 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.503 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -83.96 142.02 30.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.643 -0.708 . . . . 0.56999999999999995 110.257 172.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.0 tp -61.14 -33.26 73.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.043 -0.526 . . . . 0.96999999999999997 111.092 -177.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.63 -11.98 60.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.179 0.514 . . . . 2.23 111.067 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 17.8 mm-40 -105.79 -5.04 20.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.796 -0.638 . . . . 2.2400000000000002 110.107 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.6 tp -84.85 96.55 9.35 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.107 -0.497 . . . . 1.1000000000000001 110.352 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 p -115.0 169.63 8.94 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.833 -0.803 . . . . 0.59999999999999998 108.833 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.686 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 4.8 p-10 -75.66 -3.29 33.71 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.931 -0.308 . . . . 2.29 111.548 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.12 -20.22 60.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.14 -0.482 . . . . 2.29 110.406 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.489 ' HB2' HG21 ' A' ' 75' ' ' VAL . 16.3 m -79.74 157.69 27.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.606 0.717 . . . . 1.0600000000000001 111.541 -175.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.75 119.42 25.73 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.229 -1.026 . . . . 0.80000000000000004 108.229 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.422 ' CZ ' HG13 ' A' ' 75' ' ' VAL . 16.8 m-85 -57.72 -39.26 76.86 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.45 -0.5 . . . . 0.46999999999999997 111.642 -173.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.76 -26.91 67.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.984 0.421 . . . . 0.46000000000000002 110.472 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -68.89 -29.73 68.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.82999999999999996 110.296 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -83.59 -8.4 59.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.754 -0.657 . . . . 2.48 110.283 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.77 32.5 36.75 Favored Glycine 0 C--N 1.322 -0.225 0 C-N-CA 120.443 -0.884 . . . . 0.44 112.002 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.502 ' CG2' ' HB3' ' A' ' 47' ' ' SER . 2.7 mt -67.76 108.46 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.018 0.437 . . . . 0.52000000000000002 110.225 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -78.45 165.96 23.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.816 -0.629 . . . . 1.9399999999999999 110.48 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.0 t -51.54 -43.33 62.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 1.03 110.861 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.14 -55.91 28.8 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.142 -0.481 . . . . 0.58999999999999997 110.376 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.45 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.3 m -61.41 -44.14 97.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 1.22 111.525 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.866 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 63.7 p -68.09 -31.61 71.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.735 0.302 . . . . 0.81000000000000005 111.222 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.2 tpt -70.76 -36.45 73.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.449 0.642 . . . . 2.25 109.805 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.31 -36.39 76.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.064 -0.971 . . . . 0.35999999999999999 110.22 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.532 HD12 HD12 ' A' ' 68' ' ' LEU . 67.5 mt -59.83 -52.01 66.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.762 -0.653 . . . . 0.26000000000000001 110.753 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.5 ' HA2' ' CD2' ' A' ' 54' ' ' PHE . . . -64.04 -28.69 73.19 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.144 -0.551 . . . . 0.28999999999999998 112.197 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -49.63 76.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.767 0.318 . . . . 0.92000000000000004 110.512 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -64.6 -28.43 69.62 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.417 -0.356 . . . . 1.23 111.07 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.6 ' CE1' HG23 ' A' ' 16' ' ' VAL . 14.6 m-30 -53.9 -44.22 70.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.613 -0.514 . . . . 0.28000000000000003 109.613 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -84.86 -35.36 22.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 2.8100000000000001 111.451 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -85.79 -56.16 3.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.036 0.446 . . . . 2.2599999999999998 111.299 -174.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.28 -52.71 11.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.971 -0.559 . . . . 2.6200000000000001 111.387 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 mp -88.25 -32.13 18.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.516 . . . . 0.67000000000000004 111.849 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.9 33.91 16.91 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.524 -0.846 . . . . 0.45000000000000001 112.115 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.15 152.0 21.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.789 -0.448 . . . . 0.63 109.789 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.72 110.97 21.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.942 0.401 . . . . 2.27 110.325 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -123.8 5.56 8.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 1.6399999999999999 109.501 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.56 164.22 39.47 Favored Glycine 0 CA--C 1.509 -0.323 0 CA-C-N 115.474 -0.785 . . . . 0.75 111.456 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -87.74 -2.07 7.39 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.23 2.62 . . . . 1.1299999999999999 112.078 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -106.48 12.92 29.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.387 -0.824 . . . . 2.3599999999999999 111.036 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -93.63 111.82 23.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.055 0.455 . . . . 0.72999999999999998 110.462 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.3 m -134.5 128.18 32.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.72 -0.673 . . . . 1.3899999999999999 109.5 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.866 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 42.3 mt -66.58 -45.02 80.65 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.799 0.296 . . . . 0.72999999999999998 111.799 -173.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.96 -4.67 4.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.432 . . . . 0.58999999999999997 110.772 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -116.08 -40.35 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 O-C-N 122.223 -0.298 . . . . 0.89000000000000001 111.555 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -126.07 8.41 7.34 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.122 0.416 . . . . 2.23 112.122 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 75.9 m -147.52 88.76 1.72 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.623 -0.673 . . . . 1.0 110.412 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 p -81.73 -31.76 31.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.904 -0.589 . . . . 0.67000000000000004 111.812 -173.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.9 p -110.95 176.73 4.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.668 0.27 . . . . 0.38 110.501 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.489 HG21 ' HB2' ' A' ' 35' ' ' SER . 0.2 OUTLIER -80.77 -44.72 21.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.965 -0.383 . . . . 0.68000000000000005 109.965 -177.651 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.686 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.2 tpt180 -57.94 -32.51 67.87 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.132 -0.486 . . . . 3.23 110.551 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.59 -29.54 62.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.116 -0.493 . . . . 0.28999999999999998 111.062 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.677 ' O ' ' HG3' ' A' ' 82' ' ' MET . 3.7 tp -86.39 -55.1 4.05 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.16 -0.682 . . . . 0.64000000000000001 109.16 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -56.01 -60.35 3.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.287 -1.324 . . . . 2.3999999999999999 111.656 -174.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.472 ' HB2' ' HE ' ' A' ' 76' ' ' ARG . 9.7 t70 -66.93 -26.28 66.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.465 -0.789 . . . . 1.6599999999999999 110.681 -171.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.73 -26.58 66.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.22 -0.9 . . . . 0.98999999999999999 110.731 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.677 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 28.6 mtp . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.905 -0.589 . . . . 1.1000000000000001 110.532 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.524 0 N-CA-C 111.908 -0.477 . . . . 0.53000000000000003 111.908 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 3.2 m -118.71 157.84 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.917 0.389 . . . . 0.39000000000000001 110.172 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.4 p -83.4 172.89 12.02 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.042 -0.526 . . . . 1.5600000000000001 110.114 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -67.68 -16.79 64.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.079 0.466 . . . . 2.02 110.349 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -67.18 -46.95 72.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.491 -0.777 . . . . 1.9099999999999999 109.615 173.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.536 ' HG2' HD21 ' A' ' 60' ' ' LEU . 2.4 mptp? -66.25 -34.4 77.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.774 -0.648 . . . . 1.5800000000000001 109.931 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 17' ' ' MET . 14.7 tp -67.79 -26.88 66.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 0.98999999999999999 111.192 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.1 -28.83 27.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.176 0.513 . . . . 0.88 109.948 177.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -81.67 -30.58 32.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.29999999999999999 111.297 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.04 -43.07 96.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.828 -0.349 . . . . 0.23000000000000001 111.177 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.542 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 45.1 mtt -63.61 -28.6 70.03 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.174 -0.466 . . . . 1.6299999999999999 110.768 -174.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.662 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 15.3 ptm180 -84.1 -19.48 34.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.896 -0.322 . . . . 3.1699999999999999 111.725 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.9 t -81.37 -27.97 10.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 122.017 0.913 . . . . 0.23000000000000001 108.629 172.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.1 t -76.1 -36.11 30.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.458 -1.247 . . . . 0.33000000000000002 110.294 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.5 p -62.75 -51.48 66.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.039 0.447 . . . . 1.3799999999999999 110.496 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.662 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 9.0 mm-40 -57.35 -52.0 67.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.354 -0.839 . . . . 2.2599999999999998 111.484 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' HG3' HG12 ' A' ' 50' ' ' ILE . 76.9 mm-40 -72.41 -46.37 55.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.962 -0.563 . . . . 0.77000000000000002 112.323 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.444 ' HA ' HD11 ' A' ' 42' ' ' ILE . 17.8 m -73.67 -38.38 64.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.827 0.346 . . . . 1.23 111.587 -176.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.15 -2.19 40.64 Favored Glycine 0 N--CA 1.454 -0.124 0 C-N-CA 120.191 -1.004 . . . . 0.54000000000000004 112.07 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.462 HD11 ' HG3' ' A' ' 40' ' ' MET . 8.0 mt -94.0 123.14 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.639 -0.504 . . . . 0.80000000000000004 109.639 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.543 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -54.14 145.58 16.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.381 -0.372 . . . . 0.56999999999999995 111.552 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 tp -55.02 -36.92 65.98 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.937 -0.574 . . . . 0.96999999999999997 110.646 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.31 -10.7 59.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.983 -0.553 . . . . 2.23 111.293 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 41.4 mt-10 -116.2 2.06 13.25 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.138 -0.483 . . . . 2.2400000000000002 110.043 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -75.26 97.34 3.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.164 -0.68 . . . . 1.1000000000000001 109.164 -178.55 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.9 p -106.55 154.91 20.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.695 -0.684 . . . . 0.59999999999999998 109.273 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 57.7 m-20 -76.75 -3.67 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.055 0.455 . . . . 2.29 110.951 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.53 -6.25 59.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.498 -0.774 . . . . 2.29 110.413 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.474 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 46.9 m -79.6 150.63 30.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.594 . . . . 1.0600000000000001 110.006 177.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.767 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.1 t-20 -125.88 123.25 38.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.253 -0.647 . . . . 0.80000000000000004 109.253 -175.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.703 ' HD1' HG13 ' A' ' 42' ' ' ILE . 34.1 m-85 -56.37 -48.61 76.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.943 0.401 . . . . 0.46999999999999997 111.194 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.2 -31.0 68.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.268 -0.424 . . . . 0.46000000000000002 111.181 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.767 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 32.9 t70 -70.99 -33.24 70.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.331 0.586 . . . . 0.82999999999999996 110.589 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.462 ' HG3' HD11 ' A' ' 26' ' ' ILE . 15.1 mmt -79.8 -20.27 46.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.407 -0.815 . . . . 2.48 111.37 -176.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.03 32.81 4.23 Favored Glycine 0 C--O 1.229 -0.17 0 C-N-CA 120.271 -0.966 . . . . 0.44 112.5 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.703 HG13 ' HD1' ' A' ' 37' ' ' PHE . 28.5 mm -79.83 107.74 12.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.854 0.359 . . . . 0.52000000000000002 110.608 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -77.4 174.24 11.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.636 -0.505 . . . . 1.9399999999999999 109.636 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.688 ' HB3' ' HD2' ' A' ' 69' ' ' PHE . 90.0 p -69.9 -20.77 63.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.443 -0.577 . . . . 1.03 109.443 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.4 tm? -54.55 -61.99 1.95 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.195 -0.668 . . . . 0.58999999999999997 109.195 171.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.448 ' O ' HG13 ' A' ' 50' ' ' ILE . 6.3 m -64.7 -39.69 94.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.116 -0.493 . . . . 1.22 110.81 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.455 ' HB2' ' HA ' ' A' ' 44' ' ' SER . 48.8 m -58.93 -40.57 84.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.069 -0.514 . . . . 0.81000000000000005 111.672 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 45.1 tpp -72.35 -40.33 67.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.265 0.555 . . . . 2.25 109.674 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.506 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 54.6 t -63.51 -50.33 78.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.214 -0.903 . . . . 0.35999999999999999 110.453 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.463 HG12 ' HG3' ' A' ' 23' ' ' GLU . 77.7 mt -54.05 -54.58 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.684 0.278 . . . . 0.26000000000000001 110.92 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -58.25 -35.82 79.99 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.973 -0.632 . . . . 0.28999999999999998 112.018 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.482 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -63.47 -46.16 87.47 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.849 -0.206 . . . . 0.92000000000000004 110.527 174.886 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 7.1 mtp180 -64.11 -28.0 69.48 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.576 -0.284 . . . . 1.23 111.057 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.562 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.5 m-30 -56.63 -42.39 78.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.477 -0.564 . . . . 0.28000000000000003 109.477 173.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.482 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 65.1 mtm180 -80.16 -39.21 29.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 2.8100000000000001 110.635 -176.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.82 -48.61 7.7 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.057 0.392 . . . . 2.2599999999999998 112.057 -172.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.28 -46.91 14.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.261 -0.427 . . . . 2.6200000000000001 111.649 -177.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.1 mp -95.7 -23.25 17.08 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.84 0.681 . . . . 0.67000000000000004 112.84 -173.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.34 32.3 23.0 Favored Glycine 0 CA--C 1.517 0.174 0 C-N-CA 120.793 -0.718 . . . . 0.45000000000000001 112.664 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.536 HD21 ' HG2' ' A' ' 12' ' ' LYS . 85.4 mt -88.22 120.3 29.45 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.733 -0.275 . . . . 0.63 110.524 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -82.78 82.07 8.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.228 0.537 . . . . 2.27 109.749 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.562 HD11 ' HD2' ' A' ' 54' ' ' PHE . 97.7 mt -89.8 -94.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.692 -0.685 . . . . 1.6399999999999999 111.356 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 162.55 168.86 25.1 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.892 -0.883 . . . . 0.75 110.892 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.542 ' HG2' ' OE2' ' A' ' 65' ' ' GLU . 73.6 Cg_endo -81.85 -10.24 11.75 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.683 2.255 . . . . 1.1299999999999999 113.65 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.542 ' OE2' ' HG2' ' A' ' 64' ' ' PRO . 5.3 mp0 -88.77 -0.07 56.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.625 -0.262 . . . . 2.3599999999999999 111.47 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.75 122.05 40.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.836 0.35 . . . . 0.72999999999999998 111.441 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.3 t -141.26 124.44 16.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 1.3899999999999999 110.008 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 mt -56.13 -28.97 59.99 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.977 0.362 . . . . 0.72999999999999998 111.977 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.688 ' HD2' ' HB3' ' A' ' 44' ' ' SER . 3.2 t80 -67.91 -16.7 64.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.588 . . . . 0.58999999999999997 110.939 -173.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.1 mt -126.32 -35.93 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.803 0.335 . . . . 0.89000000000000001 110.997 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -90.48 6.28 44.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.43 -0.35 . . . . 2.23 111.689 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.4 m -154.89 155.91 35.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.1 p -131.06 -73.73 0.54 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.31 -0.405 . . . . 0.67000000000000004 110.464 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 76.8 p -83.16 -170.87 3.25 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.965 -0.384 . . . . 0.38 109.965 174.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.474 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.9 OUTLIER -83.08 -40.67 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.555 -0.906 . . . . 0.68000000000000005 108.555 -177.588 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 34.0 ttm180 -60.89 -31.5 70.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.402 -1.272 . . . . 3.23 111.238 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.18 -34.88 64.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.819 0.342 . . . . 0.28999999999999998 110.952 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.552 HD21 ' CE2' ' A' ' 54' ' ' PHE . 0.9 OUTLIER -74.8 -50.7 16.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.485 -0.561 . . . . 0.64000000000000001 109.485 177.315 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 26.1 mmtp -49.21 -53.81 19.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.236 -0.893 . . . . 2.3999999999999999 110.438 176.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.51 -45.02 62.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.877 -1.056 . . . . 1.6599999999999999 111.867 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -64.12 -37.86 88.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.014 -0.539 . . . . 0.98999999999999999 111.838 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.523 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 21.3 mtp . . . . . 0 C--N 1.326 -0.443 0 CA-C-O 121.058 0.456 . . . . 1.1000000000000001 111.285 -174.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 N-CA-C 111.497 -0.641 . . . . 0.53000000000000003 111.497 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 2.8 m -123.59 160.88 26.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.701 0.286 . . . . 0.39000000000000001 110.789 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.7 p -92.66 -176.89 4.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.123 -0.695 . . . . 1.5600000000000001 109.123 171.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -68.34 -23.35 64.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.312 0.577 . . . . 2.02 109.646 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -58.51 -44.07 89.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.333 -0.849 . . . . 1.9099999999999999 110.602 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.609 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 17.5 mttp -74.29 -24.91 59.32 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.724 -0.671 . . . . 1.5800000000000001 111.032 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.8 tp -73.45 -30.0 62.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.131 -0.486 . . . . 0.98999999999999999 110.753 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.67 -29.23 45.52 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.238 0.542 . . . . 0.88 109.843 176.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.673 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -81.61 -30.36 32.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.919 -0.582 . . . . 0.29999999999999999 111.375 -176.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.442 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 5.5 p -68.47 -45.7 81.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.396 -0.522 . . . . 0.23000000000000001 111.285 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.403 ' HB3' ' HE2' ' A' ' 17' ' ' MET . 73.6 mtp -61.05 -35.24 76.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.997 -0.547 . . . . 1.6299999999999999 111.285 -175.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 2.7 ptm180 -64.37 -35.8 82.06 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.127 -0.323 . . . . 3.1699999999999999 110.127 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.45 HG13 ' HD3' ' A' ' 53' ' ' ARG . 53.3 t -76.5 -38.09 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.544 0.688 . . . . 0.23000000000000001 109.278 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.41 -45.3 93.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.882 -1.054 . . . . 0.33000000000000002 110.473 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.8 m -60.9 -40.95 95.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.884 0.373 . . . . 1.3799999999999999 111.614 -176.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 53.1 mt-10 -58.02 -56.76 17.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.816 -0.629 . . . . 2.2599999999999998 111.976 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -76.08 -25.69 55.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.247 -0.433 . . . . 0.77000000000000002 111.946 -172.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.7 p -81.27 -44.09 18.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.003 0.43 . . . . 1.23 110.3 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.02 16.83 26.96 Favored Glycine 0 C--O 1.229 -0.183 0 C-N-CA 120.924 -0.655 . . . . 0.54000000000000004 111.619 -176.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.28 123.0 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.796 -0.446 . . . . 0.80000000000000004 109.796 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.45 143.95 6.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.299 0.481 . . . . 0.56999999999999995 112.299 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.5 tp -54.5 -37.04 64.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.444 -0.798 . . . . 0.96999999999999997 111.159 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.75 -9.86 58.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.85 -0.614 . . . . 2.23 111.256 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -110.8 -6.33 14.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.072 -0.513 . . . . 2.2400000000000002 110.927 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.3 tp -71.96 98.25 2.01 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.396 0.617 . . . . 1.1000000000000001 109.973 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.0 p -107.57 162.42 13.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.32 -0.854 . . . . 0.59999999999999998 109.079 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.426 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 80.8 m-20 -76.33 -5.54 47.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.027 0.442 . . . . 2.29 110.782 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -81.51 -22.57 37.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.352 -0.84 . . . . 2.29 111.135 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -81.03 149.9 29.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.667 0.746 . . . . 1.0600000000000001 111.132 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.591 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 20.8 t-20 -113.7 131.15 56.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.133 -0.939 . . . . 0.80000000000000004 109.638 -171.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.743 ' HD1' HG13 ' A' ' 42' ' ' ILE . 28.4 m-85 -57.95 -47.31 83.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 0.46999999999999997 111.569 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.26 -31.26 67.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.507 -0.315 . . . . 0.46000000000000002 111.318 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.0 t70 -68.76 -31.81 71.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.09 0.472 . . . . 0.82999999999999996 110.268 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.0 mmt -82.12 -18.97 41.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.548 -0.751 . . . . 2.48 111.882 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.18 28.5 6.1 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 120.275 -0.964 . . . . 0.44 112.441 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.743 HG13 ' HD1' ' A' ' 37' ' ' PHE . 32.9 mm -75.3 108.48 7.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.028 0.442 . . . . 0.52000000000000002 110.188 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -83.73 178.76 7.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.846 -0.616 . . . . 1.9399999999999999 110.691 -177.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 t -64.51 -28.04 69.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.437 -0.801 . . . . 1.03 110.006 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.69 -62.45 1.45 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.708 -0.678 . . . . 0.58999999999999997 110.27 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.1 p -64.12 -40.57 96.49 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.448 0.536 . . . . 1.22 112.448 -175.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 60.1 p -64.0 -29.86 70.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.962 0.41 . . . . 0.81000000000000005 111.071 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 48.2 tpp -75.86 -36.43 59.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.669 0.747 . . . . 2.25 109.831 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.54 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 56.9 t -71.7 -36.56 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 114.92 -1.036 . . . . 0.35999999999999999 109.466 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 46' ' ' SER . 88.0 mt -58.4 -50.11 79.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.223 -0.444 . . . . 0.26000000000000001 110.431 174.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.97 -37.48 85.34 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.099 -0.572 . . . . 0.28999999999999998 112.352 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.612 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 1.5 t -63.29 -48.32 78.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.843 -0.343 . . . . 0.92000000000000004 110.343 176.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 43.5 mtp180 -60.69 -32.74 71.96 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.659 -0.246 . . . . 1.23 111.053 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.473 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 10.7 m-30 -53.67 -40.47 65.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.056 0.455 . . . . 0.28000000000000003 110.124 174.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.612 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 67.4 mtm180 -81.89 -35.89 28.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.883 -0.598 . . . . 2.8100000000000001 110.957 -175.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.31 -51.08 6.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.983 -0.553 . . . . 2.2599999999999998 111.593 -170.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -81.74 -49.88 9.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.013 -0.539 . . . . 2.6200000000000001 110.839 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 mp -85.93 -55.12 4.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.87 -0.605 . . . . 0.67000000000000004 111.177 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.06 30.18 2.37 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.918 -0.658 . . . . 0.45000000000000001 112.057 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 59.5 mt -92.0 132.66 36.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.109 -0.33 . . . . 0.63 110.109 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -101.25 92.25 4.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.843 0.83 . . . . 2.27 110.681 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -88.07 -73.04 0.5 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.427 -0.806 . . . . 1.6399999999999999 109.95 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.69 170.14 16.81 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.469 -0.652 . . . . 0.75 111.469 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.6 8.41 4.64 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.017 2.478 . . . . 1.1299999999999999 111.979 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.9 1.03 12.62 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.092 -0.958 . . . . 2.3599999999999999 110.122 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -89.37 118.91 29.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.947 -0.57 . . . . 0.72999999999999998 110.951 -175.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.9 t -137.83 123.17 19.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.126 -0.488 . . . . 1.3899999999999999 110.211 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 90.5 mt -61.01 -37.78 83.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.169 0.509 . . . . 0.72999999999999998 110.566 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -65.46 -7.06 12.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.542 -0.754 . . . . 0.58999999999999997 111.05 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.65 -39.08 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 120.827 -0.349 . . . . 0.89000000000000001 111.618 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -121.35 7.39 10.16 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 120.33 -0.548 . . . . 2.23 112.447 -172.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 66.6 m -147.68 87.7 1.65 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.805 -0.559 . . . . 1.0 110.523 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.5 p -85.47 -33.26 21.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.057 -0.52 . . . . 0.67000000000000004 112.242 -173.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p -107.19 172.2 6.96 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.189 -0.319 . . . . 0.38 110.61 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.449 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 5.7 t -80.72 -40.05 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 120.678 0.275 . . . . 0.68000000000000005 111.108 -175.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.426 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 30.8 ttm180 -61.45 -30.43 70.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 3.23 110.875 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -56.94 -32.23 65.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.954 -0.566 . . . . 0.28999999999999998 111.14 176.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.65 -44.48 18.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 0.64000000000000001 109.213 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 25.2 mmtp -56.17 -62.11 1.94 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.599 -1.182 . . . . 2.3999999999999999 111.368 -178.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.93 -23.35 66.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 1.6599999999999999 110.833 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 73.3 t80 -67.68 -41.57 83.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.56 0.695 . . . . 0.98999999999999999 109.822 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.442 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 1.3 mtm . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 115.158 -0.928 . . . . 1.1000000000000001 112.292 -176.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.448 0 N-CA-C 111.346 -0.701 . . . . 0.53000000000000003 111.346 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -108.88 157.12 9.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.752 -0.379 . . . . 0.39000000000000001 110.807 -174.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -78.65 171.8 14.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.678 -0.49 . . . . 1.5600000000000001 109.678 173.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -72.49 -17.29 61.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.333 0.587 . . . . 2.02 110.258 -175.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -68.78 -44.76 72.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.404 -0.816 . . . . 1.9099999999999999 109.888 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -70.72 -22.87 62.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.783 -0.644 . . . . 1.5800000000000001 110.542 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 17' ' ' MET . 2.7 tp -72.26 -27.51 62.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.759 -0.655 . . . . 0.98999999999999999 110.54 173.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.22 -30.98 34.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.423 0.63 . . . . 0.88 109.383 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.61 -34.25 53.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.074 -0.967 . . . . 0.29999999999999999 110.861 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.515 HG11 ' SD ' ' A' ' 82' ' ' MET . 2.8 p -66.09 -43.19 92.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.159 -0.473 . . . . 0.23000000000000001 111.446 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.47 ' HB3' HD23 ' A' ' 31' ' ' LEU . 66.7 mtm -64.23 -30.71 71.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.394 -0.366 . . . . 1.6299999999999999 111.395 -175.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.687 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 9.1 ptm180 -83.6 -19.28 35.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.949 0.351 . . . . 3.1699999999999999 111.949 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.1 t -78.43 -32.86 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.827 0.823 . . . . 0.23000000000000001 108.892 171.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.25 -37.77 72.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.512 -1.222 . . . . 0.33000000000000002 110.333 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.6 p -61.18 -49.79 75.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.523 0.678 . . . . 1.3799999999999999 109.779 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.687 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 3.9 mm-40 -59.73 -50.17 74.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.441 -1.254 . . . . 2.2599999999999998 112.316 -176.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HB2' HG12 ' A' ' 50' ' ' ILE . 60.8 mm-40 -86.96 -9.05 56.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.208 0.447 . . . . 0.77000000000000002 112.208 -171.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.1 m -95.4 -26.03 16.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.034 0.445 . . . . 1.23 110.279 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.51 -7.23 65.85 Favored Glycine 0 C--N 1.329 0.14 0 C-N-CA 120.488 -0.863 . . . . 0.54000000000000004 112.652 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mt -91.33 154.43 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 122.568 -0.372 . . . . 0.80000000000000004 110.014 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.421 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -69.56 142.29 53.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.993 -0.549 . . . . 0.56999999999999995 110.111 178.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.625 HD11 ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -57.9 -39.32 77.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 0.96999999999999997 109.899 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -67.76 -15.15 63.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.37 -0.832 . . . . 2.23 111.355 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 33.8 mt-10 -108.68 1.95 21.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.374 -0.376 . . . . 2.2400000000000002 110.205 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 17' ' ' MET . 27.4 tp -74.68 107.3 6.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.423 -0.584 . . . . 1.1000000000000001 109.423 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.2 p -113.55 162.71 15.85 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.818 -0.808 . . . . 0.59999999999999998 108.818 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.699 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.9 p-10 -79.84 -11.96 59.79 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.654 -0.418 . . . . 2.29 110.526 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -84.03 -20.42 32.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.742 -0.663 . . . . 2.29 110.998 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.6 p -66.53 147.41 53.32 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.424 0.631 . . . . 1.0600000000000001 110.766 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.732 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.5 t-20 -114.17 127.28 55.83 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.147 -0.933 . . . . 0.80000000000000004 108.89 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.844 ' HD1' HG13 ' A' ' 42' ' ' ILE . 23.9 m-85 -56.58 -50.72 71.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.94 0.4 . . . . 0.46999999999999997 111.399 -178.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.29 68.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.133 -0.485 . . . . 0.46000000000000002 111.111 -176.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.732 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 28.7 t70 -72.17 -28.82 63.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.926 -0.579 . . . . 0.82999999999999996 110.478 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.1 mmt -83.24 -22.57 33.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.684 -0.689 . . . . 2.48 111.264 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.32 23.7 6.53 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.673 -0.775 . . . . 0.44 112.445 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.844 HG13 ' HD1' ' A' ' 37' ' ' PHE . 31.9 mm -70.97 108.22 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.223 0.535 . . . . 0.52000000000000002 111.24 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.9 176.82 9.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.587 -0.733 . . . . 1.9399999999999999 111.495 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 p -61.1 -39.39 89.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.148 -0.933 . . . . 1.03 110.989 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -52.55 -59.66 4.19 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.703 -0.68 . . . . 0.58999999999999997 110.181 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.541 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.2 m -62.2 -42.83 99.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.087 -0.506 . . . . 1.22 110.739 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.517 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 67.3 m -57.49 -37.62 73.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.169 -0.468 . . . . 0.81000000000000005 111.687 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.6 ttt -74.3 -40.32 62.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.121 0.486 . . . . 2.25 109.749 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.39 -42.37 96.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.225 -0.898 . . . . 0.35999999999999999 110.363 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 46' ' ' SER . 88.3 mt -58.48 -55.85 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.26000000000000001 111.154 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -63.56 -26.72 69.99 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.769 -0.729 . . . . 0.28999999999999998 112.224 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -50.4 68.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.585 -0.524 . . . . 0.92000000000000004 109.585 176.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -64.27 -27.05 68.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.434 -0.348 . . . . 1.23 110.844 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 10.8 m-30 -55.11 -42.53 73.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.406 -0.59 . . . . 0.28000000000000003 109.406 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -84.32 -36.47 22.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.81 -0.632 . . . . 2.8100000000000001 111.253 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -85.6 -47.97 9.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.533 -0.303 . . . . 2.2599999999999998 111.764 -172.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -86.42 -50.36 6.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.364 -0.38 . . . . 2.6200000000000001 111.268 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.42 -43.35 14.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.557 -0.292 . . . . 0.67000000000000004 111.674 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.16 20.22 11.52 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.907 -0.663 . . . . 0.45000000000000001 112.327 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.8 mt -77.46 141.96 39.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.474 0.178 . . . . 0.63 110.881 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -106.57 84.98 2.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.085 0.469 . . . . 2.27 110.477 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.515 HD12 ' HE2' ' A' ' 81' ' ' PHE . 2.9 mm? -86.57 -29.84 22.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.567 0.699 . . . . 1.6399999999999999 109.448 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 126.46 171.48 13.13 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.25 -1.14 . . . . 0.75 110.25 -173.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -85.96 -9.08 7.69 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.821 2.347 . . . . 1.1299999999999999 113.127 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -125.7 23.6 7.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.055 0.455 . . . . 2.3599999999999999 111.546 -173.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -82.08 114.4 20.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.04 -0.527 . . . . 0.72999999999999998 109.796 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.0 m -132.12 117.82 18.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.64 -0.255 . . . . 1.3899999999999999 110.421 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.73 -39.19 68.01 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 111.994 0.368 . . . . 0.72999999999999998 111.994 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.517 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 12.7 t80 -62.07 -11.28 13.07 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.331 -0.395 . . . . 0.58999999999999997 111.694 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.6 mt -124.11 -34.67 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.195 0.522 . . . . 0.89000000000000001 110.92 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -99.28 -11.87 20.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.718 0.636 . . . . 2.23 112.718 -172.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 71.9 m -141.61 165.77 26.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.6 p -135.96 -66.35 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.941 -0.303 . . . . 0.67000000000000004 111.009 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 69.1 p -87.57 178.37 6.8 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.226 -0.287 . . . . 0.38 110.226 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.479 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 4.6 t -81.86 -35.97 13.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-O 121.078 0.466 . . . . 0.68000000000000005 111.11 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.699 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.7 tpp180 -60.95 -33.64 73.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.787 -0.642 . . . . 3.23 110.77 175.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.61 69.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.745 0.307 . . . . 0.28999999999999998 111.151 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.735 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.7 OUTLIER -69.08 -48.84 61.66 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.184 -0.672 . . . . 0.64000000000000001 109.184 175.876 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -52.68 -61.62 2.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.09 -0.959 . . . . 2.3999999999999999 110.766 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.55 -39.0 64.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.478 -0.783 . . . . 1.6599999999999999 111.697 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.515 ' HE2' HD12 ' A' ' 62' ' ' LEU . 75.4 t80 -59.68 -44.85 93.46 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.849 -0.614 . . . . 0.98999999999999999 110.657 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.735 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 30.1 mtp . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.53 . . . . 1.1000000000000001 111.292 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.188 0 N-CA-C 111.279 -0.728 . . . . 0.53000000000000003 111.279 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 m -100.61 156.96 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 122.56 -0.377 . . . . 0.39000000000000001 110.174 -174.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -87.56 -179.84 6.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.599 -0.519 . . . . 1.5600000000000001 109.599 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -68.54 -28.2 66.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.187 0.518 . . . . 2.02 110.424 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -64.16 -47.07 81.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.732 -0.667 . . . . 1.9099999999999999 110.866 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -70.99 -19.26 62.55 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.791 -0.641 . . . . 1.5800000000000001 110.754 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.412 HD11 ' HD2' ' A' ' 79' ' ' LYS . 29.8 tp -73.44 -25.13 60.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.816 -0.629 . . . . 0.98999999999999999 110.804 171.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.35 -31.48 29.8 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.376 0.608 . . . . 0.88 110.038 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.51 -22.64 50.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.647 -0.706 . . . . 0.29999999999999999 111.062 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 p -78.62 -41.38 24.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.831 0.348 . . . . 0.23000000000000001 111.143 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 80.7 mtp -59.26 -31.92 69.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 1.6299999999999999 111.471 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -72.72 -35.97 67.69 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 120.941 -0.303 . . . . 3.1699999999999999 111.188 178.161 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.2 t -70.47 -33.56 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.946 0.879 . . . . 0.23000000000000001 108.951 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.72 -36.75 66.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.469 -1.242 . . . . 0.33000000000000002 109.605 174.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 t -64.91 -25.43 67.88 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.193 -0.458 . . . . 1.3799999999999999 110.507 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -82.75 -43.26 16.98 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.987 0.422 . . . . 2.2599999999999998 111.119 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.571 ' HG3' HG12 ' A' ' 50' ' ' ILE . 49.4 mm-40 -86.69 -23.31 25.63 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.217 0.451 . . . . 0.77000000000000002 112.217 -174.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.0 m -93.42 -28.7 15.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.646 0.26 . . . . 1.23 111.417 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.47 3.16 78.53 Favored Glycine 0 N--CA 1.458 0.162 0 C-N-CA 120.177 -1.011 . . . . 0.54000000000000004 112.191 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.0 mt -95.61 112.06 27.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.407 -0.59 . . . . 0.80000000000000004 109.407 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.05 143.81 2.13 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.538 0.524 . . . . 0.56999999999999995 111.894 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -52.51 -34.04 47.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.792 -0.64 . . . . 0.96999999999999997 111.763 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -76.04 -10.56 59.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.253 -0.431 . . . . 2.23 111.048 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -114.38 -6.35 12.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 2.2400000000000002 110.919 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.5 tp -70.46 99.32 1.58 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.226 0.536 . . . . 1.1000000000000001 110.192 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.435 ' O ' HG21 ' A' ' 75' ' ' VAL . 80.9 p -116.81 158.9 23.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.687 -0.688 . . . . 0.59999999999999998 109.305 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' A' ' 76' ' ' ARG . 43.4 m-20 -67.38 -7.05 21.87 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.733 0.301 . . . . 2.29 111.427 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -73.36 -24.56 60.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 2.29 110.776 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.544 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 36.0 m -69.17 146.86 52.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.057 0.456 . . . . 1.0600000000000001 110.573 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.729 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.8 t-20 -129.25 123.38 31.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.186 -1.042 . . . . 0.80000000000000004 108.186 -177.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.843 ' HD1' HG13 ' A' ' 42' ' ' ILE . 36.1 m-85 -56.29 -51.14 69.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.0 0.429 . . . . 0.46999999999999997 111.614 -174.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.86 -29.17 64.1 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.535 -0.302 . . . . 0.46000000000000002 111.359 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.729 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 23.5 t70 -72.11 -35.56 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.431 0.634 . . . . 0.82999999999999996 110.201 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 45.8 mmm -76.15 -23.76 54.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.21 -0.904 . . . . 2.48 111.177 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.26 30.53 5.32 Favored Glycine 0 C--N 1.323 -0.171 0 C-N-CA 120.328 -0.939 . . . . 0.44 112.408 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.843 HG13 ' HD1' ' A' ' 37' ' ' PHE . 29.6 mm -71.52 107.94 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.415 0.626 . . . . 0.52000000000000002 109.66 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -81.25 165.28 21.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.066 -0.97 . . . . 1.9399999999999999 110.844 -173.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.3 t -52.17 -38.93 59.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.689 -0.687 . . . . 1.03 111.283 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.0 tm? -57.1 -60.32 3.78 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.13 -0.486 . . . . 0.58999999999999997 110.38 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.494 ' O ' HG13 ' A' ' 50' ' ' ILE . 12.8 p -65.77 -33.61 76.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.623 -0.262 . . . . 1.22 111.376 -175.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.511 ' HB3' ' H ' ' A' ' 69' ' ' PHE . 50.5 m -61.38 -35.16 76.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.617 -0.265 . . . . 0.81000000000000005 111.671 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.1 ttt -84.63 -16.84 40.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 2.25 110.522 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.582 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 74.6 t -88.98 -38.96 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 109.836 -0.431 . . . . 0.35999999999999999 109.836 -177.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.571 HG12 ' HG3' ' A' ' 23' ' ' GLU . 54.3 mt -53.13 -53.46 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.763 0.316 . . . . 0.26000000000000001 110.235 172.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.21 -25.3 66.33 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.978 -0.63 . . . . 0.28999999999999998 112.285 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.624 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 2.9 m -75.28 -45.82 37.43 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 122.829 -0.218 . . . . 0.92000000000000004 111.023 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.582 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 23.7 mtp180 -63.8 -25.66 68.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 1.23 110.765 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.521 ' HD2' HD11 ' A' ' 62' ' ' LEU . 14.1 m-30 -56.99 -40.89 77.42 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 121.184 0.516 . . . . 0.28000000000000003 109.896 172.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.624 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 71.5 mtm180 -80.48 -30.02 37.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.74 -0.664 . . . . 2.8100000000000001 110.757 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.35 -61.72 1.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.073 0.463 . . . . 2.2599999999999998 111.819 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.61 -35.45 18.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.684 -0.689 . . . . 2.6200000000000001 111.535 -168.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.55 -33.23 11.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.519 -0.309 . . . . 0.67000000000000004 111.651 -175.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.69 37.94 11.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.832 -0.699 . . . . 0.45000000000000001 112.179 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.499 HD12 ' HB3' ' A' ' 54' ' ' PHE . 88.3 mt -80.56 126.61 31.46 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.779 -0.248 . . . . 0.63 110.772 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.24 76.89 4.74 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.845 0.355 . . . . 2.27 110.491 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.521 HD11 ' HD2' ' A' ' 54' ' ' PHE . 68.1 mt -97.77 -77.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.27 0.557 . . . . 1.6399999999999999 110.857 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.25 170.1 14.0 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.962 -0.855 . . . . 0.75 110.962 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -81.81 -11.21 11.46 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.718 2.278 . . . . 1.1299999999999999 112.633 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -91.12 6.59 44.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.754 -0.657 . . . . 2.3599999999999999 111.853 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -93.07 120.03 32.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.927 0.394 . . . . 0.72999999999999998 111.069 -176.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.1 m -139.89 121.39 15.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 1.3899999999999999 110.217 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.496 HD12 HD12 ' A' ' 50' ' ' ILE . 52.1 mt -58.81 -31.04 68.08 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.72999999999999998 111.869 -177.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.511 ' H ' ' HB3' ' A' ' 47' ' ' SER . 1.6 t80 -56.54 -16.26 5.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.858 0.463 . . . . 0.58999999999999997 111.713 -175.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.9 mt -126.69 -35.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.824 0.345 . . . . 0.89000000000000001 110.708 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.58 -10.36 49.03 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.575 0.954 . . . . 2.23 113.575 -172.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 75.9 m -150.95 120.21 6.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.248 0.547 . . . . 1.0 110.718 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.3 p -100.34 -51.94 3.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.98 -0.555 . . . . 0.67000000000000004 110.841 -174.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.1 p -98.19 -175.23 3.06 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.88 -0.328 . . . . 0.38 110.176 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 1.3 t -79.07 -45.71 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.32 0.581 . . . . 0.68000000000000005 109.781 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.759 ' HA ' ' HG3' ' A' ' 79' ' ' LYS . 4.3 tpp180 -61.93 -25.77 67.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.418 -0.81 . . . . 3.23 110.996 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.07 -34.67 72.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.71 0.29 . . . . 0.28999999999999998 110.511 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.699 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.7 OUTLIER -72.09 -48.68 42.23 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.707 -0.849 . . . . 0.64000000000000001 108.707 176.549 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.759 ' HG3' ' HA ' ' A' ' 76' ' ' ARG . 16.2 mmtp -50.59 -56.17 12.97 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.071 -0.968 . . . . 2.3999999999999999 110.38 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -57.44 -33.61 68.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.726 -1.125 . . . . 1.6599999999999999 111.423 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -72.17 -34.94 68.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.09 0.472 . . . . 0.98999999999999999 110.93 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.699 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 38.6 mtp . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 1.1000000000000001 111.487 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.44 0 N-CA-C 111.283 -0.727 . . . . 0.53000000000000003 111.283 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.864 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 4.2 m -108.73 157.44 8.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.947 0.403 . . . . 0.39000000000000001 110.989 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -85.97 174.7 9.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.355 -0.609 . . . . 1.5600000000000001 109.355 174.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -21.98 65.29 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.499 -0.926 . . . . 2.02 108.499 176.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.25 -53.02 61.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.863 -1.062 . . . . 1.9099999999999999 110.799 175.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.864 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 40.7 mmtm -71.16 -23.57 62.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.278 -0.419 . . . . 1.5800000000000001 110.247 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.43 HD11 ' HD3' ' A' ' 79' ' ' LYS . 14.1 tp -74.9 -26.68 59.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.906 -0.588 . . . . 0.98999999999999999 110.144 174.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -29.61 27.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.512 0.672 . . . . 0.88 109.751 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.718 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -82.86 -27.04 31.06 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.664 -0.698 . . . . 0.29999999999999999 111.359 -175.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.55 -44.22 83.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.64 -0.424 . . . . 0.23000000000000001 111.328 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.2 mtp -64.29 -30.6 71.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.317 -0.402 . . . . 1.6299999999999999 110.622 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.718 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 30.3 ptt180 -74.2 -27.01 60.6 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.009 -0.276 . . . . 3.1699999999999999 110.852 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.0 t -83.07 -33.47 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.76 0.791 . . . . 0.23000000000000001 108.923 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 t -68.01 -34.2 65.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.636 -1.166 . . . . 0.33000000000000002 110.232 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 49.4 m -58.33 -52.7 64.49 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.029 0.442 . . . . 1.3799999999999999 110.637 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -54.04 -59.08 5.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.947 -1.024 . . . . 2.2599999999999998 112.438 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -79.64 -17.49 53.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.89 -0.595 . . . . 0.77000000000000002 112.566 -167.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -97.75 -35.46 10.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.879 0.371 . . . . 1.23 111.081 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.78 8.14 58.38 Favored Glycine 0 CA--C 1.516 0.111 0 C-N-CA 120.352 -0.928 . . . . 0.54000000000000004 111.472 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 21' ' ' SER . 8.1 mt -104.38 107.81 23.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.818 -0.438 . . . . 0.80000000000000004 109.818 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.18 148.87 17.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.56999999999999995 110.977 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 tp -49.75 -32.79 14.52 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.077 0.551 . . . . 0.96999999999999997 111.551 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -73.35 -21.92 60.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.344 -0.389 . . . . 2.23 111.527 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -108.95 -1.76 18.79 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.313 0.577 . . . . 2.2400000000000002 109.686 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -76.31 96.73 4.04 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.835 -0.802 . . . . 1.1000000000000001 108.835 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.7 p -104.56 156.2 18.17 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.454 -0.794 . . . . 0.59999999999999998 108.934 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.592 ' HB2' ' HD3' ' A' ' 76' ' ' ARG . 7.9 p-10 -74.04 -13.03 60.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.026 0.441 . . . . 2.29 110.534 -176.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -89.04 -22.89 22.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.428 -0.806 . . . . 2.29 111.577 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 m -67.71 149.15 50.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.414 0.626 . . . . 1.0600000000000001 110.366 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.517 ' HB3' ' CB ' ' A' ' 39' ' ' ASP . 3.0 t-20 -109.76 125.23 52.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.531 -0.758 . . . . 0.80000000000000004 110.592 -171.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.69 ' HD1' HG13 ' A' ' 42' ' ' ILE . 30.6 m-85 -55.01 -50.68 68.43 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.959 0.409 . . . . 0.46999999999999997 110.893 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.36 -32.19 73.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.98 -0.555 . . . . 0.46000000000000002 111.591 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.517 ' CB ' ' HB3' ' A' ' 36' ' ' ASN . 16.0 t70 -71.31 -35.49 71.27 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.564 0.697 . . . . 0.82999999999999996 109.656 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 tpp -76.25 -20.46 57.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.895 -1.048 . . . . 2.48 110.849 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.0 25.24 6.55 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.411 -0.899 . . . . 0.44 112.586 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.69 HG13 ' HD1' ' A' ' 37' ' ' PHE . 27.1 mm -67.61 107.68 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.356 0.598 . . . . 0.52000000000000002 110.378 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -82.43 170.63 15.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.402 -0.817 . . . . 1.9399999999999999 110.51 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.6 p -56.85 -40.74 76.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.33 -0.395 . . . . 1.03 110.179 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.27 -53.31 59.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.94 -0.573 . . . . 0.58999999999999997 109.818 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.518 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.6 m -62.62 -42.37 99.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 1.22 110.849 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.539 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 49.1 m -60.04 -39.06 84.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.81000000000000005 110.985 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.7 ttp -67.62 -46.18 73.24 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.544 0.688 . . . . 2.25 109.216 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.457 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.6 t -57.87 -55.24 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.417 -1.265 . . . . 0.35999999999999999 110.618 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 46' ' ' SER . 63.0 mt -50.94 -52.78 16.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.616 0.246 . . . . 0.26000000000000001 111.251 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -58.76 -37.15 89.54 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.948 -0.644 . . . . 0.28999999999999998 112.098 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -44.47 79.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.592 0.234 . . . . 0.92000000000000004 110.728 177.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -67.99 -21.85 65.04 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.013 -0.275 . . . . 1.23 110.318 -177.903 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 11.7 m-30 -58.86 -43.4 90.82 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.44 -0.578 . . . . 0.28000000000000003 109.44 170.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -77.59 -28.51 51.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.464 -0.789 . . . . 2.8100000000000001 110.077 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 53' ' ' ARG . 53.8 mt-10 -71.52 -63.91 1.03 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.224 0.535 . . . . 2.2599999999999998 111.395 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -87.89 -35.72 17.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.494 -0.775 . . . . 2.6200000000000001 111.927 -169.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.8 mp -98.69 -40.06 8.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.812 0.339 . . . . 0.67000000000000004 111.114 -173.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.16 31.37 7.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.859 -0.686 . . . . 0.45000000000000001 112.417 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 96.0 mt -81.77 102.15 10.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.742 0.306 . . . . 0.63 110.521 177.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -91.84 69.9 5.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.063 0.459 . . . . 2.27 110.938 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.413 HD13 ' HE2' ' A' ' 81' ' ' PHE . 80.3 mt -88.13 -7.25 57.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.986 -0.552 . . . . 1.6399999999999999 110.53 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.12 173.99 21.21 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.562 -0.828 . . . . 0.75 111.998 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.56 -8.9 6.01 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.971 2.447 . . . . 1.1299999999999999 112.471 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -88.0 3.65 48.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.459 -0.791 . . . . 2.3599999999999999 110.584 -174.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -91.18 120.45 32.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.909 -0.587 . . . . 0.72999999999999998 110.479 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.4 m -140.18 122.42 15.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.956 -0.565 . . . . 1.3899999999999999 110.035 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.2 mt -56.04 -46.73 78.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.081 -0.508 . . . . 0.72999999999999998 111.341 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.539 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.1 t80 -56.58 -12.18 1.66 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.727 -0.669 . . . . 0.58999999999999997 112.417 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.5 mt -115.22 -40.54 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.793 -0.363 . . . . 0.89000000000000001 111.489 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -118.32 9.07 12.37 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.361 0.504 . . . . 2.23 112.361 -171.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.8 m -145.1 114.38 7.06 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.7 -0.625 . . . . 1.0 110.085 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.7 p -98.79 -74.21 0.59 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.85 -0.614 . . . . 0.67000000000000004 110.99 -170.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -83.48 -173.56 4.78 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.981 -0.449 . . . . 0.38 110.59 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 11.7 t -84.16 -38.28 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.756 0.788 . . . . 0.68000000000000005 109.206 -176.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.592 ' HD3' ' HB2' ' A' ' 33' ' ' ASP . 6.6 tpt180 -57.95 -33.79 69.21 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.252 -1.34 . . . . 3.23 110.443 175.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.89 83.08 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.592 -0.276 . . . . 0.28999999999999998 111.012 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.764 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.2 tt -69.92 -49.88 47.6 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.932 -0.766 . . . . 0.64000000000000001 108.932 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 3.1 mmpm? -53.32 -56.32 17.61 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.044 -0.98 . . . . 2.3999999999999999 110.853 178.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -56.27 -35.31 67.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.188 -0.915 . . . . 1.6599999999999999 111.36 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.413 ' HE2' HD13 ' A' ' 62' ' ' LEU . 70.4 t80 -69.92 -35.82 74.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.108 0.48 . . . . 0.98999999999999999 111.121 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.764 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 32.2 mtp . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.042 -0.526 . . . . 1.1000000000000001 110.97 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 111.518 -0.633 . . . . 0.53000000000000003 111.518 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.93 158.26 10.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.664 0.269 . . . . 0.39000000000000001 110.448 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.2 m -73.25 166.13 23.73 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.239 -0.437 . . . . 1.5600000000000001 110.324 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -59.82 -27.59 66.74 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.526 0.679 . . . . 2.02 109.4 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -50.7 -53.4 31.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.966 -1.016 . . . . 1.9099999999999999 111.753 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -66.88 -30.35 70.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.205 -0.598 . . . . 1.5800000000000001 110.242 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.26 -22.9 61.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.98999999999999999 110.933 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.55 -30.3 25.19 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.131 0.491 . . . . 0.88 110.625 173.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.605 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -79.59 -34.13 41.03 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.29999999999999999 110.867 -177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.487 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 2.9 p -58.11 -36.38 56.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.066 0.46 . . . . 0.23000000000000001 110.937 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.9 mtm -69.39 -30.11 68.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.814 -0.63 . . . . 1.6299999999999999 110.945 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 24.6 ptt180 -72.26 -30.79 65.19 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 120.34 -0.544 . . . . 3.1699999999999999 109.758 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.6 t -79.61 -38.33 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.654 0.74 . . . . 0.23000000000000001 109.175 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.9 t -62.21 -47.66 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.608 -1.178 . . . . 0.33000000000000002 110.361 175.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -62.09 -38.88 90.54 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.684 0.253 . . . . 1.3799999999999999 111.684 -176.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 18.2 mm-40 -62.69 -46.72 86.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.508 -0.314 . . . . 2.2599999999999998 111.557 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -83.47 -26.18 30.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.366 0.506 . . . . 0.77000000000000002 112.366 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.438 ' HA ' HD11 ' A' ' 42' ' ' ILE . 78.8 p -84.61 -45.24 12.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 1.23 110.444 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.88 5.64 53.27 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.795 -0.717 . . . . 0.54000000000000004 112.004 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mt -93.36 132.85 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.718 -0.284 . . . . 0.80000000000000004 110.275 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 144.68 53.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.293 -0.412 . . . . 0.56999999999999995 110.979 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -36.51 68.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.909 -0.587 . . . . 0.96999999999999997 110.48 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -70.38 -14.0 62.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.984 -0.553 . . . . 2.23 110.912 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -107.17 -4.86 18.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.017 -0.538 . . . . 2.2400000000000002 110.655 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.1 tp -78.82 96.79 5.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.46 0.648 . . . . 1.1000000000000001 109.873 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.6 p -124.17 167.87 13.68 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.273 -1.01 . . . . 0.59999999999999998 108.273 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.689 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 2.5 p30 -71.61 -3.22 20.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.853 -0.339 . . . . 2.29 111.409 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -75.68 -20.84 58.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.949 0.404 . . . . 2.29 110.214 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.511 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 19.4 m -73.33 148.58 43.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.116 0.484 . . . . 1.0600000000000001 110.214 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.1 t-20 -128.18 117.38 21.47 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.852 -0.795 . . . . 0.80000000000000004 108.852 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.809 ' HD1' HG13 ' A' ' 42' ' ' ILE . 30.0 m-85 -52.67 -54.43 33.56 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.979 0.418 . . . . 0.46999999999999997 111.524 -174.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.21 -25.94 64.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.869 -0.605 . . . . 0.46000000000000002 111.669 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.759 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 38.7 t70 -81.53 -20.51 39.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.321 0.581 . . . . 0.82999999999999996 111.116 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -85.61 -24.38 27.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.856 -0.611 . . . . 2.48 109.9 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.41 13.4 6.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.585 -0.817 . . . . 0.44 112.67 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.809 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.0 mm -67.82 107.82 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.94 0.4 . . . . 0.52000000000000002 110.082 176.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -78.74 179.6 7.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.912 -0.586 . . . . 1.9399999999999999 110.453 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.4 p -57.99 -36.22 72.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.528 -0.76 . . . . 1.03 109.791 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.44 -60.46 3.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.801 -1.091 . . . . 0.58999999999999997 110.029 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.529 ' O ' HG13 ' A' ' 50' ' ' ILE . 1.3 m -57.72 -47.33 82.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.524 . . . . 1.22 111.353 -177.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.914 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 50.9 p -65.94 -29.06 69.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.893 0.377 . . . . 0.81000000000000005 111.298 -176.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.5 tpt -76.31 -35.48 58.8 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.532 -0.544 . . . . 2.25 109.532 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.543 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 37.6 t -65.12 -50.16 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.334 -0.848 . . . . 0.35999999999999999 109.533 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 46' ' ' SER . 60.2 mt -52.7 -53.26 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.26000000000000001 111.061 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.12 -41.62 98.18 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.03 -0.605 . . . . 0.28999999999999998 112.407 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 t -59.62 -44.7 93.36 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.792 0.329 . . . . 0.92000000000000004 110.707 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 56.6 mtp180 -68.14 -20.57 64.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.395 -0.366 . . . . 1.23 111.691 -175.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.579 ' HD2' HD11 ' A' ' 62' ' ' LEU . 15.9 m-30 -59.86 -42.27 93.31 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.37 0.605 . . . . 0.28000000000000003 109.595 171.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 67.4 mtp180 -74.1 -25.98 60.1 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.184 -0.916 . . . . 2.8100000000000001 110.196 -177.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -77.82 -63.75 1.31 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.765 -0.652 . . . . 2.2599999999999998 111.577 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.69 -46.79 10.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.679 -0.692 . . . . 2.6200000000000001 111.964 -170.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.2 -26.43 25.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.233 -0.44 . . . . 0.67000000000000004 111.042 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.49 33.28 31.8 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.785 -0.721 . . . . 0.45000000000000001 112.365 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.613 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 60.2 mt -89.65 104.95 17.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.797 -0.446 . . . . 0.63 109.797 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -85.35 77.87 9.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.707 0.765 . . . . 2.27 109.826 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.579 HD11 ' HD2' ' A' ' 54' ' ' PHE . 30.5 mt -75.77 -73.44 0.26 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.675 -1.148 . . . . 1.6399999999999999 111.199 -176.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 163.2 154.98 7.9 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.46 -0.791 . . . . 0.75 111.132 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.74 -6.49 14.34 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.392 2.062 . . . . 1.1299999999999999 112.034 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -103.7 2.08 32.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.589 -0.732 . . . . 2.3599999999999999 109.948 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -92.48 123.08 35.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.044 -0.526 . . . . 0.72999999999999998 110.571 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.9 m -137.79 128.45 26.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.056 -0.52 . . . . 1.3899999999999999 109.976 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.914 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 32.9 mt -56.56 -33.44 66.13 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 120.635 0.255 . . . . 0.72999999999999998 110.833 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.507 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 24.6 t80 -58.1 -17.48 18.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.045 -0.525 . . . . 0.58999999999999997 111.633 -174.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.8 mt -125.09 -38.69 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.597 -0.274 . . . . 0.89000000000000001 111.009 176.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -96.41 4.36 52.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.665 0.617 . . . . 2.23 112.665 -170.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.3 m -155.45 93.94 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.426 0.631 . . . . 1.0 109.577 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.9 p -80.02 -68.61 0.66 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.473 -0.785 . . . . 0.67000000000000004 109.707 -171.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 65.2 p -86.5 -170.52 3.12 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.673 -0.491 . . . . 0.38 109.673 175.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.3 t -81.58 -38.13 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 108.87 -0.789 . . . . 0.68000000000000005 108.87 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.689 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 5.8 tpt180 -62.97 -30.11 71.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.52 -1.218 . . . . 3.23 110.44 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.19 -34.72 75.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.239 -0.437 . . . . 0.28999999999999998 110.986 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.535 HD21 ' CE2' ' A' ' 54' ' ' PHE . 1.1 tt -73.89 -47.28 39.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.438 0.637 . . . . 0.64000000000000001 109.349 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 31.3 mmtp -54.91 -46.81 74.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.82 -1.082 . . . . 2.3999999999999999 110.959 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.59 -48.53 80.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.502 -0.772 . . . . 1.6599999999999999 111.577 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -55.53 -37.62 68.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.819 -0.628 . . . . 0.98999999999999999 111.781 -175.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.487 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 18.7 mtt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 1.1000000000000001 111.799 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.834 -0.432 . . . . 9.1400000000000006 109.834 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 73.8 mtm 62.71 80.38 0.23 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.819 0.699 . . . . 8.7200000000000006 109.262 -174.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 72.15 123.05 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.2 -0.909 . . . . 5.1699999999999999 110.216 -170.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 3' ' ' ALA . 63.6 tttp 68.53 126.16 0.03 OUTLIER 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.31 -0.859 . . . . 6.6600000000000001 111.703 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.74 -131.31 6.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.82 -0.705 . . . . 1.74 111.685 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.14 -75.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.88 0.371 . . . . 1.1399999999999999 110.148 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 83' ' ' LEU . . . 108.04 105.62 3.01 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.615 -0.802 . . . . 0.53000000000000003 112.239 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 m -119.38 158.24 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.55 -0.537 . . . . 0.39000000000000001 109.55 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 p -83.74 172.85 11.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.186 -0.301 . . . . 1.5600000000000001 110.186 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -70.23 -16.76 63.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.279 0.561 . . . . 2.02 110.196 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -66.27 -47.69 72.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.367 -0.833 . . . . 1.9099999999999999 109.702 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -68.99 -27.56 65.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.884 -0.598 . . . . 1.5800000000000001 109.926 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -24.81 63.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.478 -0.783 . . . . 0.98999999999999999 110.688 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.26 -32.78 26.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.385 0.612 . . . . 0.88 110.246 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.08 -27.32 57.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.29999999999999999 111.051 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.626 HG11 ' HZ1' ' A' ' 79' ' ' LYS . 2.8 p -70.65 -40.73 77.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.053 -0.521 . . . . 0.23000000000000001 111.674 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.4 mtp -61.49 -31.14 71.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 1.6299999999999999 111.309 -173.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -78.69 -27.76 45.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.589 -0.444 . . . . 3.1699999999999999 111.101 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.527 HG13 ' HD3' ' A' ' 53' ' ' ARG . 42.3 t -73.72 -37.63 49.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.525 -0.917 . . . . 0.23000000000000001 108.525 176.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 t -65.14 -44.08 95.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.413 -1.267 . . . . 0.33000000000000002 110.433 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.5 p -56.01 -50.47 70.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.231 0.539 . . . . 1.3799999999999999 110.346 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -55.37 -53.92 50.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.968 -1.015 . . . . 2.2599999999999998 112.749 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -82.66 -16.43 48.28 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.62 0.6 . . . . 0.77000000000000002 112.62 -170.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 81.6 p -91.72 -36.48 13.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.093 0.473 . . . . 1.23 110.722 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.87 -0.01 56.36 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.844 -0.693 . . . . 0.54000000000000004 111.685 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.61 HD11 ' HG2' ' A' ' 40' ' ' MET . 3.1 mt -93.91 123.98 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 109.517 -0.549 . . . . 0.80000000000000004 109.517 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.66 141.76 36.59 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.315 0.385 . . . . 0.56999999999999995 111.101 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.14 -34.14 59.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.899 -0.591 . . . . 0.96999999999999997 111.227 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.35 -10.42 59.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 2.23 111.292 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -109.99 -3.85 16.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.971 0.415 . . . . 2.2400000000000002 110.231 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.9 tp -74.31 99.34 3.45 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.387 0.613 . . . . 1.1000000000000001 110.239 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.405 ' O ' HG21 ' A' ' 75' ' ' VAL . 44.6 p -121.73 164.53 17.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.271 -0.877 . . . . 0.59999999999999998 108.857 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.97 -9.88 34.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.801 0.334 . . . . 2.29 111.307 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.92 -19.6 60.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 2.29 110.487 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.521 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 18.3 m -71.5 143.08 50.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.038 0.446 . . . . 1.0600000000000001 109.835 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.663 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.9 t-20 -128.43 117.87 22.12 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.579 -0.526 . . . . 0.80000000000000004 109.579 -176.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.644 ' HD1' HG13 ' A' ' 42' ' ' ILE . 48.1 m-85 -55.36 -39.7 70.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.889 0.376 . . . . 0.46999999999999997 111.698 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.23 -29.25 60.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.875 0.369 . . . . 0.46000000000000002 111.212 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.663 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 34.6 t70 -74.81 -31.15 61.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.185 0.517 . . . . 0.82999999999999996 110.267 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.61 ' HG2' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -81.04 -14.65 57.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.401 -0.818 . . . . 2.48 110.761 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.67 42.87 6.29 Favored Glycine 0 CA--C 1.511 -0.207 0 C-N-CA 120.378 -0.915 . . . . 0.44 112.153 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.644 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.6 mm -75.54 107.28 6.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.988 0.423 . . . . 0.52000000000000002 109.903 176.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -80.19 175.19 10.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.438 0.637 . . . . 1.9399999999999999 111.82 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 t -52.86 -42.86 65.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.557 -1.201 . . . . 1.03 111.189 177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.36 -61.64 2.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.99 -0.55 . . . . 0.58999999999999997 110.257 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.511 ' O ' HG13 ' A' ' 50' ' ' ILE . 29.0 t -61.18 -47.09 87.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.473 -0.33 . . . . 1.22 111.601 -175.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.469 ' HB3' HG22 ' A' ' 42' ' ' ILE . 51.0 p -62.38 -27.44 69.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.682 0.253 . . . . 0.81000000000000005 111.682 -176.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.647 ' SD ' ' H32' ' A' ' 90' ' ' PNS . 13.9 ttt -80.36 -39.9 27.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.246 0.546 . . . . 2.25 109.841 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.85 -42.21 95.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.315 -0.857 . . . . 0.35999999999999999 109.986 -177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 46' ' ' SER . 73.8 mt -56.75 -58.18 6.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.932 -0.576 . . . . 0.26000000000000001 111.232 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -65.35 -23.73 70.26 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.607 -0.806 . . . . 0.28999999999999998 112.398 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.617 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -69.63 -45.71 67.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.803 -0.443 . . . . 0.92000000000000004 109.803 175.277 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.527 ' HD3' HG13 ' A' ' 19' ' ' VAL . 41.1 mtp180 -61.27 -31.99 71.81 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.428 -0.351 . . . . 1.23 110.533 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.474 ' CE2' HD21 ' A' ' 78' ' ' LEU . 13.1 m-30 -53.68 -40.58 66.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.892 -0.594 . . . . 0.28000000000000003 110.02 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.617 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 53.2 mtm180 -81.04 -37.76 28.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.068 -0.514 . . . . 2.8100000000000001 111.142 -175.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -87.86 -52.45 5.28 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.316 0.488 . . . . 2.2599999999999998 112.316 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -80.41 -42.24 23.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.807 -0.633 . . . . 2.6200000000000001 111.18 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.2 mp -96.08 -33.0 12.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.405 -0.361 . . . . 0.67000000000000004 111.685 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.23 35.07 9.05 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.516 -0.85 . . . . 0.45000000000000001 112.101 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.2 mt -87.08 131.15 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.582 0.23 . . . . 0.63 110.939 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -89.33 47.11 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.639 -0.504 . . . . 2.27 109.639 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -59.16 4.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.188 -0.915 . . . . 1.6399999999999999 110.726 -174.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' ' HD3' ' A' ' 55' ' ' ARG . . . 172.41 167.86 33.01 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.629 -0.588 . . . . 0.75 111.629 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.89 -37.08 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.465 2.11 . . . . 1.1299999999999999 113.38 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.14 45.34 2.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.308 0.575 . . . . 2.3599999999999999 110.438 -175.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -74.2 112.53 10.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.448 -0.797 . . . . 0.72999999999999998 109.876 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.1 p -118.3 129.04 55.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 1.3899999999999999 111.173 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.482 HD12 HD12 ' A' ' 50' ' ' ILE . 75.3 mt -76.2 2.96 11.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 0.72999999999999998 111.672 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.69 -17.7 22.93 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.122 -0.49 . . . . 0.58999999999999997 110.15 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.2 mt -132.26 -37.39 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.093 0.473 . . . . 0.89000000000000001 111.141 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.78 -2.8 46.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.684 0.754 . . . . 2.23 110.683 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.436 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 98.5 m -147.23 157.8 43.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.167 -0.924 . . . . 1.0 108.735 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.3 p -129.95 -73.41 0.56 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.163 -0.215 . . . . 0.67000000000000004 111.276 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.2 p -90.25 -171.58 3.16 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.246 -0.284 . . . . 0.38 110.625 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.521 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 1.8 t -79.47 -44.33 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.568 -0.53 . . . . 0.68000000000000005 109.568 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -59.15 -32.69 70.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.691 -0.686 . . . . 3.23 110.985 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -56.68 -37.16 70.48 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.35 -0.386 . . . . 0.28999999999999998 111.171 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.509 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -74.28 -43.2 57.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.536 0.684 . . . . 0.64000000000000001 109.398 178.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.716 ' HA ' ' NZ ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -53.92 -61.33 2.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.618 -1.174 . . . . 2.3999999999999999 112.102 178.091 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.99 -37.83 77.76 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.107 0.254 . . . . 1.6599999999999999 111.596 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 3.7 t80 -52.69 -39.65 62.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.598 0.561 . . . . 0.98999999999999999 111.067 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.509 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 7.9 mtt -55.85 -38.46 70.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.564 -0.744 . . . . 1.1000000000000001 112.092 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 83' ' ' LEU . 4.2 mp -94.74 -42.43 8.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.036 0.446 . . . . 1.3 110.289 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.25 41.11 7.6 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.938 -0.649 . . . . 2.4199999999999999 111.666 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 t -91.5 8.65 35.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.021 0.915 . . . . 4.4699999999999998 110.597 -173.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.27 -27.57 10.68 Favored Glycine 0 C--N 1.307 -1.057 0 CA-C-N 114.426 -1.261 . . . . 4.5899999999999999 111.074 172.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 t70 52.42 41.2 30.67 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.394 0.678 . . . . 6.6100000000000003 110.458 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.24 -20.13 57.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.725 -0.67 . . . . 8.4700000000000006 110.74 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.327 -1.263 . . . . 9.7300000000000004 111.629 178.584 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PNS . . . . . 0.647 ' H32' ' SD ' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 110.605 -0.146 . . . . 9.1400000000000006 110.605 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 89.9 mtp 71.46 157.55 0.18 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.036 0.835 . . . . 8.7200000000000006 110.932 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.64 135.3 14.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.098 0.475 . . . . 5.1699999999999999 111.61 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 58.8 tttp -152.13 23.54 0.65 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.102 0.953 . . . . 6.6600000000000001 109.304 175.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.08 -146.28 14.65 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.353 -0.839 . . . . 1.74 111.944 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.56 -78.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 110.051 -0.351 . . . . 1.1399999999999999 110.051 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.91 86.62 0.23 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.581 -0.819 . . . . 0.53000000000000003 111.809 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG21 ' SD ' ' A' ' 82' ' ' MET . 5.9 m -97.93 158.37 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.963 -0.384 . . . . 0.39000000000000001 109.963 -175.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.4 t -83.86 -177.11 6.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.844 -0.428 . . . . 1.5600000000000001 109.844 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -71.83 -22.03 61.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.005 0.431 . . . . 2.02 110.603 -174.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -73.96 -41.6 61.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.462 -0.495 . . . . 1.9099999999999999 110.076 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -66.71 -30.87 71.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.893 -0.78 . . . . 1.5800000000000001 108.893 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.1 tp -69.78 -26.19 64.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.975 -1.012 . . . . 0.98999999999999999 110.701 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.28 -27.07 24.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.414 0.626 . . . . 0.88 110.095 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.76 -35.36 57.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.687 -0.688 . . . . 0.29999999999999999 110.802 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.519 HG21 HD22 ' A' ' 78' ' ' LEU . 3.6 p -61.68 -45.42 98.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.989 -0.551 . . . . 0.23000000000000001 110.624 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.1 mtm -59.39 -39.0 81.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.796 -0.638 . . . . 1.6299999999999999 111.52 -174.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HA ' ' HB2' ' A' ' 21' ' ' SER . 11.8 ptt180 -74.07 -29.38 61.85 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.087 -0.645 . . . . 3.1699999999999999 111.569 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.6 t -71.68 -33.01 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.087 0.946 . . . . 0.23000000000000001 108.56 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -70.66 -43.63 77.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.032 -1.44 . . . . 0.33000000000000002 109.712 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' A' ' 18' ' ' ARG . 6.3 m -62.66 -21.87 66.03 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 122.748 0.419 . . . . 1.3799999999999999 111.828 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.09 -51.71 6.15 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.316 -0.402 . . . . 2.2599999999999998 111.365 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 15.2 mm-40 -90.49 -27.94 18.88 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.104 0.409 . . . . 0.77000000000000002 112.104 -172.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.441 ' HB3' HD11 ' A' ' 42' ' ' ILE . 17.5 m -86.4 -32.44 20.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.114 0.483 . . . . 1.23 110.544 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.41 -9.53 62.82 Favored Glycine 0 C--O 1.23 -0.111 0 C-N-CA 120.503 -0.856 . . . . 0.54000000000000004 112.682 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mt -79.37 104.77 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.623 -0.51 . . . . 0.80000000000000004 109.623 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.567 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -43.67 145.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.857 0.723 . . . . 0.56999999999999995 112.02 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.4 tp -56.47 -31.5 64.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.705 -0.679 . . . . 0.96999999999999997 111.002 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -80.39 -9.75 59.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.057 -0.519 . . . . 2.23 111.181 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.567 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 40.6 mm-40 -110.71 -13.9 14.11 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.192 -0.458 . . . . 2.2400000000000002 110.052 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.8 tp -69.6 98.14 1.12 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.639 -0.71 . . . . 1.1000000000000001 110.27 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.1 p -107.62 161.84 14.5 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.361 -0.836 . . . . 0.59999999999999998 108.969 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.741 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 7.5 p-10 -75.54 -9.05 58.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.765 0.317 . . . . 2.29 111.064 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -91.02 -23.65 20.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.416 0.525 . . . . 2.29 112.416 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.7 m -71.3 148.44 47.12 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.423 0.63 . . . . 1.0600000000000001 110.011 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.764 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 4.4 t-20 -113.24 123.49 50.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.417 -0.81 . . . . 0.80000000000000004 109.812 -170.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.787 ' HD1' HG13 ' A' ' 42' ' ' ILE . 32.3 m-85 -56.49 -53.1 61.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.964 0.412 . . . . 0.46999999999999997 111.587 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.06 -27.91 66.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.179 -0.464 . . . . 0.46000000000000002 111.321 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.764 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 23.4 t70 -72.06 -32.65 67.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.397 0.617 . . . . 0.82999999999999996 110.251 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.575 ' CE ' ' HA ' ' A' ' 40' ' ' MET . 4.8 mmt -83.48 -13.99 53.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.252 -0.885 . . . . 2.48 111.178 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.82 36.07 6.2 Favored Glycine 0 N--CA 1.457 0.071 0 C-N-CA 120.063 -1.065 . . . . 0.44 112.516 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.787 HG13 ' HD1' ' A' ' 37' ' ' PHE . 32.7 mm -73.19 108.07 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.201 0.524 . . . . 0.52000000000000002 110.013 175.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.29 163.84 27.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.539 -0.755 . . . . 1.9399999999999999 111.351 -173.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.5 t -54.49 -37.3 65.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.293 -0.867 . . . . 1.03 111.054 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.77 -61.54 2.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.58999999999999997 110.203 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.574 ' O ' HG13 ' A' ' 50' ' ' ILE . 11.6 m -62.68 -42.89 99.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.433 -0.349 . . . . 1.22 111.69 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.564 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 57.6 p -63.86 -32.18 73.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.95 0.405 . . . . 0.81000000000000005 111.204 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.9 tpt -75.78 -39.85 56.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.326 0.584 . . . . 2.25 109.734 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.9 t -60.25 -45.82 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.292 -0.867 . . . . 0.35999999999999999 109.97 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 46' ' ' SER . 78.8 mt -55.56 -54.31 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.932 -0.576 . . . . 0.26000000000000001 111.355 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.35 -36.36 92.36 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.736 -0.745 . . . . 0.28999999999999998 112.419 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 m -61.36 -47.44 85.84 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 120.591 -0.443 . . . . 0.92000000000000004 110.108 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -61.48 -32.25 72.25 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.431 -0.349 . . . . 1.23 111.31 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.502 ' HD2' HD11 ' A' ' 62' ' ' LEU . 11.0 m-30 -53.09 -38.95 62.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.151 0.5 . . . . 0.28000000000000003 110.21 176.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -83.54 -29.77 27.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.482 -0.781 . . . . 2.8100000000000001 111.116 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -85.12 -62.17 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.268 0.556 . . . . 2.2599999999999998 111.044 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -44.31 52.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.116 -0.947 . . . . 2.6200000000000001 111.094 -173.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 mp -93.7 -32.18 14.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.378 -0.374 . . . . 0.67000000000000004 111.312 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.99 29.76 30.59 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.681 -0.771 . . . . 0.45000000000000001 112.354 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.8 mt -82.54 108.15 15.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.731 -0.47 . . . . 0.63 109.731 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -81.18 78.43 7.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.641 0.734 . . . . 2.27 109.353 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.502 HD11 ' HD2' ' A' ' 54' ' ' PHE . 27.1 mt -76.07 -71.97 0.35 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.326 -1.306 . . . . 1.6399999999999999 110.995 -176.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.98 169.45 38.91 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.415 -0.811 . . . . 0.75 111.289 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.23 -15.46 11.46 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.672 2.248 . . . . 1.1299999999999999 113.006 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -119.12 10.87 12.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.313 -0.403 . . . . 2.3599999999999999 111.19 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.451 ' CD2' HD13 ' A' ' 62' ' ' LEU . 73.2 t80 -71.93 112.85 8.37 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.948 0.404 . . . . 0.72999999999999998 110.488 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.7 m -131.13 121.24 24.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.692 -0.686 . . . . 1.3899999999999999 109.628 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.647 HD21 HD11 ' A' ' 78' ' ' LEU . 2.5 mp -54.12 -32.12 54.19 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.24 0.459 . . . . 0.72999999999999998 112.24 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.564 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 1.8 t80 -65.99 -14.57 61.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.946 0.403 . . . . 0.58999999999999997 110.855 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.0 mt -124.0 -39.01 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.514 -0.312 . . . . 0.89000000000000001 110.671 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -95.15 6.09 50.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 2.23 111.796 -172.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.493 ' SG ' ' HG ' ' A' ' 78' ' ' LEU . 80.1 m -148.96 100.71 3.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.554 0.693 . . . . 1.0 109.983 -175.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.8 p -90.02 -72.88 0.54 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.694 -0.685 . . . . 0.67000000000000004 110.194 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 77.5 p -86.67 -177.67 6.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.415 -0.587 . . . . 0.38 109.415 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.7 t -80.21 -40.68 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 120.361 -0.536 . . . . 0.68000000000000005 110.419 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.741 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 8.4 tpt180 -54.67 -32.22 58.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.926 -0.579 . . . . 3.23 110.533 173.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -59.42 -31.57 69.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.28999999999999998 111.739 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.647 HD11 HD21 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -81.7 -45.28 15.93 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.706 -0.85 . . . . 0.64000000000000001 108.706 -179.007 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -53.2 -61.56 2.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.945 -1.48 . . . . 2.3999999999999999 110.832 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.17 -19.05 63.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.937 -1.029 . . . . 1.6599999999999999 111.019 -173.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 83.4 t80 -63.06 -42.66 99.75 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.278 0.561 . . . . 0.98999999999999999 109.596 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.46 ' SD ' HG21 ' A' ' 8' ' ' VAL . 12.5 mtt -55.76 -38.11 69.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.203 -0.908 . . . . 1.1000000000000001 111.385 175.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.5 mp -79.34 -46.35 17.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.353 . . . . 1.3 111.243 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.03 81.33 0.35 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.875 -0.679 . . . . 2.4199999999999999 112.397 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.3 p -82.68 67.9 8.92 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.758 -0.221 . . . . 4.4699999999999998 111.291 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.66 91.2 0.09 OUTLIER Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.681 -0.771 . . . . 4.5899999999999999 112.768 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.05 -48.81 61.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.385 0.612 . . . . 6.6100000000000003 110.561 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.55 24.21 4.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.548 -0.751 . . . . 8.4700000000000006 111.218 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.551 -1.138 . . . . 9.7300000000000004 112.271 -179.852 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.739 -0.467 . . . . 9.1400000000000006 109.739 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -78.52 132.09 37.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.61 -0.268 . . . . 8.7200000000000006 110.61 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -147.74 132.04 17.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.817 -0.809 . . . . 5.1699999999999999 108.817 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -142.65 132.09 23.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.217 -0.447 . . . . 6.6600000000000001 110.127 -175.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.64 76.39 1.25 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.729 -0.748 . . . . 1.74 111.652 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.68 -62.13 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.785 0.326 . . . . 1.1399999999999999 110.855 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.82 84.55 1.79 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.78 -0.724 . . . . 0.53000000000000003 111.557 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 12' ' ' LYS . 2.7 m -114.39 157.49 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.929 -0.397 . . . . 0.39000000000000001 109.929 -176.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.1 t -91.4 175.12 7.04 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.845 -0.798 . . . . 1.5600000000000001 108.845 173.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -67.08 -23.27 65.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.977 0.417 . . . . 2.02 110.08 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -47.51 84.46 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.469 -0.787 . . . . 1.9099999999999999 110.903 172.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.615 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -71.74 -25.23 61.97 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.554 -0.536 . . . . 1.5800000000000001 109.554 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.579 ' HA ' HG12 ' A' ' 16' ' ' VAL . 4.0 tp -72.22 -29.21 63.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.07 -0.514 . . . . 0.98999999999999999 110.421 173.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.39 -24.0 57.14 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.023 0.916 . . . . 0.88 109.301 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.35 -36.89 20.47 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.72 -1.127 . . . . 0.29999999999999999 110.884 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.581 HG23 ' CZ ' ' A' ' 54' ' ' PHE . 4.0 p -70.61 -44.11 77.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.873 -0.603 . . . . 0.23000000000000001 112.295 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.451 ' HB3' HD23 ' A' ' 31' ' ' LEU . 88.5 mtp -60.0 -32.56 70.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.847 0.314 . . . . 1.6299999999999999 111.847 -173.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.57 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 8.2 ptt180 -84.24 -18.25 37.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.37 0.507 . . . . 3.1699999999999999 112.37 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.29 -32.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.188 -1.042 . . . . 0.23000000000000001 108.188 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 t -66.71 -39.88 84.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.21 -1.359 . . . . 0.33000000000000002 110.122 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.5 p -64.37 -49.3 72.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.217 0.532 . . . . 1.3799999999999999 110.71 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 7.2 mm-40 -60.94 -39.4 89.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.401 -0.818 . . . . 2.2599999999999998 112.24 -178.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -80.14 -31.94 38.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.951 0.352 . . . . 0.77000000000000002 111.951 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.436 ' HA ' HD11 ' A' ' 42' ' ' ILE . 72.7 p -82.4 -44.59 15.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.886 0.374 . . . . 1.23 111.558 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.91 6.7 37.06 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.654 -0.784 . . . . 0.54000000000000004 111.705 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.697 HD11 ' HG2' ' A' ' 40' ' ' MET . 3.5 mt -97.61 137.07 26.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.501 -0.555 . . . . 0.80000000000000004 109.501 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.35 141.99 58.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.742 0.306 . . . . 0.56999999999999995 110.415 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -55.98 -34.48 65.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.96999999999999997 111.28 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -71.47 -10.45 59.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 2.23 111.378 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -111.61 -4.22 14.83 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.497 -0.319 . . . . 2.2400000000000002 111.103 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 17' ' ' MET . 30.0 tp -72.05 97.88 1.98 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.516 0.674 . . . . 1.1000000000000001 110.472 -173.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 34' ' ' ASP . 70.0 p -124.95 165.8 17.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.193 -0.912 . . . . 0.59999999999999998 109.052 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.496 ' CB ' ' HB2' ' A' ' 76' ' ' ARG . 7.7 p-10 -70.83 -5.87 33.62 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.206 0.527 . . . . 2.29 110.484 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.435 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 24.5 t70 -70.56 -22.04 62.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.202 -0.908 . . . . 2.29 109.687 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.467 ' HB2' HG21 ' A' ' 75' ' ' VAL . 14.1 m -81.29 147.45 29.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.648 -0.706 . . . . 1.0600000000000001 109.901 176.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.7 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 3.7 t-20 -127.64 119.78 26.64 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.074 -0.713 . . . . 0.80000000000000004 109.074 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.621 ' HD1' HG13 ' A' ' 42' ' ' ILE . 5.5 m-85 -51.52 -50.23 60.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.955 0.407 . . . . 0.46999999999999997 110.925 -176.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.03 -31.42 71.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.004 -0.543 . . . . 0.46000000000000002 111.627 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.7 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 30.8 t70 -74.94 -29.2 60.88 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.152 0.501 . . . . 0.82999999999999996 110.322 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.697 ' HG2' HD11 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -82.65 -15.07 53.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.256 -0.884 . . . . 2.48 111.08 -178.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.59 20.99 9.54 Favored Glycine 0 N--CA 1.455 -0.088 0 C-N-CA 120.231 -0.985 . . . . 0.44 112.787 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.621 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.3 mm -71.47 107.15 2.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.52 0.676 . . . . 0.52000000000000002 110.72 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -88.55 170.45 10.86 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.092 -0.958 . . . . 1.9399999999999999 110.088 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.9 t -55.19 -37.71 67.42 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.301 0.24 . . . . 1.03 111.016 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.407 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.4 tm? -58.49 -56.34 23.41 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.012 -0.366 . . . . 0.58999999999999997 110.012 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.56 ' O ' HG13 ' A' ' 50' ' ' ILE . 19.8 m -68.25 -41.43 81.14 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.874 0.324 . . . . 1.22 111.874 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.648 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 36.2 p -66.22 -30.36 70.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.03 0.443 . . . . 0.81000000000000005 110.965 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -39.57 64.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.619 -0.882 . . . . 2.25 108.619 178.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 39.6 t -64.39 -44.66 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.902 -0.59 . . . . 0.35999999999999999 110.261 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 46' ' ' SER . 65.6 mt -52.06 -59.78 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.596 -0.275 . . . . 0.26000000000000001 110.772 176.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.51 -27.33 67.79 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.11 -0.567 . . . . 0.28999999999999998 111.9 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.496 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -67.68 -44.13 78.55 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 122.902 -0.176 . . . . 0.92000000000000004 111.1 176.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 27.7 mtp180 -65.97 -23.98 66.7 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.716 0.293 . . . . 1.23 110.473 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.581 ' CZ ' HG23 ' A' ' 16' ' ' VAL . 12.2 m-30 -58.3 -40.56 82.33 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.169 0.509 . . . . 0.28000000000000003 109.688 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 66.7 mtm180 -82.03 -25.08 34.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.438 -0.801 . . . . 2.8100000000000001 111.043 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -83.0 -59.13 2.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.787 -0.642 . . . . 2.2599999999999998 110.927 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.62 -48.53 7.01 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.516 -0.766 . . . . 2.6200000000000001 111.797 -174.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.401 HD23 ' HD2' ' A' ' 12' ' ' LYS . 10.9 mp -81.71 -26.51 34.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.421 -0.354 . . . . 0.67000000000000004 111.666 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.31 40.41 49.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.12 -0.562 . . . . 0.45000000000000001 112.419 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.453 HD21 ' HG2' ' A' ' 12' ' ' LYS . 78.5 mt -86.35 146.15 26.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.839 0.352 . . . . 0.63 110.966 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.21 94.82 6.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 2.27 110.849 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 63' ' ' GLY . 0.3 OUTLIER -121.53 -52.35 2.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.117 -0.492 . . . . 1.6399999999999999 110.914 176.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' HD12 ' A' ' 62' ' ' LEU . . . 124.52 169.0 12.96 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.628 -0.796 . . . . 0.75 111.988 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.41 -4.83 11.76 Favored 'Trans proline' 0 C--N 1.333 -0.258 0 C-N-CA 122.48 2.12 . . . . 1.1299999999999999 113.041 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.26 -16.56 19.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.118 -0.492 . . . . 2.3599999999999999 111.023 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -69.77 112.8 6.47 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.102 0.477 . . . . 0.72999999999999998 110.25 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 p -128.23 132.54 48.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.052 -0.522 . . . . 1.3899999999999999 111.281 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 83.0 mt -81.23 15.13 2.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.72999999999999998 111.357 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.444 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 6.7 t80 -111.37 -8.49 14.31 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.105 0.479 . . . . 0.58999999999999997 109.907 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.6 mt -131.57 -40.64 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-O 120.862 0.363 . . . . 0.89000000000000001 111.488 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.12 5.53 42.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.228 0.537 . . . . 2.23 110.531 -170.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 96.5 m -158.77 129.24 6.0 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.2 p -109.42 -48.3 3.26 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.748 -0.381 . . . . 0.67000000000000004 111.068 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.6 p -99.87 -171.2 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.306 0.574 . . . . 0.38 111.128 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.467 HG21 ' HB2' ' A' ' 35' ' ' SER . 2.2 t -81.75 -44.45 20.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.773 -0.649 . . . . 0.68000000000000005 110.718 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HD3' ' HB2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -67.31 -24.5 65.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.585 . . . . 3.23 110.684 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.36 64.87 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.165 0.507 . . . . 0.28999999999999998 110.386 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.715 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.6 OUTLIER -77.43 -49.06 15.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.633 -0.712 . . . . 0.64000000000000001 109.339 177.065 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.507 ' HB2' ' HD3' ' A' ' 76' ' ' ARG . 30.5 mmtm -57.85 -45.43 86.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.828 -1.078 . . . . 2.3999999999999999 110.902 -176.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.45 -29.89 70.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.563 -0.744 . . . . 1.6599999999999999 110.77 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -77.0 -36.45 56.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.075 -0.511 . . . . 0.98999999999999999 111.09 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.715 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 44.4 mtp -60.58 -52.99 62.81 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.207 -0.452 . . . . 1.1000000000000001 110.914 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 83' ' ' LEU . 5.9 mp -78.0 -40.7 38.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.949 0.404 . . . . 1.3 110.47 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.86 141.28 6.18 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.922 -0.656 . . . . 2.4199999999999999 111.516 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.5 m -83.94 33.22 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.669 0.271 . . . . 4.4699999999999998 111.087 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.12 47.59 87.08 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.322 -1.111 . . . . 4.5899999999999999 110.322 -172.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -147.25 157.55 43.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.21 -0.495 . . . . 6.6100000000000003 110.216 -172.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 75.62 147.88 0.09 Allowed 'General case' 0 CA--C 1.52 -0.178 0 O-C-N 124.103 0.877 . . . . 8.4700000000000006 111.645 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.852 0 CA-C-O 118.648 -1.084 . . . . 9.7300000000000004 111.601 179.641 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.977 0.418 . . . . 9.1400000000000006 110.212 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -128.16 164.65 22.02 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.565 -0.532 . . . . 8.7200000000000006 109.565 175.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 74.26 132.99 0.05 OUTLIER 'General case' 0 C--O 1.235 0.306 0 O-C-N 124.414 1.071 . . . . 5.1699999999999999 110.744 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -152.61 97.53 2.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.72 -0.673 . . . . 6.6600000000000001 110.144 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 130.01 128.99 3.07 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.699 -0.682 . . . . 1.74 111.474 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.61 -45.27 14.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.0 0.428 . . . . 1.1399999999999999 110.588 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.15 83.78 1.55 Allowed Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.875 -0.89 . . . . 0.53000000000000003 110.875 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -113.36 156.26 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.736 0.303 . . . . 0.39000000000000001 110.274 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.9 p -71.88 157.83 37.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.12 -0.491 . . . . 1.5600000000000001 110.382 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.64 -26.17 68.28 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.118 -1.067 . . . . 2.02 108.118 175.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.44 -42.58 96.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.608 -1.178 . . . . 1.9099999999999999 110.56 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -27.77 64.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.146 -0.479 . . . . 1.5800000000000001 109.735 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.432 ' O ' ' HG3' ' A' ' 17' ' ' MET . 0.1 OUTLIER -68.32 -27.99 66.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.842 -0.617 . . . . 0.98999999999999999 109.565 175.173 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -25.78 41.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.375 0.607 . . . . 0.88 110.156 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.88 -19.29 29.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.503 -0.771 . . . . 0.29999999999999999 111.663 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.536 HG23 ' CE1' ' A' ' 54' ' ' PHE . 3.3 p -82.16 -43.59 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.758 -0.377 . . . . 0.23000000000000001 111.777 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.563 ' HB3' HD23 ' A' ' 31' ' ' LEU . 57.3 mtm -61.56 -30.39 70.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.468 -0.333 . . . . 1.6299999999999999 111.508 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.18 -33.97 74.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.476 0.179 . . . . 3.1699999999999999 111.127 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 53' ' ' ARG . 56.3 t -75.94 -37.13 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.694 0.759 . . . . 0.23000000000000001 109.113 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.03 -39.23 84.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.763 -1.108 . . . . 0.33000000000000002 111.007 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -24.25 50.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.653 0.74 . . . . 1.3799999999999999 109.729 -173.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -78.8 -42.26 28.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.788 -1.097 . . . . 2.2599999999999998 111.101 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.55 ' HG3' HG12 ' A' ' 50' ' ' ILE . 62.0 mm-40 -74.69 -37.49 62.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.27 -0.423 . . . . 0.77000000000000002 111.351 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -71.51 -44.22 65.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.869 0.366 . . . . 1.23 110.516 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.99 5.13 35.64 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.819 -0.705 . . . . 0.54000000000000004 112.071 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.568 HD11 ' HG2' ' A' ' 40' ' ' MET . 2.3 mt -90.68 160.15 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.912 0.387 . . . . 0.80000000000000004 110.107 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.37 140.23 42.89 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.766 -0.652 . . . . 0.56999999999999995 110.269 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.2 tp -58.52 -35.52 72.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.952 -0.567 . . . . 0.96999999999999997 111.229 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -73.84 -14.57 61.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.186 0.517 . . . . 2.23 110.547 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -103.98 -6.3 21.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.762 -0.654 . . . . 2.2400000000000002 110.801 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 17' ' ' MET . 46.5 tp -72.04 99.21 2.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.934 -0.575 . . . . 1.1000000000000001 109.967 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.489 ' O ' HG21 ' A' ' 75' ' ' VAL . 80.2 p -117.63 158.85 23.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.014 -0.539 . . . . 0.59999999999999998 109.71 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.692 ' OD1' ' HB2' ' A' ' 76' ' ' ARG . 6.9 t70 -54.22 -23.72 15.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.226 0.61 . . . . 2.29 112.57 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.48 -19.41 64.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.883 -0.599 . . . . 2.29 111.408 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.534 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 14.8 m -71.95 151.47 43.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.342 0.591 . . . . 1.0600000000000001 110.84 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.774 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.6 t-20 -131.0 120.42 23.46 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.473 -0.566 . . . . 0.80000000000000004 109.473 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.822 ' HD1' HG13 ' A' ' 42' ' ' ILE . 33.7 m-85 -51.36 -46.44 62.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.156 0.503 . . . . 0.46999999999999997 111.219 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.39 -29.62 63.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.784 -0.644 . . . . 0.46000000000000002 111.571 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.774 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 21.5 t70 -74.72 -31.17 61.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.43 0.633 . . . . 0.82999999999999996 110.283 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.568 ' HG2' HD11 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -75.64 -23.12 56.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.602 -0.727 . . . . 2.48 110.453 178.752 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.32 27.93 7.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.325 -0.941 . . . . 0.44 112.026 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.822 HG13 ' HD1' ' A' ' 37' ' ' PHE . 28.6 mm -68.21 107.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 0.52000000000000002 109.833 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.35 171.44 15.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.521 -0.763 . . . . 1.9399999999999999 111.211 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.3 t -57.88 -32.69 67.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.721 -1.127 . . . . 1.03 111.167 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.2 tm? -64.25 -57.48 9.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.721 -0.672 . . . . 0.58999999999999997 110.088 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.552 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.6 m -63.93 -40.84 97.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.979 -0.555 . . . . 1.22 111.585 -173.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.6 p -62.38 -30.14 70.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.211 -0.45 . . . . 0.81000000000000005 111.447 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.7 ttt -79.15 -37.64 37.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.514 0.673 . . . . 2.25 109.775 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 52' ' ' SER . 78.0 t -69.39 -40.68 80.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.765 -1.107 . . . . 0.35999999999999999 110.233 -175.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 46' ' ' SER . 73.2 mt -51.69 -54.11 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.881 0.372 . . . . 0.26000000000000001 110.705 174.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -63.46 -26.22 69.38 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.974 -0.631 . . . . 0.28999999999999998 112.247 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 10.3 m -70.99 -42.33 69.79 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 120.659 0.266 . . . . 0.92000000000000004 110.715 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.473 ' HB2' HG11 ' A' ' 19' ' ' VAL . 10.0 mtp180 -64.95 -26.34 68.26 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.525 -0.307 . . . . 1.23 110.351 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.734 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 16.5 m-30 -56.31 -43.98 79.46 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.261 0.553 . . . . 0.28000000000000003 109.58 173.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 61.7 mtp180 -79.32 -27.97 42.11 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.227 -0.897 . . . . 2.8100000000000001 110.573 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -77.29 -62.82 1.53 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.82 -0.627 . . . . 2.2599999999999998 112.023 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -88.54 -44.13 10.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 2.6200000000000001 111.477 -169.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.56 -39.11 15.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.108 -0.497 . . . . 0.67000000000000004 111.591 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.99 23.34 15.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.503 -0.856 . . . . 0.45000000000000001 112.307 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.734 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 73.2 mt -80.81 113.18 18.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.726 -0.472 . . . . 0.63 109.726 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -97.87 87.39 3.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.45 0.643 . . . . 2.27 110.01 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.644 HD11 ' HD2' ' A' ' 54' ' ' PHE . 37.2 mt -87.88 -66.1 0.95 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.756 -1.111 . . . . 1.6399999999999999 110.304 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.15 167.62 20.08 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.724 -0.95 . . . . 0.75 110.724 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -87.62 5.24 5.62 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 123.361 2.707 . . . . 1.1299999999999999 112.96 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -107.19 -7.67 16.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.708 -0.678 . . . . 2.3599999999999999 111.692 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -85.38 120.87 27.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.774 0.321 . . . . 0.72999999999999998 111.428 -171.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -135.16 127.8 30.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 1.3899999999999999 110.42 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 50' ' ' ILE . 68.2 mt -66.12 -11.02 46.24 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.223 0.453 . . . . 0.72999999999999998 112.223 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -85.12 -11.33 55.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.125 0.488 . . . . 0.58999999999999997 109.944 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.5 mt -127.52 -39.81 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.344 -0.389 . . . . 0.89000000000000001 110.906 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -95.73 8.26 43.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.529 -0.305 . . . . 2.23 111.146 -173.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 89.6 m -157.59 159.56 37.2 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -132.67 -78.28 0.49 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.303 -0.408 . . . . 0.67000000000000004 110.615 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 80.8 p -83.65 -169.72 2.7 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.26 -0.275 . . . . 0.38 110.596 177.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.6 OUTLIER -77.05 -41.84 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.568 -0.453 . . . . 0.68000000000000005 110.095 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.692 ' HB2' ' OD1' ' A' ' 33' ' ' ASP . 24.6 ttm180 -59.87 -33.43 71.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.428 -0.351 . . . . 3.23 111.324 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.69 -29.86 28.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.498 0.499 . . . . 0.28999999999999998 110.718 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.611 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.5 OUTLIER -85.39 -51.27 6.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.924 -0.58 . . . . 0.64000000000000001 109.753 175.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HD3' HD11 ' A' ' 13' ' ' LEU . 10.5 mmtp -49.58 -59.25 3.94 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.069 -0.969 . . . . 2.3999999999999999 111.298 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.45 -29.02 69.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.648 -1.16 . . . . 1.6599999999999999 110.899 -173.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.9 -37.12 75.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.98999999999999999 111.138 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.611 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 22.3 mtp -57.72 -45.03 86.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.077 -0.51 . . . . 1.1000000000000001 110.618 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 83' ' ' LEU . 5.8 mp -80.59 -41.9 23.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.197 -0.456 . . . . 1.3 110.411 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.28 -82.43 0.3 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.709 -0.556 . . . . 2.4199999999999999 111.709 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.1 t -173.9 31.43 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.637 -0.875 . . . . 4.4699999999999998 108.637 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 145.18 166.71 11.86 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.573 -1.011 . . . . 4.5899999999999999 110.573 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -140.51 125.0 17.83 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.472 0.136 . . . . 6.6100000000000003 110.81 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 53.47 82.5 0.08 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.901 0.751 . . . . 8.4700000000000006 112.705 173.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 118.44 -1.2 . . . . 9.7300000000000004 112.261 177.894 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 110.441 -0.207 . . . . 9.1400000000000006 110.441 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 59.0 tpp 63.78 76.06 0.37 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.787 0.679 . . . . 8.7200000000000006 111.275 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.47 134.18 17.76 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.69 -0.485 . . . . 5.1699999999999999 109.69 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -138.86 90.5 2.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.284 0.564 . . . . 6.6600000000000001 110.763 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.31 119.96 2.11 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.853 -0.612 . . . . 1.74 111.615 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.67 -81.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.585 0.192 . . . . 1.1399999999999999 110.814 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.71 96.29 1.11 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.583 -0.818 . . . . 0.53000000000000003 111.945 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.91 157.21 10.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.8 0.333 . . . . 0.39000000000000001 110.489 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.0 m -78.94 165.59 23.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.346 -0.388 . . . . 1.5600000000000001 110.159 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -61.37 -31.44 71.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.821 0.819 . . . . 2.02 109.204 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.14 -45.94 83.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.381 -1.281 . . . . 1.9099999999999999 110.788 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -72.87 -21.85 60.86 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.339 -0.846 . . . . 1.5800000000000001 110.823 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 tp -73.22 -26.07 61.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.828 -0.623 . . . . 0.98999999999999999 110.273 172.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -25.59 36.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.698 0.761 . . . . 0.88 109.796 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.75 -32.77 23.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.048 -0.978 . . . . 0.29999999999999999 111.356 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.512 HG11 ' SD ' ' A' ' 82' ' ' MET . 2.9 p -67.28 -44.53 87.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 120.874 -0.33 . . . . 0.23000000000000001 111.785 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.6 mtp -60.43 -27.82 67.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.204 -0.453 . . . . 1.6299999999999999 111.931 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 24.4 ptt85 -79.85 -32.87 40.51 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.598 . . . . 3.1699999999999999 111.459 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.35 -37.86 78.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.72 -0.844 . . . . 0.23000000000000001 108.72 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.2 t -64.87 -39.16 84.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.793 -1.094 . . . . 0.33000000000000002 109.977 174.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -69.16 -27.33 65.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.91 -0.586 . . . . 1.3799999999999999 111.344 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 43.9 mt-10 -85.98 -30.27 22.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.018 0.437 . . . . 2.2599999999999998 111.117 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.727 ' HG3' HG12 ' A' ' 50' ' ' ILE . 72.2 mm-40 -82.63 -45.49 14.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.859 -0.609 . . . . 0.77000000000000002 112.031 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.507 ' HA ' HD11 ' A' ' 42' ' ' ILE . 73.4 p -72.13 -45.38 60.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.85 0.357 . . . . 1.23 111.248 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.72 2.2 43.09 Favored Glycine 0 C--O 1.23 -0.095 0 N-CA-C 111.104 -0.798 . . . . 0.54000000000000004 111.104 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.755 HD11 ' HG3' ' A' ' 40' ' ' MET . 3.9 mt -93.7 104.98 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.297 -0.631 . . . . 0.80000000000000004 109.297 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -42.21 143.75 0.56 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.841 0.713 . . . . 0.56999999999999995 112.317 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.6 tp -54.44 -32.84 58.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.799 -0.637 . . . . 0.96999999999999997 111.281 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -78.0 -10.51 59.63 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.889 0.376 . . . . 2.23 111.013 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -109.3 -6.54 15.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.187 -0.672 . . . . 2.2400000000000002 109.187 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.519 HD11 HG11 ' A' ' 75' ' ' VAL . 41.3 tp -76.84 98.72 4.94 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.399 -0.819 . . . . 1.1000000000000001 110.221 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.3 p -121.93 163.63 18.97 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.967 -1.015 . . . . 0.59999999999999998 108.476 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.05 -3.75 14.39 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.782 0.29 . . . . 2.29 111.782 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -70.91 -23.44 62.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.373 -0.376 . . . . 2.29 110.595 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.463 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 21.3 m -75.65 149.8 38.1 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.527 0.68 . . . . 1.0600000000000001 111.399 -174.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.773 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 16.8 t-20 -126.13 122.15 34.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.099 -0.955 . . . . 0.80000000000000004 108.768 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.797 ' HD1' HG13 ' A' ' 42' ' ' ILE . 20.6 m-85 -55.34 -46.84 76.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.852 0.358 . . . . 0.46999999999999997 111.18 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.31 -29.59 62.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.341 -0.391 . . . . 0.46000000000000002 111.573 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.773 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 30.7 t70 -71.17 -35.58 71.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.537 0.684 . . . . 0.82999999999999996 110.36 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.755 ' HG3' HD11 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -75.54 -24.53 56.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.35 -0.841 . . . . 2.48 109.663 -175.663 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.16 28.28 4.73 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.529 -0.843 . . . . 0.44 112.429 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.797 HG13 ' HD1' ' A' ' 37' ' ' PHE . 33.2 mm -74.34 107.94 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 0.52000000000000002 110.571 176.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.77 170.97 15.75 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.512 -0.551 . . . . 1.9399999999999999 109.512 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.3 p -55.33 -36.85 66.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.884 -0.598 . . . . 1.03 110.388 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -52.23 -59.05 4.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.32 -0.854 . . . . 0.58999999999999997 110.539 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.574 ' O ' HG13 ' A' ' 50' ' ' ILE . 32.8 t -66.75 -43.26 84.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.14 -0.224 . . . . 1.22 111.134 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.538 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 87.7 p -60.35 -29.97 69.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.376 . . . . 0.81000000000000005 111.254 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.8 tpp -75.81 -46.12 32.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.895 -0.593 . . . . 2.25 109.806 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.558 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 49.8 t -59.54 -45.46 93.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.958 -1.019 . . . . 0.35999999999999999 110.616 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.727 HG12 ' HG3' ' A' ' 23' ' ' GLU . 55.8 mt -51.7 -52.8 19.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.904 0.383 . . . . 0.26000000000000001 110.447 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -57.59 -37.24 81.94 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.712 -0.677 . . . . 0.28999999999999998 112.551 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -66.46 -45.91 78.18 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.983 -0.377 . . . . 0.92000000000000004 109.983 177.523 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 6.0 mtp180 -60.64 -27.07 67.51 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.567 -0.288 . . . . 1.23 111.061 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 12.5 m-30 -58.01 -41.07 82.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.205 0.526 . . . . 0.28000000000000003 110.135 173.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.735 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 61.3 mtp180 -84.0 -32.11 25.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.833 -0.621 . . . . 2.8100000000000001 111.205 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 52' ' ' SER . 20.0 mm-40 -82.9 -47.07 12.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.237 -0.438 . . . . 2.2599999999999998 111.158 -174.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.09 -42.58 11.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 2.6200000000000001 112.151 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.55 -32.76 12.1 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.695 0.257 . . . . 0.67000000000000004 111.695 -174.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.96 33.41 8.99 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.746 -0.74 . . . . 0.45000000000000001 112.574 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.735 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 87.7 mt -86.5 115.84 24.26 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 110.409 -0.219 . . . . 0.63 110.409 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -95.21 58.37 2.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.649 0.737 . . . . 2.27 109.589 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.86 -29.79 50.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.859 -1.064 . . . . 1.6399999999999999 111.449 -175.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.28 169.9 12.59 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.734 -0.746 . . . . 0.75 112.394 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -89.36 -13.29 2.92 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.171 2.58 . . . . 1.1299999999999999 112.671 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -82.81 -17.36 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.523 . . . . 2.3599999999999999 112.239 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -82.3 114.27 20.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.173 0.511 . . . . 0.72999999999999998 111.139 -173.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.9 m -128.93 125.3 37.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.911 -0.586 . . . . 1.3899999999999999 109.94 176.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 68.2 mt -58.55 -40.0 81.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.327 -0.397 . . . . 0.72999999999999998 111.691 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -60.8 -8.1 2.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.193 -0.458 . . . . 0.58999999999999997 111.674 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.5 -40.19 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.939 -0.475 . . . . 0.89000000000000001 111.47 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -109.77 -1.91 17.65 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.56 0.578 . . . . 2.23 112.56 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.8 m -142.38 97.83 3.19 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.488 -0.757 . . . . 1.0 110.281 -175.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.6 p -89.58 -30.27 18.3 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.638 -0.71 . . . . 0.67000000000000004 111.034 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -114.46 -176.51 2.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.135 -0.484 . . . . 0.38 110.468 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.519 HG11 HD11 ' A' ' 31' ' ' LEU . 1.5 t -81.61 -43.3 19.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.998 0.428 . . . . 0.68000000000000005 110.437 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.61 ' HA ' ' CG ' ' A' ' 79' ' ' LYS . 29.3 ttm180 -64.97 -28.41 69.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.106 -0.497 . . . . 3.23 111.002 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.5 -31.21 55.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 0.28999999999999998 110.749 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.8 OUTLIER -75.7 -47.89 24.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.304 -0.628 . . . . 0.64000000000000001 109.304 176.77 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.61 ' CG ' ' HA ' ' A' ' 76' ' ' ARG . 26.8 mmtp -46.97 -50.01 19.77 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.96 -1.018 . . . . 2.3999999999999999 110.59 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -54.36 -55.33 29.66 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.301 -0.863 . . . . 1.6599999999999999 111.709 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -56.29 -37.62 70.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.479 -0.782 . . . . 0.98999999999999999 112.245 -173.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 24.8 mtp -60.17 -47.67 84.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.871 0.367 . . . . 1.1000000000000001 111.439 -174.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 82' ' ' MET . 5.7 mp -82.94 -27.62 30.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.367 -0.379 . . . . 1.3 110.816 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.54 -145.8 18.14 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.302 -0.952 . . . . 2.4199999999999999 112.432 175.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.2 m -93.99 34.72 1.21 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.09 0.471 . . . . 4.4699999999999998 110.347 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.67 23.66 59.74 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.002 -0.839 . . . . 4.5899999999999999 111.002 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -71.14 103.39 2.75 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.97 0.414 . . . . 6.6100000000000003 110.418 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -163.02 -32.88 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.823 -0.626 . . . . 8.4700000000000006 111.055 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.72 -1.044 . . . . 9.7300000000000004 112.191 -179.021 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.135 -0.321 . . . . 9.1400000000000006 110.135 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.4 ttm 65.54 91.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.901 0.751 . . . . 8.7200000000000006 111.6 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.03 136.78 24.3 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.055 0.455 . . . . 5.1699999999999999 110.415 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -156.74 112.89 2.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.588 -0.733 . . . . 6.6600000000000001 109.79 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.76 -102.83 2.82 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.695 -0.764 . . . . 1.74 111.619 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -119.73 -74.55 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 110.054 -0.35 . . . . 1.1399999999999999 110.054 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.67 98.28 1.41 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.785 -0.721 . . . . 0.53000000000000003 111.339 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 3.9 m -112.21 158.96 12.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.159 -0.312 . . . . 0.39000000000000001 110.159 -177.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.1 p -87.11 -178.59 6.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.204 -0.453 . . . . 1.5600000000000001 110.5 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -68.43 -30.34 69.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.295 -0.631 . . . . 2.02 109.295 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.4 -41.0 96.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.322 -0.854 . . . . 1.9099999999999999 110.408 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.469 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 58.1 mttt -74.3 -26.64 60.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.842 -0.617 . . . . 1.5800000000000001 111.002 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.23 -23.2 54.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.008 -0.542 . . . . 0.98999999999999999 110.057 173.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.3 -27.11 42.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.5 0.667 . . . . 0.88 109.694 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -83.9 -26.76 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.054 -0.975 . . . . 0.29999999999999999 111.66 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 p -71.83 -44.56 67.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 111.782 0.29 . . . . 0.23000000000000001 111.782 -178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.524 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 73.8 mtp -60.44 -34.37 73.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.486 -0.325 . . . . 1.6299999999999999 111.42 -175.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 12.3 ptt180 -69.64 -29.47 66.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.707 0.289 . . . . 3.1699999999999999 110.688 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.37 -39.33 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.01 -0.737 . . . . 0.23000000000000001 109.01 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.86 -49.05 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.838 -1.074 . . . . 0.33000000000000002 110.06 176.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.499 ' OG ' HD22 ' A' ' 31' ' ' LEU . 25.7 m -54.96 -47.19 74.84 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 112.401 0.519 . . . . 1.3799999999999999 112.401 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -57.33 -46.43 83.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.055 0.391 . . . . 2.2599999999999998 112.055 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HB3' ' OG ' ' A' ' 46' ' ' SER . 75.4 mm-40 -79.75 -33.51 40.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.292 -0.413 . . . . 0.77000000000000002 111.882 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.451 ' HB3' HD11 ' A' ' 42' ' ' ILE . 76.7 p -80.72 -42.8 21.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 1.23 111.525 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.32 12.92 34.59 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.982 -0.628 . . . . 0.54000000000000004 111.978 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mt -102.88 125.89 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 122.802 -0.234 . . . . 0.80000000000000004 110.544 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.45 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -56.3 145.11 27.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.394 -0.367 . . . . 0.56999999999999995 110.788 175.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.76 -43.9 38.23 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.579 0.549 . . . . 0.96999999999999997 110.404 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -76.41 -10.66 59.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.963 -0.562 . . . . 2.23 111.286 -173.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.45 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 34.1 mm-40 -107.93 -10.59 15.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.987 -0.745 . . . . 2.2400000000000002 108.987 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.499 HD22 ' OG ' ' A' ' 21' ' ' SER . 17.8 tp -79.49 97.47 6.43 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.347 -0.842 . . . . 1.1000000000000001 109.18 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.2 p -116.73 162.38 17.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.322 -0.854 . . . . 0.59999999999999998 108.855 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.834 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 45.5 m-20 -74.59 -3.54 31.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.782 0.325 . . . . 2.29 111.059 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.29 -20.22 44.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.705 -0.679 . . . . 2.29 110.528 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB2' HG21 ' A' ' 75' ' ' VAL . 43.6 m -70.88 157.32 38.34 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.749 0.785 . . . . 1.0600000000000001 111.275 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.673 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.1 t-20 -124.43 126.16 45.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.86 -1.064 . . . . 0.80000000000000004 108.682 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.516 ' HD1' HG13 ' A' ' 42' ' ' ILE . 26.1 m-85 -57.08 -52.78 63.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.116 0.484 . . . . 0.46999999999999997 111.308 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.07 -22.87 63.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.053 -0.521 . . . . 0.46000000000000002 111.254 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.6 t70 -83.54 -16.0 47.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.82999999999999996 110.538 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 65.9 mmm -101.46 1.49 38.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 2.48 111.706 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.53 26.22 23.56 Favored Glycine 0 C--O 1.23 -0.152 0 C-N-CA 119.79 -1.195 . . . . 0.44 112.767 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.516 HG13 ' HD1' ' A' ' 37' ' ' PHE . 18.3 mm -72.01 107.7 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.195 0.521 . . . . 0.52000000000000002 110.018 175.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.8 159.78 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.291 -0.868 . . . . 1.9399999999999999 110.194 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 69' ' ' PHE . 1.4 t -55.07 -39.62 69.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.433 0.635 . . . . 1.03 109.704 171.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.0 tm? -56.96 -53.09 61.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.315 -0.857 . . . . 0.58999999999999997 109.827 175.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.575 ' O ' HG13 ' A' ' 50' ' ' ILE . 32.4 t -67.91 -42.76 80.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.758 -0.201 . . . . 1.22 111.52 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 33.0 p -60.73 -34.25 74.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.005 0.431 . . . . 0.81000000000000005 111.151 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.579 ' SD ' H312 ' A' ' 90' ' ' PNS . 30.2 ttp -72.69 -36.7 67.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.738 -0.664 . . . . 2.25 109.563 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 45' ' ' LEU . 42.6 t -70.34 -41.2 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.325 -0.852 . . . . 0.35999999999999999 110.256 -177.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 46' ' ' SER . 59.0 mt -55.14 -55.63 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.742 0.306 . . . . 0.26000000000000001 110.431 176.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.74 -28.96 72.5 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.11 -0.566 . . . . 0.28999999999999998 112.031 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.26 -42.66 75.28 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.717 0.294 . . . . 0.92000000000000004 110.689 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.76 ' HA ' ' HB3' ' A' ' 56' ' ' GLU . 28.9 mtp180 -69.01 -22.53 64.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 121.0 -0.28 . . . . 1.23 110.592 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.577 ' HE2' HD21 ' A' ' 78' ' ' LEU . 13.8 m-30 -57.46 -41.89 81.44 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.246 -0.649 . . . . 0.28000000000000003 109.246 172.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.67 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 35.8 mtp180 -81.19 -25.67 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.552 -0.749 . . . . 2.8100000000000001 110.665 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.76 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 29.9 tt0 -77.68 -62.77 1.56 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.754 -0.657 . . . . 2.2599999999999998 111.687 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -87.21 -41.56 13.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.969 -0.56 . . . . 2.6200000000000001 111.415 -172.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.99 -40.67 11.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.182 -0.463 . . . . 0.67000000000000004 111.33 -174.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.59 28.26 9.77 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.019 -0.61 . . . . 0.45000000000000001 112.047 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.67 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 51.2 mt -80.8 107.41 13.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.297 -0.26 . . . . 0.63 110.297 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.55 78.78 9.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.186 0.993 . . . . 2.27 110.196 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.495 HD11 ' HD2' ' A' ' 54' ' ' PHE . 13.8 mt -83.1 -72.98 0.43 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.422 -1.263 . . . . 1.6399999999999999 110.932 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.13 156.23 16.16 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.733 -0.947 . . . . 0.75 110.733 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.446 ' HG2' ' OE2' ' A' ' 65' ' ' GLU . 58.9 Cg_endo -78.37 -26.75 5.85 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.351 2.034 . . . . 1.1299999999999999 113.613 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.446 ' OE2' ' HG2' ' A' ' 64' ' ' PRO . 37.4 mp0 -98.7 26.42 5.65 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 122.082 -0.386 . . . . 2.3599999999999999 111.178 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -92.12 112.54 24.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.46 -0.336 . . . . 0.72999999999999998 110.439 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.5 t -132.46 123.87 27.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.968 0.414 . . . . 1.3899999999999999 110.199 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.507 HD12 HD12 ' A' ' 50' ' ' ILE . 70.2 mt -61.47 -16.45 47.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.089 -0.505 . . . . 0.72999999999999998 111.546 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.474 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 8.9 t80 -73.82 -15.05 61.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.186 -0.461 . . . . 0.58999999999999997 110.76 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.0 mt -130.04 -35.82 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.197 -0.456 . . . . 0.89000000000000001 110.965 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -91.97 6.8 44.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.484 -0.325 . . . . 2.23 111.871 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.75 162.78 37.14 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -175.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.0 p -134.92 -72.65 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.306 -0.406 . . . . 0.67000000000000004 111.209 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 71.8 p -84.88 -179.46 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.999 -0.371 . . . . 0.38 109.999 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -79.68 -39.92 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 108.865 -0.791 . . . . 0.68000000000000005 108.865 -176.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.834 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 13.6 tpt180 -60.38 -30.23 69.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.476 -1.238 . . . . 3.23 111.188 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.03 -33.63 73.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.433 -0.348 . . . . 0.28999999999999998 110.491 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.658 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.0 OUTLIER -71.93 -51.18 23.37 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.81 -0.811 . . . . 0.64000000000000001 108.81 176.569 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.524 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 27.9 mmtp -48.09 -57.57 5.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.51 -1.223 . . . . 2.3999999999999999 111.833 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -60.52 -37.27 80.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.572 -0.74 . . . . 1.6599999999999999 111.506 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -62.64 -38.24 89.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.941 -0.572 . . . . 0.98999999999999999 111.125 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.658 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 30.0 mtp -59.98 -51.45 69.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 1.1000000000000001 111.519 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.1 mp -75.75 -42.3 50.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.578 0.228 . . . . 1.3 110.762 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.55 125.23 3.05 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.559 -0.829 . . . . 2.4199999999999999 112.337 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.2 m -76.87 41.36 0.27 Allowed 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 122.532 0.333 . . . . 4.4699999999999998 111.47 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.62 -59.58 4.05 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.096 -0.573 . . . . 4.5899999999999999 111.797 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -157.9 116.31 3.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.689 0.281 . . . . 6.6100000000000003 110.364 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.64 -66.98 0.45 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.043 -0.526 . . . . 8.4700000000000006 110.342 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.864 0 CA-C-O 118.512 -1.16 . . . . 9.7300000000000004 111.783 -178.943 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PNS . . . . . 0.579 H312 ' SD ' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 111.435 0.161 . . . . 9.1400000000000006 111.435 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 92.3 mtp 58.77 73.51 0.48 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.672 0.389 . . . . 8.7200000000000006 111.039 -176.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.01 130.41 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.942 0.776 . . . . 5.1699999999999999 111.861 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -137.76 118.49 14.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.488 -0.778 . . . . 6.6600000000000001 110.448 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 84' ' ' GLY . . . -107.62 -173.14 22.18 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.556 -0.747 . . . . 1.74 111.637 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.8 t -81.18 -79.78 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.785 0.326 . . . . 1.1399999999999999 110.431 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.43 94.25 1.82 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.749 -0.941 . . . . 0.53000000000000003 110.749 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.99 158.93 9.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.817 0.341 . . . . 0.39000000000000001 110.562 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.3 t -85.79 179.2 7.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.783 -0.451 . . . . 1.5600000000000001 109.783 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.81 -20.71 65.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.535 0.683 . . . . 2.02 109.643 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.9 -50.87 71.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.987 -1.006 . . . . 1.9099999999999999 110.689 175.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.489 ' HG2' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -70.54 -23.85 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.054 -0.721 . . . . 1.5800000000000001 109.054 -177.498 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.457 ' O ' ' HG3' ' A' ' 17' ' ' MET . 2.2 tp -69.49 -27.14 64.94 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.724 -0.671 . . . . 0.98999999999999999 110.403 174.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.7 -28.57 33.4 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.591 0.71 . . . . 0.88 109.986 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.51 -31.76 37.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.23 -0.895 . . . . 0.29999999999999999 111.013 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.553 HG23 ' CZ ' ' A' ' 54' ' ' PHE . 4.5 p -69.61 -46.99 73.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.275 -0.421 . . . . 0.23000000000000001 111.617 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.712 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 65.8 mtm -61.9 -28.88 69.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.426 -0.352 . . . . 1.6299999999999999 111.725 -172.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -81.61 -22.44 37.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.37 -0.377 . . . . 3.1699999999999999 111.25 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.0 t -82.42 -35.22 12.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.758 -0.83 . . . . 0.23000000000000001 108.758 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.4 t -64.89 -36.21 77.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.574 -1.194 . . . . 0.33000000000000002 110.09 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -59.7 -53.03 62.72 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.051 0.453 . . . . 1.3799999999999999 110.663 -176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -54.76 -55.61 28.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.165 -0.925 . . . . 2.2599999999999998 112.324 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -77.42 -22.84 50.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.341 0.497 . . . . 0.77000000000000002 112.341 -170.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.401 ' HA ' HD11 ' A' ' 42' ' ' ILE . 20.1 m -85.96 -31.41 22.11 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.553 -0.459 . . . . 1.23 110.006 175.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.13 -2.92 44.02 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.745 -0.741 . . . . 0.54000000000000004 112.844 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mt -101.48 153.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.833 0.349 . . . . 0.80000000000000004 110.603 -175.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.5 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -66.77 145.34 55.62 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.855 -0.612 . . . . 0.56999999999999995 110.646 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.2 tp -60.87 -36.39 79.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.996 0.427 . . . . 0.96999999999999997 110.422 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -72.58 -10.92 60.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 2.23 110.963 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.5 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 19.2 mt-10 -115.55 6.32 14.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.727 -0.669 . . . . 2.2400000000000002 110.793 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.429 HD11 HG11 ' A' ' 75' ' ' VAL . 44.6 tp -75.48 97.78 3.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.31 0.576 . . . . 1.1000000000000001 109.501 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.459 ' O ' HG21 ' A' ' 75' ' ' VAL . 59.4 p -101.11 156.85 17.18 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.203 -0.908 . . . . 0.59999999999999998 110.363 -175.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.694 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 16.5 p-10 -81.56 -4.61 56.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.279 0.562 . . . . 2.29 110.027 177.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.14 -22.85 60.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.891 -1.05 . . . . 2.29 110.841 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.438 ' HB2' HG21 ' A' ' 75' ' ' VAL . 39.8 m -77.43 155.4 31.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.957 0.884 . . . . 1.0600000000000001 111.568 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.931 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.4 t-20 -127.05 123.76 37.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.455 -1.313 . . . . 0.80000000000000004 107.455 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.649 ' HD1' HG13 ' A' ' 42' ' ' ILE . 11.6 m-85 -56.8 -54.76 42.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.855 -0.338 . . . . 0.46999999999999997 111.443 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.19 62.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.86 0.362 . . . . 0.46000000000000002 111.006 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.931 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 22.8 t70 -74.04 -29.12 61.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.495 . . . . 0.82999999999999996 110.815 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.1 mmt -83.04 -15.03 52.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.618 . . . . 2.48 111.228 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.11 14.86 15.66 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.158 -1.02 . . . . 0.44 112.258 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.649 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.0 mm -67.59 106.8 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.947 -0.76 . . . . 0.52000000000000002 108.947 174.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.91 177.52 8.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.473 -0.785 . . . . 1.9399999999999999 111.225 -177.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 t -58.59 -31.88 68.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.193 -0.912 . . . . 1.03 109.766 175.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.422 ' HA ' H281 ' A' ' 90' ' ' PNS . 3.0 tm? -60.43 -62.93 1.51 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.985 -1.007 . . . . 0.58999999999999997 110.86 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.567 ' O ' HG13 ' A' ' 50' ' ' ILE . 15.2 m -68.64 -39.34 80.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.448 -0.342 . . . . 1.22 111.519 -173.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 47.0 p -65.6 -21.93 66.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.814 0.34 . . . . 0.81000000000000005 111.255 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.39 -43.73 20.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.101 -0.703 . . . . 2.25 109.101 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.7 t -62.76 -48.02 90.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.048 -0.978 . . . . 0.35999999999999999 110.84 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 46' ' ' SER . 77.1 mt -51.32 -56.6 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.317 -0.401 . . . . 0.26000000000000001 111.473 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.85 -30.65 78.31 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.611 -0.805 . . . . 0.28999999999999998 112.459 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -39.52 89.5 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.04 -0.264 . . . . 0.92000000000000004 110.451 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 25.6 mtp180 -65.19 -23.96 67.24 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.488 0.185 . . . . 1.23 110.882 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.628 ' HD2' HD11 ' A' ' 62' ' ' LEU . 11.8 m-30 -58.51 -38.69 78.23 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.482 0.658 . . . . 0.28000000000000003 109.501 175.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -79.07 -24.67 43.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.174 -0.921 . . . . 2.8100000000000001 110.95 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -78.56 -62.07 1.81 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.996 -0.547 . . . . 2.2599999999999998 111.412 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -87.82 -53.57 4.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.023 -0.535 . . . . 2.6200000000000001 111.639 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 mp -72.81 -27.59 62.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.963 -0.562 . . . . 0.67000000000000004 111.289 -171.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.65 31.1 57.02 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.623 -0.798 . . . . 0.45000000000000001 111.708 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 54' ' ' PHE . 81.8 mt -82.05 114.55 20.68 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 110.292 -0.262 . . . . 0.63 110.292 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -88.89 75.85 8.0 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.252 -0.647 . . . . 2.27 109.252 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.628 HD11 ' HD2' ' A' ' 54' ' ' PHE . 37.1 mt -82.4 -65.47 1.01 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.165 -0.925 . . . . 1.6399999999999999 109.998 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.24 165.71 23.0 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 114.647 -1.16 . . . . 0.75 110.75 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.94 -8.3 10.09 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.02 2.48 . . . . 1.1299999999999999 113.075 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -117.56 20.64 13.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.468 0.652 . . . . 2.3599999999999999 110.709 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.411 ' HE1' ' CE2' ' A' ' 81' ' ' PHE . 83.6 t80 -77.87 111.81 14.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.074 -0.512 . . . . 0.72999999999999998 109.916 -177.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.1 m -123.16 118.17 27.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.626 -0.715 . . . . 1.3899999999999999 110.739 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 42.6 mt -63.26 -33.31 75.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 0.72999999999999998 110.489 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.483 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 37.1 t80 -59.6 -16.65 27.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.618 -0.719 . . . . 0.58999999999999997 111.151 -175.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.7 mt -121.76 -40.14 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 121.044 -0.262 . . . . 0.89000000000000001 111.515 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.51 6.84 32.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.933 -0.707 . . . . 2.23 112.526 -173.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 82.1 m -150.2 86.65 1.43 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.251 0.548 . . . . 1.0 109.639 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.1 p -78.25 -59.01 2.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.591 -0.731 . . . . 0.67000000000000004 110.927 -172.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 82.3 p -86.9 -178.92 6.42 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.852 -0.425 . . . . 0.38 109.852 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -81.59 -42.54 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.306 0.574 . . . . 0.68000000000000005 109.89 -179.246 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.694 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 4.9 tpp180 -60.13 -29.06 68.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.361 -0.836 . . . . 3.23 110.613 176.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -59.59 -35.72 74.85 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.532 -0.304 . . . . 0.28999999999999998 110.951 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.554 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -72.58 -45.3 59.82 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.192 -0.67 . . . . 0.64000000000000001 109.192 177.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.712 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.8 mmtp -51.19 -61.3 2.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.853 -1.067 . . . . 2.3999999999999999 111.048 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.95 -24.42 65.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.766 -0.652 . . . . 1.6599999999999999 111.79 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 46.5 t80 -64.82 -37.15 86.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.009 0.433 . . . . 0.98999999999999999 110.262 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 12.8 mtp -62.2 -42.86 99.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.633 -0.712 . . . . 1.1000000000000001 111.463 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.7 mp -74.84 -17.33 60.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 1.3 110.849 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' A' ' 5' ' ' GLY . . . -66.82 95.16 0.26 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.742 -0.742 . . . . 2.4199999999999999 111.964 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.9 t -103.83 11.58 35.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.982 0.896 . . . . 4.4699999999999998 109.982 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 159.48 147.13 4.78 Favored Glycine 0 C--N 1.311 -0.825 0 CA-C-N 114.485 -1.234 . . . . 4.5899999999999999 111.663 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -152.83 -82.96 0.08 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.305 -0.628 . . . . 6.6100000000000003 109.305 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 69.73 142.12 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.703 0.763 . . . . 8.4700000000000006 112.248 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.908 0 CA-C-O 118.119 -1.378 . . . . 9.7300000000000004 111.46 177.352 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PNS . . . . . 0.631 H312 ' O26' ' A' ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.636 0.255 . . . . 9.1400000000000006 110.815 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.0 mmm -94.39 147.3 23.37 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.623 -0.51 . . . . 8.7200000000000006 109.623 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.05 -14.24 36.83 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.042 0.449 . . . . 5.1699999999999999 111.441 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.4 tttt 69.25 115.31 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.643 -1.162 . . . . 6.6600000000000001 111.372 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.08 173.85 22.75 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.883 -0.887 . . . . 1.74 110.883 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.4 t -76.3 -71.27 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.91 0.386 . . . . 1.1399999999999999 110.263 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.16 83.93 1.49 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.54 -0.838 . . . . 0.53000000000000003 111.465 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 4.0 m -110.57 160.49 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.741 0.305 . . . . 0.39000000000000001 110.699 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -82.61 174.39 11.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.405 -0.591 . . . . 1.5600000000000001 109.405 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -66.9 -35.71 80.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.409 0.623 . . . . 2.02 109.74 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -56.93 -41.4 78.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.014 -0.994 . . . . 1.9099999999999999 111.202 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.587 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 47.5 mmtm -68.02 -24.72 65.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.697 -0.683 . . . . 1.5800000000000001 110.53 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.858 HD13 HD11 ' A' ' 83' ' ' LEU . 24.9 tp -70.72 -26.76 63.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.136 -0.484 . . . . 0.98999999999999999 111.146 173.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.94 -30.79 50.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.659 0.742 . . . . 0.88 109.3 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.596 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -75.83 -33.44 60.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.071 -0.968 . . . . 0.29999999999999999 110.405 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 13' ' ' LEU . 3.0 p -71.48 -45.46 68.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.318 -0.401 . . . . 0.23000000000000001 111.716 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 63.7 mtt -59.54 -33.95 72.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.69 -0.232 . . . . 1.6299999999999999 110.948 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 39.3 ptt180 -73.25 -30.35 63.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.046 -0.262 . . . . 3.1699999999999999 111.216 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -77.46 -34.17 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.739 -0.837 . . . . 0.23000000000000001 108.739 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 t -66.55 -40.96 87.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.681 -1.145 . . . . 0.33000000000000002 109.304 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.8 t -61.76 -23.48 66.2 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.318 -0.401 . . . . 1.3799999999999999 111.021 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.51 -49.69 10.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.203 0.525 . . . . 2.2599999999999998 111.165 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -84.85 -31.39 23.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.439 -0.801 . . . . 0.77000000000000002 112.372 -169.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.4 p -79.12 -35.43 42.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 1.23 111.129 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.75 13.8 56.17 Favored Glycine 0 C--O 1.234 0.106 0 C-N-CA 120.404 -0.903 . . . . 0.54000000000000004 111.336 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mt -105.08 111.73 35.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.494 -0.558 . . . . 0.80000000000000004 109.494 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.19 145.37 13.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 0.56999999999999995 111.256 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.5 tp -52.96 -34.61 56.56 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.912 -0.585 . . . . 0.96999999999999997 110.919 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.43 -19.46 61.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.865 -0.607 . . . . 2.23 111.579 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.34 -1.38 21.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.927 -0.398 . . . . 2.2400000000000002 109.927 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -73.93 97.91 2.91 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.577 0.703 . . . . 1.1000000000000001 109.493 -177.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.2 p -106.59 151.22 25.33 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.272 -0.876 . . . . 0.59999999999999998 109.097 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.831 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 27.1 m-20 -81.21 -3.19 51.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.84 0.352 . . . . 2.29 111.515 -174.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -93.62 -3.95 51.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.258 -0.428 . . . . 2.29 110.636 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.446 ' HB2' HG21 ' A' ' 75' ' ' VAL . 55.3 m -73.69 158.63 34.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.394 0.616 . . . . 1.0600000000000001 110.022 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.823 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.0 t-20 -125.82 124.95 42.07 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.538 -0.755 . . . . 0.80000000000000004 109.465 -176.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.732 ' HD1' HG13 ' A' ' 42' ' ' ILE . 35.5 m-85 -55.65 -50.19 70.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.891 0.376 . . . . 0.46999999999999997 111.181 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.07 70.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.015 0.436 . . . . 0.46000000000000002 111.221 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.823 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 32.8 t70 -72.68 -27.18 61.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.113 0.483 . . . . 0.82999999999999996 110.598 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.9 mmt -86.46 -12.28 49.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 2.48 111.423 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.44 23.17 9.73 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.317 -0.944 . . . . 0.44 112.784 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.732 HG13 ' HD1' ' A' ' 37' ' ' PHE . 24.5 mm -72.39 106.91 2.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.267 0.556 . . . . 0.52000000000000002 110.217 176.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -91.11 -178.66 5.23 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.648 -0.706 . . . . 1.9399999999999999 111.139 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.6 t -54.61 -49.03 71.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.278 -0.873 . . . . 1.03 110.796 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.533 HD23 H302 ' A' ' 90' ' ' PNS . 3.3 tm? -50.32 -58.42 5.7 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.719 -0.673 . . . . 0.58999999999999997 110.883 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.467 ' O ' HG13 ' A' ' 50' ' ' ILE . 22.6 t -66.78 -46.34 75.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.854 0.359 . . . . 1.22 111.442 -174.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 59.0 p -65.16 -30.66 71.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.427 -0.352 . . . . 0.81000000000000005 111.73 -176.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.6 tpt -74.73 -41.69 59.68 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.055 -0.72 . . . . 2.25 109.055 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 31.8 t -57.48 -53.1 48.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.278 -0.874 . . . . 0.35999999999999999 110.503 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 46' ' ' SER . 68.9 mt -49.08 -53.9 6.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 O-C-N 123.131 0.27 . . . . 0.26000000000000001 111.264 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.37 -34.99 83.15 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.81 -0.71 . . . . 0.28999999999999998 112.485 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -68.52 -41.92 79.25 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.91 -0.316 . . . . 0.92000000000000004 110.222 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 1.8 mtp180 -68.54 -20.57 64.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.67 -0.241 . . . . 1.23 110.711 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.597 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.7 m-30 -59.92 -39.83 86.78 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.646 0.736 . . . . 0.28000000000000003 109.658 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.685 ' HD2' ' O ' ' A' ' 60' ' ' LEU . 9.8 mmm180 -73.76 -28.64 61.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.887 -1.051 . . . . 2.8100000000000001 110.298 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -81.53 -64.09 1.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.078 -0.51 . . . . 2.2599999999999998 112.096 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -83.78 -34.62 24.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.977 -0.556 . . . . 2.6200000000000001 111.392 -169.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.3 mp -97.22 -39.71 9.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.051 -0.522 . . . . 0.67000000000000004 110.817 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.38 36.2 8.97 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.534 -0.841 . . . . 0.45000000000000001 111.802 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.685 ' O ' ' HD2' ' A' ' 55' ' ' ARG . 93.4 mt -78.79 133.5 37.06 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.67 -0.122 . . . . 0.63 110.67 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.62 77.71 9.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.212 0.529 . . . . 2.27 110.732 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.597 HD11 ' HD2' ' A' ' 54' ' ' PHE . 55.1 mt -94.66 -60.54 1.68 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.609 0.719 . . . . 1.6399999999999999 109.694 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.41 176.75 24.53 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 109.916 -1.274 . . . . 0.75 109.916 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.77 -23.03 7.23 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.994 1.796 . . . . 1.1299999999999999 112.608 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -119.71 70.23 0.85 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.716 0.769 . . . . 2.3599999999999999 110.695 -175.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -109.92 111.46 22.89 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.282 -0.872 . . . . 0.72999999999999998 109.487 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.2 m -121.18 118.4 29.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.198 -0.455 . . . . 1.3899999999999999 110.51 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 59.8 mt -64.58 -25.19 67.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.376 . . . . 0.72999999999999998 111.047 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.562 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.9 t80 -72.16 -4.4 28.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.841 -0.618 . . . . 0.58999999999999997 110.353 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.94 -42.59 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.28 -0.418 . . . . 0.89000000000000001 110.947 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.46 8.87 33.66 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.365 0.505 . . . . 2.23 112.365 -169.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 89.2 m -152.5 159.23 43.34 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.044 -0.41 . . . . 1.0 110.089 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.9 p -134.25 -70.61 0.51 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.405 -0.362 . . . . 0.67000000000000004 110.962 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 77.6 p -83.26 -177.65 6.82 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.242 -0.286 . . . . 0.38 110.318 175.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.525 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -83.25 -41.58 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.635 0 N-CA-C 108.637 -0.875 . . . . 0.68000000000000005 108.637 -176.291 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.831 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 7.7 tpt180 -59.26 -29.62 67.7 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 113.743 -1.572 . . . . 3.23 110.91 175.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.26 68.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.786 0.326 . . . . 0.28999999999999998 110.826 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.47 -43.07 41.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.972 0.892 . . . . 0.64000000000000001 109.151 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.53 ' HG3' ' HA ' ' A' ' 76' ' ' ARG . 24.9 mmtm -60.01 -51.54 69.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.152 -1.386 . . . . 2.3999999999999999 109.83 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.81 -29.75 70.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.714 -1.13 . . . . 1.6599999999999999 111.162 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -72.96 -39.13 66.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.864 -0.607 . . . . 0.98999999999999999 110.767 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.2 mtm -81.75 -42.61 19.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.595 -0.729 . . . . 1.1000000000000001 112.349 -174.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.858 HD11 HD13 ' A' ' 13' ' ' LEU . 6.7 mp -83.67 -46.35 12.41 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.981 -0.45 . . . . 1.3 111.13 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.61 145.12 13.14 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.941 -0.647 . . . . 2.4199999999999999 112.248 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.5 m -108.71 32.61 4.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.12 0.486 . . . . 4.4699999999999998 110.547 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.77 73.31 0.39 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.725 -0.671 . . . . 4.5899999999999999 112.008 -177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -91.33 24.18 3.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.052 0.453 . . . . 6.6100000000000003 110.037 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.27 12.84 25.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.698 -0.683 . . . . 8.4700000000000006 111.5 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.392 -1.227 . . . . 9.7300000000000004 111.356 177.904 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PNS . . . . . 0.533 H302 HD23 ' A' ' 45' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.626 0.251 . . . . 9.1400000000000006 110.767 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 15.4 tpt -120.59 132.93 55.39 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.133 -0.321 . . . . 8.7200000000000006 110.133 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -140.6 136.5 32.83 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.365 0.602 . . . . 5.1699999999999999 111.016 -177.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 5' ' ' GLY . 81.6 tttt -148.48 164.14 35.06 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.2 -0.909 . . . . 6.6600000000000001 108.773 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.662 ' HA3' ' HA2' ' A' ' 84' ' ' GLY . . . -111.44 -157.88 14.64 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.663 -0.78 . . . . 1.74 111.386 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.59 -65.9 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.087 0.47 . . . . 1.1399999999999999 109.798 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 83' ' ' LEU . . . 103.25 92.52 2.23 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.172 -0.771 . . . . 0.53000000000000003 111.172 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.713 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 2.7 m -114.26 156.28 15.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.855 0.359 . . . . 0.39000000000000001 110.344 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.6 t -95.41 -176.52 3.8 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.12 -0.491 . . . . 1.5600000000000001 109.728 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -62.65 -26.17 68.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.052 0.453 . . . . 2.02 109.969 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.48 -55.17 37.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.736 -0.666 . . . . 1.9099999999999999 110.937 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.713 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 88.0 mttt -75.32 -19.8 59.43 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.31 -0.404 . . . . 1.5800000000000001 110.468 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.601 HD11 ' HD2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -73.76 -31.14 63.17 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.022 -0.535 . . . . 0.98999999999999999 110.183 172.457 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.16 -29.39 43.02 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.232 -0.918 . . . . 0.88 109.585 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -79.54 -25.7 41.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.936 -1.029 . . . . 0.29999999999999999 111.021 -175.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.7 p -77.68 -43.76 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.557 -0.292 . . . . 0.23000000000000001 111.32 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.555 ' HB3' HD23 ' A' ' 31' ' ' LEU . 66.9 mtm -63.35 -28.99 70.38 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.983 -0.287 . . . . 1.6299999999999999 111.006 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 20.0 ptt180 -74.45 -33.62 62.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.86 -0.336 . . . . 3.1699999999999999 110.62 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.12 -38.32 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.624 0.726 . . . . 0.23000000000000001 109.143 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.3 t -61.87 -42.1 93.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.614 -1.175 . . . . 0.33000000000000002 110.982 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.0 m -71.55 -41.36 69.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.286 0.565 . . . . 1.3799999999999999 110.259 -171.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.06 -46.61 82.34 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.987 -1.006 . . . . 2.2599999999999998 111.663 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.44 -31.46 48.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.459 -0.337 . . . . 0.77000000000000002 111.502 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.414 ' HA ' HD11 ' A' ' 42' ' ' ILE . 53.1 m -77.85 -35.87 50.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.844 0.354 . . . . 1.23 111.175 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.72 0.72 36.79 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.793 -0.718 . . . . 0.54000000000000004 112.494 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.853 HD11 ' SD ' ' A' ' 40' ' ' MET . 5.7 mt -92.81 161.18 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.286 0.565 . . . . 0.80000000000000004 110.6 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -87.16 143.13 27.44 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.134 -0.939 . . . . 0.56999999999999995 109.264 171.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.0 tp -56.18 -29.17 60.47 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.278 0.362 . . . . 0.96999999999999997 111.56 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -69.32 -15.21 63.28 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.34 -0.391 . . . . 2.23 111.944 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -114.07 3.71 15.38 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.121 -0.231 . . . . 2.2400000000000002 111.334 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.555 HD23 ' HB3' ' A' ' 17' ' ' MET . 39.1 tp -78.73 99.09 6.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.332 0.587 . . . . 1.1000000000000001 110.335 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.1 p -120.06 163.28 17.89 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.007 -0.738 . . . . 0.59999999999999998 109.007 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.643 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.8 p-10 -70.91 -3.0 16.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.158 0.429 . . . . 2.29 112.158 -177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.41 -22.97 61.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.983 0.42 . . . . 2.29 110.878 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.472 ' HB3' ' CG2' ' A' ' 75' ' ' VAL . 33.7 t -76.14 158.78 31.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.422 0.63 . . . . 1.0600000000000001 111.742 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.2 t-20 -127.16 119.42 26.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.363 -0.835 . . . . 0.80000000000000004 109.277 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.775 ' HD1' HG13 ' A' ' 42' ' ' ILE . 38.5 m-85 -50.84 -49.6 58.49 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.123 0.487 . . . . 0.46999999999999997 111.291 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.8 -32.77 74.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.798 -0.637 . . . . 0.46000000000000002 111.28 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 34.2 t70 -73.51 -26.99 61.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.157 0.503 . . . . 0.82999999999999996 110.541 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.853 ' SD ' HD11 ' A' ' 26' ' ' ILE . 65.3 mtm -79.7 -24.1 41.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.805 -0.634 . . . . 2.48 110.183 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.08 26.44 6.66 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.426 -0.892 . . . . 0.44 112.584 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.775 HG13 ' HD1' ' A' ' 37' ' ' PHE . 26.9 mm -65.14 108.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.604 -0.517 . . . . 0.52000000000000002 109.604 175.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -82.34 176.49 9.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.581 -0.736 . . . . 1.9399999999999999 110.435 -175.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.0 t -61.02 -40.25 92.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.805 -0.634 . . . . 1.03 109.865 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.27 -56.71 17.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.522 -0.763 . . . . 0.58999999999999997 110.002 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.5 m -59.78 -44.22 94.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.09 -0.504 . . . . 1.22 111.206 -177.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.577 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 50.2 m -58.72 -39.29 80.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.744 -0.662 . . . . 0.81000000000000005 111.606 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.66 ' HG2' H311 ' A' ' 90' ' ' PNS . 12.4 tpt -72.66 -37.5 67.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.374 0.606 . . . . 2.25 110.13 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.606 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.0 t -62.83 -53.84 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.14 -0.936 . . . . 0.35999999999999999 109.871 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 46' ' ' SER . 66.5 mt -49.97 -52.4 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.281 -0.418 . . . . 0.26000000000000001 111.281 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.09 -36.97 93.15 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.871 -0.681 . . . . 0.28999999999999998 112.518 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t -63.66 -44.2 94.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.715 0.293 . . . . 0.92000000000000004 110.467 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 11.7 mtp180 -65.87 -27.05 67.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.394 -0.366 . . . . 1.23 110.65 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.454 ' HB3' HD12 ' A' ' 60' ' ' LEU . 13.4 m-30 -57.31 -40.66 78.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.36 0.6 . . . . 0.28000000000000003 110.032 175.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 47.5 mtp180 -78.62 -27.82 45.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.732 -0.667 . . . . 2.8100000000000001 111.002 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.74 -56.73 4.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.217 -0.447 . . . . 2.2599999999999998 111.474 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -88.14 -36.46 16.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.235 -0.439 . . . . 2.6200000000000001 112.005 -172.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.3 mp -99.76 -25.08 14.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.892 0.33 . . . . 0.67000000000000004 111.892 -172.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.26 41.62 37.75 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.514 -0.85 . . . . 0.45000000000000001 111.699 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 54' ' ' PHE . 19.1 mt -83.65 136.73 34.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.986 0.365 . . . . 0.63 111.986 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -93.4 88.38 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 2.27 110.208 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.495 HD11 ' HE2' ' A' ' 81' ' ' PHE . 0.7 OUTLIER -112.89 -61.05 1.79 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.135 -0.484 . . . . 1.6399999999999999 109.92 178.55 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.58 170.72 12.45 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.811 -0.709 . . . . 0.75 112.155 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.57 10.43 3.71 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.995 2.463 . . . . 1.1299999999999999 111.937 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.21 9.97 12.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.161 -0.927 . . . . 2.3599999999999999 110.751 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -95.47 116.21 28.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.993 -0.548 . . . . 0.72999999999999998 110.678 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.0 m -136.81 122.45 19.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.024 -0.535 . . . . 1.3899999999999999 110.255 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.412 HD12 HD12 ' A' ' 50' ' ' ILE . 57.2 mt -56.85 -41.82 78.6 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.953 -0.567 . . . . 0.72999999999999998 111.98 -176.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.577 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.4 t80 -55.67 -14.18 2.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.888 -0.596 . . . . 0.58999999999999997 112.223 -174.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.51 -40.7 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.095 -0.378 . . . . 0.89000000000000001 111.112 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -106.05 7.84 32.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.059 0.392 . . . . 2.23 112.059 -169.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 92.3 m -148.91 136.63 20.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.342 0.591 . . . . 1.0 109.863 -176.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.2 p -114.24 -76.15 0.58 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.038 -0.528 . . . . 0.67000000000000004 111.071 -173.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 77.7 p -83.19 -172.8 4.34 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.12 -0.362 . . . . 0.38 110.449 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.524 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -81.36 -40.87 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.03 -0.729 . . . . 0.68000000000000005 109.03 -175.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.643 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -66.98 -24.89 66.09 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.897 -1.047 . . . . 3.23 110.397 179.323 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.0 -34.41 71.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.444 -0.344 . . . . 0.28999999999999998 110.462 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.66 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -71.22 -48.05 53.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.745 -0.835 . . . . 0.64000000000000001 108.745 177.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HD2' HD11 ' A' ' 13' ' ' LEU . 30.0 mmtm -54.04 -50.09 67.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.964 -1.471 . . . . 2.3999999999999999 111.164 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.12 -44.99 92.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 1.6599999999999999 110.627 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 84' ' ' GLY . 34.2 t80 -63.39 -30.07 71.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.043 -0.98 . . . . 0.98999999999999999 111.162 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.66 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 32.8 mtp -61.0 -42.61 98.77 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.177 -0.465 . . . . 1.1000000000000001 110.707 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.505 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 6.2 mp -81.81 -44.55 16.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.737 0.303 . . . . 1.3 110.875 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.662 ' HA2' ' HA3' ' A' ' 5' ' ' GLY . . . -148.5 148.81 20.61 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.076 -1.059 . . . . 2.4199999999999999 112.79 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -78.8 45.34 0.6 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.319 0.581 . . . . 4.4699999999999998 110.198 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.64 24.12 24.32 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.467 -1.053 . . . . 4.5899999999999999 110.467 -172.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -83.53 73.43 10.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.447 0.641 . . . . 6.6100000000000003 110.16 -175.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.06 123.82 7.95 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.36 -0.836 . . . . 8.4700000000000006 109.957 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 118.473 -1.182 . . . . 9.7300000000000004 111.406 178.358 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PNS . . . . . 0.66 H311 ' HG2' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.751 0.31 . . . . 9.1400000000000006 110.952 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 12.2 tpt -115.29 141.23 48.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.206 -0.294 . . . . 8.7200000000000006 110.206 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.02 138.7 11.74 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.05 -0.352 . . . . 5.1699999999999999 110.05 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt 67.25 91.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.939 0.775 . . . . 6.6600000000000001 111.372 177.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.56 150.91 5.52 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.663 -0.78 . . . . 1.74 112.468 177.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.5 t -115.95 -75.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 110.16 -0.311 . . . . 1.1399999999999999 110.16 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.35 98.91 2.49 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.6 -0.809 . . . . 0.53000000000000003 111.744 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.45 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 4.0 m -114.43 162.11 12.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.324 -0.25 . . . . 0.39000000000000001 110.324 -175.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 p -84.25 174.09 10.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.153 -0.314 . . . . 1.5600000000000001 110.153 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -73.38 -19.46 60.99 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.197 -0.668 . . . . 2.02 109.197 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.59 -42.11 95.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.094 -0.957 . . . . 1.9099999999999999 109.398 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.45 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 43.8 mmtm -67.36 -36.26 81.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.364 -0.835 . . . . 1.5800000000000001 110.219 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -62.98 -29.44 70.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.941 -0.572 . . . . 0.98999999999999999 110.678 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.38 -28.6 52.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.598 0.713 . . . . 0.88 109.682 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.52 -34.24 31.34 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.098 -0.956 . . . . 0.29999999999999999 111.124 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.508 HG23 ' CE1' ' A' ' 54' ' ' PHE . 5.7 p -68.55 -45.99 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.654 0.613 . . . . 0.23000000000000001 112.654 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 58.4 mtm -56.35 -34.95 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.943 0.349 . . . . 1.6299999999999999 111.943 -172.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -78.69 -22.97 45.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.34 -0.544 . . . . 3.1699999999999999 111.673 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.58 -34.88 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 122.05 0.929 . . . . 0.23000000000000001 108.551 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 t -69.11 -36.84 75.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.184 -1.371 . . . . 0.33000000000000002 110.469 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.4 t -68.91 -22.62 64.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.787 0.327 . . . . 1.3799999999999999 110.765 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -86.23 -48.96 8.08 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.976 0.417 . . . . 2.2599999999999998 111.919 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -79.5 -9.92 59.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.475 . . . . 0.77000000000000002 112.1 -172.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -99.91 -42.8 6.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.989 0.423 . . . . 1.23 111.309 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.07 7.03 50.93 Favored Glycine 0 C--O 1.235 0.19 0 C-N-CA 120.711 -0.757 . . . . 0.54000000000000004 111.261 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.564 HD11 ' HG3' ' A' ' 40' ' ' MET . 4.9 mt -93.14 111.91 25.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.307 -0.627 . . . . 0.80000000000000004 109.307 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -48.4 144.63 3.92 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.456 0.473 . . . . 0.56999999999999995 111.229 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.2 tp -55.23 -29.3 57.72 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.141 -0.481 . . . . 0.96999999999999997 111.6 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -83.8 -10.25 58.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 2.23 111.039 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.435 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 33.2 mt-10 -105.57 -9.46 17.4 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.728 -0.842 . . . . 2.2400000000000002 108.728 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.565 HD11 HG11 ' A' ' 75' ' ' VAL . 36.7 tp -72.76 98.28 2.37 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.812 -1.085 . . . . 1.1000000000000001 109.649 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.6 p -115.79 158.89 22.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.147 -1.057 . . . . 0.59999999999999998 108.147 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.886 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 17.4 p-10 -75.6 -2.41 29.1 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.931 -0.308 . . . . 2.29 110.821 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -88.22 -3.04 58.92 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.939 -0.573 . . . . 2.29 110.842 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.474 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 45.6 m -81.61 152.91 26.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.488 0.661 . . . . 1.0600000000000001 110.704 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.686 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 15.0 t-20 -122.0 122.96 40.53 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.49 -0.777 . . . . 0.80000000000000004 109.141 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.664 ' HD1' HG13 ' A' ' 42' ' ' ILE . 23.7 m-85 -55.75 -53.58 54.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.988 0.423 . . . . 0.46999999999999997 111.359 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.86 -27.79 67.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.054 -0.521 . . . . 0.46000000000000002 111.066 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.686 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 35.8 t70 -72.45 -29.2 63.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.82999999999999996 110.586 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.564 ' HG3' HD11 ' A' ' 26' ' ' ILE . 14.9 mmt -83.35 -19.9 35.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.896 -0.593 . . . . 2.48 111.318 -176.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.92 16.73 8.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.356 -0.926 . . . . 0.44 112.441 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.664 HG13 ' HD1' ' A' ' 37' ' ' PHE . 23.4 mm -66.6 108.27 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.139 0.495 . . . . 0.52000000000000002 110.323 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -81.34 167.49 19.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.667 -0.697 . . . . 1.9399999999999999 110.068 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.8 t -54.02 -35.14 61.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.447 -0.575 . . . . 1.03 109.447 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.1 tm? -59.55 -62.56 1.78 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.562 -0.745 . . . . 0.58999999999999997 110.022 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.543 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.2 m -59.86 -44.52 94.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.247 -0.433 . . . . 1.22 112.153 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.554 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 36.4 p -65.34 -30.36 71.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.021 0.438 . . . . 0.81000000000000005 111.125 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.4 tpt -75.06 -30.82 61.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.647 -0.706 . . . . 2.25 109.621 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 45' ' ' LEU . 76.3 t -78.62 -36.78 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.148 -0.933 . . . . 0.35999999999999999 110.497 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 46' ' ' SER . 66.9 mt -56.44 -52.57 50.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.37 -0.233 . . . . 0.26000000000000001 110.37 173.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.67 -26.25 68.29 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.774 -0.727 . . . . 0.28999999999999998 111.943 178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 4.1 m -69.62 -45.21 69.05 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 120.679 0.276 . . . . 0.92000000000000004 110.863 176.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -65.07 -27.0 68.48 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.624 0.249 . . . . 1.23 110.856 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.611 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.7 m-30 -54.86 -39.97 69.18 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.718 -0.475 . . . . 0.28000000000000003 109.718 174.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.691 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 12.2 mtp180 -81.64 -34.77 30.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.72 -0.673 . . . . 2.8100000000000001 111.534 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -86.05 -63.88 1.24 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.039 0.447 . . . . 2.2599999999999998 111.544 -173.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -71.14 -36.3 72.03 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.454 -0.794 . . . . 2.6200000000000001 111.499 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.75 -57.0 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.67000000000000004 111.055 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.85 27.61 3.19 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.823 -0.703 . . . . 0.45000000000000001 113.221 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.691 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 55.2 mt -84.1 112.19 20.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.78 0.29 . . . . 0.63 110.353 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -85.58 66.37 9.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 122.235 1.017 . . . . 2.27 110.163 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.611 HD11 ' HD2' ' A' ' 54' ' ' PHE . 19.4 mt -64.72 -67.45 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.507 -1.224 . . . . 1.6399999999999999 110.682 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.75 173.25 39.12 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 110.285 -1.126 . . . . 0.75 110.285 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.8 -35.89 0.68 Allowed 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.372 2.048 . . . . 1.1299999999999999 113.048 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -108.27 62.83 0.61 Allowed 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 121.078 0.466 . . . . 2.3599999999999999 110.766 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -109.66 111.66 23.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.698 -0.482 . . . . 0.72999999999999998 109.698 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.6 m -129.27 118.89 23.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.98 -0.555 . . . . 1.3899999999999999 110.74 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 84.1 mt -64.64 -16.06 62.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.911 -0.586 . . . . 0.72999999999999998 111.092 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.554 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 46.0 t80 -82.5 -12.03 58.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.923 -0.581 . . . . 0.58999999999999997 110.948 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 71.8 mt -117.77 -41.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.773 -0.371 . . . . 0.89000000000000001 111.624 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.26 15.23 16.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.454 0.645 . . . . 2.23 110.671 -173.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 76.8 m -146.72 156.63 43.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.7 p -135.93 -63.17 0.66 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.685 0.279 . . . . 0.67000000000000004 110.776 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 44.3 p -93.04 179.08 5.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.195 -0.298 . . . . 0.38 110.195 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.565 HG11 HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -75.83 -42.91 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 121.484 0.659 . . . . 0.68000000000000005 109.397 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.886 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 40.7 ttp180 -52.86 -37.96 60.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.501 -1.227 . . . . 3.23 111.728 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -55.83 -33.9 64.91 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.852 0.72 . . . . 0.28999999999999998 111.311 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.47 -47.96 30.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.203 0.525 . . . . 0.64000000000000001 110.144 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.592 ' CD ' ' HA ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -56.4 -60.97 2.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.263 -0.88 . . . . 2.3999999999999999 110.235 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -54.62 -37.5 65.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.774 -1.103 . . . . 1.6599999999999999 111.609 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.561 ' HA ' ' HB2' ' A' ' 85' ' ' SER . 38.2 t80 -62.07 -37.88 86.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.98999999999999999 110.966 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.445 ' HB3' HG22 ' A' ' 8' ' ' VAL . 12.2 mtt -54.7 -49.87 69.67 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.059 -0.519 . . . . 1.1000000000000001 112.017 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 83' ' ' LEU . 5.7 mp -80.81 -31.32 35.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 1.3 111.147 -174.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.52 86.53 0.11 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.995 -1.098 . . . . 2.4199999999999999 112.627 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.561 ' HB2' ' HA ' ' A' ' 81' ' ' PHE . 1.8 t -78.9 65.7 4.17 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.922 0.391 . . . . 4.4699999999999998 110.739 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.15 -116.65 1.64 Allowed Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.458 -0.657 . . . . 4.5899999999999999 111.458 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -78.91 147.8 32.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.599 -0.519 . . . . 6.6100000000000003 109.599 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.82 -170.49 2.95 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.654 -0.498 . . . . 8.4700000000000006 109.654 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.545 -1.142 . . . . 9.7300000000000004 111.304 -177.085 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.857 0.36 . . . . 9.1400000000000006 110.406 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.1 ttt -124.21 118.85 27.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.183 -0.673 . . . . 8.7200000000000006 109.183 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.16 136.9 40.4 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.089 0.471 . . . . 5.1699999999999999 110.093 -176.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -136.28 80.28 1.81 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.311 -0.859 . . . . 6.6600000000000001 109.824 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.98 74.13 0.18 Allowed Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.816 -0.629 . . . . 1.74 111.731 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.6 t -81.52 -74.04 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.943 0.401 . . . . 1.1399999999999999 110.506 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.77 114.46 1.51 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.307 -0.949 . . . . 0.53000000000000003 111.829 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 m -109.92 159.31 9.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.822 0.344 . . . . 0.39000000000000001 110.46 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 m -75.49 166.99 22.74 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.777 -0.453 . . . . 1.5600000000000001 109.777 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -69.41 -29.56 67.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.99 -0.744 . . . . 2.02 108.99 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.44 -34.64 77.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.079 -0.964 . . . . 1.9099999999999999 110.242 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -63.69 -29.43 70.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 1.5800000000000001 110.31 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.672 HD13 HD11 ' A' ' 83' ' ' LEU . 18.2 tp -66.95 -23.97 66.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.831 -0.622 . . . . 0.98999999999999999 110.86 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.46 -31.57 26.49 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.585 0.707 . . . . 0.88 109.516 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -29.03 55.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.155 -0.93 . . . . 0.29999999999999999 110.509 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.459 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 3.3 p -73.65 -45.95 49.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.18 -0.464 . . . . 0.23000000000000001 111.036 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.907 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 75.6 mtp -61.13 -35.32 76.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 1.6299999999999999 111.226 -175.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.499 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 12.5 ptm180 -66.13 -37.64 86.2 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 120.459 -0.497 . . . . 3.1699999999999999 110.567 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.9 -41.03 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 109.039 -0.726 . . . . 0.23000000000000001 109.039 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -57.65 -47.23 86.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.841 -1.072 . . . . 0.33000000000000002 110.129 175.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.402 ' HA ' ' HG ' ' A' ' 24' ' ' SER . 17.2 m -68.08 -42.37 80.5 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.071 0.397 . . . . 1.3799999999999999 112.071 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 45.2 mt-10 -63.46 -27.76 69.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.252 -0.431 . . . . 2.2599999999999998 111.579 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -91.06 -38.79 12.57 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.967 0.358 . . . . 0.77000000000000002 111.967 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.402 ' HG ' ' HA ' ' A' ' 21' ' ' SER . 65.6 p -72.95 -44.98 60.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.958 0.409 . . . . 1.23 111.57 -176.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.98 38.26 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.68 -0.771 . . . . 0.54000000000000004 111.549 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mt -94.79 117.8 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.483 -0.562 . . . . 0.80000000000000004 109.483 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.662 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -47.28 141.75 4.44 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.131 0.419 . . . . 0.56999999999999995 112.131 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 tp -52.7 -38.64 60.99 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.509 -0.769 . . . . 0.96999999999999997 111.472 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.39 -9.22 58.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.761 -0.654 . . . . 2.23 111.253 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.662 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 15.6 mm-40 -110.81 -6.87 14.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.93 -0.577 . . . . 2.2400000000000002 109.983 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.5 tp -75.06 98.56 3.67 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.201 0.524 . . . . 1.1000000000000001 110.284 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.3 p -111.65 158.94 18.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.529 -0.759 . . . . 0.59999999999999998 109.696 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.705 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.2 p-10 -76.26 -4.99 44.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.349 . . . . 2.29 111.463 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.08 -21.18 60.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.811 -0.632 . . . . 2.29 110.639 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.436 ' HB3' HG21 ' A' ' 75' ' ' VAL . 16.3 t -77.31 158.07 30.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.81 0.814 . . . . 1.0600000000000001 111.207 -173.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.661 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 20.7 t-20 -126.32 122.64 36.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.861 -1.063 . . . . 0.80000000000000004 108.594 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.749 ' HD1' HG13 ' A' ' 42' ' ' ILE . 18.6 m-85 -55.17 -48.18 74.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.106 0.479 . . . . 0.46999999999999997 111.408 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.4 68.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.103 -0.499 . . . . 0.46000000000000002 110.999 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.661 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 14.3 t70 -67.58 -34.51 77.18 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.161 0.505 . . . . 0.82999999999999996 110.203 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.2 mmt -81.0 -17.67 49.52 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.633 -0.712 . . . . 2.48 111.238 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.87 22.03 9.19 Favored Glycine 0 C--O 1.23 -0.099 0 C-N-CA 120.566 -0.826 . . . . 0.44 112.773 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.749 HG13 ' HD1' ' A' ' 37' ' ' PHE . 26.9 mm -64.2 108.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.213 0.53 . . . . 0.52000000000000002 110.192 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -76.1 161.64 28.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.35 -0.841 . . . . 1.9399999999999999 111.04 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.3 t -56.07 -41.52 75.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.938 -0.574 . . . . 1.03 110.576 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.92 -53.18 60.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 0.58999999999999997 109.788 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.554 ' O ' HG13 ' A' ' 50' ' ' ILE . 16.2 m -57.84 -44.87 86.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.419 -0.355 . . . . 1.22 110.903 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.524 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 50.2 m -58.38 -37.66 75.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.096 -0.502 . . . . 0.81000000000000005 111.234 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.53 ' HG2' ' H32' ' A' ' 90' ' ' PNS . 12.2 tpt -74.71 -34.99 62.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.909 -0.587 . . . . 2.25 109.93 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 44.1 t -68.3 -48.54 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.664 -0.698 . . . . 0.35999999999999999 109.587 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 46' ' ' SER . 73.1 mt -52.04 -54.89 11.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.72 0.295 . . . . 0.26000000000000001 110.391 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.52 ' O ' ' HG3' ' A' ' 55' ' ' ARG . . . -60.41 -32.98 79.22 Favored Glycine 0 C--O 1.228 -0.245 0 CA-C-N 115.829 -0.623 . . . . 0.28999999999999998 112.578 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.509 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -72.94 -45.59 57.22 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.048 -0.261 . . . . 0.92000000000000004 110.549 177.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 6.1 mtp180 -63.39 -30.68 71.77 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.913 0.387 . . . . 1.23 110.188 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.516 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 9.1 m-30 -50.99 -48.52 61.24 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.857 -0.61 . . . . 0.28000000000000003 109.782 171.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 19.0 mtm105 -83.76 -40.51 18.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.637 -0.711 . . . . 2.8100000000000001 110.952 -170.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -88.21 -49.01 7.27 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.351 -0.386 . . . . 2.2599999999999998 111.874 -171.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -79.58 -52.05 8.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.85 0.357 . . . . 2.6200000000000001 111.349 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 mp -82.63 -58.31 2.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.194 -0.457 . . . . 0.67000000000000004 111.541 -175.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.65 24.22 1.58 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.091 -0.576 . . . . 0.45000000000000001 112.154 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.541 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 16.6 mt -104.19 92.72 4.48 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.757 -0.26 . . . . 0.63 110.516 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.451 ' HA ' ' HG2' ' A' ' 55' ' ' ARG . 18.4 t70 -101.36 80.04 2.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.581 0.705 . . . . 2.27 110.021 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.518 HD13 ' HE2' ' A' ' 81' ' ' PHE . 71.4 mt -71.17 -32.53 69.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.895 -1.048 . . . . 1.6399999999999999 109.43 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.06 160.98 21.8 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 114.642 -1.163 . . . . 0.75 110.75 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -82.99 -12.58 9.55 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.89 2.393 . . . . 1.1299999999999999 113.066 -175.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -130.67 31.36 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.812 0.815 . . . . 2.3599999999999999 110.717 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -95.01 120.24 34.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.72999999999999998 109.563 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 t -126.63 131.76 51.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.7 -0.4 . . . . 1.3899999999999999 110.498 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 72' ' ' CYS . 48.1 mt -58.4 -41.38 84.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.808 -0.633 . . . . 0.72999999999999998 110.475 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.524 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 15.0 t80 -62.59 -12.4 22.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.731 -0.668 . . . . 0.58999999999999997 111.494 -175.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 63.7 mt -109.87 -42.34 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.874 -0.33 . . . . 0.89000000000000001 111.126 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -130.71 22.11 5.04 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.64 0.978 . . . . 2.23 113.64 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 98.3 m -143.99 99.55 3.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.282 0.563 . . . . 1.0 109.81 174.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.5 p -90.81 -51.78 5.19 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.012 -0.54 . . . . 0.67000000000000004 111.624 -170.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.4 p -96.82 -178.64 4.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.19 -0.3 . . . . 0.38 110.19 176.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.568 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -81.09 -41.33 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 109.764 -0.458 . . . . 0.68000000000000005 109.764 -178.392 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.705 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 5.2 tpt180 -60.6 -28.22 68.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.671 -0.695 . . . . 3.23 110.483 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -58.32 -32.83 68.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.498 -0.319 . . . . 0.28999999999999998 110.69 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.505 HD21 ' CE2' ' A' ' 54' ' ' PHE . 0.7 OUTLIER -81.27 -48.66 11.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.546 0.689 . . . . 0.64000000000000001 109.431 176.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.907 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.9 mmtp -53.99 -57.84 9.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.695 -1.139 . . . . 2.3999999999999999 110.928 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.498 ' HB2' ' HE ' ' A' ' 76' ' ' ARG . 5.7 t70 -72.33 -19.38 61.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.208 -0.905 . . . . 1.6599999999999999 111.1 -171.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.518 ' HE2' HD13 ' A' ' 62' ' ' LEU . 76.2 t80 -73.62 -44.12 57.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.215 0.531 . . . . 0.98999999999999999 110.418 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.459 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 6.3 mtm -70.9 -32.66 69.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.73 -0.668 . . . . 1.1000000000000001 112.123 -176.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.672 HD11 HD13 ' A' ' 13' ' ' LEU . 7.5 mp -80.07 -44.69 19.61 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.772 -0.371 . . . . 1.3 110.856 172.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -109.09 73.89 0.2 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.968 -0.634 . . . . 2.4199999999999999 112.369 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.1 m -87.56 35.91 0.73 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.871 0.367 . . . . 4.4699999999999998 111.14 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.79 -31.05 7.21 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.75 -0.738 . . . . 4.5899999999999999 112.102 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -106.3 -165.76 1.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.197 -0.668 . . . . 6.6100000000000003 109.197 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.56 -34.39 0.63 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.737 0.273 . . . . 8.4700000000000006 111.737 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.415 -1.214 . . . . 9.7300000000000004 112.212 -177.305 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PNS . . . . . 0.53 ' H32' ' HG2' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 120.765 0.317 . . . . 9.1400000000000006 110.901 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 14.0 tpt -131.12 126.99 37.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.213 -0.662 . . . . 8.7200000000000006 109.213 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.16 -19.28 51.35 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.103 0.478 . . . . 5.1699999999999999 111.878 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.0 tttp -137.33 104.18 5.3 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.991 -0.549 . . . . 6.6600000000000001 110.502 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.2 125.1 1.52 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.981 -0.628 . . . . 1.74 111.593 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.18 -84.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.477 0.18 . . . . 1.1399999999999999 110.534 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.4 93.76 1.63 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.571 -0.823 . . . . 0.53000000000000003 111.324 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.03 155.36 14.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.851 0.358 . . . . 0.39000000000000001 110.167 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 t -82.96 173.63 11.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.536 -0.542 . . . . 1.5600000000000001 109.536 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -65.52 -25.8 67.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.293 0.568 . . . . 2.02 109.853 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -67.29 -46.45 73.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.395 -0.82 . . . . 1.9099999999999999 110.503 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -73.82 -20.32 60.49 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.724 -0.391 . . . . 1.5800000000000001 110.508 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 17' ' ' MET . 1.8 tp -74.18 -25.54 59.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 0.98999999999999999 110.33 172.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.37 -27.51 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.721 0.772 . . . . 0.88 110.311 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -79.54 -30.77 41.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.987 -1.006 . . . . 0.29999999999999999 110.878 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.624 HG11 ' SD ' ' A' ' 82' ' ' MET . 2.3 p -68.33 -43.59 84.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.314 -0.403 . . . . 0.23000000000000001 111.459 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.808 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 30.7 mtt -56.85 -34.77 68.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.515 -0.311 . . . . 1.6299999999999999 111.132 -174.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.617 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 12.8 ptp180 -81.85 -27.08 33.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.475 -0.329 . . . . 3.1699999999999999 111.785 -176.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.9 t -71.35 -34.93 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 108.078 -1.082 . . . . 0.23000000000000001 108.078 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.1 t -66.88 -36.82 78.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 114.025 -1.443 . . . . 0.33000000000000002 109.8 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.483 ' HB2' ' HA ' ' A' ' 18' ' ' ARG . 19.5 m -70.66 -26.12 63.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 116.231 -0.44 . . . . 1.3799999999999999 112.16 -177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.617 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 74.6 mt-10 -86.68 -37.73 17.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.865 0.364 . . . . 2.2599999999999998 111.177 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HG3' HG12 ' A' ' 50' ' ' ILE . 72.3 mm-40 -76.85 -37.91 54.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.968 -0.56 . . . . 0.77000000000000002 112.23 -176.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.482 ' CB ' HD11 ' A' ' 42' ' ' ILE . 66.4 p -80.3 -45.35 18.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.132 0.491 . . . . 1.23 110.816 -178.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.71 -4.38 26.07 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.688 -0.687 . . . . 0.54000000000000004 112.467 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.685 HD11 ' HG3' ' A' ' 40' ' ' MET . 8.6 mt -75.32 141.23 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.625 -0.43 . . . . 0.80000000000000004 110.002 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.86 140.05 56.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.097 -0.501 . . . . 0.56999999999999995 109.667 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.3 tp -55.09 -31.9 61.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 0.96999999999999997 111.763 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -77.95 -8.27 57.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.513 -0.312 . . . . 2.23 110.909 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -107.22 -5.44 17.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.934 0.397 . . . . 2.2400000000000002 110.132 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 17' ' ' MET . 32.6 tp -75.89 97.51 3.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.429 0.633 . . . . 1.1000000000000001 109.921 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.409 ' O ' HG21 ' A' ' 75' ' ' VAL . 16.0 p -116.82 165.56 13.17 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.76 -0.829 . . . . 0.59999999999999998 108.76 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.482 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.9 p-10 -72.6 -3.7 26.33 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 111.49 0.181 . . . . 2.29 111.49 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -74.81 -22.69 58.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.992 0.425 . . . . 2.29 110.429 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.478 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 18.0 m -74.15 153.98 39.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.735 0.778 . . . . 1.0600000000000001 111.34 -174.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.91 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.5 t-20 -128.31 127.55 42.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.121 -0.945 . . . . 0.80000000000000004 108.674 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.596 ' HD1' HG13 ' A' ' 42' ' ' ILE . 11.7 m-85 -56.48 -53.41 57.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.973 0.416 . . . . 0.46999999999999997 111.649 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.49 -30.01 66.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.314 -0.403 . . . . 0.46000000000000002 111.189 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.91 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.5 t70 -69.66 -30.48 68.18 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.345 0.593 . . . . 0.82999999999999996 110.412 176.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.685 ' HG3' HD11 ' A' ' 26' ' ' ILE . 1.8 tmm? -74.18 -23.37 59.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.541 -0.754 . . . . 2.48 110.461 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.3 14.69 15.76 Favored Glycine 0 CA--C 1.511 -0.175 0 C-N-CA 120.354 -0.927 . . . . 0.44 111.358 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.596 HG13 ' HD1' ' A' ' 37' ' ' PHE . 24.6 mm -76.24 113.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.584 -0.308 . . . . 0.52000000000000002 110.337 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.53 -172.74 2.58 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.05 -0.722 . . . . 1.9399999999999999 109.05 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.8 t -68.24 -30.82 69.95 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 111.618 0.229 . . . . 1.03 111.618 -174.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.69 -59.79 4.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.5 -0.318 . . . . 0.58999999999999997 110.298 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.575 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.3 t -66.03 -40.95 91.48 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.029 -0.269 . . . . 1.22 110.496 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.46 ' HB3' ' H ' ' A' ' 69' ' ' PHE . 49.0 m -56.78 -36.77 70.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.389 . . . . 0.81000000000000005 111.784 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -73.61 -43.77 58.77 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.655 -0.869 . . . . 2.25 108.655 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.44 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 64.0 t -62.26 -43.17 97.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.837 -1.074 . . . . 0.35999999999999999 110.721 -176.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 46' ' ' SER . 72.3 mt -54.0 -52.86 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.871 0.367 . . . . 0.26000000000000001 110.582 175.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -60.85 -31.87 77.46 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.076 -0.583 . . . . 0.28999999999999998 112.135 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.85 -46.39 82.06 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 122.441 0.296 . . . . 0.92000000000000004 110.802 176.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 12.4 mtp180 -65.28 -28.21 69.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.544 -0.298 . . . . 1.23 110.514 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.67 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.5 m-30 -57.66 -39.35 76.87 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.707 -0.479 . . . . 0.28000000000000003 109.707 173.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -80.17 -33.2 38.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.179 -0.464 . . . . 2.8100000000000001 110.437 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.21 -51.65 9.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.426 -0.352 . . . . 2.2599999999999998 111.024 -175.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.81 -48.74 7.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.959 -0.564 . . . . 2.6200000000000001 112.331 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -90.56 -13.29 34.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.54 -0.3 . . . . 0.67000000000000004 111.535 -173.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 33.14 68.7 Favored Glycine 0 C--O 1.229 -0.198 0 C-N-CA 121.008 -0.615 . . . . 0.45000000000000001 112.804 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.441 HD12 ' HB3' ' A' ' 54' ' ' PHE . 80.0 mt -90.64 116.65 28.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.505 0.153 . . . . 0.63 111.174 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.08 77.66 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.436 1.113 . . . . 2.27 109.706 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.67 HD11 ' HD2' ' A' ' 54' ' ' PHE . 25.2 mt -74.13 -27.01 60.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.652 -1.158 . . . . 1.6399999999999999 110.608 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.39 171.68 12.55 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 114.936 -1.029 . . . . 0.75 110.799 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -87.04 -7.32 7.14 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.999 2.466 . . . . 1.1299999999999999 112.388 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -134.49 45.44 2.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.63 0.729 . . . . 2.3599999999999999 110.291 -171.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -109.56 129.88 55.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.454 -0.794 . . . . 0.72999999999999998 110.8 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.2 t -140.69 131.09 25.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.329 -0.396 . . . . 1.3899999999999999 110.013 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.444 HD12 HD12 ' A' ' 50' ' ' ILE . 50.6 mt -60.44 -37.84 82.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.917 0.389 . . . . 0.72999999999999998 110.458 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.46 ' H ' ' HB3' ' A' ' 47' ' ' SER . 40.5 t80 -60.05 -12.39 8.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.47 -0.786 . . . . 0.58999999999999997 111.641 -174.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.52 -38.94 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.565 -0.289 . . . . 0.89000000000000001 111.417 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -114.72 10.97 16.72 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.395 0.517 . . . . 2.23 112.395 -171.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 82.9 m -150.22 100.13 2.87 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.181 0.515 . . . . 1.0 110.096 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.8 p -91.1 -54.13 4.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.26 -0.427 . . . . 0.67000000000000004 111.638 -172.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 70.1 p -94.4 -177.28 4.2 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.084 -0.385 . . . . 0.38 110.394 176.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.478 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -79.11 -43.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.457 0.646 . . . . 0.68000000000000005 109.845 -178.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.482 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.3 tpt180 -63.1 -25.65 68.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.246 -0.888 . . . . 3.23 110.637 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.43 -32.99 73.92 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 116.275 -0.421 . . . . 0.28999999999999998 110.559 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.656 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.8 OUTLIER -75.23 -50.42 16.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.87 -0.789 . . . . 0.64000000000000001 108.87 177.708 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.808 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.9 mmtp -50.32 -52.66 34.82 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.178 -0.919 . . . . 2.3999999999999999 110.897 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -63.18 -39.65 95.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.482 -0.781 . . . . 1.6599999999999999 111.373 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.27 -35.12 79.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.792 -0.64 . . . . 0.98999999999999999 111.667 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.656 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 28.7 mtp -62.25 -39.02 91.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.882 0.373 . . . . 1.1000000000000001 110.708 -177.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.1 mp -80.89 -34.81 33.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.326 0.584 . . . . 1.3 109.892 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.85 -77.83 0.9 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.699 -0.763 . . . . 2.4199999999999999 112.982 173.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.7 m -151.05 77.31 1.26 Allowed 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.743 -0.269 . . . . 4.4699999999999998 110.841 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.24 -152.25 7.02 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.987 -1.101 . . . . 4.5899999999999999 112.053 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.87 -34.56 75.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.852 0.358 . . . . 6.6100000000000003 110.099 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 72.78 3.66 4.75 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.01 -0.995 . . . . 8.4700000000000006 112.04 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.772 0 CA-C-O 118.738 -1.034 . . . . 9.7300000000000004 111.751 177.885 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.908 -0.404 . . . . 9.1400000000000006 109.908 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -142.48 150.79 40.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.627 0.251 . . . . 8.7200000000000006 110.869 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -135.52 132.47 37.32 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.327 0.584 . . . . 5.1699999999999999 109.751 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -150.93 144.91 25.26 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.171 -0.922 . . . . 6.6600000000000001 109.305 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.54 -96.39 0.59 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.844 -0.693 . . . . 1.74 111.89 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -109.71 -125.82 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.57 -0.53 . . . . 1.1399999999999999 109.57 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' ' 83' ' ' LEU . . . 124.96 106.48 1.63 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.843 -0.903 . . . . 0.53000000000000003 110.843 -174.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.407 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 3.0 m -114.3 159.24 14.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.895 0.379 . . . . 0.39000000000000001 111.153 -173.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.2 m -87.31 175.22 8.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.973 -0.558 . . . . 1.5600000000000001 110.051 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -65.76 -33.24 75.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.978 0.418 . . . . 2.02 110.885 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 1.7 mp0 -65.01 -36.27 83.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.586 0.708 . . . . 1.9099999999999999 109.783 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HD2' HD21 ' A' ' 60' ' ' LEU . 39.9 mmtm -66.39 -33.92 76.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.04 -0.982 . . . . 1.5800000000000001 110.242 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.7 tp -67.46 -25.79 66.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.781 -0.645 . . . . 0.98999999999999999 110.697 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.69 -28.82 28.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.248 0.547 . . . . 0.88 110.252 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.64 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -80.14 -27.2 39.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.893 -0.594 . . . . 0.29999999999999999 111.024 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.457 HG23 ' CZ ' ' A' ' 54' ' ' PHE . 2.7 p -72.62 -44.23 60.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.355 -0.384 . . . . 0.23000000000000001 111.661 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.1 mtp -63.69 -24.96 67.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.505 -0.316 . . . . 1.6299999999999999 111.389 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 16.1 ptt180 -76.86 -27.44 55.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 3.1699999999999999 110.757 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.1 t -82.4 -37.75 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.578 0.704 . . . . 0.23000000000000001 109.123 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.402 ' CG1' HD11 ' A' ' 31' ' ' LEU . 21.1 t -64.21 -32.03 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.913 -1.04 . . . . 0.33000000000000002 109.296 174.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -61.87 -26.63 68.26 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.842 -0.617 . . . . 1.3799999999999999 111.449 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -87.33 -53.14 4.99 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.31 0.576 . . . . 2.2599999999999998 111.308 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -73.22 -30.53 63.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.318 -0.856 . . . . 0.77000000000000002 111.898 -171.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.476 ' HA ' HD11 ' A' ' 42' ' ' ILE . 24.5 m -92.22 -25.22 18.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.592 -0.276 . . . . 1.23 111.424 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.03 7.42 65.89 Favored Glycine 0 N--CA 1.461 0.356 0 C-N-CA 120.33 -0.938 . . . . 0.54000000000000004 113.007 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.601 HD11 ' SD ' ' A' ' 40' ' ' MET . 4.3 mt -98.51 131.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.728 -0.471 . . . . 0.80000000000000004 109.728 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.07 146.28 47.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.119 -0.326 . . . . 0.56999999999999995 110.119 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.5 tp -53.24 -33.55 53.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.581 0.352 . . . . 0.96999999999999997 111.183 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -83.25 -8.97 59.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.093 -0.503 . . . . 2.23 111.342 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -114.81 -6.15 12.65 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.22 -0.659 . . . . 2.2400000000000002 109.22 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.57 98.38 2.31 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.923 -1.035 . . . . 1.1000000000000001 109.048 179.223 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.8 p -103.17 153.49 20.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.642 -0.708 . . . . 0.59999999999999998 109.723 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.934 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 20.7 m-20 -75.0 -9.95 59.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.918 0.39 . . . . 2.29 111.858 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -95.37 -11.58 27.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.869 -0.605 . . . . 2.29 111.891 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 t -78.41 156.05 29.65 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.556 0.693 . . . . 1.0600000000000001 109.946 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.566 ' HB3' ' CB ' ' A' ' 39' ' ' ASP . 18.3 t-20 -115.51 127.03 55.0 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.15 -0.932 . . . . 0.80000000000000004 110.231 -168.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.776 ' HD1' HG13 ' A' ' 42' ' ' ILE . 18.0 m-85 -56.56 -51.8 67.22 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.891 0.377 . . . . 0.46999999999999997 111.193 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.43 -31.16 71.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.239 -0.437 . . . . 0.46000000000000002 111.128 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.566 ' CB ' ' HB3' ' A' ' 36' ' ' ASN . 25.1 t70 -67.23 -31.76 72.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.076 0.465 . . . . 0.82999999999999996 110.499 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.601 ' SD ' HD11 ' A' ' 26' ' ' ILE . 68.2 mtp -89.52 -9.35 50.29 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.198 -0.456 . . . . 2.48 111.153 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.22 26.8 9.83 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.195 -1.003 . . . . 0.44 112.975 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.776 HG13 ' HD1' ' A' ' 37' ' ' PHE . 30.2 mm -71.87 107.27 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.249 -0.278 . . . . 0.52000000000000002 110.249 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -78.52 176.71 9.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.42 0.629 . . . . 1.9399999999999999 110.572 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.7 p -59.83 -41.66 91.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.011 -0.995 . . . . 1.03 111.097 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -58.98 -58.71 7.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.611 -0.722 . . . . 0.58999999999999997 110.4 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.657 ' O ' HG13 ' A' ' 50' ' ' ILE . 5.0 m -60.53 -46.01 91.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.402 -0.363 . . . . 1.22 111.39 -177.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.908 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 41.3 p -65.54 -31.49 72.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.345 -0.389 . . . . 0.81000000000000005 111.393 -177.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -40.47 66.77 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.845 -0.798 . . . . 2.25 108.845 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.556 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 24.1 t -59.5 -44.83 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 115.221 -0.899 . . . . 0.35999999999999999 110.053 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 46' ' ' SER . 39.4 mt -52.82 -56.93 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.26000000000000001 111.043 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.72 -29.62 74.41 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.021 -0.609 . . . . 0.28999999999999998 112.55 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -44.19 77.57 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.155 -0.313 . . . . 0.92000000000000004 110.155 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.556 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 16.4 mtp180 -62.94 -26.34 68.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.567 -0.288 . . . . 1.23 110.611 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.684 ' HD2' HD11 ' A' ' 62' ' ' LEU . 14.5 m-30 -56.77 -41.4 77.55 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.167 0.508 . . . . 0.28000000000000003 109.925 173.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 23.3 mtm180 -79.43 -25.78 41.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.513 -0.767 . . . . 2.8100000000000001 110.299 -177.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -74.27 -62.91 1.35 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.611 -0.722 . . . . 2.2599999999999998 111.82 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.84 -41.71 11.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.966 0.413 . . . . 2.6200000000000001 111.733 -173.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.77 -23.63 21.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.301 -0.409 . . . . 0.67000000000000004 111.572 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.89 27.55 60.35 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.145 -0.55 . . . . 0.45000000000000001 112.732 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.68 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 58.1 mt -87.03 95.72 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.767 -0.255 . . . . 0.63 110.591 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -86.83 78.2 9.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.6 0.714 . . . . 2.27 109.215 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.684 HD11 ' HD2' ' A' ' 54' ' ' PHE . 14.6 mt -71.05 -57.01 4.95 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.371 -1.286 . . . . 1.6399999999999999 110.305 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.38 150.44 9.38 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.753 -1.112 . . . . 0.75 110.807 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.49 -9.84 20.23 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.234 1.956 . . . . 1.1299999999999999 112.902 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -120.15 22.84 11.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.995 -0.548 . . . . 2.3599999999999999 110.733 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -80.34 124.43 28.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.282 -0.417 . . . . 0.72999999999999998 111.148 -177.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.4 t -139.47 125.19 19.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.641 -0.503 . . . . 1.3899999999999999 109.641 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.908 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 88.5 mt -60.37 -23.7 64.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.541 0.21 . . . . 0.72999999999999998 111.382 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.52 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 17.5 t80 -71.88 -14.06 61.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.246 0.546 . . . . 0.58999999999999997 110.445 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.2 mt -122.89 -39.75 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.89000000000000001 110.868 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -95.02 8.46 42.84 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.74 0.274 . . . . 2.23 111.74 -172.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.31 167.23 30.31 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.9 p -138.49 -68.07 0.46 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 0.67000000000000004 110.568 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 81.4 p -84.55 -175.43 5.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.747 -0.464 . . . . 0.38 109.747 174.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.0 t -83.77 -38.75 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.879 0.847 . . . . 0.68000000000000005 109.929 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.934 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 35.6 ttm180 -61.88 -30.01 70.58 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.713 -1.131 . . . . 3.23 111.252 175.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.46 -31.44 65.95 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.988 0.423 . . . . 0.28999999999999998 110.513 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.776 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.1 tt -70.5 -48.32 56.26 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.574 -0.899 . . . . 0.64000000000000001 108.574 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.552 ' CG ' ' HA ' ' A' ' 76' ' ' ARG . 20.8 mmtm -50.76 -55.06 18.48 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.984 -1.007 . . . . 2.3999999999999999 110.572 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -51.44 -49.43 61.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.276 -0.875 . . . . 1.6599999999999999 111.69 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -61.7 -36.49 81.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.743 -0.662 . . . . 0.98999999999999999 111.8 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.776 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 44.1 mtp -64.16 -45.82 86.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.367 -0.379 . . . . 1.1000000000000001 111.765 -173.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.624 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 5.3 mp -87.9 -38.78 15.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.764 0.316 . . . . 1.3 110.806 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.68 128.67 2.53 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.769 -0.729 . . . . 2.4199999999999999 112.032 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.7 m -75.74 44.9 0.31 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.049 0.539 . . . . 4.4699999999999998 111.595 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.85 32.43 4.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.145 -0.55 . . . . 4.5899999999999999 112.489 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -109.11 106.24 16.07 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.592 -0.522 . . . . 6.6100000000000003 109.592 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 73.32 148.47 0.09 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.731 0.777 . . . . 8.4700000000000006 111.396 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.928 0 CA-C-O 118.401 -1.222 . . . . 9.7300000000000004 111.313 176.793 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PNS . . . . . 0.449 H313 ' O35' ' A' ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.143 -0.317 . . . . 9.1400000000000006 110.143 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.2 ptm -106.0 150.31 25.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.758 -0.46 . . . . 8.7200000000000006 109.758 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.18 134.42 16.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.635 0.255 . . . . 5.1699999999999999 110.702 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt 68.85 160.65 0.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 O-C-N 124.19 0.932 . . . . 6.6600000000000001 110.88 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.97 -146.44 4.33 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.187 -0.765 . . . . 1.74 111.187 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.0 t -86.11 -66.61 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.897 0.38 . . . . 1.1399999999999999 110.208 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.0 103.91 1.45 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.956 -0.857 . . . . 0.53000000000000003 110.956 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.661 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 4.1 m -103.98 156.74 5.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.707 0.289 . . . . 0.39000000000000001 110.628 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.3 m -85.39 173.93 9.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.639 -0.504 . . . . 1.5600000000000001 109.639 175.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -61.75 -36.08 79.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.774 0.797 . . . . 2.02 109.013 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -59.17 -42.1 89.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.716 -1.129 . . . . 1.9099999999999999 111.211 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.661 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 41.4 mmtm -67.73 -31.65 71.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 1.5800000000000001 110.052 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.421 ' O ' ' HG3' ' A' ' 17' ' ' MET . 34.7 tp -68.11 -26.22 65.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.645 . . . . 0.98999999999999999 110.324 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.69 -29.96 36.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.103 0.478 . . . . 0.88 110.288 178.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.17 -27.22 39.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.619 . . . . 0.29999999999999999 111.051 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.6 HG23 ' CE1' ' A' ' 54' ' ' PHE . 4.0 p -75.71 -48.76 28.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.805 0.336 . . . . 0.23000000000000001 111.721 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 73.3 mtm -59.57 -30.32 68.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.176 -0.465 . . . . 1.6299999999999999 111.514 -174.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 6.5 ptm180 -70.38 -37.88 74.63 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.106 -0.638 . . . . 3.1699999999999999 110.635 176.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.456 HG12 HG23 ' A' ' 50' ' ' ILE . 29.2 t -64.5 -42.77 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.554 0.693 . . . . 0.23000000000000001 109.3 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.09 -42.03 93.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.983 -1.008 . . . . 0.33000000000000002 110.807 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -23.48 61.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.828 0.347 . . . . 1.3799999999999999 110.174 -174.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 43.9 mt-10 -79.01 -43.27 24.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.158 -0.474 . . . . 2.2599999999999998 111.6 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -86.27 -8.31 57.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.329 -0.396 . . . . 0.77000000000000002 111.273 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.4 p -97.57 -41.25 8.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.052 0.453 . . . . 1.23 110.407 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.76 41.85 3.25 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.863 -0.684 . . . . 0.54000000000000004 111.603 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 27' ' ' ALA . 5.2 mt -127.16 165.87 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.808 -0.442 . . . . 0.80000000000000004 109.808 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.503 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -83.96 142.02 30.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.643 -0.708 . . . . 0.56999999999999995 110.257 172.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.0 tp -61.14 -33.26 73.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.043 -0.526 . . . . 0.96999999999999997 111.092 -177.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.63 -11.98 60.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.179 0.514 . . . . 2.23 111.067 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 17.8 mm-40 -105.79 -5.04 20.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.796 -0.638 . . . . 2.2400000000000002 110.107 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.6 tp -84.85 96.55 9.35 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.107 -0.497 . . . . 1.1000000000000001 110.352 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 p -115.0 169.63 8.94 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.833 -0.803 . . . . 0.59999999999999998 108.833 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.686 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 4.8 p-10 -75.66 -3.29 33.71 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.931 -0.308 . . . . 2.29 111.548 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.12 -20.22 60.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.14 -0.482 . . . . 2.29 110.406 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.489 ' HB2' HG21 ' A' ' 75' ' ' VAL . 16.3 m -79.74 157.69 27.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.606 0.717 . . . . 1.0600000000000001 111.541 -175.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.75 119.42 25.73 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.229 -1.026 . . . . 0.80000000000000004 108.229 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.422 ' CZ ' HG13 ' A' ' 75' ' ' VAL . 16.8 m-85 -57.72 -39.26 76.86 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.45 -0.5 . . . . 0.46999999999999997 111.642 -173.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.76 -26.91 67.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.984 0.421 . . . . 0.46000000000000002 110.472 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -68.89 -29.73 68.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.82999999999999996 110.296 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -83.59 -8.4 59.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.754 -0.657 . . . . 2.48 110.283 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.77 32.5 36.75 Favored Glycine 0 C--N 1.322 -0.225 0 C-N-CA 120.443 -0.884 . . . . 0.44 112.002 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.502 ' CG2' ' HB3' ' A' ' 47' ' ' SER . 2.7 mt -67.76 108.46 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.018 0.437 . . . . 0.52000000000000002 110.225 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -78.45 165.96 23.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.816 -0.629 . . . . 1.9399999999999999 110.48 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.0 t -51.54 -43.33 62.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 1.03 110.861 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.14 -55.91 28.8 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.142 -0.481 . . . . 0.58999999999999997 110.376 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.45 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.3 m -61.41 -44.14 97.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 1.22 111.525 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.866 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 63.7 p -68.09 -31.61 71.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.735 0.302 . . . . 0.81000000000000005 111.222 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.578 ' HG2' H311 ' A' ' 90' ' ' PNS . 13.2 tpt -70.76 -36.45 73.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.449 0.642 . . . . 2.25 109.805 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.31 -36.39 76.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.064 -0.971 . . . . 0.35999999999999999 110.22 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.532 HD12 HD12 ' A' ' 68' ' ' LEU . 67.5 mt -59.83 -52.01 66.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.762 -0.653 . . . . 0.26000000000000001 110.753 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.5 ' HA2' ' CD2' ' A' ' 54' ' ' PHE . . . -64.04 -28.69 73.19 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.144 -0.551 . . . . 0.28999999999999998 112.197 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -49.63 76.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.767 0.318 . . . . 0.92000000000000004 110.512 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -64.6 -28.43 69.62 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.417 -0.356 . . . . 1.23 111.07 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.6 ' CE1' HG23 ' A' ' 16' ' ' VAL . 14.6 m-30 -53.9 -44.22 70.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.613 -0.514 . . . . 0.28000000000000003 109.613 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -84.86 -35.36 22.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 2.8100000000000001 111.451 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -85.79 -56.16 3.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.036 0.446 . . . . 2.2599999999999998 111.299 -174.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.28 -52.71 11.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.971 -0.559 . . . . 2.6200000000000001 111.387 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 mp -88.25 -32.13 18.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.516 . . . . 0.67000000000000004 111.849 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.9 33.91 16.91 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.524 -0.846 . . . . 0.45000000000000001 112.115 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.15 152.0 21.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.789 -0.448 . . . . 0.63 109.789 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.72 110.97 21.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.942 0.401 . . . . 2.27 110.325 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -123.8 5.56 8.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 1.6399999999999999 109.501 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.56 164.22 39.47 Favored Glycine 0 CA--C 1.509 -0.323 0 CA-C-N 115.474 -0.785 . . . . 0.75 111.456 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -87.74 -2.07 7.39 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.23 2.62 . . . . 1.1299999999999999 112.078 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -106.48 12.92 29.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.387 -0.824 . . . . 2.3599999999999999 111.036 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -93.63 111.82 23.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.055 0.455 . . . . 0.72999999999999998 110.462 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.3 m -134.5 128.18 32.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.72 -0.673 . . . . 1.3899999999999999 109.5 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.866 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 42.3 mt -66.58 -45.02 80.65 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.799 0.296 . . . . 0.72999999999999998 111.799 -173.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.96 -4.67 4.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.432 . . . . 0.58999999999999997 110.772 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -116.08 -40.35 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 O-C-N 122.223 -0.298 . . . . 0.89000000000000001 111.555 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -126.07 8.41 7.34 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.122 0.416 . . . . 2.23 112.122 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 75.9 m -147.52 88.76 1.72 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.623 -0.673 . . . . 1.0 110.412 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 p -81.73 -31.76 31.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.904 -0.589 . . . . 0.67000000000000004 111.812 -173.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.9 p -110.95 176.73 4.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.668 0.27 . . . . 0.38 110.501 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.489 HG21 ' HB2' ' A' ' 35' ' ' SER . 0.2 OUTLIER -80.77 -44.72 21.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.965 -0.383 . . . . 0.68000000000000005 109.965 -177.651 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.686 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.2 tpt180 -57.94 -32.51 67.87 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.132 -0.486 . . . . 3.23 110.551 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.59 -29.54 62.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.116 -0.493 . . . . 0.28999999999999998 111.062 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.677 ' O ' ' HG3' ' A' ' 82' ' ' MET . 3.7 tp -86.39 -55.1 4.05 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.16 -0.682 . . . . 0.64000000000000001 109.16 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -56.01 -60.35 3.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.287 -1.324 . . . . 2.3999999999999999 111.656 -174.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.472 ' HB2' ' HE ' ' A' ' 76' ' ' ARG . 9.7 t70 -66.93 -26.28 66.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.465 -0.789 . . . . 1.6599999999999999 110.681 -171.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.73 -26.58 66.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.22 -0.9 . . . . 0.98999999999999999 110.731 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.677 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 28.6 mtp -78.3 -36.72 46.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.905 -0.589 . . . . 1.1000000000000001 110.532 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.2 mp -79.28 -44.77 21.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.024 -0.535 . . . . 1.3 110.155 177.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.42 91.68 0.18 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.393 -0.908 . . . . 2.4199999999999999 113.201 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.9 m -79.62 45.59 0.7 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.244 0.545 . . . . 4.4699999999999998 111.068 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.83 51.55 0.22 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.072 -0.811 . . . . 4.5899999999999999 111.072 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -76.92 -42.16 40.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.735 0.302 . . . . 6.6100000000000003 111.068 -176.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.66 -39.95 15.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.268 0.556 . . . . 8.4700000000000006 110.081 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.283 -1.287 . . . . 9.7300000000000004 111.14 177.339 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PNS . . . . . 0.578 H311 ' HG2' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.715 0.293 . . . . 9.1400000000000006 110.303 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -80.18 107.2 12.79 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.88 -0.415 . . . . 8.7200000000000006 109.88 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -121.54 122.24 39.26 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.347 -0.612 . . . . 5.1699999999999999 109.347 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -143.29 118.38 10.09 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.363 -0.835 . . . . 6.6600000000000001 110.697 -171.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.73 161.2 26.89 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.398 -0.819 . . . . 1.74 111.55 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' ' 82' ' ' MET . 59.1 t -73.83 -64.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.916 0.358 . . . . 1.1399999999999999 110.275 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.65 91.64 2.1 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.665 -0.779 . . . . 0.53000000000000003 111.908 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 3.2 m -118.71 157.84 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.917 0.389 . . . . 0.39000000000000001 110.172 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.4 p -83.4 172.89 12.02 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.042 -0.526 . . . . 1.5600000000000001 110.114 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -67.68 -16.79 64.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.079 0.466 . . . . 2.02 110.349 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -67.18 -46.95 72.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.491 -0.777 . . . . 1.9099999999999999 109.615 173.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.536 ' HG2' HD21 ' A' ' 60' ' ' LEU . 2.4 mptp? -66.25 -34.4 77.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.774 -0.648 . . . . 1.5800000000000001 109.931 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 17' ' ' MET . 14.7 tp -67.79 -26.88 66.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 0.98999999999999999 111.192 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.1 -28.83 27.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.176 0.513 . . . . 0.88 109.948 177.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -81.67 -30.58 32.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.29999999999999999 111.297 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.04 -43.07 96.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.828 -0.349 . . . . 0.23000000000000001 111.177 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.542 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 45.1 mtt -63.61 -28.6 70.03 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.174 -0.466 . . . . 1.6299999999999999 110.768 -174.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.662 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 15.3 ptm180 -84.1 -19.48 34.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.896 -0.322 . . . . 3.1699999999999999 111.725 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.9 t -81.37 -27.97 10.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 122.017 0.913 . . . . 0.23000000000000001 108.629 172.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.1 t -76.1 -36.11 30.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.458 -1.247 . . . . 0.33000000000000002 110.294 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.5 p -62.75 -51.48 66.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.039 0.447 . . . . 1.3799999999999999 110.496 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.662 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 9.0 mm-40 -57.35 -52.0 67.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.354 -0.839 . . . . 2.2599999999999998 111.484 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' HG3' HG12 ' A' ' 50' ' ' ILE . 76.9 mm-40 -72.41 -46.37 55.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.962 -0.563 . . . . 0.77000000000000002 112.323 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.444 ' HA ' HD11 ' A' ' 42' ' ' ILE . 17.8 m -73.67 -38.38 64.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.827 0.346 . . . . 1.23 111.587 -176.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.15 -2.19 40.64 Favored Glycine 0 N--CA 1.454 -0.124 0 C-N-CA 120.191 -1.004 . . . . 0.54000000000000004 112.07 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.462 HD11 ' HG3' ' A' ' 40' ' ' MET . 8.0 mt -94.0 123.14 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.639 -0.504 . . . . 0.80000000000000004 109.639 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.543 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -54.14 145.58 16.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.381 -0.372 . . . . 0.56999999999999995 111.552 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 tp -55.02 -36.92 65.98 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.937 -0.574 . . . . 0.96999999999999997 110.646 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.31 -10.7 59.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.983 -0.553 . . . . 2.23 111.293 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 41.4 mt-10 -116.2 2.06 13.25 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.138 -0.483 . . . . 2.2400000000000002 110.043 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -75.26 97.34 3.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.164 -0.68 . . . . 1.1000000000000001 109.164 -178.55 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.9 p -106.55 154.91 20.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.695 -0.684 . . . . 0.59999999999999998 109.273 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 57.7 m-20 -76.75 -3.67 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.055 0.455 . . . . 2.29 110.951 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.53 -6.25 59.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.498 -0.774 . . . . 2.29 110.413 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.474 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 46.9 m -79.6 150.63 30.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.594 . . . . 1.0600000000000001 110.006 177.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.767 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.1 t-20 -125.88 123.25 38.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.253 -0.647 . . . . 0.80000000000000004 109.253 -175.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.703 ' HD1' HG13 ' A' ' 42' ' ' ILE . 34.1 m-85 -56.37 -48.61 76.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.943 0.401 . . . . 0.46999999999999997 111.194 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.2 -31.0 68.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.268 -0.424 . . . . 0.46000000000000002 111.181 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.767 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 32.9 t70 -70.99 -33.24 70.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.331 0.586 . . . . 0.82999999999999996 110.589 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.462 ' HG3' HD11 ' A' ' 26' ' ' ILE . 15.1 mmt -79.8 -20.27 46.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.407 -0.815 . . . . 2.48 111.37 -176.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.03 32.81 4.23 Favored Glycine 0 C--O 1.229 -0.17 0 C-N-CA 120.271 -0.966 . . . . 0.44 112.5 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.703 HG13 ' HD1' ' A' ' 37' ' ' PHE . 28.5 mm -79.83 107.74 12.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.854 0.359 . . . . 0.52000000000000002 110.608 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -77.4 174.24 11.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.636 -0.505 . . . . 1.9399999999999999 109.636 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.688 ' HB3' ' HD2' ' A' ' 69' ' ' PHE . 90.0 p -69.9 -20.77 63.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.443 -0.577 . . . . 1.03 109.443 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.457 ' HA ' H301 ' A' ' 90' ' ' PNS . 3.4 tm? -54.55 -61.99 1.95 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.195 -0.668 . . . . 0.58999999999999997 109.195 171.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.448 ' O ' HG13 ' A' ' 50' ' ' ILE . 6.3 m -64.7 -39.69 94.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.116 -0.493 . . . . 1.22 110.81 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.455 ' HB2' ' HA ' ' A' ' 44' ' ' SER . 48.8 m -58.93 -40.57 84.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.069 -0.514 . . . . 0.81000000000000005 111.672 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 45.1 tpp -72.35 -40.33 67.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.265 0.555 . . . . 2.25 109.674 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.506 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 54.6 t -63.51 -50.33 78.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.214 -0.903 . . . . 0.35999999999999999 110.453 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.463 HG12 ' HG3' ' A' ' 23' ' ' GLU . 77.7 mt -54.05 -54.58 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.684 0.278 . . . . 0.26000000000000001 110.92 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -58.25 -35.82 79.99 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.973 -0.632 . . . . 0.28999999999999998 112.018 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.482 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -63.47 -46.16 87.47 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.849 -0.206 . . . . 0.92000000000000004 110.527 174.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 7.1 mtp180 -64.11 -28.0 69.48 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.576 -0.284 . . . . 1.23 111.057 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.562 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.5 m-30 -56.63 -42.39 78.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.477 -0.564 . . . . 0.28000000000000003 109.477 173.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.482 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 65.1 mtm180 -80.16 -39.21 29.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 2.8100000000000001 110.635 -176.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.82 -48.61 7.7 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.057 0.392 . . . . 2.2599999999999998 112.057 -172.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.28 -46.91 14.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.261 -0.427 . . . . 2.6200000000000001 111.649 -177.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.1 mp -95.7 -23.25 17.08 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.84 0.681 . . . . 0.67000000000000004 112.84 -173.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.34 32.3 23.0 Favored Glycine 0 CA--C 1.517 0.174 0 C-N-CA 120.793 -0.718 . . . . 0.45000000000000001 112.664 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.536 HD21 ' HG2' ' A' ' 12' ' ' LYS . 85.4 mt -88.22 120.3 29.45 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.733 -0.275 . . . . 0.63 110.524 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -82.78 82.07 8.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.228 0.537 . . . . 2.27 109.749 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.562 HD11 ' HD2' ' A' ' 54' ' ' PHE . 97.7 mt -89.8 -94.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.692 -0.685 . . . . 1.6399999999999999 111.356 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 162.55 168.86 25.1 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.892 -0.883 . . . . 0.75 110.892 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.542 ' HG2' ' OE2' ' A' ' 65' ' ' GLU . 73.6 Cg_endo -81.85 -10.24 11.75 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.683 2.255 . . . . 1.1299999999999999 113.65 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.542 ' OE2' ' HG2' ' A' ' 64' ' ' PRO . 5.3 mp0 -88.77 -0.07 56.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.625 -0.262 . . . . 2.3599999999999999 111.47 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.75 122.05 40.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.836 0.35 . . . . 0.72999999999999998 111.441 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.3 t -141.26 124.44 16.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 1.3899999999999999 110.008 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 mt -56.13 -28.97 59.99 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.977 0.362 . . . . 0.72999999999999998 111.977 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.688 ' HD2' ' HB3' ' A' ' 44' ' ' SER . 3.2 t80 -67.91 -16.7 64.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.588 . . . . 0.58999999999999997 110.939 -173.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.1 mt -126.32 -35.93 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.803 0.335 . . . . 0.89000000000000001 110.997 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -90.48 6.28 44.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.43 -0.35 . . . . 2.23 111.689 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.4 m -154.89 155.91 35.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.1 p -131.06 -73.73 0.54 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.31 -0.405 . . . . 0.67000000000000004 110.464 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 76.8 p -83.16 -170.87 3.25 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.965 -0.384 . . . . 0.38 109.965 174.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.474 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.9 OUTLIER -83.08 -40.67 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.555 -0.906 . . . . 0.68000000000000005 108.555 -177.588 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 34.0 ttm180 -60.89 -31.5 70.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.402 -1.272 . . . . 3.23 111.238 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.18 -34.88 64.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.819 0.342 . . . . 0.28999999999999998 110.952 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.552 HD21 ' CE2' ' A' ' 54' ' ' PHE . 0.9 OUTLIER -74.8 -50.7 16.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.485 -0.561 . . . . 0.64000000000000001 109.485 177.315 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 26.1 mmtp -49.21 -53.81 19.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.236 -0.893 . . . . 2.3999999999999999 110.438 176.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.51 -45.02 62.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.877 -1.056 . . . . 1.6599999999999999 111.867 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -64.12 -37.86 88.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.014 -0.539 . . . . 0.98999999999999999 111.838 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.523 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 21.3 mtp -57.21 -49.72 75.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.058 0.456 . . . . 1.1000000000000001 111.285 -174.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 82' ' ' MET . 5.2 mp -85.01 -31.37 23.51 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.493 -0.558 . . . . 1.3 109.493 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.4 -143.62 39.33 Favored Glycine 0 CA--C 1.511 -0.207 0 C-N-CA 120.98 -0.629 . . . . 2.4199999999999999 112.124 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.0 m -105.4 36.5 2.48 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.336 0.589 . . . . 4.4699999999999998 109.987 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.77 31.13 7.53 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.759 -0.655 . . . . 4.5899999999999999 113.113 -175.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.71 -63.49 1.22 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.325 0.583 . . . . 6.6100000000000003 110.553 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.82 80.93 1.67 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.391 -0.822 . . . . 8.4700000000000006 109.643 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.651 -1.083 . . . . 9.7300000000000004 111.499 -177.364 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PNS . . . . . 0.457 H301 ' HA ' ' A' ' 45' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 121.039 0.447 . . . . 9.1400000000000006 110.11 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -98.84 138.4 36.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.064 -0.717 . . . . 8.7200000000000006 109.064 173.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.38 131.57 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.578 0.704 . . . . 5.1699999999999999 111.679 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -148.21 78.36 1.43 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.517 -0.765 . . . . 6.6600000000000001 108.978 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.72 129.65 3.05 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.973 -0.851 . . . . 1.74 110.973 -170.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.9 t -73.74 -61.59 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.928 0.394 . . . . 1.1399999999999999 110.896 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.41 76.58 0.95 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.497 -0.641 . . . . 0.53000000000000003 111.497 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 2.8 m -123.59 160.88 26.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.701 0.286 . . . . 0.39000000000000001 110.789 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.7 p -92.66 -176.89 4.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.123 -0.695 . . . . 1.5600000000000001 109.123 171.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -68.34 -23.35 64.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.312 0.577 . . . . 2.02 109.646 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -58.51 -44.07 89.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.333 -0.849 . . . . 1.9099999999999999 110.602 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.609 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 17.5 mttp -74.29 -24.91 59.32 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.724 -0.671 . . . . 1.5800000000000001 111.032 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.838 HD13 HD11 ' A' ' 83' ' ' LEU . 19.8 tp -73.45 -30.0 62.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.131 -0.486 . . . . 0.98999999999999999 110.753 175.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.67 -29.23 45.52 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.238 0.542 . . . . 0.88 109.843 176.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.673 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -81.61 -30.36 32.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.919 -0.582 . . . . 0.29999999999999999 111.375 -176.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.442 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 5.5 p -68.47 -45.7 81.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.396 -0.522 . . . . 0.23000000000000001 111.285 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.403 ' HB3' ' HE2' ' A' ' 17' ' ' MET . 73.6 mtp -61.05 -35.24 76.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.997 -0.547 . . . . 1.6299999999999999 111.285 -175.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 2.7 ptm180 -64.37 -35.8 82.06 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.127 -0.323 . . . . 3.1699999999999999 110.127 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.45 HG13 ' HD3' ' A' ' 53' ' ' ARG . 53.3 t -76.5 -38.09 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.544 0.688 . . . . 0.23000000000000001 109.278 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.41 -45.3 93.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.882 -1.054 . . . . 0.33000000000000002 110.473 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.8 m -60.9 -40.95 95.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.884 0.373 . . . . 1.3799999999999999 111.614 -176.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 53.1 mt-10 -58.02 -56.76 17.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.816 -0.629 . . . . 2.2599999999999998 111.976 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -76.08 -25.69 55.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.247 -0.433 . . . . 0.77000000000000002 111.946 -172.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.7 p -81.27 -44.09 18.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.003 0.43 . . . . 1.23 110.3 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.02 16.83 26.96 Favored Glycine 0 C--O 1.229 -0.183 0 C-N-CA 120.924 -0.655 . . . . 0.54000000000000004 111.619 -176.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.28 123.0 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.796 -0.446 . . . . 0.80000000000000004 109.796 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.45 143.95 6.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.299 0.481 . . . . 0.56999999999999995 112.299 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.5 tp -54.5 -37.04 64.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.444 -0.798 . . . . 0.96999999999999997 111.159 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.75 -9.86 58.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.85 -0.614 . . . . 2.23 111.256 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -110.8 -6.33 14.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.072 -0.513 . . . . 2.2400000000000002 110.927 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.3 tp -71.96 98.25 2.01 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.396 0.617 . . . . 1.1000000000000001 109.973 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.0 p -107.57 162.42 13.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.32 -0.854 . . . . 0.59999999999999998 109.079 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.426 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 80.8 m-20 -76.33 -5.54 47.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.027 0.442 . . . . 2.29 110.782 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -81.51 -22.57 37.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.352 -0.84 . . . . 2.29 111.135 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -81.03 149.9 29.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.667 0.746 . . . . 1.0600000000000001 111.132 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.591 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 20.8 t-20 -113.7 131.15 56.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.133 -0.939 . . . . 0.80000000000000004 109.638 -171.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.743 ' HD1' HG13 ' A' ' 42' ' ' ILE . 28.4 m-85 -57.95 -47.31 83.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 0.46999999999999997 111.569 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.26 -31.26 67.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.507 -0.315 . . . . 0.46000000000000002 111.318 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.0 t70 -68.76 -31.81 71.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.09 0.472 . . . . 0.82999999999999996 110.268 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.0 mmt -82.12 -18.97 41.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.548 -0.751 . . . . 2.48 111.882 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.18 28.5 6.1 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 120.275 -0.964 . . . . 0.44 112.441 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.743 HG13 ' HD1' ' A' ' 37' ' ' PHE . 32.9 mm -75.3 108.48 7.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.028 0.442 . . . . 0.52000000000000002 110.188 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -83.73 178.76 7.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.846 -0.616 . . . . 1.9399999999999999 110.691 -177.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 t -64.51 -28.04 69.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.437 -0.801 . . . . 1.03 110.006 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.69 -62.45 1.45 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.708 -0.678 . . . . 0.58999999999999997 110.27 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.1 p -64.12 -40.57 96.49 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.448 0.536 . . . . 1.22 112.448 -175.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 60.1 p -64.0 -29.86 70.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.962 0.41 . . . . 0.81000000000000005 111.071 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.715 ' HG2' ' H32' ' A' ' 90' ' ' PNS . 48.2 tpp -75.86 -36.43 59.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.669 0.747 . . . . 2.25 109.831 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.54 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 56.9 t -71.7 -36.56 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 114.92 -1.036 . . . . 0.35999999999999999 109.466 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 46' ' ' SER . 88.0 mt -58.4 -50.11 79.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.223 -0.444 . . . . 0.26000000000000001 110.431 174.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.97 -37.48 85.34 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.099 -0.572 . . . . 0.28999999999999998 112.352 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.612 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 1.5 t -63.29 -48.32 78.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.843 -0.343 . . . . 0.92000000000000004 110.343 176.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 43.5 mtp180 -60.69 -32.74 71.96 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.659 -0.246 . . . . 1.23 111.053 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.473 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 10.7 m-30 -53.67 -40.47 65.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.056 0.455 . . . . 0.28000000000000003 110.124 174.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.612 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 67.4 mtm180 -81.89 -35.89 28.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.883 -0.598 . . . . 2.8100000000000001 110.957 -175.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.31 -51.08 6.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.983 -0.553 . . . . 2.2599999999999998 111.593 -170.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -81.74 -49.88 9.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.013 -0.539 . . . . 2.6200000000000001 110.839 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 mp -85.93 -55.12 4.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.87 -0.605 . . . . 0.67000000000000004 111.177 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.06 30.18 2.37 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.918 -0.658 . . . . 0.45000000000000001 112.057 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 59.5 mt -92.0 132.66 36.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.109 -0.33 . . . . 0.63 110.109 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -101.25 92.25 4.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.843 0.83 . . . . 2.27 110.681 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -88.07 -73.04 0.5 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.427 -0.806 . . . . 1.6399999999999999 109.95 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.69 170.14 16.81 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.469 -0.652 . . . . 0.75 111.469 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.6 8.41 4.64 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.017 2.478 . . . . 1.1299999999999999 111.979 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.9 1.03 12.62 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.092 -0.958 . . . . 2.3599999999999999 110.122 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -89.37 118.91 29.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.947 -0.57 . . . . 0.72999999999999998 110.951 -175.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.9 t -137.83 123.17 19.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.126 -0.488 . . . . 1.3899999999999999 110.211 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 90.5 mt -61.01 -37.78 83.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.169 0.509 . . . . 0.72999999999999998 110.566 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -65.46 -7.06 12.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.542 -0.754 . . . . 0.58999999999999997 111.05 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.65 -39.08 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 120.827 -0.349 . . . . 0.89000000000000001 111.618 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -121.35 7.39 10.16 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 120.33 -0.548 . . . . 2.23 112.447 -172.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 66.6 m -147.68 87.7 1.65 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.805 -0.559 . . . . 1.0 110.523 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.5 p -85.47 -33.26 21.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.057 -0.52 . . . . 0.67000000000000004 112.242 -173.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p -107.19 172.2 6.96 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.189 -0.319 . . . . 0.38 110.61 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.449 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 5.7 t -80.72 -40.05 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 120.678 0.275 . . . . 0.68000000000000005 111.108 -175.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.426 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 30.8 ttm180 -61.45 -30.43 70.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 3.23 110.875 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -56.94 -32.23 65.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.954 -0.566 . . . . 0.28999999999999998 111.14 176.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.65 -44.48 18.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 0.64000000000000001 109.213 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 25.2 mmtp -56.17 -62.11 1.94 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.599 -1.182 . . . . 2.3999999999999999 111.368 -178.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.93 -23.35 66.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 1.6599999999999999 110.833 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 73.3 t80 -67.68 -41.57 83.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.56 0.695 . . . . 0.98999999999999999 109.822 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.442 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 1.3 mtm -78.46 -43.11 27.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.158 -0.928 . . . . 1.1000000000000001 112.292 -176.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.838 HD11 HD13 ' A' ' 13' ' ' LEU . 7.8 mp -74.94 -45.26 43.6 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.838 -0.345 . . . . 1.3 111.546 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.32 133.32 7.4 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.226 -0.988 . . . . 2.4199999999999999 112.429 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.95 46.18 0.56 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.497 0.319 . . . . 4.4699999999999998 111.519 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.09 -29.78 44.83 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.966 -0.635 . . . . 4.5899999999999999 113.224 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 67.24 -74.47 0.07 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.983 0.513 . . . . 6.6100000000000003 111.221 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 61.84 92.19 0.06 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.358 0.663 . . . . 8.4700000000000006 111.657 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.908 -0.94 . . . . 9.7300000000000004 111.64 178.365 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PNS . . . . . 0.715 ' H32' ' HG2' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.801 0.334 . . . . 9.1400000000000006 110.513 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.503 ' C ' ' H ' ' A' ' 4' ' ' LYS . 25.3 ptp -95.46 145.26 25.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.053 -0.721 . . . . 8.7200000000000006 109.053 175.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 72.44 -18.4 0.34 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.271 0.629 . . . . 5.1699999999999999 111.748 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.503 ' H ' ' C ' ' A' ' 2' ' ' MET . 58.3 tptt -120.81 89.93 3.22 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.245 -1.02 . . . . 6.6600000000000001 108.245 176.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.78 -169.05 20.84 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.769 -0.932 . . . . 1.74 110.769 -171.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.5 t -80.9 -83.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.955 0.378 . . . . 1.1399999999999999 110.938 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.8 95.85 1.43 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.469 -0.872 . . . . 0.53000000000000003 111.346 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -108.88 157.12 9.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.752 -0.379 . . . . 0.39000000000000001 110.807 -174.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -78.65 171.8 14.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.678 -0.49 . . . . 1.5600000000000001 109.678 173.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -72.49 -17.29 61.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.333 0.587 . . . . 2.02 110.258 -175.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -68.78 -44.76 72.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.404 -0.816 . . . . 1.9099999999999999 109.888 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -70.72 -22.87 62.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.783 -0.644 . . . . 1.5800000000000001 110.542 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 17' ' ' MET . 2.7 tp -72.26 -27.51 62.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.759 -0.655 . . . . 0.98999999999999999 110.54 173.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.22 -30.98 34.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.423 0.63 . . . . 0.88 109.383 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.61 -34.25 53.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.074 -0.967 . . . . 0.29999999999999999 110.861 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.515 HG11 ' SD ' ' A' ' 82' ' ' MET . 2.8 p -66.09 -43.19 92.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.159 -0.473 . . . . 0.23000000000000001 111.446 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.47 ' HB3' HD23 ' A' ' 31' ' ' LEU . 66.7 mtm -64.23 -30.71 71.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.394 -0.366 . . . . 1.6299999999999999 111.395 -175.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.687 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 9.1 ptm180 -83.6 -19.28 35.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.949 0.351 . . . . 3.1699999999999999 111.949 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.1 t -78.43 -32.86 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.827 0.823 . . . . 0.23000000000000001 108.892 171.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.25 -37.77 72.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.512 -1.222 . . . . 0.33000000000000002 110.333 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.6 p -61.18 -49.79 75.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.523 0.678 . . . . 1.3799999999999999 109.779 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.687 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 3.9 mm-40 -59.73 -50.17 74.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.441 -1.254 . . . . 2.2599999999999998 112.316 -176.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HB2' HG12 ' A' ' 50' ' ' ILE . 60.8 mm-40 -86.96 -9.05 56.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.208 0.447 . . . . 0.77000000000000002 112.208 -171.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.1 m -95.4 -26.03 16.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.034 0.445 . . . . 1.23 110.279 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.51 -7.23 65.85 Favored Glycine 0 C--N 1.329 0.14 0 C-N-CA 120.488 -0.863 . . . . 0.54000000000000004 112.652 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mt -91.33 154.43 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 122.568 -0.372 . . . . 0.80000000000000004 110.014 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.421 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -69.56 142.29 53.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.993 -0.549 . . . . 0.56999999999999995 110.111 178.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.625 HD11 ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -57.9 -39.32 77.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 0.96999999999999997 109.899 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -67.76 -15.15 63.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.37 -0.832 . . . . 2.23 111.355 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 33.8 mt-10 -108.68 1.95 21.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.374 -0.376 . . . . 2.2400000000000002 110.205 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 17' ' ' MET . 27.4 tp -74.68 107.3 6.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.423 -0.584 . . . . 1.1000000000000001 109.423 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.2 p -113.55 162.71 15.85 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.818 -0.808 . . . . 0.59999999999999998 108.818 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.699 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.9 p-10 -79.84 -11.96 59.79 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.654 -0.418 . . . . 2.29 110.526 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -84.03 -20.42 32.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.742 -0.663 . . . . 2.29 110.998 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.6 p -66.53 147.41 53.32 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.424 0.631 . . . . 1.0600000000000001 110.766 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.732 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.5 t-20 -114.17 127.28 55.83 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.147 -0.933 . . . . 0.80000000000000004 108.89 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.844 ' HD1' HG13 ' A' ' 42' ' ' ILE . 23.9 m-85 -56.58 -50.72 71.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.94 0.4 . . . . 0.46999999999999997 111.399 -178.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.29 68.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.133 -0.485 . . . . 0.46000000000000002 111.111 -176.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.732 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 28.7 t70 -72.17 -28.82 63.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.926 -0.579 . . . . 0.82999999999999996 110.478 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.1 mmt -83.24 -22.57 33.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.684 -0.689 . . . . 2.48 111.264 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.32 23.7 6.53 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.673 -0.775 . . . . 0.44 112.445 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.844 HG13 ' HD1' ' A' ' 37' ' ' PHE . 31.9 mm -70.97 108.22 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.223 0.535 . . . . 0.52000000000000002 111.24 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.9 176.82 9.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.587 -0.733 . . . . 1.9399999999999999 111.495 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 p -61.1 -39.39 89.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.148 -0.933 . . . . 1.03 110.989 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.605 ' HA ' H302 ' A' ' 90' ' ' PNS . 3.2 tm? -52.55 -59.66 4.19 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.703 -0.68 . . . . 0.58999999999999997 110.181 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.541 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.2 m -62.2 -42.83 99.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.087 -0.506 . . . . 1.22 110.739 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.517 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 67.3 m -57.49 -37.62 73.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.169 -0.468 . . . . 0.81000000000000005 111.687 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.661 ' SD ' H303 ' A' ' 90' ' ' PNS . 12.6 ttt -74.3 -40.32 62.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.121 0.486 . . . . 2.25 109.749 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.39 -42.37 96.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.225 -0.898 . . . . 0.35999999999999999 110.363 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 46' ' ' SER . 88.3 mt -58.48 -55.85 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.26000000000000001 111.154 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -63.56 -26.72 69.99 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.769 -0.729 . . . . 0.28999999999999998 112.224 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -50.4 68.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.585 -0.524 . . . . 0.92000000000000004 109.585 176.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -64.27 -27.05 68.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.434 -0.348 . . . . 1.23 110.844 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 10.8 m-30 -55.11 -42.53 73.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.406 -0.59 . . . . 0.28000000000000003 109.406 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -84.32 -36.47 22.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.81 -0.632 . . . . 2.8100000000000001 111.253 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -85.6 -47.97 9.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.533 -0.303 . . . . 2.2599999999999998 111.764 -172.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -86.42 -50.36 6.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.364 -0.38 . . . . 2.6200000000000001 111.268 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.42 -43.35 14.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.557 -0.292 . . . . 0.67000000000000004 111.674 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.16 20.22 11.52 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.907 -0.663 . . . . 0.45000000000000001 112.327 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.8 mt -77.46 141.96 39.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.474 0.178 . . . . 0.63 110.881 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -106.57 84.98 2.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.085 0.469 . . . . 2.27 110.477 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.515 HD12 ' HE2' ' A' ' 81' ' ' PHE . 2.9 mm? -86.57 -29.84 22.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.567 0.699 . . . . 1.6399999999999999 109.448 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 126.46 171.48 13.13 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.25 -1.14 . . . . 0.75 110.25 -173.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -85.96 -9.08 7.69 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.821 2.347 . . . . 1.1299999999999999 113.127 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -125.7 23.6 7.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.055 0.455 . . . . 2.3599999999999999 111.546 -173.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -82.08 114.4 20.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.04 -0.527 . . . . 0.72999999999999998 109.796 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.0 m -132.12 117.82 18.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.64 -0.255 . . . . 1.3899999999999999 110.421 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.73 -39.19 68.01 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 111.994 0.368 . . . . 0.72999999999999998 111.994 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.517 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 12.7 t80 -62.07 -11.28 13.07 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.331 -0.395 . . . . 0.58999999999999997 111.694 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.6 mt -124.11 -34.67 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.195 0.522 . . . . 0.89000000000000001 110.92 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -99.28 -11.87 20.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.718 0.636 . . . . 2.23 112.718 -172.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 71.9 m -141.61 165.77 26.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.6 p -135.96 -66.35 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.941 -0.303 . . . . 0.67000000000000004 111.009 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 69.1 p -87.57 178.37 6.8 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.226 -0.287 . . . . 0.38 110.226 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.479 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 4.6 t -81.86 -35.97 13.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-O 121.078 0.466 . . . . 0.68000000000000005 111.11 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.699 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.7 tpp180 -60.95 -33.64 73.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.787 -0.642 . . . . 3.23 110.77 175.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.61 69.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.745 0.307 . . . . 0.28999999999999998 111.151 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.735 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.7 OUTLIER -69.08 -48.84 61.66 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.184 -0.672 . . . . 0.64000000000000001 109.184 175.876 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -52.68 -61.62 2.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.09 -0.959 . . . . 2.3999999999999999 110.766 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.55 -39.0 64.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.478 -0.783 . . . . 1.6599999999999999 111.697 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.515 ' HE2' HD12 ' A' ' 62' ' ' LEU . 75.4 t80 -59.68 -44.85 93.46 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.849 -0.614 . . . . 0.98999999999999999 110.657 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.735 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 30.1 mtp -62.18 -44.45 96.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.53 . . . . 1.1000000000000001 111.292 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.0 mp -66.17 -15.09 62.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.534 -0.303 . . . . 1.3 111.641 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 127.89 25.72 1.09 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.113 -1.041 . . . . 2.4199999999999999 114.293 171.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.2 m -82.99 31.65 0.43 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.05 0.925 . . . . 4.4699999999999998 110.645 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.62 22.87 32.89 Favored Glycine 0 C--O 1.223 -0.553 0 N-CA-C 110.38 -1.088 . . . . 4.5899999999999999 110.38 176.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.93 -18.38 65.18 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.243 0.617 . . . . 6.6100000000000003 111.638 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.0 -5.27 59.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.783 -0.644 . . . . 8.4700000000000006 112.06 -176.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.668 -1.073 . . . . 9.7300000000000004 112.348 -178.881 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PNS . . . . . 0.661 H303 ' SD ' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 120.715 0.293 . . . . 9.1400000000000006 110.406 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 55.6 tpp -144.33 150.42 37.79 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.143 -0.317 . . . . 8.7200000000000006 110.143 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.83 142.27 13.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.809 -0.811 . . . . 5.1699999999999999 108.809 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.705 ' HG3' ' H ' ' A' ' 5' ' ' GLY . 9.1 tppt? 73.22 -170.2 0.13 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.793 0.683 . . . . 6.6600000000000001 109.77 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.705 ' H ' ' HG3' ' A' ' 4' ' ' LYS . . . -166.73 -141.85 3.27 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.818 -0.706 . . . . 1.74 111.931 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.4 t -95.94 -78.08 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.736 0.303 . . . . 1.1399999999999999 110.839 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.99 88.49 1.21 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.744 -0.741 . . . . 0.53000000000000003 111.279 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 m -100.61 156.96 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 122.56 -0.377 . . . . 0.39000000000000001 110.174 -174.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -87.56 -179.84 6.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.599 -0.519 . . . . 1.5600000000000001 109.599 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -68.54 -28.2 66.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.187 0.518 . . . . 2.02 110.424 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -64.16 -47.07 81.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.732 -0.667 . . . . 1.9099999999999999 110.866 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -70.99 -19.26 62.55 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.791 -0.641 . . . . 1.5800000000000001 110.754 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.534 HD13 HD11 ' A' ' 83' ' ' LEU . 29.8 tp -73.44 -25.13 60.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.816 -0.629 . . . . 0.98999999999999999 110.804 171.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.35 -31.48 29.8 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.376 0.608 . . . . 0.88 110.038 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.51 -22.64 50.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.647 -0.706 . . . . 0.29999999999999999 111.062 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 p -78.62 -41.38 24.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.831 0.348 . . . . 0.23000000000000001 111.143 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 80.7 mtp -59.26 -31.92 69.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 1.6299999999999999 111.471 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -72.72 -35.97 67.69 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 120.941 -0.303 . . . . 3.1699999999999999 111.188 178.161 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.2 t -70.47 -33.56 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.946 0.879 . . . . 0.23000000000000001 108.951 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.72 -36.75 66.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.469 -1.242 . . . . 0.33000000000000002 109.605 174.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 t -64.91 -25.43 67.88 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.193 -0.458 . . . . 1.3799999999999999 110.507 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -82.75 -43.26 16.98 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.987 0.422 . . . . 2.2599999999999998 111.119 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.571 ' HG3' HG12 ' A' ' 50' ' ' ILE . 49.4 mm-40 -86.69 -23.31 25.63 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.217 0.451 . . . . 0.77000000000000002 112.217 -174.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.0 m -93.42 -28.7 15.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.646 0.26 . . . . 1.23 111.417 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.47 3.16 78.53 Favored Glycine 0 N--CA 1.458 0.162 0 C-N-CA 120.177 -1.011 . . . . 0.54000000000000004 112.191 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.0 mt -95.61 112.06 27.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.407 -0.59 . . . . 0.80000000000000004 109.407 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.05 143.81 2.13 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.538 0.524 . . . . 0.56999999999999995 111.894 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -52.51 -34.04 47.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.792 -0.64 . . . . 0.96999999999999997 111.763 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -76.04 -10.56 59.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.253 -0.431 . . . . 2.23 111.048 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -114.38 -6.35 12.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 2.2400000000000002 110.919 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.5 tp -70.46 99.32 1.58 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.226 0.536 . . . . 1.1000000000000001 110.192 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.435 ' O ' HG21 ' A' ' 75' ' ' VAL . 80.9 p -116.81 158.9 23.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.687 -0.688 . . . . 0.59999999999999998 109.305 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' A' ' 76' ' ' ARG . 43.4 m-20 -67.38 -7.05 21.87 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.733 0.301 . . . . 2.29 111.427 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -73.36 -24.56 60.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 2.29 110.776 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.544 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 36.0 m -69.17 146.86 52.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.057 0.456 . . . . 1.0600000000000001 110.573 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.729 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.8 t-20 -129.25 123.38 31.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.186 -1.042 . . . . 0.80000000000000004 108.186 -177.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.843 ' HD1' HG13 ' A' ' 42' ' ' ILE . 36.1 m-85 -56.29 -51.14 69.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.0 0.429 . . . . 0.46999999999999997 111.614 -174.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.86 -29.17 64.1 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.535 -0.302 . . . . 0.46000000000000002 111.359 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.729 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 23.5 t70 -72.11 -35.56 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.431 0.634 . . . . 0.82999999999999996 110.201 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 45.8 mmm -76.15 -23.76 54.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.21 -0.904 . . . . 2.48 111.177 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.26 30.53 5.32 Favored Glycine 0 C--N 1.323 -0.171 0 C-N-CA 120.328 -0.939 . . . . 0.44 112.408 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.843 HG13 ' HD1' ' A' ' 37' ' ' PHE . 29.6 mm -71.52 107.94 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.415 0.626 . . . . 0.52000000000000002 109.66 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -81.25 165.28 21.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.066 -0.97 . . . . 1.9399999999999999 110.844 -173.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.3 t -52.17 -38.93 59.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.689 -0.687 . . . . 1.03 111.283 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.0 tm? -57.1 -60.32 3.78 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.13 -0.486 . . . . 0.58999999999999997 110.38 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.494 ' O ' HG13 ' A' ' 50' ' ' ILE . 12.8 p -65.77 -33.61 76.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.623 -0.262 . . . . 1.22 111.376 -175.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.511 ' HB3' ' H ' ' A' ' 69' ' ' PHE . 50.5 m -61.38 -35.16 76.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.617 -0.265 . . . . 0.81000000000000005 111.671 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.803 ' SD ' ' H32' ' A' ' 90' ' ' PNS . 21.1 ttt -84.63 -16.84 40.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 2.25 110.522 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.582 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 74.6 t -88.98 -38.96 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 109.836 -0.431 . . . . 0.35999999999999999 109.836 -177.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.571 HG12 ' HG3' ' A' ' 23' ' ' GLU . 54.3 mt -53.13 -53.46 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.763 0.316 . . . . 0.26000000000000001 110.235 172.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.21 -25.3 66.33 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.978 -0.63 . . . . 0.28999999999999998 112.285 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.624 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 2.9 m -75.28 -45.82 37.43 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 122.829 -0.218 . . . . 0.92000000000000004 111.023 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.582 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 23.7 mtp180 -63.8 -25.66 68.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 1.23 110.765 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.521 ' HD2' HD11 ' A' ' 62' ' ' LEU . 14.1 m-30 -56.99 -40.89 77.42 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 121.184 0.516 . . . . 0.28000000000000003 109.896 172.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.624 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 71.5 mtm180 -80.48 -30.02 37.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.74 -0.664 . . . . 2.8100000000000001 110.757 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.35 -61.72 1.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.073 0.463 . . . . 2.2599999999999998 111.819 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.61 -35.45 18.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.684 -0.689 . . . . 2.6200000000000001 111.535 -168.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.55 -33.23 11.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.519 -0.309 . . . . 0.67000000000000004 111.651 -175.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.69 37.94 11.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.832 -0.699 . . . . 0.45000000000000001 112.179 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.499 HD12 ' HB3' ' A' ' 54' ' ' PHE . 88.3 mt -80.56 126.61 31.46 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.779 -0.248 . . . . 0.63 110.772 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.24 76.89 4.74 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.845 0.355 . . . . 2.27 110.491 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.521 HD11 ' HD2' ' A' ' 54' ' ' PHE . 68.1 mt -97.77 -77.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.27 0.557 . . . . 1.6399999999999999 110.857 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.25 170.1 14.0 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.962 -0.855 . . . . 0.75 110.962 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -81.81 -11.21 11.46 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.718 2.278 . . . . 1.1299999999999999 112.633 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -91.12 6.59 44.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.754 -0.657 . . . . 2.3599999999999999 111.853 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -93.07 120.03 32.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.927 0.394 . . . . 0.72999999999999998 111.069 -176.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.1 m -139.89 121.39 15.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 1.3899999999999999 110.217 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.496 HD12 HD12 ' A' ' 50' ' ' ILE . 52.1 mt -58.81 -31.04 68.08 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.72999999999999998 111.869 -177.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.511 ' H ' ' HB3' ' A' ' 47' ' ' SER . 1.6 t80 -56.54 -16.26 5.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.858 0.463 . . . . 0.58999999999999997 111.713 -175.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.9 mt -126.69 -35.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.824 0.345 . . . . 0.89000000000000001 110.708 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.58 -10.36 49.03 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.575 0.954 . . . . 2.23 113.575 -172.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 75.9 m -150.95 120.21 6.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.248 0.547 . . . . 1.0 110.718 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.3 p -100.34 -51.94 3.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.98 -0.555 . . . . 0.67000000000000004 110.841 -174.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.1 p -98.19 -175.23 3.06 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.88 -0.328 . . . . 0.38 110.176 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 1.3 t -79.07 -45.71 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.32 0.581 . . . . 0.68000000000000005 109.781 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.759 ' HA ' ' HG3' ' A' ' 79' ' ' LYS . 4.3 tpp180 -61.93 -25.77 67.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.418 -0.81 . . . . 3.23 110.996 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.07 -34.67 72.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.71 0.29 . . . . 0.28999999999999998 110.511 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.699 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.7 OUTLIER -72.09 -48.68 42.23 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.707 -0.849 . . . . 0.64000000000000001 108.707 176.549 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.759 ' HG3' ' HA ' ' A' ' 76' ' ' ARG . 16.2 mmtp -50.59 -56.17 12.97 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.071 -0.968 . . . . 2.3999999999999999 110.38 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -57.44 -33.61 68.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.726 -1.125 . . . . 1.6599999999999999 111.423 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -72.17 -34.94 68.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.09 0.472 . . . . 0.98999999999999999 110.93 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.699 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 38.6 mtp -73.01 -52.9 12.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 1.1000000000000001 111.487 -176.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.534 HD11 HD13 ' A' ' 13' ' ' LEU . 6.9 mp -71.36 -33.97 70.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.552 -0.294 . . . . 1.3 110.906 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 127.14 119.05 2.22 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.452 -0.88 . . . . 2.4199999999999999 112.399 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.1 t -83.66 36.86 0.56 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.409 0.623 . . . . 4.4699999999999998 110.303 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.5 15.03 32.56 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.905 -0.664 . . . . 4.5899999999999999 112.603 -175.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.99 124.87 34.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.103 -0.332 . . . . 6.6100000000000003 110.103 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.12 -79.78 0.36 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.267 -0.424 . . . . 8.4700000000000006 111.999 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.42 -1.211 . . . . 9.7300000000000004 111.801 -175.429 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PNS . . . . . 0.803 ' H32' ' SD ' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.815 0.34 . . . . 9.1400000000000006 110.214 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.1 mmt -104.21 82.71 1.98 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.485 -0.561 . . . . 8.7200000000000006 109.485 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.98 142.05 2.79 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.403 -0.362 . . . . 5.1699999999999999 110.302 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -149.58 129.1 13.06 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.772 -0.455 . . . . 6.6600000000000001 109.772 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.735 ' HA2' ' HB2' ' A' ' 85' ' ' SER . . . -74.55 126.64 9.25 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.825 -0.702 . . . . 1.74 112.184 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.19 -75.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 110.098 -0.334 . . . . 1.1399999999999999 110.098 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.36 108.48 1.19 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.549 -0.834 . . . . 0.53000000000000003 111.283 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.864 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 4.2 m -108.73 157.44 8.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.947 0.403 . . . . 0.39000000000000001 110.989 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -85.97 174.7 9.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.355 -0.609 . . . . 1.5600000000000001 109.355 174.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -21.98 65.29 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.499 -0.926 . . . . 2.02 108.499 176.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.25 -53.02 61.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.863 -1.062 . . . . 1.9099999999999999 110.799 175.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.864 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 40.7 mmtm -71.16 -23.57 62.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.278 -0.419 . . . . 1.5800000000000001 110.247 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.43 HD11 ' HD3' ' A' ' 79' ' ' LYS . 14.1 tp -74.9 -26.68 59.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.906 -0.588 . . . . 0.98999999999999999 110.144 174.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -29.61 27.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.512 0.672 . . . . 0.88 109.751 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.718 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -82.86 -27.04 31.06 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.664 -0.698 . . . . 0.29999999999999999 111.359 -175.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.55 -44.22 83.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.64 -0.424 . . . . 0.23000000000000001 111.328 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.2 mtp -64.29 -30.6 71.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.317 -0.402 . . . . 1.6299999999999999 110.622 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.718 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 30.3 ptt180 -74.2 -27.01 60.6 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.009 -0.276 . . . . 3.1699999999999999 110.852 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.0 t -83.07 -33.47 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.76 0.791 . . . . 0.23000000000000001 108.923 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 t -68.01 -34.2 65.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.636 -1.166 . . . . 0.33000000000000002 110.232 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 49.4 m -58.33 -52.7 64.49 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.029 0.442 . . . . 1.3799999999999999 110.637 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -54.04 -59.08 5.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.947 -1.024 . . . . 2.2599999999999998 112.438 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -79.64 -17.49 53.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.89 -0.595 . . . . 0.77000000000000002 112.566 -167.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -97.75 -35.46 10.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.879 0.371 . . . . 1.23 111.081 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.78 8.14 58.38 Favored Glycine 0 CA--C 1.516 0.111 0 C-N-CA 120.352 -0.928 . . . . 0.54000000000000004 111.472 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 21' ' ' SER . 8.1 mt -104.38 107.81 23.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.818 -0.438 . . . . 0.80000000000000004 109.818 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.18 148.87 17.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.56999999999999995 110.977 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 tp -49.75 -32.79 14.52 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.077 0.551 . . . . 0.96999999999999997 111.551 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -73.35 -21.92 60.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.344 -0.389 . . . . 2.23 111.527 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -108.95 -1.76 18.79 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.313 0.577 . . . . 2.2400000000000002 109.686 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -76.31 96.73 4.04 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.835 -0.802 . . . . 1.1000000000000001 108.835 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.7 p -104.56 156.2 18.17 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.454 -0.794 . . . . 0.59999999999999998 108.934 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.592 ' HB2' ' HD3' ' A' ' 76' ' ' ARG . 7.9 p-10 -74.04 -13.03 60.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.026 0.441 . . . . 2.29 110.534 -176.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -89.04 -22.89 22.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.428 -0.806 . . . . 2.29 111.577 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 m -67.71 149.15 50.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.414 0.626 . . . . 1.0600000000000001 110.366 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.517 ' HB3' ' CB ' ' A' ' 39' ' ' ASP . 3.0 t-20 -109.76 125.23 52.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.531 -0.758 . . . . 0.80000000000000004 110.592 -171.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.69 ' HD1' HG13 ' A' ' 42' ' ' ILE . 30.6 m-85 -55.01 -50.68 68.43 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.959 0.409 . . . . 0.46999999999999997 110.893 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.36 -32.19 73.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.98 -0.555 . . . . 0.46000000000000002 111.591 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.517 ' CB ' ' HB3' ' A' ' 36' ' ' ASN . 16.0 t70 -71.31 -35.49 71.27 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.564 0.697 . . . . 0.82999999999999996 109.656 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 tpp -76.25 -20.46 57.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.895 -1.048 . . . . 2.48 110.849 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.0 25.24 6.55 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.411 -0.899 . . . . 0.44 112.586 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.69 HG13 ' HD1' ' A' ' 37' ' ' PHE . 27.1 mm -67.61 107.68 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.356 0.598 . . . . 0.52000000000000002 110.378 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -82.43 170.63 15.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.402 -0.817 . . . . 1.9399999999999999 110.51 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.6 p -56.85 -40.74 76.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.33 -0.395 . . . . 1.03 110.179 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.27 -53.31 59.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.94 -0.573 . . . . 0.58999999999999997 109.818 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.518 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.6 m -62.62 -42.37 99.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 1.22 110.849 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.539 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 49.1 m -60.04 -39.06 84.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.81000000000000005 110.985 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.407 ' HG3' H371 ' A' ' 90' ' ' PNS . 25.7 ttp -67.62 -46.18 73.24 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.544 0.688 . . . . 2.25 109.216 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.457 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.6 t -57.87 -55.24 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.417 -1.265 . . . . 0.35999999999999999 110.618 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 46' ' ' SER . 63.0 mt -50.94 -52.78 16.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.616 0.246 . . . . 0.26000000000000001 111.251 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -58.76 -37.15 89.54 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.948 -0.644 . . . . 0.28999999999999998 112.098 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -44.47 79.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.592 0.234 . . . . 0.92000000000000004 110.728 177.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -67.99 -21.85 65.04 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.013 -0.275 . . . . 1.23 110.318 -177.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 11.7 m-30 -58.86 -43.4 90.82 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.44 -0.578 . . . . 0.28000000000000003 109.44 170.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -77.59 -28.51 51.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.464 -0.789 . . . . 2.8100000000000001 110.077 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 53' ' ' ARG . 53.8 mt-10 -71.52 -63.91 1.03 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.224 0.535 . . . . 2.2599999999999998 111.395 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -87.89 -35.72 17.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.494 -0.775 . . . . 2.6200000000000001 111.927 -169.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.8 mp -98.69 -40.06 8.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.812 0.339 . . . . 0.67000000000000004 111.114 -173.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.16 31.37 7.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.859 -0.686 . . . . 0.45000000000000001 112.417 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 96.0 mt -81.77 102.15 10.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.742 0.306 . . . . 0.63 110.521 177.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -91.84 69.9 5.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.063 0.459 . . . . 2.27 110.938 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.413 HD13 ' HE2' ' A' ' 81' ' ' PHE . 80.3 mt -88.13 -7.25 57.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.986 -0.552 . . . . 1.6399999999999999 110.53 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.12 173.99 21.21 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.562 -0.828 . . . . 0.75 111.998 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.56 -8.9 6.01 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.971 2.447 . . . . 1.1299999999999999 112.471 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -88.0 3.65 48.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.459 -0.791 . . . . 2.3599999999999999 110.584 -174.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -91.18 120.45 32.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.909 -0.587 . . . . 0.72999999999999998 110.479 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.4 m -140.18 122.42 15.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.956 -0.565 . . . . 1.3899999999999999 110.035 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.2 mt -56.04 -46.73 78.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.081 -0.508 . . . . 0.72999999999999998 111.341 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.539 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.1 t80 -56.58 -12.18 1.66 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.727 -0.669 . . . . 0.58999999999999997 112.417 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.5 mt -115.22 -40.54 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.793 -0.363 . . . . 0.89000000000000001 111.489 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -118.32 9.07 12.37 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.361 0.504 . . . . 2.23 112.361 -171.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.8 m -145.1 114.38 7.06 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.7 -0.625 . . . . 1.0 110.085 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.7 p -98.79 -74.21 0.59 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.85 -0.614 . . . . 0.67000000000000004 110.99 -170.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -83.48 -173.56 4.78 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.981 -0.449 . . . . 0.38 110.59 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 11.7 t -84.16 -38.28 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.756 0.788 . . . . 0.68000000000000005 109.206 -176.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.592 ' HD3' ' HB2' ' A' ' 33' ' ' ASP . 6.6 tpt180 -57.95 -33.79 69.21 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.252 -1.34 . . . . 3.23 110.443 175.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.89 83.08 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.592 -0.276 . . . . 0.28999999999999998 111.012 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.764 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.2 tt -69.92 -49.88 47.6 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.932 -0.766 . . . . 0.64000000000000001 108.932 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 3.1 mmpm? -53.32 -56.32 17.61 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.044 -0.98 . . . . 2.3999999999999999 110.853 178.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -56.27 -35.31 67.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.188 -0.915 . . . . 1.6599999999999999 111.36 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.413 ' HE2' HD13 ' A' ' 62' ' ' LEU . 70.4 t80 -69.92 -35.82 74.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.108 0.48 . . . . 0.98999999999999999 111.121 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.764 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 32.2 mtp -64.17 -44.17 92.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.042 -0.526 . . . . 1.1000000000000001 110.97 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 83' ' ' LEU . 5.5 mp -83.46 -40.67 18.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.412 . . . . 1.3 110.63 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.19 81.37 0.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.575 -0.61 . . . . 2.4199999999999999 111.575 177.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.735 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 12.2 m -79.43 40.37 0.43 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.924 0.393 . . . . 4.4699999999999998 112.043 -174.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.36 76.02 1.22 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.976 -0.631 . . . . 4.5899999999999999 111.707 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.2 27.01 0.96 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.383 0.273 . . . . 6.6100000000000003 110.442 -176.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 61.56 81.68 0.19 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.726 0.641 . . . . 8.4700000000000006 110.098 -174.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.07 -1.406 . . . . 9.7300000000000004 111.434 -177.311 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PNS . . . . . 0.407 H371 ' HG3' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.796 0.332 . . . . 9.1400000000000006 111.005 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -117.82 145.67 44.39 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.737 -0.468 . . . . 8.7200000000000006 109.737 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.41 -13.85 61.97 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.708 0.766 . . . . 5.1699999999999999 110.584 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -141.77 123.3 15.01 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.589 -1.187 . . . . 6.6600000000000001 109.192 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.25 -157.58 33.16 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.688 -0.767 . . . . 1.74 112.349 -176.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.46 -71.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.69 -0.485 . . . . 1.1399999999999999 109.69 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 83' ' ' LEU . . . 83.68 90.44 0.73 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.381 -0.914 . . . . 0.53000000000000003 111.518 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.93 158.26 10.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.664 0.269 . . . . 0.39000000000000001 110.448 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.2 m -73.25 166.13 23.73 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.239 -0.437 . . . . 1.5600000000000001 110.324 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -59.82 -27.59 66.74 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.526 0.679 . . . . 2.02 109.4 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -50.7 -53.4 31.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.966 -1.016 . . . . 1.9099999999999999 111.753 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -66.88 -30.35 70.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.205 -0.598 . . . . 1.5800000000000001 110.242 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.26 -22.9 61.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.98999999999999999 110.933 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.55 -30.3 25.19 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.131 0.491 . . . . 0.88 110.625 173.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.605 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -79.59 -34.13 41.03 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.29999999999999999 110.867 -177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.487 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 2.9 p -58.11 -36.38 56.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.066 0.46 . . . . 0.23000000000000001 110.937 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.9 mtm -69.39 -30.11 68.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.814 -0.63 . . . . 1.6299999999999999 110.945 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 24.6 ptt180 -72.26 -30.79 65.19 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 120.34 -0.544 . . . . 3.1699999999999999 109.758 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.6 t -79.61 -38.33 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.654 0.74 . . . . 0.23000000000000001 109.175 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.9 t -62.21 -47.66 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.608 -1.178 . . . . 0.33000000000000002 110.361 175.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -62.09 -38.88 90.54 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.684 0.253 . . . . 1.3799999999999999 111.684 -176.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 18.2 mm-40 -62.69 -46.72 86.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.508 -0.314 . . . . 2.2599999999999998 111.557 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -83.47 -26.18 30.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.366 0.506 . . . . 0.77000000000000002 112.366 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.438 ' HA ' HD11 ' A' ' 42' ' ' ILE . 78.8 p -84.61 -45.24 12.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 1.23 110.444 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.88 5.64 53.27 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.795 -0.717 . . . . 0.54000000000000004 112.004 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mt -93.36 132.85 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.718 -0.284 . . . . 0.80000000000000004 110.275 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 144.68 53.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.293 -0.412 . . . . 0.56999999999999995 110.979 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -36.51 68.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.909 -0.587 . . . . 0.96999999999999997 110.48 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -70.38 -14.0 62.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.984 -0.553 . . . . 2.23 110.912 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -107.17 -4.86 18.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.017 -0.538 . . . . 2.2400000000000002 110.655 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.1 tp -78.82 96.79 5.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.46 0.648 . . . . 1.1000000000000001 109.873 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.6 p -124.17 167.87 13.68 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.273 -1.01 . . . . 0.59999999999999998 108.273 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.689 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 2.5 p30 -71.61 -3.22 20.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.853 -0.339 . . . . 2.29 111.409 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -75.68 -20.84 58.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.949 0.404 . . . . 2.29 110.214 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.511 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 19.4 m -73.33 148.58 43.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.116 0.484 . . . . 1.0600000000000001 110.214 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.1 t-20 -128.18 117.38 21.47 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.852 -0.795 . . . . 0.80000000000000004 108.852 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.809 ' HD1' HG13 ' A' ' 42' ' ' ILE . 30.0 m-85 -52.67 -54.43 33.56 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.979 0.418 . . . . 0.46999999999999997 111.524 -174.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.21 -25.94 64.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.869 -0.605 . . . . 0.46000000000000002 111.669 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.759 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 38.7 t70 -81.53 -20.51 39.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.321 0.581 . . . . 0.82999999999999996 111.116 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -85.61 -24.38 27.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.856 -0.611 . . . . 2.48 109.9 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.41 13.4 6.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.585 -0.817 . . . . 0.44 112.67 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.809 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.0 mm -67.82 107.82 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.94 0.4 . . . . 0.52000000000000002 110.082 176.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -78.74 179.6 7.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.912 -0.586 . . . . 1.9399999999999999 110.453 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.4 p -57.99 -36.22 72.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.528 -0.76 . . . . 1.03 109.791 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.44 -60.46 3.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.801 -1.091 . . . . 0.58999999999999997 110.029 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.529 ' O ' HG13 ' A' ' 50' ' ' ILE . 1.3 m -57.72 -47.33 82.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.524 . . . . 1.22 111.353 -177.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.914 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 50.9 p -65.94 -29.06 69.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.893 0.377 . . . . 0.81000000000000005 111.298 -176.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.5 tpt -76.31 -35.48 58.8 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.532 -0.544 . . . . 2.25 109.532 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.543 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 37.6 t -65.12 -50.16 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.334 -0.848 . . . . 0.35999999999999999 109.533 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 46' ' ' SER . 60.2 mt -52.7 -53.26 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.26000000000000001 111.061 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.12 -41.62 98.18 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.03 -0.605 . . . . 0.28999999999999998 112.407 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 t -59.62 -44.7 93.36 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.792 0.329 . . . . 0.92000000000000004 110.707 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 56.6 mtp180 -68.14 -20.57 64.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.395 -0.366 . . . . 1.23 111.691 -175.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.579 ' HD2' HD11 ' A' ' 62' ' ' LEU . 15.9 m-30 -59.86 -42.27 93.31 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.37 0.605 . . . . 0.28000000000000003 109.595 171.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 67.4 mtp180 -74.1 -25.98 60.1 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.184 -0.916 . . . . 2.8100000000000001 110.196 -177.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -77.82 -63.75 1.31 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.765 -0.652 . . . . 2.2599999999999998 111.577 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.69 -46.79 10.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.679 -0.692 . . . . 2.6200000000000001 111.964 -170.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.2 -26.43 25.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.233 -0.44 . . . . 0.67000000000000004 111.042 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.49 33.28 31.8 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.785 -0.721 . . . . 0.45000000000000001 112.365 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.613 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 60.2 mt -89.65 104.95 17.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.797 -0.446 . . . . 0.63 109.797 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -85.35 77.87 9.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.707 0.765 . . . . 2.27 109.826 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.579 HD11 ' HD2' ' A' ' 54' ' ' PHE . 30.5 mt -75.77 -73.44 0.26 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.675 -1.148 . . . . 1.6399999999999999 111.199 -176.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 163.2 154.98 7.9 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.46 -0.791 . . . . 0.75 111.132 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.74 -6.49 14.34 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.392 2.062 . . . . 1.1299999999999999 112.034 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -103.7 2.08 32.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.589 -0.732 . . . . 2.3599999999999999 109.948 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -92.48 123.08 35.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.044 -0.526 . . . . 0.72999999999999998 110.571 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.9 m -137.79 128.45 26.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.056 -0.52 . . . . 1.3899999999999999 109.976 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.914 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 32.9 mt -56.56 -33.44 66.13 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 120.635 0.255 . . . . 0.72999999999999998 110.833 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.507 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 24.6 t80 -58.1 -17.48 18.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.045 -0.525 . . . . 0.58999999999999997 111.633 -174.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.8 mt -125.09 -38.69 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.597 -0.274 . . . . 0.89000000000000001 111.009 176.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -96.41 4.36 52.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.665 0.617 . . . . 2.23 112.665 -170.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.3 m -155.45 93.94 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.426 0.631 . . . . 1.0 109.577 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.9 p -80.02 -68.61 0.66 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.473 -0.785 . . . . 0.67000000000000004 109.707 -171.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 65.2 p -86.5 -170.52 3.12 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.673 -0.491 . . . . 0.38 109.673 175.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.3 t -81.58 -38.13 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 108.87 -0.789 . . . . 0.68000000000000005 108.87 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.689 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 5.8 tpt180 -62.97 -30.11 71.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.52 -1.218 . . . . 3.23 110.44 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.19 -34.72 75.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.239 -0.437 . . . . 0.28999999999999998 110.986 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.535 HD21 ' CE2' ' A' ' 54' ' ' PHE . 1.1 tt -73.89 -47.28 39.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.438 0.637 . . . . 0.64000000000000001 109.349 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 31.3 mmtp -54.91 -46.81 74.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.82 -1.082 . . . . 2.3999999999999999 110.959 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.59 -48.53 80.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.502 -0.772 . . . . 1.6599999999999999 111.577 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -55.53 -37.62 68.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.819 -0.628 . . . . 0.98999999999999999 111.781 -175.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.487 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 18.7 mtt -54.44 -53.39 54.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 1.1000000000000001 111.799 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.481 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 5.6 mp -79.52 -37.76 35.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.284 -0.417 . . . . 1.3 109.962 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.23 146.63 13.11 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.646 -0.707 . . . . 2.4199999999999999 111.404 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.2 m -78.06 33.8 0.19 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.025 0.441 . . . . 4.4699999999999998 111.451 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.74 48.83 2.54 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.026 -0.607 . . . . 4.5899999999999999 111.867 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.06 106.71 5.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.116 0.484 . . . . 6.6100000000000003 110.589 -178.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.18 -53.7 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.533 -0.758 . . . . 8.4700000000000006 110.037 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.901 -0.944 . . . . 9.7300000000000004 111.786 179.178 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PNS . . . . . 0.478 H313 ' O35' ' A' ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 112.239 -0.344 . . . . 0.53 112.239 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 m -119.38 158.24 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.55 -0.537 . . . . 0.39 109.55 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 p -83.74 172.85 11.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.186 -0.301 . . . . 1.56 110.186 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -70.23 -16.76 63.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.279 0.561 . . . . 2.02 110.196 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -66.27 -47.69 72.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.367 -0.833 . . . . 1.91 109.702 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -68.99 -27.56 65.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.884 -0.598 . . . . 1.58 109.926 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -24.81 63.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.478 -0.783 . . . . 0.99 110.688 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.26 -32.78 26.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.385 0.612 . . . . 0.88 110.246 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.08 -27.32 57.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.3 111.051 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.626 HG11 ' HZ1' ' A' ' 79' ' ' LYS . 2.8 p -70.65 -40.73 77.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.053 -0.521 . . . . 0.23 111.674 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.4 mtp -61.49 -31.14 71.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 1.63 111.309 -173.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -78.69 -27.76 45.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.589 -0.444 . . . . 3.17 111.101 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.527 HG13 ' HD3' ' A' ' 53' ' ' ARG . 42.3 t -73.72 -37.63 49.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.525 -0.917 . . . . 0.23 108.525 176.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 t -65.14 -44.08 95.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.413 -1.267 . . . . 0.33 110.433 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.5 p -56.01 -50.47 70.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.231 0.539 . . . . 1.38 110.346 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -55.37 -53.92 50.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.968 -1.015 . . . . 2.26 112.749 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -82.66 -16.43 48.28 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.62 0.6 . . . . 0.77 112.62 -170.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 81.6 p -91.72 -36.48 13.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.093 0.473 . . . . 1.23 110.722 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.87 -0.01 56.36 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.844 -0.693 . . . . 0.54 111.685 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.61 HD11 ' HG2' ' A' ' 40' ' ' MET . 3.1 mt -93.91 123.98 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 109.517 -0.549 . . . . 0.8 109.517 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.66 141.76 36.59 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.315 0.385 . . . . 0.57 111.101 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.14 -34.14 59.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.899 -0.591 . . . . 0.97 111.227 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.35 -10.42 59.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 2.23 111.292 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -109.99 -3.85 16.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.971 0.415 . . . . 2.24 110.231 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.9 tp -74.31 99.34 3.45 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.387 0.613 . . . . 1.1 110.239 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.405 ' O ' HG21 ' A' ' 75' ' ' VAL . 44.6 p -121.73 164.53 17.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.271 -0.877 . . . . 0.6 108.857 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.97 -9.88 34.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.801 0.334 . . . . 2.29 111.307 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.92 -19.6 60.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 2.29 110.487 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.521 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 18.3 m -71.5 143.08 50.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.038 0.446 . . . . 1.06 109.835 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.663 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.9 t-20 -128.43 117.87 22.12 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.579 -0.526 . . . . 0.8 109.579 -176.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.644 ' HD1' HG13 ' A' ' 42' ' ' ILE . 48.1 m-85 -55.36 -39.7 70.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.889 0.376 . . . . 0.47 111.698 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.23 -29.25 60.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.875 0.369 . . . . 0.46 111.212 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.663 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 34.6 t70 -74.81 -31.15 61.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.185 0.517 . . . . 0.83 110.267 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.61 ' HG2' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -81.04 -14.65 57.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.401 -0.818 . . . . 2.48 110.761 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.67 42.87 6.29 Favored Glycine 0 CA--C 1.511 -0.207 0 C-N-CA 120.378 -0.915 . . . . 0.44 112.153 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.644 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.6 mm -75.54 107.28 6.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.988 0.423 . . . . 0.52 109.903 176.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -80.19 175.19 10.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.438 0.637 . . . . 1.94 111.82 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 t -52.86 -42.86 65.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.557 -1.201 . . . . 1.03 111.189 177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.36 -61.64 2.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.99 -0.55 . . . . 0.59 110.257 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.511 ' O ' HG13 ' A' ' 50' ' ' ILE . 29.0 t -61.18 -47.09 87.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.473 -0.33 . . . . 1.22 111.601 -175.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.469 ' HB3' HG22 ' A' ' 42' ' ' ILE . 51.0 p -62.38 -27.44 69.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.682 0.253 . . . . 0.81 111.682 -176.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.9 ttt -80.36 -39.9 27.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.246 0.546 . . . . 2.25 109.841 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.85 -42.21 95.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.315 -0.857 . . . . 0.36 109.986 -177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 46' ' ' SER . 73.8 mt -56.75 -58.18 6.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.932 -0.576 . . . . 0.26 111.232 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -65.35 -23.73 70.26 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.607 -0.806 . . . . 0.29 112.398 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.617 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -69.63 -45.71 67.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.803 -0.443 . . . . 0.92 109.803 175.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.527 ' HD3' HG13 ' A' ' 19' ' ' VAL . 41.1 mtp180 -61.27 -31.99 71.81 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.428 -0.351 . . . . 1.23 110.533 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.474 ' CE2' HD21 ' A' ' 78' ' ' LEU . 13.1 m-30 -53.68 -40.58 66.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.892 -0.594 . . . . 0.28 110.02 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.617 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 53.2 mtm180 -81.04 -37.76 28.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.068 -0.514 . . . . 2.81 111.142 -175.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -87.86 -52.45 5.28 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.316 0.488 . . . . 2.26 112.316 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -80.41 -42.24 23.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.807 -0.633 . . . . 2.62 111.18 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.2 mp -96.08 -33.0 12.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.405 -0.361 . . . . 0.67 111.685 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.23 35.07 9.05 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.516 -0.85 . . . . 0.45 112.101 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.2 mt -87.08 131.15 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.582 0.23 . . . . 0.63 110.939 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -89.33 47.11 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.639 -0.504 . . . . 2.27 109.639 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -59.16 4.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.188 -0.915 . . . . 1.64 110.726 -174.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' ' HD3' ' A' ' 55' ' ' ARG . . . 172.41 167.86 33.01 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.629 -0.588 . . . . 0.75 111.629 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.89 -37.08 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.465 2.11 . . . . 1.13 113.38 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.14 45.34 2.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.308 0.575 . . . . 2.36 110.438 -175.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -74.2 112.53 10.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.448 -0.797 . . . . 0.73 109.876 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.1 p -118.3 129.04 55.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 1.39 111.173 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.482 HD12 HD12 ' A' ' 50' ' ' ILE . 75.3 mt -76.2 2.96 11.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 0.73 111.672 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.69 -17.7 22.93 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.122 -0.49 . . . . 0.59 110.15 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.2 mt -132.26 -37.39 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.093 0.473 . . . . 0.89 111.141 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.78 -2.8 46.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.684 0.754 . . . . 2.23 110.683 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.436 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 98.5 m -147.23 157.8 43.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.167 -0.924 . . . . 1.0 108.735 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.3 p -129.95 -73.41 0.56 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.163 -0.215 . . . . 0.67 111.276 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.2 p -90.25 -171.58 3.16 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.246 -0.284 . . . . 0.38 110.625 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.521 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 1.8 t -79.47 -44.33 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.568 -0.53 . . . . 0.68 109.568 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -59.15 -32.69 70.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.691 -0.686 . . . . 3.23 110.985 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -56.68 -37.16 70.48 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.35 -0.386 . . . . 0.29 111.171 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.509 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -74.28 -43.2 57.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.536 0.684 . . . . 0.64 109.398 178.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.716 ' NZ ' ' HA ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -53.92 -61.33 2.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.618 -1.174 . . . . 2.4 112.102 178.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.99 -37.83 77.76 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.107 0.254 . . . . 1.66 111.596 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 3.7 t80 -52.69 -39.65 62.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.598 0.561 . . . . 0.99 111.067 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.509 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 7.9 mtt . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.564 -0.744 . . . . 1.1 112.092 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.124 0 N-CA-C 111.809 -0.516 . . . . 0.53 111.809 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG21 ' SD ' ' A' ' 82' ' ' MET . 5.9 m -97.93 158.37 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.963 -0.384 . . . . 0.39 109.963 -175.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.4 t -83.86 -177.11 6.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.844 -0.428 . . . . 1.56 109.844 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -71.83 -22.03 61.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.005 0.431 . . . . 2.02 110.603 -174.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -73.96 -41.6 61.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.462 -0.495 . . . . 1.91 110.076 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -66.71 -30.87 71.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.893 -0.78 . . . . 1.58 108.893 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.1 tp -69.78 -26.19 64.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.975 -1.012 . . . . 0.99 110.701 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.28 -27.07 24.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.414 0.626 . . . . 0.88 110.095 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.76 -35.36 57.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.687 -0.688 . . . . 0.3 110.802 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.519 HG21 HD22 ' A' ' 78' ' ' LEU . 3.6 p -61.68 -45.42 98.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.989 -0.551 . . . . 0.23 110.624 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.1 mtm -59.39 -39.0 81.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.796 -0.638 . . . . 1.63 111.52 -174.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HA ' ' HB2' ' A' ' 21' ' ' SER . 11.8 ptt180 -74.07 -29.38 61.85 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.087 -0.645 . . . . 3.17 111.569 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.6 t -71.68 -33.01 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.087 0.946 . . . . 0.23 108.56 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -70.66 -43.63 77.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.032 -1.44 . . . . 0.33 109.712 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' A' ' 18' ' ' ARG . 6.3 m -62.66 -21.87 66.03 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 122.748 0.419 . . . . 1.38 111.828 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.09 -51.71 6.15 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.316 -0.402 . . . . 2.26 111.365 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 15.2 mm-40 -90.49 -27.94 18.88 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.104 0.409 . . . . 0.77 112.104 -172.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.441 ' HB3' HD11 ' A' ' 42' ' ' ILE . 17.5 m -86.4 -32.44 20.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.114 0.483 . . . . 1.23 110.544 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.41 -9.53 62.82 Favored Glycine 0 C--O 1.23 -0.111 0 C-N-CA 120.503 -0.856 . . . . 0.54 112.682 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mt -79.37 104.77 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.623 -0.51 . . . . 0.8 109.623 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.567 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -43.67 145.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.857 0.723 . . . . 0.57 112.02 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.4 tp -56.47 -31.5 64.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.705 -0.679 . . . . 0.97 111.002 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -80.39 -9.75 59.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.057 -0.519 . . . . 2.23 111.181 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.567 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 40.6 mm-40 -110.71 -13.9 14.11 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.192 -0.458 . . . . 2.24 110.052 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.8 tp -69.6 98.14 1.12 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.639 -0.71 . . . . 1.1 110.27 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.1 p -107.62 161.84 14.5 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.361 -0.836 . . . . 0.6 108.969 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.741 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 7.5 p-10 -75.54 -9.05 58.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.765 0.317 . . . . 2.29 111.064 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -91.02 -23.65 20.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.416 0.525 . . . . 2.29 112.416 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.7 m -71.3 148.44 47.12 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.423 0.63 . . . . 1.06 110.011 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.764 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 4.4 t-20 -113.24 123.49 50.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.417 -0.81 . . . . 0.8 109.812 -170.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.787 ' HD1' HG13 ' A' ' 42' ' ' ILE . 32.3 m-85 -56.49 -53.1 61.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.964 0.412 . . . . 0.47 111.587 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.06 -27.91 66.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.179 -0.464 . . . . 0.46 111.321 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.764 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 23.4 t70 -72.06 -32.65 67.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.397 0.617 . . . . 0.83 110.251 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.575 ' HA ' ' CE ' ' A' ' 40' ' ' MET . 4.8 mmt -83.48 -13.99 53.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.252 -0.885 . . . . 2.48 111.178 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.82 36.07 6.2 Favored Glycine 0 N--CA 1.457 0.071 0 C-N-CA 120.063 -1.065 . . . . 0.44 112.516 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.787 HG13 ' HD1' ' A' ' 37' ' ' PHE . 32.7 mm -73.19 108.07 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.201 0.524 . . . . 0.52 110.013 175.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.29 163.84 27.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.539 -0.755 . . . . 1.94 111.351 -173.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.5 t -54.49 -37.3 65.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.293 -0.867 . . . . 1.03 111.054 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.77 -61.54 2.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.59 110.203 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.574 ' O ' HG13 ' A' ' 50' ' ' ILE . 11.6 m -62.68 -42.89 99.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.433 -0.349 . . . . 1.22 111.69 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.564 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 57.6 p -63.86 -32.18 73.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.95 0.405 . . . . 0.81 111.204 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.9 tpt -75.78 -39.85 56.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.326 0.584 . . . . 2.25 109.734 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.9 t -60.25 -45.82 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.292 -0.867 . . . . 0.36 109.97 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 46' ' ' SER . 78.8 mt -55.56 -54.31 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.932 -0.576 . . . . 0.26 111.355 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.35 -36.36 92.36 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.736 -0.745 . . . . 0.29 112.419 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 m -61.36 -47.44 85.84 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 120.591 -0.443 . . . . 0.92 110.108 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -61.48 -32.25 72.25 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.431 -0.349 . . . . 1.23 111.31 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.502 ' HD2' HD11 ' A' ' 62' ' ' LEU . 11.0 m-30 -53.09 -38.95 62.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.151 0.5 . . . . 0.28 110.21 176.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -83.54 -29.77 27.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.482 -0.781 . . . . 2.81 111.116 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -85.12 -62.17 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.268 0.556 . . . . 2.26 111.044 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -44.31 52.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.116 -0.947 . . . . 2.62 111.094 -173.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 mp -93.7 -32.18 14.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.378 -0.374 . . . . 0.67 111.312 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.99 29.76 30.59 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.681 -0.771 . . . . 0.45 112.354 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.8 mt -82.54 108.15 15.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.731 -0.47 . . . . 0.63 109.731 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -81.18 78.43 7.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.641 0.734 . . . . 2.27 109.353 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.502 HD11 ' HD2' ' A' ' 54' ' ' PHE . 27.1 mt -76.07 -71.97 0.35 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.326 -1.306 . . . . 1.64 110.995 -176.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.98 169.45 38.91 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.415 -0.811 . . . . 0.75 111.289 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.23 -15.46 11.46 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.672 2.248 . . . . 1.13 113.006 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -119.12 10.87 12.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.313 -0.403 . . . . 2.36 111.19 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.451 ' CD2' HD13 ' A' ' 62' ' ' LEU . 73.2 t80 -71.93 112.85 8.37 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.948 0.404 . . . . 0.73 110.488 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.7 m -131.13 121.24 24.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.692 -0.686 . . . . 1.39 109.628 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.647 HD21 HD11 ' A' ' 78' ' ' LEU . 2.5 mp -54.12 -32.12 54.19 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.24 0.459 . . . . 0.73 112.24 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.564 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 1.8 t80 -65.99 -14.57 61.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.946 0.403 . . . . 0.59 110.855 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.0 mt -124.0 -39.01 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.514 -0.312 . . . . 0.89 110.671 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -95.15 6.09 50.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 2.23 111.796 -172.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.493 ' SG ' ' HG ' ' A' ' 78' ' ' LEU . 80.1 m -148.96 100.71 3.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.554 0.693 . . . . 1.0 109.983 -175.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.8 p -90.02 -72.88 0.54 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.694 -0.685 . . . . 0.67 110.194 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 77.5 p -86.67 -177.67 6.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.415 -0.587 . . . . 0.38 109.415 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.7 t -80.21 -40.68 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 120.361 -0.536 . . . . 0.68 110.419 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.741 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 8.4 tpt180 -54.67 -32.22 58.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.926 -0.579 . . . . 3.23 110.533 173.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -59.42 -31.57 69.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.29 111.739 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.647 HD11 HD21 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -81.7 -45.28 15.93 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.706 -0.85 . . . . 0.64 108.706 -179.007 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -53.2 -61.56 2.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.945 -1.48 . . . . 2.4 110.832 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.17 -19.05 63.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.937 -1.029 . . . . 1.66 111.019 -173.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 83.4 t80 -63.06 -42.66 99.75 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.278 0.561 . . . . 0.99 109.596 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.46 ' SD ' HG21 ' A' ' 8' ' ' VAL . 12.5 mtt . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.203 -0.908 . . . . 1.1 111.385 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 111.557 -0.617 . . . . 0.53 111.557 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 12' ' ' LYS . 2.7 m -114.39 157.49 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.929 -0.397 . . . . 0.39 109.929 -176.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.1 t -91.4 175.12 7.04 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.845 -0.798 . . . . 1.56 108.845 173.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -67.08 -23.27 65.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.977 0.417 . . . . 2.02 110.08 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -47.51 84.46 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.469 -0.787 . . . . 1.91 110.903 172.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.615 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -71.74 -25.23 61.97 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.554 -0.536 . . . . 1.58 109.554 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.579 ' HA ' HG12 ' A' ' 16' ' ' VAL . 4.0 tp -72.22 -29.21 63.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.07 -0.514 . . . . 0.99 110.421 173.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.39 -24.0 57.14 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.023 0.916 . . . . 0.88 109.301 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.35 -36.89 20.47 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.72 -1.127 . . . . 0.3 110.884 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.581 HG23 ' CZ ' ' A' ' 54' ' ' PHE . 4.0 p -70.61 -44.11 77.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.873 -0.603 . . . . 0.23 112.295 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.451 ' HB3' HD23 ' A' ' 31' ' ' LEU . 88.5 mtp -60.0 -32.56 70.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.847 0.314 . . . . 1.63 111.847 -173.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.57 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 8.2 ptt180 -84.24 -18.25 37.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.37 0.507 . . . . 3.17 112.37 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.29 -32.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.188 -1.042 . . . . 0.23 108.188 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 t -66.71 -39.88 84.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.21 -1.359 . . . . 0.33 110.122 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.5 p -64.37 -49.3 72.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.217 0.532 . . . . 1.38 110.71 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 7.2 mm-40 -60.94 -39.4 89.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.401 -0.818 . . . . 2.26 112.24 -178.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -80.14 -31.94 38.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.951 0.352 . . . . 0.77 111.951 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.436 ' HA ' HD11 ' A' ' 42' ' ' ILE . 72.7 p -82.4 -44.59 15.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.886 0.374 . . . . 1.23 111.558 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.91 6.7 37.06 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.654 -0.784 . . . . 0.54 111.705 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.697 HD11 ' HG2' ' A' ' 40' ' ' MET . 3.5 mt -97.61 137.07 26.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.501 -0.555 . . . . 0.8 109.501 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.35 141.99 58.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.742 0.306 . . . . 0.57 110.415 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -55.98 -34.48 65.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.97 111.28 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -71.47 -10.45 59.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 2.23 111.378 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -111.61 -4.22 14.83 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.497 -0.319 . . . . 2.24 111.103 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 17' ' ' MET . 30.0 tp -72.05 97.88 1.98 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.516 0.674 . . . . 1.1 110.472 -173.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 34' ' ' ASP . 70.0 p -124.95 165.8 17.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.193 -0.912 . . . . 0.6 109.052 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.496 ' CB ' ' HB2' ' A' ' 76' ' ' ARG . 7.7 p-10 -70.83 -5.87 33.62 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.206 0.527 . . . . 2.29 110.484 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.435 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 24.5 t70 -70.56 -22.04 62.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.202 -0.908 . . . . 2.29 109.687 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.467 ' HB2' HG21 ' A' ' 75' ' ' VAL . 14.1 m -81.29 147.45 29.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.648 -0.706 . . . . 1.06 109.901 176.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.7 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 3.7 t-20 -127.64 119.78 26.64 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.074 -0.713 . . . . 0.8 109.074 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.621 ' HD1' HG13 ' A' ' 42' ' ' ILE . 5.5 m-85 -51.52 -50.23 60.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.955 0.407 . . . . 0.47 110.925 -176.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.03 -31.42 71.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.004 -0.543 . . . . 0.46 111.627 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.7 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 30.8 t70 -74.94 -29.2 60.88 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.152 0.501 . . . . 0.83 110.322 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.697 ' HG2' HD11 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -82.65 -15.07 53.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.256 -0.884 . . . . 2.48 111.08 -178.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.59 20.99 9.54 Favored Glycine 0 N--CA 1.455 -0.088 0 C-N-CA 120.231 -0.985 . . . . 0.44 112.787 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.621 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.3 mm -71.47 107.15 2.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.52 0.676 . . . . 0.52 110.72 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -88.55 170.45 10.86 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.092 -0.958 . . . . 1.94 110.088 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.9 t -55.19 -37.71 67.42 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.301 0.24 . . . . 1.03 111.016 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.407 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.4 tm? -58.49 -56.34 23.41 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.012 -0.366 . . . . 0.59 110.012 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.56 ' O ' HG13 ' A' ' 50' ' ' ILE . 19.8 m -68.25 -41.43 81.14 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.874 0.324 . . . . 1.22 111.874 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.648 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 36.2 p -66.22 -30.36 70.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.03 0.443 . . . . 0.81 110.965 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -39.57 64.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.619 -0.882 . . . . 2.25 108.619 178.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 39.6 t -64.39 -44.66 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.902 -0.59 . . . . 0.36 110.261 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 46' ' ' SER . 65.6 mt -52.06 -59.78 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.596 -0.275 . . . . 0.26 110.772 176.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.51 -27.33 67.79 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.11 -0.567 . . . . 0.29 111.9 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.496 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -67.68 -44.13 78.55 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 122.902 -0.176 . . . . 0.92 111.1 176.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 27.7 mtp180 -65.97 -23.98 66.7 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.716 0.293 . . . . 1.23 110.473 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.581 ' CZ ' HG23 ' A' ' 16' ' ' VAL . 12.2 m-30 -58.3 -40.56 82.33 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.169 0.509 . . . . 0.28 109.688 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 66.7 mtm180 -82.03 -25.08 34.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.438 -0.801 . . . . 2.81 111.043 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -83.0 -59.13 2.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.787 -0.642 . . . . 2.26 110.927 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.62 -48.53 7.01 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.516 -0.766 . . . . 2.62 111.797 -174.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.401 HD23 ' HD2' ' A' ' 12' ' ' LYS . 10.9 mp -81.71 -26.51 34.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.421 -0.354 . . . . 0.67 111.666 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.31 40.41 49.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.12 -0.562 . . . . 0.45 112.419 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.453 HD21 ' HG2' ' A' ' 12' ' ' LYS . 78.5 mt -86.35 146.15 26.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.839 0.352 . . . . 0.63 110.966 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.21 94.82 6.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 2.27 110.849 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 63' ' ' GLY . 0.3 OUTLIER -121.53 -52.35 2.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.117 -0.492 . . . . 1.64 110.914 176.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' HD12 ' A' ' 62' ' ' LEU . . . 124.52 169.0 12.96 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.628 -0.796 . . . . 0.75 111.988 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.41 -4.83 11.76 Favored 'Trans proline' 0 C--N 1.333 -0.258 0 C-N-CA 122.48 2.12 . . . . 1.13 113.041 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.26 -16.56 19.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.118 -0.492 . . . . 2.36 111.023 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -69.77 112.8 6.47 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.102 0.477 . . . . 0.73 110.25 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 p -128.23 132.54 48.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.052 -0.522 . . . . 1.39 111.281 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 83.0 mt -81.23 15.13 2.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.73 111.357 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.444 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 6.7 t80 -111.37 -8.49 14.31 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.105 0.479 . . . . 0.59 109.907 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.6 mt -131.57 -40.64 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-O 120.862 0.363 . . . . 0.89 111.488 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.12 5.53 42.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.228 0.537 . . . . 2.23 110.531 -170.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 96.5 m -158.77 129.24 6.0 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.2 p -109.42 -48.3 3.26 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.748 -0.381 . . . . 0.67 111.068 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.6 p -99.87 -171.2 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.306 0.574 . . . . 0.38 111.128 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.467 HG21 ' HB2' ' A' ' 35' ' ' SER . 2.2 t -81.75 -44.45 20.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.773 -0.649 . . . . 0.68 110.718 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HD3' ' HB2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -67.31 -24.5 65.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.585 . . . . 3.23 110.684 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.36 64.87 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.165 0.507 . . . . 0.29 110.386 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.715 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.6 OUTLIER -77.43 -49.06 15.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.633 -0.712 . . . . 0.64 109.339 177.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.507 ' HB2' ' HD3' ' A' ' 76' ' ' ARG . 30.5 mmtm -57.85 -45.43 86.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.828 -1.078 . . . . 2.4 110.902 -176.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.45 -29.89 70.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.563 -0.744 . . . . 1.66 110.77 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -77.0 -36.45 56.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.075 -0.511 . . . . 0.99 111.09 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.715 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 44.4 mtp . . . . . 0 N--CA 1.465 0.305 0 CA-C-N 116.207 -0.452 . . . . 1.1 110.914 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 110.875 -0.89 . . . . 0.53 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -113.36 156.26 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.736 0.303 . . . . 0.39 110.274 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.9 p -71.88 157.83 37.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.12 -0.491 . . . . 1.56 110.382 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.64 -26.17 68.28 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.118 -1.067 . . . . 2.02 108.118 175.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.44 -42.58 96.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.608 -1.178 . . . . 1.91 110.56 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -27.77 64.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.146 -0.479 . . . . 1.58 109.735 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.432 ' O ' ' HG3' ' A' ' 17' ' ' MET . 0.1 OUTLIER -68.32 -27.99 66.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.842 -0.617 . . . . 0.99 109.565 175.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -25.78 41.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.375 0.607 . . . . 0.88 110.156 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.88 -19.29 29.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.503 -0.771 . . . . 0.3 111.663 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.536 HG23 ' CE1' ' A' ' 54' ' ' PHE . 3.3 p -82.16 -43.59 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.758 -0.377 . . . . 0.23 111.777 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.563 ' HB3' HD23 ' A' ' 31' ' ' LEU . 57.3 mtm -61.56 -30.39 70.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.468 -0.333 . . . . 1.63 111.508 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.18 -33.97 74.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.476 0.179 . . . . 3.17 111.127 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 53' ' ' ARG . 56.3 t -75.94 -37.13 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.694 0.759 . . . . 0.23 109.113 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.03 -39.23 84.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.763 -1.108 . . . . 0.33 111.007 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -24.25 50.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.653 0.74 . . . . 1.38 109.729 -173.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -78.8 -42.26 28.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.788 -1.097 . . . . 2.26 111.101 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.55 ' HG3' HG12 ' A' ' 50' ' ' ILE . 62.0 mm-40 -74.69 -37.49 62.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.27 -0.423 . . . . 0.77 111.351 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -71.51 -44.22 65.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.869 0.366 . . . . 1.23 110.516 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.99 5.13 35.64 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.819 -0.705 . . . . 0.54 112.071 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.568 HD11 ' HG2' ' A' ' 40' ' ' MET . 2.3 mt -90.68 160.15 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.912 0.387 . . . . 0.8 110.107 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.37 140.23 42.89 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.766 -0.652 . . . . 0.57 110.269 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.2 tp -58.52 -35.52 72.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.952 -0.567 . . . . 0.97 111.229 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -73.84 -14.57 61.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.186 0.517 . . . . 2.23 110.547 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -103.98 -6.3 21.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.762 -0.654 . . . . 2.24 110.801 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 17' ' ' MET . 46.5 tp -72.04 99.21 2.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.934 -0.575 . . . . 1.1 109.967 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.489 ' O ' HG21 ' A' ' 75' ' ' VAL . 80.2 p -117.63 158.85 23.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.014 -0.539 . . . . 0.6 109.71 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.692 ' OD1' ' HB2' ' A' ' 76' ' ' ARG . 6.9 t70 -54.22 -23.72 15.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.226 0.61 . . . . 2.29 112.57 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.48 -19.41 64.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.883 -0.599 . . . . 2.29 111.408 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.534 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 14.8 m -71.95 151.47 43.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.342 0.591 . . . . 1.06 110.84 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.774 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.6 t-20 -131.0 120.42 23.46 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.473 -0.566 . . . . 0.8 109.473 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.822 ' HD1' HG13 ' A' ' 42' ' ' ILE . 33.7 m-85 -51.36 -46.44 62.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.156 0.503 . . . . 0.47 111.219 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.39 -29.62 63.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.784 -0.644 . . . . 0.46 111.571 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.774 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 21.5 t70 -74.72 -31.17 61.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.43 0.633 . . . . 0.83 110.283 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.568 ' HG2' HD11 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -75.64 -23.12 56.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.602 -0.727 . . . . 2.48 110.453 178.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.32 27.93 7.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.325 -0.941 . . . . 0.44 112.026 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.822 HG13 ' HD1' ' A' ' 37' ' ' PHE . 28.6 mm -68.21 107.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 0.52 109.833 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.35 171.44 15.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.521 -0.763 . . . . 1.94 111.211 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.3 t -57.88 -32.69 67.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.721 -1.127 . . . . 1.03 111.167 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.2 tm? -64.25 -57.48 9.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.721 -0.672 . . . . 0.59 110.088 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.552 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.6 m -63.93 -40.84 97.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.979 -0.555 . . . . 1.22 111.585 -173.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.6 p -62.38 -30.14 70.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.211 -0.45 . . . . 0.81 111.447 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.7 ttt -79.15 -37.64 37.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.514 0.673 . . . . 2.25 109.775 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 52' ' ' SER . 78.0 t -69.39 -40.68 80.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.765 -1.107 . . . . 0.36 110.233 -175.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 46' ' ' SER . 73.2 mt -51.69 -54.11 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.881 0.372 . . . . 0.26 110.705 174.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -63.46 -26.22 69.38 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.974 -0.631 . . . . 0.29 112.247 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 10.3 m -70.99 -42.33 69.79 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 120.659 0.266 . . . . 0.92 110.715 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.473 ' HB2' HG11 ' A' ' 19' ' ' VAL . 10.0 mtp180 -64.95 -26.34 68.26 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.525 -0.307 . . . . 1.23 110.351 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.734 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 16.5 m-30 -56.31 -43.98 79.46 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.261 0.553 . . . . 0.28 109.58 173.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 61.7 mtp180 -79.32 -27.97 42.11 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.227 -0.897 . . . . 2.81 110.573 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -77.29 -62.82 1.53 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.82 -0.627 . . . . 2.26 112.023 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -88.54 -44.13 10.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 2.62 111.477 -169.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.56 -39.11 15.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.108 -0.497 . . . . 0.67 111.591 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.99 23.34 15.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.503 -0.856 . . . . 0.45 112.307 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.734 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 73.2 mt -80.81 113.18 18.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.726 -0.472 . . . . 0.63 109.726 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -97.87 87.39 3.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.45 0.643 . . . . 2.27 110.01 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.644 HD11 ' HD2' ' A' ' 54' ' ' PHE . 37.2 mt -87.88 -66.1 0.95 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.756 -1.111 . . . . 1.64 110.304 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.15 167.62 20.08 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.724 -0.95 . . . . 0.75 110.724 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -87.62 5.24 5.62 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 123.361 2.707 . . . . 1.13 112.96 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -107.19 -7.67 16.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.708 -0.678 . . . . 2.36 111.692 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -85.38 120.87 27.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.774 0.321 . . . . 0.73 111.428 -171.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -135.16 127.8 30.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 1.39 110.42 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 50' ' ' ILE . 68.2 mt -66.12 -11.02 46.24 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.223 0.453 . . . . 0.73 112.223 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -85.12 -11.33 55.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.125 0.488 . . . . 0.59 109.944 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.5 mt -127.52 -39.81 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.344 -0.389 . . . . 0.89 110.906 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -95.73 8.26 43.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.529 -0.305 . . . . 2.23 111.146 -173.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 89.6 m -157.59 159.56 37.2 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -132.67 -78.28 0.49 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.303 -0.408 . . . . 0.67 110.615 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 80.8 p -83.65 -169.72 2.7 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.26 -0.275 . . . . 0.38 110.596 177.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.6 OUTLIER -77.05 -41.84 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.568 -0.453 . . . . 0.68 110.095 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.692 ' HB2' ' OD1' ' A' ' 33' ' ' ASP . 24.6 ttm180 -59.87 -33.43 71.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.428 -0.351 . . . . 3.23 111.324 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.69 -29.86 28.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.498 0.499 . . . . 0.29 110.718 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.611 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.5 OUTLIER -85.39 -51.27 6.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.924 -0.58 . . . . 0.64 109.753 175.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HD3' HD11 ' A' ' 13' ' ' LEU . 10.5 mmtp -49.58 -59.25 3.94 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.069 -0.969 . . . . 2.4 111.298 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.45 -29.02 69.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.648 -1.16 . . . . 1.66 110.899 -173.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.9 -37.12 75.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.99 111.138 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.611 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 22.3 mtp . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.077 -0.51 . . . . 1.1 110.618 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.135 0 N-CA-C 111.945 -0.462 . . . . 0.53 111.945 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.91 157.21 10.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.8 0.333 . . . . 0.39 110.489 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.0 m -78.94 165.59 23.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.346 -0.388 . . . . 1.56 110.159 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -61.37 -31.44 71.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.821 0.819 . . . . 2.02 109.204 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.14 -45.94 83.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.381 -1.281 . . . . 1.91 110.788 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -72.87 -21.85 60.86 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.339 -0.846 . . . . 1.58 110.823 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 tp -73.22 -26.07 61.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.828 -0.623 . . . . 0.99 110.273 172.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -25.59 36.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.698 0.761 . . . . 0.88 109.796 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.75 -32.77 23.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.048 -0.978 . . . . 0.3 111.356 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.512 HG11 ' SD ' ' A' ' 82' ' ' MET . 2.9 p -67.28 -44.53 87.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 120.874 -0.33 . . . . 0.23 111.785 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.6 mtp -60.43 -27.82 67.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.204 -0.453 . . . . 1.63 111.931 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 24.4 ptt85 -79.85 -32.87 40.51 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.598 . . . . 3.17 111.459 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.35 -37.86 78.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.72 -0.844 . . . . 0.23 108.72 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.2 t -64.87 -39.16 84.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.793 -1.094 . . . . 0.33 109.977 174.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -69.16 -27.33 65.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.91 -0.586 . . . . 1.38 111.344 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 43.9 mt-10 -85.98 -30.27 22.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.018 0.437 . . . . 2.26 111.117 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.727 ' HG3' HG12 ' A' ' 50' ' ' ILE . 72.2 mm-40 -82.63 -45.49 14.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.859 -0.609 . . . . 0.77 112.031 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.507 ' HA ' HD11 ' A' ' 42' ' ' ILE . 73.4 p -72.13 -45.38 60.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.85 0.357 . . . . 1.23 111.248 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.72 2.2 43.09 Favored Glycine 0 C--O 1.23 -0.095 0 N-CA-C 111.104 -0.798 . . . . 0.54 111.104 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.755 HD11 ' HG3' ' A' ' 40' ' ' MET . 3.9 mt -93.7 104.98 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.297 -0.631 . . . . 0.8 109.297 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -42.21 143.75 0.56 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.841 0.713 . . . . 0.57 112.317 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.6 tp -54.44 -32.84 58.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.799 -0.637 . . . . 0.97 111.281 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -78.0 -10.51 59.63 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.889 0.376 . . . . 2.23 111.013 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -109.3 -6.54 15.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.187 -0.672 . . . . 2.24 109.187 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.519 HD11 HG11 ' A' ' 75' ' ' VAL . 41.3 tp -76.84 98.72 4.94 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.399 -0.819 . . . . 1.1 110.221 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.3 p -121.93 163.63 18.97 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.967 -1.015 . . . . 0.6 108.476 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.05 -3.75 14.39 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.782 0.29 . . . . 2.29 111.782 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -70.91 -23.44 62.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.373 -0.376 . . . . 2.29 110.595 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.463 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 21.3 m -75.65 149.8 38.1 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.527 0.68 . . . . 1.06 111.399 -174.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.773 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 16.8 t-20 -126.13 122.15 34.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.099 -0.955 . . . . 0.8 108.768 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.797 ' HD1' HG13 ' A' ' 42' ' ' ILE . 20.6 m-85 -55.34 -46.84 76.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.852 0.358 . . . . 0.47 111.18 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.31 -29.59 62.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.341 -0.391 . . . . 0.46 111.573 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.773 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 30.7 t70 -71.17 -35.58 71.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.537 0.684 . . . . 0.83 110.36 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.755 ' HG3' HD11 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -75.54 -24.53 56.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.35 -0.841 . . . . 2.48 109.663 -175.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.16 28.28 4.73 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.529 -0.843 . . . . 0.44 112.429 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.797 HG13 ' HD1' ' A' ' 37' ' ' PHE . 33.2 mm -74.34 107.94 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 0.52 110.571 176.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.77 170.97 15.75 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.512 -0.551 . . . . 1.94 109.512 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.3 p -55.33 -36.85 66.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.884 -0.598 . . . . 1.03 110.388 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -52.23 -59.05 4.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.32 -0.854 . . . . 0.59 110.539 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.574 ' O ' HG13 ' A' ' 50' ' ' ILE . 32.8 t -66.75 -43.26 84.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.14 -0.224 . . . . 1.22 111.134 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.538 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 87.7 p -60.35 -29.97 69.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.376 . . . . 0.81 111.254 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.8 tpp -75.81 -46.12 32.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.895 -0.593 . . . . 2.25 109.806 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.558 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 49.8 t -59.54 -45.46 93.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.958 -1.019 . . . . 0.36 110.616 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.727 HG12 ' HG3' ' A' ' 23' ' ' GLU . 55.8 mt -51.7 -52.8 19.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.904 0.383 . . . . 0.26 110.447 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -57.59 -37.24 81.94 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.712 -0.677 . . . . 0.29 112.551 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -66.46 -45.91 78.18 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.983 -0.377 . . . . 0.92 109.983 177.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 6.0 mtp180 -60.64 -27.07 67.51 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.567 -0.288 . . . . 1.23 111.061 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 12.5 m-30 -58.01 -41.07 82.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.205 0.526 . . . . 0.28 110.135 173.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.735 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 61.3 mtp180 -84.0 -32.11 25.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.833 -0.621 . . . . 2.81 111.205 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 52' ' ' SER . 20.0 mm-40 -82.9 -47.07 12.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.237 -0.438 . . . . 2.26 111.158 -174.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.09 -42.58 11.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 2.62 112.151 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.55 -32.76 12.1 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.695 0.257 . . . . 0.67 111.695 -174.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.96 33.41 8.99 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.746 -0.74 . . . . 0.45 112.574 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.735 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 87.7 mt -86.5 115.84 24.26 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 110.409 -0.219 . . . . 0.63 110.409 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -95.21 58.37 2.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.649 0.737 . . . . 2.27 109.589 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.86 -29.79 50.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.859 -1.064 . . . . 1.64 111.449 -175.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.28 169.9 12.59 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.734 -0.746 . . . . 0.75 112.394 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -89.36 -13.29 2.92 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.171 2.58 . . . . 1.13 112.671 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -82.81 -17.36 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.523 . . . . 2.36 112.239 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -82.3 114.27 20.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.173 0.511 . . . . 0.73 111.139 -173.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.9 m -128.93 125.3 37.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.911 -0.586 . . . . 1.39 109.94 176.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 68.2 mt -58.55 -40.0 81.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.327 -0.397 . . . . 0.73 111.691 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -60.8 -8.1 2.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.193 -0.458 . . . . 0.59 111.674 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.5 -40.19 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.939 -0.475 . . . . 0.89 111.47 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -109.77 -1.91 17.65 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.56 0.578 . . . . 2.23 112.56 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.8 m -142.38 97.83 3.19 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.488 -0.757 . . . . 1.0 110.281 -175.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.6 p -89.58 -30.27 18.3 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.638 -0.71 . . . . 0.67 111.034 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -114.46 -176.51 2.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.135 -0.484 . . . . 0.38 110.468 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.519 HG11 HD11 ' A' ' 31' ' ' LEU . 1.5 t -81.61 -43.3 19.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.998 0.428 . . . . 0.68 110.437 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.61 ' HA ' ' CG ' ' A' ' 79' ' ' LYS . 29.3 ttm180 -64.97 -28.41 69.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.106 -0.497 . . . . 3.23 111.002 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.5 -31.21 55.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 0.29 110.749 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.8 OUTLIER -75.7 -47.89 24.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.304 -0.628 . . . . 0.64 109.304 176.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.61 ' CG ' ' HA ' ' A' ' 76' ' ' ARG . 26.8 mmtp -46.97 -50.01 19.77 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.96 -1.018 . . . . 2.4 110.59 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -54.36 -55.33 29.66 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.301 -0.863 . . . . 1.66 111.709 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -56.29 -37.62 70.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.479 -0.782 . . . . 0.99 112.245 -173.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 24.8 mtp . . . . . 0 C--N 1.324 -0.506 0 CA-C-O 120.871 0.367 . . . . 1.1 111.439 -174.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 111.339 -0.704 . . . . 0.53 111.339 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 3.9 m -112.21 158.96 12.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.159 -0.312 . . . . 0.39 110.159 -177.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.1 p -87.11 -178.59 6.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.204 -0.453 . . . . 1.56 110.5 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -68.43 -30.34 69.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.295 -0.631 . . . . 2.02 109.295 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.4 -41.0 96.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.322 -0.854 . . . . 1.91 110.408 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.469 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 58.1 mttt -74.3 -26.64 60.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.842 -0.617 . . . . 1.58 111.002 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.23 -23.2 54.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.008 -0.542 . . . . 0.99 110.057 173.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.3 -27.11 42.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.5 0.667 . . . . 0.88 109.694 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -83.9 -26.76 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.054 -0.975 . . . . 0.3 111.66 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 p -71.83 -44.56 67.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 111.782 0.29 . . . . 0.23 111.782 -178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.524 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 73.8 mtp -60.44 -34.37 73.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.486 -0.325 . . . . 1.63 111.42 -175.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 12.3 ptt180 -69.64 -29.47 66.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.707 0.289 . . . . 3.17 110.688 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.37 -39.33 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.01 -0.737 . . . . 0.23 109.01 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.86 -49.05 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.838 -1.074 . . . . 0.33 110.06 176.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.499 ' OG ' HD22 ' A' ' 31' ' ' LEU . 25.7 m -54.96 -47.19 74.84 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 112.401 0.519 . . . . 1.38 112.401 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -57.33 -46.43 83.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.055 0.391 . . . . 2.26 112.055 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HB3' ' OG ' ' A' ' 46' ' ' SER . 75.4 mm-40 -79.75 -33.51 40.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.292 -0.413 . . . . 0.77 111.882 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.451 ' HB3' HD11 ' A' ' 42' ' ' ILE . 76.7 p -80.72 -42.8 21.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 1.23 111.525 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.32 12.92 34.59 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.982 -0.628 . . . . 0.54 111.978 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mt -102.88 125.89 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 122.802 -0.234 . . . . 0.8 110.544 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.45 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -56.3 145.11 27.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.394 -0.367 . . . . 0.57 110.788 175.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.76 -43.9 38.23 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.579 0.549 . . . . 0.97 110.404 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -76.41 -10.66 59.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.963 -0.562 . . . . 2.23 111.286 -173.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.45 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 34.1 mm-40 -107.93 -10.59 15.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.987 -0.745 . . . . 2.24 108.987 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.499 HD22 ' OG ' ' A' ' 21' ' ' SER . 17.8 tp -79.49 97.47 6.43 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.347 -0.842 . . . . 1.1 109.18 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.2 p -116.73 162.38 17.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.322 -0.854 . . . . 0.6 108.855 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.834 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 45.5 m-20 -74.59 -3.54 31.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.782 0.325 . . . . 2.29 111.059 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.29 -20.22 44.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.705 -0.679 . . . . 2.29 110.528 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB2' HG21 ' A' ' 75' ' ' VAL . 43.6 m -70.88 157.32 38.34 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.749 0.785 . . . . 1.06 111.275 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.673 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.1 t-20 -124.43 126.16 45.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.86 -1.064 . . . . 0.8 108.682 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.516 ' HD1' HG13 ' A' ' 42' ' ' ILE . 26.1 m-85 -57.08 -52.78 63.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.116 0.484 . . . . 0.47 111.308 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.07 -22.87 63.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.053 -0.521 . . . . 0.46 111.254 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.6 t70 -83.54 -16.0 47.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.83 110.538 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 65.9 mmm -101.46 1.49 38.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 2.48 111.706 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.53 26.22 23.56 Favored Glycine 0 C--O 1.23 -0.152 0 C-N-CA 119.79 -1.195 . . . . 0.44 112.767 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.516 HG13 ' HD1' ' A' ' 37' ' ' PHE . 18.3 mm -72.01 107.7 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.195 0.521 . . . . 0.52 110.018 175.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.8 159.78 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.291 -0.868 . . . . 1.94 110.194 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 69' ' ' PHE . 1.4 t -55.07 -39.62 69.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.433 0.635 . . . . 1.03 109.704 171.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.0 tm? -56.96 -53.09 61.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.315 -0.857 . . . . 0.59 109.827 175.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.575 ' O ' HG13 ' A' ' 50' ' ' ILE . 32.4 t -67.91 -42.76 80.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.758 -0.201 . . . . 1.22 111.52 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 33.0 p -60.73 -34.25 74.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.005 0.431 . . . . 0.81 111.151 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 30.2 ttp -72.69 -36.7 67.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.738 -0.664 . . . . 2.25 109.563 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 45' ' ' LEU . 42.6 t -70.34 -41.2 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.325 -0.852 . . . . 0.36 110.256 -177.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 46' ' ' SER . 59.0 mt -55.14 -55.63 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.742 0.306 . . . . 0.26 110.431 176.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.74 -28.96 72.5 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.11 -0.566 . . . . 0.29 112.031 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.26 -42.66 75.28 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.717 0.294 . . . . 0.92 110.689 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.76 ' HA ' ' HB3' ' A' ' 56' ' ' GLU . 28.9 mtp180 -69.01 -22.53 64.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 121.0 -0.28 . . . . 1.23 110.592 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.577 ' HE2' HD21 ' A' ' 78' ' ' LEU . 13.8 m-30 -57.46 -41.89 81.44 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.246 -0.649 . . . . 0.28 109.246 172.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.67 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 35.8 mtp180 -81.19 -25.67 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.552 -0.749 . . . . 2.81 110.665 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.76 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 29.9 tt0 -77.68 -62.77 1.56 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.754 -0.657 . . . . 2.26 111.687 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -87.21 -41.56 13.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.969 -0.56 . . . . 2.62 111.415 -172.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.99 -40.67 11.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.182 -0.463 . . . . 0.67 111.33 -174.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.59 28.26 9.77 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.019 -0.61 . . . . 0.45 112.047 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.67 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 51.2 mt -80.8 107.41 13.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.297 -0.26 . . . . 0.63 110.297 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.55 78.78 9.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.186 0.993 . . . . 2.27 110.196 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.495 HD11 ' HD2' ' A' ' 54' ' ' PHE . 13.8 mt -83.1 -72.98 0.43 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.422 -1.263 . . . . 1.64 110.932 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.13 156.23 16.16 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.733 -0.947 . . . . 0.75 110.733 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.446 ' HG2' ' OE2' ' A' ' 65' ' ' GLU . 58.9 Cg_endo -78.37 -26.75 5.85 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.351 2.034 . . . . 1.13 113.613 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.446 ' OE2' ' HG2' ' A' ' 64' ' ' PRO . 37.4 mp0 -98.7 26.42 5.65 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 122.082 -0.386 . . . . 2.36 111.178 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -92.12 112.54 24.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.46 -0.336 . . . . 0.73 110.439 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.5 t -132.46 123.87 27.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.968 0.414 . . . . 1.39 110.199 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.507 HD12 HD12 ' A' ' 50' ' ' ILE . 70.2 mt -61.47 -16.45 47.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.089 -0.505 . . . . 0.73 111.546 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.474 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 8.9 t80 -73.82 -15.05 61.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.186 -0.461 . . . . 0.59 110.76 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.0 mt -130.04 -35.82 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.197 -0.456 . . . . 0.89 110.965 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -91.97 6.8 44.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.484 -0.325 . . . . 2.23 111.871 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.75 162.78 37.14 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -175.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.0 p -134.92 -72.65 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.306 -0.406 . . . . 0.67 111.209 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 71.8 p -84.88 -179.46 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.999 -0.371 . . . . 0.38 109.999 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -79.68 -39.92 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 108.865 -0.791 . . . . 0.68 108.865 -176.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.834 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 13.6 tpt180 -60.38 -30.23 69.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.476 -1.238 . . . . 3.23 111.188 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.03 -33.63 73.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.433 -0.348 . . . . 0.29 110.491 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.658 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.0 OUTLIER -71.93 -51.18 23.37 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.81 -0.811 . . . . 0.64 108.81 176.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.524 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 27.9 mmtp -48.09 -57.57 5.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.51 -1.223 . . . . 2.4 111.833 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -60.52 -37.27 80.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.572 -0.74 . . . . 1.66 111.506 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -62.64 -38.24 89.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.941 -0.572 . . . . 0.99 111.125 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.658 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 30.0 mtp . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 1.1 111.519 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 110.749 -0.941 . . . . 0.53 110.749 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.99 158.93 9.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.817 0.341 . . . . 0.39 110.562 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.3 t -85.79 179.2 7.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.783 -0.451 . . . . 1.56 109.783 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.81 -20.71 65.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.535 0.683 . . . . 2.02 109.643 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.9 -50.87 71.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.987 -1.006 . . . . 1.91 110.689 175.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.489 ' HG2' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -70.54 -23.85 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.054 -0.721 . . . . 1.58 109.054 -177.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.457 ' O ' ' HG3' ' A' ' 17' ' ' MET . 2.2 tp -69.49 -27.14 64.94 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.724 -0.671 . . . . 0.99 110.403 174.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.7 -28.57 33.4 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.591 0.71 . . . . 0.88 109.986 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.51 -31.76 37.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.23 -0.895 . . . . 0.3 111.013 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.553 HG23 ' CZ ' ' A' ' 54' ' ' PHE . 4.5 p -69.61 -46.99 73.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.275 -0.421 . . . . 0.23 111.617 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.712 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 65.8 mtm -61.9 -28.88 69.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.426 -0.352 . . . . 1.63 111.725 -172.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -81.61 -22.44 37.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.37 -0.377 . . . . 3.17 111.25 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.0 t -82.42 -35.22 12.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.758 -0.83 . . . . 0.23 108.758 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.4 t -64.89 -36.21 77.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.574 -1.194 . . . . 0.33 110.09 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -59.7 -53.03 62.72 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.051 0.453 . . . . 1.38 110.663 -176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -54.76 -55.61 28.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.165 -0.925 . . . . 2.26 112.324 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -77.42 -22.84 50.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.341 0.497 . . . . 0.77 112.341 -170.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.401 ' HA ' HD11 ' A' ' 42' ' ' ILE . 20.1 m -85.96 -31.41 22.11 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.553 -0.459 . . . . 1.23 110.006 175.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.13 -2.92 44.02 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.745 -0.741 . . . . 0.54 112.844 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mt -101.48 153.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.833 0.349 . . . . 0.8 110.603 -175.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.5 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -66.77 145.34 55.62 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.855 -0.612 . . . . 0.57 110.646 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.2 tp -60.87 -36.39 79.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.996 0.427 . . . . 0.97 110.422 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -72.58 -10.92 60.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 2.23 110.963 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.5 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 19.2 mt-10 -115.55 6.32 14.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.727 -0.669 . . . . 2.24 110.793 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.429 HD11 HG11 ' A' ' 75' ' ' VAL . 44.6 tp -75.48 97.78 3.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.31 0.576 . . . . 1.1 109.501 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.459 ' O ' HG21 ' A' ' 75' ' ' VAL . 59.4 p -101.11 156.85 17.18 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.203 -0.908 . . . . 0.6 110.363 -175.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.694 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 16.5 p-10 -81.56 -4.61 56.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.279 0.562 . . . . 2.29 110.027 177.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.14 -22.85 60.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.891 -1.05 . . . . 2.29 110.841 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.438 ' HB2' HG21 ' A' ' 75' ' ' VAL . 39.8 m -77.43 155.4 31.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.957 0.884 . . . . 1.06 111.568 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.931 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.4 t-20 -127.05 123.76 37.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.455 -1.313 . . . . 0.8 107.455 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.649 ' HD1' HG13 ' A' ' 42' ' ' ILE . 11.6 m-85 -56.8 -54.76 42.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.855 -0.338 . . . . 0.47 111.443 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.19 62.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.86 0.362 . . . . 0.46 111.006 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.931 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 22.8 t70 -74.04 -29.12 61.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.495 . . . . 0.83 110.815 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.1 mmt -83.04 -15.03 52.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.618 . . . . 2.48 111.228 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.11 14.86 15.66 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.158 -1.02 . . . . 0.44 112.258 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.649 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.0 mm -67.59 106.8 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.947 -0.76 . . . . 0.52 108.947 174.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.91 177.52 8.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.473 -0.785 . . . . 1.94 111.225 -177.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 t -58.59 -31.88 68.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.193 -0.912 . . . . 1.03 109.766 175.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.43 -62.93 1.51 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.985 -1.007 . . . . 0.59 110.86 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.567 ' O ' HG13 ' A' ' 50' ' ' ILE . 15.2 m -68.64 -39.34 80.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.448 -0.342 . . . . 1.22 111.519 -173.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 47.0 p -65.6 -21.93 66.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.814 0.34 . . . . 0.81 111.255 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.39 -43.73 20.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.101 -0.703 . . . . 2.25 109.101 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.7 t -62.76 -48.02 90.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.048 -0.978 . . . . 0.36 110.84 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 46' ' ' SER . 77.1 mt -51.32 -56.6 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.317 -0.401 . . . . 0.26 111.473 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.85 -30.65 78.31 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.611 -0.805 . . . . 0.29 112.459 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -39.52 89.5 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.04 -0.264 . . . . 0.92 110.451 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 25.6 mtp180 -65.19 -23.96 67.24 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.488 0.185 . . . . 1.23 110.882 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.628 ' HD2' HD11 ' A' ' 62' ' ' LEU . 11.8 m-30 -58.51 -38.69 78.23 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.482 0.658 . . . . 0.28 109.501 175.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -79.07 -24.67 43.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.174 -0.921 . . . . 2.81 110.95 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -78.56 -62.07 1.81 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.996 -0.547 . . . . 2.26 111.412 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -87.82 -53.57 4.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.023 -0.535 . . . . 2.62 111.639 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 mp -72.81 -27.59 62.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.963 -0.562 . . . . 0.67 111.289 -171.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.65 31.1 57.02 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.623 -0.798 . . . . 0.45 111.708 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 54' ' ' PHE . 81.8 mt -82.05 114.55 20.68 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 110.292 -0.262 . . . . 0.63 110.292 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -88.89 75.85 8.0 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.252 -0.647 . . . . 2.27 109.252 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.628 HD11 ' HD2' ' A' ' 54' ' ' PHE . 37.1 mt -82.4 -65.47 1.01 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.165 -0.925 . . . . 1.64 109.998 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.24 165.71 23.0 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 114.647 -1.16 . . . . 0.75 110.75 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.94 -8.3 10.09 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.02 2.48 . . . . 1.13 113.075 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -117.56 20.64 13.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.468 0.652 . . . . 2.36 110.709 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.411 ' HE1' ' CE2' ' A' ' 81' ' ' PHE . 83.6 t80 -77.87 111.81 14.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.074 -0.512 . . . . 0.73 109.916 -177.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.1 m -123.16 118.17 27.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.626 -0.715 . . . . 1.39 110.739 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 42.6 mt -63.26 -33.31 75.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 0.73 110.489 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.483 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 37.1 t80 -59.6 -16.65 27.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.618 -0.719 . . . . 0.59 111.151 -175.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.7 mt -121.76 -40.14 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 121.044 -0.262 . . . . 0.89 111.515 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.51 6.84 32.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.933 -0.707 . . . . 2.23 112.526 -173.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 82.1 m -150.2 86.65 1.43 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.251 0.548 . . . . 1.0 109.639 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.1 p -78.25 -59.01 2.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.591 -0.731 . . . . 0.67 110.927 -172.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 82.3 p -86.9 -178.92 6.42 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.852 -0.425 . . . . 0.38 109.852 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -81.59 -42.54 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.306 0.574 . . . . 0.68 109.89 -179.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.694 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 4.9 tpp180 -60.13 -29.06 68.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.361 -0.836 . . . . 3.23 110.613 176.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -59.59 -35.72 74.85 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.532 -0.304 . . . . 0.29 110.951 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.554 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -72.58 -45.3 59.82 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.192 -0.67 . . . . 0.64 109.192 177.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.712 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.8 mmtp -51.19 -61.3 2.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.853 -1.067 . . . . 2.4 111.048 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.95 -24.42 65.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.766 -0.652 . . . . 1.66 111.79 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 46.5 t80 -64.82 -37.15 86.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.009 0.433 . . . . 0.99 110.262 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 12.8 mtp . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.633 -0.712 . . . . 1.1 111.463 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 N-CA-C 111.465 -0.654 . . . . 0.53 111.465 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 4.0 m -110.57 160.49 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.741 0.305 . . . . 0.39 110.699 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -82.61 174.39 11.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.405 -0.591 . . . . 1.56 109.405 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -66.9 -35.71 80.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.409 0.623 . . . . 2.02 109.74 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -56.93 -41.4 78.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.014 -0.994 . . . . 1.91 111.202 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.587 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 47.5 mmtm -68.02 -24.72 65.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.697 -0.683 . . . . 1.58 110.53 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 17' ' ' MET . 24.9 tp -70.72 -26.76 63.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.136 -0.484 . . . . 0.99 111.146 173.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.94 -30.79 50.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.659 0.742 . . . . 0.88 109.3 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.596 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -75.83 -33.44 60.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.071 -0.968 . . . . 0.3 110.405 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 13' ' ' LEU . 3.0 p -71.48 -45.46 68.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.318 -0.401 . . . . 0.23 111.716 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 63.7 mtt -59.54 -33.95 72.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.69 -0.232 . . . . 1.63 110.948 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 39.3 ptt180 -73.25 -30.35 63.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.046 -0.262 . . . . 3.17 111.216 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -77.46 -34.17 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.739 -0.837 . . . . 0.23 108.739 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 t -66.55 -40.96 87.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.681 -1.145 . . . . 0.33 109.304 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.8 t -61.76 -23.48 66.2 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.318 -0.401 . . . . 1.38 111.021 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.51 -49.69 10.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.203 0.525 . . . . 2.26 111.165 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -84.85 -31.39 23.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.439 -0.801 . . . . 0.77 112.372 -169.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.4 p -79.12 -35.43 42.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 1.23 111.129 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.75 13.8 56.17 Favored Glycine 0 C--O 1.234 0.106 0 C-N-CA 120.404 -0.903 . . . . 0.54 111.336 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mt -105.08 111.73 35.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.494 -0.558 . . . . 0.8 109.494 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.19 145.37 13.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 0.57 111.256 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.5 tp -52.96 -34.61 56.56 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.912 -0.585 . . . . 0.97 110.919 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.43 -19.46 61.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.865 -0.607 . . . . 2.23 111.579 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.34 -1.38 21.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.927 -0.398 . . . . 2.24 109.927 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -73.93 97.91 2.91 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.577 0.703 . . . . 1.1 109.493 -177.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.2 p -106.59 151.22 25.33 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.272 -0.876 . . . . 0.6 109.097 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.831 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 27.1 m-20 -81.21 -3.19 51.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.84 0.352 . . . . 2.29 111.515 -174.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -93.62 -3.95 51.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.258 -0.428 . . . . 2.29 110.636 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.446 ' HB2' HG21 ' A' ' 75' ' ' VAL . 55.3 m -73.69 158.63 34.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.394 0.616 . . . . 1.06 110.022 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.823 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.0 t-20 -125.82 124.95 42.07 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.538 -0.755 . . . . 0.8 109.465 -176.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.732 ' HD1' HG13 ' A' ' 42' ' ' ILE . 35.5 m-85 -55.65 -50.19 70.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.891 0.376 . . . . 0.47 111.181 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.07 70.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.015 0.436 . . . . 0.46 111.221 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.823 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 32.8 t70 -72.68 -27.18 61.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.113 0.483 . . . . 0.83 110.598 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.9 mmt -86.46 -12.28 49.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 2.48 111.423 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.44 23.17 9.73 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.317 -0.944 . . . . 0.44 112.784 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.732 HG13 ' HD1' ' A' ' 37' ' ' PHE . 24.5 mm -72.39 106.91 2.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.267 0.556 . . . . 0.52 110.217 176.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -91.11 -178.66 5.23 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.648 -0.706 . . . . 1.94 111.139 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.6 t -54.61 -49.03 71.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.278 -0.873 . . . . 1.03 110.796 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.3 tm? -50.32 -58.42 5.7 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.719 -0.673 . . . . 0.59 110.883 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.467 ' O ' HG13 ' A' ' 50' ' ' ILE . 22.6 t -66.78 -46.34 75.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.854 0.359 . . . . 1.22 111.442 -174.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 59.0 p -65.16 -30.66 71.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.427 -0.352 . . . . 0.81 111.73 -176.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.6 tpt -74.73 -41.69 59.68 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.055 -0.72 . . . . 2.25 109.055 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 31.8 t -57.48 -53.1 48.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.278 -0.874 . . . . 0.36 110.503 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 46' ' ' SER . 68.9 mt -49.08 -53.9 6.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 O-C-N 123.131 0.27 . . . . 0.26 111.264 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.37 -34.99 83.15 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.81 -0.71 . . . . 0.29 112.485 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -68.52 -41.92 79.25 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.91 -0.316 . . . . 0.92 110.222 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 1.8 mtp180 -68.54 -20.57 64.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.67 -0.241 . . . . 1.23 110.711 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.597 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.7 m-30 -59.92 -39.83 86.78 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.646 0.736 . . . . 0.28 109.658 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.685 ' HD2' ' O ' ' A' ' 60' ' ' LEU . 9.8 mmm180 -73.76 -28.64 61.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.887 -1.051 . . . . 2.81 110.298 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -81.53 -64.09 1.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.078 -0.51 . . . . 2.26 112.096 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -83.78 -34.62 24.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.977 -0.556 . . . . 2.62 111.392 -169.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.3 mp -97.22 -39.71 9.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.051 -0.522 . . . . 0.67 110.817 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.38 36.2 8.97 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.534 -0.841 . . . . 0.45 111.802 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.685 ' O ' ' HD2' ' A' ' 55' ' ' ARG . 93.4 mt -78.79 133.5 37.06 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.67 -0.122 . . . . 0.63 110.67 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.62 77.71 9.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.212 0.529 . . . . 2.27 110.732 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.597 HD11 ' HD2' ' A' ' 54' ' ' PHE . 55.1 mt -94.66 -60.54 1.68 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.609 0.719 . . . . 1.64 109.694 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.41 176.75 24.53 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 109.916 -1.274 . . . . 0.75 109.916 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.77 -23.03 7.23 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.994 1.796 . . . . 1.13 112.608 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -119.71 70.23 0.85 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.716 0.769 . . . . 2.36 110.695 -175.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -109.92 111.46 22.89 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.282 -0.872 . . . . 0.73 109.487 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.2 m -121.18 118.4 29.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.198 -0.455 . . . . 1.39 110.51 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 59.8 mt -64.58 -25.19 67.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.376 . . . . 0.73 111.047 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.562 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.9 t80 -72.16 -4.4 28.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.841 -0.618 . . . . 0.59 110.353 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.94 -42.59 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.28 -0.418 . . . . 0.89 110.947 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.46 8.87 33.66 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.365 0.505 . . . . 2.23 112.365 -169.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 89.2 m -152.5 159.23 43.34 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.044 -0.41 . . . . 1.0 110.089 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.9 p -134.25 -70.61 0.51 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.405 -0.362 . . . . 0.67 110.962 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 77.6 p -83.26 -177.65 6.82 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.242 -0.286 . . . . 0.38 110.318 175.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.525 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -83.25 -41.58 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.635 0 N-CA-C 108.637 -0.875 . . . . 0.68 108.637 -176.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.831 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 7.7 tpt180 -59.26 -29.62 67.7 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 113.743 -1.572 . . . . 3.23 110.91 175.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.26 68.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.786 0.326 . . . . 0.29 110.826 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.47 -43.07 41.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.972 0.892 . . . . 0.64 109.151 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.53 ' HG3' ' HA ' ' A' ' 76' ' ' ARG . 24.9 mmtm -60.01 -51.54 69.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.152 -1.386 . . . . 2.4 109.83 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.81 -29.75 70.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.714 -1.13 . . . . 1.66 111.162 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -72.96 -39.13 66.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.864 -0.607 . . . . 0.99 110.767 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.595 -0.729 . . . . 1.1 112.349 -174.588 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.708 0 N-CA-C 111.172 -0.771 . . . . 0.53 111.172 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.713 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 2.7 m -114.26 156.28 15.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.855 0.359 . . . . 0.39 110.344 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.6 t -95.41 -176.52 3.8 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.12 -0.491 . . . . 1.56 109.728 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -62.65 -26.17 68.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.052 0.453 . . . . 2.02 109.969 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.48 -55.17 37.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.736 -0.666 . . . . 1.91 110.937 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.713 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 88.0 mttt -75.32 -19.8 59.43 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.31 -0.404 . . . . 1.58 110.468 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.601 HD11 ' HD2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -73.76 -31.14 63.17 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.022 -0.535 . . . . 0.99 110.183 172.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.16 -29.39 43.02 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.232 -0.918 . . . . 0.88 109.585 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -79.54 -25.7 41.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.936 -1.029 . . . . 0.3 111.021 -175.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.7 p -77.68 -43.76 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.557 -0.292 . . . . 0.23 111.32 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.555 ' HB3' HD23 ' A' ' 31' ' ' LEU . 66.9 mtm -63.35 -28.99 70.38 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.983 -0.287 . . . . 1.63 111.006 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 20.0 ptt180 -74.45 -33.62 62.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.86 -0.336 . . . . 3.17 110.62 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.12 -38.32 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.624 0.726 . . . . 0.23 109.143 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.3 t -61.87 -42.1 93.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.614 -1.175 . . . . 0.33 110.982 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.0 m -71.55 -41.36 69.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.286 0.565 . . . . 1.38 110.259 -171.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.06 -46.61 82.34 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.987 -1.006 . . . . 2.26 111.663 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.44 -31.46 48.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.459 -0.337 . . . . 0.77 111.502 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.414 ' HA ' HD11 ' A' ' 42' ' ' ILE . 53.1 m -77.85 -35.87 50.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.844 0.354 . . . . 1.23 111.175 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.72 0.72 36.79 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.793 -0.718 . . . . 0.54 112.494 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.853 HD11 ' SD ' ' A' ' 40' ' ' MET . 5.7 mt -92.81 161.18 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.286 0.565 . . . . 0.8 110.6 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -87.16 143.13 27.44 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.134 -0.939 . . . . 0.57 109.264 171.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.0 tp -56.18 -29.17 60.47 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.278 0.362 . . . . 0.97 111.56 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -69.32 -15.21 63.28 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.34 -0.391 . . . . 2.23 111.944 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -114.07 3.71 15.38 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.121 -0.231 . . . . 2.24 111.334 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.555 HD23 ' HB3' ' A' ' 17' ' ' MET . 39.1 tp -78.73 99.09 6.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.332 0.587 . . . . 1.1 110.335 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.1 p -120.06 163.28 17.89 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.007 -0.738 . . . . 0.6 109.007 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.643 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.8 p-10 -70.91 -3.0 16.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.158 0.429 . . . . 2.29 112.158 -177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.41 -22.97 61.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.983 0.42 . . . . 2.29 110.878 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.472 ' HB3' ' CG2' ' A' ' 75' ' ' VAL . 33.7 t -76.14 158.78 31.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.422 0.63 . . . . 1.06 111.742 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.2 t-20 -127.16 119.42 26.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.363 -0.835 . . . . 0.8 109.277 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.775 ' HD1' HG13 ' A' ' 42' ' ' ILE . 38.5 m-85 -50.84 -49.6 58.49 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.123 0.487 . . . . 0.47 111.291 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.8 -32.77 74.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.798 -0.637 . . . . 0.46 111.28 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 34.2 t70 -73.51 -26.99 61.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.157 0.503 . . . . 0.83 110.541 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.853 ' SD ' HD11 ' A' ' 26' ' ' ILE . 65.3 mtm -79.7 -24.1 41.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.805 -0.634 . . . . 2.48 110.183 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.08 26.44 6.66 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.426 -0.892 . . . . 0.44 112.584 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.775 HG13 ' HD1' ' A' ' 37' ' ' PHE . 26.9 mm -65.14 108.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.604 -0.517 . . . . 0.52 109.604 175.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -82.34 176.49 9.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.581 -0.736 . . . . 1.94 110.435 -175.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.0 t -61.02 -40.25 92.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.805 -0.634 . . . . 1.03 109.865 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.27 -56.71 17.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.522 -0.763 . . . . 0.59 110.002 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.5 m -59.78 -44.22 94.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.09 -0.504 . . . . 1.22 111.206 -177.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.577 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 50.2 m -58.72 -39.29 80.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.744 -0.662 . . . . 0.81 111.606 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.4 tpt -72.66 -37.5 67.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.374 0.606 . . . . 2.25 110.13 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.606 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.0 t -62.83 -53.84 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.14 -0.936 . . . . 0.36 109.871 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 46' ' ' SER . 66.5 mt -49.97 -52.4 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.281 -0.418 . . . . 0.26 111.281 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.09 -36.97 93.15 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.871 -0.681 . . . . 0.29 112.518 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t -63.66 -44.2 94.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.715 0.293 . . . . 0.92 110.467 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 11.7 mtp180 -65.87 -27.05 67.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.394 -0.366 . . . . 1.23 110.65 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.454 ' HB3' HD12 ' A' ' 60' ' ' LEU . 13.4 m-30 -57.31 -40.66 78.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.36 0.6 . . . . 0.28 110.032 175.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 47.5 mtp180 -78.62 -27.82 45.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.732 -0.667 . . . . 2.81 111.002 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.74 -56.73 4.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.217 -0.447 . . . . 2.26 111.474 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -88.14 -36.46 16.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.235 -0.439 . . . . 2.62 112.005 -172.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 58' ' ' LEU . 8.3 mp -99.76 -25.08 14.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.892 0.33 . . . . 0.67 111.892 -172.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.26 41.62 37.75 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.514 -0.85 . . . . 0.45 111.699 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 54' ' ' PHE . 19.1 mt -83.65 136.73 34.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.986 0.365 . . . . 0.63 111.986 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -93.4 88.38 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 2.27 110.208 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.495 HD11 ' HE2' ' A' ' 81' ' ' PHE . 0.7 OUTLIER -112.89 -61.05 1.79 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.135 -0.484 . . . . 1.64 109.92 178.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.58 170.72 12.45 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.811 -0.709 . . . . 0.75 112.155 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.57 10.43 3.71 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.995 2.463 . . . . 1.13 111.937 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.21 9.97 12.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.161 -0.927 . . . . 2.36 110.751 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -95.47 116.21 28.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.993 -0.548 . . . . 0.73 110.678 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.0 m -136.81 122.45 19.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.024 -0.535 . . . . 1.39 110.255 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.412 HD12 HD12 ' A' ' 50' ' ' ILE . 57.2 mt -56.85 -41.82 78.6 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.953 -0.567 . . . . 0.73 111.98 -176.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.577 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.4 t80 -55.67 -14.18 2.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.888 -0.596 . . . . 0.59 112.223 -174.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.51 -40.7 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.095 -0.378 . . . . 0.89 111.112 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -106.05 7.84 32.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.059 0.392 . . . . 2.23 112.059 -169.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 92.3 m -148.91 136.63 20.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.342 0.591 . . . . 1.0 109.863 -176.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.2 p -114.24 -76.15 0.58 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.038 -0.528 . . . . 0.67 111.071 -173.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 77.7 p -83.19 -172.8 4.34 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.12 -0.362 . . . . 0.38 110.449 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.524 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -81.36 -40.87 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.03 -0.729 . . . . 0.68 109.03 -175.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.643 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -66.98 -24.89 66.09 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.897 -1.047 . . . . 3.23 110.397 179.323 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.0 -34.41 71.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.444 -0.344 . . . . 0.29 110.462 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.66 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -71.22 -48.05 53.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.745 -0.835 . . . . 0.64 108.745 177.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HD2' HD11 ' A' ' 13' ' ' LEU . 30.0 mmtm -54.04 -50.09 67.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.964 -1.471 . . . . 2.4 111.164 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.12 -44.99 92.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 1.66 110.627 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.495 ' HE2' HD11 ' A' ' 62' ' ' LEU . 34.2 t80 -63.39 -30.07 71.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.043 -0.98 . . . . 0.99 111.162 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.66 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 32.8 mtp . . . . . 0 N--CA 1.462 0.175 0 CA-C-N 116.177 -0.465 . . . . 1.1 110.707 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 111.744 -0.543 . . . . 0.53 111.744 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.45 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 4.0 m -114.43 162.11 12.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.324 -0.25 . . . . 0.39 110.324 -175.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 p -84.25 174.09 10.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.153 -0.314 . . . . 1.56 110.153 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -73.38 -19.46 60.99 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.197 -0.668 . . . . 2.02 109.197 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.59 -42.11 95.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.094 -0.957 . . . . 1.91 109.398 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.45 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 43.8 mmtm -67.36 -36.26 81.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.364 -0.835 . . . . 1.58 110.219 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -62.98 -29.44 70.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.941 -0.572 . . . . 0.99 110.678 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.38 -28.6 52.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.598 0.713 . . . . 0.88 109.682 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.52 -34.24 31.34 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.098 -0.956 . . . . 0.3 111.124 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.508 HG23 ' CE1' ' A' ' 54' ' ' PHE . 5.7 p -68.55 -45.99 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.654 0.613 . . . . 0.23 112.654 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 58.4 mtm -56.35 -34.95 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.943 0.349 . . . . 1.63 111.943 -172.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -78.69 -22.97 45.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.34 -0.544 . . . . 3.17 111.673 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.58 -34.88 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 122.05 0.929 . . . . 0.23 108.551 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 t -69.11 -36.84 75.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.184 -1.371 . . . . 0.33 110.469 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.4 t -68.91 -22.62 64.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.787 0.327 . . . . 1.38 110.765 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -86.23 -48.96 8.08 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.976 0.417 . . . . 2.26 111.919 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -79.5 -9.92 59.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.475 . . . . 0.77 112.1 -172.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -99.91 -42.8 6.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.989 0.423 . . . . 1.23 111.309 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.07 7.03 50.93 Favored Glycine 0 C--O 1.235 0.19 0 C-N-CA 120.711 -0.757 . . . . 0.54 111.261 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.564 HD11 ' HG3' ' A' ' 40' ' ' MET . 4.9 mt -93.14 111.91 25.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.307 -0.627 . . . . 0.8 109.307 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -48.4 144.63 3.92 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.456 0.473 . . . . 0.57 111.229 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.2 tp -55.23 -29.3 57.72 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.141 -0.481 . . . . 0.97 111.6 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -83.8 -10.25 58.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 2.23 111.039 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.435 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 33.2 mt-10 -105.57 -9.46 17.4 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.728 -0.842 . . . . 2.24 108.728 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.565 HD11 HG11 ' A' ' 75' ' ' VAL . 36.7 tp -72.76 98.28 2.37 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.812 -1.085 . . . . 1.1 109.649 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.6 p -115.79 158.89 22.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.147 -1.057 . . . . 0.6 108.147 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.886 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 17.4 p-10 -75.6 -2.41 29.1 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.931 -0.308 . . . . 2.29 110.821 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -88.22 -3.04 58.92 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.939 -0.573 . . . . 2.29 110.842 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.474 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 45.6 m -81.61 152.91 26.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.488 0.661 . . . . 1.06 110.704 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.686 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 15.0 t-20 -122.0 122.96 40.53 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.49 -0.777 . . . . 0.8 109.141 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.664 ' HD1' HG13 ' A' ' 42' ' ' ILE . 23.7 m-85 -55.75 -53.58 54.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.988 0.423 . . . . 0.47 111.359 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.86 -27.79 67.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.054 -0.521 . . . . 0.46 111.066 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.686 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 35.8 t70 -72.45 -29.2 63.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.83 110.586 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.564 ' HG3' HD11 ' A' ' 26' ' ' ILE . 14.9 mmt -83.35 -19.9 35.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.896 -0.593 . . . . 2.48 111.318 -176.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.92 16.73 8.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.356 -0.926 . . . . 0.44 112.441 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.664 HG13 ' HD1' ' A' ' 37' ' ' PHE . 23.4 mm -66.6 108.27 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.139 0.495 . . . . 0.52 110.323 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -81.34 167.49 19.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.667 -0.697 . . . . 1.94 110.068 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.8 t -54.02 -35.14 61.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.447 -0.575 . . . . 1.03 109.447 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.1 tm? -59.55 -62.56 1.78 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.562 -0.745 . . . . 0.59 110.022 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.543 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.2 m -59.86 -44.52 94.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.247 -0.433 . . . . 1.22 112.153 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.554 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 36.4 p -65.34 -30.36 71.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.021 0.438 . . . . 0.81 111.125 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.4 tpt -75.06 -30.82 61.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.647 -0.706 . . . . 2.25 109.621 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 45' ' ' LEU . 76.3 t -78.62 -36.78 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.148 -0.933 . . . . 0.36 110.497 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 46' ' ' SER . 66.9 mt -56.44 -52.57 50.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.37 -0.233 . . . . 0.26 110.37 173.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.67 -26.25 68.29 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.774 -0.727 . . . . 0.29 111.943 178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 4.1 m -69.62 -45.21 69.05 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 120.679 0.276 . . . . 0.92 110.863 176.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -65.07 -27.0 68.48 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.624 0.249 . . . . 1.23 110.856 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.611 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.7 m-30 -54.86 -39.97 69.18 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.718 -0.475 . . . . 0.28 109.718 174.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.691 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 12.2 mtp180 -81.64 -34.77 30.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.72 -0.673 . . . . 2.81 111.534 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -86.05 -63.88 1.24 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.039 0.447 . . . . 2.26 111.544 -173.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -71.14 -36.3 72.03 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.454 -0.794 . . . . 2.62 111.499 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.75 -57.0 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.67 111.055 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.85 27.61 3.19 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.823 -0.703 . . . . 0.45 113.221 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.691 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 55.2 mt -84.1 112.19 20.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.78 0.29 . . . . 0.63 110.353 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -85.58 66.37 9.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 122.235 1.017 . . . . 2.27 110.163 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.611 HD11 ' HD2' ' A' ' 54' ' ' PHE . 19.4 mt -64.72 -67.45 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.507 -1.224 . . . . 1.64 110.682 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.75 173.25 39.12 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 110.285 -1.126 . . . . 0.75 110.285 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.8 -35.89 0.68 Allowed 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.372 2.048 . . . . 1.13 113.048 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -108.27 62.83 0.61 Allowed 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 121.078 0.466 . . . . 2.36 110.766 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -109.66 111.66 23.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.698 -0.482 . . . . 0.73 109.698 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.6 m -129.27 118.89 23.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.98 -0.555 . . . . 1.39 110.74 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 84.1 mt -64.64 -16.06 62.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.911 -0.586 . . . . 0.73 111.092 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.554 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 46.0 t80 -82.5 -12.03 58.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.923 -0.581 . . . . 0.59 110.948 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 71.8 mt -117.77 -41.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.773 -0.371 . . . . 0.89 111.624 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.26 15.23 16.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.454 0.645 . . . . 2.23 110.671 -173.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 76.8 m -146.72 156.63 43.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.7 p -135.93 -63.17 0.66 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.685 0.279 . . . . 0.67 110.776 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 44.3 p -93.04 179.08 5.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.195 -0.298 . . . . 0.38 110.195 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.565 HG11 HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -75.83 -42.91 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 121.484 0.659 . . . . 0.68 109.397 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.886 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 40.7 ttp180 -52.86 -37.96 60.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.501 -1.227 . . . . 3.23 111.728 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -55.83 -33.9 64.91 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.852 0.72 . . . . 0.29 111.311 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.47 -47.96 30.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.203 0.525 . . . . 0.64 110.144 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.592 ' CD ' ' HA ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -56.4 -60.97 2.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.263 -0.88 . . . . 2.4 110.235 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -54.62 -37.5 65.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.774 -1.103 . . . . 1.66 111.609 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 38.2 t80 -62.07 -37.88 86.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.99 110.966 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.445 ' HB3' HG22 ' A' ' 8' ' ' VAL . 12.2 mtt . . . . . 0 C--O 1.235 0.307 0 CA-C-N 116.059 -0.519 . . . . 1.1 112.017 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 111.829 -0.508 . . . . 0.53 111.829 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 m -109.92 159.31 9.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.822 0.344 . . . . 0.39 110.46 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 m -75.49 166.99 22.74 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.777 -0.453 . . . . 1.56 109.777 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -69.41 -29.56 67.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.99 -0.744 . . . . 2.02 108.99 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.44 -34.64 77.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.079 -0.964 . . . . 1.91 110.242 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -63.69 -29.43 70.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 1.58 110.31 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.407 ' O ' ' HG3' ' A' ' 17' ' ' MET . 18.2 tp -66.95 -23.97 66.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.831 -0.622 . . . . 0.99 110.86 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.46 -31.57 26.49 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.585 0.707 . . . . 0.88 109.516 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -29.03 55.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.155 -0.93 . . . . 0.3 110.509 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.459 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 3.3 p -73.65 -45.95 49.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.18 -0.464 . . . . 0.23 111.036 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.907 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 75.6 mtp -61.13 -35.32 76.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 1.63 111.226 -175.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.499 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 12.5 ptm180 -66.13 -37.64 86.2 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 120.459 -0.497 . . . . 3.17 110.567 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.9 -41.03 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 109.039 -0.726 . . . . 0.23 109.039 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -57.65 -47.23 86.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.841 -1.072 . . . . 0.33 110.129 175.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.402 ' HA ' ' HG ' ' A' ' 24' ' ' SER . 17.2 m -68.08 -42.37 80.5 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.071 0.397 . . . . 1.38 112.071 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 45.2 mt-10 -63.46 -27.76 69.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.252 -0.431 . . . . 2.26 111.579 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -91.06 -38.79 12.57 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.967 0.358 . . . . 0.77 111.967 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.402 ' HG ' ' HA ' ' A' ' 21' ' ' SER . 65.6 p -72.95 -44.98 60.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.958 0.409 . . . . 1.23 111.57 -176.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.98 38.26 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.68 -0.771 . . . . 0.54 111.549 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mt -94.79 117.8 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.483 -0.562 . . . . 0.8 109.483 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.662 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -47.28 141.75 4.44 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.131 0.419 . . . . 0.57 112.131 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 tp -52.7 -38.64 60.99 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.509 -0.769 . . . . 0.97 111.472 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.39 -9.22 58.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.761 -0.654 . . . . 2.23 111.253 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.662 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 15.6 mm-40 -110.81 -6.87 14.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.93 -0.577 . . . . 2.24 109.983 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.5 tp -75.06 98.56 3.67 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.201 0.524 . . . . 1.1 110.284 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.3 p -111.65 158.94 18.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.529 -0.759 . . . . 0.6 109.696 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.705 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.2 p-10 -76.26 -4.99 44.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.349 . . . . 2.29 111.463 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.08 -21.18 60.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.811 -0.632 . . . . 2.29 110.639 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.436 ' HB3' HG21 ' A' ' 75' ' ' VAL . 16.3 t -77.31 158.07 30.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.81 0.814 . . . . 1.06 111.207 -173.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.661 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 20.7 t-20 -126.32 122.64 36.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.861 -1.063 . . . . 0.8 108.594 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.749 ' HD1' HG13 ' A' ' 42' ' ' ILE . 18.6 m-85 -55.17 -48.18 74.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.106 0.479 . . . . 0.47 111.408 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.4 68.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.103 -0.499 . . . . 0.46 110.999 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.661 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 14.3 t70 -67.58 -34.51 77.18 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.161 0.505 . . . . 0.83 110.203 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.2 mmt -81.0 -17.67 49.52 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.633 -0.712 . . . . 2.48 111.238 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.87 22.03 9.19 Favored Glycine 0 C--O 1.23 -0.099 0 C-N-CA 120.566 -0.826 . . . . 0.44 112.773 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.749 HG13 ' HD1' ' A' ' 37' ' ' PHE . 26.9 mm -64.2 108.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.213 0.53 . . . . 0.52 110.192 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -76.1 161.64 28.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.35 -0.841 . . . . 1.94 111.04 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.3 t -56.07 -41.52 75.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.938 -0.574 . . . . 1.03 110.576 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.92 -53.18 60.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 0.59 109.788 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.554 ' O ' HG13 ' A' ' 50' ' ' ILE . 16.2 m -57.84 -44.87 86.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.419 -0.355 . . . . 1.22 110.903 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.524 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 50.2 m -58.38 -37.66 75.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.096 -0.502 . . . . 0.81 111.234 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.2 tpt -74.71 -34.99 62.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.909 -0.587 . . . . 2.25 109.93 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 44.1 t -68.3 -48.54 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.664 -0.698 . . . . 0.36 109.587 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 46' ' ' SER . 73.1 mt -52.04 -54.89 11.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.72 0.295 . . . . 0.26 110.391 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.52 ' O ' ' HG3' ' A' ' 55' ' ' ARG . . . -60.41 -32.98 79.22 Favored Glycine 0 C--O 1.228 -0.245 0 CA-C-N 115.829 -0.623 . . . . 0.29 112.578 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.509 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -72.94 -45.59 57.22 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.048 -0.261 . . . . 0.92 110.549 177.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 6.1 mtp180 -63.39 -30.68 71.77 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.913 0.387 . . . . 1.23 110.188 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.516 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 9.1 m-30 -50.99 -48.52 61.24 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.857 -0.61 . . . . 0.28 109.782 171.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 19.0 mtm105 -83.76 -40.51 18.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.637 -0.711 . . . . 2.81 110.952 -170.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -88.21 -49.01 7.27 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.351 -0.386 . . . . 2.26 111.874 -171.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -79.58 -52.05 8.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.85 0.357 . . . . 2.62 111.349 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 mp -82.63 -58.31 2.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.194 -0.457 . . . . 0.67 111.541 -175.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.65 24.22 1.58 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.091 -0.576 . . . . 0.45 112.154 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.541 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 16.6 mt -104.19 92.72 4.48 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.757 -0.26 . . . . 0.63 110.516 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.451 ' HA ' ' HG2' ' A' ' 55' ' ' ARG . 18.4 t70 -101.36 80.04 2.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.581 0.705 . . . . 2.27 110.021 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.518 HD13 ' HE2' ' A' ' 81' ' ' PHE . 71.4 mt -71.17 -32.53 69.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.895 -1.048 . . . . 1.64 109.43 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.06 160.98 21.8 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 114.642 -1.163 . . . . 0.75 110.75 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -82.99 -12.58 9.55 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.89 2.393 . . . . 1.13 113.066 -175.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -130.67 31.36 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.812 0.815 . . . . 2.36 110.717 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -95.01 120.24 34.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.73 109.563 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 t -126.63 131.76 51.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.7 -0.4 . . . . 1.39 110.498 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 72' ' ' CYS . 48.1 mt -58.4 -41.38 84.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.808 -0.633 . . . . 0.73 110.475 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.524 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 15.0 t80 -62.59 -12.4 22.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.731 -0.668 . . . . 0.59 111.494 -175.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 63.7 mt -109.87 -42.34 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.874 -0.33 . . . . 0.89 111.126 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -130.71 22.11 5.04 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.64 0.978 . . . . 2.23 113.64 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 98.3 m -143.99 99.55 3.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.282 0.563 . . . . 1.0 109.81 174.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.5 p -90.81 -51.78 5.19 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.012 -0.54 . . . . 0.67 111.624 -170.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.4 p -96.82 -178.64 4.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.19 -0.3 . . . . 0.38 110.19 176.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.568 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -81.09 -41.33 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 109.764 -0.458 . . . . 0.68 109.764 -178.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.705 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 5.2 tpt180 -60.6 -28.22 68.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.671 -0.695 . . . . 3.23 110.483 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -58.32 -32.83 68.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.498 -0.319 . . . . 0.29 110.69 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.505 HD21 ' CE2' ' A' ' 54' ' ' PHE . 0.7 OUTLIER -81.27 -48.66 11.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.546 0.689 . . . . 0.64 109.431 176.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.907 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.9 mmtp -53.99 -57.84 9.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.695 -1.139 . . . . 2.4 110.928 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.498 ' HB2' ' HE ' ' A' ' 76' ' ' ARG . 5.7 t70 -72.33 -19.38 61.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.208 -0.905 . . . . 1.66 111.1 -171.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.518 ' HE2' HD13 ' A' ' 62' ' ' LEU . 76.2 t80 -73.62 -44.12 57.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.215 0.531 . . . . 0.99 110.418 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.459 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 6.3 mtm . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.73 -0.668 . . . . 1.1 112.123 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 111.324 -0.71 . . . . 0.53 111.324 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.03 155.36 14.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.851 0.358 . . . . 0.39 110.167 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 t -82.96 173.63 11.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.536 -0.542 . . . . 1.56 109.536 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -65.52 -25.8 67.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.293 0.568 . . . . 2.02 109.853 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -67.29 -46.45 73.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.395 -0.82 . . . . 1.91 110.503 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -73.82 -20.32 60.49 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.724 -0.391 . . . . 1.58 110.508 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 17' ' ' MET . 1.8 tp -74.18 -25.54 59.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 0.99 110.33 172.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.37 -27.51 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.721 0.772 . . . . 0.88 110.311 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -79.54 -30.77 41.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.987 -1.006 . . . . 0.3 110.878 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.624 HG11 ' SD ' ' A' ' 82' ' ' MET . 2.3 p -68.33 -43.59 84.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.314 -0.403 . . . . 0.23 111.459 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.808 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 30.7 mtt -56.85 -34.77 68.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.515 -0.311 . . . . 1.63 111.132 -174.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.617 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 12.8 ptp180 -81.85 -27.08 33.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.475 -0.329 . . . . 3.17 111.785 -176.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.9 t -71.35 -34.93 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 108.078 -1.082 . . . . 0.23 108.078 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.1 t -66.88 -36.82 78.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 114.025 -1.443 . . . . 0.33 109.8 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.483 ' HB2' ' HA ' ' A' ' 18' ' ' ARG . 19.5 m -70.66 -26.12 63.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 116.231 -0.44 . . . . 1.38 112.16 -177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.617 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 74.6 mt-10 -86.68 -37.73 17.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.865 0.364 . . . . 2.26 111.177 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HG3' HG12 ' A' ' 50' ' ' ILE . 72.3 mm-40 -76.85 -37.91 54.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.968 -0.56 . . . . 0.77 112.23 -176.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.482 ' CB ' HD11 ' A' ' 42' ' ' ILE . 66.4 p -80.3 -45.35 18.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.132 0.491 . . . . 1.23 110.816 -178.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.71 -4.38 26.07 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.688 -0.687 . . . . 0.54 112.467 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.685 HD11 ' HG3' ' A' ' 40' ' ' MET . 8.6 mt -75.32 141.23 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.625 -0.43 . . . . 0.8 110.002 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.86 140.05 56.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.097 -0.501 . . . . 0.57 109.667 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.3 tp -55.09 -31.9 61.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 0.97 111.763 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -77.95 -8.27 57.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.513 -0.312 . . . . 2.23 110.909 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -107.22 -5.44 17.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.934 0.397 . . . . 2.24 110.132 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 17' ' ' MET . 32.6 tp -75.89 97.51 3.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.429 0.633 . . . . 1.1 109.921 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.409 ' O ' HG21 ' A' ' 75' ' ' VAL . 16.0 p -116.82 165.56 13.17 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.76 -0.829 . . . . 0.6 108.76 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.482 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.9 p-10 -72.6 -3.7 26.33 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 111.49 0.181 . . . . 2.29 111.49 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -74.81 -22.69 58.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.992 0.425 . . . . 2.29 110.429 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.478 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 18.0 m -74.15 153.98 39.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.735 0.778 . . . . 1.06 111.34 -174.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.91 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.5 t-20 -128.31 127.55 42.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.121 -0.945 . . . . 0.8 108.674 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.596 ' HD1' HG13 ' A' ' 42' ' ' ILE . 11.7 m-85 -56.48 -53.41 57.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.973 0.416 . . . . 0.47 111.649 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.49 -30.01 66.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.314 -0.403 . . . . 0.46 111.189 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.91 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.5 t70 -69.66 -30.48 68.18 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.345 0.593 . . . . 0.83 110.412 176.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.685 ' HG3' HD11 ' A' ' 26' ' ' ILE . 1.8 tmm? -74.18 -23.37 59.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.541 -0.754 . . . . 2.48 110.461 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.3 14.69 15.76 Favored Glycine 0 CA--C 1.511 -0.175 0 C-N-CA 120.354 -0.927 . . . . 0.44 111.358 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.596 HG13 ' HD1' ' A' ' 37' ' ' PHE . 24.6 mm -76.24 113.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.584 -0.308 . . . . 0.52 110.337 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.53 -172.74 2.58 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.05 -0.722 . . . . 1.94 109.05 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.8 t -68.24 -30.82 69.95 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 111.618 0.229 . . . . 1.03 111.618 -174.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.69 -59.79 4.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.5 -0.318 . . . . 0.59 110.298 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.575 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.3 t -66.03 -40.95 91.48 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.029 -0.269 . . . . 1.22 110.496 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.46 ' HB3' ' H ' ' A' ' 69' ' ' PHE . 49.0 m -56.78 -36.77 70.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.389 . . . . 0.81 111.784 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -73.61 -43.77 58.77 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.655 -0.869 . . . . 2.25 108.655 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.44 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 64.0 t -62.26 -43.17 97.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.837 -1.074 . . . . 0.36 110.721 -176.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 46' ' ' SER . 72.3 mt -54.0 -52.86 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.871 0.367 . . . . 0.26 110.582 175.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -60.85 -31.87 77.46 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.076 -0.583 . . . . 0.29 112.135 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.85 -46.39 82.06 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 122.441 0.296 . . . . 0.92 110.802 176.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 12.4 mtp180 -65.28 -28.21 69.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.544 -0.298 . . . . 1.23 110.514 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.67 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.5 m-30 -57.66 -39.35 76.87 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.707 -0.479 . . . . 0.28 109.707 173.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -80.17 -33.2 38.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.179 -0.464 . . . . 2.81 110.437 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.21 -51.65 9.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.426 -0.352 . . . . 2.26 111.024 -175.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.81 -48.74 7.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.959 -0.564 . . . . 2.62 112.331 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -90.56 -13.29 34.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.54 -0.3 . . . . 0.67 111.535 -173.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 33.14 68.7 Favored Glycine 0 C--O 1.229 -0.198 0 C-N-CA 121.008 -0.615 . . . . 0.45 112.804 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.441 HD12 ' HB3' ' A' ' 54' ' ' PHE . 80.0 mt -90.64 116.65 28.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.505 0.153 . . . . 0.63 111.174 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.08 77.66 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.436 1.113 . . . . 2.27 109.706 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.67 HD11 ' HD2' ' A' ' 54' ' ' PHE . 25.2 mt -74.13 -27.01 60.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.652 -1.158 . . . . 1.64 110.608 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.39 171.68 12.55 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 114.936 -1.029 . . . . 0.75 110.799 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -87.04 -7.32 7.14 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.999 2.466 . . . . 1.13 112.388 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -134.49 45.44 2.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.63 0.729 . . . . 2.36 110.291 -171.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -109.56 129.88 55.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.454 -0.794 . . . . 0.73 110.8 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.2 t -140.69 131.09 25.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.329 -0.396 . . . . 1.39 110.013 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.444 HD12 HD12 ' A' ' 50' ' ' ILE . 50.6 mt -60.44 -37.84 82.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.917 0.389 . . . . 0.73 110.458 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.46 ' H ' ' HB3' ' A' ' 47' ' ' SER . 40.5 t80 -60.05 -12.39 8.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.47 -0.786 . . . . 0.59 111.641 -174.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.52 -38.94 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.565 -0.289 . . . . 0.89 111.417 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -114.72 10.97 16.72 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.395 0.517 . . . . 2.23 112.395 -171.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 82.9 m -150.22 100.13 2.87 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.181 0.515 . . . . 1.0 110.096 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.8 p -91.1 -54.13 4.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.26 -0.427 . . . . 0.67 111.638 -172.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 70.1 p -94.4 -177.28 4.2 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.084 -0.385 . . . . 0.38 110.394 176.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.478 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -79.11 -43.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.457 0.646 . . . . 0.68 109.845 -178.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.482 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.3 tpt180 -63.1 -25.65 68.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.246 -0.888 . . . . 3.23 110.637 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.43 -32.99 73.92 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 116.275 -0.421 . . . . 0.29 110.559 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.656 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.8 OUTLIER -75.23 -50.42 16.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.87 -0.789 . . . . 0.64 108.87 177.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.808 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.9 mmtp -50.32 -52.66 34.82 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.178 -0.919 . . . . 2.4 110.897 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -63.18 -39.65 95.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.482 -0.781 . . . . 1.66 111.373 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.27 -35.12 79.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.792 -0.64 . . . . 0.99 111.667 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.656 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 28.7 mtp . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 120.882 0.373 . . . . 1.1 110.708 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 110.843 -0.903 . . . . 0.53 110.843 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.407 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 3.0 m -114.3 159.24 14.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.895 0.379 . . . . 0.39 111.153 -173.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.2 m -87.31 175.22 8.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.973 -0.558 . . . . 1.56 110.051 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -65.76 -33.24 75.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.978 0.418 . . . . 2.02 110.885 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 1.7 mp0 -65.01 -36.27 83.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.586 0.708 . . . . 1.91 109.783 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HD2' HD21 ' A' ' 60' ' ' LEU . 39.9 mmtm -66.39 -33.92 76.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.04 -0.982 . . . . 1.58 110.242 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.7 tp -67.46 -25.79 66.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.781 -0.645 . . . . 0.99 110.697 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.69 -28.82 28.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.248 0.547 . . . . 0.88 110.252 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.64 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -80.14 -27.2 39.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.893 -0.594 . . . . 0.3 111.024 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.457 HG23 ' CZ ' ' A' ' 54' ' ' PHE . 2.7 p -72.62 -44.23 60.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.355 -0.384 . . . . 0.23 111.661 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.1 mtp -63.69 -24.96 67.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.505 -0.316 . . . . 1.63 111.389 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 16.1 ptt180 -76.86 -27.44 55.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 3.17 110.757 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.1 t -82.4 -37.75 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.578 0.704 . . . . 0.23 109.123 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.402 ' CG1' HD11 ' A' ' 31' ' ' LEU . 21.1 t -64.21 -32.03 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.913 -1.04 . . . . 0.33 109.296 174.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -61.87 -26.63 68.26 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.842 -0.617 . . . . 1.38 111.449 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -87.33 -53.14 4.99 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.31 0.576 . . . . 2.26 111.308 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -73.22 -30.53 63.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.318 -0.856 . . . . 0.77 111.898 -171.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.476 ' HA ' HD11 ' A' ' 42' ' ' ILE . 24.5 m -92.22 -25.22 18.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.592 -0.276 . . . . 1.23 111.424 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.03 7.42 65.89 Favored Glycine 0 N--CA 1.461 0.356 0 C-N-CA 120.33 -0.938 . . . . 0.54 113.007 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.601 HD11 ' SD ' ' A' ' 40' ' ' MET . 4.3 mt -98.51 131.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.728 -0.471 . . . . 0.8 109.728 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.07 146.28 47.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.119 -0.326 . . . . 0.57 110.119 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.5 tp -53.24 -33.55 53.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.581 0.352 . . . . 0.97 111.183 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -83.25 -8.97 59.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.093 -0.503 . . . . 2.23 111.342 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -114.81 -6.15 12.65 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.22 -0.659 . . . . 2.24 109.22 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.57 98.38 2.31 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.923 -1.035 . . . . 1.1 109.048 179.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.8 p -103.17 153.49 20.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.642 -0.708 . . . . 0.6 109.723 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.934 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 20.7 m-20 -75.0 -9.95 59.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.918 0.39 . . . . 2.29 111.858 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -95.37 -11.58 27.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.869 -0.605 . . . . 2.29 111.891 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 t -78.41 156.05 29.65 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.556 0.693 . . . . 1.06 109.946 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.566 ' HB3' ' CB ' ' A' ' 39' ' ' ASP . 18.3 t-20 -115.51 127.03 55.0 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.15 -0.932 . . . . 0.8 110.231 -168.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.776 ' HD1' HG13 ' A' ' 42' ' ' ILE . 18.0 m-85 -56.56 -51.8 67.22 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.891 0.377 . . . . 0.47 111.193 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.43 -31.16 71.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.239 -0.437 . . . . 0.46 111.128 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.566 ' CB ' ' HB3' ' A' ' 36' ' ' ASN . 25.1 t70 -67.23 -31.76 72.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.076 0.465 . . . . 0.83 110.499 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.601 ' SD ' HD11 ' A' ' 26' ' ' ILE . 68.2 mtp -89.52 -9.35 50.29 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.198 -0.456 . . . . 2.48 111.153 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.22 26.8 9.83 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.195 -1.003 . . . . 0.44 112.975 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.776 HG13 ' HD1' ' A' ' 37' ' ' PHE . 30.2 mm -71.87 107.27 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.249 -0.278 . . . . 0.52 110.249 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -78.52 176.71 9.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.42 0.629 . . . . 1.94 110.572 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.7 p -59.83 -41.66 91.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.011 -0.995 . . . . 1.03 111.097 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -58.98 -58.71 7.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.611 -0.722 . . . . 0.59 110.4 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.657 ' O ' HG13 ' A' ' 50' ' ' ILE . 5.0 m -60.53 -46.01 91.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.402 -0.363 . . . . 1.22 111.39 -177.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.908 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 41.3 p -65.54 -31.49 72.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.345 -0.389 . . . . 0.81 111.393 -177.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -40.47 66.77 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.845 -0.798 . . . . 2.25 108.845 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.556 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 24.1 t -59.5 -44.83 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 115.221 -0.899 . . . . 0.36 110.053 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 46' ' ' SER . 39.4 mt -52.82 -56.93 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.26 111.043 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.72 -29.62 74.41 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.021 -0.609 . . . . 0.29 112.55 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -44.19 77.57 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.155 -0.313 . . . . 0.92 110.155 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.556 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 16.4 mtp180 -62.94 -26.34 68.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.567 -0.288 . . . . 1.23 110.611 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.684 ' HD2' HD11 ' A' ' 62' ' ' LEU . 14.5 m-30 -56.77 -41.4 77.55 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.167 0.508 . . . . 0.28 109.925 173.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 23.3 mtm180 -79.43 -25.78 41.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.513 -0.767 . . . . 2.81 110.299 -177.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -74.27 -62.91 1.35 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.611 -0.722 . . . . 2.26 111.82 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.84 -41.71 11.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.966 0.413 . . . . 2.62 111.733 -173.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.77 -23.63 21.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.301 -0.409 . . . . 0.67 111.572 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.89 27.55 60.35 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.145 -0.55 . . . . 0.45 112.732 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.68 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 58.1 mt -87.03 95.72 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.767 -0.255 . . . . 0.63 110.591 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -86.83 78.2 9.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.6 0.714 . . . . 2.27 109.215 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.684 HD11 ' HD2' ' A' ' 54' ' ' PHE . 14.6 mt -71.05 -57.01 4.95 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.371 -1.286 . . . . 1.64 110.305 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.38 150.44 9.38 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.753 -1.112 . . . . 0.75 110.807 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.49 -9.84 20.23 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.234 1.956 . . . . 1.13 112.902 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -120.15 22.84 11.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.995 -0.548 . . . . 2.36 110.733 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -80.34 124.43 28.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.282 -0.417 . . . . 0.73 111.148 -177.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.4 t -139.47 125.19 19.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.641 -0.503 . . . . 1.39 109.641 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.908 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 88.5 mt -60.37 -23.7 64.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.541 0.21 . . . . 0.73 111.382 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.52 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 17.5 t80 -71.88 -14.06 61.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.246 0.546 . . . . 0.59 110.445 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.2 mt -122.89 -39.75 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.89 110.868 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -95.02 8.46 42.84 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.74 0.274 . . . . 2.23 111.74 -172.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.31 167.23 30.31 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.9 p -138.49 -68.07 0.46 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 0.67 110.568 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 81.4 p -84.55 -175.43 5.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.747 -0.464 . . . . 0.38 109.747 174.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.0 t -83.77 -38.75 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.879 0.847 . . . . 0.68 109.929 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.934 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 35.6 ttm180 -61.88 -30.01 70.58 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.713 -1.131 . . . . 3.23 111.252 175.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.46 -31.44 65.95 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.988 0.423 . . . . 0.29 110.513 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.776 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.1 tt -70.5 -48.32 56.26 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.574 -0.899 . . . . 0.64 108.574 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.552 ' CG ' ' HA ' ' A' ' 76' ' ' ARG . 20.8 mmtm -50.76 -55.06 18.48 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.984 -1.007 . . . . 2.4 110.572 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -51.44 -49.43 61.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.276 -0.875 . . . . 1.66 111.69 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -61.7 -36.49 81.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.743 -0.662 . . . . 0.99 111.8 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.776 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 44.1 mtp . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.367 -0.379 . . . . 1.1 111.765 -173.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.513 0 N-CA-C 110.956 -0.857 . . . . 0.53 110.956 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.661 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 4.1 m -103.98 156.74 5.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.707 0.289 . . . . 0.39 110.628 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.3 m -85.39 173.93 9.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.639 -0.504 . . . . 1.56 109.639 175.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -61.75 -36.08 79.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.774 0.797 . . . . 2.02 109.013 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -59.17 -42.1 89.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.716 -1.129 . . . . 1.91 111.211 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.661 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 41.4 mmtm -67.73 -31.65 71.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 1.58 110.052 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.421 ' O ' ' HG3' ' A' ' 17' ' ' MET . 34.7 tp -68.11 -26.22 65.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.645 . . . . 0.99 110.324 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.69 -29.96 36.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.103 0.478 . . . . 0.88 110.288 178.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.17 -27.22 39.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.619 . . . . 0.3 111.051 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.6 HG23 ' CE1' ' A' ' 54' ' ' PHE . 4.0 p -75.71 -48.76 28.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.805 0.336 . . . . 0.23 111.721 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 73.3 mtm -59.57 -30.32 68.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.176 -0.465 . . . . 1.63 111.514 -174.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 6.5 ptm180 -70.38 -37.88 74.63 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.106 -0.638 . . . . 3.17 110.635 176.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.456 HG12 HG23 ' A' ' 50' ' ' ILE . 29.2 t -64.5 -42.77 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.554 0.693 . . . . 0.23 109.3 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.09 -42.03 93.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.983 -1.008 . . . . 0.33 110.807 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -23.48 61.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.828 0.347 . . . . 1.38 110.174 -174.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 43.9 mt-10 -79.01 -43.27 24.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.158 -0.474 . . . . 2.26 111.6 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -86.27 -8.31 57.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.329 -0.396 . . . . 0.77 111.273 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.4 p -97.57 -41.25 8.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.052 0.453 . . . . 1.23 110.407 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.76 41.85 3.25 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.863 -0.684 . . . . 0.54 111.603 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 27' ' ' ALA . 5.2 mt -127.16 165.87 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.808 -0.442 . . . . 0.8 109.808 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.503 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -83.96 142.02 30.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.643 -0.708 . . . . 0.57 110.257 172.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.0 tp -61.14 -33.26 73.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.043 -0.526 . . . . 0.97 111.092 -177.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.63 -11.98 60.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.179 0.514 . . . . 2.23 111.067 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 17.8 mm-40 -105.79 -5.04 20.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.796 -0.638 . . . . 2.24 110.107 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.6 tp -84.85 96.55 9.35 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.107 -0.497 . . . . 1.1 110.352 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 p -115.0 169.63 8.94 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.833 -0.803 . . . . 0.6 108.833 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.686 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 4.8 p-10 -75.66 -3.29 33.71 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.931 -0.308 . . . . 2.29 111.548 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.12 -20.22 60.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.14 -0.482 . . . . 2.29 110.406 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.489 ' HB2' HG21 ' A' ' 75' ' ' VAL . 16.3 m -79.74 157.69 27.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.606 0.717 . . . . 1.06 111.541 -175.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.75 119.42 25.73 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.229 -1.026 . . . . 0.8 108.229 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.422 ' CZ ' HG13 ' A' ' 75' ' ' VAL . 16.8 m-85 -57.72 -39.26 76.86 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.45 -0.5 . . . . 0.47 111.642 -173.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.76 -26.91 67.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.984 0.421 . . . . 0.46 110.472 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -68.89 -29.73 68.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.83 110.296 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -83.59 -8.4 59.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.754 -0.657 . . . . 2.48 110.283 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.77 32.5 36.75 Favored Glycine 0 C--N 1.322 -0.225 0 C-N-CA 120.443 -0.884 . . . . 0.44 112.002 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.502 ' CG2' ' HB3' ' A' ' 47' ' ' SER . 2.7 mt -67.76 108.46 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.018 0.437 . . . . 0.52 110.225 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -78.45 165.96 23.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.816 -0.629 . . . . 1.94 110.48 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.0 t -51.54 -43.33 62.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 1.03 110.861 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.14 -55.91 28.8 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.142 -0.481 . . . . 0.59 110.376 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.45 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.3 m -61.41 -44.14 97.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 1.22 111.525 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.866 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 63.7 p -68.09 -31.61 71.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.735 0.302 . . . . 0.81 111.222 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.2 tpt -70.76 -36.45 73.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.449 0.642 . . . . 2.25 109.805 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.31 -36.39 76.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.064 -0.971 . . . . 0.36 110.22 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.532 HD12 HD12 ' A' ' 68' ' ' LEU . 67.5 mt -59.83 -52.01 66.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.762 -0.653 . . . . 0.26 110.753 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.5 ' HA2' ' CD2' ' A' ' 54' ' ' PHE . . . -64.04 -28.69 73.19 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.144 -0.551 . . . . 0.29 112.197 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -49.63 76.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.767 0.318 . . . . 0.92 110.512 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -64.6 -28.43 69.62 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.417 -0.356 . . . . 1.23 111.07 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.6 ' CE1' HG23 ' A' ' 16' ' ' VAL . 14.6 m-30 -53.9 -44.22 70.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.613 -0.514 . . . . 0.28 109.613 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -84.86 -35.36 22.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 2.81 111.451 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -85.79 -56.16 3.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.036 0.446 . . . . 2.26 111.299 -174.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.28 -52.71 11.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.971 -0.559 . . . . 2.62 111.387 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 mp -88.25 -32.13 18.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.516 . . . . 0.67 111.849 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.9 33.91 16.91 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.524 -0.846 . . . . 0.45 112.115 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.15 152.0 21.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.789 -0.448 . . . . 0.63 109.789 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.72 110.97 21.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.942 0.401 . . . . 2.27 110.325 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -123.8 5.56 8.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 1.64 109.501 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.56 164.22 39.47 Favored Glycine 0 CA--C 1.509 -0.323 0 CA-C-N 115.474 -0.785 . . . . 0.75 111.456 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -87.74 -2.07 7.39 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.23 2.62 . . . . 1.13 112.078 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -106.48 12.92 29.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.387 -0.824 . . . . 2.36 111.036 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -93.63 111.82 23.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.055 0.455 . . . . 0.73 110.462 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.3 m -134.5 128.18 32.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.72 -0.673 . . . . 1.39 109.5 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.866 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 42.3 mt -66.58 -45.02 80.65 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.799 0.296 . . . . 0.73 111.799 -173.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.96 -4.67 4.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.432 . . . . 0.59 110.772 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -116.08 -40.35 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 O-C-N 122.223 -0.298 . . . . 0.89 111.555 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -126.07 8.41 7.34 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.122 0.416 . . . . 2.23 112.122 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 75.9 m -147.52 88.76 1.72 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.623 -0.673 . . . . 1.0 110.412 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 p -81.73 -31.76 31.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.904 -0.589 . . . . 0.67 111.812 -173.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.9 p -110.95 176.73 4.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.668 0.27 . . . . 0.38 110.501 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.489 HG21 ' HB2' ' A' ' 35' ' ' SER . 0.2 OUTLIER -80.77 -44.72 21.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.965 -0.383 . . . . 0.68 109.965 -177.651 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.686 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.2 tpt180 -57.94 -32.51 67.87 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.132 -0.486 . . . . 3.23 110.551 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.59 -29.54 62.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.116 -0.493 . . . . 0.29 111.062 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.677 ' O ' ' HG3' ' A' ' 82' ' ' MET . 3.7 tp -86.39 -55.1 4.05 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.16 -0.682 . . . . 0.64 109.16 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -56.01 -60.35 3.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.287 -1.324 . . . . 2.4 111.656 -174.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.472 ' HB2' ' HE ' ' A' ' 76' ' ' ARG . 9.7 t70 -66.93 -26.28 66.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.465 -0.789 . . . . 1.66 110.681 -171.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.73 -26.58 66.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.22 -0.9 . . . . 0.99 110.731 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.677 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 28.6 mtp . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.905 -0.589 . . . . 1.1 110.532 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.524 0 N-CA-C 111.908 -0.477 . . . . 0.53 111.908 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 3.2 m -118.71 157.84 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.917 0.389 . . . . 0.39 110.172 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.4 p -83.4 172.89 12.02 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.042 -0.526 . . . . 1.56 110.114 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -67.68 -16.79 64.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.079 0.466 . . . . 2.02 110.349 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -67.18 -46.95 72.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.491 -0.777 . . . . 1.91 109.615 173.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.536 ' HG2' HD21 ' A' ' 60' ' ' LEU . 2.4 mptp? -66.25 -34.4 77.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.774 -0.648 . . . . 1.58 109.931 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 17' ' ' MET . 14.7 tp -67.79 -26.88 66.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 0.99 111.192 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.1 -28.83 27.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.176 0.513 . . . . 0.88 109.948 177.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -81.67 -30.58 32.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.3 111.297 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.04 -43.07 96.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.828 -0.349 . . . . 0.23 111.177 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.542 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 45.1 mtt -63.61 -28.6 70.03 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.174 -0.466 . . . . 1.63 110.768 -174.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.662 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 15.3 ptm180 -84.1 -19.48 34.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.896 -0.322 . . . . 3.17 111.725 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.9 t -81.37 -27.97 10.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 122.017 0.913 . . . . 0.23 108.629 172.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.1 t -76.1 -36.11 30.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.458 -1.247 . . . . 0.33 110.294 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.5 p -62.75 -51.48 66.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.039 0.447 . . . . 1.38 110.496 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.662 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 9.0 mm-40 -57.35 -52.0 67.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.354 -0.839 . . . . 2.26 111.484 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' HG3' HG12 ' A' ' 50' ' ' ILE . 76.9 mm-40 -72.41 -46.37 55.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.962 -0.563 . . . . 0.77 112.323 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.444 ' HA ' HD11 ' A' ' 42' ' ' ILE . 17.8 m -73.67 -38.38 64.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.827 0.346 . . . . 1.23 111.587 -176.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.15 -2.19 40.64 Favored Glycine 0 N--CA 1.454 -0.124 0 C-N-CA 120.191 -1.004 . . . . 0.54 112.07 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.462 HD11 ' HG3' ' A' ' 40' ' ' MET . 8.0 mt -94.0 123.14 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.639 -0.504 . . . . 0.8 109.639 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.543 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -54.14 145.58 16.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.381 -0.372 . . . . 0.57 111.552 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 tp -55.02 -36.92 65.98 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.937 -0.574 . . . . 0.97 110.646 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.31 -10.7 59.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.983 -0.553 . . . . 2.23 111.293 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 41.4 mt-10 -116.2 2.06 13.25 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.138 -0.483 . . . . 2.24 110.043 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -75.26 97.34 3.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.164 -0.68 . . . . 1.1 109.164 -178.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.9 p -106.55 154.91 20.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.695 -0.684 . . . . 0.6 109.273 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 57.7 m-20 -76.75 -3.67 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.055 0.455 . . . . 2.29 110.951 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.53 -6.25 59.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.498 -0.774 . . . . 2.29 110.413 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.474 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 46.9 m -79.6 150.63 30.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.594 . . . . 1.06 110.006 177.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.767 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.1 t-20 -125.88 123.25 38.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.253 -0.647 . . . . 0.8 109.253 -175.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.703 ' HD1' HG13 ' A' ' 42' ' ' ILE . 34.1 m-85 -56.37 -48.61 76.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.943 0.401 . . . . 0.47 111.194 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.2 -31.0 68.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.268 -0.424 . . . . 0.46 111.181 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.767 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 32.9 t70 -70.99 -33.24 70.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.331 0.586 . . . . 0.83 110.589 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.462 ' HG3' HD11 ' A' ' 26' ' ' ILE . 15.1 mmt -79.8 -20.27 46.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.407 -0.815 . . . . 2.48 111.37 -176.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.03 32.81 4.23 Favored Glycine 0 C--O 1.229 -0.17 0 C-N-CA 120.271 -0.966 . . . . 0.44 112.5 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.703 HG13 ' HD1' ' A' ' 37' ' ' PHE . 28.5 mm -79.83 107.74 12.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.854 0.359 . . . . 0.52 110.608 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -77.4 174.24 11.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.636 -0.505 . . . . 1.94 109.636 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.688 ' HB3' ' HD2' ' A' ' 69' ' ' PHE . 90.0 p -69.9 -20.77 63.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.443 -0.577 . . . . 1.03 109.443 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.4 tm? -54.55 -61.99 1.95 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.195 -0.668 . . . . 0.59 109.195 171.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.448 ' O ' HG13 ' A' ' 50' ' ' ILE . 6.3 m -64.7 -39.69 94.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.116 -0.493 . . . . 1.22 110.81 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.455 ' HB2' ' HA ' ' A' ' 44' ' ' SER . 48.8 m -58.93 -40.57 84.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.069 -0.514 . . . . 0.81 111.672 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 45.1 tpp -72.35 -40.33 67.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.265 0.555 . . . . 2.25 109.674 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.506 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 54.6 t -63.51 -50.33 78.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.214 -0.903 . . . . 0.36 110.453 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.463 HG12 ' HG3' ' A' ' 23' ' ' GLU . 77.7 mt -54.05 -54.58 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.684 0.278 . . . . 0.26 110.92 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -58.25 -35.82 79.99 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.973 -0.632 . . . . 0.29 112.018 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.482 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -63.47 -46.16 87.47 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.849 -0.206 . . . . 0.92 110.527 174.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 7.1 mtp180 -64.11 -28.0 69.48 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.576 -0.284 . . . . 1.23 111.057 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.562 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.5 m-30 -56.63 -42.39 78.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.477 -0.564 . . . . 0.28 109.477 173.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.482 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 65.1 mtm180 -80.16 -39.21 29.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 2.81 110.635 -176.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.82 -48.61 7.7 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.057 0.392 . . . . 2.26 112.057 -172.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.28 -46.91 14.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.261 -0.427 . . . . 2.62 111.649 -177.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.1 mp -95.7 -23.25 17.08 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.84 0.681 . . . . 0.67 112.84 -173.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.34 32.3 23.0 Favored Glycine 0 CA--C 1.517 0.174 0 C-N-CA 120.793 -0.718 . . . . 0.45 112.664 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.536 HD21 ' HG2' ' A' ' 12' ' ' LYS . 85.4 mt -88.22 120.3 29.45 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.733 -0.275 . . . . 0.63 110.524 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -82.78 82.07 8.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.228 0.537 . . . . 2.27 109.749 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.562 HD11 ' HD2' ' A' ' 54' ' ' PHE . 97.7 mt -89.8 -94.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.692 -0.685 . . . . 1.64 111.356 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 162.55 168.86 25.1 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.892 -0.883 . . . . 0.75 110.892 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.542 ' HG2' ' OE2' ' A' ' 65' ' ' GLU . 73.6 Cg_endo -81.85 -10.24 11.75 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.683 2.255 . . . . 1.13 113.65 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.542 ' OE2' ' HG2' ' A' ' 64' ' ' PRO . 5.3 mp0 -88.77 -0.07 56.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.625 -0.262 . . . . 2.36 111.47 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.75 122.05 40.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.836 0.35 . . . . 0.73 111.441 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.3 t -141.26 124.44 16.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 1.39 110.008 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 mt -56.13 -28.97 59.99 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.977 0.362 . . . . 0.73 111.977 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.688 ' HD2' ' HB3' ' A' ' 44' ' ' SER . 3.2 t80 -67.91 -16.7 64.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.588 . . . . 0.59 110.939 -173.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.1 mt -126.32 -35.93 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.803 0.335 . . . . 0.89 110.997 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -90.48 6.28 44.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.43 -0.35 . . . . 2.23 111.689 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.4 m -154.89 155.91 35.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.1 p -131.06 -73.73 0.54 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.31 -0.405 . . . . 0.67 110.464 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 76.8 p -83.16 -170.87 3.25 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.965 -0.384 . . . . 0.38 109.965 174.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.474 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.9 OUTLIER -83.08 -40.67 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.555 -0.906 . . . . 0.68 108.555 -177.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 34.0 ttm180 -60.89 -31.5 70.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.402 -1.272 . . . . 3.23 111.238 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.18 -34.88 64.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.819 0.342 . . . . 0.29 110.952 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.552 HD21 ' CE2' ' A' ' 54' ' ' PHE . 0.9 OUTLIER -74.8 -50.7 16.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.485 -0.561 . . . . 0.64 109.485 177.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 26.1 mmtp -49.21 -53.81 19.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.236 -0.893 . . . . 2.4 110.438 176.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.51 -45.02 62.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.877 -1.056 . . . . 1.66 111.867 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -64.12 -37.86 88.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.014 -0.539 . . . . 0.99 111.838 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.523 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 21.3 mtp . . . . . 0 C--N 1.326 -0.443 0 CA-C-O 121.058 0.456 . . . . 1.1 111.285 -174.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 N-CA-C 111.497 -0.641 . . . . 0.53 111.497 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 2.8 m -123.59 160.88 26.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.701 0.286 . . . . 0.39 110.789 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.7 p -92.66 -176.89 4.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.123 -0.695 . . . . 1.56 109.123 171.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -68.34 -23.35 64.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.312 0.577 . . . . 2.02 109.646 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -58.51 -44.07 89.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.333 -0.849 . . . . 1.91 110.602 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.609 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 17.5 mttp -74.29 -24.91 59.32 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.724 -0.671 . . . . 1.58 111.032 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.8 tp -73.45 -30.0 62.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.131 -0.486 . . . . 0.99 110.753 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.67 -29.23 45.52 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.238 0.542 . . . . 0.88 109.843 176.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.673 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -81.61 -30.36 32.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.919 -0.582 . . . . 0.3 111.375 -176.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.442 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 5.5 p -68.47 -45.7 81.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.396 -0.522 . . . . 0.23 111.285 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.403 ' HB3' ' HE2' ' A' ' 17' ' ' MET . 73.6 mtp -61.05 -35.24 76.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.997 -0.547 . . . . 1.63 111.285 -175.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 2.7 ptm180 -64.37 -35.8 82.06 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.127 -0.323 . . . . 3.17 110.127 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.45 HG13 ' HD3' ' A' ' 53' ' ' ARG . 53.3 t -76.5 -38.09 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.544 0.688 . . . . 0.23 109.278 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.41 -45.3 93.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.882 -1.054 . . . . 0.33 110.473 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.8 m -60.9 -40.95 95.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.884 0.373 . . . . 1.38 111.614 -176.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 53.1 mt-10 -58.02 -56.76 17.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.816 -0.629 . . . . 2.26 111.976 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -76.08 -25.69 55.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.247 -0.433 . . . . 0.77 111.946 -172.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.7 p -81.27 -44.09 18.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.003 0.43 . . . . 1.23 110.3 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.02 16.83 26.96 Favored Glycine 0 C--O 1.229 -0.183 0 C-N-CA 120.924 -0.655 . . . . 0.54 111.619 -176.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.28 123.0 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.796 -0.446 . . . . 0.8 109.796 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.45 143.95 6.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.299 0.481 . . . . 0.57 112.299 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.5 tp -54.5 -37.04 64.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.444 -0.798 . . . . 0.97 111.159 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.75 -9.86 58.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.85 -0.614 . . . . 2.23 111.256 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -110.8 -6.33 14.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.072 -0.513 . . . . 2.24 110.927 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.3 tp -71.96 98.25 2.01 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.396 0.617 . . . . 1.1 109.973 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.0 p -107.57 162.42 13.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.32 -0.854 . . . . 0.6 109.079 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.426 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 80.8 m-20 -76.33 -5.54 47.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.027 0.442 . . . . 2.29 110.782 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -81.51 -22.57 37.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.352 -0.84 . . . . 2.29 111.135 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -81.03 149.9 29.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.667 0.746 . . . . 1.06 111.132 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.591 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 20.8 t-20 -113.7 131.15 56.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.133 -0.939 . . . . 0.8 109.638 -171.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.743 ' HD1' HG13 ' A' ' 42' ' ' ILE . 28.4 m-85 -57.95 -47.31 83.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 0.47 111.569 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.26 -31.26 67.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.507 -0.315 . . . . 0.46 111.318 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.0 t70 -68.76 -31.81 71.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.09 0.472 . . . . 0.83 110.268 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.0 mmt -82.12 -18.97 41.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.548 -0.751 . . . . 2.48 111.882 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.18 28.5 6.1 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 120.275 -0.964 . . . . 0.44 112.441 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.743 HG13 ' HD1' ' A' ' 37' ' ' PHE . 32.9 mm -75.3 108.48 7.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.028 0.442 . . . . 0.52 110.188 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -83.73 178.76 7.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.846 -0.616 . . . . 1.94 110.691 -177.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 t -64.51 -28.04 69.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.437 -0.801 . . . . 1.03 110.006 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.69 -62.45 1.45 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.708 -0.678 . . . . 0.59 110.27 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.1 p -64.12 -40.57 96.49 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.448 0.536 . . . . 1.22 112.448 -175.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 60.1 p -64.0 -29.86 70.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.962 0.41 . . . . 0.81 111.071 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 48.2 tpp -75.86 -36.43 59.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.669 0.747 . . . . 2.25 109.831 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.54 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 56.9 t -71.7 -36.56 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 114.92 -1.036 . . . . 0.36 109.466 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 46' ' ' SER . 88.0 mt -58.4 -50.11 79.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.223 -0.444 . . . . 0.26 110.431 174.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.97 -37.48 85.34 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.099 -0.572 . . . . 0.29 112.352 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.612 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 1.5 t -63.29 -48.32 78.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.843 -0.343 . . . . 0.92 110.343 176.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 43.5 mtp180 -60.69 -32.74 71.96 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.659 -0.246 . . . . 1.23 111.053 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.473 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 10.7 m-30 -53.67 -40.47 65.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.056 0.455 . . . . 0.28 110.124 174.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.612 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 67.4 mtm180 -81.89 -35.89 28.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.883 -0.598 . . . . 2.81 110.957 -175.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.31 -51.08 6.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.983 -0.553 . . . . 2.26 111.593 -170.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -81.74 -49.88 9.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.013 -0.539 . . . . 2.62 110.839 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 mp -85.93 -55.12 4.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.87 -0.605 . . . . 0.67 111.177 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.06 30.18 2.37 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.918 -0.658 . . . . 0.45 112.057 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 59.5 mt -92.0 132.66 36.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.109 -0.33 . . . . 0.63 110.109 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -101.25 92.25 4.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.843 0.83 . . . . 2.27 110.681 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -88.07 -73.04 0.5 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.427 -0.806 . . . . 1.64 109.95 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.69 170.14 16.81 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.469 -0.652 . . . . 0.75 111.469 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.6 8.41 4.64 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.017 2.478 . . . . 1.13 111.979 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.9 1.03 12.62 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.092 -0.958 . . . . 2.36 110.122 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -89.37 118.91 29.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.947 -0.57 . . . . 0.73 110.951 -175.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.9 t -137.83 123.17 19.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.126 -0.488 . . . . 1.39 110.211 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 90.5 mt -61.01 -37.78 83.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.169 0.509 . . . . 0.73 110.566 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -65.46 -7.06 12.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.542 -0.754 . . . . 0.59 111.05 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.65 -39.08 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 120.827 -0.349 . . . . 0.89 111.618 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -121.35 7.39 10.16 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 120.33 -0.548 . . . . 2.23 112.447 -172.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 66.6 m -147.68 87.7 1.65 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.805 -0.559 . . . . 1.0 110.523 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.5 p -85.47 -33.26 21.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.057 -0.52 . . . . 0.67 112.242 -173.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p -107.19 172.2 6.96 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.189 -0.319 . . . . 0.38 110.61 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.449 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 5.7 t -80.72 -40.05 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 120.678 0.275 . . . . 0.68 111.108 -175.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.426 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 30.8 ttm180 -61.45 -30.43 70.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 3.23 110.875 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -56.94 -32.23 65.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.954 -0.566 . . . . 0.29 111.14 176.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.65 -44.48 18.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 0.64 109.213 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 25.2 mmtp -56.17 -62.11 1.94 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.599 -1.182 . . . . 2.4 111.368 -178.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.93 -23.35 66.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 1.66 110.833 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 73.3 t80 -67.68 -41.57 83.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.56 0.695 . . . . 0.99 109.822 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.442 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 1.3 mtm . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 115.158 -0.928 . . . . 1.1 112.292 -176.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.448 0 N-CA-C 111.346 -0.701 . . . . 0.53 111.346 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -108.88 157.12 9.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.752 -0.379 . . . . 0.39 110.807 -174.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -78.65 171.8 14.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.678 -0.49 . . . . 1.56 109.678 173.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.433 HD22 ' N ' ' A' ' 10' ' ' ASN . 0.9 OUTLIER -72.49 -17.29 61.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.333 0.587 . . . . 2.02 110.258 -175.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -68.78 -44.76 72.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.404 -0.816 . . . . 1.91 109.888 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -70.72 -22.87 62.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.783 -0.644 . . . . 1.58 110.542 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 17' ' ' MET . 2.7 tp -72.26 -27.51 62.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.759 -0.655 . . . . 0.99 110.54 173.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.22 -30.98 34.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.423 0.63 . . . . 0.88 109.383 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.61 -34.25 53.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.074 -0.967 . . . . 0.3 110.861 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.515 HG11 ' SD ' ' A' ' 82' ' ' MET . 2.8 p -66.09 -43.19 92.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.159 -0.473 . . . . 0.23 111.446 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.47 ' HB3' HD23 ' A' ' 31' ' ' LEU . 66.7 mtm -64.23 -30.71 71.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.394 -0.366 . . . . 1.63 111.395 -175.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.687 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 9.1 ptm180 -83.6 -19.28 35.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.949 0.351 . . . . 3.17 111.949 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.1 t -78.43 -32.86 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.827 0.823 . . . . 0.23 108.892 171.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.25 -37.77 72.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.512 -1.222 . . . . 0.33 110.333 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.6 p -61.18 -49.79 75.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.523 0.678 . . . . 1.38 109.779 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.687 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 3.9 mm-40 -59.73 -50.17 74.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.441 -1.254 . . . . 2.26 112.316 -176.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HB2' HG12 ' A' ' 50' ' ' ILE . 60.8 mm-40 -86.96 -9.05 56.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.208 0.447 . . . . 0.77 112.208 -171.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.1 m -95.4 -26.03 16.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.034 0.445 . . . . 1.23 110.279 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.51 -7.23 65.85 Favored Glycine 0 C--N 1.329 0.14 0 C-N-CA 120.488 -0.863 . . . . 0.54 112.652 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mt -91.33 154.43 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 122.568 -0.372 . . . . 0.8 110.014 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.421 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -69.56 142.29 53.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.993 -0.549 . . . . 0.57 110.111 178.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.625 HD11 ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -57.9 -39.32 77.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 0.97 109.899 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -67.76 -15.15 63.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.37 -0.832 . . . . 2.23 111.355 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 33.8 mt-10 -108.68 1.95 21.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.374 -0.376 . . . . 2.24 110.205 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 17' ' ' MET . 27.4 tp -74.68 107.3 6.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.423 -0.584 . . . . 1.1 109.423 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.2 p -113.55 162.71 15.85 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.818 -0.808 . . . . 0.6 108.818 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.699 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.9 p-10 -79.84 -11.96 59.79 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.654 -0.418 . . . . 2.29 110.526 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -84.03 -20.42 32.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.742 -0.663 . . . . 2.29 110.998 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.6 p -66.53 147.41 53.32 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.424 0.631 . . . . 1.06 110.766 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.732 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.5 t-20 -114.17 127.28 55.83 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.147 -0.933 . . . . 0.8 108.89 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.844 ' HD1' HG13 ' A' ' 42' ' ' ILE . 23.9 m-85 -56.58 -50.72 71.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.94 0.4 . . . . 0.47 111.399 -178.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.29 68.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.133 -0.485 . . . . 0.46 111.111 -176.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.732 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 28.7 t70 -72.17 -28.82 63.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.926 -0.579 . . . . 0.83 110.478 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.1 mmt -83.24 -22.57 33.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.684 -0.689 . . . . 2.48 111.264 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.32 23.7 6.53 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.673 -0.775 . . . . 0.44 112.445 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.844 HG13 ' HD1' ' A' ' 37' ' ' PHE . 31.9 mm -70.97 108.22 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.223 0.535 . . . . 0.52 111.24 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.9 176.82 9.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.587 -0.733 . . . . 1.94 111.495 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 p -61.1 -39.39 89.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.148 -0.933 . . . . 1.03 110.989 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -52.55 -59.66 4.19 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.703 -0.68 . . . . 0.59 110.181 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.541 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.2 m -62.2 -42.83 99.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.087 -0.506 . . . . 1.22 110.739 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.517 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 67.3 m -57.49 -37.62 73.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.169 -0.468 . . . . 0.81 111.687 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.6 ttt -74.3 -40.32 62.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.121 0.486 . . . . 2.25 109.749 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.39 -42.37 96.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.225 -0.898 . . . . 0.36 110.363 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 46' ' ' SER . 88.3 mt -58.48 -55.85 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.26 111.154 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -63.56 -26.72 69.99 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.769 -0.729 . . . . 0.29 112.224 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -50.4 68.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.585 -0.524 . . . . 0.92 109.585 176.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -64.27 -27.05 68.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.434 -0.348 . . . . 1.23 110.844 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 10.8 m-30 -55.11 -42.53 73.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.406 -0.59 . . . . 0.28 109.406 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -84.32 -36.47 22.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.81 -0.632 . . . . 2.81 111.253 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -85.6 -47.97 9.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.533 -0.303 . . . . 2.26 111.764 -172.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -86.42 -50.36 6.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.364 -0.38 . . . . 2.62 111.268 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.42 -43.35 14.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.557 -0.292 . . . . 0.67 111.674 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.16 20.22 11.52 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.907 -0.663 . . . . 0.45 112.327 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.8 mt -77.46 141.96 39.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.474 0.178 . . . . 0.63 110.881 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -106.57 84.98 2.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.085 0.469 . . . . 2.27 110.477 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.515 HD12 ' HE2' ' A' ' 81' ' ' PHE . 2.9 mm? -86.57 -29.84 22.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.567 0.699 . . . . 1.64 109.448 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 126.46 171.48 13.13 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.25 -1.14 . . . . 0.75 110.25 -173.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -85.96 -9.08 7.69 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.821 2.347 . . . . 1.13 113.127 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -125.7 23.6 7.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.055 0.455 . . . . 2.36 111.546 -173.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -82.08 114.4 20.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.04 -0.527 . . . . 0.73 109.796 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.0 m -132.12 117.82 18.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.64 -0.255 . . . . 1.39 110.421 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.73 -39.19 68.01 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 111.994 0.368 . . . . 0.73 111.994 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.517 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 12.7 t80 -62.07 -11.28 13.07 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.331 -0.395 . . . . 0.59 111.694 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.6 mt -124.11 -34.67 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.195 0.522 . . . . 0.89 110.92 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -99.28 -11.87 20.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.718 0.636 . . . . 2.23 112.718 -172.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 71.9 m -141.61 165.77 26.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.6 p -135.96 -66.35 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.941 -0.303 . . . . 0.67 111.009 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 69.1 p -87.57 178.37 6.8 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.226 -0.287 . . . . 0.38 110.226 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.479 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 4.6 t -81.86 -35.97 13.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-O 121.078 0.466 . . . . 0.68 111.11 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.699 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.7 tpp180 -60.95 -33.64 73.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.787 -0.642 . . . . 3.23 110.77 175.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.61 69.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.745 0.307 . . . . 0.29 111.151 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.735 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.7 OUTLIER -69.08 -48.84 61.66 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.184 -0.672 . . . . 0.64 109.184 175.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -52.68 -61.62 2.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.09 -0.959 . . . . 2.4 110.766 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.55 -39.0 64.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.478 -0.783 . . . . 1.66 111.697 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.515 ' HE2' HD12 ' A' ' 62' ' ' LEU . 75.4 t80 -59.68 -44.85 93.46 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.849 -0.614 . . . . 0.99 110.657 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.735 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 30.1 mtp . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.53 . . . . 1.1 111.292 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.188 0 N-CA-C 111.279 -0.728 . . . . 0.53 111.279 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 m -100.61 156.96 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 122.56 -0.377 . . . . 0.39 110.174 -174.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -87.56 -179.84 6.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.599 -0.519 . . . . 1.56 109.599 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -68.54 -28.2 66.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.187 0.518 . . . . 2.02 110.424 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -64.16 -47.07 81.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.732 -0.667 . . . . 1.91 110.866 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -70.99 -19.26 62.55 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.791 -0.641 . . . . 1.58 110.754 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.412 HD11 ' HD2' ' A' ' 79' ' ' LYS . 29.8 tp -73.44 -25.13 60.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.816 -0.629 . . . . 0.99 110.804 171.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.35 -31.48 29.8 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.376 0.608 . . . . 0.88 110.038 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.51 -22.64 50.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.647 -0.706 . . . . 0.3 111.062 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 p -78.62 -41.38 24.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.831 0.348 . . . . 0.23 111.143 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 80.7 mtp -59.26 -31.92 69.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 1.63 111.471 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -72.72 -35.97 67.69 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 120.941 -0.303 . . . . 3.17 111.188 178.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.2 t -70.47 -33.56 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.946 0.879 . . . . 0.23 108.951 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.72 -36.75 66.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.469 -1.242 . . . . 0.33 109.605 174.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 t -64.91 -25.43 67.88 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.193 -0.458 . . . . 1.38 110.507 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -82.75 -43.26 16.98 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.987 0.422 . . . . 2.26 111.119 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.571 ' HG3' HG12 ' A' ' 50' ' ' ILE . 49.4 mm-40 -86.69 -23.31 25.63 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.217 0.451 . . . . 0.77 112.217 -174.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.0 m -93.42 -28.7 15.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.646 0.26 . . . . 1.23 111.417 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.47 3.16 78.53 Favored Glycine 0 N--CA 1.458 0.162 0 C-N-CA 120.177 -1.011 . . . . 0.54 112.191 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.0 mt -95.61 112.06 27.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.407 -0.59 . . . . 0.8 109.407 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.05 143.81 2.13 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.538 0.524 . . . . 0.57 111.894 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -52.51 -34.04 47.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.792 -0.64 . . . . 0.97 111.763 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -76.04 -10.56 59.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.253 -0.431 . . . . 2.23 111.048 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -114.38 -6.35 12.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 2.24 110.919 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.5 tp -70.46 99.32 1.58 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.226 0.536 . . . . 1.1 110.192 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.435 ' O ' HG21 ' A' ' 75' ' ' VAL . 80.9 p -116.81 158.9 23.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.687 -0.688 . . . . 0.6 109.305 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' A' ' 76' ' ' ARG . 43.4 m-20 -67.38 -7.05 21.87 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.733 0.301 . . . . 2.29 111.427 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -73.36 -24.56 60.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 2.29 110.776 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.544 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 36.0 m -69.17 146.86 52.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.057 0.456 . . . . 1.06 110.573 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.729 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.8 t-20 -129.25 123.38 31.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.186 -1.042 . . . . 0.8 108.186 -177.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.843 ' HD1' HG13 ' A' ' 42' ' ' ILE . 36.1 m-85 -56.29 -51.14 69.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.0 0.429 . . . . 0.47 111.614 -174.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.86 -29.17 64.1 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.535 -0.302 . . . . 0.46 111.359 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.729 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 23.5 t70 -72.11 -35.56 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.431 0.634 . . . . 0.83 110.201 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 45.8 mmm -76.15 -23.76 54.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.21 -0.904 . . . . 2.48 111.177 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.26 30.53 5.32 Favored Glycine 0 C--N 1.323 -0.171 0 C-N-CA 120.328 -0.939 . . . . 0.44 112.408 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.843 HG13 ' HD1' ' A' ' 37' ' ' PHE . 29.6 mm -71.52 107.94 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.415 0.626 . . . . 0.52 109.66 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -81.25 165.28 21.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.066 -0.97 . . . . 1.94 110.844 -173.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.3 t -52.17 -38.93 59.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.689 -0.687 . . . . 1.03 111.283 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.0 tm? -57.1 -60.32 3.78 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.13 -0.486 . . . . 0.59 110.38 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.494 ' O ' HG13 ' A' ' 50' ' ' ILE . 12.8 p -65.77 -33.61 76.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.623 -0.262 . . . . 1.22 111.376 -175.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.511 ' HB3' ' H ' ' A' ' 69' ' ' PHE . 50.5 m -61.38 -35.16 76.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.617 -0.265 . . . . 0.81 111.671 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.1 ttt -84.63 -16.84 40.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 2.25 110.522 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.582 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 74.6 t -88.98 -38.96 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 109.836 -0.431 . . . . 0.36 109.836 -177.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.571 HG12 ' HG3' ' A' ' 23' ' ' GLU . 54.3 mt -53.13 -53.46 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.763 0.316 . . . . 0.26 110.235 172.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.21 -25.3 66.33 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.978 -0.63 . . . . 0.29 112.285 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.624 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 2.9 m -75.28 -45.82 37.43 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 122.829 -0.218 . . . . 0.92 111.023 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.582 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 23.7 mtp180 -63.8 -25.66 68.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 1.23 110.765 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.521 ' HD2' HD11 ' A' ' 62' ' ' LEU . 14.1 m-30 -56.99 -40.89 77.42 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 121.184 0.516 . . . . 0.28 109.896 172.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.624 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 71.5 mtm180 -80.48 -30.02 37.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.74 -0.664 . . . . 2.81 110.757 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.35 -61.72 1.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.073 0.463 . . . . 2.26 111.819 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.61 -35.45 18.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.684 -0.689 . . . . 2.62 111.535 -168.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.55 -33.23 11.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.519 -0.309 . . . . 0.67 111.651 -175.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.69 37.94 11.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.832 -0.699 . . . . 0.45 112.179 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.499 HD12 ' HB3' ' A' ' 54' ' ' PHE . 88.3 mt -80.56 126.61 31.46 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.779 -0.248 . . . . 0.63 110.772 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.24 76.89 4.74 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.845 0.355 . . . . 2.27 110.491 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.521 HD11 ' HD2' ' A' ' 54' ' ' PHE . 68.1 mt -97.77 -77.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.27 0.557 . . . . 1.64 110.857 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.25 170.1 14.0 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.962 -0.855 . . . . 0.75 110.962 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -81.81 -11.21 11.46 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.718 2.278 . . . . 1.13 112.633 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -91.12 6.59 44.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.754 -0.657 . . . . 2.36 111.853 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -93.07 120.03 32.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.927 0.394 . . . . 0.73 111.069 -176.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.1 m -139.89 121.39 15.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 1.39 110.217 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.496 HD12 HD12 ' A' ' 50' ' ' ILE . 52.1 mt -58.81 -31.04 68.08 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.73 111.869 -177.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.511 ' H ' ' HB3' ' A' ' 47' ' ' SER . 1.6 t80 -56.54 -16.26 5.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.858 0.463 . . . . 0.59 111.713 -175.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.9 mt -126.69 -35.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.824 0.345 . . . . 0.89 110.708 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.58 -10.36 49.03 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.575 0.954 . . . . 2.23 113.575 -172.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 75.9 m -150.95 120.21 6.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.248 0.547 . . . . 1.0 110.718 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.3 p -100.34 -51.94 3.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.98 -0.555 . . . . 0.67 110.841 -174.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.1 p -98.19 -175.23 3.06 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.88 -0.328 . . . . 0.38 110.176 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 1.3 t -79.07 -45.71 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.32 0.581 . . . . 0.68 109.781 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.759 ' HA ' ' HG3' ' A' ' 79' ' ' LYS . 4.3 tpp180 -61.93 -25.77 67.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.418 -0.81 . . . . 3.23 110.996 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.07 -34.67 72.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.71 0.29 . . . . 0.29 110.511 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.699 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.7 OUTLIER -72.09 -48.68 42.23 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.707 -0.849 . . . . 0.64 108.707 176.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.759 ' HG3' ' HA ' ' A' ' 76' ' ' ARG . 16.2 mmtp -50.59 -56.17 12.97 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.071 -0.968 . . . . 2.4 110.38 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -57.44 -33.61 68.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.726 -1.125 . . . . 1.66 111.423 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -72.17 -34.94 68.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.09 0.472 . . . . 0.99 110.93 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.699 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 38.6 mtp . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 1.1 111.487 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.44 0 N-CA-C 111.283 -0.727 . . . . 0.53 111.283 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.864 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 4.2 m -108.73 157.44 8.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.947 0.403 . . . . 0.39 110.989 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -85.97 174.7 9.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.355 -0.609 . . . . 1.56 109.355 174.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -21.98 65.29 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.499 -0.926 . . . . 2.02 108.499 176.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.25 -53.02 61.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.863 -1.062 . . . . 1.91 110.799 175.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.864 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 40.7 mmtm -71.16 -23.57 62.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.278 -0.419 . . . . 1.58 110.247 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.43 HD11 ' HD3' ' A' ' 79' ' ' LYS . 14.1 tp -74.9 -26.68 59.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.906 -0.588 . . . . 0.99 110.144 174.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -29.61 27.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.512 0.672 . . . . 0.88 109.751 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.718 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -82.86 -27.04 31.06 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.664 -0.698 . . . . 0.3 111.359 -175.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.55 -44.22 83.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.64 -0.424 . . . . 0.23 111.328 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.2 mtp -64.29 -30.6 71.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.317 -0.402 . . . . 1.63 110.622 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.718 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 30.3 ptt180 -74.2 -27.01 60.6 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.009 -0.276 . . . . 3.17 110.852 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.0 t -83.07 -33.47 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.76 0.791 . . . . 0.23 108.923 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 t -68.01 -34.2 65.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.636 -1.166 . . . . 0.33 110.232 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 49.4 m -58.33 -52.7 64.49 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.029 0.442 . . . . 1.38 110.637 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -54.04 -59.08 5.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.947 -1.024 . . . . 2.26 112.438 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -79.64 -17.49 53.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.89 -0.595 . . . . 0.77 112.566 -167.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -97.75 -35.46 10.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.879 0.371 . . . . 1.23 111.081 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.78 8.14 58.38 Favored Glycine 0 CA--C 1.516 0.111 0 C-N-CA 120.352 -0.928 . . . . 0.54 111.472 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 21' ' ' SER . 8.1 mt -104.38 107.81 23.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.818 -0.438 . . . . 0.8 109.818 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.18 148.87 17.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.57 110.977 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 tp -49.75 -32.79 14.52 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.077 0.551 . . . . 0.97 111.551 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -73.35 -21.92 60.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.344 -0.389 . . . . 2.23 111.527 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -108.95 -1.76 18.79 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.313 0.577 . . . . 2.24 109.686 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.486 ' HA ' HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -76.31 96.73 4.04 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.835 -0.802 . . . . 1.1 108.835 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.7 p -104.56 156.2 18.17 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.454 -0.794 . . . . 0.6 108.934 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.592 ' HB2' ' HD3' ' A' ' 76' ' ' ARG . 7.9 p-10 -74.04 -13.03 60.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.026 0.441 . . . . 2.29 110.534 -176.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -89.04 -22.89 22.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.428 -0.806 . . . . 2.29 111.577 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 m -67.71 149.15 50.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.414 0.626 . . . . 1.06 110.366 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.517 ' HB3' ' CB ' ' A' ' 39' ' ' ASP . 3.0 t-20 -109.76 125.23 52.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.531 -0.758 . . . . 0.8 110.592 -171.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.69 ' HD1' HG13 ' A' ' 42' ' ' ILE . 30.6 m-85 -55.01 -50.68 68.43 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.959 0.409 . . . . 0.47 110.893 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.36 -32.19 73.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.98 -0.555 . . . . 0.46 111.591 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.517 ' CB ' ' HB3' ' A' ' 36' ' ' ASN . 16.0 t70 -71.31 -35.49 71.27 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.564 0.697 . . . . 0.83 109.656 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 tpp -76.25 -20.46 57.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.895 -1.048 . . . . 2.48 110.849 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.0 25.24 6.55 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.411 -0.899 . . . . 0.44 112.586 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.69 HG13 ' HD1' ' A' ' 37' ' ' PHE . 27.1 mm -67.61 107.68 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.356 0.598 . . . . 0.52 110.378 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -82.43 170.63 15.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.402 -0.817 . . . . 1.94 110.51 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.6 p -56.85 -40.74 76.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.33 -0.395 . . . . 1.03 110.179 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.27 -53.31 59.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.94 -0.573 . . . . 0.59 109.818 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.518 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.6 m -62.62 -42.37 99.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 1.22 110.849 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.539 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 49.1 m -60.04 -39.06 84.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.81 110.985 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.7 ttp -67.62 -46.18 73.24 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.544 0.688 . . . . 2.25 109.216 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.457 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.6 t -57.87 -55.24 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.417 -1.265 . . . . 0.36 110.618 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 46' ' ' SER . 63.0 mt -50.94 -52.78 16.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.616 0.246 . . . . 0.26 111.251 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -58.76 -37.15 89.54 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.948 -0.644 . . . . 0.29 112.098 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -44.47 79.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.592 0.234 . . . . 0.92 110.728 177.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -67.99 -21.85 65.04 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.013 -0.275 . . . . 1.23 110.318 -177.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 11.7 m-30 -58.86 -43.4 90.82 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.44 -0.578 . . . . 0.28 109.44 170.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -77.59 -28.51 51.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.464 -0.789 . . . . 2.81 110.077 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 53' ' ' ARG . 53.8 mt-10 -71.52 -63.91 1.03 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.224 0.535 . . . . 2.26 111.395 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -87.89 -35.72 17.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.494 -0.775 . . . . 2.62 111.927 -169.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 58' ' ' LEU . 7.8 mp -98.69 -40.06 8.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.812 0.339 . . . . 0.67 111.114 -173.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.16 31.37 7.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.859 -0.686 . . . . 0.45 112.417 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 96.0 mt -81.77 102.15 10.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.742 0.306 . . . . 0.63 110.521 177.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -91.84 69.9 5.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.063 0.459 . . . . 2.27 110.938 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.413 HD13 ' HE2' ' A' ' 81' ' ' PHE . 80.3 mt -88.13 -7.25 57.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.986 -0.552 . . . . 1.64 110.53 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.12 173.99 21.21 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.562 -0.828 . . . . 0.75 111.998 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.56 -8.9 6.01 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.971 2.447 . . . . 1.13 112.471 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -88.0 3.65 48.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.459 -0.791 . . . . 2.36 110.584 -174.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -91.18 120.45 32.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.909 -0.587 . . . . 0.73 110.479 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.4 m -140.18 122.42 15.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.956 -0.565 . . . . 1.39 110.035 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.2 mt -56.04 -46.73 78.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.081 -0.508 . . . . 0.73 111.341 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.539 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.1 t80 -56.58 -12.18 1.66 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.727 -0.669 . . . . 0.59 112.417 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.5 mt -115.22 -40.54 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.793 -0.363 . . . . 0.89 111.489 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -118.32 9.07 12.37 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.361 0.504 . . . . 2.23 112.361 -171.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.8 m -145.1 114.38 7.06 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.7 -0.625 . . . . 1.0 110.085 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.7 p -98.79 -74.21 0.59 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.85 -0.614 . . . . 0.67 110.99 -170.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -83.48 -173.56 4.78 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.981 -0.449 . . . . 0.38 110.59 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 11.7 t -84.16 -38.28 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.756 0.788 . . . . 0.68 109.206 -176.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.592 ' HD3' ' HB2' ' A' ' 33' ' ' ASP . 6.6 tpt180 -57.95 -33.79 69.21 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.252 -1.34 . . . . 3.23 110.443 175.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.89 83.08 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.592 -0.276 . . . . 0.29 111.012 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.764 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.2 tt -69.92 -49.88 47.6 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.932 -0.766 . . . . 0.64 108.932 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 3.1 mmpm? -53.32 -56.32 17.61 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.044 -0.98 . . . . 2.4 110.853 178.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -56.27 -35.31 67.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.188 -0.915 . . . . 1.66 111.36 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.413 ' HE2' HD13 ' A' ' 62' ' ' LEU . 70.4 t80 -69.92 -35.82 74.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.108 0.48 . . . . 0.99 111.121 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.764 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 32.2 mtp . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.042 -0.526 . . . . 1.1 110.97 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 111.518 -0.633 . . . . 0.53 111.518 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.93 158.26 10.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.664 0.269 . . . . 0.39 110.448 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.2 m -73.25 166.13 23.73 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.239 -0.437 . . . . 1.56 110.324 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -59.82 -27.59 66.74 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.526 0.679 . . . . 2.02 109.4 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -50.7 -53.4 31.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.966 -1.016 . . . . 1.91 111.753 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -66.88 -30.35 70.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.205 -0.598 . . . . 1.58 110.242 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.26 -22.9 61.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.99 110.933 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.55 -30.3 25.19 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.131 0.491 . . . . 0.88 110.625 173.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.605 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -79.59 -34.13 41.03 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.3 110.867 -177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.487 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 2.9 p -58.11 -36.38 56.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.066 0.46 . . . . 0.23 110.937 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.9 mtm -69.39 -30.11 68.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.814 -0.63 . . . . 1.63 110.945 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 24.6 ptt180 -72.26 -30.79 65.19 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 120.34 -0.544 . . . . 3.17 109.758 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.6 t -79.61 -38.33 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.654 0.74 . . . . 0.23 109.175 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.9 t -62.21 -47.66 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.608 -1.178 . . . . 0.33 110.361 175.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -62.09 -38.88 90.54 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.684 0.253 . . . . 1.38 111.684 -176.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 18.2 mm-40 -62.69 -46.72 86.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.508 -0.314 . . . . 2.26 111.557 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -83.47 -26.18 30.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.366 0.506 . . . . 0.77 112.366 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.438 ' HA ' HD11 ' A' ' 42' ' ' ILE . 78.8 p -84.61 -45.24 12.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 1.23 110.444 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.88 5.64 53.27 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.795 -0.717 . . . . 0.54 112.004 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mt -93.36 132.85 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.718 -0.284 . . . . 0.8 110.275 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 144.68 53.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.293 -0.412 . . . . 0.57 110.979 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -36.51 68.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.909 -0.587 . . . . 0.97 110.48 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -70.38 -14.0 62.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.984 -0.553 . . . . 2.23 110.912 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -107.17 -4.86 18.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.017 -0.538 . . . . 2.24 110.655 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.1 tp -78.82 96.79 5.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.46 0.648 . . . . 1.1 109.873 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.6 p -124.17 167.87 13.68 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.273 -1.01 . . . . 0.6 108.273 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.689 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 2.5 p30 -71.61 -3.22 20.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.853 -0.339 . . . . 2.29 111.409 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -75.68 -20.84 58.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.949 0.404 . . . . 2.29 110.214 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.511 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 19.4 m -73.33 148.58 43.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.116 0.484 . . . . 1.06 110.214 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.1 t-20 -128.18 117.38 21.47 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.852 -0.795 . . . . 0.8 108.852 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.809 ' HD1' HG13 ' A' ' 42' ' ' ILE . 30.0 m-85 -52.67 -54.43 33.56 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.979 0.418 . . . . 0.47 111.524 -174.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.21 -25.94 64.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.869 -0.605 . . . . 0.46 111.669 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.759 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 38.7 t70 -81.53 -20.51 39.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.321 0.581 . . . . 0.83 111.116 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -85.61 -24.38 27.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.856 -0.611 . . . . 2.48 109.9 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.41 13.4 6.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.585 -0.817 . . . . 0.44 112.67 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.809 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.0 mm -67.82 107.82 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.94 0.4 . . . . 0.52 110.082 176.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -78.74 179.6 7.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.912 -0.586 . . . . 1.94 110.453 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.4 p -57.99 -36.22 72.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.528 -0.76 . . . . 1.03 109.791 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.44 -60.46 3.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.801 -1.091 . . . . 0.59 110.029 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.529 ' O ' HG13 ' A' ' 50' ' ' ILE . 1.3 m -57.72 -47.33 82.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.524 . . . . 1.22 111.353 -177.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.914 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 50.9 p -65.94 -29.06 69.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.893 0.377 . . . . 0.81 111.298 -176.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.5 tpt -76.31 -35.48 58.8 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.532 -0.544 . . . . 2.25 109.532 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.543 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 37.6 t -65.12 -50.16 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.334 -0.848 . . . . 0.36 109.533 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 46' ' ' SER . 60.2 mt -52.7 -53.26 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.26 111.061 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.12 -41.62 98.18 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.03 -0.605 . . . . 0.29 112.407 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 t -59.62 -44.7 93.36 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.792 0.329 . . . . 0.92 110.707 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 56.6 mtp180 -68.14 -20.57 64.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.395 -0.366 . . . . 1.23 111.691 -175.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.579 ' HD2' HD11 ' A' ' 62' ' ' LEU . 15.9 m-30 -59.86 -42.27 93.31 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.37 0.605 . . . . 0.28 109.595 171.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 67.4 mtp180 -74.1 -25.98 60.1 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.184 -0.916 . . . . 2.81 110.196 -177.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -77.82 -63.75 1.31 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.765 -0.652 . . . . 2.26 111.577 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.69 -46.79 10.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.679 -0.692 . . . . 2.62 111.964 -170.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.2 -26.43 25.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.233 -0.44 . . . . 0.67 111.042 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.49 33.28 31.8 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.785 -0.721 . . . . 0.45 112.365 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.613 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 60.2 mt -89.65 104.95 17.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.797 -0.446 . . . . 0.63 109.797 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -85.35 77.87 9.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.707 0.765 . . . . 2.27 109.826 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.579 HD11 ' HD2' ' A' ' 54' ' ' PHE . 30.5 mt -75.77 -73.44 0.26 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.675 -1.148 . . . . 1.64 111.199 -176.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 163.2 154.98 7.9 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.46 -0.791 . . . . 0.75 111.132 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.74 -6.49 14.34 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.392 2.062 . . . . 1.13 112.034 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -103.7 2.08 32.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.589 -0.732 . . . . 2.36 109.948 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -92.48 123.08 35.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.044 -0.526 . . . . 0.73 110.571 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.9 m -137.79 128.45 26.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.056 -0.52 . . . . 1.39 109.976 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.914 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 32.9 mt -56.56 -33.44 66.13 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 120.635 0.255 . . . . 0.73 110.833 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.507 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 24.6 t80 -58.1 -17.48 18.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.045 -0.525 . . . . 0.59 111.633 -174.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.8 mt -125.09 -38.69 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.597 -0.274 . . . . 0.89 111.009 176.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -96.41 4.36 52.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.665 0.617 . . . . 2.23 112.665 -170.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.3 m -155.45 93.94 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.426 0.631 . . . . 1.0 109.577 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.9 p -80.02 -68.61 0.66 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.473 -0.785 . . . . 0.67 109.707 -171.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 65.2 p -86.5 -170.52 3.12 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.673 -0.491 . . . . 0.38 109.673 175.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.3 t -81.58 -38.13 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 108.87 -0.789 . . . . 0.68 108.87 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.689 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 5.8 tpt180 -62.97 -30.11 71.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.52 -1.218 . . . . 3.23 110.44 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.19 -34.72 75.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.239 -0.437 . . . . 0.29 110.986 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.535 HD21 ' CE2' ' A' ' 54' ' ' PHE . 1.1 tt -73.89 -47.28 39.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.438 0.637 . . . . 0.64 109.349 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 31.3 mmtp -54.91 -46.81 74.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.82 -1.082 . . . . 2.4 110.959 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.59 -48.53 80.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.502 -0.772 . . . . 1.66 111.577 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -55.53 -37.62 68.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.819 -0.628 . . . . 0.99 111.781 -175.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.487 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 18.7 mtt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 1.1 111.799 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.834 -0.432 . . . . 9.14 109.834 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 73.8 mtm 62.71 80.38 0.23 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.819 0.699 . . . . 8.72 109.262 -174.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 72.15 123.05 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.2 -0.909 . . . . 5.17 110.216 -170.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 3' ' ' ALA . 63.6 tttp 68.53 126.16 0.03 OUTLIER 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.31 -0.859 . . . . 6.66 111.703 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.74 -131.31 6.59 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.82 -0.705 . . . . 1.74 111.685 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.14 -75.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.88 0.371 . . . . 1.14 110.148 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 83' ' ' LEU . . . 108.04 105.62 3.01 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.615 -0.802 . . . . 0.53 112.239 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 m -119.38 158.24 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.55 -0.537 . . . . 0.39 109.55 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 p -83.74 172.85 11.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.186 -0.301 . . . . 1.56 110.186 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -70.23 -16.76 63.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.279 0.561 . . . . 2.02 110.196 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -66.27 -47.69 72.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.367 -0.833 . . . . 1.91 109.702 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -68.99 -27.56 65.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.884 -0.598 . . . . 1.58 109.926 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -24.81 63.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.478 -0.783 . . . . 0.99 110.688 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.26 -32.78 26.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.385 0.612 . . . . 0.88 110.246 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.08 -27.32 57.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.3 111.051 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.626 HG11 ' HZ1' ' A' ' 79' ' ' LYS . 2.8 p -70.65 -40.73 77.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.053 -0.521 . . . . 0.23 111.674 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.4 mtp -61.49 -31.14 71.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 1.63 111.309 -173.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -78.69 -27.76 45.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.589 -0.444 . . . . 3.17 111.101 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.527 HG13 ' HD3' ' A' ' 53' ' ' ARG . 42.3 t -73.72 -37.63 49.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.525 -0.917 . . . . 0.23 108.525 176.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 t -65.14 -44.08 95.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.413 -1.267 . . . . 0.33 110.433 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.5 p -56.01 -50.47 70.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.231 0.539 . . . . 1.38 110.346 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -55.37 -53.92 50.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.968 -1.015 . . . . 2.26 112.749 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -82.66 -16.43 48.28 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.62 0.6 . . . . 0.77 112.62 -170.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 81.6 p -91.72 -36.48 13.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.093 0.473 . . . . 1.23 110.722 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.87 -0.01 56.36 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.844 -0.693 . . . . 0.54 111.685 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.61 HD11 ' HG2' ' A' ' 40' ' ' MET . 3.1 mt -93.91 123.98 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 109.517 -0.549 . . . . 0.8 109.517 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.66 141.76 36.59 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.315 0.385 . . . . 0.57 111.101 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.14 -34.14 59.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.899 -0.591 . . . . 0.97 111.227 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.35 -10.42 59.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 2.23 111.292 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -109.99 -3.85 16.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.971 0.415 . . . . 2.24 110.231 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.9 tp -74.31 99.34 3.45 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.387 0.613 . . . . 1.1 110.239 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.405 ' O ' HG21 ' A' ' 75' ' ' VAL . 44.6 p -121.73 164.53 17.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.271 -0.877 . . . . 0.6 108.857 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -65.97 -9.88 34.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.801 0.334 . . . . 2.29 111.307 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.92 -19.6 60.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 2.29 110.487 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.521 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 18.3 m -71.5 143.08 50.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.038 0.446 . . . . 1.06 109.835 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.663 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.9 t-20 -128.43 117.87 22.12 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.579 -0.526 . . . . 0.8 109.579 -176.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.644 ' HD1' HG13 ' A' ' 42' ' ' ILE . 48.1 m-85 -55.36 -39.7 70.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.889 0.376 . . . . 0.47 111.698 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.23 -29.25 60.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.875 0.369 . . . . 0.46 111.212 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.663 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 34.6 t70 -74.81 -31.15 61.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.185 0.517 . . . . 0.83 110.267 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.61 ' HG2' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -81.04 -14.65 57.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.401 -0.818 . . . . 2.48 110.761 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.67 42.87 6.29 Favored Glycine 0 CA--C 1.511 -0.207 0 C-N-CA 120.378 -0.915 . . . . 0.44 112.153 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.644 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.6 mm -75.54 107.28 6.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.988 0.423 . . . . 0.52 109.903 176.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -80.19 175.19 10.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.438 0.637 . . . . 1.94 111.82 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 t -52.86 -42.86 65.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.557 -1.201 . . . . 1.03 111.189 177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.36 -61.64 2.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.99 -0.55 . . . . 0.59 110.257 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.511 ' O ' HG13 ' A' ' 50' ' ' ILE . 29.0 t -61.18 -47.09 87.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.473 -0.33 . . . . 1.22 111.601 -175.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.469 ' HB3' HG22 ' A' ' 42' ' ' ILE . 51.0 p -62.38 -27.44 69.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.682 0.253 . . . . 0.81 111.682 -176.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.647 ' SD ' ' H32' ' A' ' 90' ' ' PNS . 13.9 ttt -80.36 -39.9 27.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.246 0.546 . . . . 2.25 109.841 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.85 -42.21 95.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.315 -0.857 . . . . 0.36 109.986 -177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 46' ' ' SER . 73.8 mt -56.75 -58.18 6.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.932 -0.576 . . . . 0.26 111.232 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -65.35 -23.73 70.26 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.607 -0.806 . . . . 0.29 112.398 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.617 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -69.63 -45.71 67.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.803 -0.443 . . . . 0.92 109.803 175.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.527 ' HD3' HG13 ' A' ' 19' ' ' VAL . 41.1 mtp180 -61.27 -31.99 71.81 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.428 -0.351 . . . . 1.23 110.533 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.474 ' CE2' HD21 ' A' ' 78' ' ' LEU . 13.1 m-30 -53.68 -40.58 66.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.892 -0.594 . . . . 0.28 110.02 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.617 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 53.2 mtm180 -81.04 -37.76 28.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.068 -0.514 . . . . 2.81 111.142 -175.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -87.86 -52.45 5.28 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.316 0.488 . . . . 2.26 112.316 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -80.41 -42.24 23.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.807 -0.633 . . . . 2.62 111.18 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.2 mp -96.08 -33.0 12.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.405 -0.361 . . . . 0.67 111.685 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.23 35.07 9.05 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.516 -0.85 . . . . 0.45 112.101 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.2 mt -87.08 131.15 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.582 0.23 . . . . 0.63 110.939 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -89.33 47.11 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.639 -0.504 . . . . 2.27 109.639 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -59.16 4.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.188 -0.915 . . . . 1.64 110.726 -174.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' ' HD3' ' A' ' 55' ' ' ARG . . . 172.41 167.86 33.01 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.629 -0.588 . . . . 0.75 111.629 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.89 -37.08 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.465 2.11 . . . . 1.13 113.38 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.14 45.34 2.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.308 0.575 . . . . 2.36 110.438 -175.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -74.2 112.53 10.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.448 -0.797 . . . . 0.73 109.876 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.1 p -118.3 129.04 55.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.234 0.54 . . . . 1.39 111.173 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.482 HD12 HD12 ' A' ' 50' ' ' ILE . 75.3 mt -76.2 2.96 11.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 0.73 111.672 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.69 -17.7 22.93 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.122 -0.49 . . . . 0.59 110.15 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.2 mt -132.26 -37.39 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.093 0.473 . . . . 0.89 111.141 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.78 -2.8 46.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.684 0.754 . . . . 2.23 110.683 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.436 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 98.5 m -147.23 157.8 43.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.167 -0.924 . . . . 1.0 108.735 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.3 p -129.95 -73.41 0.56 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.163 -0.215 . . . . 0.67 111.276 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.2 p -90.25 -171.58 3.16 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.246 -0.284 . . . . 0.38 110.625 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.521 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 1.8 t -79.47 -44.33 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.568 -0.53 . . . . 0.68 109.568 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -59.15 -32.69 70.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.691 -0.686 . . . . 3.23 110.985 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -56.68 -37.16 70.48 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.35 -0.386 . . . . 0.29 111.171 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.509 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -74.28 -43.2 57.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.536 0.684 . . . . 0.64 109.398 178.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.716 ' NZ ' ' HA ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -53.92 -61.33 2.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.618 -1.174 . . . . 2.4 112.102 178.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.99 -37.83 77.76 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.107 0.254 . . . . 1.66 111.596 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 3.7 t80 -52.69 -39.65 62.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.598 0.561 . . . . 0.99 111.067 -176.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.509 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 7.9 mtt -55.85 -38.46 70.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.564 -0.744 . . . . 1.1 112.092 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 83' ' ' LEU . 4.2 mp -94.74 -42.43 8.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.036 0.446 . . . . 1.3 110.289 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.25 41.11 7.6 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.938 -0.649 . . . . 2.42 111.666 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 t -91.5 8.65 35.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.021 0.915 . . . . 4.47 110.597 -173.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.27 -27.57 10.68 Favored Glycine 0 C--N 1.307 -1.057 0 CA-C-N 114.426 -1.261 . . . . 4.59 111.074 172.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 t70 52.42 41.2 30.67 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.394 0.678 . . . . 6.61 110.458 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.24 -20.13 57.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.725 -0.67 . . . . 8.47 110.74 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.327 -1.263 . . . . 9.73 111.629 178.584 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . 0.647 ' H32' ' SD ' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 110.605 -0.146 . . . . 9.14 110.605 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 89.9 mtp 71.46 157.55 0.18 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.036 0.835 . . . . 8.72 110.932 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.64 135.3 14.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.098 0.475 . . . . 5.17 111.61 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 58.8 tttp -152.13 23.54 0.65 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.102 0.953 . . . . 6.66 109.304 175.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.08 -146.28 14.65 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.353 -0.839 . . . . 1.74 111.944 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.56 -78.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 110.051 -0.351 . . . . 1.14 110.051 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.91 86.62 0.23 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.581 -0.819 . . . . 0.53 111.809 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG21 ' SD ' ' A' ' 82' ' ' MET . 5.9 m -97.93 158.37 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.963 -0.384 . . . . 0.39 109.963 -175.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.4 t -83.86 -177.11 6.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.844 -0.428 . . . . 1.56 109.844 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -71.83 -22.03 61.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.005 0.431 . . . . 2.02 110.603 -174.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -73.96 -41.6 61.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.462 -0.495 . . . . 1.91 110.076 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -66.71 -30.87 71.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.893 -0.78 . . . . 1.58 108.893 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.1 tp -69.78 -26.19 64.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.975 -1.012 . . . . 0.99 110.701 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.28 -27.07 24.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.414 0.626 . . . . 0.88 110.095 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.76 -35.36 57.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.687 -0.688 . . . . 0.3 110.802 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.519 HG21 HD22 ' A' ' 78' ' ' LEU . 3.6 p -61.68 -45.42 98.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.989 -0.551 . . . . 0.23 110.624 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.1 mtm -59.39 -39.0 81.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.796 -0.638 . . . . 1.63 111.52 -174.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HA ' ' HB2' ' A' ' 21' ' ' SER . 11.8 ptt180 -74.07 -29.38 61.85 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.087 -0.645 . . . . 3.17 111.569 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.6 t -71.68 -33.01 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.087 0.946 . . . . 0.23 108.56 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -70.66 -43.63 77.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.032 -1.44 . . . . 0.33 109.712 175.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' A' ' 18' ' ' ARG . 6.3 m -62.66 -21.87 66.03 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 122.748 0.419 . . . . 1.38 111.828 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -86.09 -51.71 6.15 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.316 -0.402 . . . . 2.26 111.365 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 15.2 mm-40 -90.49 -27.94 18.88 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.104 0.409 . . . . 0.77 112.104 -172.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.441 ' HB3' HD11 ' A' ' 42' ' ' ILE . 17.5 m -86.4 -32.44 20.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.114 0.483 . . . . 1.23 110.544 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.41 -9.53 62.82 Favored Glycine 0 C--O 1.23 -0.111 0 C-N-CA 120.503 -0.856 . . . . 0.54 112.682 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mt -79.37 104.77 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.623 -0.51 . . . . 0.8 109.623 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.567 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -43.67 145.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.857 0.723 . . . . 0.57 112.02 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.4 tp -56.47 -31.5 64.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.705 -0.679 . . . . 0.97 111.002 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -80.39 -9.75 59.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.057 -0.519 . . . . 2.23 111.181 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.567 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 40.6 mm-40 -110.71 -13.9 14.11 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.192 -0.458 . . . . 2.24 110.052 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.8 tp -69.6 98.14 1.12 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.639 -0.71 . . . . 1.1 110.27 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.1 p -107.62 161.84 14.5 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.361 -0.836 . . . . 0.6 108.969 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.741 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 7.5 p-10 -75.54 -9.05 58.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.765 0.317 . . . . 2.29 111.064 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -91.02 -23.65 20.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.416 0.525 . . . . 2.29 112.416 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.7 m -71.3 148.44 47.12 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.423 0.63 . . . . 1.06 110.011 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.764 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 4.4 t-20 -113.24 123.49 50.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.417 -0.81 . . . . 0.8 109.812 -170.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.787 ' HD1' HG13 ' A' ' 42' ' ' ILE . 32.3 m-85 -56.49 -53.1 61.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.964 0.412 . . . . 0.47 111.587 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.06 -27.91 66.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.179 -0.464 . . . . 0.46 111.321 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.764 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 23.4 t70 -72.06 -32.65 67.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.397 0.617 . . . . 0.83 110.251 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.575 ' HA ' ' CE ' ' A' ' 40' ' ' MET . 4.8 mmt -83.48 -13.99 53.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.252 -0.885 . . . . 2.48 111.178 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.82 36.07 6.2 Favored Glycine 0 N--CA 1.457 0.071 0 C-N-CA 120.063 -1.065 . . . . 0.44 112.516 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.787 HG13 ' HD1' ' A' ' 37' ' ' PHE . 32.7 mm -73.19 108.07 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.201 0.524 . . . . 0.52 110.013 175.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.29 163.84 27.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.539 -0.755 . . . . 1.94 111.351 -173.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.5 t -54.49 -37.3 65.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.293 -0.867 . . . . 1.03 111.054 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.77 -61.54 2.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.59 110.203 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.574 ' O ' HG13 ' A' ' 50' ' ' ILE . 11.6 m -62.68 -42.89 99.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.433 -0.349 . . . . 1.22 111.69 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.564 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 57.6 p -63.86 -32.18 73.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.95 0.405 . . . . 0.81 111.204 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.9 tpt -75.78 -39.85 56.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.326 0.584 . . . . 2.25 109.734 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.9 t -60.25 -45.82 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 115.292 -0.867 . . . . 0.36 109.97 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 46' ' ' SER . 78.8 mt -55.56 -54.31 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.932 -0.576 . . . . 0.26 111.355 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.35 -36.36 92.36 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.736 -0.745 . . . . 0.29 112.419 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 m -61.36 -47.44 85.84 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 120.591 -0.443 . . . . 0.92 110.108 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -61.48 -32.25 72.25 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.431 -0.349 . . . . 1.23 111.31 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.502 ' HD2' HD11 ' A' ' 62' ' ' LEU . 11.0 m-30 -53.09 -38.95 62.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.151 0.5 . . . . 0.28 110.21 176.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -83.54 -29.77 27.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.482 -0.781 . . . . 2.81 111.116 -175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -85.12 -62.17 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.268 0.556 . . . . 2.26 111.044 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -44.31 52.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.116 -0.947 . . . . 2.62 111.094 -173.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 mp -93.7 -32.18 14.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.378 -0.374 . . . . 0.67 111.312 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.99 29.76 30.59 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.681 -0.771 . . . . 0.45 112.354 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.8 mt -82.54 108.15 15.72 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.731 -0.47 . . . . 0.63 109.731 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -81.18 78.43 7.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.641 0.734 . . . . 2.27 109.353 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.502 HD11 ' HD2' ' A' ' 54' ' ' PHE . 27.1 mt -76.07 -71.97 0.35 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.326 -1.306 . . . . 1.64 110.995 -176.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.98 169.45 38.91 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.415 -0.811 . . . . 0.75 111.289 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.23 -15.46 11.46 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.672 2.248 . . . . 1.13 113.006 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -119.12 10.87 12.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.313 -0.403 . . . . 2.36 111.19 -174.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.451 ' CD2' HD13 ' A' ' 62' ' ' LEU . 73.2 t80 -71.93 112.85 8.37 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.948 0.404 . . . . 0.73 110.488 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.7 m -131.13 121.24 24.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.692 -0.686 . . . . 1.39 109.628 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.647 HD21 HD11 ' A' ' 78' ' ' LEU . 2.5 mp -54.12 -32.12 54.19 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.24 0.459 . . . . 0.73 112.24 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.564 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 1.8 t80 -65.99 -14.57 61.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.946 0.403 . . . . 0.59 110.855 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.0 mt -124.0 -39.01 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.514 -0.312 . . . . 0.89 110.671 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -95.15 6.09 50.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 2.23 111.796 -172.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.493 ' SG ' ' HG ' ' A' ' 78' ' ' LEU . 80.1 m -148.96 100.71 3.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.554 0.693 . . . . 1.0 109.983 -175.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.8 p -90.02 -72.88 0.54 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.694 -0.685 . . . . 0.67 110.194 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 77.5 p -86.67 -177.67 6.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.415 -0.587 . . . . 0.38 109.415 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.7 t -80.21 -40.68 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 120.361 -0.536 . . . . 0.68 110.419 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.741 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 8.4 tpt180 -54.67 -32.22 58.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.926 -0.579 . . . . 3.23 110.533 173.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -59.42 -31.57 69.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.29 111.739 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.647 HD11 HD21 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -81.7 -45.28 15.93 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.706 -0.85 . . . . 0.64 108.706 -179.007 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -53.2 -61.56 2.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.945 -1.48 . . . . 2.4 110.832 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.17 -19.05 63.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.937 -1.029 . . . . 1.66 111.019 -173.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 83.4 t80 -63.06 -42.66 99.75 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.278 0.561 . . . . 0.99 109.596 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.46 ' SD ' HG21 ' A' ' 8' ' ' VAL . 12.5 mtt -55.76 -38.11 69.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.203 -0.908 . . . . 1.1 111.385 175.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.5 mp -79.34 -46.35 17.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.353 . . . . 1.3 111.243 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.03 81.33 0.35 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.875 -0.679 . . . . 2.42 112.397 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.3 p -82.68 67.9 8.92 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.758 -0.221 . . . . 4.47 111.291 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.66 91.2 0.09 OUTLIER Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.681 -0.771 . . . . 4.59 112.768 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.05 -48.81 61.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.385 0.612 . . . . 6.61 110.561 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.55 24.21 4.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.548 -0.751 . . . . 8.47 111.218 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.551 -1.138 . . . . 9.73 112.271 -179.852 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.739 -0.467 . . . . 9.14 109.739 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -78.52 132.09 37.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.61 -0.268 . . . . 8.72 110.61 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -147.74 132.04 17.5 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.817 -0.809 . . . . 5.17 108.817 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -142.65 132.09 23.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.217 -0.447 . . . . 6.66 110.127 -175.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.64 76.39 1.25 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.729 -0.748 . . . . 1.74 111.652 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.68 -62.13 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.785 0.326 . . . . 1.14 110.855 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.82 84.55 1.79 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.78 -0.724 . . . . 0.53 111.557 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' A' ' 12' ' ' LYS . 2.7 m -114.39 157.49 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.929 -0.397 . . . . 0.39 109.929 -176.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.1 t -91.4 175.12 7.04 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.845 -0.798 . . . . 1.56 108.845 173.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -67.08 -23.27 65.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.977 0.417 . . . . 2.02 110.08 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -47.51 84.46 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.469 -0.787 . . . . 1.91 110.903 172.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.615 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -71.74 -25.23 61.97 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.554 -0.536 . . . . 1.58 109.554 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.579 ' HA ' HG12 ' A' ' 16' ' ' VAL . 4.0 tp -72.22 -29.21 63.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.07 -0.514 . . . . 0.99 110.421 173.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.39 -24.0 57.14 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.023 0.916 . . . . 0.88 109.301 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.35 -36.89 20.47 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.72 -1.127 . . . . 0.3 110.884 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.581 HG23 ' CZ ' ' A' ' 54' ' ' PHE . 4.0 p -70.61 -44.11 77.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.873 -0.603 . . . . 0.23 112.295 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.451 ' HB3' HD23 ' A' ' 31' ' ' LEU . 88.5 mtp -60.0 -32.56 70.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.847 0.314 . . . . 1.63 111.847 -173.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.57 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 8.2 ptt180 -84.24 -18.25 37.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.37 0.507 . . . . 3.17 112.37 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.8 t -80.29 -32.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.188 -1.042 . . . . 0.23 108.188 172.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 t -66.71 -39.88 84.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.21 -1.359 . . . . 0.33 110.122 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.5 p -64.37 -49.3 72.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.217 0.532 . . . . 1.38 110.71 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 7.2 mm-40 -60.94 -39.4 89.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.401 -0.818 . . . . 2.26 112.24 -178.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -80.14 -31.94 38.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.951 0.352 . . . . 0.77 111.951 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.436 ' HA ' HD11 ' A' ' 42' ' ' ILE . 72.7 p -82.4 -44.59 15.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.886 0.374 . . . . 1.23 111.558 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.91 6.7 37.06 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.654 -0.784 . . . . 0.54 111.705 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.697 HD11 ' HG2' ' A' ' 40' ' ' MET . 3.5 mt -97.61 137.07 26.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.501 -0.555 . . . . 0.8 109.501 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.35 141.99 58.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.742 0.306 . . . . 0.57 110.415 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.5 tp -55.98 -34.48 65.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.97 111.28 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -71.47 -10.45 59.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 2.23 111.378 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -111.61 -4.22 14.83 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.497 -0.319 . . . . 2.24 111.103 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 17' ' ' MET . 30.0 tp -72.05 97.88 1.98 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.516 0.674 . . . . 1.1 110.472 -173.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 34' ' ' ASP . 70.0 p -124.95 165.8 17.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.193 -0.912 . . . . 0.6 109.052 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.496 ' CB ' ' HB2' ' A' ' 76' ' ' ARG . 7.7 p-10 -70.83 -5.87 33.62 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.206 0.527 . . . . 2.29 110.484 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.435 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 24.5 t70 -70.56 -22.04 62.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.202 -0.908 . . . . 2.29 109.687 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.467 ' HB2' HG21 ' A' ' 75' ' ' VAL . 14.1 m -81.29 147.45 29.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.648 -0.706 . . . . 1.06 109.901 176.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.7 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 3.7 t-20 -127.64 119.78 26.64 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.074 -0.713 . . . . 0.8 109.074 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.621 ' HD1' HG13 ' A' ' 42' ' ' ILE . 5.5 m-85 -51.52 -50.23 60.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.955 0.407 . . . . 0.47 110.925 -176.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.03 -31.42 71.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.004 -0.543 . . . . 0.46 111.627 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.7 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 30.8 t70 -74.94 -29.2 60.88 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.152 0.501 . . . . 0.83 110.322 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.697 ' HG2' HD11 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -82.65 -15.07 53.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.256 -0.884 . . . . 2.48 111.08 -178.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.59 20.99 9.54 Favored Glycine 0 N--CA 1.455 -0.088 0 C-N-CA 120.231 -0.985 . . . . 0.44 112.787 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.621 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.3 mm -71.47 107.15 2.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.52 0.676 . . . . 0.52 110.72 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -88.55 170.45 10.86 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.092 -0.958 . . . . 1.94 110.088 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.9 t -55.19 -37.71 67.42 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.301 0.24 . . . . 1.03 111.016 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.407 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.4 tm? -58.49 -56.34 23.41 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.012 -0.366 . . . . 0.59 110.012 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.56 ' O ' HG13 ' A' ' 50' ' ' ILE . 19.8 m -68.25 -41.43 81.14 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.874 0.324 . . . . 1.22 111.874 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.648 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 36.2 p -66.22 -30.36 70.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.03 0.443 . . . . 0.81 110.965 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -39.57 64.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.619 -0.882 . . . . 2.25 108.619 178.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 39.6 t -64.39 -44.66 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.902 -0.59 . . . . 0.36 110.261 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 46' ' ' SER . 65.6 mt -52.06 -59.78 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.596 -0.275 . . . . 0.26 110.772 176.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.51 -27.33 67.79 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.11 -0.567 . . . . 0.29 111.9 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.496 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -67.68 -44.13 78.55 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 122.902 -0.176 . . . . 0.92 111.1 176.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 27.7 mtp180 -65.97 -23.98 66.7 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.716 0.293 . . . . 1.23 110.473 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.581 ' CZ ' HG23 ' A' ' 16' ' ' VAL . 12.2 m-30 -58.3 -40.56 82.33 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.169 0.509 . . . . 0.28 109.688 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 66.7 mtm180 -82.03 -25.08 34.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.438 -0.801 . . . . 2.81 111.043 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -83.0 -59.13 2.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.787 -0.642 . . . . 2.26 110.927 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.62 -48.53 7.01 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.516 -0.766 . . . . 2.62 111.797 -174.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.401 HD23 ' HD2' ' A' ' 12' ' ' LYS . 10.9 mp -81.71 -26.51 34.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.421 -0.354 . . . . 0.67 111.666 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.31 40.41 49.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.12 -0.562 . . . . 0.45 112.419 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.453 HD21 ' HG2' ' A' ' 12' ' ' LYS . 78.5 mt -86.35 146.15 26.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.839 0.352 . . . . 0.63 110.966 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.21 94.82 6.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 2.27 110.849 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 63' ' ' GLY . 0.3 OUTLIER -121.53 -52.35 2.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.117 -0.492 . . . . 1.64 110.914 176.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' HD12 ' A' ' 62' ' ' LEU . . . 124.52 169.0 12.96 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.628 -0.796 . . . . 0.75 111.988 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.41 -4.83 11.76 Favored 'Trans proline' 0 C--N 1.333 -0.258 0 C-N-CA 122.48 2.12 . . . . 1.13 113.041 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.26 -16.56 19.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.118 -0.492 . . . . 2.36 111.023 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -69.77 112.8 6.47 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.102 0.477 . . . . 0.73 110.25 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 p -128.23 132.54 48.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.052 -0.522 . . . . 1.39 111.281 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 83.0 mt -81.23 15.13 2.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.73 111.357 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.444 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 6.7 t80 -111.37 -8.49 14.31 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.105 0.479 . . . . 0.59 109.907 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.6 mt -131.57 -40.64 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-O 120.862 0.363 . . . . 0.89 111.488 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.12 5.53 42.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.228 0.537 . . . . 2.23 110.531 -170.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 96.5 m -158.77 129.24 6.0 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.2 p -109.42 -48.3 3.26 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.748 -0.381 . . . . 0.67 111.068 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.6 p -99.87 -171.2 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.306 0.574 . . . . 0.38 111.128 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.467 HG21 ' HB2' ' A' ' 35' ' ' SER . 2.2 t -81.75 -44.45 20.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.773 -0.649 . . . . 0.68 110.718 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HD3' ' HB2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -67.31 -24.5 65.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.914 -0.585 . . . . 3.23 110.684 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.36 64.87 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.165 0.507 . . . . 0.29 110.386 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.715 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.6 OUTLIER -77.43 -49.06 15.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.633 -0.712 . . . . 0.64 109.339 177.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.507 ' HB2' ' HD3' ' A' ' 76' ' ' ARG . 30.5 mmtm -57.85 -45.43 86.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.828 -1.078 . . . . 2.4 110.902 -176.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.45 -29.89 70.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.563 -0.744 . . . . 1.66 110.77 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -77.0 -36.45 56.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.075 -0.511 . . . . 0.99 111.09 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.715 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 44.4 mtp -60.58 -52.99 62.81 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.207 -0.452 . . . . 1.1 110.914 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 83' ' ' LEU . 5.9 mp -78.0 -40.7 38.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.949 0.404 . . . . 1.3 110.47 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.86 141.28 6.18 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.922 -0.656 . . . . 2.42 111.516 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.5 m -83.94 33.22 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.669 0.271 . . . . 4.47 111.087 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.12 47.59 87.08 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.322 -1.111 . . . . 4.59 110.322 -172.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -147.25 157.55 43.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.21 -0.495 . . . . 6.61 110.216 -172.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 75.62 147.88 0.09 Allowed 'General case' 0 CA--C 1.52 -0.178 0 O-C-N 124.103 0.877 . . . . 8.47 111.645 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.852 0 CA-C-O 118.648 -1.084 . . . . 9.73 111.601 179.641 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.977 0.418 . . . . 9.14 110.212 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -128.16 164.65 22.02 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.565 -0.532 . . . . 8.72 109.565 175.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 74.26 132.99 0.05 OUTLIER 'General case' 0 C--O 1.235 0.306 0 O-C-N 124.414 1.071 . . . . 5.17 110.744 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -152.61 97.53 2.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.72 -0.673 . . . . 6.66 110.144 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 130.01 128.99 3.07 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.699 -0.682 . . . . 1.74 111.474 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.61 -45.27 14.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.0 0.428 . . . . 1.14 110.588 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.15 83.78 1.55 Allowed Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.875 -0.89 . . . . 0.53 110.875 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -113.36 156.26 14.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.736 0.303 . . . . 0.39 110.274 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.9 p -71.88 157.83 37.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.12 -0.491 . . . . 1.56 110.382 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.64 -26.17 68.28 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.118 -1.067 . . . . 2.02 108.118 175.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.44 -42.58 96.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.608 -1.178 . . . . 1.91 110.56 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -27.77 64.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.146 -0.479 . . . . 1.58 109.735 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.432 ' O ' ' HG3' ' A' ' 17' ' ' MET . 0.1 OUTLIER -68.32 -27.99 66.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.842 -0.617 . . . . 0.99 109.565 175.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -25.78 41.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.375 0.607 . . . . 0.88 110.156 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.88 -19.29 29.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.503 -0.771 . . . . 0.3 111.663 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.536 HG23 ' CE1' ' A' ' 54' ' ' PHE . 3.3 p -82.16 -43.59 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.758 -0.377 . . . . 0.23 111.777 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.563 ' HB3' HD23 ' A' ' 31' ' ' LEU . 57.3 mtm -61.56 -30.39 70.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.468 -0.333 . . . . 1.63 111.508 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.18 -33.97 74.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.476 0.179 . . . . 3.17 111.127 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 53' ' ' ARG . 56.3 t -75.94 -37.13 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.694 0.759 . . . . 0.23 109.113 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.03 -39.23 84.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.763 -1.108 . . . . 0.33 111.007 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -24.25 50.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.653 0.74 . . . . 1.38 109.729 -173.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -78.8 -42.26 28.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.788 -1.097 . . . . 2.26 111.101 -176.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.55 ' HG3' HG12 ' A' ' 50' ' ' ILE . 62.0 mm-40 -74.69 -37.49 62.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.27 -0.423 . . . . 0.77 111.351 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -71.51 -44.22 65.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.869 0.366 . . . . 1.23 110.516 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.99 5.13 35.64 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.819 -0.705 . . . . 0.54 112.071 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.568 HD11 ' HG2' ' A' ' 40' ' ' MET . 2.3 mt -90.68 160.15 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.912 0.387 . . . . 0.8 110.107 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.37 140.23 42.89 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.766 -0.652 . . . . 0.57 110.269 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.2 tp -58.52 -35.52 72.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.952 -0.567 . . . . 0.97 111.229 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -73.84 -14.57 61.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.186 0.517 . . . . 2.23 110.547 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -103.98 -6.3 21.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.762 -0.654 . . . . 2.24 110.801 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 17' ' ' MET . 46.5 tp -72.04 99.21 2.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.934 -0.575 . . . . 1.1 109.967 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.489 ' O ' HG21 ' A' ' 75' ' ' VAL . 80.2 p -117.63 158.85 23.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.014 -0.539 . . . . 0.6 109.71 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.692 ' OD1' ' HB2' ' A' ' 76' ' ' ARG . 6.9 t70 -54.22 -23.72 15.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.226 0.61 . . . . 2.29 112.57 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.48 -19.41 64.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.883 -0.599 . . . . 2.29 111.408 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.534 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 14.8 m -71.95 151.47 43.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.342 0.591 . . . . 1.06 110.84 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.774 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.6 t-20 -131.0 120.42 23.46 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.473 -0.566 . . . . 0.8 109.473 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.822 ' HD1' HG13 ' A' ' 42' ' ' ILE . 33.7 m-85 -51.36 -46.44 62.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.156 0.503 . . . . 0.47 111.219 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.39 -29.62 63.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.784 -0.644 . . . . 0.46 111.571 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.774 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 21.5 t70 -74.72 -31.17 61.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.43 0.633 . . . . 0.83 110.283 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.568 ' HG2' HD11 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -75.64 -23.12 56.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.602 -0.727 . . . . 2.48 110.453 178.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.32 27.93 7.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.325 -0.941 . . . . 0.44 112.026 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.822 HG13 ' HD1' ' A' ' 37' ' ' PHE . 28.6 mm -68.21 107.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.125 0.488 . . . . 0.52 109.833 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.35 171.44 15.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.521 -0.763 . . . . 1.94 111.211 -176.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.3 t -57.88 -32.69 67.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.721 -1.127 . . . . 1.03 111.167 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.2 tm? -64.25 -57.48 9.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.721 -0.672 . . . . 0.59 110.088 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.552 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.6 m -63.93 -40.84 97.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.979 -0.555 . . . . 1.22 111.585 -173.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.6 p -62.38 -30.14 70.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.211 -0.45 . . . . 0.81 111.447 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 5.7 ttt -79.15 -37.64 37.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.514 0.673 . . . . 2.25 109.775 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 52' ' ' SER . 78.0 t -69.39 -40.68 80.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.765 -1.107 . . . . 0.36 110.233 -175.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 46' ' ' SER . 73.2 mt -51.69 -54.11 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.881 0.372 . . . . 0.26 110.705 174.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -63.46 -26.22 69.38 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.974 -0.631 . . . . 0.29 112.247 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 10.3 m -70.99 -42.33 69.79 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 120.659 0.266 . . . . 0.92 110.715 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.473 ' HB2' HG11 ' A' ' 19' ' ' VAL . 10.0 mtp180 -64.95 -26.34 68.26 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.525 -0.307 . . . . 1.23 110.351 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.734 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 16.5 m-30 -56.31 -43.98 79.46 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.261 0.553 . . . . 0.28 109.58 173.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 61.7 mtp180 -79.32 -27.97 42.11 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.227 -0.897 . . . . 2.81 110.573 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -77.29 -62.82 1.53 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.82 -0.627 . . . . 2.26 112.023 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -88.54 -44.13 10.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.783 -0.644 . . . . 2.62 111.477 -169.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.56 -39.11 15.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.108 -0.497 . . . . 0.67 111.591 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.99 23.34 15.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.503 -0.856 . . . . 0.45 112.307 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.734 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 73.2 mt -80.81 113.18 18.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.726 -0.472 . . . . 0.63 109.726 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -97.87 87.39 3.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.45 0.643 . . . . 2.27 110.01 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.644 HD11 ' HD2' ' A' ' 54' ' ' PHE . 37.2 mt -87.88 -66.1 0.95 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.756 -1.111 . . . . 1.64 110.304 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.15 167.62 20.08 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.724 -0.95 . . . . 0.75 110.724 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -87.62 5.24 5.62 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 123.361 2.707 . . . . 1.13 112.96 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -107.19 -7.67 16.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.708 -0.678 . . . . 2.36 111.692 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -85.38 120.87 27.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.774 0.321 . . . . 0.73 111.428 -171.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -135.16 127.8 30.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.293 -0.412 . . . . 1.39 110.42 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 50' ' ' ILE . 68.2 mt -66.12 -11.02 46.24 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.223 0.453 . . . . 0.73 112.223 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -85.12 -11.33 55.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.125 0.488 . . . . 0.59 109.944 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.5 mt -127.52 -39.81 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.344 -0.389 . . . . 0.89 110.906 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -95.73 8.26 43.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.529 -0.305 . . . . 2.23 111.146 -173.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 89.6 m -157.59 159.56 37.2 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -132.67 -78.28 0.49 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.303 -0.408 . . . . 0.67 110.615 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 80.8 p -83.65 -169.72 2.7 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.26 -0.275 . . . . 0.38 110.596 177.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.6 OUTLIER -77.05 -41.84 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.568 -0.453 . . . . 0.68 110.095 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.692 ' HB2' ' OD1' ' A' ' 33' ' ' ASP . 24.6 ttm180 -59.87 -33.43 71.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.428 -0.351 . . . . 3.23 111.324 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.69 -29.86 28.97 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.498 0.499 . . . . 0.29 110.718 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.611 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.5 OUTLIER -85.39 -51.27 6.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.924 -0.58 . . . . 0.64 109.753 175.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HD3' HD11 ' A' ' 13' ' ' LEU . 10.5 mmtp -49.58 -59.25 3.94 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.069 -0.969 . . . . 2.4 111.298 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.45 -29.02 69.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.648 -1.16 . . . . 1.66 110.899 -173.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.9 -37.12 75.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.99 111.138 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.611 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 22.3 mtp -57.72 -45.03 86.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.077 -0.51 . . . . 1.1 110.618 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 83' ' ' LEU . 5.8 mp -80.59 -41.9 23.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.197 -0.456 . . . . 1.3 110.411 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.28 -82.43 0.3 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.709 -0.556 . . . . 2.42 111.709 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.1 t -173.9 31.43 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.637 -0.875 . . . . 4.47 108.637 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 145.18 166.71 11.86 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.573 -1.011 . . . . 4.59 110.573 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -140.51 125.0 17.83 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.472 0.136 . . . . 6.61 110.81 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 53.47 82.5 0.08 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.901 0.751 . . . . 8.47 112.705 173.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 118.44 -1.2 . . . . 9.73 112.261 177.894 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 110.441 -0.207 . . . . 9.14 110.441 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 59.0 tpp 63.78 76.06 0.37 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.787 0.679 . . . . 8.72 111.275 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.47 134.18 17.76 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.69 -0.485 . . . . 5.17 109.69 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -138.86 90.5 2.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.284 0.564 . . . . 6.66 110.763 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.31 119.96 2.11 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.853 -0.612 . . . . 1.74 111.615 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.67 -81.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.585 0.192 . . . . 1.14 110.814 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.71 96.29 1.11 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.583 -0.818 . . . . 0.53 111.945 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.91 157.21 10.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.8 0.333 . . . . 0.39 110.489 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.0 m -78.94 165.59 23.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.346 -0.388 . . . . 1.56 110.159 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -61.37 -31.44 71.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.821 0.819 . . . . 2.02 109.204 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.14 -45.94 83.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.381 -1.281 . . . . 1.91 110.788 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -72.87 -21.85 60.86 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.339 -0.846 . . . . 1.58 110.823 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 tp -73.22 -26.07 61.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.828 -0.623 . . . . 0.99 110.273 172.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -25.59 36.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.698 0.761 . . . . 0.88 109.796 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.75 -32.77 23.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.048 -0.978 . . . . 0.3 111.356 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.512 HG11 ' SD ' ' A' ' 82' ' ' MET . 2.9 p -67.28 -44.53 87.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 120.874 -0.33 . . . . 0.23 111.785 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.6 mtp -60.43 -27.82 67.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.204 -0.453 . . . . 1.63 111.931 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 24.4 ptt85 -79.85 -32.87 40.51 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.598 . . . . 3.17 111.459 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.35 -37.86 78.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.72 -0.844 . . . . 0.23 108.72 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.2 t -64.87 -39.16 84.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.793 -1.094 . . . . 0.33 109.977 174.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -69.16 -27.33 65.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.91 -0.586 . . . . 1.38 111.344 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 43.9 mt-10 -85.98 -30.27 22.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.018 0.437 . . . . 2.26 111.117 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.727 ' HG3' HG12 ' A' ' 50' ' ' ILE . 72.2 mm-40 -82.63 -45.49 14.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.859 -0.609 . . . . 0.77 112.031 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.507 ' HA ' HD11 ' A' ' 42' ' ' ILE . 73.4 p -72.13 -45.38 60.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.85 0.357 . . . . 1.23 111.248 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.72 2.2 43.09 Favored Glycine 0 C--O 1.23 -0.095 0 N-CA-C 111.104 -0.798 . . . . 0.54 111.104 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.755 HD11 ' HG3' ' A' ' 40' ' ' MET . 3.9 mt -93.7 104.98 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.297 -0.631 . . . . 0.8 109.297 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -42.21 143.75 0.56 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.841 0.713 . . . . 0.57 112.317 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.6 tp -54.44 -32.84 58.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.799 -0.637 . . . . 0.97 111.281 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -78.0 -10.51 59.63 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.889 0.376 . . . . 2.23 111.013 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -109.3 -6.54 15.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.187 -0.672 . . . . 2.24 109.187 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.519 HD11 HG11 ' A' ' 75' ' ' VAL . 41.3 tp -76.84 98.72 4.94 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.399 -0.819 . . . . 1.1 110.221 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.3 p -121.93 163.63 18.97 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.967 -1.015 . . . . 0.6 108.476 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -69.05 -3.75 14.39 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.782 0.29 . . . . 2.29 111.782 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -70.91 -23.44 62.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.373 -0.376 . . . . 2.29 110.595 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.463 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 21.3 m -75.65 149.8 38.1 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.527 0.68 . . . . 1.06 111.399 -174.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.773 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 16.8 t-20 -126.13 122.15 34.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.099 -0.955 . . . . 0.8 108.768 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.797 ' HD1' HG13 ' A' ' 42' ' ' ILE . 20.6 m-85 -55.34 -46.84 76.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.852 0.358 . . . . 0.47 111.18 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.31 -29.59 62.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.341 -0.391 . . . . 0.46 111.573 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.773 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 30.7 t70 -71.17 -35.58 71.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.537 0.684 . . . . 0.83 110.36 177.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.755 ' HG3' HD11 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -75.54 -24.53 56.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.35 -0.841 . . . . 2.48 109.663 -175.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.16 28.28 4.73 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.529 -0.843 . . . . 0.44 112.429 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.797 HG13 ' HD1' ' A' ' 37' ' ' PHE . 33.2 mm -74.34 107.94 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 0.52 110.571 176.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.77 170.97 15.75 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.512 -0.551 . . . . 1.94 109.512 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.3 p -55.33 -36.85 66.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.884 -0.598 . . . . 1.03 110.388 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -52.23 -59.05 4.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.32 -0.854 . . . . 0.59 110.539 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.574 ' O ' HG13 ' A' ' 50' ' ' ILE . 32.8 t -66.75 -43.26 84.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.14 -0.224 . . . . 1.22 111.134 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.538 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 87.7 p -60.35 -29.97 69.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.376 . . . . 0.81 111.254 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.8 tpp -75.81 -46.12 32.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.895 -0.593 . . . . 2.25 109.806 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.558 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 49.8 t -59.54 -45.46 93.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.958 -1.019 . . . . 0.36 110.616 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.727 HG12 ' HG3' ' A' ' 23' ' ' GLU . 55.8 mt -51.7 -52.8 19.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.904 0.383 . . . . 0.26 110.447 174.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -57.59 -37.24 81.94 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.712 -0.677 . . . . 0.29 112.551 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -66.46 -45.91 78.18 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.983 -0.377 . . . . 0.92 109.983 177.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 6.0 mtp180 -60.64 -27.07 67.51 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.567 -0.288 . . . . 1.23 111.061 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 12.5 m-30 -58.01 -41.07 82.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.205 0.526 . . . . 0.28 110.135 173.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.735 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 61.3 mtp180 -84.0 -32.11 25.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.833 -0.621 . . . . 2.81 111.205 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 52' ' ' SER . 20.0 mm-40 -82.9 -47.07 12.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.237 -0.438 . . . . 2.26 111.158 -174.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.09 -42.58 11.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 2.62 112.151 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.55 -32.76 12.1 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.695 0.257 . . . . 0.67 111.695 -174.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.96 33.41 8.99 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.746 -0.74 . . . . 0.45 112.574 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.735 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 87.7 mt -86.5 115.84 24.26 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 110.409 -0.219 . . . . 0.63 110.409 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -95.21 58.37 2.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.649 0.737 . . . . 2.27 109.589 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.86 -29.79 50.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.859 -1.064 . . . . 1.64 111.449 -175.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.28 169.9 12.59 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.734 -0.746 . . . . 0.75 112.394 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -89.36 -13.29 2.92 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.171 2.58 . . . . 1.13 112.671 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -82.81 -17.36 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.048 -0.523 . . . . 2.36 112.239 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -82.3 114.27 20.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.173 0.511 . . . . 0.73 111.139 -173.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.9 m -128.93 125.3 37.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.911 -0.586 . . . . 1.39 109.94 176.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 68.2 mt -58.55 -40.0 81.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.327 -0.397 . . . . 0.73 111.691 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -60.8 -8.1 2.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.193 -0.458 . . . . 0.59 111.674 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.5 -40.19 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.939 -0.475 . . . . 0.89 111.47 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -109.77 -1.91 17.65 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.56 0.578 . . . . 2.23 112.56 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.8 m -142.38 97.83 3.19 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.488 -0.757 . . . . 1.0 110.281 -175.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.6 p -89.58 -30.27 18.3 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.638 -0.71 . . . . 0.67 111.034 -174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -114.46 -176.51 2.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.135 -0.484 . . . . 0.38 110.468 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.519 HG11 HD11 ' A' ' 31' ' ' LEU . 1.5 t -81.61 -43.3 19.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.998 0.428 . . . . 0.68 110.437 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.61 ' HA ' ' CG ' ' A' ' 79' ' ' LYS . 29.3 ttm180 -64.97 -28.41 69.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.106 -0.497 . . . . 3.23 111.002 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.5 -31.21 55.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 0.29 110.749 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.8 OUTLIER -75.7 -47.89 24.29 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.304 -0.628 . . . . 0.64 109.304 176.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.61 ' CG ' ' HA ' ' A' ' 76' ' ' ARG . 26.8 mmtp -46.97 -50.01 19.77 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.96 -1.018 . . . . 2.4 110.59 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -54.36 -55.33 29.66 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.301 -0.863 . . . . 1.66 111.709 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -56.29 -37.62 70.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.479 -0.782 . . . . 0.99 112.245 -173.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 24.8 mtp -60.17 -47.67 84.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.871 0.367 . . . . 1.1 111.439 -174.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 82' ' ' MET . 5.7 mp -82.94 -27.62 30.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.367 -0.379 . . . . 1.3 110.816 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.54 -145.8 18.14 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.302 -0.952 . . . . 2.42 112.432 175.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.2 m -93.99 34.72 1.21 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.09 0.471 . . . . 4.47 110.347 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.67 23.66 59.74 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.002 -0.839 . . . . 4.59 111.002 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -71.14 103.39 2.75 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.97 0.414 . . . . 6.61 110.418 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -163.02 -32.88 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.823 -0.626 . . . . 8.47 111.055 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.72 -1.044 . . . . 9.73 112.191 -179.021 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.135 -0.321 . . . . 9.14 110.135 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.4 ttm 65.54 91.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.901 0.751 . . . . 8.72 111.6 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.03 136.78 24.3 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.055 0.455 . . . . 5.17 110.415 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -156.74 112.89 2.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.588 -0.733 . . . . 6.66 109.79 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.76 -102.83 2.82 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.695 -0.764 . . . . 1.74 111.619 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.8 t -119.73 -74.55 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 110.054 -0.35 . . . . 1.14 110.054 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.67 98.28 1.41 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.785 -0.721 . . . . 0.53 111.339 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 3.9 m -112.21 158.96 12.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.159 -0.312 . . . . 0.39 110.159 -177.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.1 p -87.11 -178.59 6.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.204 -0.453 . . . . 1.56 110.5 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -68.43 -30.34 69.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.295 -0.631 . . . . 2.02 109.295 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.4 -41.0 96.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.322 -0.854 . . . . 1.91 110.408 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.469 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 58.1 mttt -74.3 -26.64 60.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.842 -0.617 . . . . 1.58 111.002 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.23 -23.2 54.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.008 -0.542 . . . . 0.99 110.057 173.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.3 -27.11 42.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.5 0.667 . . . . 0.88 109.694 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -83.9 -26.76 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.054 -0.975 . . . . 0.3 111.66 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 p -71.83 -44.56 67.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 111.782 0.29 . . . . 0.23 111.782 -178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.524 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 73.8 mtp -60.44 -34.37 73.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.486 -0.325 . . . . 1.63 111.42 -175.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 12.3 ptt180 -69.64 -29.47 66.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.707 0.289 . . . . 3.17 110.688 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.37 -39.33 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.01 -0.737 . . . . 0.23 109.01 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.86 -49.05 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.838 -1.074 . . . . 0.33 110.06 176.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.499 ' OG ' HD22 ' A' ' 31' ' ' LEU . 25.7 m -54.96 -47.19 74.84 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 112.401 0.519 . . . . 1.38 112.401 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -57.33 -46.43 83.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.055 0.391 . . . . 2.26 112.055 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HB3' ' OG ' ' A' ' 46' ' ' SER . 75.4 mm-40 -79.75 -33.51 40.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.292 -0.413 . . . . 0.77 111.882 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.451 ' HB3' HD11 ' A' ' 42' ' ' ILE . 76.7 p -80.72 -42.8 21.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.85 0.357 . . . . 1.23 111.525 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.32 12.92 34.59 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.982 -0.628 . . . . 0.54 111.978 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mt -102.88 125.89 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 122.802 -0.234 . . . . 0.8 110.544 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.45 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -56.3 145.11 27.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.394 -0.367 . . . . 0.57 110.788 175.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.76 -43.9 38.23 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.579 0.549 . . . . 0.97 110.404 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -76.41 -10.66 59.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.963 -0.562 . . . . 2.23 111.286 -173.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.45 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 34.1 mm-40 -107.93 -10.59 15.49 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.987 -0.745 . . . . 2.24 108.987 177.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.499 HD22 ' OG ' ' A' ' 21' ' ' SER . 17.8 tp -79.49 97.47 6.43 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.347 -0.842 . . . . 1.1 109.18 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.2 p -116.73 162.38 17.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.322 -0.854 . . . . 0.6 108.855 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.834 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 45.5 m-20 -74.59 -3.54 31.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.782 0.325 . . . . 2.29 111.059 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.29 -20.22 44.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.705 -0.679 . . . . 2.29 110.528 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB2' HG21 ' A' ' 75' ' ' VAL . 43.6 m -70.88 157.32 38.34 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.749 0.785 . . . . 1.06 111.275 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.673 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.1 t-20 -124.43 126.16 45.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.86 -1.064 . . . . 0.8 108.682 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.516 ' HD1' HG13 ' A' ' 42' ' ' ILE . 26.1 m-85 -57.08 -52.78 63.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.116 0.484 . . . . 0.47 111.308 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.07 -22.87 63.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.053 -0.521 . . . . 0.46 111.254 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.6 t70 -83.54 -16.0 47.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.83 110.538 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 65.9 mmm -101.46 1.49 38.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 2.48 111.706 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.53 26.22 23.56 Favored Glycine 0 C--O 1.23 -0.152 0 C-N-CA 119.79 -1.195 . . . . 0.44 112.767 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.516 HG13 ' HD1' ' A' ' 37' ' ' PHE . 18.3 mm -72.01 107.7 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.195 0.521 . . . . 0.52 110.018 175.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.8 159.78 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.291 -0.868 . . . . 1.94 110.194 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 69' ' ' PHE . 1.4 t -55.07 -39.62 69.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.433 0.635 . . . . 1.03 109.704 171.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.0 tm? -56.96 -53.09 61.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.315 -0.857 . . . . 0.59 109.827 175.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.575 ' O ' HG13 ' A' ' 50' ' ' ILE . 32.4 t -67.91 -42.76 80.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.758 -0.201 . . . . 1.22 111.52 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 33.0 p -60.73 -34.25 74.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.005 0.431 . . . . 0.81 111.151 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.579 ' SD ' H312 ' A' ' 90' ' ' PNS . 30.2 ttp -72.69 -36.7 67.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.738 -0.664 . . . . 2.25 109.563 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 45' ' ' LEU . 42.6 t -70.34 -41.2 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.325 -0.852 . . . . 0.36 110.256 -177.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 46' ' ' SER . 59.0 mt -55.14 -55.63 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.742 0.306 . . . . 0.26 110.431 176.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.74 -28.96 72.5 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.11 -0.566 . . . . 0.29 112.031 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.26 -42.66 75.28 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.717 0.294 . . . . 0.92 110.689 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.76 ' HA ' ' HB3' ' A' ' 56' ' ' GLU . 28.9 mtp180 -69.01 -22.53 64.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 121.0 -0.28 . . . . 1.23 110.592 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.577 ' HE2' HD21 ' A' ' 78' ' ' LEU . 13.8 m-30 -57.46 -41.89 81.44 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.246 -0.649 . . . . 0.28 109.246 172.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.67 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 35.8 mtp180 -81.19 -25.67 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.552 -0.749 . . . . 2.81 110.665 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.76 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 29.9 tt0 -77.68 -62.77 1.56 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.754 -0.657 . . . . 2.26 111.687 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -87.21 -41.56 13.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.969 -0.56 . . . . 2.62 111.415 -172.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.99 -40.67 11.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.182 -0.463 . . . . 0.67 111.33 -174.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.59 28.26 9.77 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.019 -0.61 . . . . 0.45 112.047 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.67 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 51.2 mt -80.8 107.41 13.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.297 -0.26 . . . . 0.63 110.297 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.55 78.78 9.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.186 0.993 . . . . 2.27 110.196 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.495 HD11 ' HD2' ' A' ' 54' ' ' PHE . 13.8 mt -83.1 -72.98 0.43 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.422 -1.263 . . . . 1.64 110.932 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.13 156.23 16.16 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.733 -0.947 . . . . 0.75 110.733 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.446 ' HG2' ' OE2' ' A' ' 65' ' ' GLU . 58.9 Cg_endo -78.37 -26.75 5.85 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.351 2.034 . . . . 1.13 113.613 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.446 ' OE2' ' HG2' ' A' ' 64' ' ' PRO . 37.4 mp0 -98.7 26.42 5.65 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 122.082 -0.386 . . . . 2.36 111.178 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -92.12 112.54 24.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.46 -0.336 . . . . 0.73 110.439 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.5 t -132.46 123.87 27.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.968 0.414 . . . . 1.39 110.199 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.507 HD12 HD12 ' A' ' 50' ' ' ILE . 70.2 mt -61.47 -16.45 47.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.089 -0.505 . . . . 0.73 111.546 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.474 ' CD2' ' HB2' ' A' ' 44' ' ' SER . 8.9 t80 -73.82 -15.05 61.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.186 -0.461 . . . . 0.59 110.76 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.0 mt -130.04 -35.82 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.197 -0.456 . . . . 0.89 110.965 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -91.97 6.8 44.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.484 -0.325 . . . . 2.23 111.871 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.75 162.78 37.14 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -175.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.0 p -134.92 -72.65 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.306 -0.406 . . . . 0.67 111.209 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 71.8 p -84.88 -179.46 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.999 -0.371 . . . . 0.38 109.999 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -79.68 -39.92 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 108.865 -0.791 . . . . 0.68 108.865 -176.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.834 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 13.6 tpt180 -60.38 -30.23 69.45 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.476 -1.238 . . . . 3.23 111.188 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.03 -33.63 73.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.433 -0.348 . . . . 0.29 110.491 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.658 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.0 OUTLIER -71.93 -51.18 23.37 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.81 -0.811 . . . . 0.64 108.81 176.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.524 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 27.9 mmtp -48.09 -57.57 5.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.51 -1.223 . . . . 2.4 111.833 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -60.52 -37.27 80.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.572 -0.74 . . . . 1.66 111.506 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -62.64 -38.24 89.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.941 -0.572 . . . . 0.99 111.125 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.658 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 30.0 mtp -59.98 -51.45 69.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.937 -0.574 . . . . 1.1 111.519 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.1 mp -75.75 -42.3 50.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.578 0.228 . . . . 1.3 110.762 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.55 125.23 3.05 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.559 -0.829 . . . . 2.42 112.337 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.2 m -76.87 41.36 0.27 Allowed 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 122.532 0.333 . . . . 4.47 111.47 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.62 -59.58 4.05 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.096 -0.573 . . . . 4.59 111.797 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -157.9 116.31 3.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.689 0.281 . . . . 6.61 110.364 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.64 -66.98 0.45 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.043 -0.526 . . . . 8.47 110.342 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.864 0 CA-C-O 118.512 -1.16 . . . . 9.73 111.783 -178.943 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . 0.579 H312 ' SD ' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 111.435 0.161 . . . . 9.14 111.435 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 92.3 mtp 58.77 73.51 0.48 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.672 0.389 . . . . 8.72 111.039 -176.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.01 130.41 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.942 0.776 . . . . 5.17 111.861 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -137.76 118.49 14.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.488 -0.778 . . . . 6.66 110.448 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 84' ' ' GLY . . . -107.62 -173.14 22.18 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.556 -0.747 . . . . 1.74 111.637 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.8 t -81.18 -79.78 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.785 0.326 . . . . 1.14 110.431 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.43 94.25 1.82 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.749 -0.941 . . . . 0.53 110.749 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.99 158.93 9.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.817 0.341 . . . . 0.39 110.562 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.3 t -85.79 179.2 7.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.783 -0.451 . . . . 1.56 109.783 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.81 -20.71 65.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.535 0.683 . . . . 2.02 109.643 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.9 -50.87 71.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.987 -1.006 . . . . 1.91 110.689 175.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.489 ' HG2' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -70.54 -23.85 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.054 -0.721 . . . . 1.58 109.054 -177.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.457 ' O ' ' HG3' ' A' ' 17' ' ' MET . 2.2 tp -69.49 -27.14 64.94 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.724 -0.671 . . . . 0.99 110.403 174.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.7 -28.57 33.4 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.591 0.71 . . . . 0.88 109.986 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.51 -31.76 37.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.23 -0.895 . . . . 0.3 111.013 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.553 HG23 ' CZ ' ' A' ' 54' ' ' PHE . 4.5 p -69.61 -46.99 73.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.275 -0.421 . . . . 0.23 111.617 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.712 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 65.8 mtm -61.9 -28.88 69.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.426 -0.352 . . . . 1.63 111.725 -172.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -81.61 -22.44 37.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.37 -0.377 . . . . 3.17 111.25 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.0 t -82.42 -35.22 12.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.758 -0.83 . . . . 0.23 108.758 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.4 t -64.89 -36.21 77.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.574 -1.194 . . . . 0.33 110.09 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -59.7 -53.03 62.72 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.051 0.453 . . . . 1.38 110.663 -176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -54.76 -55.61 28.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.165 -0.925 . . . . 2.26 112.324 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -77.42 -22.84 50.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.341 0.497 . . . . 0.77 112.341 -170.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.401 ' HA ' HD11 ' A' ' 42' ' ' ILE . 20.1 m -85.96 -31.41 22.11 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.553 -0.459 . . . . 1.23 110.006 175.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.13 -2.92 44.02 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.745 -0.741 . . . . 0.54 112.844 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mt -101.48 153.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.833 0.349 . . . . 0.8 110.603 -175.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.5 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -66.77 145.34 55.62 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.855 -0.612 . . . . 0.57 110.646 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.2 tp -60.87 -36.39 79.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.996 0.427 . . . . 0.97 110.422 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -72.58 -10.92 60.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.036 -0.529 . . . . 2.23 110.963 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.5 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 19.2 mt-10 -115.55 6.32 14.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.727 -0.669 . . . . 2.24 110.793 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.429 HD11 HG11 ' A' ' 75' ' ' VAL . 44.6 tp -75.48 97.78 3.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.31 0.576 . . . . 1.1 109.501 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.459 ' O ' HG21 ' A' ' 75' ' ' VAL . 59.4 p -101.11 156.85 17.18 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.203 -0.908 . . . . 0.6 110.363 -175.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.694 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 16.5 p-10 -81.56 -4.61 56.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.279 0.562 . . . . 2.29 110.027 177.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.14 -22.85 60.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.891 -1.05 . . . . 2.29 110.841 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.438 ' HB2' HG21 ' A' ' 75' ' ' VAL . 39.8 m -77.43 155.4 31.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.957 0.884 . . . . 1.06 111.568 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.931 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.4 t-20 -127.05 123.76 37.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.455 -1.313 . . . . 0.8 107.455 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.649 ' HD1' HG13 ' A' ' 42' ' ' ILE . 11.6 m-85 -56.8 -54.76 42.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.855 -0.338 . . . . 0.47 111.443 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.99 -26.19 62.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.86 0.362 . . . . 0.46 111.006 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.931 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 22.8 t70 -74.04 -29.12 61.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.495 . . . . 0.83 110.815 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.1 mmt -83.04 -15.03 52.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.618 . . . . 2.48 111.228 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.11 14.86 15.66 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.158 -1.02 . . . . 0.44 112.258 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.649 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.0 mm -67.59 106.8 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.947 -0.76 . . . . 0.52 108.947 174.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.91 177.52 8.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.473 -0.785 . . . . 1.94 111.225 -177.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 t -58.59 -31.88 68.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.193 -0.912 . . . . 1.03 109.766 175.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.422 ' HA ' H281 ' A' ' 90' ' ' PNS . 3.0 tm? -60.43 -62.93 1.51 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.985 -1.007 . . . . 0.59 110.86 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.567 ' O ' HG13 ' A' ' 50' ' ' ILE . 15.2 m -68.64 -39.34 80.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.448 -0.342 . . . . 1.22 111.519 -173.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 47.0 p -65.6 -21.93 66.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.814 0.34 . . . . 0.81 111.255 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.39 -43.73 20.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.101 -0.703 . . . . 2.25 109.101 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.7 t -62.76 -48.02 90.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.048 -0.978 . . . . 0.36 110.84 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 46' ' ' SER . 77.1 mt -51.32 -56.6 4.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.317 -0.401 . . . . 0.26 111.473 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.85 -30.65 78.31 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.611 -0.805 . . . . 0.29 112.459 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -39.52 89.5 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.04 -0.264 . . . . 0.92 110.451 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 25.6 mtp180 -65.19 -23.96 67.24 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.488 0.185 . . . . 1.23 110.882 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.628 ' HD2' HD11 ' A' ' 62' ' ' LEU . 11.8 m-30 -58.51 -38.69 78.23 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.482 0.658 . . . . 0.28 109.501 175.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -79.07 -24.67 43.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.174 -0.921 . . . . 2.81 110.95 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -78.56 -62.07 1.81 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.996 -0.547 . . . . 2.26 111.412 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -87.82 -53.57 4.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.023 -0.535 . . . . 2.62 111.639 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 mp -72.81 -27.59 62.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.963 -0.562 . . . . 0.67 111.289 -171.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.65 31.1 57.02 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.623 -0.798 . . . . 0.45 111.708 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 54' ' ' PHE . 81.8 mt -82.05 114.55 20.68 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 110.292 -0.262 . . . . 0.63 110.292 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -88.89 75.85 8.0 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.252 -0.647 . . . . 2.27 109.252 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.628 HD11 ' HD2' ' A' ' 54' ' ' PHE . 37.1 mt -82.4 -65.47 1.01 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.165 -0.925 . . . . 1.64 109.998 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.24 165.71 23.0 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 114.647 -1.16 . . . . 0.75 110.75 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.94 -8.3 10.09 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.02 2.48 . . . . 1.13 113.075 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -117.56 20.64 13.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.468 0.652 . . . . 2.36 110.709 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.411 ' HE1' ' CE2' ' A' ' 81' ' ' PHE . 83.6 t80 -77.87 111.81 14.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.074 -0.512 . . . . 0.73 109.916 -177.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.1 m -123.16 118.17 27.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.626 -0.715 . . . . 1.39 110.739 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 42.6 mt -63.26 -33.31 75.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.489 . . . . 0.73 110.489 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.483 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 37.1 t80 -59.6 -16.65 27.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.618 -0.719 . . . . 0.59 111.151 -175.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 62.7 mt -121.76 -40.14 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 121.044 -0.262 . . . . 0.89 111.515 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.51 6.84 32.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.933 -0.707 . . . . 2.23 112.526 -173.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 82.1 m -150.2 86.65 1.43 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.251 0.548 . . . . 1.0 109.639 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.1 p -78.25 -59.01 2.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.591 -0.731 . . . . 0.67 110.927 -172.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 82.3 p -86.9 -178.92 6.42 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.852 -0.425 . . . . 0.38 109.852 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -81.59 -42.54 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.306 0.574 . . . . 0.68 109.89 -179.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.694 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 4.9 tpp180 -60.13 -29.06 68.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.361 -0.836 . . . . 3.23 110.613 176.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -59.59 -35.72 74.85 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.532 -0.304 . . . . 0.29 110.951 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.554 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -72.58 -45.3 59.82 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.192 -0.67 . . . . 0.64 109.192 177.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.712 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.8 mmtp -51.19 -61.3 2.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.853 -1.067 . . . . 2.4 111.048 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.95 -24.42 65.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.766 -0.652 . . . . 1.66 111.79 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 46.5 t80 -64.82 -37.15 86.64 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.009 0.433 . . . . 0.99 110.262 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 12.8 mtp -62.2 -42.86 99.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.633 -0.712 . . . . 1.1 111.463 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.7 mp -74.84 -17.33 60.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 1.3 110.849 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' A' ' 5' ' ' GLY . . . -66.82 95.16 0.26 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.742 -0.742 . . . . 2.42 111.964 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.9 t -103.83 11.58 35.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.982 0.896 . . . . 4.47 109.982 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 159.48 147.13 4.78 Favored Glycine 0 C--N 1.311 -0.825 0 CA-C-N 114.485 -1.234 . . . . 4.59 111.663 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -152.83 -82.96 0.08 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.305 -0.628 . . . . 6.61 109.305 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 69.73 142.12 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.703 0.763 . . . . 8.47 112.248 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.908 0 CA-C-O 118.119 -1.378 . . . . 9.73 111.46 177.352 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . 0.631 H312 ' O26' ' A' ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.636 0.255 . . . . 9.14 110.815 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.0 mmm -94.39 147.3 23.37 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.623 -0.51 . . . . 8.72 109.623 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.05 -14.24 36.83 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.042 0.449 . . . . 5.17 111.441 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.4 tttt 69.25 115.31 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.643 -1.162 . . . . 6.66 111.372 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.08 173.85 22.75 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.883 -0.887 . . . . 1.74 110.883 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.4 t -76.3 -71.27 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.91 0.386 . . . . 1.14 110.263 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.16 83.93 1.49 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.54 -0.838 . . . . 0.53 111.465 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 4.0 m -110.57 160.49 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.741 0.305 . . . . 0.39 110.699 -174.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -82.61 174.39 11.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.405 -0.591 . . . . 1.56 109.405 173.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -66.9 -35.71 80.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.409 0.623 . . . . 2.02 109.74 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -56.93 -41.4 78.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.014 -0.994 . . . . 1.91 111.202 174.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.587 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 47.5 mmtm -68.02 -24.72 65.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.697 -0.683 . . . . 1.58 110.53 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.858 HD13 HD11 ' A' ' 83' ' ' LEU . 24.9 tp -70.72 -26.76 63.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.136 -0.484 . . . . 0.99 111.146 173.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.94 -30.79 50.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.659 0.742 . . . . 0.88 109.3 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.596 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -75.83 -33.44 60.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.071 -0.968 . . . . 0.3 110.405 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 13' ' ' LEU . 3.0 p -71.48 -45.46 68.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.318 -0.401 . . . . 0.23 111.716 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 63.7 mtt -59.54 -33.95 72.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.69 -0.232 . . . . 1.63 110.948 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 39.3 ptt180 -73.25 -30.35 63.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.046 -0.262 . . . . 3.17 111.216 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.1 t -77.46 -34.17 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.739 -0.837 . . . . 0.23 108.739 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.1 t -66.55 -40.96 87.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.681 -1.145 . . . . 0.33 109.304 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.8 t -61.76 -23.48 66.2 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.318 -0.401 . . . . 1.38 111.021 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -81.51 -49.69 10.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.203 0.525 . . . . 2.26 111.165 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -84.85 -31.39 23.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.439 -0.801 . . . . 0.77 112.372 -169.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.4 p -79.12 -35.43 42.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 1.23 111.129 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.75 13.8 56.17 Favored Glycine 0 C--O 1.234 0.106 0 C-N-CA 120.404 -0.903 . . . . 0.54 111.336 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mt -105.08 111.73 35.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.494 -0.558 . . . . 0.8 109.494 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.19 145.37 13.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.48 . . . . 0.57 111.256 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.5 tp -52.96 -34.61 56.56 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.912 -0.585 . . . . 0.97 110.919 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.43 -19.46 61.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.865 -0.607 . . . . 2.23 111.579 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.34 -1.38 21.68 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.927 -0.398 . . . . 2.24 109.927 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -73.93 97.91 2.91 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.577 0.703 . . . . 1.1 109.493 -177.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.2 p -106.59 151.22 25.33 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.272 -0.876 . . . . 0.6 109.097 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.831 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 27.1 m-20 -81.21 -3.19 51.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.84 0.352 . . . . 2.29 111.515 -174.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -93.62 -3.95 51.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.258 -0.428 . . . . 2.29 110.636 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.446 ' HB2' HG21 ' A' ' 75' ' ' VAL . 55.3 m -73.69 158.63 34.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.394 0.616 . . . . 1.06 110.022 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.823 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.0 t-20 -125.82 124.95 42.07 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.538 -0.755 . . . . 0.8 109.465 -176.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.732 ' HD1' HG13 ' A' ' 42' ' ' ILE . 35.5 m-85 -55.65 -50.19 70.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.891 0.376 . . . . 0.47 111.181 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.07 70.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.015 0.436 . . . . 0.46 111.221 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.823 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 32.8 t70 -72.68 -27.18 61.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.113 0.483 . . . . 0.83 110.598 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.9 mmt -86.46 -12.28 49.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 2.48 111.423 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.44 23.17 9.73 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.317 -0.944 . . . . 0.44 112.784 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.732 HG13 ' HD1' ' A' ' 37' ' ' PHE . 24.5 mm -72.39 106.91 2.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.267 0.556 . . . . 0.52 110.217 176.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -91.11 -178.66 5.23 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.648 -0.706 . . . . 1.94 111.139 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.6 t -54.61 -49.03 71.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.278 -0.873 . . . . 1.03 110.796 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.533 HD23 H302 ' A' ' 90' ' ' PNS . 3.3 tm? -50.32 -58.42 5.7 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.719 -0.673 . . . . 0.59 110.883 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.467 ' O ' HG13 ' A' ' 50' ' ' ILE . 22.6 t -66.78 -46.34 75.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.854 0.359 . . . . 1.22 111.442 -174.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 59.0 p -65.16 -30.66 71.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.427 -0.352 . . . . 0.81 111.73 -176.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.6 tpt -74.73 -41.69 59.68 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.055 -0.72 . . . . 2.25 109.055 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 31.8 t -57.48 -53.1 48.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.278 -0.874 . . . . 0.36 110.503 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 46' ' ' SER . 68.9 mt -49.08 -53.9 6.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 O-C-N 123.131 0.27 . . . . 0.26 111.264 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.37 -34.99 83.15 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.81 -0.71 . . . . 0.29 112.485 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -68.52 -41.92 79.25 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.91 -0.316 . . . . 0.92 110.222 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 1.8 mtp180 -68.54 -20.57 64.56 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.67 -0.241 . . . . 1.23 110.711 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.597 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.7 m-30 -59.92 -39.83 86.78 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.646 0.736 . . . . 0.28 109.658 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.685 ' HD2' ' O ' ' A' ' 60' ' ' LEU . 9.8 mmm180 -73.76 -28.64 61.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.887 -1.051 . . . . 2.81 110.298 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -81.53 -64.09 1.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.078 -0.51 . . . . 2.26 112.096 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -83.78 -34.62 24.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.977 -0.556 . . . . 2.62 111.392 -169.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.3 mp -97.22 -39.71 9.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.051 -0.522 . . . . 0.67 110.817 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.38 36.2 8.97 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.534 -0.841 . . . . 0.45 111.802 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.685 ' O ' ' HD2' ' A' ' 55' ' ' ARG . 93.4 mt -78.79 133.5 37.06 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.67 -0.122 . . . . 0.63 110.67 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.62 77.71 9.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.212 0.529 . . . . 2.27 110.732 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.597 HD11 ' HD2' ' A' ' 54' ' ' PHE . 55.1 mt -94.66 -60.54 1.68 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.609 0.719 . . . . 1.64 109.694 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.41 176.75 24.53 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 109.916 -1.274 . . . . 0.75 109.916 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.77 -23.03 7.23 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.994 1.796 . . . . 1.13 112.608 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -119.71 70.23 0.85 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.716 0.769 . . . . 2.36 110.695 -175.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -109.92 111.46 22.89 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.282 -0.872 . . . . 0.73 109.487 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.2 m -121.18 118.4 29.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.198 -0.455 . . . . 1.39 110.51 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 59.8 mt -64.58 -25.19 67.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.376 . . . . 0.73 111.047 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.562 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.9 t80 -72.16 -4.4 28.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.841 -0.618 . . . . 0.59 110.353 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.94 -42.59 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.28 -0.418 . . . . 0.89 110.947 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.46 8.87 33.66 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.365 0.505 . . . . 2.23 112.365 -169.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 89.2 m -152.5 159.23 43.34 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.044 -0.41 . . . . 1.0 110.089 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.9 p -134.25 -70.61 0.51 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.405 -0.362 . . . . 0.67 110.962 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 77.6 p -83.26 -177.65 6.82 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.242 -0.286 . . . . 0.38 110.318 175.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.525 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -83.25 -41.58 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.635 0 N-CA-C 108.637 -0.875 . . . . 0.68 108.637 -176.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.831 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 7.7 tpt180 -59.26 -29.62 67.7 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 113.743 -1.572 . . . . 3.23 110.91 175.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.26 68.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.786 0.326 . . . . 0.29 110.826 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.47 -43.07 41.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.972 0.892 . . . . 0.64 109.151 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.53 ' HG3' ' HA ' ' A' ' 76' ' ' ARG . 24.9 mmtm -60.01 -51.54 69.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.152 -1.386 . . . . 2.4 109.83 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.81 -29.75 70.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.714 -1.13 . . . . 1.66 111.162 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -72.96 -39.13 66.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.864 -0.607 . . . . 0.99 110.767 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.2 mtm -81.75 -42.61 19.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.595 -0.729 . . . . 1.1 112.349 -174.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.858 HD11 HD13 ' A' ' 13' ' ' LEU . 6.7 mp -83.67 -46.35 12.41 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.981 -0.45 . . . . 1.3 111.13 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.61 145.12 13.14 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.941 -0.647 . . . . 2.42 112.248 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.5 m -108.71 32.61 4.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.12 0.486 . . . . 4.47 110.547 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.77 73.31 0.39 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.725 -0.671 . . . . 4.59 112.008 -177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -91.33 24.18 3.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.052 0.453 . . . . 6.61 110.037 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.27 12.84 25.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.698 -0.683 . . . . 8.47 111.5 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.392 -1.227 . . . . 9.73 111.356 177.904 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . 0.533 H302 HD23 ' A' ' 45' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.626 0.251 . . . . 9.14 110.767 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 15.4 tpt -120.59 132.93 55.39 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.133 -0.321 . . . . 8.72 110.133 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -140.6 136.5 32.83 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.365 0.602 . . . . 5.17 111.016 -177.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 5' ' ' GLY . 81.6 tttt -148.48 164.14 35.06 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.2 -0.909 . . . . 6.66 108.773 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.662 ' HA3' ' HA2' ' A' ' 84' ' ' GLY . . . -111.44 -157.88 14.64 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.663 -0.78 . . . . 1.74 111.386 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.59 -65.9 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.087 0.47 . . . . 1.14 109.798 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 83' ' ' LEU . . . 103.25 92.52 2.23 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.172 -0.771 . . . . 0.53 111.172 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.713 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 2.7 m -114.26 156.28 15.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.855 0.359 . . . . 0.39 110.344 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.6 t -95.41 -176.52 3.8 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.12 -0.491 . . . . 1.56 109.728 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -62.65 -26.17 68.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.052 0.453 . . . . 2.02 109.969 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -56.48 -55.17 37.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.736 -0.666 . . . . 1.91 110.937 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.713 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 88.0 mttt -75.32 -19.8 59.43 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.31 -0.404 . . . . 1.58 110.468 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.601 HD11 ' HD2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -73.76 -31.14 63.17 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.022 -0.535 . . . . 0.99 110.183 172.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.16 -29.39 43.02 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.232 -0.918 . . . . 0.88 109.585 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -79.54 -25.7 41.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.936 -1.029 . . . . 0.3 111.021 -175.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.7 p -77.68 -43.76 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.557 -0.292 . . . . 0.23 111.32 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.555 ' HB3' HD23 ' A' ' 31' ' ' LEU . 66.9 mtm -63.35 -28.99 70.38 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.983 -0.287 . . . . 1.63 111.006 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 20.0 ptt180 -74.45 -33.62 62.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.86 -0.336 . . . . 3.17 110.62 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.12 -38.32 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.624 0.726 . . . . 0.23 109.143 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.3 t -61.87 -42.1 93.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.614 -1.175 . . . . 0.33 110.982 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.0 m -71.55 -41.36 69.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.286 0.565 . . . . 1.38 110.259 -171.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.06 -46.61 82.34 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.987 -1.006 . . . . 2.26 111.663 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.44 -31.46 48.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.459 -0.337 . . . . 0.77 111.502 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.414 ' HA ' HD11 ' A' ' 42' ' ' ILE . 53.1 m -77.85 -35.87 50.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.844 0.354 . . . . 1.23 111.175 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.72 0.72 36.79 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.793 -0.718 . . . . 0.54 112.494 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.853 HD11 ' SD ' ' A' ' 40' ' ' MET . 5.7 mt -92.81 161.18 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.286 0.565 . . . . 0.8 110.6 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -87.16 143.13 27.44 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.134 -0.939 . . . . 0.57 109.264 171.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.0 tp -56.18 -29.17 60.47 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.278 0.362 . . . . 0.97 111.56 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -69.32 -15.21 63.28 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.34 -0.391 . . . . 2.23 111.944 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -114.07 3.71 15.38 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.121 -0.231 . . . . 2.24 111.334 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.555 HD23 ' HB3' ' A' ' 17' ' ' MET . 39.1 tp -78.73 99.09 6.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.332 0.587 . . . . 1.1 110.335 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.1 p -120.06 163.28 17.89 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.007 -0.738 . . . . 0.6 109.007 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.643 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.8 p-10 -70.91 -3.0 16.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.158 0.429 . . . . 2.29 112.158 -177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.41 -22.97 61.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.983 0.42 . . . . 2.29 110.878 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.472 ' HB3' ' CG2' ' A' ' 75' ' ' VAL . 33.7 t -76.14 158.78 31.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.422 0.63 . . . . 1.06 111.742 -172.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.2 t-20 -127.16 119.42 26.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.363 -0.835 . . . . 0.8 109.277 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.775 ' HD1' HG13 ' A' ' 42' ' ' ILE . 38.5 m-85 -50.84 -49.6 58.49 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.123 0.487 . . . . 0.47 111.291 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.8 -32.77 74.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.798 -0.637 . . . . 0.46 111.28 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 34.2 t70 -73.51 -26.99 61.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.157 0.503 . . . . 0.83 110.541 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.853 ' SD ' HD11 ' A' ' 26' ' ' ILE . 65.3 mtm -79.7 -24.1 41.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.805 -0.634 . . . . 2.48 110.183 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.08 26.44 6.66 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.426 -0.892 . . . . 0.44 112.584 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.775 HG13 ' HD1' ' A' ' 37' ' ' PHE . 26.9 mm -65.14 108.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.604 -0.517 . . . . 0.52 109.604 175.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -82.34 176.49 9.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.581 -0.736 . . . . 1.94 110.435 -175.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.0 t -61.02 -40.25 92.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.805 -0.634 . . . . 1.03 109.865 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.27 -56.71 17.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.522 -0.763 . . . . 0.59 110.002 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.5 m -59.78 -44.22 94.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.09 -0.504 . . . . 1.22 111.206 -177.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.577 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 50.2 m -58.72 -39.29 80.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.744 -0.662 . . . . 0.81 111.606 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.66 ' HG2' H311 ' A' ' 90' ' ' PNS . 12.4 tpt -72.66 -37.5 67.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.374 0.606 . . . . 2.25 110.13 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.606 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.0 t -62.83 -53.84 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.14 -0.936 . . . . 0.36 109.871 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 46' ' ' SER . 66.5 mt -49.97 -52.4 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.281 -0.418 . . . . 0.26 111.281 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -61.09 -36.97 93.15 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.871 -0.681 . . . . 0.29 112.518 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t -63.66 -44.2 94.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.715 0.293 . . . . 0.92 110.467 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 11.7 mtp180 -65.87 -27.05 67.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.394 -0.366 . . . . 1.23 110.65 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.454 ' HB3' HD12 ' A' ' 60' ' ' LEU . 13.4 m-30 -57.31 -40.66 78.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.36 0.6 . . . . 0.28 110.032 175.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 47.5 mtp180 -78.62 -27.82 45.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.732 -0.667 . . . . 2.81 111.002 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.74 -56.73 4.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.217 -0.447 . . . . 2.26 111.474 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -88.14 -36.46 16.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.235 -0.439 . . . . 2.62 112.005 -172.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 58' ' ' LEU . 8.3 mp -99.76 -25.08 14.49 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.892 0.33 . . . . 0.67 111.892 -172.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.26 41.62 37.75 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.514 -0.85 . . . . 0.45 111.699 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 54' ' ' PHE . 19.1 mt -83.65 136.73 34.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.986 0.365 . . . . 0.63 111.986 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -93.4 88.38 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 2.27 110.208 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.495 HD11 ' HE2' ' A' ' 81' ' ' PHE . 0.7 OUTLIER -112.89 -61.05 1.79 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.135 -0.484 . . . . 1.64 109.92 178.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.58 170.72 12.45 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.811 -0.709 . . . . 0.75 112.155 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.57 10.43 3.71 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.995 2.463 . . . . 1.13 111.937 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -118.21 9.97 12.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.161 -0.927 . . . . 2.36 110.751 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -95.47 116.21 28.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.993 -0.548 . . . . 0.73 110.678 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.0 m -136.81 122.45 19.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.024 -0.535 . . . . 1.39 110.255 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.412 HD12 HD12 ' A' ' 50' ' ' ILE . 57.2 mt -56.85 -41.82 78.6 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.953 -0.567 . . . . 0.73 111.98 -176.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.577 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.4 t80 -55.67 -14.18 2.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.888 -0.596 . . . . 0.59 112.223 -174.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.51 -40.7 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.095 -0.378 . . . . 0.89 111.112 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -106.05 7.84 32.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.059 0.392 . . . . 2.23 112.059 -169.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 92.3 m -148.91 136.63 20.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.342 0.591 . . . . 1.0 109.863 -176.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.2 p -114.24 -76.15 0.58 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.038 -0.528 . . . . 0.67 111.071 -173.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 77.7 p -83.19 -172.8 4.34 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.12 -0.362 . . . . 0.38 110.449 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.524 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -81.36 -40.87 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.03 -0.729 . . . . 0.68 109.03 -175.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.643 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -66.98 -24.89 66.09 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.897 -1.047 . . . . 3.23 110.397 179.323 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.0 -34.41 71.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.444 -0.344 . . . . 0.29 110.462 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.66 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.9 OUTLIER -71.22 -48.05 53.62 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.745 -0.835 . . . . 0.64 108.745 177.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HD2' HD11 ' A' ' 13' ' ' LEU . 30.0 mmtm -54.04 -50.09 67.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.964 -1.471 . . . . 2.4 111.164 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.12 -44.99 92.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 1.66 110.627 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 84' ' ' GLY . 34.2 t80 -63.39 -30.07 71.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.043 -0.98 . . . . 0.99 111.162 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.66 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 32.8 mtp -61.0 -42.61 98.77 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.177 -0.465 . . . . 1.1 110.707 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.505 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 6.2 mp -81.81 -44.55 16.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.737 0.303 . . . . 1.3 110.875 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.662 ' HA2' ' HA3' ' A' ' 5' ' ' GLY . . . -148.5 148.81 20.61 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.076 -1.059 . . . . 2.42 112.79 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -78.8 45.34 0.6 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.319 0.581 . . . . 4.47 110.198 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.64 24.12 24.32 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.467 -1.053 . . . . 4.59 110.467 -172.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -83.53 73.43 10.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.447 0.641 . . . . 6.61 110.16 -175.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.06 123.82 7.95 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.36 -0.836 . . . . 8.47 109.957 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 118.473 -1.182 . . . . 9.73 111.406 178.358 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . 0.66 H311 ' HG2' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.751 0.31 . . . . 9.14 110.952 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 12.2 tpt -115.29 141.23 48.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.206 -0.294 . . . . 8.72 110.206 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.02 138.7 11.74 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.05 -0.352 . . . . 5.17 110.05 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt 67.25 91.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.939 0.775 . . . . 6.66 111.372 177.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.56 150.91 5.52 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.663 -0.78 . . . . 1.74 112.468 177.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.5 t -115.95 -75.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 110.16 -0.311 . . . . 1.14 110.16 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.35 98.91 2.49 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.6 -0.809 . . . . 0.53 111.744 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.45 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 4.0 m -114.43 162.11 12.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.324 -0.25 . . . . 0.39 110.324 -175.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 p -84.25 174.09 10.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.153 -0.314 . . . . 1.56 110.153 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -73.38 -19.46 60.99 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.197 -0.668 . . . . 2.02 109.197 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.59 -42.11 95.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.094 -0.957 . . . . 1.91 109.398 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.45 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 43.8 mmtm -67.36 -36.26 81.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.364 -0.835 . . . . 1.58 110.219 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -62.98 -29.44 70.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.941 -0.572 . . . . 0.99 110.678 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.38 -28.6 52.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.598 0.713 . . . . 0.88 109.682 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.52 -34.24 31.34 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.098 -0.956 . . . . 0.3 111.124 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.508 HG23 ' CE1' ' A' ' 54' ' ' PHE . 5.7 p -68.55 -45.99 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.654 0.613 . . . . 0.23 112.654 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 58.4 mtm -56.35 -34.95 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.943 0.349 . . . . 1.63 111.943 -172.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -78.69 -22.97 45.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.34 -0.544 . . . . 3.17 111.673 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.58 -34.88 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 122.05 0.929 . . . . 0.23 108.551 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 t -69.11 -36.84 75.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.184 -1.371 . . . . 0.33 110.469 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.4 t -68.91 -22.62 64.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.787 0.327 . . . . 1.38 110.765 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -86.23 -48.96 8.08 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.976 0.417 . . . . 2.26 111.919 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -79.5 -9.92 59.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.475 . . . . 0.77 112.1 -172.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -99.91 -42.8 6.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.989 0.423 . . . . 1.23 111.309 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.07 7.03 50.93 Favored Glycine 0 C--O 1.235 0.19 0 C-N-CA 120.711 -0.757 . . . . 0.54 111.261 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.564 HD11 ' HG3' ' A' ' 40' ' ' MET . 4.9 mt -93.14 111.91 25.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.307 -0.627 . . . . 0.8 109.307 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -48.4 144.63 3.92 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.456 0.473 . . . . 0.57 111.229 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.2 tp -55.23 -29.3 57.72 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.141 -0.481 . . . . 0.97 111.6 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -83.8 -10.25 58.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 2.23 111.039 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.435 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 33.2 mt-10 -105.57 -9.46 17.4 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.728 -0.842 . . . . 2.24 108.728 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.565 HD11 HG11 ' A' ' 75' ' ' VAL . 36.7 tp -72.76 98.28 2.37 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.812 -1.085 . . . . 1.1 109.649 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.6 p -115.79 158.89 22.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.147 -1.057 . . . . 0.6 108.147 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.886 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 17.4 p-10 -75.6 -2.41 29.1 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.931 -0.308 . . . . 2.29 110.821 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -88.22 -3.04 58.92 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.939 -0.573 . . . . 2.29 110.842 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.474 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 45.6 m -81.61 152.91 26.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.488 0.661 . . . . 1.06 110.704 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.686 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 15.0 t-20 -122.0 122.96 40.53 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.49 -0.777 . . . . 0.8 109.141 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.664 ' HD1' HG13 ' A' ' 42' ' ' ILE . 23.7 m-85 -55.75 -53.58 54.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.988 0.423 . . . . 0.47 111.359 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.86 -27.79 67.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.054 -0.521 . . . . 0.46 111.066 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.686 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 35.8 t70 -72.45 -29.2 63.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.83 110.586 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.564 ' HG3' HD11 ' A' ' 26' ' ' ILE . 14.9 mmt -83.35 -19.9 35.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.896 -0.593 . . . . 2.48 111.318 -176.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.92 16.73 8.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.356 -0.926 . . . . 0.44 112.441 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.664 HG13 ' HD1' ' A' ' 37' ' ' PHE . 23.4 mm -66.6 108.27 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.139 0.495 . . . . 0.52 110.323 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -81.34 167.49 19.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.667 -0.697 . . . . 1.94 110.068 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.8 t -54.02 -35.14 61.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.447 -0.575 . . . . 1.03 109.447 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.1 tm? -59.55 -62.56 1.78 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.562 -0.745 . . . . 0.59 110.022 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.543 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.2 m -59.86 -44.52 94.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.247 -0.433 . . . . 1.22 112.153 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.554 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 36.4 p -65.34 -30.36 71.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.021 0.438 . . . . 0.81 111.125 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.4 tpt -75.06 -30.82 61.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.647 -0.706 . . . . 2.25 109.621 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 45' ' ' LEU . 76.3 t -78.62 -36.78 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.148 -0.933 . . . . 0.36 110.497 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 46' ' ' SER . 66.9 mt -56.44 -52.57 50.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.37 -0.233 . . . . 0.26 110.37 173.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.67 -26.25 68.29 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.774 -0.727 . . . . 0.29 111.943 178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 4.1 m -69.62 -45.21 69.05 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 120.679 0.276 . . . . 0.92 110.863 176.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -65.07 -27.0 68.48 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.624 0.249 . . . . 1.23 110.856 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.611 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.7 m-30 -54.86 -39.97 69.18 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.718 -0.475 . . . . 0.28 109.718 174.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.691 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 12.2 mtp180 -81.64 -34.77 30.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.72 -0.673 . . . . 2.81 111.534 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -86.05 -63.88 1.24 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.039 0.447 . . . . 2.26 111.544 -173.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -71.14 -36.3 72.03 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.454 -0.794 . . . . 2.62 111.499 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.75 -57.0 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.67 111.055 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.85 27.61 3.19 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.823 -0.703 . . . . 0.45 113.221 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.691 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 55.2 mt -84.1 112.19 20.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.78 0.29 . . . . 0.63 110.353 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -85.58 66.37 9.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 122.235 1.017 . . . . 2.27 110.163 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.611 HD11 ' HD2' ' A' ' 54' ' ' PHE . 19.4 mt -64.72 -67.45 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.507 -1.224 . . . . 1.64 110.682 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.75 173.25 39.12 Favored Glycine 0 N--CA 1.438 -1.232 0 N-CA-C 110.285 -1.126 . . . . 0.75 110.285 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.8 -35.89 0.68 Allowed 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.372 2.048 . . . . 1.13 113.048 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -108.27 62.83 0.61 Allowed 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 121.078 0.466 . . . . 2.36 110.766 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -109.66 111.66 23.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.698 -0.482 . . . . 0.73 109.698 174.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.6 m -129.27 118.89 23.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.98 -0.555 . . . . 1.39 110.74 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 84.1 mt -64.64 -16.06 62.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.911 -0.586 . . . . 0.73 111.092 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.554 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 46.0 t80 -82.5 -12.03 58.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.923 -0.581 . . . . 0.59 110.948 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 71.8 mt -117.77 -41.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.773 -0.371 . . . . 0.89 111.624 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.26 15.23 16.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.454 0.645 . . . . 2.23 110.671 -173.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 76.8 m -146.72 156.63 43.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.7 p -135.93 -63.17 0.66 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.685 0.279 . . . . 0.67 110.776 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 44.3 p -93.04 179.08 5.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.195 -0.298 . . . . 0.38 110.195 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.565 HG11 HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -75.83 -42.91 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 121.484 0.659 . . . . 0.68 109.397 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.886 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 40.7 ttp180 -52.86 -37.96 60.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.501 -1.227 . . . . 3.23 111.728 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -55.83 -33.9 64.91 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.852 0.72 . . . . 0.29 111.311 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.47 -47.96 30.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.203 0.525 . . . . 0.64 110.144 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.592 ' CD ' ' HA ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -56.4 -60.97 2.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.263 -0.88 . . . . 2.4 110.235 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -54.62 -37.5 65.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.774 -1.103 . . . . 1.66 111.609 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.561 ' HA ' ' HB2' ' A' ' 85' ' ' SER . 38.2 t80 -62.07 -37.88 86.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.99 110.966 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.445 ' HB3' HG22 ' A' ' 8' ' ' VAL . 12.2 mtt -54.7 -49.87 69.67 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.059 -0.519 . . . . 1.1 112.017 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 83' ' ' LEU . 5.7 mp -80.81 -31.32 35.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 1.3 111.147 -174.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.52 86.53 0.11 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 119.995 -1.098 . . . . 2.42 112.627 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.561 ' HB2' ' HA ' ' A' ' 81' ' ' PHE . 1.8 t -78.9 65.7 4.17 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.922 0.391 . . . . 4.47 110.739 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.15 -116.65 1.64 Allowed Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.458 -0.657 . . . . 4.59 111.458 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -78.91 147.8 32.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.599 -0.519 . . . . 6.61 109.599 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -139.82 -170.49 2.95 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.654 -0.498 . . . . 8.47 109.654 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.545 -1.142 . . . . 9.73 111.304 -177.085 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.857 0.36 . . . . 9.14 110.406 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.1 ttt -124.21 118.85 27.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.183 -0.673 . . . . 8.72 109.183 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.16 136.9 40.4 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.089 0.471 . . . . 5.17 110.093 -176.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -136.28 80.28 1.81 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.311 -0.859 . . . . 6.66 109.824 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.98 74.13 0.18 Allowed Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.816 -0.629 . . . . 1.74 111.731 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.6 t -81.52 -74.04 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.943 0.401 . . . . 1.14 110.506 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.77 114.46 1.51 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.307 -0.949 . . . . 0.53 111.829 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 m -109.92 159.31 9.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.822 0.344 . . . . 0.39 110.46 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 m -75.49 166.99 22.74 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.777 -0.453 . . . . 1.56 109.777 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -69.41 -29.56 67.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.99 -0.744 . . . . 2.02 108.99 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.44 -34.64 77.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.079 -0.964 . . . . 1.91 110.242 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -63.69 -29.43 70.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 1.58 110.31 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.672 HD13 HD11 ' A' ' 83' ' ' LEU . 18.2 tp -66.95 -23.97 66.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.831 -0.622 . . . . 0.99 110.86 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.46 -31.57 26.49 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.585 0.707 . . . . 0.88 109.516 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.85 -29.03 55.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.155 -0.93 . . . . 0.3 110.509 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.459 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 3.3 p -73.65 -45.95 49.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.18 -0.464 . . . . 0.23 111.036 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.907 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 75.6 mtp -61.13 -35.32 76.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 1.63 111.226 -175.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.499 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 12.5 ptm180 -66.13 -37.64 86.2 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 120.459 -0.497 . . . . 3.17 110.567 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.9 -41.03 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 109.039 -0.726 . . . . 0.23 109.039 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -57.65 -47.23 86.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.841 -1.072 . . . . 0.33 110.129 175.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.402 ' HA ' ' HG ' ' A' ' 24' ' ' SER . 17.2 m -68.08 -42.37 80.5 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.071 0.397 . . . . 1.38 112.071 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 45.2 mt-10 -63.46 -27.76 69.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.252 -0.431 . . . . 2.26 111.579 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -91.06 -38.79 12.57 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.967 0.358 . . . . 0.77 111.967 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.402 ' HG ' ' HA ' ' A' ' 21' ' ' SER . 65.6 p -72.95 -44.98 60.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.958 0.409 . . . . 1.23 111.57 -176.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.99 -2.98 38.26 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.68 -0.771 . . . . 0.54 111.549 -174.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 mt -94.79 117.8 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.483 -0.562 . . . . 0.8 109.483 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.662 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -47.28 141.75 4.44 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.131 0.419 . . . . 0.57 112.131 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.9 tp -52.7 -38.64 60.99 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.509 -0.769 . . . . 0.97 111.472 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.39 -9.22 58.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.761 -0.654 . . . . 2.23 111.253 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.662 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 15.6 mm-40 -110.81 -6.87 14.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.93 -0.577 . . . . 2.24 109.983 -178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.5 tp -75.06 98.56 3.67 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.201 0.524 . . . . 1.1 110.284 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.3 p -111.65 158.94 18.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.529 -0.759 . . . . 0.6 109.696 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.705 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.2 p-10 -76.26 -4.99 44.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.349 . . . . 2.29 111.463 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.08 -21.18 60.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.811 -0.632 . . . . 2.29 110.639 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.436 ' HB3' HG21 ' A' ' 75' ' ' VAL . 16.3 t -77.31 158.07 30.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.81 0.814 . . . . 1.06 111.207 -173.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.661 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 20.7 t-20 -126.32 122.64 36.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.861 -1.063 . . . . 0.8 108.594 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.749 ' HD1' HG13 ' A' ' 42' ' ' ILE . 18.6 m-85 -55.17 -48.18 74.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.106 0.479 . . . . 0.47 111.408 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.06 -31.4 68.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.103 -0.499 . . . . 0.46 110.999 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.661 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 14.3 t70 -67.58 -34.51 77.18 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.161 0.505 . . . . 0.83 110.203 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.2 mmt -81.0 -17.67 49.52 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.633 -0.712 . . . . 2.48 111.238 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.87 22.03 9.19 Favored Glycine 0 C--O 1.23 -0.099 0 C-N-CA 120.566 -0.826 . . . . 0.44 112.773 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.749 HG13 ' HD1' ' A' ' 37' ' ' PHE . 26.9 mm -64.2 108.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.213 0.53 . . . . 0.52 110.192 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -76.1 161.64 28.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.35 -0.841 . . . . 1.94 111.04 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.3 t -56.07 -41.52 75.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.938 -0.574 . . . . 1.03 110.576 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.92 -53.18 60.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.564 -0.744 . . . . 0.59 109.788 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.554 ' O ' HG13 ' A' ' 50' ' ' ILE . 16.2 m -57.84 -44.87 86.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.419 -0.355 . . . . 1.22 110.903 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.524 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 50.2 m -58.38 -37.66 75.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.096 -0.502 . . . . 0.81 111.234 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.53 ' HG2' ' H32' ' A' ' 90' ' ' PNS . 12.2 tpt -74.71 -34.99 62.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.909 -0.587 . . . . 2.25 109.93 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.525 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 44.1 t -68.3 -48.54 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.664 -0.698 . . . . 0.36 109.587 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 46' ' ' SER . 73.1 mt -52.04 -54.89 11.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.72 0.295 . . . . 0.26 110.391 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.52 ' O ' ' HG3' ' A' ' 55' ' ' ARG . . . -60.41 -32.98 79.22 Favored Glycine 0 C--O 1.228 -0.245 0 CA-C-N 115.829 -0.623 . . . . 0.29 112.578 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.509 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -72.94 -45.59 57.22 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.048 -0.261 . . . . 0.92 110.549 177.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 6.1 mtp180 -63.39 -30.68 71.77 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.913 0.387 . . . . 1.23 110.188 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.516 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 9.1 m-30 -50.99 -48.52 61.24 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.857 -0.61 . . . . 0.28 109.782 171.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 19.0 mtm105 -83.76 -40.51 18.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.637 -0.711 . . . . 2.81 110.952 -170.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -88.21 -49.01 7.27 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.351 -0.386 . . . . 2.26 111.874 -171.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -79.58 -52.05 8.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.85 0.357 . . . . 2.62 111.349 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 mp -82.63 -58.31 2.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.194 -0.457 . . . . 0.67 111.541 -175.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.65 24.22 1.58 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.091 -0.576 . . . . 0.45 112.154 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.541 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 16.6 mt -104.19 92.72 4.48 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.757 -0.26 . . . . 0.63 110.516 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.451 ' HA ' ' HG2' ' A' ' 55' ' ' ARG . 18.4 t70 -101.36 80.04 2.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.581 0.705 . . . . 2.27 110.021 -178.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.518 HD13 ' HE2' ' A' ' 81' ' ' PHE . 71.4 mt -71.17 -32.53 69.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.895 -1.048 . . . . 1.64 109.43 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.06 160.98 21.8 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 114.642 -1.163 . . . . 0.75 110.75 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -82.99 -12.58 9.55 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.89 2.393 . . . . 1.13 113.066 -175.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -130.67 31.36 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.812 0.815 . . . . 2.36 110.717 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -95.01 120.24 34.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.73 109.563 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 t -126.63 131.76 51.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.7 -0.4 . . . . 1.39 110.498 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 72' ' ' CYS . 48.1 mt -58.4 -41.38 84.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.808 -0.633 . . . . 0.73 110.475 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.524 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 15.0 t80 -62.59 -12.4 22.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.731 -0.668 . . . . 0.59 111.494 -175.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 63.7 mt -109.87 -42.34 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.874 -0.33 . . . . 0.89 111.126 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -130.71 22.11 5.04 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.64 0.978 . . . . 2.23 113.64 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 98.3 m -143.99 99.55 3.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.282 0.563 . . . . 1.0 109.81 174.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.5 p -90.81 -51.78 5.19 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.012 -0.54 . . . . 0.67 111.624 -170.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.4 p -96.82 -178.64 4.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.19 -0.3 . . . . 0.38 110.19 176.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.568 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -81.09 -41.33 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 109.764 -0.458 . . . . 0.68 109.764 -178.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.705 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 5.2 tpt180 -60.6 -28.22 68.33 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.671 -0.695 . . . . 3.23 110.483 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -58.32 -32.83 68.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.498 -0.319 . . . . 0.29 110.69 177.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.505 HD21 ' CE2' ' A' ' 54' ' ' PHE . 0.7 OUTLIER -81.27 -48.66 11.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.546 0.689 . . . . 0.64 109.431 176.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.907 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.9 mmtp -53.99 -57.84 9.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.695 -1.139 . . . . 2.4 110.928 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.498 ' HB2' ' HE ' ' A' ' 76' ' ' ARG . 5.7 t70 -72.33 -19.38 61.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.208 -0.905 . . . . 1.66 111.1 -171.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.518 ' HE2' HD13 ' A' ' 62' ' ' LEU . 76.2 t80 -73.62 -44.12 57.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.215 0.531 . . . . 0.99 110.418 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.459 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 6.3 mtm -70.9 -32.66 69.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.73 -0.668 . . . . 1.1 112.123 -176.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.672 HD11 HD13 ' A' ' 13' ' ' LEU . 7.5 mp -80.07 -44.69 19.61 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.772 -0.371 . . . . 1.3 110.856 172.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -109.09 73.89 0.2 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.968 -0.634 . . . . 2.42 112.369 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.1 m -87.56 35.91 0.73 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.871 0.367 . . . . 4.47 111.14 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.79 -31.05 7.21 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.75 -0.738 . . . . 4.59 112.102 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -106.3 -165.76 1.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.197 -0.668 . . . . 6.61 109.197 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.56 -34.39 0.63 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.737 0.273 . . . . 8.47 111.737 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.415 -1.214 . . . . 9.73 112.212 -177.305 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . 0.53 ' H32' ' HG2' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 120.765 0.317 . . . . 9.14 110.901 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 14.0 tpt -131.12 126.99 37.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.213 -0.662 . . . . 8.72 109.213 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.16 -19.28 51.35 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.103 0.478 . . . . 5.17 111.878 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.0 tttp -137.33 104.18 5.3 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.991 -0.549 . . . . 6.66 110.502 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.2 125.1 1.52 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.981 -0.628 . . . . 1.74 111.593 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.18 -84.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.477 0.18 . . . . 1.14 110.534 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.4 93.76 1.63 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.571 -0.823 . . . . 0.53 111.324 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.03 155.36 14.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.851 0.358 . . . . 0.39 110.167 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 t -82.96 173.63 11.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.536 -0.542 . . . . 1.56 109.536 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -65.52 -25.8 67.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.293 0.568 . . . . 2.02 109.853 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -67.29 -46.45 73.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.395 -0.82 . . . . 1.91 110.503 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -73.82 -20.32 60.49 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.724 -0.391 . . . . 1.58 110.508 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 17' ' ' MET . 1.8 tp -74.18 -25.54 59.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 0.99 110.33 172.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.37 -27.51 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.721 0.772 . . . . 0.88 110.311 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -79.54 -30.77 41.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.987 -1.006 . . . . 0.3 110.878 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.624 HG11 ' SD ' ' A' ' 82' ' ' MET . 2.3 p -68.33 -43.59 84.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.314 -0.403 . . . . 0.23 111.459 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.808 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 30.7 mtt -56.85 -34.77 68.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.515 -0.311 . . . . 1.63 111.132 -174.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.617 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 12.8 ptp180 -81.85 -27.08 33.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.475 -0.329 . . . . 3.17 111.785 -176.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.9 t -71.35 -34.93 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 108.078 -1.082 . . . . 0.23 108.078 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.1 t -66.88 -36.82 78.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 114.025 -1.443 . . . . 0.33 109.8 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.483 ' HB2' ' HA ' ' A' ' 18' ' ' ARG . 19.5 m -70.66 -26.12 63.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 116.231 -0.44 . . . . 1.38 112.16 -177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.617 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 74.6 mt-10 -86.68 -37.73 17.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.865 0.364 . . . . 2.26 111.177 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HG3' HG12 ' A' ' 50' ' ' ILE . 72.3 mm-40 -76.85 -37.91 54.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.968 -0.56 . . . . 0.77 112.23 -176.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.482 ' CB ' HD11 ' A' ' 42' ' ' ILE . 66.4 p -80.3 -45.35 18.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.132 0.491 . . . . 1.23 110.816 -178.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.71 -4.38 26.07 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.688 -0.687 . . . . 0.54 112.467 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.685 HD11 ' HG3' ' A' ' 40' ' ' MET . 8.6 mt -75.32 141.23 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.625 -0.43 . . . . 0.8 110.002 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.86 140.05 56.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.097 -0.501 . . . . 0.57 109.667 173.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.3 tp -55.09 -31.9 61.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 0.97 111.763 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -77.95 -8.27 57.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.513 -0.312 . . . . 2.23 110.909 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -107.22 -5.44 17.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.934 0.397 . . . . 2.24 110.132 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 17' ' ' MET . 32.6 tp -75.89 97.51 3.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.429 0.633 . . . . 1.1 109.921 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.409 ' O ' HG21 ' A' ' 75' ' ' VAL . 16.0 p -116.82 165.56 13.17 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.76 -0.829 . . . . 0.6 108.76 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.482 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.9 p-10 -72.6 -3.7 26.33 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 111.49 0.181 . . . . 2.29 111.49 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -74.81 -22.69 58.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.992 0.425 . . . . 2.29 110.429 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.478 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 18.0 m -74.15 153.98 39.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.735 0.778 . . . . 1.06 111.34 -174.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.91 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.5 t-20 -128.31 127.55 42.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.121 -0.945 . . . . 0.8 108.674 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.596 ' HD1' HG13 ' A' ' 42' ' ' ILE . 11.7 m-85 -56.48 -53.41 57.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.973 0.416 . . . . 0.47 111.649 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.49 -30.01 66.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.314 -0.403 . . . . 0.46 111.189 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.91 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.5 t70 -69.66 -30.48 68.18 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.345 0.593 . . . . 0.83 110.412 176.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.685 ' HG3' HD11 ' A' ' 26' ' ' ILE . 1.8 tmm? -74.18 -23.37 59.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.541 -0.754 . . . . 2.48 110.461 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.3 14.69 15.76 Favored Glycine 0 CA--C 1.511 -0.175 0 C-N-CA 120.354 -0.927 . . . . 0.44 111.358 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.596 HG13 ' HD1' ' A' ' 37' ' ' PHE . 24.6 mm -76.24 113.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.584 -0.308 . . . . 0.52 110.337 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.53 -172.74 2.58 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.05 -0.722 . . . . 1.94 109.05 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.8 t -68.24 -30.82 69.95 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 111.618 0.229 . . . . 1.03 111.618 -174.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.69 -59.79 4.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.5 -0.318 . . . . 0.59 110.298 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.575 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.3 t -66.03 -40.95 91.48 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.029 -0.269 . . . . 1.22 110.496 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.46 ' HB3' ' H ' ' A' ' 69' ' ' PHE . 49.0 m -56.78 -36.77 70.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.345 -0.389 . . . . 0.81 111.784 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -73.61 -43.77 58.77 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.655 -0.869 . . . . 2.25 108.655 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.44 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 64.0 t -62.26 -43.17 97.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.837 -1.074 . . . . 0.36 110.721 -176.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 46' ' ' SER . 72.3 mt -54.0 -52.86 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.871 0.367 . . . . 0.26 110.582 175.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -60.85 -31.87 77.46 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.076 -0.583 . . . . 0.29 112.135 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.85 -46.39 82.06 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 122.441 0.296 . . . . 0.92 110.802 176.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 12.4 mtp180 -65.28 -28.21 69.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.544 -0.298 . . . . 1.23 110.514 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.67 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.5 m-30 -57.66 -39.35 76.87 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.707 -0.479 . . . . 0.28 109.707 173.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -80.17 -33.2 38.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.179 -0.464 . . . . 2.81 110.437 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.21 -51.65 9.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.426 -0.352 . . . . 2.26 111.024 -175.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.81 -48.74 7.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.959 -0.564 . . . . 2.62 112.331 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.8 mp -90.56 -13.29 34.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.54 -0.3 . . . . 0.67 111.535 -173.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 33.14 68.7 Favored Glycine 0 C--O 1.229 -0.198 0 C-N-CA 121.008 -0.615 . . . . 0.45 112.804 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.441 HD12 ' HB3' ' A' ' 54' ' ' PHE . 80.0 mt -90.64 116.65 28.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.505 0.153 . . . . 0.63 111.174 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.08 77.66 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.436 1.113 . . . . 2.27 109.706 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.67 HD11 ' HD2' ' A' ' 54' ' ' PHE . 25.2 mt -74.13 -27.01 60.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.652 -1.158 . . . . 1.64 110.608 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.39 171.68 12.55 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 114.936 -1.029 . . . . 0.75 110.799 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -87.04 -7.32 7.14 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.999 2.466 . . . . 1.13 112.388 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -134.49 45.44 2.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.63 0.729 . . . . 2.36 110.291 -171.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -109.56 129.88 55.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.454 -0.794 . . . . 0.73 110.8 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.2 t -140.69 131.09 25.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.329 -0.396 . . . . 1.39 110.013 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.444 HD12 HD12 ' A' ' 50' ' ' ILE . 50.6 mt -60.44 -37.84 82.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.917 0.389 . . . . 0.73 110.458 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.46 ' H ' ' HB3' ' A' ' 47' ' ' SER . 40.5 t80 -60.05 -12.39 8.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.47 -0.786 . . . . 0.59 111.641 -174.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.52 -38.94 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.565 -0.289 . . . . 0.89 111.417 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -114.72 10.97 16.72 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.395 0.517 . . . . 2.23 112.395 -171.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 82.9 m -150.22 100.13 2.87 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.181 0.515 . . . . 1.0 110.096 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.8 p -91.1 -54.13 4.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.26 -0.427 . . . . 0.67 111.638 -172.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 70.1 p -94.4 -177.28 4.2 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.084 -0.385 . . . . 0.38 110.394 176.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.478 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -79.11 -43.61 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.457 0.646 . . . . 0.68 109.845 -178.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.482 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.3 tpt180 -63.1 -25.65 68.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.246 -0.888 . . . . 3.23 110.637 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.43 -32.99 73.92 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 116.275 -0.421 . . . . 0.29 110.559 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.656 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.8 OUTLIER -75.23 -50.42 16.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.87 -0.789 . . . . 0.64 108.87 177.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.808 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 29.9 mmtp -50.32 -52.66 34.82 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.178 -0.919 . . . . 2.4 110.897 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -63.18 -39.65 95.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.482 -0.781 . . . . 1.66 111.373 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -63.27 -35.12 79.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.792 -0.64 . . . . 0.99 111.667 -176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.656 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 28.7 mtp -62.25 -39.02 91.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.882 0.373 . . . . 1.1 110.708 -177.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.1 mp -80.89 -34.81 33.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.326 0.584 . . . . 1.3 109.892 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.85 -77.83 0.9 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.699 -0.763 . . . . 2.42 112.982 173.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.7 m -151.05 77.31 1.26 Allowed 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.743 -0.269 . . . . 4.47 110.841 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.24 -152.25 7.02 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.987 -1.101 . . . . 4.59 112.053 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.87 -34.56 75.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.852 0.358 . . . . 6.61 110.099 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 72.78 3.66 4.75 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.01 -0.995 . . . . 8.47 112.04 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.772 0 CA-C-O 118.738 -1.034 . . . . 9.73 111.751 177.885 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.908 -0.404 . . . . 9.14 109.908 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -142.48 150.79 40.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.627 0.251 . . . . 8.72 110.869 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -135.52 132.47 37.32 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.327 0.584 . . . . 5.17 109.751 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -150.93 144.91 25.26 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.171 -0.922 . . . . 6.66 109.305 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.54 -96.39 0.59 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.844 -0.693 . . . . 1.74 111.89 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -109.71 -125.82 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.57 -0.53 . . . . 1.14 109.57 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' ' 83' ' ' LEU . . . 124.96 106.48 1.63 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.843 -0.903 . . . . 0.53 110.843 -174.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.407 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 3.0 m -114.3 159.24 14.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.895 0.379 . . . . 0.39 111.153 -173.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.2 m -87.31 175.22 8.12 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.973 -0.558 . . . . 1.56 110.051 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -65.76 -33.24 75.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.978 0.418 . . . . 2.02 110.885 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 1.7 mp0 -65.01 -36.27 83.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.586 0.708 . . . . 1.91 109.783 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HD2' HD21 ' A' ' 60' ' ' LEU . 39.9 mmtm -66.39 -33.92 76.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.04 -0.982 . . . . 1.58 110.242 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.7 tp -67.46 -25.79 66.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.781 -0.645 . . . . 0.99 110.697 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.69 -28.82 28.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.248 0.547 . . . . 0.88 110.252 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.64 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -80.14 -27.2 39.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.893 -0.594 . . . . 0.3 111.024 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.457 HG23 ' CZ ' ' A' ' 54' ' ' PHE . 2.7 p -72.62 -44.23 60.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.355 -0.384 . . . . 0.23 111.661 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.1 mtp -63.69 -24.96 67.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.505 -0.316 . . . . 1.63 111.389 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 16.1 ptt180 -76.86 -27.44 55.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.85 0.357 . . . . 3.17 110.757 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.1 t -82.4 -37.75 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.578 0.704 . . . . 0.23 109.123 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.402 ' CG1' HD11 ' A' ' 31' ' ' LEU . 21.1 t -64.21 -32.03 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.913 -1.04 . . . . 0.33 109.296 174.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -61.87 -26.63 68.26 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.842 -0.617 . . . . 1.38 111.449 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -87.33 -53.14 4.99 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.31 0.576 . . . . 2.26 111.308 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -73.22 -30.53 63.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.318 -0.856 . . . . 0.77 111.898 -171.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.476 ' HA ' HD11 ' A' ' 42' ' ' ILE . 24.5 m -92.22 -25.22 18.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.592 -0.276 . . . . 1.23 111.424 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.03 7.42 65.89 Favored Glycine 0 N--CA 1.461 0.356 0 C-N-CA 120.33 -0.938 . . . . 0.54 113.007 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.601 HD11 ' SD ' ' A' ' 40' ' ' MET . 4.3 mt -98.51 131.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.728 -0.471 . . . . 0.8 109.728 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.07 146.28 47.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.119 -0.326 . . . . 0.57 110.119 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.5 tp -53.24 -33.55 53.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.581 0.352 . . . . 0.97 111.183 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -83.25 -8.97 59.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.093 -0.503 . . . . 2.23 111.342 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -114.81 -6.15 12.65 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.22 -0.659 . . . . 2.24 109.22 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.57 98.38 2.31 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.923 -1.035 . . . . 1.1 109.048 179.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.8 p -103.17 153.49 20.29 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.642 -0.708 . . . . 0.6 109.723 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.934 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 20.7 m-20 -75.0 -9.95 59.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.918 0.39 . . . . 2.29 111.858 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -95.37 -11.58 27.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.869 -0.605 . . . . 2.29 111.891 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 t -78.41 156.05 29.65 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.556 0.693 . . . . 1.06 109.946 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.566 ' HB3' ' CB ' ' A' ' 39' ' ' ASP . 18.3 t-20 -115.51 127.03 55.0 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.15 -0.932 . . . . 0.8 110.231 -168.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.776 ' HD1' HG13 ' A' ' 42' ' ' ILE . 18.0 m-85 -56.56 -51.8 67.22 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.891 0.377 . . . . 0.47 111.193 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.43 -31.16 71.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.239 -0.437 . . . . 0.46 111.128 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.566 ' CB ' ' HB3' ' A' ' 36' ' ' ASN . 25.1 t70 -67.23 -31.76 72.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.076 0.465 . . . . 0.83 110.499 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.601 ' SD ' HD11 ' A' ' 26' ' ' ILE . 68.2 mtp -89.52 -9.35 50.29 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.198 -0.456 . . . . 2.48 111.153 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.22 26.8 9.83 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.195 -1.003 . . . . 0.44 112.975 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.776 HG13 ' HD1' ' A' ' 37' ' ' PHE . 30.2 mm -71.87 107.27 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.249 -0.278 . . . . 0.52 110.249 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -78.52 176.71 9.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.42 0.629 . . . . 1.94 110.572 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.7 p -59.83 -41.66 91.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.011 -0.995 . . . . 1.03 111.097 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -58.98 -58.71 7.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.611 -0.722 . . . . 0.59 110.4 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.657 ' O ' HG13 ' A' ' 50' ' ' ILE . 5.0 m -60.53 -46.01 91.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.402 -0.363 . . . . 1.22 111.39 -177.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.908 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 41.3 p -65.54 -31.49 72.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.345 -0.389 . . . . 0.81 111.393 -177.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -40.47 66.77 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.845 -0.798 . . . . 2.25 108.845 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.556 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 24.1 t -59.5 -44.83 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 115.221 -0.899 . . . . 0.36 110.053 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 46' ' ' SER . 39.4 mt -52.82 -56.93 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.26 111.043 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -62.72 -29.62 74.41 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.021 -0.609 . . . . 0.29 112.55 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -44.19 77.57 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.155 -0.313 . . . . 0.92 110.155 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.556 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 16.4 mtp180 -62.94 -26.34 68.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.567 -0.288 . . . . 1.23 110.611 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.684 ' HD2' HD11 ' A' ' 62' ' ' LEU . 14.5 m-30 -56.77 -41.4 77.55 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.167 0.508 . . . . 0.28 109.925 173.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 23.3 mtm180 -79.43 -25.78 41.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.513 -0.767 . . . . 2.81 110.299 -177.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -74.27 -62.91 1.35 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.611 -0.722 . . . . 2.26 111.82 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.84 -41.71 11.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.966 0.413 . . . . 2.62 111.733 -173.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.77 -23.63 21.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.301 -0.409 . . . . 0.67 111.572 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.89 27.55 60.35 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.145 -0.55 . . . . 0.45 112.732 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.68 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 58.1 mt -87.03 95.72 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.767 -0.255 . . . . 0.63 110.591 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -86.83 78.2 9.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.6 0.714 . . . . 2.27 109.215 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.684 HD11 ' HD2' ' A' ' 54' ' ' PHE . 14.6 mt -71.05 -57.01 4.95 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.371 -1.286 . . . . 1.64 110.305 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.38 150.44 9.38 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.753 -1.112 . . . . 0.75 110.807 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.49 -9.84 20.23 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.234 1.956 . . . . 1.13 112.902 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -120.15 22.84 11.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.995 -0.548 . . . . 2.36 110.733 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -80.34 124.43 28.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.282 -0.417 . . . . 0.73 111.148 -177.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.4 t -139.47 125.19 19.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.641 -0.503 . . . . 1.39 109.641 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.908 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 88.5 mt -60.37 -23.7 64.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.541 0.21 . . . . 0.73 111.382 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.52 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 17.5 t80 -71.88 -14.06 61.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.246 0.546 . . . . 0.59 110.445 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.2 mt -122.89 -39.75 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.89 110.868 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -95.02 8.46 42.84 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.74 0.274 . . . . 2.23 111.74 -172.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 95.5 m -158.31 167.23 30.31 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.9 p -138.49 -68.07 0.46 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 0.67 110.568 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 81.4 p -84.55 -175.43 5.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.747 -0.464 . . . . 0.38 109.747 174.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.0 t -83.77 -38.75 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.879 0.847 . . . . 0.68 109.929 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.934 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 35.6 ttm180 -61.88 -30.01 70.58 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.713 -1.131 . . . . 3.23 111.252 175.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.46 -31.44 65.95 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.988 0.423 . . . . 0.29 110.513 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.776 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.1 tt -70.5 -48.32 56.26 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.574 -0.899 . . . . 0.64 108.574 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.552 ' CG ' ' HA ' ' A' ' 76' ' ' ARG . 20.8 mmtm -50.76 -55.06 18.48 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.984 -1.007 . . . . 2.4 110.572 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -51.44 -49.43 61.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.276 -0.875 . . . . 1.66 111.69 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -61.7 -36.49 81.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.743 -0.662 . . . . 0.99 111.8 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.776 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 44.1 mtp -64.16 -45.82 86.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.367 -0.379 . . . . 1.1 111.765 -173.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.624 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 5.3 mp -87.9 -38.78 15.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.764 0.316 . . . . 1.3 110.806 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.68 128.67 2.53 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.769 -0.729 . . . . 2.42 112.032 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.7 m -75.74 44.9 0.31 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.049 0.539 . . . . 4.47 111.595 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.85 32.43 4.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.145 -0.55 . . . . 4.59 112.489 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -109.11 106.24 16.07 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.592 -0.522 . . . . 6.61 109.592 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 73.32 148.47 0.09 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.731 0.777 . . . . 8.47 111.396 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.928 0 CA-C-O 118.401 -1.222 . . . . 9.73 111.313 176.793 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . 0.449 H313 ' O35' ' A' ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.143 -0.317 . . . . 9.14 110.143 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.2 ptm -106.0 150.31 25.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.758 -0.46 . . . . 8.72 109.758 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.18 134.42 16.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.635 0.255 . . . . 5.17 110.702 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt 68.85 160.65 0.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 O-C-N 124.19 0.932 . . . . 6.66 110.88 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.97 -146.44 4.33 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.187 -0.765 . . . . 1.74 111.187 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.0 t -86.11 -66.61 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.897 0.38 . . . . 1.14 110.208 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.0 103.91 1.45 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.956 -0.857 . . . . 0.53 110.956 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.661 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 4.1 m -103.98 156.74 5.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.707 0.289 . . . . 0.39 110.628 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.3 m -85.39 173.93 9.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.639 -0.504 . . . . 1.56 109.639 175.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -61.75 -36.08 79.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.774 0.797 . . . . 2.02 109.013 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -59.17 -42.1 89.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.716 -1.129 . . . . 1.91 111.211 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.661 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . 41.4 mmtm -67.73 -31.65 71.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 1.58 110.052 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.421 ' O ' ' HG3' ' A' ' 17' ' ' MET . 34.7 tp -68.11 -26.22 65.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.645 . . . . 0.99 110.324 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.69 -29.96 36.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.103 0.478 . . . . 0.88 110.288 178.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.17 -27.22 39.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.619 . . . . 0.3 111.051 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.6 HG23 ' CE1' ' A' ' 54' ' ' PHE . 4.0 p -75.71 -48.76 28.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.805 0.336 . . . . 0.23 111.721 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 73.3 mtm -59.57 -30.32 68.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.176 -0.465 . . . . 1.63 111.514 -174.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 6.5 ptm180 -70.38 -37.88 74.63 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.106 -0.638 . . . . 3.17 110.635 176.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.456 HG12 HG23 ' A' ' 50' ' ' ILE . 29.2 t -64.5 -42.77 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.554 0.693 . . . . 0.23 109.3 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.09 -42.03 93.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.983 -1.008 . . . . 0.33 110.807 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -23.48 61.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.828 0.347 . . . . 1.38 110.174 -174.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 43.9 mt-10 -79.01 -43.27 24.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.158 -0.474 . . . . 2.26 111.6 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -86.27 -8.31 57.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.329 -0.396 . . . . 0.77 111.273 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.4 p -97.57 -41.25 8.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.052 0.453 . . . . 1.23 110.407 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.76 41.85 3.25 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.863 -0.684 . . . . 0.54 111.603 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 27' ' ' ALA . 5.2 mt -127.16 165.87 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.808 -0.442 . . . . 0.8 109.808 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.503 ' HB3' ' HG2' ' A' ' 30' ' ' GLU . . . -83.96 142.02 30.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.643 -0.708 . . . . 0.57 110.257 172.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.0 tp -61.14 -33.26 73.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.043 -0.526 . . . . 0.97 111.092 -177.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -75.63 -11.98 60.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.179 0.514 . . . . 2.23 111.067 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' A' ' 27' ' ' ALA . 17.8 mm-40 -105.79 -5.04 20.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.796 -0.638 . . . . 2.24 110.107 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.6 tp -84.85 96.55 9.35 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.107 -0.497 . . . . 1.1 110.352 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.2 p -115.0 169.63 8.94 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.833 -0.803 . . . . 0.6 108.833 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.686 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 4.8 p-10 -75.66 -3.29 33.71 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.931 -0.308 . . . . 2.29 111.548 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.12 -20.22 60.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.14 -0.482 . . . . 2.29 110.406 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.489 ' HB2' HG21 ' A' ' 75' ' ' VAL . 16.3 m -79.74 157.69 27.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.606 0.717 . . . . 1.06 111.541 -175.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.75 119.42 25.73 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.229 -1.026 . . . . 0.8 108.229 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.422 ' CZ ' HG13 ' A' ' 75' ' ' VAL . 16.8 m-85 -57.72 -39.26 76.86 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.45 -0.5 . . . . 0.47 111.642 -173.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.76 -26.91 67.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.984 0.421 . . . . 0.46 110.472 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -68.89 -29.73 68.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.83 110.296 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -83.59 -8.4 59.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.754 -0.657 . . . . 2.48 110.283 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.77 32.5 36.75 Favored Glycine 0 C--N 1.322 -0.225 0 C-N-CA 120.443 -0.884 . . . . 0.44 112.002 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.502 ' CG2' ' HB3' ' A' ' 47' ' ' SER . 2.7 mt -67.76 108.46 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.018 0.437 . . . . 0.52 110.225 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -78.45 165.96 23.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.816 -0.629 . . . . 1.94 110.48 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.0 t -51.54 -43.33 62.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 1.03 110.861 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.14 -55.91 28.8 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.142 -0.481 . . . . 0.59 110.376 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.45 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.3 m -61.41 -44.14 97.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 1.22 111.525 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.866 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 63.7 p -68.09 -31.61 71.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.735 0.302 . . . . 0.81 111.222 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.578 ' HG2' H311 ' A' ' 90' ' ' PNS . 13.2 tpt -70.76 -36.45 73.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.449 0.642 . . . . 2.25 109.805 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.0 t -64.31 -36.39 76.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.064 -0.971 . . . . 0.36 110.22 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.532 HD12 HD12 ' A' ' 68' ' ' LEU . 67.5 mt -59.83 -52.01 66.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.762 -0.653 . . . . 0.26 110.753 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.5 ' HA2' ' CD2' ' A' ' 54' ' ' PHE . . . -64.04 -28.69 73.19 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.144 -0.551 . . . . 0.29 112.197 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -49.63 76.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.767 0.318 . . . . 0.92 110.512 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -64.6 -28.43 69.62 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.417 -0.356 . . . . 1.23 111.07 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.6 ' CE1' HG23 ' A' ' 16' ' ' VAL . 14.6 m-30 -53.9 -44.22 70.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.613 -0.514 . . . . 0.28 109.613 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -84.86 -35.36 22.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 2.81 111.451 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -85.79 -56.16 3.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.036 0.446 . . . . 2.26 111.299 -174.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.28 -52.71 11.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.971 -0.559 . . . . 2.62 111.387 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 mp -88.25 -32.13 18.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.516 . . . . 0.67 111.849 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.9 33.91 16.91 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.524 -0.846 . . . . 0.45 112.115 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.15 152.0 21.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.789 -0.448 . . . . 0.63 109.789 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -112.72 110.97 21.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.942 0.401 . . . . 2.27 110.325 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -123.8 5.56 8.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 1.64 109.501 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.56 164.22 39.47 Favored Glycine 0 CA--C 1.509 -0.323 0 CA-C-N 115.474 -0.785 . . . . 0.75 111.456 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -87.74 -2.07 7.39 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.23 2.62 . . . . 1.13 112.078 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -106.48 12.92 29.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.387 -0.824 . . . . 2.36 111.036 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -93.63 111.82 23.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.055 0.455 . . . . 0.73 110.462 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.3 m -134.5 128.18 32.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.72 -0.673 . . . . 1.39 109.5 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.866 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 42.3 mt -66.58 -45.02 80.65 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.799 0.296 . . . . 0.73 111.799 -173.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.96 -4.67 4.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.008 0.432 . . . . 0.59 110.772 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -116.08 -40.35 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 O-C-N 122.223 -0.298 . . . . 0.89 111.555 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -126.07 8.41 7.34 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.122 0.416 . . . . 2.23 112.122 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 68' ' ' LEU . 75.9 m -147.52 88.76 1.72 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.623 -0.673 . . . . 1.0 110.412 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 p -81.73 -31.76 31.9 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.904 -0.589 . . . . 0.67 111.812 -173.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.9 p -110.95 176.73 4.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.668 0.27 . . . . 0.38 110.501 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.489 HG21 ' HB2' ' A' ' 35' ' ' SER . 0.2 OUTLIER -80.77 -44.72 21.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.965 -0.383 . . . . 0.68 109.965 -177.651 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.686 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.2 tpt180 -57.94 -32.51 67.87 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.132 -0.486 . . . . 3.23 110.551 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.59 -29.54 62.19 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.116 -0.493 . . . . 0.29 111.062 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.677 ' O ' ' HG3' ' A' ' 82' ' ' MET . 3.7 tp -86.39 -55.1 4.05 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.16 -0.682 . . . . 0.64 109.16 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -56.01 -60.35 3.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.287 -1.324 . . . . 2.4 111.656 -174.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.472 ' HB2' ' HE ' ' A' ' 76' ' ' ARG . 9.7 t70 -66.93 -26.28 66.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.465 -0.789 . . . . 1.66 110.681 -171.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.73 -26.58 66.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.22 -0.9 . . . . 0.99 110.731 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.677 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 28.6 mtp -78.3 -36.72 46.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.905 -0.589 . . . . 1.1 110.532 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 83' ' ' LEU . 6.2 mp -79.28 -44.77 21.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.024 -0.535 . . . . 1.3 110.155 177.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.42 91.68 0.18 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.393 -0.908 . . . . 2.42 113.201 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.9 m -79.62 45.59 0.7 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.244 0.545 . . . . 4.47 111.068 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.83 51.55 0.22 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.072 -0.811 . . . . 4.59 111.072 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -76.92 -42.16 40.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.735 0.302 . . . . 6.61 111.068 -176.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.66 -39.95 15.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.268 0.556 . . . . 8.47 110.081 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.283 -1.287 . . . . 9.73 111.14 177.339 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . 0.578 H311 ' HG2' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.715 0.293 . . . . 9.14 110.303 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -80.18 107.2 12.79 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.88 -0.415 . . . . 8.72 109.88 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -121.54 122.24 39.26 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.347 -0.612 . . . . 5.17 109.347 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -143.29 118.38 10.09 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.363 -0.835 . . . . 6.66 110.697 -171.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.73 161.2 26.89 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.398 -0.819 . . . . 1.74 111.55 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' ' 82' ' ' MET . 59.1 t -73.83 -64.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.916 0.358 . . . . 1.14 110.275 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.65 91.64 2.1 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.665 -0.779 . . . . 0.53 111.908 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 12' ' ' LYS . 3.2 m -118.71 157.84 20.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.917 0.389 . . . . 0.39 110.172 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.4 p -83.4 172.89 12.02 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.042 -0.526 . . . . 1.56 110.114 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -67.68 -16.79 64.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.079 0.466 . . . . 2.02 110.349 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -67.18 -46.95 72.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.491 -0.777 . . . . 1.91 109.615 173.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.536 ' HG2' HD21 ' A' ' 60' ' ' LEU . 2.4 mptp? -66.25 -34.4 77.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.774 -0.648 . . . . 1.58 109.931 177.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 17' ' ' MET . 14.7 tp -67.79 -26.88 66.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 0.99 111.192 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.1 -28.83 27.23 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.176 0.513 . . . . 0.88 109.948 177.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -81.67 -30.58 32.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.3 111.297 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.04 -43.07 96.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.828 -0.349 . . . . 0.23 111.177 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.542 ' HG2' ' HE2' ' A' ' 79' ' ' LYS . 45.1 mtt -63.61 -28.6 70.03 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.174 -0.466 . . . . 1.63 110.768 -174.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.662 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 15.3 ptm180 -84.1 -19.48 34.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.896 -0.322 . . . . 3.17 111.725 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.9 t -81.37 -27.97 10.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 122.017 0.913 . . . . 0.23 108.629 172.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.1 t -76.1 -36.11 30.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.458 -1.247 . . . . 0.33 110.294 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.5 p -62.75 -51.48 66.99 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.039 0.447 . . . . 1.38 110.496 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.662 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 9.0 mm-40 -57.35 -52.0 67.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.354 -0.839 . . . . 2.26 111.484 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' HG3' HG12 ' A' ' 50' ' ' ILE . 76.9 mm-40 -72.41 -46.37 55.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.962 -0.563 . . . . 0.77 112.323 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.444 ' HA ' HD11 ' A' ' 42' ' ' ILE . 17.8 m -73.67 -38.38 64.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.827 0.346 . . . . 1.23 111.587 -176.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.15 -2.19 40.64 Favored Glycine 0 N--CA 1.454 -0.124 0 C-N-CA 120.191 -1.004 . . . . 0.54 112.07 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.462 HD11 ' HG3' ' A' ' 40' ' ' MET . 8.0 mt -94.0 123.14 46.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.639 -0.504 . . . . 0.8 109.639 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.543 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -54.14 145.58 16.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.381 -0.372 . . . . 0.57 111.552 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.8 tp -55.02 -36.92 65.98 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.937 -0.574 . . . . 0.97 110.646 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.31 -10.7 59.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.983 -0.553 . . . . 2.23 111.293 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 41.4 mt-10 -116.2 2.06 13.25 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.138 -0.483 . . . . 2.24 110.043 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -75.26 97.34 3.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.164 -0.68 . . . . 1.1 109.164 -178.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.9 p -106.55 154.91 20.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.695 -0.684 . . . . 0.6 109.273 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 57.7 m-20 -76.75 -3.67 39.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.055 0.455 . . . . 2.29 110.951 -176.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.53 -6.25 59.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.498 -0.774 . . . . 2.29 110.413 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.474 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 46.9 m -79.6 150.63 30.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.892 -0.594 . . . . 1.06 110.006 177.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.767 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 19.1 t-20 -125.88 123.25 38.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.253 -0.647 . . . . 0.8 109.253 -175.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.703 ' HD1' HG13 ' A' ' 42' ' ' ILE . 34.1 m-85 -56.37 -48.61 76.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.943 0.401 . . . . 0.47 111.194 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.2 -31.0 68.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.268 -0.424 . . . . 0.46 111.181 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.767 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 32.9 t70 -70.99 -33.24 70.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.331 0.586 . . . . 0.83 110.589 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.462 ' HG3' HD11 ' A' ' 26' ' ' ILE . 15.1 mmt -79.8 -20.27 46.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.407 -0.815 . . . . 2.48 111.37 -176.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.03 32.81 4.23 Favored Glycine 0 C--O 1.229 -0.17 0 C-N-CA 120.271 -0.966 . . . . 0.44 112.5 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.703 HG13 ' HD1' ' A' ' 37' ' ' PHE . 28.5 mm -79.83 107.74 12.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.854 0.359 . . . . 0.52 110.608 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -77.4 174.24 11.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.636 -0.505 . . . . 1.94 109.636 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.688 ' HB3' ' HD2' ' A' ' 69' ' ' PHE . 90.0 p -69.9 -20.77 63.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.443 -0.577 . . . . 1.03 109.443 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.457 ' HA ' H301 ' A' ' 90' ' ' PNS . 3.4 tm? -54.55 -61.99 1.95 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.195 -0.668 . . . . 0.59 109.195 171.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.448 ' O ' HG13 ' A' ' 50' ' ' ILE . 6.3 m -64.7 -39.69 94.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.116 -0.493 . . . . 1.22 110.81 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.455 ' HB2' ' HA ' ' A' ' 44' ' ' SER . 48.8 m -58.93 -40.57 84.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.069 -0.514 . . . . 0.81 111.672 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 45.1 tpp -72.35 -40.33 67.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.265 0.555 . . . . 2.25 109.674 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.506 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 54.6 t -63.51 -50.33 78.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.214 -0.903 . . . . 0.36 110.453 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.463 HG12 ' HG3' ' A' ' 23' ' ' GLU . 77.7 mt -54.05 -54.58 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.684 0.278 . . . . 0.26 110.92 176.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -58.25 -35.82 79.99 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.973 -0.632 . . . . 0.29 112.018 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.482 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -63.47 -46.16 87.47 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.849 -0.206 . . . . 0.92 110.527 174.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 7.1 mtp180 -64.11 -28.0 69.48 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.576 -0.284 . . . . 1.23 111.057 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.562 ' HD2' HD11 ' A' ' 62' ' ' LEU . 12.5 m-30 -56.63 -42.39 78.79 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.477 -0.564 . . . . 0.28 109.477 173.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.482 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 65.1 mtm180 -80.16 -39.21 29.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 2.81 110.635 -176.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.82 -48.61 7.7 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.057 0.392 . . . . 2.26 112.057 -172.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.28 -46.91 14.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.261 -0.427 . . . . 2.62 111.649 -177.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.1 mp -95.7 -23.25 17.08 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.84 0.681 . . . . 0.67 112.84 -173.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.34 32.3 23.0 Favored Glycine 0 CA--C 1.517 0.174 0 C-N-CA 120.793 -0.718 . . . . 0.45 112.664 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.536 HD21 ' HG2' ' A' ' 12' ' ' LYS . 85.4 mt -88.22 120.3 29.45 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.733 -0.275 . . . . 0.63 110.524 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -82.78 82.07 8.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.228 0.537 . . . . 2.27 109.749 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.562 HD11 ' HD2' ' A' ' 54' ' ' PHE . 97.7 mt -89.8 -94.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.692 -0.685 . . . . 1.64 111.356 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 162.55 168.86 25.1 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.892 -0.883 . . . . 0.75 110.892 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.542 ' HG2' ' OE2' ' A' ' 65' ' ' GLU . 73.6 Cg_endo -81.85 -10.24 11.75 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.683 2.255 . . . . 1.13 113.65 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.542 ' OE2' ' HG2' ' A' ' 64' ' ' PRO . 5.3 mp0 -88.77 -0.07 56.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.625 -0.262 . . . . 2.36 111.47 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.75 122.05 40.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.836 0.35 . . . . 0.73 111.441 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.3 t -141.26 124.44 16.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 1.39 110.008 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 mt -56.13 -28.97 59.99 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.977 0.362 . . . . 0.73 111.977 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.688 ' HD2' ' HB3' ' A' ' 44' ' ' SER . 3.2 t80 -67.91 -16.7 64.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.588 . . . . 0.59 110.939 -173.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.1 mt -126.32 -35.93 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.803 0.335 . . . . 0.89 110.997 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -90.48 6.28 44.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.43 -0.35 . . . . 2.23 111.689 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.4 m -154.89 155.91 35.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.1 p -131.06 -73.73 0.54 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.31 -0.405 . . . . 0.67 110.464 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 76.8 p -83.16 -170.87 3.25 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.965 -0.384 . . . . 0.38 109.965 174.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.474 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 0.9 OUTLIER -83.08 -40.67 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 108.555 -0.906 . . . . 0.68 108.555 -177.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 34.0 ttm180 -60.89 -31.5 70.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.402 -1.272 . . . . 3.23 111.238 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.18 -34.88 64.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.819 0.342 . . . . 0.29 110.952 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.552 HD21 ' CE2' ' A' ' 54' ' ' PHE . 0.9 OUTLIER -74.8 -50.7 16.3 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.485 -0.561 . . . . 0.64 109.485 177.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HE2' ' HG2' ' A' ' 17' ' ' MET . 26.1 mmtp -49.21 -53.81 19.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.236 -0.893 . . . . 2.4 110.438 176.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.51 -45.02 62.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.877 -1.056 . . . . 1.66 111.867 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -64.12 -37.86 88.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.014 -0.539 . . . . 0.99 111.838 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.523 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 21.3 mtp -57.21 -49.72 75.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.058 0.456 . . . . 1.1 111.285 -174.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 82' ' ' MET . 5.2 mp -85.01 -31.37 23.51 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.493 -0.558 . . . . 1.3 109.493 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.4 -143.62 39.33 Favored Glycine 0 CA--C 1.511 -0.207 0 C-N-CA 120.98 -0.629 . . . . 2.42 112.124 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.0 m -105.4 36.5 2.48 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.336 0.589 . . . . 4.47 109.987 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.77 31.13 7.53 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.759 -0.655 . . . . 4.59 113.113 -175.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.71 -63.49 1.22 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.325 0.583 . . . . 6.61 110.553 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.82 80.93 1.67 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.391 -0.822 . . . . 8.47 109.643 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.651 -1.083 . . . . 9.73 111.499 -177.364 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . 0.457 H301 ' HA ' ' A' ' 45' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 121.039 0.447 . . . . 9.14 110.11 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -98.84 138.4 36.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.064 -0.717 . . . . 8.72 109.064 173.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.38 131.57 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.578 0.704 . . . . 5.17 111.679 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -148.21 78.36 1.43 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.517 -0.765 . . . . 6.66 108.978 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.72 129.65 3.05 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.973 -0.851 . . . . 1.74 110.973 -170.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.9 t -73.74 -61.59 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.928 0.394 . . . . 1.14 110.896 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.41 76.58 0.95 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.497 -0.641 . . . . 0.53 111.497 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 2.8 m -123.59 160.88 26.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.701 0.286 . . . . 0.39 110.789 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.7 p -92.66 -176.89 4.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.123 -0.695 . . . . 1.56 109.123 171.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -68.34 -23.35 64.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.312 0.577 . . . . 2.02 109.646 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -58.51 -44.07 89.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.333 -0.849 . . . . 1.91 110.602 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.609 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 17.5 mttp -74.29 -24.91 59.32 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.724 -0.671 . . . . 1.58 111.032 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.838 HD13 HD11 ' A' ' 83' ' ' LEU . 19.8 tp -73.45 -30.0 62.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.131 -0.486 . . . . 0.99 110.753 175.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.67 -29.23 45.52 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.238 0.542 . . . . 0.88 109.843 176.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.673 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -81.61 -30.36 32.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.919 -0.582 . . . . 0.3 111.375 -176.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.442 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 5.5 p -68.47 -45.7 81.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.396 -0.522 . . . . 0.23 111.285 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.403 ' HB3' ' HE2' ' A' ' 17' ' ' MET . 73.6 mtp -61.05 -35.24 76.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.997 -0.547 . . . . 1.63 111.285 -175.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 2.7 ptm180 -64.37 -35.8 82.06 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.127 -0.323 . . . . 3.17 110.127 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.45 HG13 ' HD3' ' A' ' 53' ' ' ARG . 53.3 t -76.5 -38.09 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.544 0.688 . . . . 0.23 109.278 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.0 t -65.41 -45.3 93.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.882 -1.054 . . . . 0.33 110.473 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.8 m -60.9 -40.95 95.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.884 0.373 . . . . 1.38 111.614 -176.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 53.1 mt-10 -58.02 -56.76 17.79 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.816 -0.629 . . . . 2.26 111.976 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -76.08 -25.69 55.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.247 -0.433 . . . . 0.77 111.946 -172.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.7 p -81.27 -44.09 18.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.003 0.43 . . . . 1.23 110.3 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.02 16.83 26.96 Favored Glycine 0 C--O 1.229 -0.183 0 C-N-CA 120.924 -0.655 . . . . 0.54 111.619 -176.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.28 123.0 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.796 -0.446 . . . . 0.8 109.796 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.45 143.95 6.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.299 0.481 . . . . 0.57 112.299 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.5 tp -54.5 -37.04 64.85 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.444 -0.798 . . . . 0.97 111.159 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.75 -9.86 58.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.85 -0.614 . . . . 2.23 111.256 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -110.8 -6.33 14.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.072 -0.513 . . . . 2.24 110.927 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.3 tp -71.96 98.25 2.01 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.396 0.617 . . . . 1.1 109.973 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.0 p -107.57 162.42 13.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.32 -0.854 . . . . 0.6 109.079 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.426 ' HB3' ' HB2' ' A' ' 76' ' ' ARG . 80.8 m-20 -76.33 -5.54 47.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.027 0.442 . . . . 2.29 110.782 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -81.51 -22.57 37.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.352 -0.84 . . . . 2.29 111.135 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -81.03 149.9 29.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.667 0.746 . . . . 1.06 111.132 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.591 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 20.8 t-20 -113.7 131.15 56.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.133 -0.939 . . . . 0.8 109.638 -171.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.743 ' HD1' HG13 ' A' ' 42' ' ' ILE . 28.4 m-85 -57.95 -47.31 83.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.851 0.358 . . . . 0.47 111.569 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.26 -31.26 67.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.507 -0.315 . . . . 0.46 111.318 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 15.0 t70 -68.76 -31.81 71.11 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.09 0.472 . . . . 0.83 110.268 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.0 mmt -82.12 -18.97 41.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.548 -0.751 . . . . 2.48 111.882 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.18 28.5 6.1 Favored Glycine 0 C--N 1.321 -0.293 0 C-N-CA 120.275 -0.964 . . . . 0.44 112.441 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.743 HG13 ' HD1' ' A' ' 37' ' ' PHE . 32.9 mm -75.3 108.48 7.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.028 0.442 . . . . 0.52 110.188 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -83.73 178.76 7.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.846 -0.616 . . . . 1.94 110.691 -177.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 t -64.51 -28.04 69.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.437 -0.801 . . . . 1.03 110.006 175.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.69 -62.45 1.45 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.708 -0.678 . . . . 0.59 110.27 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.1 p -64.12 -40.57 96.49 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.448 0.536 . . . . 1.22 112.448 -175.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 60.1 p -64.0 -29.86 70.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.962 0.41 . . . . 0.81 111.071 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.715 ' HG2' ' H32' ' A' ' 90' ' ' PNS . 48.2 tpp -75.86 -36.43 59.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.669 0.747 . . . . 2.25 109.831 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.54 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 56.9 t -71.7 -36.56 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 114.92 -1.036 . . . . 0.36 109.466 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 46' ' ' SER . 88.0 mt -58.4 -50.11 79.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.223 -0.444 . . . . 0.26 110.431 174.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.97 -37.48 85.34 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.099 -0.572 . . . . 0.29 112.352 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.612 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 1.5 t -63.29 -48.32 78.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.843 -0.343 . . . . 0.92 110.343 176.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 43.5 mtp180 -60.69 -32.74 71.96 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.659 -0.246 . . . . 1.23 111.053 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.473 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 10.7 m-30 -53.67 -40.47 65.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.056 0.455 . . . . 0.28 110.124 174.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.612 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 67.4 mtm180 -81.89 -35.89 28.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.883 -0.598 . . . . 2.81 110.957 -175.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.31 -51.08 6.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.983 -0.553 . . . . 2.26 111.593 -170.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -81.74 -49.88 9.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.013 -0.539 . . . . 2.62 110.839 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 mp -85.93 -55.12 4.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.87 -0.605 . . . . 0.67 111.177 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.06 30.18 2.37 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.918 -0.658 . . . . 0.45 112.057 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 59.5 mt -92.0 132.66 36.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.109 -0.33 . . . . 0.63 110.109 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -101.25 92.25 4.88 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.843 0.83 . . . . 2.27 110.681 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -88.07 -73.04 0.5 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.427 -0.806 . . . . 1.64 109.95 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.69 170.14 16.81 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 111.469 -0.652 . . . . 0.75 111.469 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.6 8.41 4.64 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.017 2.478 . . . . 1.13 111.979 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.9 1.03 12.62 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.092 -0.958 . . . . 2.36 110.122 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -89.37 118.91 29.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.947 -0.57 . . . . 0.73 110.951 -175.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.9 t -137.83 123.17 19.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.126 -0.488 . . . . 1.39 110.211 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 90.5 mt -61.01 -37.78 83.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.169 0.509 . . . . 0.73 110.566 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -65.46 -7.06 12.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.542 -0.754 . . . . 0.59 111.05 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.65 -39.08 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 120.827 -0.349 . . . . 0.89 111.618 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -121.35 7.39 10.16 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 120.33 -0.548 . . . . 2.23 112.447 -172.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 66.6 m -147.68 87.7 1.65 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.805 -0.559 . . . . 1.0 110.523 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.5 p -85.47 -33.26 21.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.057 -0.52 . . . . 0.67 112.242 -173.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p -107.19 172.2 6.96 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.189 -0.319 . . . . 0.38 110.61 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.449 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 5.7 t -80.72 -40.05 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 120.678 0.275 . . . . 0.68 111.108 -175.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.426 ' HB2' ' HB3' ' A' ' 33' ' ' ASP . 30.8 ttm180 -61.45 -30.43 70.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 3.23 110.875 176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 81' ' ' PHE . . . -56.94 -32.23 65.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.954 -0.566 . . . . 0.29 111.14 176.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.65 -44.48 18.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 0.64 109.213 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 25.2 mmtp -56.17 -62.11 1.94 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.599 -1.182 . . . . 2.4 111.368 -178.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.93 -23.35 66.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 1.66 110.833 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 77' ' ' ALA . 73.3 t80 -67.68 -41.57 83.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.56 0.695 . . . . 0.99 109.822 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.442 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 1.3 mtm -78.46 -43.11 27.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.158 -0.928 . . . . 1.1 112.292 -176.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.838 HD11 HD13 ' A' ' 13' ' ' LEU . 7.8 mp -74.94 -45.26 43.6 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.838 -0.345 . . . . 1.3 111.546 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.32 133.32 7.4 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.226 -0.988 . . . . 2.42 112.429 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.95 46.18 0.56 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 122.497 0.319 . . . . 4.47 111.519 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.09 -29.78 44.83 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.966 -0.635 . . . . 4.59 113.224 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 67.24 -74.47 0.07 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.983 0.513 . . . . 6.61 111.221 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 61.84 92.19 0.06 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.358 0.663 . . . . 8.47 111.657 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.908 -0.94 . . . . 9.73 111.64 178.365 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . 0.715 ' H32' ' HG2' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.801 0.334 . . . . 9.14 110.513 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.503 ' C ' ' H ' ' A' ' 4' ' ' LYS . 25.3 ptp -95.46 145.26 25.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.053 -0.721 . . . . 8.72 109.053 175.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 72.44 -18.4 0.34 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.271 0.629 . . . . 5.17 111.748 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.503 ' H ' ' C ' ' A' ' 2' ' ' MET . 58.3 tptt -120.81 89.93 3.22 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.245 -1.02 . . . . 6.66 108.245 176.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.78 -169.05 20.84 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.769 -0.932 . . . . 1.74 110.769 -171.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.5 t -80.9 -83.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.955 0.378 . . . . 1.14 110.938 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.8 95.85 1.43 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.469 -0.872 . . . . 0.53 111.346 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -108.88 157.12 9.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.752 -0.379 . . . . 0.39 110.807 -174.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -78.65 171.8 14.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.678 -0.49 . . . . 1.56 109.678 173.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.433 HD22 ' N ' ' A' ' 10' ' ' ASN . 0.9 OUTLIER -72.49 -17.29 61.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.333 0.587 . . . . 2.02 110.258 -175.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -68.78 -44.76 72.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.404 -0.816 . . . . 1.91 109.888 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -70.72 -22.87 62.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.783 -0.644 . . . . 1.58 110.542 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 17' ' ' MET . 2.7 tp -72.26 -27.51 62.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.759 -0.655 . . . . 0.99 110.54 173.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.22 -30.98 34.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.423 0.63 . . . . 0.88 109.383 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.61 -34.25 53.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.074 -0.967 . . . . 0.3 110.861 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.515 HG11 ' SD ' ' A' ' 82' ' ' MET . 2.8 p -66.09 -43.19 92.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.159 -0.473 . . . . 0.23 111.446 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.47 ' HB3' HD23 ' A' ' 31' ' ' LEU . 66.7 mtm -64.23 -30.71 71.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.394 -0.366 . . . . 1.63 111.395 -175.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.687 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 9.1 ptm180 -83.6 -19.28 35.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.949 0.351 . . . . 3.17 111.949 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.1 t -78.43 -32.86 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.827 0.823 . . . . 0.23 108.892 171.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.25 -37.77 72.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.512 -1.222 . . . . 0.33 110.333 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.6 p -61.18 -49.79 75.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.523 0.678 . . . . 1.38 109.779 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.687 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 3.9 mm-40 -59.73 -50.17 74.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.441 -1.254 . . . . 2.26 112.316 -176.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HB2' HG12 ' A' ' 50' ' ' ILE . 60.8 mm-40 -86.96 -9.05 56.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.208 0.447 . . . . 0.77 112.208 -171.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.1 m -95.4 -26.03 16.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.034 0.445 . . . . 1.23 110.279 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.51 -7.23 65.85 Favored Glycine 0 C--N 1.329 0.14 0 C-N-CA 120.488 -0.863 . . . . 0.54 112.652 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mt -91.33 154.43 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 122.568 -0.372 . . . . 0.8 110.014 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.421 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . . . -69.56 142.29 53.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.993 -0.549 . . . . 0.57 110.111 178.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.625 HD11 ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -57.9 -39.32 77.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 0.97 109.899 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -67.76 -15.15 63.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.37 -0.832 . . . . 2.23 111.355 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 33.8 mt-10 -108.68 1.95 21.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.374 -0.376 . . . . 2.24 110.205 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 17' ' ' MET . 27.4 tp -74.68 107.3 6.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.423 -0.584 . . . . 1.1 109.423 175.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.2 p -113.55 162.71 15.85 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.818 -0.808 . . . . 0.6 108.818 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.699 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 5.9 p-10 -79.84 -11.96 59.79 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.654 -0.418 . . . . 2.29 110.526 -179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -84.03 -20.42 32.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.742 -0.663 . . . . 2.29 110.998 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.6 p -66.53 147.41 53.32 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.424 0.631 . . . . 1.06 110.766 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.732 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.5 t-20 -114.17 127.28 55.83 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.147 -0.933 . . . . 0.8 108.89 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.844 ' HD1' HG13 ' A' ' 42' ' ' ILE . 23.9 m-85 -56.58 -50.72 71.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.94 0.4 . . . . 0.47 111.399 -178.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.59 -30.29 68.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.133 -0.485 . . . . 0.46 111.111 -176.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.732 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 28.7 t70 -72.17 -28.82 63.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.926 -0.579 . . . . 0.83 110.478 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.1 mmt -83.24 -22.57 33.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.684 -0.689 . . . . 2.48 111.264 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.32 23.7 6.53 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.673 -0.775 . . . . 0.44 112.445 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.844 HG13 ' HD1' ' A' ' 37' ' ' PHE . 31.9 mm -70.97 108.22 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.223 0.535 . . . . 0.52 111.24 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.9 176.82 9.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.587 -0.733 . . . . 1.94 111.495 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 p -61.1 -39.39 89.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.148 -0.933 . . . . 1.03 110.989 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.605 ' HA ' H302 ' A' ' 90' ' ' PNS . 3.2 tm? -52.55 -59.66 4.19 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.703 -0.68 . . . . 0.59 110.181 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.541 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.2 m -62.2 -42.83 99.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.087 -0.506 . . . . 1.22 110.739 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.517 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 67.3 m -57.49 -37.62 73.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.169 -0.468 . . . . 0.81 111.687 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.661 ' SD ' H303 ' A' ' 90' ' ' PNS . 12.6 ttt -74.3 -40.32 62.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.121 0.486 . . . . 2.25 109.749 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.39 -42.37 96.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.225 -0.898 . . . . 0.36 110.363 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 46' ' ' SER . 88.3 mt -58.48 -55.85 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.26 111.154 177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -63.56 -26.72 69.99 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.769 -0.729 . . . . 0.29 112.224 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -50.4 68.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.585 -0.524 . . . . 0.92 109.585 176.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -64.27 -27.05 68.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.434 -0.348 . . . . 1.23 110.844 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 10.8 m-30 -55.11 -42.53 73.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.406 -0.59 . . . . 0.28 109.406 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -84.32 -36.47 22.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.81 -0.632 . . . . 2.81 111.253 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -85.6 -47.97 9.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.533 -0.303 . . . . 2.26 111.764 -172.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -86.42 -50.36 6.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.364 -0.38 . . . . 2.62 111.268 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.42 -43.35 14.75 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.557 -0.292 . . . . 0.67 111.674 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.16 20.22 11.52 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.907 -0.663 . . . . 0.45 112.327 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.8 mt -77.46 141.96 39.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.474 0.178 . . . . 0.63 110.881 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -106.57 84.98 2.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.085 0.469 . . . . 2.27 110.477 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.515 HD12 ' HE2' ' A' ' 81' ' ' PHE . 2.9 mm? -86.57 -29.84 22.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.567 0.699 . . . . 1.64 109.448 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 126.46 171.48 13.13 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.25 -1.14 . . . . 0.75 110.25 -173.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -85.96 -9.08 7.69 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.821 2.347 . . . . 1.13 113.127 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -125.7 23.6 7.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.055 0.455 . . . . 2.36 111.546 -173.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -82.08 114.4 20.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.04 -0.527 . . . . 0.73 109.796 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.0 m -132.12 117.82 18.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.64 -0.255 . . . . 1.39 110.421 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.73 -39.19 68.01 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 111.994 0.368 . . . . 0.73 111.994 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.517 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 12.7 t80 -62.07 -11.28 13.07 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.331 -0.395 . . . . 0.59 111.694 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 67.6 mt -124.11 -34.67 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.195 0.522 . . . . 0.89 110.92 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -99.28 -11.87 20.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.718 0.636 . . . . 2.23 112.718 -172.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 71.9 m -141.61 165.77 26.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.6 p -135.96 -66.35 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.941 -0.303 . . . . 0.67 111.009 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 69.1 p -87.57 178.37 6.8 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.226 -0.287 . . . . 0.38 110.226 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.479 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 4.6 t -81.86 -35.97 13.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-O 121.078 0.466 . . . . 0.68 111.11 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.699 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 7.7 tpp180 -60.95 -33.64 73.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.787 -0.642 . . . . 3.23 110.77 175.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.61 69.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.745 0.307 . . . . 0.29 111.151 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.735 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.7 OUTLIER -69.08 -48.84 61.66 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.184 -0.672 . . . . 0.64 109.184 175.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -52.68 -61.62 2.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.09 -0.959 . . . . 2.4 110.766 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.55 -39.0 64.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.478 -0.783 . . . . 1.66 111.697 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.515 ' HE2' HD12 ' A' ' 62' ' ' LEU . 75.4 t80 -59.68 -44.85 93.46 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.849 -0.614 . . . . 0.99 110.657 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.735 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 30.1 mtp -62.18 -44.45 96.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.035 -0.53 . . . . 1.1 111.292 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.0 mp -66.17 -15.09 62.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.534 -0.303 . . . . 1.3 111.641 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 127.89 25.72 1.09 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.113 -1.041 . . . . 2.42 114.293 171.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.2 m -82.99 31.65 0.43 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.05 0.925 . . . . 4.47 110.645 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.62 22.87 32.89 Favored Glycine 0 C--O 1.223 -0.553 0 N-CA-C 110.38 -1.088 . . . . 4.59 110.38 176.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.93 -18.38 65.18 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.243 0.617 . . . . 6.61 111.638 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.0 -5.27 59.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.783 -0.644 . . . . 8.47 112.06 -176.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.668 -1.073 . . . . 9.73 112.348 -178.881 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . 0.661 H303 ' SD ' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 120.715 0.293 . . . . 9.14 110.406 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 55.6 tpp -144.33 150.42 37.79 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.143 -0.317 . . . . 8.72 110.143 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.83 142.27 13.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.809 -0.811 . . . . 5.17 108.809 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.705 ' HG3' ' H ' ' A' ' 5' ' ' GLY . 9.1 tppt? 73.22 -170.2 0.13 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.793 0.683 . . . . 6.66 109.77 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.705 ' H ' ' HG3' ' A' ' 4' ' ' LYS . . . -166.73 -141.85 3.27 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.818 -0.706 . . . . 1.74 111.931 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.4 t -95.94 -78.08 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.736 0.303 . . . . 1.14 110.839 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.99 88.49 1.21 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.744 -0.741 . . . . 0.53 111.279 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 m -100.61 156.96 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 122.56 -0.377 . . . . 0.39 110.174 -174.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -87.56 -179.84 6.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.599 -0.519 . . . . 1.56 109.599 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -68.54 -28.2 66.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.187 0.518 . . . . 2.02 110.424 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -64.16 -47.07 81.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.732 -0.667 . . . . 1.91 110.866 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -70.99 -19.26 62.55 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.791 -0.641 . . . . 1.58 110.754 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.534 HD13 HD11 ' A' ' 83' ' ' LEU . 29.8 tp -73.44 -25.13 60.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.816 -0.629 . . . . 0.99 110.804 171.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.35 -31.48 29.8 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.376 0.608 . . . . 0.88 110.038 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.51 -22.64 50.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.647 -0.706 . . . . 0.3 111.062 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 p -78.62 -41.38 24.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.831 0.348 . . . . 0.23 111.143 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 80.7 mtp -59.26 -31.92 69.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 1.63 111.471 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -72.72 -35.97 67.69 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 120.941 -0.303 . . . . 3.17 111.188 178.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.2 t -70.47 -33.56 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.946 0.879 . . . . 0.23 108.951 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.72 -36.75 66.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.469 -1.242 . . . . 0.33 109.605 174.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 t -64.91 -25.43 67.88 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.193 -0.458 . . . . 1.38 110.507 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -82.75 -43.26 16.98 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.987 0.422 . . . . 2.26 111.119 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.571 ' HG3' HG12 ' A' ' 50' ' ' ILE . 49.4 mm-40 -86.69 -23.31 25.63 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.217 0.451 . . . . 0.77 112.217 -174.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.0 m -93.42 -28.7 15.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.646 0.26 . . . . 1.23 111.417 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.47 3.16 78.53 Favored Glycine 0 N--CA 1.458 0.162 0 C-N-CA 120.177 -1.011 . . . . 0.54 112.191 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.0 mt -95.61 112.06 27.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.407 -0.59 . . . . 0.8 109.407 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.05 143.81 2.13 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.538 0.524 . . . . 0.57 111.894 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -52.51 -34.04 47.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.792 -0.64 . . . . 0.97 111.763 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -76.04 -10.56 59.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.253 -0.431 . . . . 2.23 111.048 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -114.38 -6.35 12.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 2.24 110.919 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.5 tp -70.46 99.32 1.58 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.226 0.536 . . . . 1.1 110.192 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.435 ' O ' HG21 ' A' ' 75' ' ' VAL . 80.9 p -116.81 158.9 23.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.687 -0.688 . . . . 0.6 109.305 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' A' ' 76' ' ' ARG . 43.4 m-20 -67.38 -7.05 21.87 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.733 0.301 . . . . 2.29 111.427 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -73.36 -24.56 60.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 2.29 110.776 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.544 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 36.0 m -69.17 146.86 52.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.057 0.456 . . . . 1.06 110.573 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.729 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 21.8 t-20 -129.25 123.38 31.78 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.186 -1.042 . . . . 0.8 108.186 -177.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.843 ' HD1' HG13 ' A' ' 42' ' ' ILE . 36.1 m-85 -56.29 -51.14 69.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.0 0.429 . . . . 0.47 111.614 -174.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.86 -29.17 64.1 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.535 -0.302 . . . . 0.46 111.359 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.729 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 23.5 t70 -72.11 -35.56 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.431 0.634 . . . . 0.83 110.201 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 45.8 mmm -76.15 -23.76 54.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.21 -0.904 . . . . 2.48 111.177 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.26 30.53 5.32 Favored Glycine 0 C--N 1.323 -0.171 0 C-N-CA 120.328 -0.939 . . . . 0.44 112.408 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.843 HG13 ' HD1' ' A' ' 37' ' ' PHE . 29.6 mm -71.52 107.94 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.415 0.626 . . . . 0.52 109.66 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -81.25 165.28 21.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.066 -0.97 . . . . 1.94 110.844 -173.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.3 t -52.17 -38.93 59.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.689 -0.687 . . . . 1.03 111.283 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.0 tm? -57.1 -60.32 3.78 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.13 -0.486 . . . . 0.59 110.38 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.494 ' O ' HG13 ' A' ' 50' ' ' ILE . 12.8 p -65.77 -33.61 76.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.623 -0.262 . . . . 1.22 111.376 -175.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.511 ' HB3' ' H ' ' A' ' 69' ' ' PHE . 50.5 m -61.38 -35.16 76.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.617 -0.265 . . . . 0.81 111.671 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.803 ' SD ' ' H32' ' A' ' 90' ' ' PNS . 21.1 ttt -84.63 -16.84 40.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 2.25 110.522 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.582 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 74.6 t -88.98 -38.96 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 109.836 -0.431 . . . . 0.36 109.836 -177.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.571 HG12 ' HG3' ' A' ' 23' ' ' GLU . 54.3 mt -53.13 -53.46 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.763 0.316 . . . . 0.26 110.235 172.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.21 -25.3 66.33 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.978 -0.63 . . . . 0.29 112.285 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.624 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 2.9 m -75.28 -45.82 37.43 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 122.829 -0.218 . . . . 0.92 111.023 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.582 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 23.7 mtp180 -63.8 -25.66 68.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 1.23 110.765 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.521 ' HD2' HD11 ' A' ' 62' ' ' LEU . 14.1 m-30 -56.99 -40.89 77.42 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 121.184 0.516 . . . . 0.28 109.896 172.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.624 ' HE ' ' HA ' ' A' ' 52' ' ' SER . 71.5 mtm180 -80.48 -30.02 37.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.74 -0.664 . . . . 2.81 110.757 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.35 -61.72 1.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.073 0.463 . . . . 2.26 111.819 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.61 -35.45 18.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.684 -0.689 . . . . 2.62 111.535 -168.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.55 -33.23 11.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.519 -0.309 . . . . 0.67 111.651 -175.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.69 37.94 11.23 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.832 -0.699 . . . . 0.45 112.179 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.499 HD12 ' HB3' ' A' ' 54' ' ' PHE . 88.3 mt -80.56 126.61 31.46 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.779 -0.248 . . . . 0.63 110.772 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -78.24 76.89 4.74 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.845 0.355 . . . . 2.27 110.491 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.521 HD11 ' HD2' ' A' ' 54' ' ' PHE . 68.1 mt -97.77 -77.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.27 0.557 . . . . 1.64 110.857 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.25 170.1 14.0 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.962 -0.855 . . . . 0.75 110.962 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -81.81 -11.21 11.46 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.718 2.278 . . . . 1.13 112.633 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -91.12 6.59 44.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.754 -0.657 . . . . 2.36 111.853 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -93.07 120.03 32.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.927 0.394 . . . . 0.73 111.069 -176.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.1 m -139.89 121.39 15.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 1.39 110.217 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.496 HD12 HD12 ' A' ' 50' ' ' ILE . 52.1 mt -58.81 -31.04 68.08 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.73 111.869 -177.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.511 ' H ' ' HB3' ' A' ' 47' ' ' SER . 1.6 t80 -56.54 -16.26 5.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.858 0.463 . . . . 0.59 111.713 -175.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.9 mt -126.69 -35.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.824 0.345 . . . . 0.89 110.708 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.58 -10.36 49.03 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.575 0.954 . . . . 2.23 113.575 -172.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 75.9 m -150.95 120.21 6.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.248 0.547 . . . . 1.0 110.718 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.3 p -100.34 -51.94 3.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.98 -0.555 . . . . 0.67 110.841 -174.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.1 p -98.19 -175.23 3.06 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.88 -0.328 . . . . 0.38 110.176 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 35' ' ' SER . 1.3 t -79.07 -45.71 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.32 0.581 . . . . 0.68 109.781 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.759 ' HA ' ' HG3' ' A' ' 79' ' ' LYS . 4.3 tpp180 -61.93 -25.77 67.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.418 -0.81 . . . . 3.23 110.996 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.07 -34.67 72.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.71 0.29 . . . . 0.29 110.511 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.699 ' O ' ' HG3' ' A' ' 82' ' ' MET . 0.7 OUTLIER -72.09 -48.68 42.23 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.707 -0.849 . . . . 0.64 108.707 176.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.759 ' HG3' ' HA ' ' A' ' 76' ' ' ARG . 16.2 mmtp -50.59 -56.17 12.97 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.071 -0.968 . . . . 2.4 110.38 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -57.44 -33.61 68.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.726 -1.125 . . . . 1.66 111.423 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -72.17 -34.94 68.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.09 0.472 . . . . 0.99 110.93 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.699 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 38.6 mtp -73.01 -52.9 12.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 1.1 111.487 -176.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.534 HD11 HD13 ' A' ' 13' ' ' LEU . 6.9 mp -71.36 -33.97 70.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.552 -0.294 . . . . 1.3 110.906 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 127.14 119.05 2.22 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.452 -0.88 . . . . 2.42 112.399 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.1 t -83.66 36.86 0.56 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.409 0.623 . . . . 4.47 110.303 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.5 15.03 32.56 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.905 -0.664 . . . . 4.59 112.603 -175.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.99 124.87 34.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.103 -0.332 . . . . 6.61 110.103 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.12 -79.78 0.36 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.267 -0.424 . . . . 8.47 111.999 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.42 -1.211 . . . . 9.73 111.801 -175.429 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . 0.803 ' H32' ' SD ' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.815 0.34 . . . . 9.14 110.214 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.1 mmt -104.21 82.71 1.98 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.485 -0.561 . . . . 8.72 109.485 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.98 142.05 2.79 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.403 -0.362 . . . . 5.17 110.302 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -149.58 129.1 13.06 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.772 -0.455 . . . . 6.66 109.772 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.735 ' HA2' ' HB2' ' A' ' 85' ' ' SER . . . -74.55 126.64 9.25 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.825 -0.702 . . . . 1.74 112.184 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.19 -75.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 110.098 -0.334 . . . . 1.14 110.098 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.36 108.48 1.19 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.549 -0.834 . . . . 0.53 111.283 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.864 ' HB ' ' HB2' ' A' ' 12' ' ' LYS . 4.2 m -108.73 157.44 8.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.947 0.403 . . . . 0.39 110.989 -174.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -85.97 174.7 9.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.355 -0.609 . . . . 1.56 109.355 174.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -21.98 65.29 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.499 -0.926 . . . . 2.02 108.499 176.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.25 -53.02 61.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.863 -1.062 . . . . 1.91 110.799 175.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.864 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 40.7 mmtm -71.16 -23.57 62.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.278 -0.419 . . . . 1.58 110.247 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.43 HD11 ' HD3' ' A' ' 79' ' ' LYS . 14.1 tp -74.9 -26.68 59.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.906 -0.588 . . . . 0.99 110.144 174.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -29.61 27.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.512 0.672 . . . . 0.88 109.751 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.718 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -82.86 -27.04 31.06 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.664 -0.698 . . . . 0.3 111.359 -175.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.55 -44.22 83.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.64 -0.424 . . . . 0.23 111.328 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.2 mtp -64.29 -30.6 71.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.317 -0.402 . . . . 1.63 110.622 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.718 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 30.3 ptt180 -74.2 -27.01 60.6 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.009 -0.276 . . . . 3.17 110.852 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.0 t -83.07 -33.47 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.76 0.791 . . . . 0.23 108.923 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 t -68.01 -34.2 65.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.636 -1.166 . . . . 0.33 110.232 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 49.4 m -58.33 -52.7 64.49 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.029 0.442 . . . . 1.38 110.637 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -54.04 -59.08 5.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.947 -1.024 . . . . 2.26 112.438 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -79.64 -17.49 53.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.89 -0.595 . . . . 0.77 112.566 -167.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -97.75 -35.46 10.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.879 0.371 . . . . 1.23 111.081 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.78 8.14 58.38 Favored Glycine 0 CA--C 1.516 0.111 0 C-N-CA 120.352 -0.928 . . . . 0.54 111.472 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 21' ' ' SER . 8.1 mt -104.38 107.81 23.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.818 -0.438 . . . . 0.8 109.818 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.18 148.87 17.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.57 110.977 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 tp -49.75 -32.79 14.52 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.077 0.551 . . . . 0.97 111.551 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -73.35 -21.92 60.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.344 -0.389 . . . . 2.23 111.527 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -108.95 -1.76 18.79 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.313 0.577 . . . . 2.24 109.686 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.486 ' HA ' HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -76.31 96.73 4.04 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.835 -0.802 . . . . 1.1 108.835 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.7 p -104.56 156.2 18.17 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.454 -0.794 . . . . 0.6 108.934 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.592 ' HB2' ' HD3' ' A' ' 76' ' ' ARG . 7.9 p-10 -74.04 -13.03 60.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.026 0.441 . . . . 2.29 110.534 -176.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -89.04 -22.89 22.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.428 -0.806 . . . . 2.29 111.577 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 m -67.71 149.15 50.36 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.414 0.626 . . . . 1.06 110.366 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.517 ' HB3' ' CB ' ' A' ' 39' ' ' ASP . 3.0 t-20 -109.76 125.23 52.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.531 -0.758 . . . . 0.8 110.592 -171.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.69 ' HD1' HG13 ' A' ' 42' ' ' ILE . 30.6 m-85 -55.01 -50.68 68.43 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.959 0.409 . . . . 0.47 110.893 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.36 -32.19 73.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.98 -0.555 . . . . 0.46 111.591 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.517 ' CB ' ' HB3' ' A' ' 36' ' ' ASN . 16.0 t70 -71.31 -35.49 71.27 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.564 0.697 . . . . 0.83 109.656 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 tpp -76.25 -20.46 57.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.895 -1.048 . . . . 2.48 110.849 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.0 25.24 6.55 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.411 -0.899 . . . . 0.44 112.586 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.69 HG13 ' HD1' ' A' ' 37' ' ' PHE . 27.1 mm -67.61 107.68 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.356 0.598 . . . . 0.52 110.378 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -82.43 170.63 15.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.402 -0.817 . . . . 1.94 110.51 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.6 p -56.85 -40.74 76.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.33 -0.395 . . . . 1.03 110.179 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.27 -53.31 59.61 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.94 -0.573 . . . . 0.59 109.818 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.518 ' O ' HG13 ' A' ' 50' ' ' ILE . 20.6 m -62.62 -42.37 99.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 1.22 110.849 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.539 ' OG ' ' HB2' ' A' ' 69' ' ' PHE . 49.1 m -60.04 -39.06 84.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.81 110.985 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.407 ' HG3' H371 ' A' ' 90' ' ' PNS . 25.7 ttp -67.62 -46.18 73.24 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.544 0.688 . . . . 2.25 109.216 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.457 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 38.6 t -57.87 -55.24 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.417 -1.265 . . . . 0.36 110.618 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 46' ' ' SER . 63.0 mt -50.94 -52.78 16.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.616 0.246 . . . . 0.26 111.251 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 54' ' ' PHE . . . -58.76 -37.15 89.54 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.948 -0.644 . . . . 0.29 112.098 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -44.47 79.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.592 0.234 . . . . 0.92 110.728 177.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 0.8 OUTLIER -67.99 -21.85 65.04 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.013 -0.275 . . . . 1.23 110.318 -177.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 11.7 m-30 -58.86 -43.4 90.82 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.44 -0.578 . . . . 0.28 109.44 170.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -77.59 -28.51 51.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.464 -0.789 . . . . 2.81 110.077 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 53' ' ' ARG . 53.8 mt-10 -71.52 -63.91 1.03 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.224 0.535 . . . . 2.26 111.395 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -87.89 -35.72 17.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.494 -0.775 . . . . 2.62 111.927 -169.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 58' ' ' LEU . 7.8 mp -98.69 -40.06 8.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.812 0.339 . . . . 0.67 111.114 -173.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.16 31.37 7.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.859 -0.686 . . . . 0.45 112.417 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 96.0 mt -81.77 102.15 10.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.742 0.306 . . . . 0.63 110.521 177.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -91.84 69.9 5.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.063 0.459 . . . . 2.27 110.938 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.413 HD13 ' HE2' ' A' ' 81' ' ' PHE . 80.3 mt -88.13 -7.25 57.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.986 -0.552 . . . . 1.64 110.53 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.12 173.99 21.21 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.562 -0.828 . . . . 0.75 111.998 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.56 -8.9 6.01 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.971 2.447 . . . . 1.13 112.471 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -88.0 3.65 48.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.459 -0.791 . . . . 2.36 110.584 -174.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -91.18 120.45 32.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.909 -0.587 . . . . 0.73 110.479 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.4 m -140.18 122.42 15.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.956 -0.565 . . . . 1.39 110.035 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.2 mt -56.04 -46.73 78.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.081 -0.508 . . . . 0.73 111.341 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.539 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.1 t80 -56.58 -12.18 1.66 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.727 -0.669 . . . . 0.59 112.417 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.5 mt -115.22 -40.54 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.793 -0.363 . . . . 0.89 111.489 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -118.32 9.07 12.37 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.361 0.504 . . . . 2.23 112.361 -171.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.8 m -145.1 114.38 7.06 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.7 -0.625 . . . . 1.0 110.085 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.7 p -98.79 -74.21 0.59 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.85 -0.614 . . . . 0.67 110.99 -170.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -83.48 -173.56 4.78 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.981 -0.449 . . . . 0.38 110.59 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 11.7 t -84.16 -38.28 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.756 0.788 . . . . 0.68 109.206 -176.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.592 ' HD3' ' HB2' ' A' ' 33' ' ' ASP . 6.6 tpt180 -57.95 -33.79 69.21 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.252 -1.34 . . . . 3.23 110.443 175.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.89 83.08 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.592 -0.276 . . . . 0.29 111.012 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.764 ' O ' ' HG3' ' A' ' 82' ' ' MET . 1.2 tt -69.92 -49.88 47.6 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.932 -0.766 . . . . 0.64 108.932 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 3.1 mmpm? -53.32 -56.32 17.61 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.044 -0.98 . . . . 2.4 110.853 178.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -56.27 -35.31 67.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.188 -0.915 . . . . 1.66 111.36 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.413 ' HE2' HD13 ' A' ' 62' ' ' LEU . 70.4 t80 -69.92 -35.82 74.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.108 0.48 . . . . 0.99 111.121 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.764 ' HG3' ' O ' ' A' ' 78' ' ' LEU . 32.2 mtp -64.17 -44.17 92.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.042 -0.526 . . . . 1.1 110.97 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 83' ' ' LEU . 5.5 mp -83.46 -40.67 18.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.412 . . . . 1.3 110.63 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.19 81.37 0.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.575 -0.61 . . . . 2.42 111.575 177.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.735 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 12.2 m -79.43 40.37 0.43 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.924 0.393 . . . . 4.47 112.043 -174.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.36 76.02 1.22 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.976 -0.631 . . . . 4.59 111.707 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.2 27.01 0.96 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.383 0.273 . . . . 6.61 110.442 -176.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 61.56 81.68 0.19 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.726 0.641 . . . . 8.47 110.098 -174.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.07 -1.406 . . . . 9.73 111.434 -177.311 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . 0.407 H371 ' HG3' ' A' ' 48' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.796 0.332 . . . . 9.14 111.005 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -117.82 145.67 44.39 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.737 -0.468 . . . . 8.72 109.737 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.41 -13.85 61.97 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.708 0.766 . . . . 5.17 110.584 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -141.77 123.3 15.01 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.589 -1.187 . . . . 6.66 109.192 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.25 -157.58 33.16 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.688 -0.767 . . . . 1.74 112.349 -176.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.46 -71.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.69 -0.485 . . . . 1.14 109.69 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 83' ' ' LEU . . . 83.68 90.44 0.73 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.381 -0.914 . . . . 0.53 111.518 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -109.93 158.26 10.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.664 0.269 . . . . 0.39 110.448 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.2 m -73.25 166.13 23.73 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.239 -0.437 . . . . 1.56 110.324 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -59.82 -27.59 66.74 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 121.526 0.679 . . . . 2.02 109.4 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -50.7 -53.4 31.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.966 -1.016 . . . . 1.91 111.753 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -66.88 -30.35 70.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.205 -0.598 . . . . 1.58 110.242 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.26 -22.9 61.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.99 110.933 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.55 -30.3 25.19 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.131 0.491 . . . . 0.88 110.625 173.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.605 ' O ' ' HG2' ' A' ' 18' ' ' ARG . . . -79.59 -34.13 41.03 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.3 110.867 -177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.487 ' HB ' ' HE1' ' A' ' 82' ' ' MET . 2.9 p -58.11 -36.38 56.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.066 0.46 . . . . 0.23 110.937 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.9 mtm -69.39 -30.11 68.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.814 -0.63 . . . . 1.63 110.945 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 24.6 ptt180 -72.26 -30.79 65.19 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 120.34 -0.544 . . . . 3.17 109.758 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.6 t -79.61 -38.33 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.654 0.74 . . . . 0.23 109.175 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.9 t -62.21 -47.66 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.608 -1.178 . . . . 0.33 110.361 175.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -62.09 -38.88 90.54 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.684 0.253 . . . . 1.38 111.684 -176.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 18.2 mm-40 -62.69 -46.72 86.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.508 -0.314 . . . . 2.26 111.557 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -83.47 -26.18 30.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.366 0.506 . . . . 0.77 112.366 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.438 ' HA ' HD11 ' A' ' 42' ' ' ILE . 78.8 p -84.61 -45.24 12.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 1.23 110.444 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.88 5.64 53.27 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.795 -0.717 . . . . 0.54 112.004 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mt -93.36 132.85 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.718 -0.284 . . . . 0.8 110.275 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 144.68 53.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.293 -0.412 . . . . 0.57 110.979 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -36.51 68.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.909 -0.587 . . . . 0.97 110.48 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -70.38 -14.0 62.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.984 -0.553 . . . . 2.23 110.912 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -107.17 -4.86 18.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.017 -0.538 . . . . 2.24 110.655 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.1 tp -78.82 96.79 5.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.46 0.648 . . . . 1.1 109.873 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.6 p -124.17 167.87 13.68 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.273 -1.01 . . . . 0.6 108.273 177.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.689 ' HB2' ' HB2' ' A' ' 76' ' ' ARG . 2.5 p30 -71.61 -3.22 20.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.853 -0.339 . . . . 2.29 111.409 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -75.68 -20.84 58.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.949 0.404 . . . . 2.29 110.214 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.511 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . 19.4 m -73.33 148.58 43.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.116 0.484 . . . . 1.06 110.214 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 39' ' ' ASP . 2.1 t-20 -128.18 117.38 21.47 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.852 -0.795 . . . . 0.8 108.852 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.809 ' HD1' HG13 ' A' ' 42' ' ' ILE . 30.0 m-85 -52.67 -54.43 33.56 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.979 0.418 . . . . 0.47 111.524 -174.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.21 -25.94 64.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.869 -0.605 . . . . 0.46 111.669 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.759 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . 38.7 t70 -81.53 -20.51 39.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.321 0.581 . . . . 0.83 111.116 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -85.61 -24.38 27.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.856 -0.611 . . . . 2.48 109.9 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.41 13.4 6.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.585 -0.817 . . . . 0.44 112.67 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.809 HG13 ' HD1' ' A' ' 37' ' ' PHE . 25.0 mm -67.82 107.82 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.94 0.4 . . . . 0.52 110.082 176.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -78.74 179.6 7.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.912 -0.586 . . . . 1.94 110.453 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.4 p -57.99 -36.22 72.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.528 -0.76 . . . . 1.03 109.791 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.44 -60.46 3.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.801 -1.091 . . . . 0.59 110.029 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.529 ' O ' HG13 ' A' ' 50' ' ' ILE . 1.3 m -57.72 -47.33 82.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.524 . . . . 1.22 111.353 -177.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.914 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . 50.9 p -65.94 -29.06 69.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.893 0.377 . . . . 0.81 111.298 -176.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.5 tpt -76.31 -35.48 58.8 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.532 -0.544 . . . . 2.25 109.532 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.543 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 37.6 t -65.12 -50.16 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.334 -0.848 . . . . 0.36 109.533 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 46' ' ' SER . 60.2 mt -52.7 -53.26 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.26 111.061 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.12 -41.62 98.18 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.03 -0.605 . . . . 0.29 112.407 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 t -59.62 -44.7 93.36 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.792 0.329 . . . . 0.92 110.707 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 49' ' ' VAL . 56.6 mtp180 -68.14 -20.57 64.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.395 -0.366 . . . . 1.23 111.691 -175.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.579 ' HD2' HD11 ' A' ' 62' ' ' LEU . 15.9 m-30 -59.86 -42.27 93.31 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.37 0.605 . . . . 0.28 109.595 171.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 67.4 mtp180 -74.1 -25.98 60.1 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.184 -0.916 . . . . 2.81 110.196 -177.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -77.82 -63.75 1.31 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.765 -0.652 . . . . 2.26 111.577 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.69 -46.79 10.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.679 -0.692 . . . . 2.62 111.964 -170.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.2 -26.43 25.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.233 -0.44 . . . . 0.67 111.042 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.49 33.28 31.8 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.785 -0.721 . . . . 0.45 112.365 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.613 ' O ' ' HG2' ' A' ' 55' ' ' ARG . 60.2 mt -89.65 104.95 17.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.797 -0.446 . . . . 0.63 109.797 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -85.35 77.87 9.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.707 0.765 . . . . 2.27 109.826 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.579 HD11 ' HD2' ' A' ' 54' ' ' PHE . 30.5 mt -75.77 -73.44 0.26 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.675 -1.148 . . . . 1.64 111.199 -176.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 163.2 154.98 7.9 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.46 -0.791 . . . . 0.75 111.132 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.74 -6.49 14.34 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.392 2.062 . . . . 1.13 112.034 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -103.7 2.08 32.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.589 -0.732 . . . . 2.36 109.948 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -92.48 123.08 35.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.044 -0.526 . . . . 0.73 110.571 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.9 m -137.79 128.45 26.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.056 -0.52 . . . . 1.39 109.976 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.914 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 32.9 mt -56.56 -33.44 66.13 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 120.635 0.255 . . . . 0.73 110.833 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.507 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 24.6 t80 -58.1 -17.48 18.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.045 -0.525 . . . . 0.59 111.633 -174.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.8 mt -125.09 -38.69 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.597 -0.274 . . . . 0.89 111.009 176.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -96.41 4.36 52.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.665 0.617 . . . . 2.23 112.665 -170.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.3 m -155.45 93.94 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.426 0.631 . . . . 1.0 109.577 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.9 p -80.02 -68.61 0.66 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.473 -0.785 . . . . 0.67 109.707 -171.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 36' ' ' ASN . 65.2 p -86.5 -170.52 3.12 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.673 -0.491 . . . . 0.38 109.673 175.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.3 t -81.58 -38.13 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 108.87 -0.789 . . . . 0.68 108.87 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.689 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 5.8 tpt180 -62.97 -30.11 71.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.52 -1.218 . . . . 3.23 110.44 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.19 -34.72 75.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.239 -0.437 . . . . 0.29 110.986 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.535 HD21 ' CE2' ' A' ' 54' ' ' PHE . 1.1 tt -73.89 -47.28 39.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.438 0.637 . . . . 0.64 109.349 177.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 31.3 mmtp -54.91 -46.81 74.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.82 -1.082 . . . . 2.4 110.959 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.59 -48.53 80.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.502 -0.772 . . . . 1.66 111.577 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -55.53 -37.62 68.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.819 -0.628 . . . . 0.99 111.781 -175.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.487 ' HE1' ' HB ' ' A' ' 16' ' ' VAL . 18.7 mtt -54.44 -53.39 54.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 1.1 111.799 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.481 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 5.6 mp -79.52 -37.76 35.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.284 -0.417 . . . . 1.3 109.962 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.23 146.63 13.11 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.646 -0.707 . . . . 2.42 111.404 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.2 m -78.06 33.8 0.19 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.025 0.441 . . . . 4.47 111.451 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.74 48.83 2.54 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.026 -0.607 . . . . 4.59 111.867 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.06 106.71 5.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.116 0.484 . . . . 6.61 110.589 -178.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.18 -53.7 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.533 -0.758 . . . . 8.47 110.037 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.901 -0.944 . . . . 9.73 111.786 179.178 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PNS . . . . . 0.478 H313 ' O35' ' A' ' 90' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_